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12:30 - 13:30 Room E2  
The Beauty of Basic Knowledge: Skeletal Radiology  
MC 26 A  
Plain radiographs: analysis and 
interpretation  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK 
A-001 12:30 
Plain radiographs: analysis and interpretation  
I. McCall; Devon/UK (mccalli832@btinternet.com) 
The radiograph remains a quick and inexpensive imaging modality. Factors to 
evaluate include the thickness and outlines of cortical bone, the density and 
pattern of trabecular bone and the presence or absence of periosteal new 
bone. The position of lesions within the bone, their outline, size and margin and 
whether they are single or multiple also provide important diagnostic 
information. Adjacent soft tissues are affected by many conditions, particularly 
trauma and infection and are integral to image interpretation. While MRI is 
essential for internal joint structures, radiographs demonstrate subchondral 
bones, alignment, erosions and surrounding soft tissues. Knowledge of normal 
radiographic anatomy and variants is essential. In trauma, subtle changes in 
bone alignment, discontinuity of bone outline or alteration in density of 
trabecular bone may indicate injury. Generalised increased or decreased bone 
density indicates imbalance in bone creation or loss due to systemic diseases 
and may be difficult to recognise at an early stage, but is recognisable when 
localised in comparison to the unaffected bone. Localised reduced density may 
result from hyperaemia, disuse or from replacement by cysts and sclerotic 
reaction by trauma and infection, while primary and secondary bone tumours 
may result in either response. Other features including cortical expansion or 
scalloping and marginal bone response internal calcification will refine the 
diagnosis. Periosteal new bone in differing patterns results from local insult or 
more generalised metabolic and haemodynamic changes, while soft tissue 
swelling, muscle and ligament outline alterations and presence of calcification 
provide vital clues to disease recognition and diagnosis.  
Learning Objectives:
1. To learn about the current role of plain radiographs. 
2. To appreciate the strengths and weaknesses of plain radiographs in 
musculoskeletal disease. 
3. To understand methods for analysing radiographic abnormalities and an 
approach to their correct interpretation. 
12:30 - 13:30 Room F1  
The Beauty of Basic Knowledge: Interventional Radiology  
MC 25 A  
Needles and samples: a practical 
approach to image-guided biopsy  
Moderator:  
M. Bezzi; Rome/IT 
A-002 12:30 
Needles and samples: a practical approach to image-guided biopsy  
M. Bezzi; Rome/IT (mario.bezzi@uniroma1.it) 
Percutaneous needle biopsy has been a mainstay of oncologic diagnosis for 
almost three decades, since the advent of ultrasound and CT. The basic 
principles of fine-needle aspiration and core needle biopsy can be applied to 
almost any site in the body, with subtle differences in technique depending on 
the organ being investigated and the imaging modality utilised. While 
excisional biopsy is still appropriate in certain cases, percutaneous needle 
biopsy has become the standard of care in the diagnosis of most tumors 
throughout the body and is also used to diagnose noncancerous conditions, 
such as infection. Percutaneous biopsy is also beneficial in the staging of 
patients with cancer, particularly when another treatment method may be more 
appropriate than surgical resection. The advantages of percutaneous biopsy 
over surgical excisional biopsy include time and cost savings and reduction in 
morbidity. The aim of this course is to discuss the practical aspects of biopsy, 
needle selection, and guidance techniques and to show how to approach 
difficult lesions and avoid complications.  
Learning Objectives:
1. To understand the indications for percutaneous image-guided biopsy. 
2. To learn about the practical aspects of biopsy, needle selection and 
guidance techniques. 
3. To learn how to approach difficult lesions and avoid complications. 
14:00 - 15:30 Room C  
Interactive Teaching Session  
E³ 220  
The treated breast: what you need to know  
A-003 14:00 
A. Imaging after treatment of breast cancer  
M.H. Fuchsjäger; Graz/AT (michael.fuchsjaeger@medunigraz.at) 
Imaging after treatment of breast cancer is for confirmation of lesion removal, 
identification of postprocedural fluid collections, detection of residual or 
recurrent cancer and screening for metachronous cancers. Posttherapy 
changes - which include fluid collections, edema, skin thickening, architectural 
distortion, scarring and calcifications - are mainly due to surgery, axillary 
dissection and radiotherapy. The greatest treatment-related changes occur 6-
12 months after therapy, and mammographic stability is achieved after two to 
three years. For mammography, pre- and all posttherapeutic images have to 
be compared. Ultrasound is the method of choice for evaluation of fluid 
collections. MRI is for problem solving (i.e. differentiation between scar and 
relapse) and should not be performed prior to 12 months after therapy to avoid 
false-positive diagnoses. Dystrophic calcifications may develop in areas of fat 
necrosis mimicking malignancy. Fat necrosis predominantly occurs at the 
treated site; however, it can develop anywhere in the ipsilateral breast. Its 
appearance may be indistinguishable from cancer at all imaging modalities. To 
differentiate between fat necrosis and other common post-treatment changes 
from relapse, it is important to know the timeline when these changes occur 
and schedule follow̻up imaging accordingly. Mammography serves as the 
basis for postoperative surveillance. Ultrasound is helpful in the early 
postoperative phase, whereas MRI is the method of choice, especially for 
differentiation of scar and relapse in the later postoperative phases.  
Learning Objectives:
1. To understand common features related to breast surgery. 
2. To recognise changes related to non-surgical treatments. 
A-004 14:45 
B. Imaging after treatment of benign breast conditions  
J. Camps Herrero; Valencia/ES (juliacamps@gmail.com) 
Breast radiologists need to be familiar with post-treatment imaging findings in 
patients with breast cancer, but often patients are also imaged after a 
diagnosis of benign entities which are treated surgically (fibroadenomas, radial 
scars, papillary lesions) or after a percutaneous diagnosis of a high-risk lesion 
which has undergone a surgical biopsy to avoid underestimation (atypical 
ductal hyperplasia, lobular neoplasia or flat epithelial atypia). These 
procedures will leave an imprint on the breast which can be a cause of concern 
due to the surgical scar. Furthermore, imaging findings after plastic surgery for 
mastopexy, reduction mastoplasties, implants or auxiliary techniques 
(lipofilling, hyaluronic acid) are becoming frequent in our daily practice and 
have their peculiarities that can overshadow breast cancers. Interventional 
percutaneous procedures can also be a cause of tissue distortion. There are 
advanced systems for biopsy (BLES) and for percutaneous removal of benign 
lesions (fibroadenomas, papillomas), which use large-gauge needles and have 
to be accounted for due to their trace in the breast tissue.  
Learning Objectives:
1. To understand common features related to breast surgery. 
2. To recognise changes related to non-surgical treatments. 
Author Disclosure:
 J. Camps Herrero: Advisory Board; Bayer. Speaker; Bayer. 
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16:00 - 17:30 Room B  
GI Tract  
RC 301  
Cross-sectional imaging of colitis  
A-005 16:00 
Chairman's introduction  
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk) 
Cross-sectional imaging is playing an increasing role in the diagnosis, staging 
and follow-up of colitis. Often, the radiologist diagnoses colitis on cross-
sectional imaging, and the clinician requires the most likely diagnosis. 
Alternatively, imaging is used to assess the severity of a known colitis and 
monitor treatment response. This session will describe state-of-the-art 
protocols for assessing the inflamed colon using CT, MRI and USS. The 
common aetiologies of colitis will then be discussed and tips and tricks as to 
how to limit the differential diagnosis presented. Finally, the role of cross-
sectional imaging in the management of inflammatory bowel disease (IBD) will 
be described with emphasis on disease activity. An integrated approach to 
imaging patients with colonic IBD will be presented.  
Author Disclosure:
 S.A. Taylor: Grant Recipient; NIHR HTA. Other; Study reader for Robarts. 
A-006 16:05 
A. Which protocol to use?  
S. Schmidt; Lausanne/CH (sabine.schmidt@chuv.ch) 
The role of cross-sectional imaging in the diagnosis of colitis is increasing 
following recent technologic advances. Prior colonic cleansing is usually not 
required, unlike in CTC. However, careful attention to the examination 
technique is essential, since collapsed colon may suggest colonic wall 
thickening, thus mimicking colitis. When using CT or MRI, adequate luminal 
distension is necessary, while this is optional in US where direct compression 
of the bowel aids diagnosis. Recommended imaging protocols will be 
discussed. CT remains the workhorse for imaging suspected colitis, especially 
in emergency settings. It is widely available and facilitates rapid data 
acquisition with excellent spatial resolution. Intravenous contrast medium 
administration can reveal the typical target sign of colitis, which can easily be 
differentiated from other wall patterns, such as diffuse enhancement seen in 
cancer. MRI does not expose patients to radiation and provides excellent 
tissue contrast facilitating the detailed analysis of the inflamed colonic wall. 
Both conventional and diffusion-weighted sequences provide functional non-
invasive assessment of the severity of colitis and monitoring of treatment 
responses, essential in Crohn patients. Colonic US is safe, well tolerated and, 
in general, freely available, although it requires specific operator expertise. It 
simultaneously provides morphological and functional information. Absent 
peristalsis and wall thickening in acute colitis usually reduce intraluminal air, 
thus facilitating colonic assessment compared to healthy subjects. Akin to CT 
and MRI, the three colonic wall layers are differentiated and pericolonic 
findings can be assessed. However, US can be limited by the patient's body 
habit and the radiologist's practical experience.  
Learning Objectives:
1. To become familiar with the role of colonic distension prior to imaging of 
suspected or known colitis. 
2. To understand typical CT, MRI and US protocols. 
3. To learn about the pros and cons of CT, MRI and US. 
A-007 16:28 
B. Differentiating between the causes of colitis  
B. Gallix; Montreal, QC/CA (b-gallix@chu-montpellier.fr) 
The final diagnosis in determining the type of colitis is based on clinical and 
laboratory data and colonoscopic and biopsy findings. However, information 
provided by endoscopy is limited to the mucosal surface. Cross-sectional 
imaging techniques, such as ultrasound, computed tomography, and magnetic 
resonance, are widely used to assess patients with non-specific abdominal 
pain and are gaining acceptance for the assessment of patients with suspected 
acute or chronic colitis. Cross-sectional studies are useful, alternative tools not 
only in the assessment of bowel wall abnormalities, but also for the 
assessment of extraluminal alterations. Differentiating between the causes of 
colitis is based on the location of involvement, extent and appearance of 
colonic wall thickening, extraluminal changes, and type of complications 
encountered. When chronic inflammatory colitis is suspected, imaging helps to 
distinguish ulcerative colitis from Crohn's colitis. Infectious types of colitis share 
the features of wall thickening, pericolonic stranding, and various degrees of 
ascites according to the severity of the disease. Pseudomembranous 
colitisdemonstrates marked wall thickening and, occasionally, skips areas, but 
is associated with broad-spectrum antibiotic treatment or chemotherapy. 
Neutropeniccolitis is characterised by right-sided colonic and ileal involvement, 
whereas ischaemic colitis is characterised by a vascular distribution pattern 
and history. Diverticulitis is a focal, asymmetric process with fascial thickening 
and inflamed diverticula. The diagnosis of ischaemic colitis is suspected when 
the distribution of the colon wall involvement follows the vasculature. The 
ischaemic changes are commonly segmental, especially in the left colon in 
elderly patients.  
Learning Objectives:
1. To learn about the most common cause of colitis through cross-sectional 
imaging in both immune-competent and immune-compromised patients. 
2. To become familiar with differentiating infectious, inflammatory, ischaemic 
and autoimmune conditions based on cross-sectional imaging criteria. 
3. To understand the limitations of cross-sectional imaging in differentiating 
between its causes. 
A-008 16:51 
C. The role of cross-sectional imaging in colonic inflammatory bowel 
disease  
J. Rimola; Barcelona/ES (jrimola@clinic.ub.es) 
Endoscopy is currently considered the reference standard for the evaluation of 
colonic disease activity in patients with inflammatory bowel disease (IBD). 
However, it only allows evaluation of the mucosal surface and is not always 
complete. It cannot, therefore, help to estimate the depth of involvement of 
transmural inflammation and extraluminal complications, both characteristics of 
IBD. An evolving role for cross-sectional imaging in the evaluation of patients 
with IBD is increasingly recognised, especially in the setting of Crohn's disease 
(CD) since the cross-sectional imaging has been demonstrated to have a high 
diagnostic accuracy not only for assessing the presence and extension of 
luminal disease, but also for evaluating the CD-related acute or chronic 
complications. Available evidence suggests that ultrasound, computed 
tomography and magnetic resonance have similarly high diagnostic accuracy 
in the detection of disease activity, location, severity and complications: in 
particular, the penetrating and stricturing lesions which are characteristic of 
CD. Thus, the choice of the technique for assessing CD may be influenced by 
local availability or expertise. In the case of ulcerative colitis, cross-sectional 
imaging, although less evaluated, may also be helpful in certain circumstances. 
There is evidence indicating that cross-sectional imaging is an alternative 
problem-solving tool to endoscopy whenever tissue sampling is not required 
and can provide valuable guidance for performing medical and surgical 
treatment with maximised efficacy and safety. Overall, findings from cross-
sectional imaging accurately reflect disease activity and provide reliable 
information for decision-making and patient care optimisation.  
Learning Objectives:
1. To learn about optimised examination protocols for ulcerative colitis and 
colonic Crohn's disease in the acute, subacute and chronic disease setting. 
2. To become familiar with the criteria for the assessment of disease activity 
through CT, MRI and ultrasound. 
3. To learn about an integrated approach to the use of cross-sectional imaging 
in colonic inflammatory bowel disease. 
Panel discussion:  
The role of cross-sectional imaging in the diagnosis and follow-up of 
colitis  17:14
16:00 - 17:30 Room C  
Interactive Teaching Session  
E³ 320  
The treated liver  
A-009 16:00 
A. Imaging of liver transplantation  
J.B. Karani; London/UK (johnbkarani@hotmail.com) 
Liver transplantation is the accepted treatment of patients with irreversible liver 
cell failure and some metabolic disorders and in a selected group of patients 
with hepatocellular carcinomas. Over the last decade, major transplant centres 
have reported improving survival rates, though during this period they have 
developed more complex surgical techniques, including split-liver, auxiliary and 
live-related transplantation, and have treated more marginal higher risk 
patients. This successful outcome has been dependent on appropriate 
recipient selection, robust surgical technique, improvements in 
immunosuppression and intensive care management and the prompt 
recognition and treatment of complications. Diagnostic and interventional 
radiology have been core specialties in achieving the goals of improved graft 
and patient survival. Improvement in surgical techniques has decreased the 
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more common vascular and biliary complications, but the newer techniques 
present differing diagnostic and interventional challenges, particularly in 
paediatric recipients. Developments in MR and MDCT allow many of these 
vascular, biliary and infective complications to be diagnosed non-invasively. 
Vascular techniques of angioplasty and stent placement may reverse the 
sequel of graft ischaemia or portal hypertension. MRC allows the diagnosis of 
biliary strictures that may be treated by dilatation or stent placement. Imaging 
is also important in the diagnosis of recurrent disease and the acquired 
diseases of prolonged immunosuppression including atypical infections and the 
post-transplant lymphoproliferative disorders (PTLD). This interactive session 
will present these appearances by case example and provide guidance of the 
appropriate diagnostic and treatment paradigm.  
Learning Objectives:
1. To understand the common imaging findings after liver transplantation. 
2. To recognise significant complications following liver transplantation. 
A-010 16:45 
B. Imaging of treated liver tumours  
I. Bargellini; Pisa/IT (irenebargellini@hotmail.com) 
Imaging findings after systemic and loco-regional treatments vary greatly 
depending on baseline features of the treated tumour and treatment modality. 
Conventional uni-dimensional and bi-dimensional criteria (such as RECIST 1.1 
and WHO criteria) have been extensively validated in metastatic lesions 
treated with conventional chemotherapy. However, their prognostic value is 
limited in patients treated with new molecular targeted therapies and after loco-
regional treatments. In the setting of hepatocellular carcinoma (HCC), specific 
response criteria (such as EASL and mRECIST) have been proposed that take 
into account variation in the size of the viable tumour. These criteria have been 
extensively validated, although their interpretation could be troublesome after 
some specific treatments, such as molecular targeted agents and Y90-
radioembolisation. On the other hand, there is no consensus regarding tumour 
response criteria for metastatic lesions after loco-regional treatments. The role 
of morphological criteria and several imaging biomarkers (such as those 
provided by diffusion and perfusion imaging, FDG activity, dual source CT) is 
under investigation, being able to provide additional information on tumour 
activity and biology. While new drugs with different mechanisms of action and 
new treatments are becoming available, the work of radiologists is changing 
and there is increasing evidence that tailored radiological response criteria are 
required for these new targeted and tailored treatments.  
Learning Objectives:
1. To understand the common imaging findings after chemotherapy for liver 
tumours. 
2. To recognise common imaging findings after radiofrequency ablation of liver 
tumours. 
3. To be aware of the common imaging findings following transarterial 
treatment of liver tumours. 
16:00 - 17:30 Room D  
Chest  
RC 304  
Pulmonary vasculitis and systemic 
diseases  
Moderator:  
A. Persson; Linköping/SE 
A-011 16:00 
A. Pulmonary manifestations of systemic diseases  
C. Engelke; Göttingen/DE 
"No abstract submitted" 
Learning Objectives:
1. To learn about the different systemic diseases that affect the lung. 
2. To become familiar with pulmonary abnormalities due to systemic disease. 
A-012 16:22 
B. Large-vessel vasculitis  
J. Vilar; Valencia/ES (vilarsamper@gmail.com) 
Pulmonary vasculitides are a challenge for radiologists for two reasons: 
vasculitides are rare diseases and at the same time the pathologic and 
radiological manifestations are very diverse. Primary vasculitides present with 
different clinical scenarios and often confusing situations that mimic other 
diseases. By definition, vasculitides are disorders affecting the blood vessels 
that may be primary or secondary. Classification of vasculitis according to the 
vessel size is practical, since it is related to the pathological changes as well as 
to the clinical and radiological presentation. The two main large vessel 
vasculitides are giant cell arteritis and Takayasu arteritis. Behcet disease may 
combine large and small vessel vasculitis. Imaging plays an important role in 
primary vasculitis. Chest radiographs are not especially useful in large vessel 
vasculitis. Contrast CT and MRI further detect and especially help in the 
characterisation of large vessel vasculitis. Vessel wall changes are well 
detected with both techniques. Contrast enhancement, distribution of vessel 
involvement and morphological vascular changes should be considered. 
Today, PET/CT is the recommended imaging technique in the assessment of 
vessel wall inflammatory changes and in the evaluation of treatment response. 
Although the clinical scenario differs usually between Takayasu and giant cell 
arteritis, the radiologist should combine the imaging findings with clinical and 
laboratory data to suspect a specific vasculitis. Therefore, this presentation will 
concentrate on the basic signs and associated findings in large vessel 
vasculitis, pathologic correlation, imaging protocols and the differential 
diagnosis.  
Learning Objectives:
1. To learn about the different types of large-vessel vasculitis. 
2. To become familiar with histopathological correlates in vasculitis. 
3. To appreciate the different manifestations and imaging appearances of 
large-vessel thoracic vasculitis. 
A-013 16:44 
C. HRCT patterns in pulmonary vasculitis  
C.M. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
The term vasculitis refers to a variety of clinico-pathological entities. The most 
widely used Chapel-Hill classification divides the vasculitis syndromes into 
three groups based on the size of vessels primarily involved. Small vessel 
vasculitis such as ANCA- associated granulomatous vasculitis (Wegener's 
disease), Churg-Strauss granulomatosis and microscopic polyangitis are most 
often associated with pulmonary abnormalities. The spectrum of HRCT findings 
is quite variable and differs by entity. The HRCT findings will be discussed 
together with clinical and laboratory findings to be integrated into a 
multidisciplinary diagnostic approach. The typical findings in Wegener's 
granulomatosis include solitary or multiple, often cavitary nodules or masses, 
or focal or diffuse consolidations, Churg Strauss is dominated by interlobular 
thickening or transient multifocal and nonsegmental consolidations frequently 
in subpleural distribution. All types of pulmonary vasculitis may present with 
focal or diffuse pulmonary haemorrhage that produces pulmonary ground glass 
or consolidations in various distributions. A number of collagen vascular 
diseases (e.g., lupus erythematosus) or other granulomatous diseases (e.g. 
sarcoidosis) may affect the small pulmonary vessels causing haemorrhage or 
pulmonary hypertension. Per disease entity, the course will review typical and 
more rare HRCT features and key features that allow for diagnosis and 
classification, discuss side-to-side overlapping of morphologic features 
important for differential diagnosis and illustrate the findings of other diseases 
that represent the most challenging differential diagnosis, e.g. oedema, 
infection or malignant diseases.  
Learning Objectives:
1. To learn when HRCT is of value in investigating pulmonary vasculitis. 
2. To appreciate the different appearances of pulmonary vasculitis on HRCT. 
A-014 17:07 
D. Inflammation and remodeling  
A.A. Bankier; Boston, MA/US (abankier@bidmc.harvard.edu) 
The presentation will lay out the pathological and pathophysiological basis for 
the complex processes of inflammation and remodelling. The implications of 
these processes for imaging will be discussed and illustrated by selected 
pathologies. Finally, the presentation will indicate how the imaging reflections 
of these processes could be used in the future as imaging biomarkers for the 
diagnosis, follow-up, and outcome evaluation of disease.  
Learning Objectives:
1. To learn about the different causes of pulmonary inflammation. 
2. To understand how the lung responds to inflammation. 
3. To become familiar with pulmonary changes following inflammation. 
Author Disclosure:
 A.A. Bankier: Author; Elsevier. Consultant; Olympus. Research/Grant 
Support; NIH. Speaker; ATS. 
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16:00 - 17:30 Board Room B  
Cardiac  
RC 303  
Hybrid cardiovascular imaging: where 
should we go?  
Moderator:  
K. Gruszczynska; Katowice/PL 
A-015 16:00 
A. PET/CT: present state and future prospects  
M. Schwaiger; Munich/DE (markus.schwaiger@tum.de) 
Multimodal cardiac imaging with PET/CT has gained increasing clinical 
acceptance, since the combination of structural definition of coronary anatomy 
as well as quantification of regional myocardial perfusion allows very 
comprehensive workup of patients with suspected coronary artery disease. 
Independently of detection of coronary artery disease the quantification of 
regional and global myocardial perfusion has to be shown of prognostic value. 
The combination of extent of coronary artery disease as well as restriction of 
macro and micro circulation provides an integrative measure of the ischemic 
burden to patients with known or suspected coronary artery disease. The 
diagnostic and prognostic value of this combined PET/CT approach competes 
successfully with invasive diagnostic workup. However, there are no 
prospective randomised studies to document the relative value of invasive vs 
non-invasive strategies in the workup of patients with coronary artery disease, 
which has to be related to patient workup.  
Learning Objectives:
1. To become aware of the present state of PET/CT in cardiovascular imaging. 
2. To become familiar with appropriate indications for PET/CT studies of the 
heart. 
3. To learn about technical innovations in PET/CT imaging. 
Author Disclosure:
 M. Schwaiger: Consultant; Navidea. Research/Grant Support; Siemens PET. 
A-016 16:30 
B. SPECT/CT: is it just PET/CT's little brother?  
M. Hacker; Vienna/AT (marcus.hacker@meduniwien.ac.at) 
Appropriate diagnosis and therapy of coronary artery disease (CAD) frequently 
require information about both the morphological and functional status of the 
coronary artery tree. Thus, combined imaging consisting of invasive coronary 
angiography (ICA) plus SPECT myocardial perfusion imaging (MPI) is 
practiced in clinical routine diagnostic of patients with stable angina since many 
years and can therefore be accepted as the reference standard in the 
diagnosis of hemodynamically relevant coronary artery stenoses. Both 
morphological and functional information are mandatory for the decision of 
performing an interventional therapy or initiating/maintaining medical treatment 
in numerous symptomatic patients. The hemodynamically relevance of 
coronary artery lesions is a major condition to decide whether an interventional 
therapy should be performed or not. A non-invasive concept providing both 
information could provide accurate allocation of perfusion defects to their 
determining coronary lesion and specific morphological and functional 
classification of patients with coronary artery disease. In symptomatic patients, 
a normal stress MPI confers a very low short-term risk for cardiac death and/or 
acute myocardial infarction. However, a normal MPI does not exclude the 
presence of underlying coronary atherosclerosis, which may be extensive 
although not yet flow-limiting. In this regard, CT will unmask a sizeable 
subgroup of patients with coronary atherosclerosis who should receive more 
intensive antiatherosclerotic intervention than would have been indicated by 
MPI results alone. Knowledge regarding the presence and extent of subclinical 
coronary atherosclerosis in patients who do not have ischemia by MPI can be 
of importance in patient management.  
Learning Objectives:
1. To appreciate the scope of information a SPECT/CT cardiac study can 
deliver. 
2. To become familiar with protocols of SPECT/CT studies. 
3. To learn a structured approach to performing and reporting a SPECT/CT 
study. 
A-017 17:00 
C. MR/PET: do we really need it?  
H.H. Quick; Erlangen/DE (Harald.Quick@imp.uni-erlangen.de) 
Following PET/CT and SPECT/CT, MR/PET hybrid imaging is the most recent 
addition to the palette of hybrid imaging modalities. MR/PET synergistically 
combines the excellent soft tissue contrast and detailed image resolution of 
MR with metabolic information provided by PET. Integrated MR/PET systems 
furthermore offer the ability to acquire hybrid imaging data simultaneously. This 
can be applied to MR-based motion correction of PET data. These features 
open up several cardiac applications, e.g. evaluation of cardiac function and 
viability, diagnosis of cardiac inflammatory diseases and tumorous diseases. 
To fully assess the diagnostic potential of MR/PET, however, several technical 
challenges have to be considered: attenuation correction (AC) of the patient 
tissues in MR/PET has to be based on MR-images and is currently hampered 
by a limited number of tissue classes and undercorrection of bone tissue. 
Cardiac radiofrequency coils and ECG gating equipment are currently not 
considered in AC. Consequently, quantification of PET data therefore might be 
biased. The clinical workflow is rather complex and needs to be tailored to 
cardiac examinations. Few research groups currently explore this new hybrid 
imaging modality in selected cardiac applications. Cardiac MR/PET: Do we 
really need it? Considering the sparse clinical experience that is available 
today, it is quite early to answer this question yet. However, once the 
remaining technical hurdles are overcome and the diagnostic potential can be 
fully exploited clinically, the answer is most likely positive.  
Learning Objectives:
1. To learn about technical requirements for performing cardiac PET/MRI 
studies. 
2. To learn if cardiac PET/MRI can be successfully performed in clinical 
routine. 
3. To become familiar with the principal advantages/disadvantages of PET/MRI 
compared to other hybrid imaging technologies. 
Author Disclosure:
 H.H. Quick: Equipment Support Recipient; The Biograph mMR sytsem at the 
Institute of Medical Physics, Erlangen, was funded by a research agreement 
between the University of Erlangen and Siemens AG, Healthcare Sector, 
Erlangen. 
16:00 - 17:30 Room E1  
Molecular Imaging  
RC 306  
Functional and multimodality 
neuroimaging
Moderator:  
O. Clément; Paris/FR 
A-018 16:00 
A. Clinical applications of PET/CT in neurology  
A.H. Jacobs; Münster/DE 
Positron Emission Tomography (PET) is being used together with various 
radiotracers to investigate alterations of metabolism and neurotransmission in 
various neurological diseases. Target structures for PET imaging comprise 
neurons (e.g. glucose or oxygen consumption; enzyme activity; receptor 
density); glial and endothelial aminoacid transporters; microglial function; and 
interstitial protein deposits. Together with MRI, PET helps to delineate (i) the 
penumbra in stroke; (ii) inflammatory activity in multiple sclerosis; (iii) 
epileptogenic foci in epilepsy; (iv) protein deposits and altered glucose 
consumption in Alzheimer‘s disease; (v) altered dopaminergic transmission in 
Parkinson‘s disease; and (vi) increased uptake of radiolabeled amino acids in 
gliomas. The lecture will outline the additional value of PET/CT imaging in the 
various most common neurological diseases to specifically increase the 
diagnostic accuracy and to help in the establishment of imaging-guided therapy 
paradigms. In addition, an outlook will be given from the clinical research 
programme of the 7th FW EU INMiND project (Imaging Neuroinflammation in 
Neurodegenerative Diseases; http://www.uni-muenster.de/InMind/). 
Learning Objectives:
1. To become familiar with the role of PET/CT in neurology. 
2. To learn about radiotracers that can be used in neuroimaging. 
3. To understand PET/CT applications in relationship to disease presentations. 
Author Disclosure: 
A.H. Jacobs: Grant Recipient; 7th FW EU Programme QuicConcept and 
INMIND 




B. MR/PET changes and challenges  
B.J. Pichler; Tübingen/DE 
"No abstract submitted" 
Learning Objectives:
1. To understand the fundamentals of MR physics relevant to MR/PET 
imaging. 
2. To appreciate the advantages of MR/PET and its complementary role in 
diagnostic neuroimaging. 
3. To learn about the benefits and challenges of combined MR/PET. 
A-020 17:00 
C. Advanced MR neuroimaging techniques  
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl) 
Functional MR imaging (fMRI) and diffusion tensor imaging (DTI) are used 
extensively in the research arena to study an infinite number of questions 
regarding the brain's function and structure under normal conditions, as well as 
with neurological and psychiatric disease. The clinical use of these techniques, 
however, is by comparison fairly limited. The current main indication is the 
presurgical assessment of the relationship between the brain tissue to be 
resected and functionally eloquent brain tissue. In the context of brain tumour 
surgery, the aim is maximum tumour resection, while at the same time avoiding 
functional deficit. With tumour localisation in or near presumed eloquent brain 
areas, such as the motor or language areas, additional fMRI and DTI may be 
advantageous to guide the neurosurgical approach, shorten surgery duration 
and obtain prognostic information prior to surgery. fMRI is used to localise 
eloquent cortex, which is particularly useful when normal anatomy is obscured 
by tumour mass effect or in cases of cortical plasticity. With DTI the anatomy 
and involvement of white matter tracts may be evaluated. Inadvertent 
transection of white matter tracts during surgery leads to severe neurological 
deficit. DTI-tractography offers attractive visualisation of the major white matter 
tracts, such as the corticospinal tract and the arcuate fasciculus, and offers 
valuable preoperative information on their relationships with the brain tumour to 
be resected. As well as providing such anatomical information, colour-coded 
eigenvector maps obtained with DTI can be used to categorise involvement of 
the white matter tracts by brain tumour.  
Learning Objectives:
1. To learn about functional MR imaging (fMRI) and diffusion tensor imaging 
(DTI). 
2. To understand the application of these techniques in the study of the healthy 
and diseased human brain. 
3. To learn about the brain's activity and its connections. 
16:00 - 17:30 Room E2  
Multidisciplinary Session: Managing Patients with Cancer  
MS 3
Multidisciplinary approach for detection 
and treatment of malignant primary bone 
tumours
A-021 16:00 
Chairman's introduction  
K. Verstraete; Ghent/BE (koenraad.verstraete@ugent.be) 
Malignant bone tumours are rare and have poor prognosis, unless a 
multidisciplinary approach is applied. First, the radiologist plays an important 
role in diagnosis, staging and treatment follow-up of bone tumours. Plain 
radiography and routine and dynamic contrast-enhanced MRI are the most 
important imaging techniques. In this session, we will focus on osteosarcoma 
and Ewing sarcoma. Once the diagnosis is proven by biopsy, neoadjuvant 
chemotherapy will be given by the oncologist during a preoperative period of 
about 3 months. Then, a new MR study is required for preoperative staging 
and assessment of response. Whenever possible, a limb-saving surgery will be 
performed, preferably by a dedicated oncologic surgeon, in a referral centre for 
bone tumours. After surgery, tumour response will be measured by the 
pathologist, and adjuvant chemotherapy will be given for about one more year. 
Close follow-up by the multidisciplinary team is required for 5 more years. Two 
case presentations will illustrate how the multidisciplinary approach works and 
clarify the role of the radiologist, oncologist and oncologic surgeon.  
Session Objectives: 
1. To learn about the task of the radiologist in diagnosis, staging and treatment 
follow-up of bone tumours. 
2. To understand the oncologic and surgical treatment of bone tumours. 
3. To become familiar with the multidisciplinary approach to diagnosis staging 
and treatment of bone tumours. 
A-022 16:05 
Imaging malignant primary bone tumours  
K. Verstraete; Ghent/BE (koenraad.verstraete@ugent.be) 
The majority of malignant bone tumours can be detected on plain radiography. 
The age of the patient, location of the tumour in a bone and history of a pre-
existing bone abnormality should be included in determining the likely 
diagnosis. Careful analysis of the pattern of bone destruction, periosteal 
reaction and matrix mineralisation allow for characterisation of most cases of 
osteosarcoma, Ewing's sarcoma, chondrosarcoma and adamantinoma. MRI is 
the best imaging technique for staging by displaying 1. the extent of bone 
marrow involvement, including epiphyseal infiltration and skip lesions, 2. the 
presence and extent of extraosseous soft tissue mass, 3. involvement of the 
neurovascular bundle, muscle compartments and adjacent joint. This allows to 
find the best biopsy approach and establish the feasibility of limb salvage as 
opposed to amputation. Longitudinal non-contrast T1 sequences are the most 
accurate for determining intraosseous extent. Axial fat-suppressed PD or T2 
sequences optimally demonstrate soft tissue extension, and dynamic contrast-
enhanced MRI is useful for differentiation of extraosseous tumour from edema 
and for assessment of tumour response to chemotherapy. Chest CT is the 
most sensitive modality for detection of pulmonary metastases, and technetium 
skeletal scintigraphy is still frequently used for detection of osseous 
metastases. The most valuable, readily available and easy-to-use techniques 
to assess response to radiation therapy and chemotherapy are dynamic 
contrast-enhanced MR imaging, diffusion MRI and colour-Doppler ultrasound. 
To evaluate local control of disease and for detection of local recurrence, MRI 
is usually the best imaging technique. Plain radiography may detect 
complications of prosthesis.  
Learning Objectives:
1. To consolidate knowledge on malignant primary bone tumors on plain 
radiography, CT and MRI. 
2. To understand the principles of tumour staging and monitoring 
chemotherapy. 
3. To become familiar with imaging findings following chemotherapy and 
surgery. 
A-023 16:25 
Oncologic approach to malignant primary bone tumours  
C. Dhooge; Ghent/BE (Catharina.Dhooge@UGent.be) 
The most common bone sarcomas are osteosarcoma (OS) and Ewing 
sarcoma. OS occurs primarily in long bones, Ewing sarcoma occurs also in the 
pelvis, spine or chest wall. Localised disease confers a 65% cure rate, and 
initially metastatic disease 25%. A multidisciplinary approach which includes 
neo-adjuvant systemic chemotherapy and local control measures for primary 
and metastatic sites followed by adjuvant chemotherapy has become the 
standard of care. Complete surgical excision is mandatory in OS; in Ewing, 
radiation can also be used. Standard chemotherapy for OS is based on a 
combination of cisplatin, doxorubicin and high-dose methotrexate. Ifosfamide 
and etoposide will be further considered (EURAMOS). Systemic therapy for 
Ewing includes vincristine, doxoribicin, cyclofosfamide, ifosfamide and 
etoposide. High-dose chemotherapy with autologous stem cell reinfusion is 
evaluated in intermediate prognosis and metastatic disease (euro-EWING). 
Among the different prognostic factors, response to neo-adjuvant 
chemotherapy by measuring chemotherapy-induced necrosis is a powerful 
indicator of outcome in bone sarcomas. Patients who achieve a good 
histological response to pre-operative chemotherapy, defined as < 10% viable 
tumour at the time of tumour resection, have a better survival than those who 
show poor response (>= 10% viable tumour). Five-year survival for good 
responders is 7O-75% compared to 45-50% for poor responders. However, the 
outcome for malignant bone tumours has improved little in the last 25 years. 
Large international studies exploring new drugs such as biologic agents 
(interferon) or mechanisms conferring drug resistance (topoisomerase 
inhibitors) in randomised controlled trials will hopefully lead to therapeutic 
innovation.  
Learning Objectives:
1. To become familiar with the principles of chemotherapy in malignant primary 
bone tumours. 
2. To understand what the oncologist expects from the radiologist. 
3. To recognise the value and limits of chemotherapy in malignant primary 
bone tumours. 




Surgical approach of malignant primary bone tumours  
G.M.L. Sys; Ghent/BE (Gwen.Sys@UGent.be) 
In primary malignant bone tumours, three surgical procedures are necessary: 
biopsy, resection and reconstruction. Whether a biopsy is performed in an 
open or a percutaneous way is a matter of preference, but in each case it 
should provide sufficient and representative material for pathological 
investigation without compromising the following treatment. The area of 
interest and the trajectory should be determined preoperatively in a 
multidisciplinary meeting. As the biopsy tract has to be removed during the 
resection surgery, it should be close to the planned approach for the 
subsequent resection. If a biopsy is performed improperly, the diagnosis may 
be wrong or the following resection may be impaired because of extensive 
contamination of compartments, resulting in a severe functional deficit. Surgery 
planning is based on clear imaging and a multidisciplinary discussion of tumour 
extension, aiming for a wide resection of the tumour with clear margins. Correct 
perioperative measurements are based on predefined fixed bony landmarks 
that should preferably be visible on the same image as the tumour. An 
amputation is performed if a surgical limb-salvage procedure is expected to 
result in a non-functional limb. Nowadays, several reconstruction techniques 
for bones (bone grafts or prostheses), tendons (artificial or human ligaments) 
and skin (skin flaps or grafts) are available. Invasion of the soft tissues such as 
the neurovascular structures, muscles and skin, will determine which 
reconstruction technique (s) are necessary to restore the patient's function. 
Each reconstruction technique bears inherent complications requiring a regular 
follow-up.  
Learning Objectives:
1. To become familiar with the basic principles of oncologic surgery in 
malignant primary bone tumours. 
2. To understand what the surgeon expects from the radiologist. 
3. To recognise the value and limits of limb-saving surgery. 
Case presentation and discussion  17:05
16:00 - 17:30 Room F1  
Professional Challenges Session  
PC 3
Radiology: opportunities and threats  
A-025 16:00 
Chairman's introduction  
J.A. Reekers; Amsterdam/NL (j.a.reekers@amc.uva.nl) 
We outline the current opportunities and threats in diagnostic radiology: 
Traditional diagnostic radiology has been rapidly replaced by clinical radiology 
and the role of the radiologist is changing from image interpreter to clinical 
manager of imaging data. To care for the patient`s medical problem and not 
only his images is important. This contains great opportunities for radiology to 
develop and for the radiologist to become a central player in patient 
management. However, this requires not only clinical knowledge and 
involvement, but also visibility and sometimes even 24/7 availability. The need 
for " only" image reporting is declining as clinical subspecialisation easily brings 
image interpretation into the domain of non-radiologists. To understand the 
importance of identity, visibility is very important. Visibility can be achieved by 
being part of MDT s and also in many other ways. Clinical radiology is an idea 
which, after all these years, has not been very well embedded in current 
radiology and radiology training. To understand the importance of certified 
training, maybe the most important action we have to undertake now is to 
capitalise on our radiological expertise. Image interpretation in a clinical 
context can only be done or franchised (to non-radiologist) under conditions of 
certification and accreditation by radiology. We should never let the primate of 
education and certification slip to non-radiologists. Radiology certification 
should be a quality standard, recognised by international and national medical 
bodies, such as medical chambers and specialist societies. The latter should 
have high priority.  
Session Objectives: 
1. To learn about the current opportunities and threats in diagnostic radiology. 
2. To understand the importance of identity. 
3. To acknowledge the importance of certified training. 
A-026 16:05 
Where are the turf battles in diagnostic imaging?  
G.M. Bongartz; Basle/CH (georg.bongartz@usb.ch) 
Turf battles in radiology are a foreseeable development for most imaging 
techniques which evolve push-button methods and readily interpretable 
imaging results. We as radiologists must learn to accept competition. Turfs 
should rather be seen as challenge than as threat. Predominantly, non-
irradiating techniques like ultrasound and MRI have become progressively 
easier to apply (US) or to understand (MRI), where the final image in some 
standardised areas (eg joints) can readily be interpreted by medical specialists 
in this field. But also x-ray diagnostics in dental medicine or orthopedic imaging 
is largely applied outside the radiologic department. CT today seems still 
relatively excluded because of its complexity. But with increasing resolution, 
optimal 3D reconstruction and fast accessibility, it is only a question of time 
when the added value of the radiologist will be under question. Radiology has 
changed. We must become experts with respect to patho-anatomy and 
radiological differential diagnosis. This requires profound education, both initial 
training and ongoing education. Radiology must be advertised internally and 
externally. In radiological publications, outcome studies are still 
underrepresented. Demonstration of our dedicated skills, fostering our special 
expertise and offering this as support to our medical colleagues will preserve 
radiology for the future. Cooperation with partners seems the only way out of a 
turf battle - we need to search for alliances and integrate our partners to create 
a win-win situation.  
Learning Objectives:
1. To know about turf battles with clinicians around imaging. 
2. To learn which imaging modalities are most at risk. 
3. To learn how to create win-win situations. 
Author Disclosure:
 G.M. Bongartz: Research/Grant Support; Siemens Medical Systems 
Germany, Bayer, Switzerland. 
A-027 16:23 
Beating threats in Europe with radiological training  
A.K. Dixon; Cambridge/UK (akd15@radiol.cam.ac.uk) 
By introducing radiology to medical students, it is hoped that they will begin to 
appreciate how difficult it is! Likewise, when teaching residents, they must 
come to understand the basic anatomy and principles better than their clinical 
colleagues; this is very much the tenet of subspecialty training. They should 
also appreciate that patient care is optimal when there is close collaboration 
between clinicians and radiologists. Passing of an examination (national or 
EDiR) offers some proof that a radiologist has attained a certain standard, but 
the principle of testing oneself formally or informally at regular intervals again 
provides a measure of continuing competence. Such certification can be of 
value in the case of litigation. Radiology is one of the fastest growing 
specialties and the techniques that we learn during training are quickly 
outdated; hence, the need for life-long learning and effective continuing 
professional development.  
Learning Objectives:
1. To understand how to teach radiology to undergraduate medical students. 
2. To become familiar with the principles of self-assessment. 
3. To appreciate the necessity for life-long learning. 
A-028 16:41 
History of ultrasound in radiology: lessons learned  
L.E. Derchi; Genoa/IT (derchi@unige.it) 
The relationship between radiology and US has never been an easy love story, 
and still isn't. In the early 1970s this new imaging field was not readily covered 
by radiologists and many other colleagues established US sections within their 
departments. Then, important fields of US (cardiology, obstetrics, gynecology) 
became almost exclusive domain of non-radiologists. In the 1980s, the 
increasing success of US initiated turf battles with other clinicians. Nowadays, 
clinical specialists perform > 50% of US examinations wordwide. In Europe, 
most in-hospital US examinations is still performed in radiology, but this is not 
the case in all countries. A strong practice in US is quite important since this is 
often the first approach to patients. If initial US referrals are kept, radiologists 
will continue to guide decisions in subsequent imaging workup. Furthermore, 
US keeps close to patients; in Europe the examination is usually done directly 
by radiologists or, if by sonographers, the radiologist usually checks the case 
with limited directed US imaging. This clearly shows our role as physicians. To 
maintain a key role in US radiologists need to: 1) Have the best specialists in 
US; attention must be given to US in residency programs. 2) Invest in US 
technology (as examples: CEUS, elastography, 3D/4D). 3) Invest in US 
research. 4) Have high visibility in the US community, keeping close contact 
with all clinical colleagues. 5) Present higher visibility of US within radiology, 
with leaders supporting US within the radiological community and each 
radiologist promoting US in his/her environment.  
Learning Objectives:
1. To understand why ultrasound has moved out of the hands of radiology in 
some subspecialties. 
2. To learn what this means for daily radiology practice and the quality of work. 
3. To know about the threats and how we should deal with them. 




Interdisciplinary cooperation without losing identity  
M.F. Reiser; Munich/DE 
Recently, major shifts in the paradigms of patient care took place: 
interdisciplinary counseling and including the patient in the decision making 
process for diagnostic and therapeutic measures. The new concept is that the 
patient no longer comes to the specialist, but the specialists come jointly to the 
patient. This is reinforced by the competition among health care providers, 
political decision makers and the public. In many hospitals this general trend 
has resulted in the establishment of various centers and boards such as the 
breast cancer centers, vascular centers and tumor boards for several cancer 
entities to name only few. At the university hospital of Munich 46 centers and 
boards have been implemented up to now. In almost all of them the 
participation of radiologists is required. This results in a major challenge in 
terms of personal resources. Together with the regular clinical-radiological 
rounds the time necessary for these activities equals 2 full-time radiologist 
posts. The participation of radiologists has many beneficial aspects: 
Acknowledgement of radiology as an important clinical discipline and of the 
radiologist as a clinical consultant; participation in and influence on the 
creations of SOPs and (internal) guidelines; opportunity to advocate 
appropriate radiological methods for diagnosis and interventions; increase of 
knowledge in clinical medicine and new concepts of therapy; close personal 
links with our clinical partners. In order to prevent radiologists from losing their 
identity as radiologists it is mandatory that they remain firmly integrated in the 
radiology department and to strengthen the position of radiology as the central 
institution for providing cost-effective imaging and interventional services. 
Moreover it must be taken care to offer attractive career options within the field 
of radiology.  
Learning Objectives:
1. To appreciate how radiologists can work closely with clinicians without losing 
their identity. 
2. To understand what the pitfalls and threats are and how we should deal with 
them. 
3. To learn the central role of radiologists in clinical management of patient 
care. 
Panel discussion:  
How to stay in the driver's seat as radiologist 2.0?  17:17
16:00 - 17:30 Room F2  
Breast  
RC 302  
Breast ultrasound  
Moderator:  
M. Müller-Schimpfle; Frankfurt a. Main/DE 
A-030 16:00 
A. Physics and practical aspects of high-quality hand-held US and 
automated breast US  
M.H. Fuchsjäger; Graz/AT (michael.fuchsjaeger@medunigraz.at) 
Ultrasound (US) is the adjunct method of choice to mammography in breast 
imaging. Over the past two decades, US technology has undergone profound 
advancements and refinements. US has, therefore, become an assessment 
tool with a defined field of indications as well as a unique set of diagnostic 
descriptors for breast lesion differentiation. The ACRIN 6666 study has 
demonstrated the special benefit of US in patients at risk with dense breast 
tissue. The BI-RADS Lexicon for Ultrasound, in its second edition, expanded 
the role of breast US. Further enhancement of image quality as well as the 
recent advent of automated breast US has even fueled scientific discussions 
on the potential role of US for breast cancer screening. Automated breast US, 
which is based on computed generation of a 3D imaging data set obtained 
from many parallel 2D images, offers a different approach with a variety of 
benefits. Images are obtained by the sonographer in standardised fashion, 
whole breast data sets can be reviewed at any time after the examination, 
reducing operator dependence, and image fusion with, i.e. MRI is easily 
possible. The basic physical background, the significance as well as important 
aspects of practical use of handheld and automated breast US will be 
explained and illustrated by the respective imaging examples. Emphasis will be 
laid on strengths and potential weaknesses of both US technologies with 
regard to breast imaging.  
Learning Objectives:
1. To understand the physics of hand-held US and whole breast US. 
2. To become familiar with the practical techniques of hand-held US and whole 
breast US. 
3. To appreciate the clinical applications of hand-held US and whole breast 
US, including automated screening. 
A-031 16:30 
B. Complicated cysts and complex-cystic lesions: differentiation and 
management  
C.F. Weismann; Salzburg/AT (christian.weismann@inode.at) 
The terms "complicated cyst" and "complex-cystic lesion" are based on breast 
ultrasound (US) terminology. The simple cyst is a fluid-filled, clearly defined, 
anechoic lesion without any suspicion of a solid intracystic mass. If a simple 
cyst is complicated by echogenic fluid, it is called complicated cyst. This 
echogenic fluid can be caused, e. g., by cell debris. Thin echogenic septa are 
common in complicated cysts. Vascularisation can never be found in these 
echogenic components. A complicated cyst has no solid component and no 
thickened wall or thickened septa. The expected probability of malignancy is 
2%. The US criteria of a complex-cystic lesion following Berg et al. categorise it 
into 4 types: type 1, thick outer wall and thick internal septa (alone or in 
combination of both); type 2, one or more intracystic masses; type 3, mass of 
mixed cystic and solid components (at least 50% cystic); type 4, predominantly 
solid with eccentric cystic foci (at least 50% solid). Complex means there is a 
suspicion of a tumour inside a cyst or a solid tumour with cystic components. A 
complicated cyst will usually be followed by US after 6 months. A complex-
cystic lesion needs a correlation with mammography. US-guided large core 
needle biopsy in combination with a US and mammography visible marker 
placement is useful in type 3 and in type 4 complex-cystic lesions. In type 1 
and type 2 complex-cystic lesions, a preoperative hook wire placement and 
excision surgery is the typical procedure.  
Learning Objectives:
1. To learn about the US appearance of complicated cysts and complex-cystic 
lesions. 
2. To consolidate knowledge on differential diagnosis for these respective 
lesions. 
3. To understand the diagnostic algorithm for a work-up of these lesions. 
A-032 17:00 
C. The use of ultrasound in the evaluation of the nipple-areolar complex  
R. Salvador; Barcelona/ES (rafasalvador@imaginebarcelona.com) 
The nipple and areola can be well examined by any clinician. Ultrasonography 
can add new findings mostly related to the main ducts merging at the 
retroareolar region. A thorough description of the anatomical aspects of the 
region, and its pathological benign and malignant conditions will be described. 
Duct ectasia, infection, ductal papillomas, hyperplasia, and DCIS, as well as 
Paget disease of the nipple and some other skin pathologies can arise in this 
area of the breast. A brief description is presented of the US techniques to 
review the region, including the use of Doppler US, elastography, 3D 
ultrasound, the so-called automated breast ultrasound scan (ABVS) and other 
techniques that have been used not only to diagnose, but also to treat some 
diseases. US ductography and pecutaneous sampling or excision of 
papillomas will also be explained.  
Learning Objectives:
1. To understand the normal anatomy of the nipple-areolar complex. 
2. To become familiar with conditions commonly affecting the nipple-areolar 
complex. 
3. To appreciate the value of US for diagnosis and management of these 
conditions. 
Author Disclosure:
 R. Salvador: Advisory Board; Member of the Medical Advsory Board of 
Philips Healthcare. 
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16:00 - 17:30 Room G/H  
Genitourinary  
RC 307  
Stone disease: new concepts  
Moderator:  
A. Magnusson; Uppsala/SE 
A-033 16:00 
A. From the Stone Age to the New Age  
N.C. Cowan; Oxford/UK (nccowan.uro@gmail.com) 
Urinary tract stones have affected humans since civilisation began. Stones 
were first reported in the Aphorisms of Hippocrates and are still a major health 
problem. Their aetiology is multifactorial. Recent advances in diagnosis and 
treatment have proved significant. The usual presentation is with loin pain, 
vomiting, fever, and nonvisible or visible haematuria. They may also be 
asymptomatic. Standard evaluation includes a detailed medical history, 
physical examination, diagnostic imaging, blood analysis and urinalysis. 
Principal imaging techniques are ultrasonography and unenhanced CT with 
judicial use of contrast medium enhancement and plain abdominal x-ray. 
Secondary imaging techniques include excretory urography, magnetic 
resonance imaging and antegrade or retrograde pyelography. The advantages 
and disadvantages of these techniques will be discussed. The imaging 
technique used depends on diagnostic accuracy, patient acceptability, 
availability, cost and patient safety. Diagnostic imaging is used to determine if 
stones are present and if present to measure the size, number, location and 
possible composition. Imaging may also be used to determine whether there 
has been an increase in size over a relatively short time period, indicating 
metabolically active stone disease, or a decrease in size, indicating a response 
to therapy. Imaging may find an underlying anatomical abnormality 
predisposing to stone formation such as pelviureteric junction obstruction or 
tubular ectasia and may also provide essential information regarding the 
function of the other kidney. Construction of smart pathways of investigation 
uses ultrasonography and unenhanced CT as principal diagnostic imaging 
techniques. Various risk factors are used to determine the selection and order 
of diagnostic imaging investigations. The clinical scenarios are explored.  
Learning Objectives:
1. To become familiar with the symptoms, signs, risk factors and significance of 
stone disease in the urinary tract. 
2. To understand the strengths and weaknesses of Stone Age to New Age 
imaging techniques for stone disease. 
3. To be able to construct a state-of-the-art diagnostic imaging pathway for 
urinary tract stone disease. 
A-034 16:30 
B. The contribution of imaging in planning urinary stone therapy  
U. Patel; London/UK (Uday.Patel@stgeorges.nhs.uk) 
Urinary stone treatment is influenced by stone size, density and composition, 
stone location and the collecting system anatomy. 1. Stone size: renal stones, 
< 1.5 cm in size, are suitable for surveillance. Larger stones, > 2 cm, are better 
treated surgically by PCNL. 68% of ureteric stones, < 5 mm in diameter, will 
spontaneously pass compared to 47% of > 5 mm. Very small opacities may 
represent Randall plaques. The diagnostic appearance of Randall's plaques on 
CT has not been defined, but opacities < 2 mm are likely to be stones. 2. Stone 
density and composition: stone density can vary from 100 HU up to > 1400 HU. 
Calcium containing stones can vary from 200-1400 HU, uric acid are 200-
500 HU, struvite (or matrix) calculi lie in the 100-700 HU range and cystine 
stones are around 300-400 HU. Dense stones are less likely to fragment and a 
threshold of < 800-1000 HU is the cutoff point for selecting patients for ESWL. 
Cystine and calcium oxalate monohydrate stones are relatively resistant to 
ESWL. Dual-energy CT is able to differentiate uric acid stones from other 
varieties, and to a lesser extent can also predict other stone composites (such 
as cystine). 3. Stone location: stones located in the lower third of the ureter are 
more likely to drain (75% vs. 50%). Location in the kidney is also of 
importance. 4. Collecting system anatomy: appreciation of the collecting 
system anatomy by 3D CT pyelography is the ideal modality for surgical 
planning.  
Learning Objectives:
1. To understand how stone morphology, constituency and intrarenal anatomy 
influence treatment of urinary tract stones 
2. To know how to carry out 3D CT reconstruction of the renal collecting 
system, and understand key technical factors necessary for recreating 
accurate anatomical or surgical maps. 
3. To understand what information the interventionalist or urologist needs for 
planning urinary stone therapy. 
A-035 17:00 
C. Imaging of stone disease in pregnancy  
G. Masselli, G. Gualdi; Rome/IT (gabrielemasselli@libero.it) 
Renal colic is the most frequent non-obstetric cause for abdominal pain and 
subsequent hospitalisation during pregnancy. Intervention is necessary in 
patients who do not respond to conservative treatment. Ultrasound (US) is 
widely used as the first-line diagnostic test in pregnant women with 
nephrolithiasis, despite that it is highly nonspecific and may be unable to 
differentiate between ureteral obstruction secondary to calculi and physiologic 
hydronephrosis. Magnetic resonance imaging (MRI) should be considered as a 
second-line test, when US fails to establish a diagnosis and there are 
continued symptoms despite conservative management. Moreover, MRI is able 
to differentiate physiologic from pathologic dilatation. In fact in the cases of 
obstruction secondary to calculi, there is renal enlargement and perinephric 
oedema, not seen with physiological dilatation. In the latter, there is smooth 
tapering of the middle third of the ureter because of the mass effect between 
the uterus and adjacent retroperitoneal musculature. When the stone is lodged 
in the lower ureter, a standing column of dilated ureter is seen below this 
physiological constriction. MRI is also helpful in demonstrating complications 
such as pyelonephritis. In the unresolved cases, computed tomography 
remains a reliable technique for depicting obstructing urinary tract calculi in 
pregnant women, but it involves ionising radiation. Nephrolithiasis during 
pregnancy requires a collaboration between urologists, obstetricians, and 
radiologists.  
Learning Objectives:
1. To list the US, MR and CT imaging findings of urolithiasis and urinary tract 
infections. 
2. To discuss the role and the appropriate uses of US, MR and CT for imaging 
these suspected conditions in pregnancy. 
3. To discuss how imaging can influence the management of nephrolithiasis 
during pregnancy. 
16:00 - 17:30 Room I/K  
Special Focus Session  
SF 3  
Pitfalls in FDG PET/CT imaging  
A-036 16:00 
Chairman's introduction  
K. Ahlström Riklund; Umea/SE (katrine.riklund.ahlstrom@diagrad.umu.se) 
Pitfalls in FDG PET/CT studies will give an overview of what information you 
really get from an FDG PET/CT study and which pitfalls to avoid. Are all 
uptakes bad or are they also good and how to judge them? The following talks 
aim to cover pitfalls in the use of FDG in various fields of medicine.  
Session Objectives: 
1. To learn about imaging with FDG PET/CT. 
2. To learn about drawbacks and pitfalls. 
Author Disclosure:
 K. Ahlström Riklund: Board Member; Swedish Society of Radiology, CMIV, 
Linköping; Sweden, Örebro University, Sweden. Grant Recipient; ALF 




T.F. Hany; Zurich/CH (thomas.hany@gmail.com) 
In malignant tumours, PET/CT imaging using 18-fluoro-deoxyglucose (FDG) is 
widely used nowadays. FDG-uptake is an unspecific process and results in 
physiological as well as pathological malignant and non-malignant tissue 
uptake. To properly understand and interpret PET/CT imaging, knowledge of 
the mechanism and pathways of FDG in different tissue types like brain and 
the gastrointestinal tract is key. Intrinsic as well as extrinsic factors influence 
uptake pattern not related to oncological disease like uptake in brown fat in 
patients exposed to cold ambient temperature and psychological stress or 
increased muscular uptake in nonfasting patient. Typical treatment-related 
changes occur during and after treatment and must be recognised correctly so 
as not to overstage patient disease. A systematic analysis and knowledge of all 
these factors facilitate and improve the reading of oncological clinical cases.  
Learning Objectives:
1. To understand pattern of physiological FDG-uptake. 
2. To learn about the pattern of non-pathological uptake in several tissue types. 
3. To understand the influence of chemotherapy and other agents on FDG-
uptake in the body. 





J. Knuuti; Turku/FI (juhani.knuuti@utu.fi) 
The most common clinical situation for FDG PET/CT is the detection of 
myocardial viability. Also, FDG PET is increasingly used for detection of 
inflammatory cardiac diseases such as cardiac sarcoidosis. Cardiac tissue 
utilizes various energy substrates and the selection of substrate is mainly 
based on availability of these and on the metabolic conditions of the patient. 
When myocardial viability is studied with FDG PET, the patient must be studied 
in conditions when glucose is the preferred substrate. This can be achieved by 
using glucose loading or preferably by using insulin-glucose infusion. Nicotinic 
acid derivatives such as Acipimox can also be used. Diabetic patients are 
challenging, since tracer remains in the blood for a longer time. Blood glucose 
needs to be monitored and insulin may be needed. The reporting of viability 
studies is usually combined with the assessment of perfusion, allowing 
classifying the myocardial regions into normal, dysfunctional but viable or 
scarred myocardium. With a hybrid PET/CT system, coronary CT angiography 
can also be performed in the same session. However, in many patients 
invasive coronary angiography has been already performed. In addition, many 
of these patients have kidney problems, making the use of CT contrast 
challenging. In inflammatory cardiac diseases the aim is to suppress the 
myocardial glucose uptake as much as possible and patients should be studied 
in the fasting state or after special low-carbohydrate diet. The challenge is the 
physiological heterogeneity of glucose utilization in the fasting state. In most 
cases the localized tracer uptake by inflammation can be separated from more 
diffuse physiological uptake. 
Learning Objectives:
1. To understand the benefits and limitations of anatomical and functional 
imaging in cardiology. 
2. To learn about the quantitative analysis and limitations of the current 
methodology. 
3. To become familiar with typical and challenging findings in cardiac FDG 
PET/CT. 
Author Disclosure:
 J. Knuuti: Advisory Board; Lantheus Inc. Grant Recipient; Cardirad. 
A-039 16:41 
Neurology  
K. Van Laere; Leuven/BE (koen.vanlaere@med.kuleuven.be) 
FDG PET (/CT) is in the CNS mainly used in the routine evaluation of 
dementia, movement disorders, epilepsy and brain tumours. In dementia, the 
main goal of FDG PET is differential diagnosis (e.g. Alzheimer's disease (AD), 
frontotemporal dementia, primary progressive aphasia, posterior cortical 
atrophy, etc)., as well as for the early diagnosis of AD and prediction of 
conversion in the pre-dementia stage of mild cognitive impairment (MCI). FDG 
PET allows differential diagnosis of parkinsonism (idiopathic versus MSA, PSP 
and CBD) with good accuracy. In refractory epilepsy, FDG PET is used for 
definition of the functional deficit zone and lateralisation of the epileptogenic 
focus and carries high prognostic value in determining surgical outcome. In 
brain tumours, FDG PET is used for grading and detection of recurrence, best 
used in combination with anatomical information. Methodologically, normal 
patterns need to be discerned, which are age dependent. Although underlying 
CT information is able to provide atrophy assessment, proper partial volume 
correction needs more detailed MRI information. When hybrid scanning is 
performed with CT, movement artefacts need to be prevented to avoid 
attenuation artefacts. Semiquantitative analysis and surface rendering 
techniques with voxel-based comparison to normal datasets should be applied 
routinely, to obtain maximal accuracy on the individual patient level.  
Learning Objectives:
1. To understand the benefits and limitations of FDG PET/CT in neurological 
disorders. 
2. To become familiar with the normal and abnormal uptake patterns of FDG in 
the brain and potential pitfalls. 
3. To learn about the value of semiquantitative analysis of brain FDG PET/CT 
in comparison to normal data. 
A-040 16:59 
Inflammation  
J. Sorensen; Uppsala/SE (Jens.Sorensen@medsci.uu.se) 
Glucose transport is increased in inflammatory lesions due to increased 
metabolic needs of activated inflammatory cells and proliferating connective 
tissue cells. Reports on the use of FDG PET/CT for visualising inflammation 
provide some evidence for routine clinical use in selected scenarios such as 
evaluation of patients with prolonged fever of unknown origin, infections after 
joint replacement surgery and other osteomyelitic conditions, graft infections 
after endovascular surgery, vasculitis in autoimmune disorders and patients 
with granulomatous diseases. This paper covers the documented indications 
and provides an overview of the common pitfalls related to each.  
Learning Objectives:
1. To learn about the role of FDG PET/CT in the evaluation of inflammatory 
diseases. 
2. To understand the shortcomings and pitfalls of FDG PET/CT in inflammatory 
diseases. 
3. To appreciate the difficulties of differentiating between inflammation, 
infection and malignancy. 
Panel discussion: Is bright always bad?  17:17
16:00 - 17:30 Room N/O  
Head and Neck  
RC 308  
Head and neck emergency: for the general 
radiologist or the patient?  
Moderator:  
A. Trojanowska; Lublin/PL 
A-041 16:00 
A. Pseudolesions mimicking disease  
C. Karaman; Aydin/TR (cankaraman@hotmail.com) 
Radiologists mostly prefer to use the comparative technique while evaluating 
radiological images, especially when the anatomy is identical for both sides. 
Comparative analysis mostly works if the anatomic details are not complex or 
the right resembles the left. However, the complex anatomy and relatively high 
incidence of individual variations in head and neck may hinder this way of 
interpretation. Variable pneumatisation of paranasal sinuses and temporal 
bone may cause difficulty. Vascular system, especially venous structures may 
be sources for pseudolesions. For example, asymmetrically enlarged jugular 
vein or venous plexuses at any location may be misinterpreted as mass of any 
origin. Veins may also become problematic on MR imaging due to entry slice 
phenomenon, in-plane flow, and flow turbulence effects and can have variable 
enhancement. Normal anatomical structures such as facial nerve may enhance 
and can be mistaken to be pathologic on MRI. Technical issues can be 
considered as a group that may cause pseudolesions. Images of the 
improperly positioned patient may become problematic while evaluating tiny 
structures. PET and PET-CT carry their own risks for pitfalls. Normal structures 
may confound interpretation and result in false-positive findings. The situation 
may become much more complicated when there is asymmetry. Similarly, 
atrophy and unilateral absence of a structure may be misread as a mass on 
the contralateral side. Because of the complex anatomy and relatively high 
incidence of individual variations, head and neck imaging demands much more 
attention and careful analysis. The appropriate imaging technique and detailed 
knowledge of anatomy are essential to recognise pseudolesions.  
Learning Objectives:
1. To learn how to choose and tailor imaging techniques according to the 
clinical presentation. 
2. To become familiar with common artefacts. 
3. To be able to recognise typical pseudolesions. 
A-042 16:30 
B. Where medical history and previous images help to rule out tumour  
D. Farina; Brescia/IT (nappaje@yahoo.it) 
As a general rule, detailed knowledge of the patient's clinical history is 
essential before any imaging study is performed, to evaluate the 
appropriateness of the indication, tailor the acquisition protocol and correctly 
interpret the study. In head and neck imaging, this rule particularly fits in the 
emergency setting. In certain circumstances, the swelling and enhancement of 
soft tissues produced by infectious lesions may mimic a neoplasm. Even more 
so, in patients already treated with surgery or chemoradiation. In these 
patients, the challenge is double: to identify any abnormality in the new 
anatomy produced by treatment and to discriminate between inflammation, 
complication and relapse. These can be very difficult without knowledge, for 
example, of the reconstructive procedure after surgery. Previous images are 
extremely useful, not only because they help detect abnormalities, but also 
because through indirect information on the growth rate of the lesion they are 
crucial for correct interpretation of findings.  




1. To understand the importance of medical history and previous images. 
2. To become familiar with typical postsurgical and post-radiation imaging 
findings. 
3. To learn about less common anatomical variants without clinical 
consequence. 
A-043 17:00 
C. Findings that can't wait for follow-up  
M.G. Mack; Munich/DE (m.mack@radiologie-muenchen.de) 
Head and neck emergencies which cannot wait for follow-up are variable. Of 
course, all traumatic injuries affecting vascular structures have to be diagnosed 
and treated immediately. Due to the close anatomical relationships, nerves and 
vascular structures can direct inflammatory and tumorous lesion to the skull 
base and can cause severe clinical complications. It is also important to know 
all the dangerous spaces downwards to the mediastinum, which can also 
cause severe clinical problems. During this lecture, efficient imaging protocols 
and the most relevant traumatic, vascular and infectious emergencies will be 
discussed.  
Learning Objectives:
1. To learn about vascular head and neck emergencies. 
2. To understand main pathways of skull base invasion. 
3. To be familiar with infections in dangerous spaces. 
16:00 - 17:30 Conf. Room M3  
Computer Applications  
RC 305  
Mobile IT in radiology  
A-044 16:00 
Chairman's introduction  
E. Neri; Pisa/IT (emanueleneri1@gmail.com) 
Tablets in radiology represent a novelty. Since the introduction of the tablets on 
the market, the radiological field has been probably the first medical discipline 
to discover the many advantages of these devices. In fact, many applications 
for image management have been made available on the app stores (Apple 
and Android), and allow radiologists and non-radiologists to handle DICOM 
images on the tablet, as part of the patient's record. However, the emerging 
applications are driving the process from the simple DICOM image viewing to 
the full integration of the tablet with the PACS, allowing the handling of a 
patient's full record and presumably the possibility to report. In view of this 
rapid technological development, again radiology falls in the middle of a storm 
and is asked to find a solution to problem: are tablets suitable to read and 
report DICOM images? And if so, which kinds of images (CT, MRI, x-ray, etc).? 
How can we manage the portability of patients' data (security issues, data loss, 
etc).? What will be the impact on teleradiology? These issues will be 
addressed by the panel of experts who will speak in the refresher course.  
Session Objectives: 
1. To appreciate the current state of tablet technology and its practical use in 
radiology. 
2. To understand the pros and cons of the use of tablets. 
3. To learn about specific critical areas of utilisation (DICOM images reading 
and teleradiology). 
A-045 16:05 
A. Tablet-computers: a technical overview  
J. Fernandez-Bayo; Sabadell/ES (jFernandezB@cspt.es) 
Since their introduction in 2001, tablet PCs have evolved extensively. They 
have become very popular, filling the gap between laptop computers and smart 
mobile phones. We will review technical aspects like the processors, storage 
space and memory, size and weight, connectivity and networking, software, 
autonomy, and battery life in different devices. Special focus will be on the 
displays and different possible uses in radiology. For diagnostic purposes, 
different technical aspects must be taken into consideration, like the display 
size, resolution, pixel size (pixel pitch or pixels per inch), luminance, and 
contrast. Displays in radiology normally have sizes between 20" and 24" and 
resolutions up to 5 Mpx, with luminance that ranges from 250 cd/m2 to 600 
cd/m2. By contrast, tablets have screen sizes between 9" and 10" and 
resolutions up to 3 Mpx, with luminance that ranges from 370 cd/m2 to 480 
Cd/m2. Due to their screen size, tablets score better in pixel pitch, with around 
250 ppi versus 150 ppi in medical displays. The two systems have similar 
contrast ratios. Other technical aspects of display that we should take into 
consideration are the number of distinguishable grays that can be represented, 
which in tablets correlates with the number of colours that can be displayed 
(Color Gamut) and colour accuracy (Delta-E). Additionally, we should take into 
consideration that displays should be calibrated for medical diagnostic 
purposes and tools to calibrate tablets have recently become available.  
Learning Objectives:
1. To learn about the PC evolution: from desktops, to laptops and tablets. 
2. To appreciate the versatility features of a tablet. 
3. To understand the hardware features with a specific focus on display. 
4. To understand the hardware features with a specific focus on networking. 
A-046 16:28 
B. Reading DICOM images on the tablet  
O. Ratib; Geneva/CH 
Touch screen tablets are becoming widely available, providing convenient 
mobile solutions for physicians and health-care providers. This is particularly 
attractive in medicine to "nomad" physicians, who need to be able to access 
relevant patient data and images anywhere-anytime in their daily practice 
where they are rarely at a single location. While they may not always be 
adequate for routine diagnostic tasks, they provide a convenient mobile 
solution for on-call and remote consultations. There are different types of 
software architecture that can be implemented for such tasks. Two different 
major designs are: (1) online web-based applications where the device serves 
as a "thin-client" to display images rendered and manipulated on a remote 
computer and (2) local applications that reside on the mobile device and can 
run independently after images have been downloaded on the device. The first 
solution requires the user to be constantly connected to the network, while the 
second solution can continue to function after being disconnected from the 
network. Most PACS vendors are starting to provide web access to their 
imaging solutions that can be accessed from mobile devices. Web access can 
however be slow and dependent on reliable access to wireless network. We 
chose to develop a stand-alone companion application to our Open Source 
imaging platform OsiriX. With the increasing capacity and computing power of 
mobile devices, users will soon be able to perform most of the processing and 
image manipulation functions that are today only feasible on desktop or laptop 
computers.  
Learning Objectives:
1. To learn which DICOM readers are available for tablets. 
2. To appreciate the different approaches to DICOM reading (local vs remote) 
and the PACS/tablets integration. 
3. To understand the pros and cons of DICOM image reading with the tablet in 
regards to image quality and displays. 
A-047 16:51 
C. Mobile teleradiology: radiological features of the tablet-computer  
E.R. Ranschaert; 's-Hertogenbosch/NL (ranschaert@telenet.be) 
Over the past few years, several applications and viewers have been 
developed for tablet computers to enable remote viewing and interpretation of 
radiological images. When connected to a wireless network, the images can be 
viewed from any location within or outside the hospital. Both inside and outside 
the hospital, tablets seem most useful in radiological emergency settings. 
Within the hospital, tablet computers may have several other purposes such as 
teaching, clinical reviewing and communication with referring doctors or even 
patients. Nevertheless, tablet computers still have limitations both in hardware 
and software. The implementation of mobile devices in the hospital 
environment also introduces new questions about security and safety of patient 
information. These issues and potential solutions will be discussed.  
Learning Objectives:
1. To learn about mobile teleradiology within the hospital. 
2. To learn about mobile teleradiology outside the hospital. 
3. To appreciate the potential risks of mobile teleradiology (data security, 
confidentiality, etc). 
Panel discussion:  
Confidence in the use of tablets in our clinical practice  17:14
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16:00 - 17:30 Board Room A  
Vascular  
RC 315  
How to perform venous sampling for 
endocrine disease  
Moderator:  
W.R. Jaschke; Innsbruck/AT 
A-048 16:00 
A. Role of venous sampling in localising endocrine disease  
C. Degenhart; Munich/DE (christoph.degenhart@med.uni-muenchen.de) 
Among the selective venous sampling procedures for the evaluation of 
endocrine disease, adrenal vein sampling (AVS) and bilateral inferior petrosal 
sinus sampling (BIPSS) are used most frequently. AVS is recommended by 
current guidelines to identify surgically curable causes of hyperaldosteronism. 
However this procedure is regarded as a challenging procedure and the results 
may be difficult to interpret. Moreover, there is a lack of generally accepted 
standards for the performance of AVS. The key issues consist in the selection 
and preparation of the patients for AVS and the procedure for an optimal 
performance and interpretation of laboratory findings. Cushing's disease (CD) 
is the most common cause of endogenous hypercortisolism and it is caused by 
an adrenocorticotrophin (ACTH) secreting pituitary adenoma. In patients with a 
negative MRI, a positive BIPSS test is associated with a high rate of 
postoperative biochemical remission. When high suspicion of Cushing's 
syndrome (CS) exists, recommended screening tests include the overnight 
dexamethasone suppression test, the low-dose dexamethasone suppression 
test, or late night salivary cortisol. Corticotrophin releasing hormone (CRH) test 
helps to distinguish pituitary CD from ectopic ACTH-dependent CS, BIPPS. In 
special cases, less common selective venous sampling procedures are 
indicated for the evaluation of parathyroid diseases, the localisation of 
pancreatic endocrine tumors or the evaluation of ovarian endocrine disease.  
Learning Objectives:
1. To learn about the diagnostic accuracy of venous sampling. 
2. To become familiar with the indications for venous sampling. 
3. To learn about the impact of sampling results on patient management. 
A-049 16:30 
B. Adrenal venous sampling  
M. Matson; London/UK (matthew.matson@mac.com) 
Adrenal venous sampling is an essential diagnostic tool in the investigation of 
primary hyperaldosteronism as it can provide information to distinguish 
unilateral from bilateral hyper secretion and thus direct therapy. The place of 
AVS in the diagnostic algorithm will be discussed in relation to cross-sectional 
imaging, and the technicalities of the procedure explained, including common 
reasons for failure and how they can be avoided. Interpretation of the 
biochemical results will be demonstrated.  
Learning Objectives:
1. To learn how to perform adrenal venous sampling. 
2. To learn some tips and tricks for difficult procedures. 
3. To learn about the complications. 
A-050 17:00 
C. Inferior petrosal sinus sampling  
D.K. Tsetis; Iraklion/GR (tsetis@med.uoc.gr) 
Bilateral Inferior petrosal sinus sampling (BIPSS) is considered by many 
centres to be the gold standard for confirming the origin of ACTH secretion in 
patients with Cushing's syndrome. The procedure is technically challenging 
and includes the following steps: a) conscious sedation, b) sterile preparation 
of both groins with bilateral insertion of femoral venous sheaths, c) heparin 
infusion, d) fluoroscopically guided placement of catheters into bilateral inferior 
petrosal sinuses, e) contrast-enhanced fluoroscopy to confirm reflux into 
ipsilateral cavernous sinus, f) collection of baseline blood samples, g) CRH 
injection, h) collection of post-CRH injection blood samples, i) catheter removal 
and groin pressure until venous haemostasis. Occasionally, it is not possible to 
perform BIPSS via a femoral approach (due to aberrant anatomy, inferior vena 
cava filters, thrombosis, or inability to cross the internal jugular valve) and 
alternative access, such as direct internal jugular access is used. The most 
common complication of BIPSS is groin haematoma, occurring in 3-4% of 
cases. Injection of iodinated contrast material may deteriorate renal function, 
so measurement of BUN and creatinine is recommended prior to the 
procedure. Pre-procedure assessment of the coagulation system, platelets, 
and haematocrit is recommended as heparin is frequently infused following the 
insertion of sampling catheters to protect against cavernous sinus thrombosis. 
The placement of the catheter may cause discomfort, headache, ear pain, or 
hearing noises. Very rare complications include deep venous thrombosis and 
pulmonary thromboembolism, pontocerebellar junction stroke, brain stem 
injury, cranial nerve palsy, venous subarachnoid haemorrhage and obstructive 
hydrocephalus.  
Learning Objectives:
1. To learn how to perform sinus venous sampling. 
2. To learn some tips and tricks for difficult procedures. 
3. To learn about the complications. 
16:00 - 17:30 Room P  
BIA Session  
Biomedical image analysis: novel tools in 
neurodegenerative disease and breast 
cancer  
Moderator:  
W.J. Niessen; Rotterdam/NL 
16:00 
Introduction  
W.J. Niessen; Rotterdam/NL (w.niessen@erasmusmc.nl) 
A-051 16:10 
VPH-PRISM: opening doors in breast cancer care  
H. Hahn; Bremen/DE (horst.hahn@mevis.fraunhofer.de) 
The optimisation of clinical breast cancer care comprises the prevention of 
over-diagnosis, reduction of over-treatment, and avoiding unsuccessful 
treatments. These goals are targeted in the VPH-PRISM project by seven 
European and two US partner institutions. From the prospectively collected 
data, we will derive optimised imaging protocols that comprehensively take a 
woman's history and risk factors into account. The tight integration of 
radiological and histopathological images enables joint assessment of 
quantitative tissue parameters from microscopic and macroscopic imaging. 
More informed therapy decisions can be taken by such enhanced multi-
disciplinary data, backed by a powerful case database. The reduction of over-
treatment, and highly individualised diagnosis and therapy decisions are 
closely related. We ultimately aim at deriving predictive parameters from the 
multi-modal and multi-disciplinary database to select the treatment option with 
the best chance of enduring recurrence-free survival. Prospectively collected 
data, personal risk factors, and corresponding imaging data fed into the 
database from three large cohort studies are expected to provide insights into 
the individual preconditions and factors affecting disease progression. To 
optimise therapy, the decision between therapy options is key. This will be 
addressed by a decision support system using the project database. For 
surgical excision planning, VPH-PRISM will aim at providing better estimates of 
tumour size, and with visual planning aids supporting radiologists and 
surgeons. For chemotherapy, quantitative lesion parameters, tracked over time 
during therapy, may help to detect success or failure of the treatment early on, 
such that a chemotherapy regime can for a non-responder be switched to a 
different regime in due time.  
A-052 16:30 
Quantitative imaging biomarkers in dementia; the FP7 VPH-Dare@IT 
project  
W.J. Niessen; Rotterdam/NL (w.niessen@erasmusmc.nl) 
The number of individuals suffering from dementia today is roughly 36 million. 
Due to ageing societies, this number is predicted to increase to 115 million by 
2050. Worldwide annual costs are estimated to be €450 billion. In 2012, the 
WHO declared dementia a global health priority, highlighting the urgent need 
for improvements in this area. VPH-DARE@IT's aim is to enable more 
objective, earlier, predictive and individualised diagnoses and prognoses of 
dementias to cope with the challenge of an ageing European society. The 
expected impact of VPH-DARE@IT will influence the scientific, clinical and 
industrial communities across Europe and internationally to improve health 
care of dementia patients. In this presentation we will introduce the VPH-
DARE@IT project. We will then focus on the development, validation and 
implementation of quantitative imaging biomarkers for the early detection and 
differential diagnosis, which will take place as part of the project.  
Author Disclosure:
 W.J. Niessen: Advisory Board; part-time detached to Quantib BV as 
Scientific Director. Shareholder; co-founder and shareholder of Quantib BV. 




Horizon 2020: Improving diagnosis and medical interventions and 
support to medical imaging  
J.-L. Sanne; Brussels/BE (Jean-Luc.Sanne@ec.europa.eu) 
Research and innovation contribute to increasing Europe’s competitiveness. At 
the same time, research and innovation help make people’s lives better by 
improving things like healthcare. In January 2014 the European Union 
launches Horizon 2020, the biggest EU research and innovation programme 
ever, with a budget of € 79 billion (current prices) over seven years (2014-
2020). EU support for research and innovation helps drive international 
projects across the European Union and beyond, and promotes the progress of 
knowledge and technology. One of the three key pillars of Horizon 2020 will be 
tackling Societal Challenges (Priority 3) such "Health, demographic change 
and well-being". One feature is the development of new and more effective 
diagnostics. Relevant tools and technology innovations will be supported in 
view to improve disease outcomes through earlier, more accurate diagnosis 
and by allowing for more patient-adapted treatment. Support will be provided 
through the Work Programme 2014 - 2015 of Societal Challenge 1 "Health, 
demographic change and wellbeing". Additional opportunities are offered in the 
Work Programme 2014 - 2015 of Priority 2 (Industrial leadership) "LEIT - 
Information and Communication Technologies". 
Discussion  17:10
18:30 - 18:50 Room A  
Plenary Session  
OL  
Presiding:  
V.E. Sinitsyn; Moscow/RU 
A-055 18:30 
Etudes of space radiology  
O. Atkov; Moscow/RU (cz-oa@css-rzd.ru) 
Practically, all imaging modalities have been used in space research since a 
long time ago. First of all, radiology is targeted in research activities, because 
by definition all cosmonauts and astronauts are healthy persons. The biggest 
volume of examinations had been performed on crew members for studies of 
organs and functions of the human body before and after long-term flights. 
Health effects of zero gravity were of special interest. For example, multiple 
studies with involvement of both Russian and international specialists were 
done on bone mineralisation (bone densitometry), muscle volume (MRI) and 
metabolism (MR-spectroscopy) both in astronauts and healthy control subjects. 
First, ultrasound (US) examinations were conducted in space onboard Russian 
orbital stations in 1982. Complex US studies were done by the author himself 
during his flight as a crew member of "Salut-7" orbital station in 1984. The 
author had found some complex changes in blood and fluid dynamics under 
weightlessness. Teleradiology was used for data transfer to medical specialists 
on the Earth. Today, we are continuing to use radiology for research on 
astronauts. For example, applications of sophisticated brain MRI and fMRI 
methods are of special interest for studies of subtle brain changes in space 
travellers. Among our targets are flights to the moon, Mars and large asteroids. 
To be better prepared for that task, we need better diagnostic tools. New 
versions of mobile US systems, miniature X-Ray and CT machines suitable for 
use inside spaceships are under development.  
Learning Objectives:
1. To learn about the history of imaging experiments on board of space 
stations. 
2. To understand the need for use of radiological examinations in astronauts. 
3. To become familiar with future perspectives of diagnostic imaging in space 
biomedical research. 
A B C D E F G S15  
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08:30 - 10:00 Room A  
Interactive Teaching Session  
E³ 420a  
Pitfalls in female pelvic imaging  
A-056 08:30 
A. Pitfalls in MRI  
E. Sala; New York, NY/US (salae@mskcc.org) 
There are several MRI pitfalls that should be recognised when imaging the 
female pelvis. MRI appearances of uterus and ovaries are dependent on the 
phase of menstrual cycle/use of exogenous hormone therapy. Normal 
postsurgical and post-radiation appearances of the pelvis can sometimes 
mimic tumour recurrence. It is important to become familiar with these 
appearances to avoid potential pitfalls. One very common pitfall is 
differentiation of transient myometrial contraction from adenomyosis. 
Interrogation of all imaging planes over the duration of the entire MRI 
examination can be useful to distinguish between the two, although myometrial 
contractions can last up to 45 min. The choice of the correct imaging plane is 
crucial for the precise classification of uterine anomalies (coronal oblique) and 
accurate evaluation of parametrial invasion (axial oblique) in patients with 
cervical cancer. Both dynamic contrast-enhanced MRI and diffusion-weighted 
MRI improve the accuracy of MRI in the evaluation of malignant pelvic 
conditions. However, certain pitfalls related to each technique should be 
recognised to avoid misinterpretation. It is crucial to be familiar with the 
anatomy of the uterovesical (UV) ligament, as it is often the site of pelvic 
lymphoma (such as bladder or cervix lymphoma). However, some benign 
conditions such as endometriosis can involve the UV fold and invade both 
bladder and uterine wall. Certain MRI features can be helpful in making the 
correct diagnosis.  
Learning Objectives:
1. To become familiar with normal variations in MRI appearances of female 
pelvis resulting from physiological conditions (e.g. different phases of 
menstrual cycle) and treatments (including exogenous hormone therapy, 
surgery and radiation) potentially mimicking disease. 
2. To consolidate knowledge on the role of the correct MR imaging plane in 
avoiding potential mis-classification of uterine anomalies and parametrial 
invasion in patients with cervical cancer. 
3. To learn about certain pitfalls related to dynamic contrast-enhanced MRI and 
diffusion-weighted MRI. 
A-057 09:15 
B. Pitfalls in ultrasound  
K. Kinkel; Chêne-Bougeries/CH (karen.kinkel-trugli@wanadoo.fr) 
Pitfalls of sonographic findings in the pelvis can be related to technical issues, 
interpretation errors or to the patient's specific condition or pathology. Common 
problems consist of insufficient bladder filling, misinterpretation of posterior 
enhancement or shadowing according to the anatomical structure and 
pathology of a size that goes beyond the field of view of the probe. Organ-
specific problems will be illustrated in interactive questions, particularly for the 
uterus and the ovaries.  
Learning Objectives:
1. To become familiar with anatomical variants potentially mimicking disease. 
2. To describe common pitfalls in pelvic ultrasound. 
Author Disclosure:
 K. Kinkel: Research/Grant Support; Clinique des Grangettes. 
08:30 - 10:00 Room B  
GI Tract  
RC 401  
Misses and difficulties in abdominal 
imaging
A-058 08:30 
Chairman's introduction  
J. Stoker; Amsterdam/NL (j.stoker@amc.uva.nl) 
Identification of diseases can be difficult in many areas of abdominal imaging 
and therefore misses are easily made, also by the more experienced 
radiologist. It is difficult in the mesentery and peritoneum, covering a large area 
but being a very thin structure where abnormalities are easily missed. 
Therefore, knowledge of the peritoneal anatomy and pathophysiology of 
peritoneal diseases is not widespread and differential diagnosis can be difficult. 
Hence, special attention should be paid to prevent misses. Another difficult 
area is diagnosing occult gastrointestinal bleeding. Here, the choice of the 
proper imaging method is crucial as well as understanding the pros and cons 
of the method. The technique used should be optimised, as otherwise 
sometimes subtle signs of bleeding are missed. The presence of bowel 
dilatation itself is often correctly diagnosed, but the extent of the obstruction, 
the cause of the obstruction and especially complications (ischaemia) might be 
misdiagnosed. CT is the preferred technique for evaluation of bowel dilatation. 
Care should be taken to scrutinise the examination for principal findings in 
patients with bowel obstruction.  
A-059 08:35 
A. Mesentery and peritoneum  
D. Akata; Ankara/TR (dakata@hacettepe.edu.tr) 
Imaging findings of neoplastic or inflammatory diseases within the peritoneal 
cavity and the mesentery sometimes overlap and cause difficulties in 
interpretation. Even disease processes in the peritoneum, mesentery or 
omentum may not be recognised on radiological examination, causing major 
difficulties in the management. Peritoneal anatomy and physiopathology of 
peritoneal diseases must be well understood for better evaluation. CT is the 
best modality to assess the whole cavity. MR is equally sensitive with better 
contrast resolution; however, both modalities have advantages and limitations. 
Ultrasound has a complementary role in evaluating the peritoneal fluid content. 
The presence of lacelike mobile thin septa is highly significant for tuberculosis. 
For better diagnosing the pathology, systematic approach is needed such as 
assessing the presence or absence of fluid in the peritoneal cavity, its 
character and location, accompanying soft tissue densities and their location. 
Some inflammatory or infectious causes, such as acute pancreatitis and 
tuberculosis, involve typically parietal peritoneum and certain peritoneal 
reflections. Peritoneal carcinomatosis involves typically both visceral and 
parietal peritoneum as well as subdiaphragmatic space. Contrast enhancement 
patterns of the peritoneal membranes and the mesentery also have a 
complementary role in differentiating a variety of diseases.  
Learning Objectives:
1. To learn about the imaging characteristics of peritoneal and mesenteric 
masses and their differentials. 
2. To appreciate the potential and limitations of imaging techniques in the 
detection of such lesions. 
3. To understand the common pitfalls in diagnosis. 
A-060 08:58 
B. Occult GI bleeding  
A. Filippone; Chieti/IT (a.filippone@rad.unich.it) 
Patients with persistent, recurrent, or intermittent bleeding from the 
gastrointestinal tract for which no definite cause has been identified by initial 
oesophagogastroduodenoscopy, colonoscopy, or conventional radiologic 
evaluation are considered to have an occult gastrointestinal bleeding (OGIB). 
The management of OGIB is clinically challenging, since the causes of such a 
bleeding frequently arise in the small bowel (SB), until now considered as the 
''dark continent''. Conventional barium contrast studies allow only a limited 
evaluation of SB, whereas angiographic diagnosis is strictly related to active 
bleeding. The introduction of capsule endoscopy (CE) as well as of cross-
sectional imaging dedicated to the SB visualisation, such as multidetector-row 
computed tomography enteroclysis (CTE) and magnetic resonance 
enteroclysis (MRE), represents significant technological advances that have 
overcome the limitations of older diagnostic tests. Although CE is 
recommended as a first-line investigation in OGIB patients, CTE or MRE are 
alternative diagnostic tools when CE is contraindicated due to 
suspected/known obstruction or stricture. Moreover, in patients in whom a 
tumour is suspected, CTE or MRE may be the preferred initial test. Therefore, 
radiologists have to be familiar with CTE and MRE techniques, in terms of 
bowel distension, scanning parameter selection, contrast administration as well 
as with specific imaging findings. Similarly, they have to be aware of the 
potential pitfalls such as suboptimal bowel distension, artefacts due to 
peristalsis or breathing, intraluminal food debris and previous surgery.  
Learning Objectives:
1. To understand the causes of GI bleeding and underlying pathophysiology. 
2. To appreciate the strengths and limitations of the imaging techniques used 
in diagnosis. 
3. To learn about common pitfalls in diagnosis. 
A-061 09:21 
C. Bowel dilatation  
E. Danse; Brussels/BE (etienne.danse@uclouvain.be) 
Patients with bowel dilatation frequently require imaging procedures, mainly in 
case of admission in the emergency room as well as in the early post-operative 
period. Plain films, sonography and CT contribute to the management of bowel 
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dilatation. Presently, CT takes a major place in this setting with a reduced role 
for plain films. Sonography is an alternative method when CT is not 
recommended. The questions of Mondor in 1947 were pointed before the 
advent of cross-sectional imaging; these are still valid and have to be 
answered: 1) Is this a true occlusion (how to differentiate it from adynamic 
ileus)? 2) Does the obstruction concern the small bowel or the colon (impacting 
on the decision to operate or not)? 3) What is the cause of the obstruction? 4) 
Are there signs of bowel ischaemia? The key points to avoid missing imaging 
diagnoses in bowel dilatation are to make the distinction between true 
mechanical obstruction and adynamic ileus (an early sign of mesenteric infarct) 
and to detect signs of strangulation leading to ischaemia (such imaging 
findings are present despite normal blood tests). In this setting, CT is the 
preferred technique; if it is not available, plain films and sonography can help in 
an optimal medical decision.  
Learning Objectives:
1. To become familiar with the normal appearances of the bowel and the 
physiological causes of bowel dilatation. 
2. To learn about the different imaging techniques to diagnose bowel dilatation 
and their limitations. 
3. To understand common pitfalls in diagnosis. 
Panel discussion:  
What have I learned from misses and can improvements be made to 
reduce misses?  09:44
08:30 - 10:00 Room C  
Controversies in Chest Imaging  
MC 424  
Computed tomography screening for lung 
cancer: is it time to implement individual 
lung cancer screening in clinical practice?  
Moderator:  
D.M. Hansell; London/UK 
Teaser:  
S. Diederich; Düsseldorf/DE 
A-062 08:30 
A. Implications of the national lung screening trials (NLST)  
D.R. Aberle; Los Angeles, CA/US (daberle@mednet.ucla.edu) 
The National Lung Screening Trial (NLST) found a 20% reduction in lung 
cancer mortality with three annual screens using helical CT relative to chest x-
ray. The US Preventive Services Task Force has issued draft 
recommendations to provide annual CT screening to high risk individuals 
defined by age and smoking criteria. Questions remain regarding the 
implementation of CT screening: the determination of risk to identify those who 
should be screened, the frequency and duration of screening, definitions of 
screen positivity based on detected nodule characteristics, diagnostic 
algorithms for the follow-up of positive screens, overall societal costs of 
screening, and methods to adequately diffuse this technology across all 
socioeconomic groups at risk. Answers to these questions are being 
addressed by several groups through ongoing research and secondary 
analyses of trial data. Several models exist to identify individuals at highest risk 
of lung cancer (and lung cancer mortality), which may be enhanced if validated 
molecular markers are included. Ongoing analyses of nodule features and 
likelihood of lung cancer will better inform screening interpretation guidelines 
and diagnostic algorithms. Estimates from the NLST suggest that screening as 
performed in the NLST will be cost effective: the base case estimates $67,000 
per quality adjusted life year gained (QALY). Subset analyses suggest that 
screening is much more cost-effective in women than men, in higher versus 
lower risk groups, and in current versus prior smokers. While several variables 
influence cost-effectiveness, major drivers of cost are the cost of CT screening 
exams as well as the number of follow-up CT scans per positive screen (1.26 
in NLST).  
Learning Objectives:
1. To learn about the design and findings of the trial. 
2. To understand the harms associated with screening. 
3. To understand the need for better determination of appropriate risk cohorts 
for screening. 
Author Disclosure:
 D.R. Aberle: Advisory Board; Member - LUNGevity Science Advisory Board 
(Unpaid), Consultant - Siemens Medical Advisory Board (Unpaid). Grant 
Recipient; NIH/NCI, U01 CA80098, American College of Radiology Imaging 
Network (ACRIN), ACRIN / NIH-NCI Prime 20080299. 
A-063 08:55 
B. Implications of the European Trials  
M. Prokop; Nijmegen/NL 
While the National Lung Screening Trial (NLST) had shown a significantly 
reduced lung cancer-specific mortality and all-cause mortality, the current 
results from the various European trials do not show such positive results. The 
Dutch-Belgian NELSON trial, the German LUSI trial and the British UKLS have 
not yet published their results. So far, more cancers were detected in the 
screening arm of published Danish and Italian trials, but the positive effect on 
cancer mortality could not yet be shown. The Italian MILD trial even showed 
higher mortality in the yearly screening arm, and no difference between 2-
yearly screening and the control arm. This presentation discusses the 
implications of these findings and the consequences on implementation on 
screening in clinical practice. While limited in number of participants, European 
trials used advanced approaches that are most likely to be used if screening 
will ever be implemented. This presentation will discuss issues such as growth 
assessment and volumetry as critical factors for nodule assessment, handling 
of sub-solid lesions, computer aided detection and evaluation, and use of non-
radiologists for reading and standardised follow-up. The goal is to provide an 
insight into how the European trials have affected our idea on practical 
implementation of lung cancer screening. 
Learning Objectives:
1. To learn what positive screening is, what the optimal management 
algorithms are for the interpretation of scans showing solid or non-solid 
nodules, and how positive subjects should be investigated. 
2. To learn what the optimal follow-up duration and screening interval are. 
Author Disclosure: 
M. Prokop: Research/Grant Support; Toshiba Medical Systems. Speaker; 
Bracco, Bayer, Toshiba. 
A-064 09:20 
Discussion  
D.M. Hansell1, S. Diederich2; 1London/UK, 2Düsseldorf/DE 
The discussion will address the following issues: 
1. Are there sufficient data to support the implementation of individual lung 
cancer screening in clinical practice? 
2. If yes, how to move from efficacy to effectiveness: 
What are the most optimised risk profiles for screening? 
What is the minimum level of infrastructure support and organisation required? 
How should subjects be informed about screening? 
What are the optimal follow-up duration and screening interval? 
What are the technical and positive screen management requirements? 
3. What about the alternatives of waiting for additional data from ongoing trials 
or the validation of new biomarkers of lung cancer, permitting better selection 
of screened population before implementing individual lung cancer screening? 
Attendees' opinions will be collected interactively. The speakers will be asked 
to comment and debate. 
08:30 - 10:00 Room D  
Oncologic Imaging  
RC 416  
Multiparametric MRI for prostate cancer 
management: the essential guide for 
radiologists
A-065 08:30 
Chairman's introduction  
H.-P. Schlemmer; Heidelberg/DE (h.schlemmer@dkfz.de) 
Prostate cancer is the most frequent cancer in men with high medical and 
socioeconomic impact. Cancer detection and treatment decision making is 
frequently based on PSA serum measurement and subsequent TRUS-guided 
biopsy, although considerable limitations are well known. Multiparametric MR 
imaging (mpMRI) on the other hand provides comprehensive morphologic-
biologic information useful as clinically valuable biomarker for: (1) cancer 
detection and patient stratification according to individual tumour 
aggressiveness, (2) localisation of the most aggressive cancer spot (index 
lesion) in this remarkably multifocal and biologically heterogeneous disease, 
(3) guidance of biopsy and therewith establishing the ultimate diagnosis, (3) 
selection and planning of the individually well-adapted therapy, (4) active 
surveillance and if necessary guidance of re-biopsies. The method may 
considerably contribute to the urgently required separation of clinical significant 
from clinical insignificant prostate cancer as overtreatment is still suspected in 
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a significant number of patients. This course gives an overview of the currently 
existing knowledge about diagnosis and treatment of prostate cancer and the 
role of multiparametric MR imaging for individually optimised patient 
management.  
A-066 08:35 
A. The clinical arena: when and how to treat prostate cancer  
F.H. Schröder; Rotterdam/NL (f.schroder@erasmusmc.nl) 
Treatment of prostate cancer depends strongly on the stage of the disease at 
the time of detection. However, treatment is controversial, even in prostate 
cancers found through early detection. This presentation will be based on a 
careful recent literature review. Early detection of prostate cancer by use of 
PSA testing leads to a significant reduction of at least 30% of disease-related 
mortality in screened men. This is however at the price of 40-50% of 
overdiagnosis, usually resulting in overtreatment. Diagnostic developments 
which reduce overdiagnosis and the proper identification of cases which may 
not require treatment are central issues of current research and will be 
addressed by referring to available evidence. Active observation of potentially 
nonaggressive cancers is an option in the management of this disease until, 
preferably, the diagnosis of such cases can be avoided all together. Radical 
prostatectomy and radiotherapy are the options for treating those cancers 
which are judged to be aggressive.  
Learning Objectives:
1. To learn how the diagnosis of prostate cancer is established through PSA 
testing and biopsy. 
2. To understand the various treatment options available to the patient. 
3. To become familiar with the role of imaging in clinical decision-making. 
A-067 08:58 
B. The radiologist's contribution: capabilities of multiparametric MRI in 
clinical routine  
H. Hricak; New York, NY/US 
Treatment recommendations for prostate cancer continue to evolve and are 
affected by technological advances in surgery, new discoveries in tumour 
biology, and the development of predictive and prognostic biomarkers. With the 
increased complexity of treatment decision-making, the role of MRI is also 
evolving. The more individualised and targeted the treatment approach, the 
greater is the role of imaging in treatment selection, planning and follow-up. 
MRI is especially crucial for planning technologically sophisticated treatment 
approaches such as robotic surgery, IGRT, or focal therapy and in assessing 
patients' eligibility for active surveillance. Though needs for uniform 
interpretation and standardised reporting remain unresolved, the value of MRI 
in pretreatment staging of prostate cancer, particularly for evaluating 
extracapsular extension and seminal vesicle invasion, has been documented. 
Not only the tumour stage, but also its size, volume and grade 
(aggressiveness) are important factors that influence treatment selection. 
Therefore, the introduction of functional MR is essential. When added to T2-
weighted MRI, diffusion-weighted MRI, dynamic-contrast-enhanced MRI, and 
MR spectroscopy, in addition to improving tumour detection, can provide an 
indication of tumour aggressiveness. MRI performance on all sequences is 
dependent on lesion size/volume and grade, and this should be considered 
when applying MRI results to treatment selection and planning. While it has 
been shown that multiparametric MRI is generally more accurate and 
informative than anatomic MRI alone, evidence-based guidelines specifying 
which combinations of sequences are essential for specific indications in 
patients with prostate cancer are yet to be developed and validated in well-
designed studies with robust outcome measures.  
Learning Objectives:
1. To learn how to perform and interpret multiparamteric MRI. 
2. To become familiar with the PiRADS classification system. 
3. To become familiar with the role of imaging for patient stratification and 
treatment planning. 
A-068 09:21 
C. The joint action: MR-guided, MR/TRUS-fusion biopsy  
F. Cornud; Paris/FR (frcornud@imagerie-tourville.com) 
The accuracy of multiparametric MRI has greatly improved the ability of 
localising tumour foci of prostate cancer. This property can be used to perform 
a TRUS-MR image registration, a new technological advance, which allows for 
an overlay of an MRI onto a TRUS image to target a prostate biopsy towards a 
suspicious area. Three types of registrations have been developed: cognitive-
based, sensor-based and organ-based registration. Cognitive registration 
consists of aiming at a suspicious area during biopsy with the knowledge of the 
lesion location identified on multiparametric MRI. Sensor-based registration 
consists of tracking in real time the TRUS probe with a magnetic device, 
achieving a global positioning system which overlays in real time prostate 
image on both modalities. Its main limitation is that it does not take into 
account prostate and patient motion during biopsy Two systems (Artemis and 
Uronav) have been developed to partially circumvent this drawback. Organ-
based registration (Koelis) does not aim at tracking the TRUS probe, but the 
prostate itself to compute in a 3D acquisition the TRUS prostate shape, 
allowing for a registration with the corresponding 3D MRI shape. This system is 
not limited by prostate/patient motion and allows for a deformation of the organ 
during registration. Pros and cons of each technique and the rationale for a 
targeted biopsy only policy are discussed.  
Learning Objectives:
1. To understand the clinical challenges and techniques of prostate biopsy. 
2. To become familiar with the MR-guided and MR/TRUS fusion approach. 
3. To learn how MRI improves the diagnosis and characterisation of prostate 
cancer. 
Panel discussion:  
Is multiparametric MRI essential for the management of prostate cancer 
patients?  09:44
08:30 - 10:00 Board Room B  
Emergency Radiology  
RC 417  
Vascular: emergent, not urgent!  
A-069 08:30 
Chairman's introduction: highlighting the benefits of minimally invasive 
procedures in vascular emergencies  
G. Schueller; Bülach/CH (gerd.schueller@spitalbuelach.ch) 
In major trauma, it is essential to immediately recognise life-threatening 
conditions and to initiate early treatment. The majority of these patients 
succumb at the site of the injury to severe injuries of the central nervous 
system, heart and great vessels. However, there is another peak of early 
deaths within the first four hours after the injury. In the majority, these patients 
are at risk due to haemorrhage which is basically controllable by early 
minimally invasive treatment. Consequently, this means that the vast majority 
of internal injuries can be survived as long as bleeding control is achieved 
within the first four hours after an injury. Minimally invasive interventional 
techniques are already in use at a very early stage of the clinical decision-
making process. Particularly, we have witnessed a major paradigm shift in the 
treatment of blunt aortic injuries. Endovascular repair has replaced open repair 
in many trauma centres. In appropriately selected patients, this adoption of 
endovascular stent grafts has resulted in a reduction in perioperative mortality, 
stroke and paraplegia, as compared to open repair. This entire session will 
provide knowledge about indications, requirements, standard procedures, and 
outcome of vascular emergencies, pardon me, urgencies.  
A-070 08:40 
A. Aortic emergencies  
M. Cejna; Feldkirch/AT (manfred.cejna@lkhf.at) 
Aortic emergencies can be classified into several categories. "Acute aortic 
syndrome": Acute aortic syndrome is an entity of changes of the aortic wall. 
These include aortic dissection, intramural thrombus, and penetrating 
atherosclerotic aortic ulcer. Besides coronary malperfusion and aortic valve 
insufficiency (type A dissection), emergency presentation is often due to 
visceral/limb ischaemia. Sequelae of aortic syndromes are pseudoaneurysm 
formation and potentially aortic rupture. Endovascular treatment has been 
established as the treatment option in at least type B dissections and 
penetrating aortic ulcers. Aortic aneurysm rupture: With increasing diameter, 
aneurysms in the thoracic, thoraco-abdominal and abdominal aorta are prone 
to rupture. Signs of impending aortic rupture are pain and imaging signs are 
sometimes subtle just like blurred contours of the aorta and (blister like) 
vascular wall deformation. Endovascular treatment is an alternative to vascular 
surgery. Aortic trauma: In severe thoracic trauma (mostly deceleration trauma), 
pseudoaneurysm formation and aortic rupture occur at the level of the aortic 
isthmus. Endovascular treatment is considered the treatment of choice. 
Inflammation, mycotic aneurysms and aorto-enteric fistulae: With acute and 
chronic inflammation, aneurysm and pseudoaneurysm formation and fistulae to 
enteric structures can occur. Endovascular treatment is more often considered 
as bridging to vascular surgery instead of being a definitive cure. Iatrogenic 
aortic injuries: Besides accidental aortic injury during operations or 
interventional procedures, transaortic valve replacement and placement of 
aortic balloon pumps can result in iatrogenic trauma. Endovascular treatment 
may be a minimally invasive approach. The focus will be on systematic 
presentation of aortic emergencies and the role of endovascular treatment.  




1. To become familiar with the most important imaging findings and their 
impact on patient management. 
2. To understand common classification systems and their impact on patient 
management. 
3. To learn about typical interventional radiological procedures. 
Author Disclosure:
 M. Cejna: Speaker; ABBOTT, COOK, BIOTRONIK. 
A-071 09:00 
B. Visceral emergencies  
G. Goh; London/UK (gerard.goh@stgeorges.nhs.uk) 
There are a number of vascular visceral emergencies that may be traumatic or 
nontraumatic in origin. The degree of urgency or potential for urgency varies 
with each condition and the subsequent management and intervention 
techniques will vary accordingly. An understanding of the natural history, 
pathophysiology, diagnostic tests and interventional techniques for these 
conditions will aid the diagnostic and interventional radiologist in identifying the 
pathology and knowing when to refer or initiate definitive treatment.  
Learning Objectives:
1. To become familiar with the most important imaging findings and their 
impact on patient management. 
2. To understand common classification systems and their impact on patient 
management. 
3. To learn about typical interventional radiological procedures. 
Author Disclosure:
 G. Goh: Consultant; Boston Scientific, Covidien. Research/Grant Support; 
Covidien. Speaker; Cook Medical, St Jude Medical. 
A-072 09:25 
C. Peripheral emergencies  
R. Omidi; Bülach/CH (reza.omidi@spitalbuelach.ch) 
I talk about embryonal development and anatomical differentiation of 
cardiovascular system, with special attention to the peripheral vascular system. 
The goal of this part of presentation would be to understand the anatomical 
structure and architecture of arteries and capillaries. We will discuss the 
Casual Classification of different kinds of peripheral arterial emegencies; e.g. 
congenital, posttrauma, arteriosclerotic and iatrogenic. The audience will learn 
about different therapy approaches, interventional and non-interventional, with 
accent on PAD (classification, pathophysiology, Risk factors, statistical facts 
and therapy). At the end, we will review different studies about combination 
therapy (conventional and interventional) with different possibilities and 
outcomes.  
Learning Objectives:
1. To become familiar with the most important imaging findings and their 
impact on patient management. 
2. To understand common classification systems and their impact on patient 
management. 
3. To learn about typical interventional radiological procedures. 
Panel discussion:  
Cooperation with clinicians: what still needs to be done?  09:45
08:30 - 10:00 Room E1  
New Horizons Session  
NH 4  
Imaging the hallmarks of cancer  
A-073 08:30 
Chairman's introduction: importance of cancer hallmarks for radiologists  
A.R. Padhani; Northwood/UK (anwar.padhani@stricklandscanner.org.uk) 
Modern cancer research and increasing therapy are mechanism based with 
the development of disease-modifying therapies that target the hallmarks of 
cancer. Modern imaging tools enable the visualisation and quantitative 
assessment of the expression of molecular targets, of their interaction with 
potential ligands, as well as of the functional consequences of interactions at a 
molecular, cellular, metabolic, physiological, and morphological levels in a 
temporo-spatially resolved manner. The ability to gather such information from 
the intact organism renders imaging highly attractive for biomedical research 
and drug development.  
Session Objectives: 
1. To understand that human cancers acquire functional capabilities, which 
allow cancer cells to survive, proliferate, and disseminate acquired during a 
multistep development process. 
2. To become familiar with established hallmarks (sustained proliferative 
signalling, evading growth suppressors, resisting cell death, enabling 
replicative immortality, inducing angiogenesis, and activating invasion and 
metastasis) and enabling hallmarks (genomic instability and inflammation). 
3. To understand that cancer hallmark development creates vulnerabilities, 
providing new means to develop treatments for human cancer. 
4. To consolidate knowledge of imaging techniques, which allow for serial 
observation of the heterogeneous development of hallmark distribution and 
monitoring of adaptive changes in response to therapy interventions. 
A-074 08:35 
Cell proliferation and death  
U. Haberkorn; Heidelberg/DE (Uwe_Haberkorn@med.uni-heidelberg.de) 
The determination of cell proliferation with radiolabelled thymidine is a well-
established method in various life science branches where [3H]thymidine has 
been used for more than 40 years and still represents the gold standard for the 
assessment of tumour cell proliferation. Since non-invasive determination of 
this parameter is required in clinical studies, considerable efforts have been 
made in radiopharmaceutical research. The synthesis of a large series of 
proliferation markers resulted therefrom mostly focussing on pyrimidine 
nucleosides. The labels used were gamma as well as positron emitting 
radionuclides. Here, [18 F]FLT (3'-deoxy-3'-fluorothymidine) is examined and 
discussed with respect to its preclinical and clinical application. Since 
apoptosis is an important mechanism of cell death in tumours responding to 
treatment, the non-invasive assessment of apoptosis with tracers for the 
detection of phosphytidyl-serine presentation and/or caspase activation could 
be used as surrogate marker for therapeutic efficacy. Several approaches have 
been followed during the last years; their potential and limitations will be 
presented.  
Learning Objectives:
1. To understand the biochemical processes in apoptosis and proliferation. 
2. To learn about the changes in apoptosis and proliferation that can be used 
as targets for the development of tracers. 
3. To learn about the challenges in apoptosis and proliferation imaging. 
4. To consolidate knowledge of preclincial and clinical applications. 
A-075 09:00 
Angiogenesis  
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de) 
Angiogenesis is one of the hallmarks of cancer that is considerably easy to 
characterise with many different imaging modalities and methods. It is not only 
crucial for invasive and metastatic tumour growth, but is also a prerequisite for 
the accumulation of anticancer drugs and highly impacts the success of 
radiotherapy. This talk summarises our experiences in microstructural, 
functional, and molecular imaging of tumour angiogenesis. The micro-
architecture of vessels can longitudinally be studied using high-resolution 
()CT. DCE MRI and HF-US are introduced as favourable tools to characterise 
perfusion, vessel permeability and vessel maturation during antiangiogenic 
treatments. Using targeted probes, it is shown that "fluorescence molecular 
tomography (FMT)", MRI and US are capable of estimating the expression of 
angiogenic marker molecules on tumour vessels and of matrix-associated 
enzymes in the interstitial space during vascular remodelling. Additionally, 
examples are also given for EPR-based nano-sized theranostics and it is 
shown how US can aid in better accumulating them at the target site by 
inducing vascular permeation. Many of these novel imaging concepts and tools 
can relatively easily be translated into clinics. Thus, one can expect them to 
play a major role in the clinical management of tumour treatments soon.  
Learning Objectives:
1. To understand the basic molecular and physiological processes during 
angiogenesis. 
2. To learn about important imaging techniques for characterising vessel 
function. 
3. To become familiar with techniques and contrast agent methods for 
molecular imaging of angiogenesis. 
4. To learn about its potential for basic research and clinical use. 
A-076 09:25 
Dysregulated metabolism  
K. Brindle; Cambridge/UK (kmb1001@cam.ac.uk) 
Tumour cells display high rates of aerobic glycolysis (Warburg effect). While 
the tumour microenvironment, which is frequently hypoxic, might select for cells 
that are glycolytic, and thus can generate ATP in the absence of oxygen, it has 
become increasingly clear that this and the other metabolic changes observed 
in tumour cells are driven by oncogene activation and tumour suppressor loss. 
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Moreover, while these metabolic changes are important for generating ATP 
under the often anaerobic conditions found in the tumour microenvironment, 
they also have other important functions, such as the generation of metabolic 
intermediates for biosynthetic pathways. This altered metabolism has provided 
new ways of detecting tumours and their responses to treatment using 
metabolic imaging. Nuclear spin hyperpolarisation can increase sensitivity in 
the magnetic resonance experiment by > 10,000x. This has allowed imaging of 
injected hyperpolarised 13C labelled cell substrates in vivo and, more 
importantly, their metabolic conversion into other metabolites. Exchange of 
hyperpolarised 13C label between lactate and pyruvate has been shown to 
decrease post-treatment and hyperpolarised [1.4-13C] fumarate has been 
shown to detect tumour cell necrosis. Tumour pH can be imaged using 
hyperpolarised H13CO3¯ and redox state can be determined by monitoring the 
oxidation and reduction of [1-13C] ascorbate and [1-13C] dehydroascorbate, 
respectively. Tumour glycolysis can be monitored by measuring the conversion 
of hyperpolarised [U-2H, U-13C] glucose to lactate and this flux was shown to 
decrease post-treatment. This new technique, which has recently transitioned 
to the clinic, has provided new ways of investigating tumour metabolism and 
the tumour microenvironment and for detecting treatment response.  
Learning Objectives:
1. To learn about metabolic imaging using hyperpolarised 13C MR 
spectroscopic imaging and to appreciate its limitations with respect to the short 
half-life of the polarisation. 
2. To understand how this technique can be used to study tumour metabolism. 
3. To become familiar with applications of the technique to monitor tumour 
responses to treatment. 
4. To consolidate knowledge of this technique in relation to other imaging 
methods for imaging tumour metabolism and for detecting treatment response. 
Author Disclosure:
 K. Brindle: Patent Holder; A number of patents held jointly with GE 
Healthcare on the use of hyperpolarised 13C magnetic resonance 
spectroscopic imaging. Research/Grant Support; Research agreement with GE 
Healthcare covering the development of hyperpolarised 13C magnetic 
resonance spectroscopic imaging in oncology. 
Panel discussion: 
Cancer hallmarks as therapeutic targets  09:50
08:30 - 10:00 Room E2  
Foundation Course: Breast Imaging  
E³ 420b  
Mammography  
Moderator:  
P. Skaane; Oslo/NO 
A-077 08:30 
A. Digital mammography: technique and quality assurance  
M.G. Wallis; Cambridge/UK (matthewwallis492@btinternet.com) 
Mammography technique from the point of view of radiographic compression 
and positioning is no different from film screening and radiologists ignore this at 
our peril. We will discuss the danger areas at the edges and the back of the 
breast and help you to find lesions only seen on one view. With digital capture 
the technologist can view images immediately, but the temptation is for them to 
repeat exposures to obtain radiographic perfection on otherwise clinically 
acceptable images. However, the task of assessing quality cannot be left to 
them, as viewing conditions on the 'lower resolution' acquisition monitor in a 
bright x-ray room is not enough. There is now evidence from 2 population 
screening programmes that poor image quality can reduce cancer detection 
from between 15% in France to 24% in Ontario. 'Quality' can be lost at 3 keys 
points in the imaging chain: the x-ray beam and dose, the detector and finally 
display. In Flanders, poor detector performance was compensated for by 
increasing the x-ray dose by 60% and by meticulous quality control. Post-
processing is less well understood, but reader studies now show different 
algorithms will affect performance particularly for the detection and 
classification of micro-calcification. Finally, it does not matter how good all the 
equipment is if we try and read the images with the lights on full.  
Learning Objectives:
1. To become familiar with basic digital mammography techniques. 
2. To appreciate radio-anatomical considerations. 
3. To understand what can go wrong if the quality is not adequate. 
A-078 09:00 
B. Tomosynthesis and contrast-enhanced digital mammography  
J. Barkhausen; Lübeck/DE (joerg.barkhausen@uksh.de) 
Mammography is the most important breast imaging technique allowing the 
visualisation of masses and micro-calcifications. However, in conventional 
mammography the three-dimensional breast tissue is reduced to a two-
dimensional image. Therefore, small lesions may be undetectable due to 
superimposed glandular tissue. Digital breast tomosynthesis (DBT) has 
emerged as a new imaging modality to overcome this limitation. Several low-
dose mammographic projections are performed over a limited angle of up to 50 
degree using a standard mammography system. The average glandular dose 
of a tomosynthesis scan is somewhat higher compared to one-view 
mammography, but lower compared to a standard mammography in two 
projections. Based on the low-dose projections, a stack of cross-sectional 
images covering the entire breast is reconstructed with an interslice distance of 
about 1 mm. Several studies have shown that tomosynthesis improves both 
tumour detection and the characterisation of focal masses. Due to the cross-
sectional nature of DBT, the techniques allow on the one hand the reliable 
differentiation of true focal masses from summation artefacts. On the other 
hand, tomosynthesis improves the detailed analysis of the lesions' border to 
differentiate benign lesions and carcinomas. Additionally, contrast-enhanced 
spectral tomosynthesis may allow analysing signal-intensity time curves. In 
conclusion, DBT adds important information to standard two-projection 
mammography and can replace spot compression and rolled views as problem 
solver for difficult cases. However, the impact of tomosynthesis on breast 
cancer screening has to be investigated in larger clinical trials.  
Learning Objectives:
1. To understand the implications of switching to 3D (technique, dose, 
reading). 
2. To become familiar with the pros and cons of 2D vs. 3D reading. 
3. To learn about the effects of digital tomosynthesis on productivity. 
A-079 09:30 
C. Screening mammography  
E. Azavedo; Stockholm/SE (edward.azavedo@ki.se) 
Reading screening mammograms is not the same as reading diagnostic 
mammograms. The vast majority of women attending a screening programme 
are usually asymptomatic and do not have abnormalities associated with a 
malignancy. The task of a mammogram reader is to scan a mammogram and 
perceive any possible abnormalities that could be associated with a 
malignancy. In other words, we are talking about perception and not diagnosis 
of a finding. Examples will be shown about this crucial step. In modern 
population-based screening programmes, we use computerised reading and 
recording systems. Since the work flow is rather quick, we have to ensure 
basic steps such as identity control and see that both RIS and PACS are 
synchronised so that decisions of screening readings are recorded in both the 
systems of one and the same patient. In computerised screening programmes, 
we use standard reports informing a woman that no signs of malignancy have 
been detected on her screening mammograms. In case of findings that need 
further assessment, there are several ways to deal with this situation. The most 
common way is via a phone call, but this can also be done with a letter. A 
screening report should be short and concise and should only inform whether 
we see signs of a possible abnormality that can be associated with a 
malignancy. Extensive reports describing the contents of a breast or findings of 
no clinical relevance should not be part of a screening report.  
Learning Objectives:
1. To understand the basics of human vision. 
2. To become familiar with the key components of a computerised 
mammography reading system. 
3. To learn about reporting strategies. 
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08:30 - 10:00 Room F1  
Joint Course of ESR and RSNA (Radiological Society  
of North America): Emergency Radiology  
MC 422  
General principles: paediatric and ENT 
emergencies  
Moderators:  
S.E. Mirvis; Baltimore, MD/US 
A. Palko; Szeged/HU 
A-080 08:30 
A. General principles  
U. Linsenmaier, S. Wirth; Munich/DE 
(Ulrich.Linsenmaier@kliniken-pasing-perlach.de) 
Emergency radiology services are very much on the rise in the last decade. 
Medical emergencies and trauma are of enormous importance and a leading 
cause of death in all age groups. The use of radiological imaging in emergency 
departments showed an exponential increase since the 1990s. The annual 
growth rate in CT is 5-15% per year depending on the institution. Even for 
advanced level 3° medical centres running an own emergency radiology unit, it 
is a challenge to integrate advanced radiology services in an interdisciplinary 
team treating patients with acute traumatic and non-traumatic emergencies. 
General principles: radiology and radiological imaging procedures should be 
integrated in an interdisciplinary team. Imaging should be guided by 
interdisciplinary clinical algorithms or guidelines (e.g. NEXUS or Canadian C-
spine Rule). Many clinical diagnoses relay today on a early and thorough initial 
radiological diagnostic workup - mostly based on MDCT. Emergency radiology 
(ER) is still a relatively young subspecialty in European radiology - it deserves 
specific training. The lecture will cover: the development of emergency 
radiology and its future perspectives; the use of conventional radiography, 
ultrasound and MDCT; logistics and management of the patient; clinical 
guidelines and MDCT in the primary patient survey (e.g. using ATLS for 
trauma) and advanced scanning protocols for MDCT.  
Learning Objectives:
1. To learn about general principles of diagnostic imaging in emergency 
radiology in traumatic and non-traumatic emergencies. 
2. To understand the etiology, background and management of common 
radiological emergencies. 
3. To appreciate the role, indications and protocols for US, CR, MDCT in 
modern emergency radiology. 
A-081 09:00 
B. Challenges of imaging paediatric abdominal emergencies  
S.D. John; Houston, TX/US (Susan.D.John@uth.tmc.edu) 
Infants and children with abdominal emergencies present special diagnostic 
challenges because of similarities in clinical findings between various 
paediatric conditions. Imaging is frequently a critical part of the diagnostic 
process, but the choice of the best imaging modality can be controversial. 
Patient age and safety issues such as radiation exposure must be taken into 
consideration when planning imaging. Because certain pathologies are more 
likely to occur in specific age groups, patient age is a primary determinant of 
the imaging approach. This presentation will illustrate the differences in 
pathology between several paediatric age groups and discuss effective 
imaging algorithms for congenital and developmental, inflammatory, and 
obstructive conditions. The optimal use of radiographs, ultrasound, CT, and 
MRI will be discussed. Pitfalls that should be avoided in ultrasound and CT will 
be emphasised.  
Learning Objectives:
1. To learn how to plan safe and effective imaging strategies for evaluating 
abdominal pain in infants and children. 
2. To understand the common and unusual causes of abdominal pain in 
different paediatric age groups. 
3. To become familiar with potentially confusing variations in the appearance of 
these conditions with imaging. 
A-082 09:30 
C. Imaging in ENT emergencies  
D. Nunez; New Haven, CT/US (Diego.Nunez@ynhh.org) 
Non-traumatic emergent conditions involving the ear, nose and throat comprise 
a variety of disease entities, some of which may become life threatening if not 
readily recognised and treated. They typically present as bleeding, or as 
difficulty in breathing or swallowing. Occasionally, imaging studies may aid in 
the appropriate localisation of airway obstructing foreign bodies or in the 
diagnosis and treatment of epistaxis by guided interventional procedures. It is 
however in the assessment of head and neck infections and their 
complications that cross-sectional imaging plays a fundamental role. Facial 
and cervical infections are common clinical problems and although a 
presumptive diagnosis can be made clinically, imaging studies are often 
requested to confirm the diagnosis, to localise the infectious process and 
importantly to exclude the possibility of abscess formation or other 
complications. The contribution of imaging becomes more relevant in patients 
with clinical suspicion of deep neck infection where access to appropriate 
clinical evaluation may be limited. This presentation will analyse the imaging 
findings of head and neck infections using a systematic a spatial approach, as 
well as the indications for emergent CT and MR when necessary. A variety of 
complications will be discussed including intracranial extension of disease, 
airway compromise, vascular lesions and osseous involvement.  
Learning Objectives:
1. To understand imaging findings in patients presenting with acute head and 
neck conditions using a systematic spatial approach. 
2. To get an understanding of the role and indications of CT and MR in acute 
non-traumatic ENT case management. 
3. To learn how to identify the extent of disease and recognise specific 
complications of cervicofacial infections. 
08:30 - 10:00 Room F2  
Radiographers  
RC 414  
Child protection issues: raising awareness 
among medical imaging professionals  
A-083 08:30 
Chairman's introduction  
J. McNulty; Dublin/IE (jonathan.mcnulty@ucd.ie) 
In diagnostic imaging, we tend to focus on radiation protection, justification and 
optimisation, as the primary opportunity for radiographers and radiologists to 
ensure the safety of patients, both adults and children; however, this ignores 
some other important issues. This session aims to raise awareness amongst 
medical imaging professionals of some key considerations in relation to a 
number of child protection issues. When imaging a child in case of suspected 
non-accidental injury, every detail of that examination from conversations with 
the child and their parents or guardians, technical aspects of the examination, 
observations during the examination and the language used following the 
examination need to be carefully considered. Another area of medical imaging 
requiring attention is how we communicate any radiation risks associated with 
examinations or procedures with children and their parents. There is evidence 
that while consent processes for invasive procedures are usually in place, 
these often lack focus on the risks associated with a high exposure to ionising 
radiation. These two medico-legal areas, suspected non-accidental injury and 
risk communication, are commonly encountered by radiographers and 
radiologists and as such it is important to make sure that we operate at the 
highest possible professional standards and in keeping with both regulations 
and best practice including the production of witness 
statements/contemporaneous notes. On rare occasions, we may find ourselves 
involved in legal proceedings as a witness or expert witness and it is thus 
important that we are all aware of the key considerations in this regard.  
Session Objectives:
1. To appreciate the need for radiographers to focus on more than just the 
imaging procedure in paediatric examinations. 
2. To understand the extremely vulnerable nature of paediatric patients and the 
need for all health professionals to pay particular attention to this. 
A-084 08:35 
A. Professional responsibilities: an international perspective  
M. Davis; Dublin/IE (michaela.davis@ucd.ie) 
Radiographers play a vital role in imaging children with suspected non-
accidental Injuries. This session will also explore the wider role that 
radiographers have in child protection. Current legislation and its implications 
will be explored from a variety of countries including those outside Europe. In 
addition, case studies will be presented focussing upon child protection issues 
that have arisen in the x-ray department during imaging procedures. Several of 
the barriers to radiographers becoming involved in child protection will be 
explored. Radiographers and their contribution to child protection will be 
discussed and practical examples given.  




1. To become familiar with current legislation and guidelines which have 
particular relevance to radiographers from an international perspective. 
2. To appreciate best practice in child protection and the need for all 
radiographers to be aware of this. 
3. To learn about child protection case reports involving imaging, radiologists 
and radiographers. 
A-085 08:58 
B. Risk communication in paediatric examinations  
J.L. Portelli; Msida/MT (jonathan.portelli@um.edu.mt) 
Medical imaging plays a vital role in the diagnosis and treatment of numerous 
medical conditions for millions of patients worldwide. However since most 
medical imaging examinations utilise ionising radiation, the associated risks of 
radiation exposure also need to be acknowledged, especially since high doses 
of radiation are known to cause adverse biological effects. Medical imaging 
professionals should have a good understanding of the benefits and risks 
associated with the imaging examinations they perform, so as to ensure a high 
benefit-risk ratio for all patients undergoing diagnostic imaging procedures, and 
to be able to appropriately communicate such information to patients, their 
families and other healthcare professionals. This may be particularly more 
important when imaging paediatric patients, who are relatively more 
susceptible to the effects of radiation and receive a higher effective dose per 
unit of radiation when compared with adults undergoing the same medical 
imaging examination. Indeed, following worldwide media attention about 
radiation incidents and their adverse effects, some parents/legal guardians 
may be concerned and reluctant to pursue important medical imaging 
examinations requested for their child, as they may have a misconception of 
the risks involved. In this regard, this lecture will seek to enhance awareness 
about the radiation doses associated with common paediatric imaging 
examinations; highlight the importance of medical imaging professionals 
having an appropriate understanding of benefits and risks associated with 
these examinations; and encourage such professionals to improve patient care 
by making use of this knowledge to have better discussions with referring 
clinicians, patients and their families.  
Learning Objectives:
1. To appreciate the frequency and radiation dose associated with certain 
paediatric imaging examinations. 
2. To become familiar with the current status quo in the communication of 
radiation dose-related risks. 
3. To understand best practice and potential considerations in providing 
accurate information to referring clinicians, patients and their families. 
A-086 09:21 
C. What to do if you find yourself being called to give evidence  
M.D. Viner; London/UK 
Radiology is a powerful tool in the investigation of cases of suspected non-
accidental injury and suspicious death in children. The evidence obtained can 
be pivotal in bringing successful prosecutions against suspects and protecting 
the child and others from further harm. It is essential that evidence is obtained, 
recorded and presented in accordance with applicable rules of evidence in 
order to be admissible in court. It is thus important that those undertaking such 
examinations are appropriately trained, conversant with standards of evidence 
and maintain continuity of evidence throughout the investigation. This 
presentation will review rules of evidence for cases of suspected child abuse 
and their application to imaging examinations. It will examine the role of the 
radiographer and the importance of training and familiarity with legislation and 
guidelines that underpin forensic practice, highlighting the pitfalls that lawyers 
may exploit if procedures have not been followed. Drawing on examples, it will 
discuss best practice from the radiographer's perspective, detailing the 
importance of continuity of evidence and maintenance of contemporaneous 
notes and witness statements. It will address key considerations for 
radiographers and others who provide evidence or act as an expert witness. 
Imaging professionals play a pivotal role in the investigation of suspected child 
abuse. It is essential that this evidence is obtained, recorded and presented 
with regard to the applicable standards of evidence. For those called to give 
evidence, the importance of appropriate imaging protocols and procedures, 
detailed documentation and thorough preparation cannot be understated.  
Learning Objectives:
1. To understand the importance of contemporaneous notes and witness 
statements if involved in any forensic or suspected non-accidental injury 
examination. 
2. To become familiar with the importance of continuity of evidence in forensic 
examinations. 
3. To appreciate the key considerations if you are asked to provide evidence or 
act as an expert witness in court. 
Panel discussion:  
Is there a need for further education and training for radiologists and 
radiographers?  09:44
08:30 - 10:00 Room G/H  
Neuro  
RC 411  
The paediatric brain: not just a small brain  
Moderator:  
N. Girard; Marseille/FR 
A-087 08:30 
A. Neurocutaneous syndromes: more than neurofibromatosis  
B. Ertl-Wagner; Munich/DE (Birgit.Ertl-Wagner@med.uni-muenchen.de) 
Neurofibromatosis type 1 is the most common, but certainly not the only 
neurocutaneous syndrome. In children, white matter signal alterations are a 
common neuroimaging finding. The incidence of optic gliomas and other 
gliomas has increased. Neurofibromas can occur in almost any body region. 
Plexiform neurofibromas show a diffuse and often locally destructive growth. 
Neurofibrosarcomas are malignant nerve sheath tumours. Neurofibromatosis 
type 2 is characterised by "acoustic neuromas" (mostly vestibular 
schwannomas), which can be uni- or bilateral. Schwannomas can also affect 
other cranial nerves and spinal nerves. The incidence of meningiomas and to a 
lesser extent of gliomas is also increased. The hallmark feature of tuberous 
sclerosis is the combination of cortical or subcortical tubers and subependymal 
nodules. Tubers are hyperintense on T2w and FLAIR sequences. 
Subependymal nodules are NOT isointense to grey matter (vs. subependymal 
heterotopias). Giant cell astrocytomas are located at the foramina of Monroi, 
increase in size over time and show a contrast enhancement. Sturge-Weber 
disease (encephalotrigeminal angiomatosis) is characterised by a 
leptomeningeal angioma and facial naevus flammeus. There is increased 
leptomeningeal enhancement and hypertrophy of the ipsilateral choroid plexus. 
Atrophy of the affected region and tramtrack calcifications typically ensue. Von 
Hippel-Lindau disease is not a neurocutaneous syndrome per se, but 
classically considered a phakomatosis. Typical features include 
haemangioblastomas of the brain, spinal cord or retina, and papillary 
cystadenomas of the endolymphatic sac. Most neurocutaneous syndromes 
have manifestations outside the central and peripheral nervous systems as 
well. Moreover, there are multiple rare neurocutaneous syndromes.  
Learning Objectives:
1. To become familiar with the typical clinical presentations of neurocutaneous 
syndromes. 
2. To consolidate knowledge of the typical imaging patterns of the major 
neurocutaneous syndromes. 
3. To become familiar with some less common features of neurocutaneous 
syndromes. 
A-088 09:00 
B. Patterns of white matter disease in children  
A. Rossi; Genoa/IT (andrearossi@ospedale-gaslini.ge.it) 
Pediatric white matter disorders can be distinguished into well-defined 
leukoencephalopathies and undefined leukoencephalopathies. The first 
category may be subdivided into: (a) hypomyelinating disorders; (b) 
dysmyelinating disorders; (c) leukodystrophies; (d) disorders related to cystic 
degeneration of myelin; and (e) disorders secondary to axonal damage. The 
second category, representing up to 50% of leukoencephalopathies in 
childhood, requires a multidisciplinary approach in order to define novel 
homogeneous subgroups of patients, possibly representing '"new genetic 
disorders''. An integrated description of the clinical, neuroimaging, and 
pathophysiological features is crucial for categorising myelin disorders and 
better understanding their genetic basis. A review of the MR imaging findings 
in the main genetic disorders affecting white matter in the pediatric age, 
including some novel entities, will be provided with a highlight on the concept 
of pattern recognition.  
Learning Objectives:
1. To become familiar with the most common white matter diseases in children. 
2. To learn how to differentiate between white matter diseases in children. 
3. To consolidate knowledge of appropriate imaging protocols for MRI of 
children with white matter disease. 




C. Paediatric brain tumours  
M. Bekiesinska-Figatowska; Warsaw/PL (m.figatowska@gmail.com) 
Brain tumours are the second most common neoplasms in children after 
leukaemia. As "paediatric brain is not just a small brain", paediatric brain 
tumours are not the same as tumours in adults. MRI is a method of choice in 
their diagnosis in accordance with the principle ALARA in the paediatric 
population. By the age of approximately 3 years, supratentorial tumours 
dominate; later (4-10 years of age), the majority of children show infratentorial 
neoplasms which are pilocytic astrocytomas, most often found in the 
hemispheres, and medulloblastomas or ependymomas - in the fourth ventricle. 
After the age of 10, both groups are diagnosed with equal frequency. Cerebral 
hemispheric tumours include astrocytoma which is the most frequent, teratoma 
in neonates, and in older children atypical teratoid/rhabdoid tumour, 
ependymoma, PNET, ganglioglioma and DNET. In the midline, we deal with 
chiasmatic or hypothalamic glioma, craniopharyngioma and germ cell tumours 
of the pineal region. Extraparenchymal tumours are uncommon in the 
paediatric population. Apart from the location, imaging pattern in various 
sequences, and contrast enhancement of the tumour, advanced MRI 
techniques are helpful in establishing the diagnosis. DWI helps to differentiate 
between tumours of high and low cellularity showing low ADC values in case of 
medulloblastoma and high in astrocytoma. MRS, PWI and DTI also add 
important information to the diagnosis. MRI of the spinal canal is obligatory in 
case of these primary brain neoplasms that have a high propensity to 
metastasise to other parts of the central nervous system such as 
medulloblastomas, ependymomas, high-grade gliomas, cerebral 
neuroblastomas, and pineal region neoplasms.  
Learning Objectives:
1. To learn about the difference between paediatric and adult brain tumours. 
2. To understand the imaging strategy for the paediatric population. 
3. To become familiar with the most common paediatric brain tumours. 
08:30 - 10:00 Room I/K  
Multidisciplinary Session: Managing Patients with Cancer  
MS 4
Pancreatic neuro-endocrine tumours  
A-090 08:30 
Chairman's introduction  
R. Pozzi-Mucelli; Verona/IT (roberto.pozzimucelli@univr.it) 
Pancreatic endocrine tumours (p-NETs) include both pancreatic 
neuroendocrine tumours associated with a functional syndrome (functional p-
NETs) and those associated with no distinct clinical syndrome (non-functional 
p-NETs). Non-functional p-NETs may show immunohistochemical positivity for 
hormones which may be produced, but not secreted, which are clinically inert 
and whose serum concentrations are insufficient to induce symptoms. Among 
functional p-NET, the most common are gastrinomas and insulinomas, 
whereas those secreting vasoactive intestinal peptide, glucagon, somatostatin 
and other hormones are considered together as a group called rare functional 
p-NETs. Non-functional p-NETs are classified, according to the WHO 2010 
classification, in well-differentiated neuroendocrine tumours and poorly 
differentiated neuroendocrine carcinomas (NECs) of small or large cell type. 
Well-differentiated neuroendocrine tumours are then divided according to a 
grading scheme based on mitotic count or Ki67 index in NETs-G1 (with a 
mitotic count < 2 per 10 high-power fields (HPF) and/or  2% Ki67 index), and 
NETs-G2 (with a mitotic count 2-20 per 10 HPF and/or 3-20% Ki67 index). All 
poorly differentiated neuroendocrine carcinomas are graded G3 (with a mitotic 
count > 20 per 10 HPF and/or > 20% Ki67 index). Most pancreatic non-
functional p-NETs are well-differentiated tumours, whereas poorly 
differentiated neuroendocrine carcinomas are uncommon.  
Session Objectives: 
1. To understand the biology, clinical presentation and recent classification of 
pancreatic NET. 
2. To recognise the role of multimodality imaging in detecting, staging and 
characterising biological patterns of lesions. 
3. To become familiar with the different treatment options. 
A-091 08:35 
Radiologist's point of view  
R. Pozzi-Mucelli; Verona/IT (roberto.pozzimucelli@univr.it) 
Pancreatic endocrine tumours (p-NET) are divided into functional p-NETs and 
non-functional p-NETs. Diagnostic imaging of these tumours includes 
detection, characterisation and staging. There are significant differences when 
dealing with functional p-NETs and non-functional p-NETs. In fact, in the first 
case the main aim of diagnostic imaging modalities is the detection of the 
tumour, while for non-functional p-NETs the main aim is the characterisation 
and the differential diagnosis with other tumours of the pancreas, mainly with 
pancreatic adenocarcinoma. Staging is also important for both tumours, but 
mainly for non-functional p-NETs. A large number of imaging modalities are 
available, both "morphological" and "functional". We can arbitrarily divide the 
imaging modalities for the diagnosis of p-NETs into three levels: the first level 
includes US (with contrast-enhanced US), MDCT, MRI and nuclear medicine 
techniques; the second, endoscopic US, angiography and venous sampling; 
the third, intra-operative US. Functional p-NETs are represented mainly by 
insulinomas and gastrinomas which are small in size in most cases. Their 
detection is still difficult, but significant improvements have been made with 
US, MDCT and MRI, so that these tumours are detected in most cases if 
appropriate imaging techniques are performed. However, still, no single 
modality is 100% effective. Non-functional p-NETs can be differentiated from 
pancreatic adenocarcinoma, since they are hypervascular and usually large in 
size. Since they are potentially malignant, they require accurate staging by 
imaging modalities, both morphological (MDCT, MRI) and functional (PET/CT) 
to plan surgery and chemotherapy.  
Learning Objectives:
1. To learn how to recognise the specific imaging features of pancreatic NET 
and how to differentiate NET from other pancreatic tumours. 
2. To understand the strengths and weaknesses of the different imaging 
modalities. 
3. To learn about the optimal imaging protocol for the diagnosis, staging and 
follow-up of NETs. 
A-092 08:55 
Surgeon's point of view  
C. Bassi; Verona/IT (claudio.bassi@univr.it) 
There is worldwide consensus about surgical treatment of resectable p-NETs 
in the following clinical situations: proven malignancy, whenever it is possible 
to remove the primary tumour and at least 90% of liver metastases (debulking); 
p-Nets associated with a clinical syndrome caused by hormonal hypersecretion 
(insulinomas and gastrinomas mainly); non-functional p-NETs with a size larger 
than 2 cm. Vice versa, there are different expert opinions about the surgical 
treatment of functional and non-functional p-NETs in MEN1 syndromes and in 
sporadic non-functional p-NETs less than 2 cm in size. In MEN1 all 
insulinomas should be resected, while for gastrinomas the extent of resection 
is patient tailored, deserving standard Whipple for selected cases. In the most 
common sporadic small incidentalomas, where long-term prognosis is 
favourable, surgical treatment has to be weighted with co-morbidities and 
morbidities of the patient and the procedure planned. These tumours have a 
risk of node metastases at the time of diagnosis in less than 10 % of patients. 
Whenever possible, mini-invasive approach with pancreas-sparing operations 
should be recommended. In elderly patients, a first period of follow-up should 
be preferable and surgery should be offered only if the size of the tumour 
demonstrates increasing trends.  
Learning Objectives:
1. To understand the rationale of surgical indication. 
2. To consolidate knowledge on the resectability criteria and extension of the 
radical resection. 
3. To learn about the role of surgery within multimodality treatment. 
A-093 09:15 
Oncologist's point of view  
G. Tortora; Verona/IT (giampaolo.tortora@univr.it) 
G1-G2 Pancreatic NETs show moderate responsiveness to chemotherapy. 
While single agents have limited activity in advanced pNETs, doublet 
containing streptozotocin with adriamycin or 5-fluorouracil are considered 
standard regimens, leading to RR from 6 to 36%, median PFS from 3.9 to 16 
months and OS of 20-24 months. Intensification with three drug regimens did 
not increase the efficacy. Recently, a combination of temozolomide and 
capecitabine showed 70% of partial remission, median PFS of 18 months and 
OS of 92% at 2 years. PI3K-Akt-mTOR is a key pathway in NETs. In advanced 
pNETs, the phase III registrative RADIANT-3 study randomised patients to the 
anti-mTOR everolimus versus placebo; pretreatment with chemotherapy was a 
stratification criteria and treatment with SSA was allowed. PFS, the primary 
end point was 11.4 months with everolimus versus 5.4 months in the placebo 
arm, with a reduction in the risk of progression of nearly 65%. NETs are highly 
vascularised tumours and high VEGF expression is a negative prognostic 
factor in pancreatic NET, related to higher microvessel density, higher 
incidence of metastases and shorter PFS. A phase III registrative study 
randomised advanced pNET patients to receive the antiangiogenic drug 
sunitinib or placebo together with best supportive care. A statistically significant 
difference in PFS, the primary end point, was observed with everolimus (11.4 
months) versus placebo (5.5 months), along with increased RR (9.3% vs. 0%, 
respectively). Recent studies have identified critical alterations in the signaling 
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pathways of NETs that may be translated into new therapeutic strategies with 
novel targeted agents.  
Learning Objectives:
1. To learn about the relationship between NET biology, signalling pathways 
and available therapeutics. 
2. To understand current treatment options. 
3. To learn how to contextualise the clinical management of NETs. 
Case presentation and discussion  09:35
08:30 - 10:00 Room N/O  
Interventional Radiology  
RC 409  
Endovascular treatment of acute thoracic 
aorta syndrome  
A-094 08:30 
Chairman's introduction  
T. Pfammatter; Zurich/CH (thomas.pfammatter@usz.ch) 
The "acute aortic syndrome" includes three closely related emergency entities 
of the thoracic aorta: aortic dissection, intramural hematoma and penetrating 
atherosclerotic ulcer. As these conditions present with similar symptoms, 
cross-sectional aortic imaging is essential for diagnosis, triage and treatment 
planning. Initial imaging features of these pathologies including typical early 
complications as well as their differential diagnosis will be reviewed. As 
nowadays several of these patients will undergo early endovascular thoracic 
aortic repair, an update on its indication, the different technical options and 
their clinical results will follow. Finally, the focus will be on repair-related late 
complications and progression of aortic disease. Imaging follow-up protocols, 
features of chronic complications and their interventional repair will be 
discussed.  
A-095 08:35 
A. Pre-therapeutic radiological evaluation  
J. Ferda; Plzen/CZ (ferda@fnplzen.cz) 
The acute thoracic aorta syndrome covers patients suffering from acute chest 
pain and those injured during high-energy trauma. Despite the similar 
symptoms, the aortic pathologies are heterogeneous, including acute aortic 
injury, intramural haematoma, aortic dissection, and ruptured thoracic aortic 
aneurysm and mycotic aneurysms. The diagnostic approaches could include 
the whole pallete of the imaging modalities: chest X-ray, transesopheageal 
echocardiography (TEE), multidetector CT angiography (MDCTA), MRI and 
PET/CT. Because of some disadvantages of TEE, like problems with intubation 
in injured patients or problems of MRI with seriously ill patient monitoring, 
MDCTA has become the most used modality due to its ability of discrimination 
between aortic and non-aortic pathologies, and also due to its high sensitivity, 
specificity, availability and especially superior geometrical resolution and 
potential of 3D imaging. The proper pre-therapeutic MDCTA protocol is using 
sub-millimeter isotropic resolution covering the entire aorta with pelvic arteries. 
When the pathology of thoracic aorta is found during the triple rule-out triage 
protocol, additional MDCTA of the rest of the aorta and pelvic arteries has to 
be completed. ECG triggering could be an important advantage in the 
reduction of pulsation-derived artefact. The volume of applied contrast material 
used should be as small as possible to plan applications during endovascular 
treatment. 3D reconstruction of the thoracic aorta with its side branches and 
advanced vessel analysis have a crucial role in the measurement of the aortic 
diameter, diameter profile and lengths in the selection of proper stent graft type 
and size.  
Learning Objectives:
1. To learn about the best pretreatment imaging modality. 
2. To understand planning and sizing of appropriate stent-graft. 
3. To become familiar with critical criteria and vessel morphology. 
Author Disclosure:
 J. Ferda: Speaker; Invited speaker on Somatom World Summit organised by 
Siemens HealthCare 2013. 
A-096 08:58 
B. EVAR techniques and results  
F. Fanelli; Rome/IT (fabrizio.fanelli@uniroma1.it) 
Endovascular abdominal aortic aneurysm repair (EVAR) has gained 
acceptance as a minimally invasive alternative to open surgery in selected 
patients. Many technical improvements have been obtained in the last years 
with the introduction of new-generation devices. Presenting a lower profile, 
they can be accommodated even in patients with small vessels and tortuous 
anatomy. Calcified arteries can be no longer considered absolute exclusion 
criteria. Some devices are designed to reduce the incidence of endoleaks, 
improving sealing capabilities by the use of a polymer to better adjust to the 
variable morphology of the proximal neck or to fill the aneurysmatic sac 
completely. More importantly, the introduction of fenestrated devices has 
resolved the problem of facing difficult anatomies when the aneurismatic 
pathology involves renal or visceral arteries. Obviously, the use of these new 
devices requires a learning curve. Beyond an increase of cost, they permit 
treating those patients who in the past were considered unfit candidates for 
EVAR. The EVAR new frontier requires performing the procedure in an 
outpatient fashion. A multicentre study was conducted on 100 patients who 
were discharged 4/6 hours after uncomplicated stent-graft implantation. Cases 
(4%) with access vessel complications required additional procedures and 
patients were hospitalised overnight. The 30-day readmission rate was 4% for 
access vessel stenosis or false aneurysm. From the time of the first EVAR 
procedure, significant improvements have been achieved but there is still room 
for further progress.  
Learning Objectives:
1. To understand indications and contraindications for EVAR. 
2. To learn more about the advantages of different types of stent-graft. 
3. To become familiar with percutaneous vascular access. 
4. To learn about the latest trials. 
Author Disclosure:
 F. Fanelli: Consultant; WL Gore & Associates, Medtronic, Cook. Speaker; WL 
Gore & Associates, Medtronic, Cook, Covidien. 
A-097 09:21 
C. Imaging follow-up and complications  
R. Morgan; London/UK (robert.morgan@stgeorges.nhs.uk) 
The standard imaging modality after endovascular treatment for thoracic aortic 
pathology (TEVR) is CT angiography (CTA). CTA enables the radiologist to 
assess for the patency of the endografts, the presence of any complications 
after TEVR, and the development of any new pathology related not only to the 
aorta, but elsewhere above and below the diaphragm. The role of MR is 
reduced compared with CTA, particularly in the presence of stainless steel 
endografts. However, good images can be obtained by MRI and MRA if nitinol 
endografts have been inserted. MR is a useful modality for follow-up in young 
patients who require lifelong follow-up and, therefore, limited exposure to 
ionising radiation. Ultrasound has no practical role in the follow-up after TEVR, 
and although plain thoracic radiographs are routinely performed by some 
centres post-TEVR, in practice almost equivalent information can be obtained 
by CT. The main complications after TEVR are endoleaks, type A dissection, 
paraplegia and stroke. The classification of endoleaks is similar to the 
classification for EVAR. Type 1 and type 3 endoleaks require treatment by 
additional endograft coverage with or without supraaortic or visceral artery 
bypass. Other treatment options include the use of branched, fenestrated 
endografts or the use of chimneys and snorkels. Type 2 endoleaks are less 
common than post-EVAR. Similar to the EVAR population, intervention is 
mandated for an enlarging aortic diameter and involves embolisation in most 
cases.  
Learning Objectives:
1. To learn about available imaging methods for follow-up. 
2. To become familiar with complications and failure of EVAR. 
3. To learn how to treat endoleaks. 
Panel discussion:  
What are the best imaging methods for follow-up?  09:44
08:30 - 10:00 Conf. Room M3  
Professional Challenges Session  
PC 4
Interventional radiology in oncology  
A-098 08:30 
Chairman's introduction  
A. Adam; London/UK (andy.adam@kcl.ac.uk) 
Interventional oncology is a discipline that uses imaging-guided procedures in 
the treatment of cancer patients. When the malignant disease in not curable, 
interventional techniques such as biliary and oesophageal stenting can provide 
useful palliation and improve the patient's quality of life. In patients with 
potentially curable tumours, thermal ablation, cryotherapy and 
radioembolisation provide useful alternatives to radiotherapy and surgery in 
carefully selected patients. Interventional radiologists who treat patients with 
cancer should practise as clinicians, participating in multidisciplinary meetings 
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where treatment choices can be discussed with specialists from other 
oncological disciplines. They should involve themselves in all stages of clinical 
practice, including pre-treatment consultations, ward rounds and patient 
follow-up. Radiation oncology and interventional oncology have much in 
common, including the potential for curing cancer using minimally invasive 
techniques. Interventional oncologists can usefully adopt many of the principles 
and methods of practice in radiation oncology, including quality assurance and 
the collection of robust outcome measures. An alliance between these 
disciplines would be beneficial to clinical practice and research in both 
disciplines.  
Session Objectives: 
1. To understand the contribution of interventional radiology to oncology. 
2. To appreciate the areas of overlap between radiation oncology and 
interventional oncology. 
3. To understand the need for a clinical pattern of practice in interventional 
radiology in oncology. 
A-099 08:35 
The current scope and future challenges  
J.I. Bilbao; Pamplona/ES (jibilbao@unav.es) 
Together with chemotherapy, surgery and radiotherapy, interventional 
radiology (IR) is the fourth pillar in oncology. Transcutaneous and 
endovascular procedures, guided by imaging, constitute a fundamental 
knowledge essential for the multidisciplinary management of oncologic 
patients. The range is wide and covers most of the needs in patient´s care. In 
short: obtaining samples for making an accurate diagnosis and also to know 
more about its specific biology (biomarkers); IR covers any possibility needed 
for vascular access; percutaneous needle ablation is the best alternative in 
selected patients; endovascular embolisation with "vehiculisation" of therapies 
is an outstanding method for selective treatment, and sometimes precise 
ablation, of different tumors; IR is a unique way to offer palliation in a wide 
range of tumoral complications, such as embolisation for bleeding, stenting for 
vein obstructions or drainage of fluid collections. There is an obvious need of 
continuous technical refinement. Image-guided therapy is a continuous 
process that implies many disciplines and that includes every step, from 
staging through guidance of the procedure to the evaluation of the outcomes, 
both immediately, during and in the follow-up. Future developments in IR may 
be focused towards the personalisation of therapies to each patient and to a 
better understanding of the biological mechanisms of tumour response or 
progression and their image expression. Finally, radiologists must be actively 
involved in the whole process of clinical trials, from the creation of new lines to 
the performance of therapy until the evaluation and diffusion of the data.  
Learning Objectives:
1. To learn about the range of interventional radiological procedures in the field 
of oncology. 
2. To appreciate the importance of technology and imaging in interventional 
oncology. 
3. To learn about likely future developments in interventional oncology. 
Author Disclosure:
 J.I. Bilbao: Speaker; Sirtex Medical Europe. 
A-100 08:58 
How an oncologist works and why technology alone is not enough  
L.M. Kenny; Brisbane/AU (lizkenny@bigpond.net.au) 
Radiation treatment has a fundamental role in the multidisciplinary 
management of people with cancer. The evidence base for radiation therapy is 
robust and approximately 50% of people diagnosed with cancer will benefit 
from radiation treatment. Most of this benefit comes from an increase in cure. 
The technical quality of delivery of radiation treatment is of great importance in 
avoiding a geographic miss and also in reducing the amount of normal tissue 
being irradiated unnecessarily. As well as the excellent technical delivery of 
any treatment offered, of paramount importance is the intelligent integration of 
care with attention to evidence base choices for both local and systemic 
treatment. Multidisciplinary teams are in the best position to integrate surgery, 
radiation treatment, interventional oncology and systemic therapy in a planned 
and deliberate fashion. The members of the team need to understand what 
each has to offer and what choices are available. The full delivery of 
multidisciplinary care requires input from nursing and allied health. Great 
technical care, although critical, is insufficient. Caring for people with cancer 
requires caring for them as a person and being a competent cancer clinician, 
accepting full clinical responsibility before during and after care. Without this, 
any member of the team is but a technician and the full potential of what they 
have to offer is likely to be unrealised.  
Learning Objectives:
1. To learn about the role of radiation oncology in the local treatment of 
tumours. 
2. To understand the main elements of oncological practice. 
3. To understand the importance of primary clinical responsibility in the care of 
patients with cancer. 
A-101 09:21 
Best practice: how to organise an interventional oncology unit  
A. Gangi, J. Garnon, G. Tsoumakidou; Strasbourg/FR (gangi@unistra.fr) 
Interventional oncology is a fast growing field. Interventional oncology is a 
clinical and technical speciality. Solid clinical knowledge associated with the 
technical skills is mandatory for a successful practice. The technical skills 
should be associated to the clinical part. The knowledge of all treatment 
modalities and the participation of a multidisciplinary team is vital for the best 
practice. Every single patient should be seen by the interventional oncologist 
and followed-up. The interventional oncologist is part of a multidisciplinary 
team, taking care of the patient. The team includes oncologists, 
radiotherapists, pain specialists, psychologists, surgeons, and 
anesthesiologists. The interventional oncology unit should include specialised 
nurses, technician, anesthesiologist, anesthesiologist nurses, and the 
interventional radiologist. The team should be able to take care of the patient's 
follow-up and eventual complications. To summarise, high-quality 
interventional oncology services are essential for safe and effective patient 
care. The technical skills of the interventional oncologist should be associated 
with an excellent clinical knowledge of the disease. A multidisciplinary team 
work is mandatory for a successful interventional team. Harmonisation of 
training and appropriate credentialing is required for clinical services of the 
best quality. Interventional radiologists continuously improving their skills and 
knowledge, patient access to safe and effective minimally invasive treatment 
options is increasing.  
Learning Objectives:
1. To learn how to organise an interventional oncology unit. 
2. To understand the clinical role of an interventional oncologist. 
3. To learn how interventional oncologists collaborate with other specialists 
caring for patients with cancer. 
Author Disclosure:
 A. Gangi: Other; Proctoring Galil Medical. 
Panel discussion:  
Interventional radiology as a new link between oncology  
and imaging  09:44
08:30 - 10:00 Board Room A  
Special Focus Session  
SF 4  
Right heart morphology and function  
A-102 08:30 
Chairmen's introduction  
M. Remy-Jardin1, M. Gutberlet2; 1Lille/FR, 2Leipzig/DE
Whereas cardiac CT and MRI are routine examinations for specialised 
radiologists, it has been necessary to wait for the introduction of fast scanning 
techniques to modify the behavior of nonspecialised radiologists regarding the 
interpretation of cardiac cavities. The objective of this session is twofold. First, 
cardiac radiologists will underline the role of these imaging modalities in the 
assessment of congenital heart disease but also in ischaemic and 
nonischaemic cardiomyopathies. In the second part of this session, chest 
radiologists will focus on the diagnostic information accessible at the level of 
the right ventricle, known to be the target of numerous respiratory disorders. 
Two practical situations will illustrate this approach: pulmonary thromboembolic 
and chronic respiratory diseases. 
Session Objectives: 
1. To make the attendees familiar with the impact of RV dysfunction in various 
cardiac and respiratory disorders. 
2. To describe basic anatomical and functional information that can be 
deduced from routine cross-sectional imaging. 
3. To underline the pros and cons of dedicated cardiac examinations and those 
carried out using cardiothoracic imaging. 
A-103 08:35 
Role of cardiac CT and MRI in assessment of RV in congenital heart 
disease  
A.M. Taylor; London/UK (a.taylor76@ucl.ac.uk) 
Accurate assessment of the right ventricle (RV) is crucial for the management 
of congenital heart disease. Echocardiography can provide some information, 
but as the RV sits directly behind the sternum and as many patients have 
undergone multiple operations, visualisation can be difficult. Furthermore, for 
long-term follow-up and treatment planning, accurate measurement of 
ventricular size and mass, and valvular flow (tricuspid and pulmonary), and 
assessment of anatomy in 3D and 4D are vital. This presentation will outline 
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the role of cross-sectional MRI and CT for assessing the RV, and describing 
the indications, imaging protocols, technical pitfalls and relevant information for 
treatment planning.  
Learning Objectives:
1. To become familiar with the most frequent congenital heart diseases (CHD) 
in which the RV is involved. 
2. To learn about the most frequent surgical procedures in CHD with right heart 
involvement. 
3. To understand which modality to choose and for which CHD. 
Author Disclosure:
 A.M. Taylor: Employee; UCL Institute of Cardiovascular Science. Grant 
Recipient; Siemens, UK NIHR, BHF, Heart Research UK,. Research/Grant 
Support; Siemens - Research agreement. 
A-104 08:53 
Right heart failure in ischaemic and non-ischaemic cardiomyopathies  
M. Grothoff; Leipzig/DE (Matthias.Grothoff@herzzentrum-leipzig.de) 
The role of the right ventricle (RV) has been underestimated for many years. 
Today, we know that the RV is of importance for keeping up a sufficient 
circulation and that right heart failure in both ischemic and non-ischemic 
cardiomyopathies can result in hemodynamic compromise. RV ischemia has a 
higher in-hospital morbidity and mortality but post-infarction chronic right heart 
failure is a rare finding. As the RV has a different physiology from the left 
ventricle (LV), also the pathophysiology of ischemia is different here. Using our 
standard CMR tools T2 weighted imaging for detection of edema and late 
gadolinium enhancement imaging for detection of necrosis/scar we can find 
that the rate of myocardial salvage is much higher in the RV than in the LV and 
that RV failure in the acute phase is basically caused by reversible ischemic 
effects. In non-ischemic cardiomyopathies like HCM and DCM changes in the 
RV myocardium mostly resemble changes of the LV. In arrhythmogenic right 
ventricular cardiomyopathy/dysplasia (ARVC/D) however, there are specific 
findings in the RV and the role of imaging in diagnosing ARVC has been 
strengthened by the revised task force criteria published in 2010. Cine imaging 
should be performed carefully for detection of RV akinesia, dyskinesia or small 
aneurysms as well as the planimetry of the RV. Findings like the detection of 
fibrosis in LGE imaging and the detection of fat in T1 imaging can provide 
additional information, but are not diagnostic for ARVC.  
Learning Objectives:
1. To learn about the different CT and MRI techniques for evaluating right heart 
morphology and function. 
2. To understand the prognostic impact of right heart involvement in ischaemic 
heart disease. 
3. To learn about the basic morphological and functional features of different 
non-ischaemic cardiomyopathies. 
A-105 09:11 
Right heart and chronic respiratory diseases: can CT be used as a one-
stop-shop?  
M. Remy-Jardin; Lille/FR (martine.remy@chru-lille.fr) 
Over the last decade, CT technology has evolved towards fast scanning 
capabilities and high temporal resolution, enabling improved evaluation of the 
heart and surrounding structures in the course of routine thoracic CT imaging. 
This has progressively modified the radiologist's implication in the interpretation 
of chest CT examinations. Firstly, it is more and more common to integrate the 
physiological interactions between heart and lung when analysing the CT 
features depicted on a given examination. Secondly, it is now possible to 
integrate cardiac functional information into a diagnostic CT examination of the 
chest, providing prognostic information in the management of patients with a 
wide variety of chronic respiratory disorders. The purpose of this presentation 
is to provide non-specialised radiologists with some practical guidelines in the 
choice of the scanning protocols and range of functional information that can 
be deducted from chest CT examinations. Right ventricular dysfunction and 
levels of pressure within the pulmonary circulation are the key points of such 
approaches. 
Learning Objectives:
1. To appreciate the clinical impact of a cardiothoracic evaluation from the 
same CT examination. 
2. To learn about the scanning protocols enabling such a combined analysis. 
3. To understand its compatibility with other non-invasive modalities. 
A-106 09:29 
RV and prognosis in pulmonary thromboembolic disease  
N.J. Screaton; Cambridge/UK (Nicholas.Screaton@papworth.nhs.uk) 
Right ventricular failure is the most common cause of early death following 
acute pulmonary embolism and in patients with chronic thromboembolic 
pulmonary hypertension. Echocardiography is sensitive in diagnosing and 
quantifying RV dysfunction. CT is the reference standard for the diagnosis of 
acute PE diagnosis and has the potential to provide comprehensive evaluation 
of the pulmonary arteries, heart and lung parenchyma. CT signs of right 
ventricular dysfunction which have shown predictive value for adverse outcome 
include: flattening of the inter-ventricular septum or bowing towards the left 
ventricle, reflux of contrast medium into the IVC, relative RV/LV diameter ratios 
on transverse and 4-chamber reconstructions, and ventricular volumetry as 
assessed both on routine non-gated CTPA and ECG-gated CT. In patients with 
CTEPH, MRI permits imaging of the pulmonary vasculature and functional 
evaluation of the right ventricle and pulmonary circulation, enabling both 
morphological assessment and prognostic evaluation.  
Learning Objectives:
1. To learn about clinical and imaging factors associated with prognosis of 
thromboembolic disease. 
2. To understand the benefits and weaknesses of different imaging modalities 
in predicting prognosis in thromboembolism. 
3. To discuss the merits of comprehensive imaging evaluation in the routine 
diagnostic workup of suspected thromboembolic disease. 
Panel discussion:  
What is the impact of RV function assessment 
on patient management?  09:47
08:30 - 10:00 Room P  
Joint Session of the ESR and EFSUMB  
Advances in diagnostic ultrasound: better 
results through combinations  
Moderators:  
L.E. Derchi; Genoa/IT 
C.F. Dietrich; Bad Mergentheim/DE 
A-107 08:30 
US/MRI fusion to guide prostate biopsies  
F.M. Drudi; Rome/IT (FrancescoM.Drudi@uniroma1.it) 
Patients should undergo 1.5-3 Tesla MRI using a 6-16 channel surface coil 
placed over the pelvis or with an endorectal coil. To rperform MRI/TRUS image 
fusion-guided prostate biopsy, MRI sequences should include tri-planar T2-
weighted imaging, axial diffusion-weighted imaging with apparent diffusion 
coefficient mapping, 3D point resolved spatially localised spectroscopy and 
dynamic contrast-enhanced axial MRI. MRI/TRUS biopsy is performed with 
electromagnetic tracking of suspicious lesions identified on MRI. An 
electromagnetic field generator is placed above the pelvis to allow real-time 
tracking using a probe with a passive electromagnetic tracking sensor. 2D 
TRUS transverse images of the prostate are recorded to render a 3D US 
image which can be fused with MRI. Suspicious areas identified on MRI are 
imported and manually or semi-automatically fused with the US data set. This 
allows lesions marked on MRI scans to be superimposed on the real-time 
TRUS image. Electromagnetic tracking allows localisation and mapping of 
needle trajectories in both random and subsequent targeted biopsies. 
Indications for MRI/TRUS image fusion-guided biopsy include screening of 
patients at increased risk due to age, elevated PSA blood level and clinical 
suspicion of prostate cancer. Moreover, this diagnostic method is particularly 
useful in patients with negative TRUS outcome, as MRI/TRUS fusion permits 
targeted biopsy of suspicious areas which might have been missed at TRUS.  
Learning Objectives:
1. To learn about the technologies needed to fuse US/MRI of the prostate. 
2. To learn how to perform prostate biopsies with US/MRI fusion image 
guidance. 
3. To understand indications for the use of these technologies. 
A-108 08:50 
CT/US and US/MRI images: are they useful for diagnostic applications?  
C. Ewertsen; Copenhagen/DK (caroline.ewertsen@dadlnet.dk) 
Multimodality imaging including ultrasound has within recent years been 
introduced in several anatomical regions. PET, CT and MRI datasets can after 
an initial co-registration be fused and shown either side by side or using 
overlay on screen while doing real-time ultrasound; thus, the PET, CT or MRI 
dataset is reformatted in a projection to fit the real-time ultrasound images. 
Several methods of aligning the images are available and have been shown to 
have a high accuracy. Image fusion involving ultrasound has been tested in 
phantoms, animals and in patient studies, mainly in abdominal imaging. By 
combining several imaging modalities, it is possible to benefit from the 
strengths of each modality. It is useful for characterisation of and intervention 
on liver lesions, abscesses containing air and lesions in areas with poor 
overview by ultrasound. Also, the method is useful for characterisation and 
biopsy of PET-positive lesions, especially in patients with a history of cancer. 
The background of the method and clinical examples, mainly from abdominal 
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applications, will be covered. Also, perspectives and future research topics will 
be highlighted.  
Learning Objectives:
1. To learn about the technologies needed to fuse CT/US and US/MRI images. 
2. To understand how to use them in clinical practice. 
3. To understand the indications for these technologies in difficult cases. 
Author Disclosure:
 C. Ewertsen: Speaker; Speaker honorarium from GE. 
A-109 09:10 
Imaging tumour perfusion: CEUS compared with CT, MRI and PET  
N. Lassau; Villejuif/FR (nathalie.lassau@gustaveroussy.fr) 
Contrast-enhanced ultrasound (CEUS) has proved to improve the detection 
and characterisation of pathologies compared to conventional ultrasound, CT 
and MRI in a number of indications. Ultrasound contrast agents (UCA), which 
are purely intravascular, do not show any interstitial diffusion or glomerular 
filtration like iodinated complexes or gadolinium chelates. Dynamic contrast-
enhanced ultrasound (DCE-US) allows to display the enhancement of a lesion 
with a high frame rate after bolus or infusion administration of UCA, and to 
compare enhancement profiles between normal and abnormal tissue. 
Quantification of DCE-US is useful to quantify tumour enhancement and to limit 
intra- and interobserver variability. Mathematical models with several perfusion 
parameters can be used. DCE-US has shown to be of interest after 
antiangiogenic therapies as it allows an earlier evaluation of tumour response 
than usually done with CT and MRI, which remain mainly based on the 
RECIST criteria. In clinical applications, recent mono-centric and multi-centric 
DCE-US studies evaluating anti-angiogenic drugs have demonstrated the 
relevance of this technique compared to CT and MRI with a significant 
correlation with PFS and OS in different types of tumours (HCC, metastatic 
RCC, colon cancer, breast cancer, GIST and melanoma). A consensus paper 
has been recently published by EFSUMB (European Federation of the 
Societies for Ultrasound in Medicine and Biology), providing recommendations 
in DCE-US. The development of targeted contrast agents opens the area of 
molecular ultrasound.  
Learning Objectives:
1. To learn how to image tumour perfusion with CEUS. 
2. To compare the results of CEUS with those of CT, MRI and PET. 
3. To understand differences among the techniques, and how to choose from 
among them. 
A-110 09:30 
3D/4D ultrasonography: tool or toy?  
M. Claudon1, S.T. Elliott2; 1Vandoeuvre-les-Nancy/FR,
2Newcastle upon Tyne/UK (m.claudon@chu-nancy.fr) 
The common perception of 3D ultrasound (US) is of surface-rendered images, 
especially of the foetus. The same approach, enhanced by new transducer 
technology and software, can be used to take ultrasonography to another level 
in general body imaging, providing different image presentations and working 
practices similar to those of CT and MR. The technology involved in a US 
volume acquisition was represented initially by mechanical 3D transducers, 
and more recently by purely electronic, matrix probes. This latest technology 
allows bi-plane real-time acquisitions, fast switch to volume acquisition up to 
100 degrees, and 4D acquisitions with acceptable frame rates. Protocols have 
been described for major abdominal and retroperitoneal organs, with fast 
optimisation of acquisition settings. The technology supports contrast-
enhanced ultrasound (CEUS). After volume acquisition, interpretation for 
volume US datasets requires a post-treatment phase, including multi-planar 
reconstruction, multislice imaging, and volumetric analysis. Virtual cystoscopy 
and volume CEUS quantification are new options. The implementation of this 
new, efficient US modality in a radiology department supposes deep changes 
in the daily practice with delayed post-treatment reporting times. It should 
represent a more effective way for comparison between different examinations 
and a better communication tool with clinicians. The proven and potential 
benefits, in terms of clinical accuracy, training, workflow and overall efficiency, 
will be discussed.  
Learning Objectives:
1. To learn about the technologies available to perform 3D/4D ultrasonography. 
2. To understand their possible role in clinical practice. 
3. To understand the advantages in workflow offered by the use of 3D/4D 
ultrasonography. 
Author Disclosure:
 M. Claudon: Consultant; Philips Ultrasound. 
Panel discussion:  
Technical advances in ultrasonography: it is our responsibility to make 
them work 09:50
10:30 - 12:00 Room A  
Interactive Teaching Session  
E³ 520a  
Pitfalls in abdominal imaging  
A-111 10:30 
A. Liver  
V. Vilgrain, M. Ronot, A. Kerbaol, O. Bruno; Clichy/FR
(valerie.vilgrain@bjn.aphp.fr) 
The purpose of this lecture is to emphasise some pitfalls in liver imaging. 
Morphologic changes in the liver are usually attributed to chronic liver disease 
where liver cirrhosis represents the most important cause. However, non-
cirrhotic diseases may also induce atrophy-hypertrophic changes of the liver. 
The most common mechanisms are related to venous obstruction (either portal 
or hepatic venous) and biliary obstruction. Multidetector CT and MR imaging 
are essential to highlight these abnormalities. When dealing with liver tumours, 
the most important question that has to be solved is tumour characterisation. 
Yet, it is often difficult to assess whether a large tumour is intra- or 
extrahepatic. Imaging findings that might be helpful will be shown. Last, some 
liver lesions can mimic liver tumors. Vascular disorders and focal fatty changes 
or focal fatty sparing are the most common causes. Some other conditions can 
be also mimickers and such cases will be shown.  
Learning Objectives:
1. To learn about morphological changes in the liver observed in non-cirrhotic 
diseases. 
2. To understand imaging features enabling a distinction between intrahepatic 
and extrahepatic tumours. 
3. To become familiar with liver lesions mimicking liver tumours. 
A-112 11:15 
B. Pancreas and bile ducts  
R. Manfredi; Verona/IT (riccardo.manfredi@univr.it) 
The technique and the anatomy of the bile duct and pancreatic duct will be 
described. The anatomical variants of the biliary duct and the pancreatic duct 
system will be analysed and their possible role in generating diagnostic 
imaging pitfalls described. Strategies to avoid pitfalls in diagnostic imaging of 
the bile duct and the pancreatic duct system will be illustrated, considering the 
possible source of pitfalls. Diagnostic imaging findings of different diseases 
involving the biliary ducts and pancreatic duct system will be illustrated, as well 
as the diagnostic imaging criteria useful for the differential diagnosis.  
Learning Objectives:
1. To understand the MRI technique for evaluating the pancreatic parenchyma, 
the pancreatic duct system, the biliary tree, and the functional assessment 
following secretin stimulation. 
2. To become familiar with the signs in MR imaging of the pancreas and bile 
ducts. 
3. To understand the diagnostic imaging criteria useful for differential 
diagnosis. 
10:30 - 12:00 Room B  
ESR meets Russia  
EM 1
Crossroads of diagnostic imaging in the 
big country  
Welcome by the ESR President  
G. Frija; Paris/FR 
Presiding:  
N. Rozhkova; Moscow/RU 
V.E. Sinitsyn; Moscow/RU 
I.E. Tyurin; Moscow/RU 
A-113 10:30 
Introduction: Russian radiology today  
N. Rozhkova, I.E. Tyurin; Moscow/RU
Diagnostic radiology in the Russian Federation is a fast-growing part of clinical 
medicine. The implementation of national projects in health care has led to 
substantial improvement in the facilities of hospitals' modern diagnostic 
equipment. We have 14,189 radiologists and 29,445 technologists working in 
9,000 hospitals. We have about 150 million x-ray-only investigations per year. 
Over the last two years, the number of CT and MRI units has increased by 
A B C D E F G S28  
Friday 
 !"!"!
30%, and modern PET centers and leading centers for radiotherapy have been 
built. We can identify an approximately 20% increase in the number of 
radiological research projects--mainly ultrasound, CT, and MRI investigations. 
During the last ten years the total number of vascular interventions and MR 
studies has increased by ten times, four times for CT, and the annual growth of 
US and x-ray investigations is about 10%. Unfortunately, these technical 
innovations are not always accompanied with PACS and RIS installations; this 
is a reason why all advantages of digital equipment are not achieved. We see 
rapid development of private medicine; new private hospitals and ambulances 
have grown by more than 10% and investment companies are looking for new 
projects in this field. However, the professional education of radiologists is not 
enough to work with new diagnostic equipment. This is a reason why in 2014 
we will start a pilot project to create a new system of continuing medical 
education in clinical medicine, including diagnostic radiology. We hope, this 
pilot project will increase the efficiency of clinical practise.  
Session Objectives: 
1. To learn about the organisational structure of radiology in Russia. 
2. To become aware of Russian radiologists' involvement in ESR activities. 
3. To express gratitude to the ESR for inviting Russia as a guest country to the 
ECR.
A-114 10:35 
CT perfusion in the differential diagnosis of CNS pathology  
I.N. Pronin; Moscow/RU (pronin@nsi.ru) 
Differential diagnosis (DD) including tumour and non-tumour brain pathologies 
is an integral part of neuroradiological diagnostics and in some cases is a 
challenge to experienced neuroradiologists. More than 5000 patients with 
different CNS pathologies have been investigated in the Department of 
Neuroradiology, Burdenko Neurosurgical Institute since 2002. In the vast 
majority of the cases, there were tumours. We used deconvolution method for 
	BV,	BF, MTT and PS maps reconstruction on commercially available 
software (Perfusion 1.2.0, 4.0 protocols, ADW, GE). CT perfusion has 
demonstrated high level of information in determining the degree of malignancy 
in glial brain tumours. A strong correlation between 	BV and PS and tumour 
degree has been demonstrated. The use of CT-PWI makes it possible to 
successfully carry out DD between radiation necrosis and tumour progression. 
Some histological types of brain lesions are characterised by unique 
haemodynamic properties which enable using this method as non-invasive 
"biopsy". CT-PWI has been especially useful in DD of the skull base region, 
bone and extracranial pathologies. The absence of artefacts created by the 
skull base bones makes this method especially valuable as compared to the 
MRI T2*- and ASL- perfusions. CT- PWI makes it possible to successfully 
differentiate tumours and a number of non-tumour CNS lesions including 
demyelinating diseases, infectious and non-infectious granulomas, etc. CT-
PWI is a powerful method for differential diagnosis of brain pathology. 	T-PWI 
can provide unique functional information regarding tumour pathophysiology 
and haemodynamics, which are not available with routine CT and MRI.  
Learning Objectives:
1. To become familiar with the technique of brain perfusion CT. 
2. To understand the added diagnostic value of perfusion CT. 
3. To learn about input of CT perfusion for assessment of treatment. 
A-115 10:55 
Interlude: Development and use of web-based teleradiology in Russia  
O.S. Pianykh; Newton Highlands, MA/US (opiany@gmail.com) 
The largest territory in the world, Russia, presents a perfect teleradiology use 
case of extremely unevenly distributed health care, concentrated in Moscow 
and spread thin outside over an enormous area and sparse population. This 
unevenness deeply affects the quality and availability of radiological services, 
and cries out for efficient and practical teleradiology solutions. However, the 
same unevenness in medical expertise, financing and IT infrastructure 
frequently acts against the advancement of teleradiology projects, blocking 
their natural progress. As a result, technical, financial, educational and clinical 
matters, interleaved into the nascent Russian teleradiology ventures, require 
serious and predictable solutions, based on analysis and adaptation of already 
developed, internationally proven strategies. Currently, Russian teleradiology 
simply takes advantage of whatever is available to make its progress better, 
but needs to develop itself up to the tasks it faces.  
A-116 11:00 
Tuberculosis in Russia: a challenge for a national radiological service  
I.E. Tyurin; Moscow/RU (igortyurin@gmail.com) 
Approximately, 1.7 billion people worldwide are infected with Mycobacterium 
tuberculosis, of which 20 million are active cases. The reasons for resurgence 
of TB infection include the HIV epidemic, a rise in reactivation disease in the 
elderly, a growing migrant population and spread of drug-resistant strains. The 
incidence of atypical TB infection is also on the rise, of which Mycobacterium 
avium intracellulare is the most important human pathogen. The pathologic 
form of the pulmonary infection depends on the sensitivity of the infected host 
and is classified as primary or postprimary. Primary TB pattern represents 
infection resulting from recent contact with the pathogen. Postprimary TB 
pattern results from reactivation of a dormant focus within the lungs. Thoracic 
tuberculosis produces a broad spectrum of radiographic abnormalities. The 
radiological patterns had been described as parenchymal, airway, vascular, 
mediastinal, pleural, and chest wall lesions. Common causes of a missed 
diagnosis of thoracic tuberculosis are failure to recognise hilar and mediastinal 
lymphadenopathy as a manifestation of primary disease in adults, overlooking 
of minimal productive lesions or reporting them as inactive, and failure to 
recognise that an upper lobe or superior segment of lower lobe mass might be 
tuberculosis. In AIDS patients, the imaging features depend on the degree of 
immune suppression. A pattern of postprimary TB is also usually seen among 
patients with decreased immunity due to alcoholism, renal failure, diabetes 
mellitus, ageing, malignancy, and renal and cardiac transplantation.  
Learning Objectives:
1. To understand the scope of the problem with tuberculosis screening in the 
Russian Federation. 
2. To learn about the changing imaging patterns of thoracic tuberculosis. 
3. To appreciate the current role of imaging in the differential diagnosis and 
follow-up of this pathology. 
A-117 11:20 
Interlude: Mystery of Denisov's cave and paleoradiology  
M. Mednikova; Moscow/RU (medma_pa@mail.ru) 
This study focuses on the anatomical identification of fossil bones from Altai 
highland in Southern Siberia, their radiological description, and parallels 
among other hominin fossils. Methods describe the small and isolated tubular 
bones. We used microCT VersaXRM-500 by Xradia Inc. and digital microfocus 
x-ray. Denisova Cave is the best studied Paleolithic cave in North Asia. 
Archaeological data suggest that about 300 thousand years before the present, 
a group of humans migrated to Southern Siberia from the west. Their 
descendants had lived in the Altai Mountains in relative isolation for 250 
thousand years. The taxonomic status of the early inhabitants of Southern 
Siberia was clarified thanks to palaeogenetic studies. It was concluded that the 
Altai hominin was genetically twice further from modern humans than were 
Neanderthals. Phylogenetic analysis suggests that this clade diverged from 
that ancestral to humans and Neanderthals very early - about 1 billion years 
ago. Descendants of this clade apparently survived in the Altai refugium until 
the period 50 - 40 thousand years ago. Due to structural patterns of preserved 
pedal and manual phalanxes, humans from Denisova Cave could be expected 
to be the bearer of "archaic" traits. The extraordinarily thick walls of tubular 
bones in adults reflect a high level of occupational stress. Radiological 
volumetric microscopy of the Denisovan girl phalanx gave evidence for the 
histological estimation of the developmental age. Radiological methods seem 
to be the perspective approach in the study of rare and fragmentary fossil 
human remains, differentiating between archaic and modern humans.  
A-118 11:25 
Advances in imaging of pancreatic masses  
G.G. Karmazanovsky; Moscow/RU (karmazanovsky@ixv.ru) 
Modern diagnostic radiology allows not only to detect pancreatic tumours, but 
also to carry out their differential diagnosis with high accuracy. This is 
especially important because many benign tumours of the pancreas do not 
require immediate surgery. At the same time, many benign tumours may 
become malignant. The differential diagnosis of the pancreatic cystic lesions 
using endoscopic ultrasound and magnetic resonance 
pancreaticocholangiography has now become particularly accurate. Contrast 
enhancement allows detecting signs of tumor invasion into the main blood 
vessels and adjacent organs. Modern developments of radiology help to use 
extended operations for malignant tumours and sparing surgery with minimal 
removal of intact functioning pancreatic tissue in benign tumours.  
Learning Objectives:
1. To become familiar with major types of pancreatic masses and their 
radiological manifestations. 
2. To understand approaches to the selection of diagnostic pathways in 
pancreatic tumours. 
3. To become acquainted with new developments in diagnostic imaging of 
pancreatic tumours. 
A-119 11:45 
Interlude: An artistic view of CT  
A.L. Yudin; Moscow/RU (prof_yudin@mail.ru) 
Radiology is a specialty based largely on figurative perception of diagnostic 
imaging. The radiological picture of many symptoms reminds one of objects 
and environmental phenomena (for example, vanishing lung, draped aorta, 
geographic liver, porcelain gallbladder, dirty fat and others). Training of 
creative mentation promotes lasting assimilation of educational material at the 
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associative level. Metaphorical thinking skills can also be improved by 
searching for amusing fragments in radiological images similar to the objects in 
everyday life; animals, cartoon characters, and others. The essential help in 
the study of the physical foundations of radiology and functional capabilities of 
workstations provide the execution and study of X-ray films, CT or MRI of fruits 
and vegetables, flowers, various artifacts and other objects in the environment. 
Eventually, it is just beautiful.  
Panel discussion:  
Future developments in Russian radiology: which path to take?  11:50
10:30 - 12:00 Room E2  
Foundation Course: Breast Imaging  
E³ 520b  
Breast US  
Moderator:  
R. Schulz-Wendtland; Erlangen/DE 
A-120 10:30 
A. Clinical US technique (2D and automated)  
G. Ivanac; Zagreb/HR (gordana.augustan@zg.t-com.hr) 
Ultrasound of the breast is an established imaging technique with several 
advantages. It has been used to differentiate solid from cystic breast lesions for 
a long time. It has also been increasingly used to visualise small lesions in 
mammographically dense breasts and is the initial imaging method of the 
breast in young women. The features of the lesions that need to be analysed 
are: shape, relation to anteroposterior to laterolateral diameter, margins, 
internal structure and absorption of sound (distal acoustic phenomena). Color 
Doppler enables the thorough assessment of flow within the breast lesions. 
Elastography is established as a useful method to differentiate breast lesions 
on the basis of their stiffness, which can be quantified. The accurate staging of 
axillary disease is an important aspect in the management of patients with 
breast cancer. It is recognised, however, that underlying malignancy can be 
found in lymph nodes that appear morphologically normal. A variety of 
morphological features that may be seen in pathological nodes have been 
described (cortical thickness of > 3.5 mm and absence of a fatty hilum). The 
automated breast ultrasound technique has been known for a long time, but 
with recent improvements now may play an important role. The automated 
breast volume scanner (AVBS) employs frequencies of 5-14 MHz. AVBS has 
various major advantages, such as being independent of the experience of the 
operator as well as supplying consistent and reproducible results. Additionally, 
for the first time it has become possible to obtain coronal images of the 
complete breast, which greatly assists in the planning of surgical interventions.  
Learning Objectives:
1. To understand the role of US in lesion characterisation. 
2. To become familiar with the principles of axillary lymph node status 
assessment. 
3. To learn about automated 3D US. 
A-121 11:00 
B. US of the breast and axilla  
C.F. Weismann; Salzburg/AT (christian.weismann@inode.at) 
To study the technical basics in breast ultrasound (US), a breast scanning 
phantom helps to understand different US settings of greyscale imaging. 
Typically, breast US work has a linear array transducer with a minimum field of 
view of 3.8 cm and a high frequency of minimum 7 MHz. A broadband 
transducer (e.g. 6-16 MHz) with different bands is preferred. In the central 
axillary area, a lower frequency band offers a deeper penetration depth. High 
frequencies improve the tissue contrast and optimise the axial and lateral 
resolution. The transmitter focus is adapted to the region of interest. Highly 
sensitive color Doppler detects slow flow rates (1 cm/s and less). For 
frequencies and power settings used in diagnostic greyscale and color Doppler 
studies, no safety limitations have to be considered. Breast US is mainly used 
as a second-line imaging tool to mammography (MG). A correlation between 
both imaging modalities is crucial. Skin markers and additional MGs may help 
to solve the correlation problem. In BI-RADS 4 or 5 US lesions with unclear 
correlation in MG, a marker placement after US-guided large-core needle 
biopsy helps to clear the problem. The pathomorphological growth pattern of a 
lesion is the basis to understand different imaging aspects with different 
modalities. Second-look US after MRI is an important correlation of lesions, 
which were first visible with MRI. Understanding the complementary imaging 
criteria will help to reduce the number of false-positive results. 
Learning Objectives:
1. To understand basic technical and safety considerations. 
2. To learn about radio-pathological correlations. 
3. To become familiar with possible ways to decrease the number of biopsies. 
A-122 11:30 
C. Sonoelastography and ancillary modalities  
C.S. Balleyguier, S. Canale, L. Ciolovan, C. Dromain; Villejuif/FR
(balleyguier@igr.fr) 
Ultrasonography (US) B-mode is an established and powerful imaging tool in 
the diagnosis of breast tissue abnormalities. US provides a high degree of 
sensitivity in differentiating malignancies, nevertheless, false positive results 
represent a drawback for US. Elastography imaging has been shown to 
improve specificity of the US evaluation of breast masses, in evaluating tissue 
stiffness. Most common elasticity imaging techniques are represented by free-
hand elastography, with requires manual compression on a lesion with the 
ultrasound probe. This technique is easily feasible with a learning curve, but 
remains dependant of the operator. Shear-wave elasticity imaging is a new 
technology which provides qualitative and quantitative analysis on a lesion, 
less dependant on the operator. Performances of shear-wave elasticity may 
improve breast lesion characterisation and help to better categorise 
undetermined lesions such as Bi-Rads 4a and 3 nodules. Elasticity imaging 
characteristics will be added in the new version of Bi-Rads ultrasound lexicon. 
Elasticity imaging principles with an overview of the different elasticity modes 
which may be used will be presented during this session.  
Learning Objectives:
1. To get acquainted with ancillary modalities. 
2. To learn about radio-pathological correlations. 
3. To appreciate the future use of ancillary modalities. 
10:30 - 12:00 Room F1  
Joint Course of ESR and RSNA (Radiological Society  
of North America): Emergency Radiology  
MC 522  
CNS emergencies  
Moderators:  
S.E. Mirvis; Baltimore, MD/US 
A. Palko; Szeged/HU 
A-123 10:30 
A. CNS trauma and neurovascular injury  
H.A. Rowley; Madison, WI/US (hrowley@uwhealth.org) 
A practical imaging approach to brain and neurovascular trauma will be 
reviewed, with an emphasis on understanding the correlation between 
pathophysiology and imaging signs. Guidelines on when to order acute 
neurovascular studies will be presented. Special technical considerations to 
help optimise CT and MR imaging protocols for suspected brain injury, CNS 
haemorrhage, and arterial dissection will be discussed.  
Learning Objectives:
1. To become familiar with traumatic brain injury demographics and 
classification schemes. 
2. To learn how to apply appropriateness criteria for head trauma imaging to 
children and adults. 
3. To identify key imaging patterns and pitfalls in the evaluation of brain and 
neurovascular trauma. 
Author Disclosure:
 H.A. Rowley: Consultant; GE, Bracco, Guerbet, Gore, Genentech, and 
Lundbeck. 
A-124 11:00 
B. CNS non-traumatic emergencies  
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl) 
Neurological emergencies are often associated with high morbidity and 
mortality, and thus require prompt diagnostic and therapeutic action. Non-
traumatic emergencies may however have a subacute onset, and radiological 
signs may be subtle, which can lead to delay in diagnosis and treatment. Since 
clinical features are often nonspecific, the radiologist may be the first to point 
the clinician in the direction of the correct diagnosis. It is therefore of great 
importance that the radiologist is aware of and familiar with the various imaging 
findings, on both computed tomography (CT) and magnetic resonance imaging 
(MRI), of non-traumatic neurological emergencies. These include vascular, 
infectious and inflammatory diseases. Commonly encountered emergencies 
are ischaemic and haemorrhage stroke, venous thrombosis, arterial dissection, 
abscess, acute disseminated encephalomyelitis (ADEM), and encephalitis. 
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Radiological findings in rarer diseases may mimic those in the more commonly 
occurring diseases, but need to be correctly interpreted as therapeutic 
strategies and prognosis may be entirely different. Such entities include for 
instance posterior reversible encephalopathy syndrome (PRES), reversible 
cerebral vasoconstriction syndrome, Susac's syndrome, and status epilepticus. 
Furthermore, initial findings of (impending) complications of brain disease, 
such as hydrocephalus and herniation of brain structures, may be subtle, while 
early recognition allows for prompt and adequate intervention. Finally, 
diagnostic and therapeutic interventions performed in an emergency setting 
may interfere with the diagnosis and interpretation of clinical and imaging 
findings. Associated limitations and pitfalls therefore need to be recognised to 
avoid false-negative or false-positive diagnosis, respectively.  
Learning Objectives:
1. To learn about the modalities (CT/MRI) and protocols for non-traumatic 
neurological emergencies. 
2. To learn how to diagnose the main non-traumatic neurological vascular and 
non-vascular emergencies. 
3. To become aware of the pitfalls and limitations of clinical presentation and 
imaging findings in non-traumatic neurological emergencies. 
A-125 11:30 
C. Interactive case discussion  
H.A. Rowley1, M. Smits2; 1Madison, WI/US, 2Rotterdam/NL
Brain and neurovascular trauma cases will be reviewed in an interactive 
format, with an emphasis on understanding the correlation between 
pathophysiology and imaging signs. Imaging 'pearls and pitfalls' will be 
presented using a variety of CT and MR examples. Guidelines on when to 
order and how to perform acute neurovascular studies will be illustrated. 
Special technical considerations to help optimise CT and MR imaging protocols 
for suspected brain injury, CNS haemorrhage, and arterial dissection will be 
highlighted through use of memorable case examples.  
Learning Objectives:
1. To learn about traumatic brain injury (TBI) and non-traumatic neurological 
emergencies. 
2. To become familiar with imaging manifestations of TBI and non-traumatic 
neurological emergencies. 
3. To understand the clinical implications of radiological imaging findings in TBI 
and non-traumatic neurological emergencies. 
4. To learn about the state-of-the-art radiological imaging options for the 
assessment of acute TBI and non-traumatic neurological emergencies. 
Author Disclosure:
 H.A. Rowley: Consultant; GE, Bracco, Guerbet, Gore, Genentech, and 
Lundbeck. 
10:30 - 12:00 Room P  
ESR Radiation Protection Session  
Launch of ESR EuroSafe Imaging 
Campaign: dealing with challenges of 
radiation protection  
Moderators:  
C. Owens; London/UK 
P. Vock; Spiegel/CH 
A-126 10:30 
ESR EuroSafe Imaging Campaign  
M.M. Rehani; Vienna/AT (madan.rehani@gmail.com) 
The current century has brought with it new challenges in radiation protection, 
many of which follow the development of MDCT which greatly enhanced 
diagnostic capabilities and substantially reduced scanning time to just a single 
breath-hold for chest CT, making CT scanning both patient-friendly and the 
physician's preferred tool. CT has also been added to nuclear imaging systems 
to create hybrid scanners (PET/CT; SPECT/CT). Skin injuries to patients from 
CT were for the first time reported in 2005-2009. Surveys in many countries in 
Europe and elsewhere show wide variations in the radiation dose given to 
patients for a particular radiological examination, and there are an increasing 
number of reports of inappropriate examinations. ESR has recently published 
its position statement on Insights into Imaging on GPS implying: Globalisation 
(detailing all the steps and involving all stakeholders), Personalised medicine 
and Safety. The EuroSafe Imaging will involve a number of actions, including: 
1. Survey of paediatric CT practices in European countries. 2. EuroSafe 
Imaging Posters for ECR 2014. 3. Development of individual 10-point lists of 
criteria for safe radiological examinations for CT, mammography, radiography, 
etc. Additionally, the criteria for each examination will be applied to specific 
body parts. The intention is to make the criteria available in all European 
languages. 4. Orienting chairs and senior radiologists on radiation protection. 
5. Session at ECR 2014 to announce EuroSafe Imaging campaign. 6. A 
column on radiation protection in each issue of the ESR's Newsletter. 7. 
Actions for residents and fellows using social media. 8. Certification: Is your 
imaging EuroSafe?  
Learning Objectives:
1. To learn about the ESR's new EuroSafe Imaging campaign. 
2. To understand the issues that require a European campaign. 
A-127 10:40 
Image Gently Campaign  
M.J. Goske; Cincinnati, OH/US (marilyn.goske@cchmc.org) 
Image Gently 5 years later: Lessons learned in radiation protection for children. 
The Alliance for Radiation Safety in Pediatric Imaging was founded in 2007 to 
promote radiation protection for children worldwide through awareness, 
education and advocacy. Comprising over 75 medical professional societies 
and agencies, the Alliance seeks to change practice locally for improved 
paediatric patient safety in medical imaging. Since its inception, the Alliance 
has had 6 campaigns in CT, diagnostic and interventional radiology, nuclear 
medicine, digital radiography and an outreach campaign to parents and 3 
educational summits. Yet, there is still work to be done. There is a need for 
parents and patients to receive information about their imaging test prior to the 
performance of imaging procedures, particularly those involving ionising 
radiation. The paediatric medical imaging community should work tirelessly 
with the manufacturers of imaging equipment to tailor equipment for children to 
optimise the study and ensure that the users of the equipment are 
knowledgeable in its safe use in children. The routine display of size-specific 
dose estimate on CT scanners will better estimate patient dose for quality 
improvement within facilities and in dose registries. Finally, there is a need for 
diagnostic reference levels in paediatric radiology. This presentation will 
update the audience in progress to date regarding these challenges.  
Learning Objectives:
1. To learn about the Image Gently Campaign for radiation protection of 
children. 
2. To understand the lessons learnt while communicating messages. 
A-128 10:50 
Image Wisely Campaign  
J.A. Brink; Boston, MA/US (JABRINK@partners.org) 
The Image Wisely programme continues to move forward, guided largely by its 
steering committee, composed of two representatives each from ACR and 
RSNA and one representative each from AAPM and ASRT. The Image Wisely 
website (www.imagewisely.org) has educational content for imaging 
professionals (radiologists, medical physicists, and technologists) and referring 
physicians. A patient tab features links to radiologyinfo.org and the Image 
Gently website. A tab for "My Equipment" links visitors to radiation dose-related 
'microsites' developed by GE, Hitachi, Philips, Siemens and Toshiba. As of 
August 29, 2013, 18,646 individuals, facilities and associations have taken the 
Image Wisely pledge. To attract traffic to its website, Image Wisely has recently 
instituted 'News' and 'Top Reads' sections on the splash page highlighting 
recent articles and announcement, highlighting breaking news coverage and 
journal publications on relevant topics. In 2012, content on nuclear medicine 
procedures was finalised, completing two of the three targeted foci of the initial 
action plan_CT and nuclear medicine. In October 2013, a launch meeting will 
initiate the process of developing content for the third target area, fluoroscopy. 
In 2012 and 2013, Image Wisely has concentrated on efforts to engage 
referring physician communities, with particular interest in paediatricians and 
emergency medicine physicians. Progress has been slow, but has recently 
gained traction with emergency medicine in the form of radiologist participation 
in a 2015 symposium, Diagnostic Imaging in the Emergency Department: A 
Research Agenda to Optimise Utilisation, organised by the Society of 
Academic Emergency Medicine.  
Learning Objectives:
1. To learn about the Image Wisely Campaign for radiation protection of adults. 
2. To understand the lessons learnt while communicating messages. 
A-129 11:00 
Lessons from a national approach to patient safety in radiation protection  
P. Cavanagh; Taunton/UK (petecavanagh@gmail.com) 
In considering a European campaign on radiation awareness, it is useful to 
gain information from similar campaigns in health care. There have been a 
number of national patient safety campaigns based on the Institute for 
Healthcare Improvement (IHI) 100,000 lives campaign initiated in the USA in 
2006. Following the success of this, a similar campaign was launched in 
England. Part of this process included an analysis of the success of the 
programme and the key interventions and drivers that were considered 
essential at both the national and local level. These included strong leadership, 
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measurable outcomes, continual effective communication and support as well 
as a clear package of evidence-based interventions.  
Learning Objectives:
1. To learn about the national patient safety campaign in the UK. 
2. To understand the lessons learnt during the national campaign. 
A-129/1 11:10 
Current challenges for radiation protection research in Europe 
J. Repussard; Paris/FR  
Panel discussion  11:20
Moderator: L. Bonomo; Rome/IT 
Panellists: 
M.M. Rehani; Vienna/AT, M.J. Goske; Cincinnati OH/US, J.A. Brink; Boston, MA/US, 
P. Cavanagh; Taunton/UK, J. Repussard; Paris/FR 
European Commission, G. Simeonov; Luxembourg/LU 
IAEA, R. Chhem; Vienna/AT 
WHO, M. del Rosario Perez; Geneva/CH 
HERCA and Federal Office for Radiation Protection (Bfs), J. Griebel; Munich/DE 
Art. 31 Group of Experts/ICRP, E. Vano; Madrid/ES 
COCIR, N. Denjoy; Brussels/BE 
EFRS, G. Paulo; Coimbra/PT 
EFOMP, J. Damilakis; Heraklion/GR 
CIRSE, W. Jaschke; Innsbruck/AT 
12:30 - 13:30 Room E2  
The Beauty of Basic Knowledge: Skeletal Radiology  
MC 26B  
Tumoural and pseudotumoural MSK 
lesions  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK 
A-130 12:30 
Tumoural and pseudotumoural MSK lesions  
K. Verstraete; Ghent/BE (koenraad.verstraete@ugent.be) 
1. Bone (pseudo)-tumours: The majority of bone tumours can be detected on 
plain radiography. The age of the patient, location of the tumour in a bone and 
history of pre-existing bone abnormality should be included in determining the 
likely diagnosis. Careful analysis of pattern of bone destruction, periosteal 
reaction and matrix mineralisation allow for characterisation of most bone 
tumours and differentiation from pseudotumours. CT may be useful for osteoid 
osteoma and MRI is the best imaging technique for further diagnosis and 
staging by displaying tumour composition and extent of bone marrow 
involvement, including skip lesions, presence and extent of extraosseous soft 
tissue mass, and involvement of neurovascular bundle, muscle compartments 
and adjacent joint. This allows to find the best biopsy and surgical approach. 
To evaluate local control of disease and for detection of local recurrence, MRI 
is usually the best imaging technique. 2. Soft tissue (pseudo)-tumours: The 
majority of soft tissue tumours can be detected on ultrasound. Except for cysts 
and subcutaneous lipoma, MR will be the next imaging technique for diagnosis, 
local staging, and eventually to find the best biopsy and surgical approach. The 
age of the patient, location of the tumour and careful analysis of the signal 
characteristics on MRI allow for characterisation of many soft tissue tumours 
and differentiation from pseudotumours. Plain radiography and CT may be 
useful for detection of calcifications and myositis ossificans. To evaluate local 
control of disease and for detection of local recurrence, ultrasound and MRI 
are the best imaging techniques.  
Learning Objectives:
1. To become familiar with the common pathological features of bone and soft 
tissue tumoural lesions. 
2. To appreciate the imaging hallmarks of pseudotumoural bone and soft tissue 
lesions. 
3. To learn how best to use imaging modalities in differential diagnosis. 
12:30 - 13:30 Room F1  
The Beauty of Basic Knowledge: Interventional Radiology  
MC 25B  
Percutaneous drainages and 
nephrostomies
Moderator:  
M. Bezzi; Rome/IT 
A-131 12:30 
Percutaneous drainages and nephrostomies  
R. Portugaller; Graz/AT (rupert.portugaller@medunigraz.at) 
Image-guided catheter drainage is regarded to be effective if fluid collections 
are infected, produce symptoms or communicate with fistulas. Coagulopathy 
and the lack of a safe puncture access route represent contraindications. In the 
first scenario, coagulation factors are mostly helpful and in the second hydro-
dissection may be applied to oust organs from the access route. The clinical 
success of catheter drainage is achieved in about 85%. Complications like 
septic shock, haemorrhage and bowel or pleural transgression were reported 
in up to 10%. Criteria for catheter removal comprise improvement of clinical 
condition, laboratory results and resolution of the cavity in the absence of a 
fistula. The amount of drained fluid should decrease beyond 10 ml to 20 ml/24 
hours. Percutaneous nephrostomy is mostly performed to relieve the urinary 
tract from benign or malignant obstructions, urinary leakage or fistulas, or to 
obtain access to the collecting system for manipulations like stone 
disintegration and removal. Technical success rates of approximately 98% 
were reported for obstructed collecting systems, whereas the success declined 
to 85% in non-dilated tracts. Severe complications like septic shock and 
transfusion-demanding haemorrhage occur in 1.3% to 1.8% and 2% to 4%, 
respectively. In case of pyonephrosis, the rate of septic shock can be as high 
as 7%. To prevent encrustation of the nephrostomy catheters, outpatient 
catheter exchanges are usually scheduled at 8-week intervals. If the urinary 
bladder function is preserved, antegrade double-j ureter-stent insertion via the 
nephrostomy access may be reasonable. Then, every 3 months transvesical 
stent exchange is recommended.  
Learning Objectives:
1. To understand the indications for percutaneous fluid drainage and 
nephrostomy. 
2. To learn the various imaging modalities for guidance and basic techniques. 
3. To appreciate the efficacy of the procedures and the appropriate follow-up. 
12:45 - 13:15 Room A  
Plenary Session  
HL 1  
Josef Lissner Honorary Lecture  
Presiding:  
V.E. Sinitsyn; Moscow/RU 
A-132 12:45 
Research in cardiac imaging: how I do it  
A. de Roos; Leiden/NL (A.de_Roos@lumc.nl) 
In this honorary lecture, I will review a number of personal impressions that 
may contribute to the successful performance of research projects in 
cardiovascular radiology. Also, issues and obstacles in performing successful 
research in the field of radiology will be considered. Key factors for success 
include guidance by inspiring mentor, genuine interest and motivation, some 
creativity and serendipity. Radiology has developed tremendously with many 
innovative modalities over the last 25 years, providing ample opportunity to 
participate in clinical research. Potential issues that should be addressed are 
subspecialisation, turf battles, competition from other clinicians/ imaging 
specialists and adequate training in radiology research. The field of imaging 
research includes traditionally more clinically oriented research by focussing on 
developing and testing of new modalities and applications, now becoming 
more basic by including molecular imaging, population imaging, outcome 
studies and alike.  
Learning Objectives:
1. To learn about personal impressions how to succeed in research. 
2. To learn what makes research exciting.  
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14:00 - 15:30 Room E2  
Foundation Course: Breast Imaging  
E³ 620  
MRI of the breast  
Moderator:  
F. Pediconi; Rome/IT 
A-133 14:00 
A. Technique and diagnosis  
K. Kinkel; Chêne-Bougeries/CH (karen.kinkel-trugli@wanadoo.fr) 
MRI of the breast is ideally performed during the second week of the cycle (day 
7-14) when hormonal glandular background enhancement is minimal. The 
protocol includes T2-weighted imaging for anatomical purposes and T1-
weighted images for the detection of breast cancer after intravenous injection 
of contrast media. Fat suppression techniques are important to visualise the 
enhancing lesion in the presence of T1 high signal intensity fat. Subtraction 
techniques (postcontrast image minus precontrast image) require no motion 
artefact which is obtained through dedicated breast coils with gentle breast 
compression. Spectral fat suppression is another fat suppression technique 
often used in 3D sequences allowing for high spatial resolution. Lesion 
characterisation relies on both morphology and kinetic enhancement 
characteristics over time. Spiculated borders, rim enhancement and segmental 
or irregular linear enhancement are typical morphological features of breast 
cancer, whereas washout kinetic demonstrates high positive predictive value of 
cancer. Lesion interpretation takes into account the patient's age, hormonal 
status, personal risk for breast cancer and history of current medical, surgical 
or radiation therapy. Comparison with prior imaging studies is crucial to identify 
benign stable disease of the breast and MRI-only lesions changing patient 
management. Suspicious MRI-only lesions not identified at second-look 
ultrasound will undergo MRI-guided biopsy with clip positioning.  
Learning Objectives:
1. To learn how to do it. 
2. To learn how to read the images. 
3. To understand which patients can benefit from it. 
Author Disclosure:
 K. Kinkel: Research/Grant Support; Clinique des Grangettes. 
A-134 14:30 
B. MRI of the postoperative breast  
A. Tardivon; Paris/FR (anne.tardivon@curie.net) 
Silicone-filled implants (single or double lumen) require a dedicated sequence 
where silicone exhibits a high signal intensity, whereas signals from fatty and 
fibro-glandular tissues are cancelled. Diagnosis of intracapsular rupture relies 
on the detection of a linguine sign (direct sign) or multiple "key-hole" and/or " 
teardrop" images (indirect signs). Extracapsular rupture is defined as the 
presence of silicone outside the capsule (breast, soft tissues, lymph nodes). 
Breast reconstruction after mastectomy may involve autologous tissue flaps 
(skin, fatty tissue, muscle and fascia). The transferred muscle is inserted in 
front of the major pectoralis muscle and enhances after contrast medium 
injection. The most common benign findings seen in such reconstructed 
breasts and also after a breast-conserving treatment are oedema, seroma, 
haematoma, fat necrosis and fibrosis. Diffuse thickening of the skin and 
trabeculae is usually observed the first year after completion of radiation 
therapy. Small focal areas (less than 5 mm) of non-mass-like enhancement 
and thin linear or rim enhancement at the lumpectomy site can all be expected 
findings. These benign findings decrease progressively, but residual 
enhancement may be observed in 15% of women at 5 or more years. In 
patients who were switched from tamoxifen to aromatase inhibitors, a stronger 
or re-appearance of a background enhancement may be observed. Before 
classifying such findings as benign or probably benign, clinical examination 
and standard imaging data must be taken into account. Highly suspicious 
lesions in such patients are similar to BI-RADS 5 lesions in the nontreated 
breast.  
Learning Objectives:
1. To understand the MRI technique used. 
2. To become familiar with different implant types. 
3. To learn when to raise the flag. 
A-135 15:00 
C. MRI in the high-risk population  
C.K. Kuhl; Aachen/DE (ckuhl@ukaachen.de) 
Prevention strategies for women at high lifetime risk of breast cancer are 
usually adapted to the individual woman's risk of breast cancer. Women at high 
risk (BRCA mutation carriers or women with a 30% likelihood of BRCA-
heterzygosity) are offered primary prevention, which includes chemoprevention 
by Tamoxifen or surgery (risk-reducing mastectomy and/or salpingo-
oopherectomy, where the latter also helps reduce the risk of subsequent breast 
cancer by 30%). If women opt for secondary prevention (active 
surveillance/screening), this has to start at 30 at the latest. MRI is considered a 
compulsory component of all programs worldwide. Due to the very limited 
added cancer yield of mammography in this subset of women, and because of 
the still unsettled issue of possibly increased radiosensitivity of BRCA-mutation 
carriers, mammographic screening is not recommended until the age of 40. 
There is broad agreement that (at least) an annual screening is important; 
especially for BRCA1 mutation carriers, screening every 6 months may be 
more appropriate. We recommend interleaved screening, with annual MRI and 
annual ultrasound (± mammography) phase-shifted by 6 months. There are 
important differences between BRCA1- and BRCA2-associated cancers in 
terms of age distribution and incidence rates, histologic features, but also 
specific imaging features which must be known by radiologists. MRI screening 
protocols must be adjusted to the specific needs of this (usually very young) 
screening population. This presentation will review the current evidence with 
respect to screening of women at high familial risk of breast cancer and will 
provide information on all aspects mentioned above.  
Learning Objectives:
1. To understand breast cancer genetics (genes, DNA, mRNA). 
2. To understand the importance of family history, genetic disorders and 
syndromes with increased incidence. 
3. To appreciate the role of MRI in screening and downstream management. 
14:00 - 15:30 Room F1  
Joint Course of ESR and RSNA (Radiological Society  
of North America): Emergency Radiology  
MC 622  
Chest emergencies  
Moderators:  
S.E. Mirvis; Baltimore, MD/US 
A. Palko; Szeged/HU 
A-136 14:00 
A. Thoracic injuries  
S.E. Mirvis; Baltimore, MD/US (smirvis@umm.edu) 
Chest trauma is directly responsible for 25% of all trauma deaths and is a 
major contributor in another 50% of all trauma mortality. Blunt trauma, 
accounting for 90% of chest injuries, is the third most common site of injury in 
polytrauma patients. Plain radiographs still have a role in recognition of some 
acute thoracic pathology that requires immediate further management, either 
diagnostically and/or therapeutically, such as tension pneumothorax, major 
transdiaphragmatic herniation, large hemothorax or obvious mediastinal 
hematoma. MDCT of the chest is now typically included in a whole body scan 
with IV contrast to facilitate rapid diagnosis on polytrauma cases using less 
radiation than selected segmental scans. MDCT is the well-proven diagnostic 
gold standard for chest injury evaluation. The major advantages of MDCT over 
other modalities include identification of active bleeding, direct signs of trachea 
or esophageal injury, direct evidence of major arterial vascular injury, such as 
pseudoanurysms, pneumo and hemopericardium, location and extent of lung 
contusion and laceration, and assessment for thoracic spine, shoulder girdle 
and rib fractures. Diaphragm injuries are well depicted by MDCT, especially on 
the left by identifying both the torn diaphragm edges, herniation and 
constriction of abdominal contents at the level of the torn diaphragm (collar 
sign), and direct contact of herniated structures with the posterior chest wall 
(dependent viscera). Tracheal injuries are suggested by diffuse and 
progressive pneumomediastinum, dilated tracheostomy cuff, ectopic 
endotracheal tube, and direct connection of mediastinal air with the trachea 
lumen. CT-angiography eliminates the majority of indications for diagnostic 
catheter angiography.  
Learning Objectives:
1. To learn how to differentiate traumatic aortic injuries from congenital variants 
that mimic injury, to distinguish minor from major aortic injuries, and to 
understand how injury classification can influence management. 
2. To become familiar with the various CT appearances suggesting and 
verifying major airway injury. 
3. To understand the various CT appearances of blood/bleeding in the chest 
and how the location, quantity of blood/bleeding and patient clinical status 
determine initial treatment. 
4. To appreciate the spectrum of cardiac injuries that can be diagnosed on 
admission contrast-enhanced CT and those that require urgent intervention. 




B. Non-traumatic thoracic emergencies  
C.M. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
Pulmonary symptoms such as chest pain, shortness of breath or wheezing are 
common non-traumatic symptoms prompting ER visits. Because clinical 
symptoms are very non-specific, imaging plays a major role in differentiating 
life-threatening from less severe diseases and forming a diagnosis. The chest 
radiograph remains the first imaging despite its limited sensitivity for certain 
diseases and being prone to inter-observer variability. Comprehensive 
cardiothoracic CT examinations using most modern CT equipment are well 
evaluated in their diagnostic accuracy to determine the presence of vascular 
life-threatening events such as aortic dissection, acute coronary disease or 
pulmonary embolism. Protocols and literature evidence will be discussed. The 
main focus of the course, however, will lie on the analysis of pulmonary CT 
findings and its contribution to the differential diagnosis of pulmonary 
emergencies (e.g. pneumonia, oedema, pneumothorax, exacerbation of fibrotic 
or obstructive lung diseases) and how to further integrate imaging findings, 
laboratory findings, patient history and clinical information to tackle the 
differential diagnosis. Imaging findings will be discussed by clinical case 
studies, key findings and also overlapping morphological features of other 
differential diagnosis will be discussed side by side, illustrating the options and 
also limitations of imaging findings.  
Learning Objectives:
1. To become familiar with protocols and diagnostic performance of 
comprehensive cardiothoracic CT examinations for determining the presence 
of life-threatening vascular events such as aortic dissection, acute coronary 
disease and pulmonary embolism. 
2. To understand typical but, also less common, CXR and CT findings in 
patients with pulmonary or mediastinal diseases causing acute dyspnoea 
and/or requiring immediate treatment, and to learn about key imaging findings 
in these patients allowing for a fast differential diagnosis. 
3. To learn how to adapt CT protocols to CXR findings and to integrate imaging 
findings into lab findings, patient history and clinical information in order to 
make a diagnosis. 
A-138 15:00 
C. Interactive case discussion  
S.E. Mirvis1, C.M. Schaefer-Prokop2; 1Baltimore, MD/US, 2Amersfoort/NL  
14:00 - 15:30 Room N/O  
ESOR Session  
Mentoring in radiology  
Moderators:  
G. Frija; Paris/FR 
N. Gourtsoyiannis; Athens/GR 
A-139 14:00 
Introduction  
G. Frija; Paris/FR (guy.frija@egp.aphp.fr) 
Mentor was first introduced in Greek mythology, and in its modern usage first 
recorded by a French writer, François Fénelon, in 1699. Since then, this 
concept has been widely used in the development of mentoring, mentorship 
and more recently of mentees, with an overarching principle based on 
accompanying, sowing, catalysing, showing and harvesting. This concept 
remains today as a fundamental one in all teaching activities and implies 
generally a close contact between the mentor and the mentee. However, the 
development of Internet with concomitant e-learning capabilities, which are 
hugely increasing, raises the very challenging necessity to re-think this concept 
and to adapt it to this new era. The ESR is very concerned by this endeavour 
in the context of the striking development of ESOR, on one hand, and with the 
launching of its e-library, on the other.  
A-140 14:05 
ESOR in action 2014  
N. Gourtsoyiannis; Athens/GR (gournick@gmail.com) 
The presentation "ESOR in action" gives an overview on all ESOR activities in 
2013 and 2014. A detailed report on the ESOR courses and teaching 
programmes in 2013 is presented, containing statistics about the number of 
course participants and of scholarship and fellowship grants. Additionally, all 
educational activities in 2014, including dates, venues, topics and local 
organisers, are announced.  
A-141 14:20 
Evidence-based radiology: the basics  
F. Sardanelli; Milan/IT (f.sardanelli@grupposandonato.it) 
Evidence-based medicine (EBM) was derived from clinical epidemiology during 
the last century. It "is the conscientious, explicit, and judicious use of current 
best evidence in making decision about the care of individual patients" (Dave 
L. Sackett, 1996). This means integrating (1) individual clinical expertise with 
(2) the best available external evidence from systematic research and (3) 
patient's values and preferences. When considering evidence-based radiology 
(EBR), the needed expertise is not only clinical, but also technical, while (4) 
radioprotection issues assume a relevant value according to the "as low as 
reasonably achievable" (ALARA) principle. EBM (and EBR) can be practised 
according to the "top-down" model, when using guidelines issued by 
governmental, professional, or academic bodies, or the "bottom-up" model, 
when local physicians (1) formulate an answerable question, (2) search for the 
best evidence; (3) appraise critically; (4) apply findings to practice; and (5) 
evaluate the performance. A hierarchy of radiological studies has been 
established according to the investigated matter: 1. technical performance; 2. 
diagnostic performance; 3. diagnostic impact; 4. therapeutic impact; 5. patient 
outcome; 6. societal impact. Different degrees of recommendations are based 
on different levels of evidence, with experts' opinion as the lowest level and 
meta-analyses of high-quality homogeneous studies and multicenter studies 
being the best level of evidence. To practise EBR, radiologists should be 
familiar at least with basic statistics and epidemiology as well as of methods for 
study design, thus recognising the principal types of bias which can limit the 
value of published studies.  
Learning Objectives:
1. To understand the historical development and general principles of 
evidence-based medicine (EBM) with its top-down and bottom-up approaches. 
2. To learn how to apply EBM principles to radiology (evidence-based 
radiology, EBR) and to illustrate the main reasons for the relative delay in 
developing EBR, including the challenges of fast technological innovation in 
medical imaging. 
3. To learn about the relationship between levels of evidence and the strength 
of recommendations for diagnostic imaging and interventional radiology. 
4. To learn how radiologists could play a stronger role in building the evidence 
in favour of diagnostic imaging and interventional radiology, taking the patient's 
interest as the primary aim of clinical practice and science. 
A-142 14:35 
Education in research: action plan  
J. Hodler; Zurich/CH 
A survey regarding education in research has been commissioned by the ESR 
and published in Insights Imaging (2012) 3: 535-542. The results indicate that 
education in research, associated with career models, needs promotion. The 
Research Committee of the ESR is working on possible future steps to 
promote research through education. Several problems will have to be 
addressed, most notably inhomogeneity within Europe, motivation issues, ill-
defined career paths as well as funding issues. Several stakeholders will play 
an important role, including scientific societies, although this is the core 
business of academic radiology chairmen.  
Learning Objectives:
1. To become familiar with the current status of research education in 
radiology. 
2. To understand the importance of research education for the long term 
development of radiology. 
3. To learn about possible actions for promotion of education in research. 
Author Disclosure:
 J. Hodler: Equipment Support Recipient; Siemens, General Electric. Grant 
Recipient; Guerbet, Bayer. 
A-143 14:50 
Mentoring in radiology  
H.-U. Kauczor; Heidelberg/DE (Hans-Ulrich.Kauczor@med.uni-heidelberg.de) 
Most young professionals starting a career in academic institutions are eager 
to expand their professional and personal aptitudes. An effective way to 
support young professionals in this regard is by mentoring. Mentorship is a 
relationship where the mentor supports a junior faculty member (mentee) in 
personal and professional development. The mentee benefits from early 
determination and initiation of career-relevant steps, greater productivity in 
research and publishing activity and developing techniques in networking and 
collaboration. Moreover, the mentee gains perspectives on how his/her 
discipline operates academically, socially and politically, improves self-efficacy 
and deals more confidently with challenging intellectual work. The mentor, a 
knowledgeable, experienced and regarded person, benefits from fresh ideas, 
energy and curiosity of mentees, as well as through acceptance as a mentor 
an enhanced status in the department. It is a trusted relationship of dialogue, 
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learning and challenges, based on mutual interests. However, the mentor is 
not automatically the best friend or the sole exclusive advisor of the mentee. 
More and more academic medical institutions offer facilitated mentoring 
programmes, which help the mentoring pairs to create an effective mentoring 
relationship to accomplish the desired skills. Evaluation of faculty mentoring 
programmes in academic medical institutions demonstrates the importance of 
mentoring in research and academic development as well as in patient care. 
Especially in radiology where over many years there have been challenges in 
recruiting and retaining talented young professionals, mentoring is considered 
as an essential way for preparing the next generation of scientific and 
intellectual leaders.  
Learning Objectives:
1. To learn the definition, types and benefits of mentoring. 
2. To become familiar with the roles and tasks of mentor and mentee. 
3. To understand the importance of mentoring for career development. 
4. To appreciate potential reservations and gender issues in mentoring. 
Author Disclosure:
 H.-U. Kauczor: Equipment Support Recipient; Siemens, Philips. Speaker; 
Bracco, Siemens, Boehringer, Bayer, Novartis. 
Awards  15:05
16:00 - 17:30 Room A  
Interactive Teaching Session  
E³ 720a  
Pitfalls in head and neck imaging  
A-144 16:00 
A. Pitfalls in neck imaging  
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Pitfall: "a hidden or unexpected danger or difficulty". Imaging methods can 
provide an extraordinary amount of useful data to specialists treating head and 
neck (cancer) patients. It is crucial that these data are used to full advantage of 
individual patients. The most important factor in this process is mutual 
cooperation between the physicians in charge of patient care and the 
diagnostic imaging specialist. Pitfalls in the head and neck may present in 
various ways: normal variants may look like disease, incidental findings are 
frequently encountered and suboptimal technique may obscure important 
findings. Moreover, many pitfalls are directly related to technical errors. The 
presentation aims to familiarise general radiologists, who have an interest in 
head and neck imaging, with common pitfalls encountered on CT and MR 
studies focussing on the neck. In an interactive setting, examples from daily 
practice will be discussed.  
Learning Objectives:
1. To understand the variations of normal anatomy in the neck that should not 
be interpreted as abnormal. 
2. To become familiar with the incidental findings which are frequently 
encountered when searching for neck disease. 
3. To learn about suboptimal neck studies, or technique related problems, and 
understand how these may influence interpretation. 
A-145 16:45 
B. Pitfalls in maxillofacial and skull-base imaging  
R. Hermans; Leuven/BE (Robert.Hermans@uzleuven.be) 
Imaging of the skull base and maxillofacial skeleton requires a meticulous 
imaging technique and a good knowledge of normal anatomy and possible 
anatomical variants. Asymmetry in the pneumatisation of the paranasal 
sinuses, skull base or temporal bone is a common reason for misinterpretation. 
For example, hypoplasia of the maxillary sinus may be misinterpreted on 
conventional radiography as maxillary sinusitis or orbital blowout fracture, 
depending on the context; asymmetric pneumatisation of the petrous apex or 
mastoid bone may mimic, respectively, a cholesterol granuloma and fluid 
effusion in the non-pneumatised side on MRI. Vascular variants may also 
cause interpretation problems. For example, turbulent flow in a large jugular 
bulb may mimic a jugular foramen tumour on MRI. Variants in the vascular 
plexus surrounding the trigeminal or facial nerve may occur, and cause 
asymmetric findings on MRI, possibly mimicking neuritis or perineural tumour 
spread. Incomplete maturation or arrested development of skull base 
structures may also cause confusion. Examples are the cochlear cleft, not to 
be confused with otosclerosis, or arrested pneumatisation of the sphenoid 
sinus, possibly mimicking a tumoural lesion in the central skull base. To avoid 
problems, one should keep in mind the existence of such variants, while 
correlating the imaging findings with the clinical problem; in some cases, an 
additional imaging study may be needed to exclude a pathological process 
more confidently.  
Learning Objectives:
1. To understand the basic requirements for an optimal imaging study of the 
skull base and maxillofacial region. 
2. To become familiar with anatomical variants potentially mimicking disease. 
3. To learn to appreciate incidental findings, thus avoiding unnecessary 
concern while recognising relevant pathology. 
16:00 - 17:30 Room B  
State of the Art Symposium  
SA 7  
Cardiac computed tomography: from 
diagnosis to prognosis  
A-146 16:00 
Chairman's introduction  
M. Dewey; Berlin/DE (dewey@charite.de) 
This short 5-min introduction by the session chairman will give an overview of 
the current state of cardiac computed tomography (CT) for diagnosis and 
prognosis. In addition, the introduction will provide the basis for the subsequent 
dedicated lectures covering low radiation dose, diagnostic accuracy, and 
incidental findings in cardiac CT.  
Session Objectives: 
1. To become familiar with the potential of cardiac CT to diagnose coronary 
artery disease. 
2. To understand current research projects about on non-invasive diagnosis of 
coronary artery disease. 
3. To learn about the facilitation of clinical management decisions in patients 
with suspected or known disease. 
Author Disclosure:
 M. Dewey: Author; editor of Coronary CT Angiography and Cardiac CT, both 
published by Springer. Consultant; Guerbet. Equipment Support Recipient; 
Institutional master research agreements exist with Siemens Medical Solutions, 
Philips Medical Systems, and Toshiba Medical Systems. The terms of these 
arrangements are managed by the legal department. Grant Recipient; 
Heisenberg Program of the DFG. European Regional Development Fund. 
German Heart Foundation. German Federal Ministry of Education and 
Research. GE Healthcare, Bracco, Guerbet, and Toshiba. Speaker; Toshiba 
Medical Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer (Schering-
Berlex). 
A-147 16:05 
What are the protocols with the lowest radiation dose in clinical practice?  
J.-F. Paul; Le Plessis Robinson/FR (pauljf@ccml.fr) 
The radiation dose delivered for coronary CT angiography using retrospective 
gating is high, because only a small part of the total radiation delivered is used 
for the reconstruction of the image in the retrospective mode. On average, 20% 
of the radiation burden is used to reconstruct one phase of the cardiac cycle. 
ECG-triggered tube current modulation allows reducing the nominal dose by up 
to 96% in the systolic phase. Another approach for reducing radiation exposure 
is to use prospective, sequential acquisition, with this approach being 
associated with 75% dose reduction compared to the spiral retrospective 
acquisition. Exposure time may be also shortened by an increase of pitch, in 
particular on the dual-source CT. However, applicability to each dose-sparing 
technique depends on the heart rate and its regularity. Dose-sparing strategies 
should be modified in case of high or irregular heart rate and radiation dose 
reduction may be less effective. For coronary CT angiography, individually 
weight-adapted protocols have been successfully applied, by adjusting mAs to 
patient's weight. More recently, settings of 100 kV and even 80 kV have been 
successfully used for cardiac studies, especially in slim patients or children. 
Reduction of exposure time and individual adaptation have an additive effect 
on dose reduction: it has thus been possible to scan down under 1 mSv in 
selected, slim patients, using this combined approach. In many cases, using 
the latest technology, radiation dose may be lower than the mean radiation 
dose associated with conventional angiography.  
Learning Objectives:
1. To understand various protocols to lower radiation dose in cardiac CT with 
regard to the clinical situation and the risk of image quality impairment. 
2. To learn how to tailor the radiation dose level to each patient in terms of 
morphology. 
3. To become familiar with modulating exposure windows in regards to a 
patient's ECG. 




How accurate and prognostically valid is coronary CT angiography?  
F. Cademartiri, E. Maffei; Monastier di Treviso/IT
(filippocademartiri@gmail.com) 
The role of cardiac computed tomography in cardiovascular diseases is 
becoming increasingly important. CCT is a robust and reliable investigation for 
the detection and exclusion of significant coronary artery disease. In addition, 
CCT provides reliable noninvasive information concerning coronary plaque 
burden (severity, distribution, type), morphology and function of left and right 
ventricle, valves, aorta, and so forth. In the past 5 years, the prognostic role of 
CCT has been established. The prognostic information that can be 
extrapolated from CCT is very diverse and most of it is still under investigation. 
There are converging evidences that CCT can stratify cardiovascular risk better 
than conventional clinical methods, especially in symptomatic patients. For 
asymptomatic individuals, the role is still controversial since coronary calcium 
score alone has a very important role already. Several aspects of CCT 
information seem to have importance for prognostic stratification: plaque 
presence, obstruction, plaque type and distribution. More recent studies have 
started showing the relationship between CCT and pharmacological treatment. 
This is a very new and appealing topic, since the evidence is towards the fact 
that the most effective pharmacological treatment (e.g. statin) should be 
restricted to patients with at least some nonobstructive CAD as detected by 
CCT. This might become a revolutionary concept in cardiovascular medicine 
with several implications.  
Learning Objectives:
1. To learn about and integrate the prognostic information from coronary CT 
angiography into conventional methods. 
2. To learn about coronary CT angiography and conventional methods. 
3. To appreciate the prognostic impact of coronary CT angiography and 
conventional methods. 
A-149 16:51 
Incidental findings in cardiac CT: how to report and proceed  
S. Leschka; St. Gallen/CH (sebastian.leschka@kssg.ch) 
Rapid advances in computed tomographic (CT) technology have facilitated the 
widespread use of CT for cardiac imaging worldwide, and can be considered 
nowadays an essential part of the clinical workup of patients with suspected 
coronary artery disease. Albeit that the performed CT study is focussed on the 
cardiac structures and the coronary arteries, adjacent noncardiac structures 
are in the field of view whenever a patient undergoes cardiac CT to quantify 
coronary calcium or to perform a noninvasive coronary angiogram. In addition, 
the location of the heart near other anatomic regions, including the lungs, 
mediastinum, upper abdomen, and bones, necessitate that these structures 
are included when acquiring coronary CT angiographic images. Several 
publications have demonstrated a high frequency of incidental findings on 
coronary CT angiography. The availability of this information is part of an 
ongoing clinical debate. While some radiologists believe that every image 
should be interpreted completely, others believe that examining noncardiac 
structures reveal too many incidental findings of uncertain clinical significance, 
which may harm because additional testing increases risk, cost, and patient 
anxiety. The aim of this lecture is to separate solid facts from opinions and 
beliefs.  
Learning Objectives:
1. To understand the pros and cons of reporting extracardiac findings at 
cardiac CT. 
2. To understand the clinical consequences of incidental findings. 
3. To learn when additional testing is reasonable and when it's not. 
Author Disclosure:
 S. Leschka: Speaker; Siemens Healthcare, Guerbet, GE Healthcare. 
Panel discussion:  
Cardiac CT: ready to go clinical?  17:14
16:00 - 17:30 Room C  
Controversies in Chest Imaging  
MC 724  
Diagnosis of pulmonary embolism when 
CTA is indeterminate or unfeasible  
Moderator:  
A. Perrier; Geneva/CH 
Teaser:  
M. Rémy-Jardin; Lille/FR 
A-150 16:00 
A. Radiological approach: ultrasound and MR imaging  
M.-P. Revel; Paris/FR (marie-pierre.revel@htd.aphp.fr) 
MR imaging and ultrasound may be used as alternative techniques for 
pulmonary embolism (PE) diagnosis, when CT angiography is indeterminate or 
not feasible, which occurs in up to 22% of the cases. Deep venous thrombosis 
(DVT) and pulmonary embolism are two clinical presentations of the same 
disease. Finding a proximal DVT in patients suspected of PE is sufficient to 
warrant anticoagulant treatment without further testing. The only validated 
diagnostic criterion for DVT is incomplete compressibility of the vein on 
compression ultrasound (CUS). A positive CUS of the proximal lower limb 
veins is highly predictive of PE on computed tomography in suspected 
patients. A large prospective outcome study reported 39% sensitivity of CUS 
for the presence of PE on MSCT and 99% specificity. Including the distal veins 
increases CUS sensitivity, but decreases specificity to only 84%. The 
probability of a positive proximal CUS in suspected PE is higher in patients 
with leg symptoms. MRI diagnosis of PE is mainly based on MR angiography 
(MRA) sequences. Unenhanced sequences using steady-state-free precession 
are now available, in addition to traditional gadolinium-enhanced MRA. There 
are conflicting results regarding the diagnostic value of perfusion sequences, 
with reported sensitivity reaching 100% in some series, whereas others report 
only 75-79% sensitivity. MR shows very high specificity for the diagnosis of PE, 
reaching 99%, but still limited sensitivity, except for proximal PE diagnosis. Its 
main limitation is the high proportion of technically inadequate or inconclusive 
images, ranging from 25 to 30%, but ongoing developments should overcome 
this current limitation.  
Learning Objectives:
1. To understand the role of ultrasound in the diagnostic strategy for pulmonary 
embolism. 
2. To learn about the technical aspects of MR imaging in the diagnosis of 
pulmonary embolism. 
3. To appreciate the performance and limitations of MRI in the diagnosis of 
pulmonary embolism. 
A-151 16:25 
B. Nuclear medicine approach: combined ventilation-perfusion SPECT 
and low-dose CT  
H. Gutte; Copenhagen/DK (henrikgb@gmail.com) 
The diagnosis of pulmonary embolism (PE) is usually established by a 
combination of clinical assessment, D-dimer testing, and imaging with either 
pulmonary ventilation-perfusion (V/Q) scintigraphy or pulmonary multidetector 
CT angiography (CTPA). V/Q scintigraphy is a functional imaging method 
using isotopes for the visualisation of ventilation and perfusion distribution in 
the lungs. In recent years, the imaging techniques for diagnosing PE have 
improved. Many nuclear medicine centres have adopted the single photon 
emission computed tomography (SPECT) technique as opposed to the planar 
technique when diagnosing PE. The introduction of 3-dimensional V/Q SPECT
technology instead of 2-dimensional planar V/Q scintigraphy has resulted in 
fewer indeterminate results and a higher diagnostic value. The latest 
improvement is the addition and combination of a low-dose CT without contrast 
to the V/P SPECT (SPECT/CT) technique. The SPECT/CT in combination has 
been compared to CTPA, planar scintigraphy and SPECT alone, and one 
study has shown that SPECT/CT in combination had the highest diagnostic 
accuracy for PE diagnosis. SPECT in combination with low-dose CT without 
contrast enhancement is superior, especially for small subsegmental emboli; 
however, consensus is lacking regarding the clinical impact and treatment. 
SPECT and SPECT/CT may provide alternative diagnosis if PE is refuted and 
are feasible in almost all patients, because there are no definitive 
contraindications. In the present lecture, SPECT and SPECT in combination 
with low-dose CT are discussed in the context of diagnosing PE.  
Learning Objectives:
1. To understand the principle of hybrid gamma-camera/MDCT system. 
2. To appreciate the diagnostic performance and limitations of SPECT-CT for 
the diagnosis of pulmonary embolism. 





A. Perrier1, M. Rémy-Jardin2; 1Geneva/CH, 2Lille/FR 
The discussion will address the following issues: 
The choice of imaging modality in cases of indeterminate or unfeasible CTA 
depends on: patient age, pregnancy, presence or absence of clinical 
symptoms suggesting limb venous thrombosis, acute or chronic clinical 
situation, imaging technique availability, level of clinical probability of 
thromboembolic disease 
16:00 - 17:30 Room D  
Emergency Radiology  
RC 717  
ER: basic principles - polytrauma: feel 
your own pulse first!  
Moderator:  
D.R. Kool; Nijmegen/NL 
A-153 16:00 
A. Logistics and management  
M. Körner; Landshut/DE (markus@dr-koerner.net) 
Over the last few years, emergency radiology (ER) has been a subspeciality 
with growing interest. Because of rapid developments in technology, CT has 
become the most useful tool in evaluating trauma and other emergency 
patients. In this lecture, the basics of planning and organising an ER 
department are presented and discussed. Besides optimising technical 
equipment and protocols for imaging, different logistic concepts have to be 
considered in planning and organising ER departments. First of all, logistic 
concepts have to be considered for obtaining an optimal workflow: the 
radiology department has to be in close proximity to the emergency 
department and the admitting area, in particular. The whole workflow must be 
optimised for speed and accuracy. This also mandates having dedicated and 
standardised examination and viewing protocols for CT. In contrast to the USA 
where dedicated emergency radiology departments are well established, non-
specialised radiologists still frequently do the reading of emergency radiology 
cases in European countries. The radiologic staff involved has to be trained for 
interpretation of trauma and other emergent cases. This does not only account 
for residents, but also for consultants and attending radiologists. Since a large 
number of cases will arrive during after hours and on weekends, staffing has to 
be adjusted to this fact, which includes attending radiologists to be available 
during these hours on call or, preferably, on-site. This lecture will give an 
overview of logistic concepts and organisation of an emergency department 
and will also discuss critical issues in polytrauma imaging.  
Learning Objectives:
1. To understand how an emergency radiology department should be 
organised. 
2. To become familiar with the logistics, staffing and technical equipment of an 
ER department operating 24/7. 
A-154 16:30 
B. Polytrauma: choosing the right protocol  
S. Wirth, M. Muggenthaler, L. Geyer, K. Weber, F. Mück, M.F. Reiser; 
Munich/DE (swirth@med.uni-muenchen.de) 
At least during the radiological training in hospitals, every radiologist will 
personally be confronted with the treatment of polytraumatised patients. It is a 
fact that standardised whole body MDCT (WB-CT) as an independent predictor 
is able to save around 20% of patient lives. Thus, WB-CT is the major 
diagnostic tool and should be performed as fast as possible. Some institutions 
bypass the emergency room and directly start patient stabilisation in the CT 
cabinet. However, radiographs and focused ultrasound remain important in 
general settings as long as they are performed in a way which does not delay 
CT diagnostics. After scanning, specially trained radiologists support the whole 
interdisciplinary team with correct, appropriate and prioritised diagnoses. 
Besides optimisation of parameters like logistics, patient positioning preferably 
'feet first', reading and communication, 'choosing the right protocol' is a crucial 
factor for ideal radiological patient care. Four types of protocols should be 
differentiated: 1. Polytrauma 1 - WB-CT with scanning the upper abdomen 
twice, one time in arterial and one time in portal venous phase; 2. Polytrauma 2 
- WB-CT without scanning the upper abdomen twice, but instead utilising a 
double bolus protocol for mixed phase contrast enhancement; 3. WB-CT under 
resuscitation; 4. WB-CT as triage tool in the case of mass casuality incidents 
(MCI, up to 20 patients per hour).  
Learning Objectives:
1. To understand the relationship between emergent imaging and emergency 
radiology. 
2. To learn more about the rational use of CR, US and CT according to patient 
priorities in the emergency setting. 
3. To become familiar with established whole-body MDCT protocols and their 
relation to injuries. 
A-155 17:00 
C. Whole-body CT: dose reduction and data handling  
M. Rieger; Hall i. Tirol/AT (michael.rieger@tilak.at) 
There is a wide agreement that for patients with polytrauma, integrating whole 
body computed tomography (CT) scan into early trauma care significantly 
increases the probability of survival. Therefore, CT is today considered the 
most important imaging technique in the diagnostic workup of polytrauma 
patients. The downside of whole body CT represents the relatively high 
radiation exposure. To overcome this handicap, the following measures can be 
taken: 1. positioning of the arms during whole body CT above the head results 
in reduction of radiation dose; 2. adaption of scan parameters, especially 
reduction of tube voltage to 100 kV reduces radiation dose; 3. installation of 
recent technical improvements like iterative reconstruction algorithm reduces 
noise in the image, allowing a downward adjustment in radiation dose to obtain 
standard diagnostic quality images; 4. installation of dose control software 
enables optimisation and improved dose management over time. Another 
disadvantage of high-resolution whole body CT is the amount of acquired data. 
To optimise the workflow in the evaluation of a couple of thousand sub-
millimetre images it is necessary to connect the MDCT scanner with a 
dedicated workstation for volume image reading, which offers the possibility of 
quick multiplanar online evaluation.  
Learning Objectives:
1. To understand new concepts of CT dose reduction. 
2. To become familiar with the correlation of large data sets and the need for 
rapid data acquisition in the emergency radiology setting. 
16:00 - 17:30 Board Room B  
New Horizons Session  
NH 7  
The human connectome: a comprehensive 
map of brain connections  
A-156 16:00 
Chairman's introduction: definitions and basic imaging technique  
P. Hagmann; Lausanne/CH (patric.hagmann@epfl.ch) 
In this introduction I will define the connectome (a comprehensive map of 
neural connections in the brain) and related concepts such as scaling, 
structural and functional connectivity as well as the integration-segregation 
paradigm. The development of MRI-based techniques such as white matter 
tractography and segmentation of white and gray matter has played a crucial 
role in the emergence of connectomics by providing tools to map in vivo the 
entire human structural connectivity at a macroscopic scale. I will explain these 
methods and how from MR imaging a human connectome can be mapped and 
represented as a network (set of nodes and edges). Finally, I will also review 
the validation work related to those techniques and mention the foreseen 
technical advancements in the field.  
Session Objectives: 
1. To learn what the human connectome is and how it is affected by brain 
disease. 
2. To understand how the human connectome can be imaged and 
characterised with MRI. 
3. To become familiar with the network formalism and its interpretation. 
4. To understand the relationship between brain function and underlying 
structural connectivity. 
5. To understand the conceptual ideas behind connectomics. 
6. To learn about the general workflow, from diffusion imaging to mapping a 
structural brain network. 
7. To become familiar with the robustness of the technique by reviewing 
validation studies and getting a glimpse of the technical challenges. 




The economics of brain networks  
E. Bullmore; Cambridge/UK (etb23@cam.ac.uk) 
We review the methods and recent results of network analysis of human 
neuroimaging data. Human functional MRI and structural MRI data can be 
analysed using mathematical tools drawn from graph theory to quantify the 
complex (non-random) topological properties of brain networks. These results 
can be substantiated by meta-analysis of prior neuroimaging results and 
analysis of non-human nervous systems. Brain networks consistently express 
complex topological features, such as small-worldness, hubs, modules and rich 
clubs. Some of these features entail disproportionate biological cost, but may 
be "worth it" by supporting integrative information processing and adaptive 
behaviours. Highly connected hub nodes are high cost/high value network 
components that likely also represent special points of vulnerability for diverse 
brain disorders. These economical principles of brain network organisation are 
expressed at the microscopic scale, e.g., in the nervous system of the 
nematode worm C. elegans, and may therefore provide a new axis for 
translation between macro and micro systems neuroscience. Neuroimaging 
can be used to elucidate the economical principles of human brain network 
organisation in health and disease.  
Learning Objectives:
1. To understand network metrics through examples of different network types 
and their characteristics. 
2. To appreciate the organisation of the human connectome in health and 
disease. 
3. To become familiar with the relation between network organisation and 
cognition. 
Author Disclosure:
 E. Bullmore: Employee; GlaxoSmithKline. Shareholder; GlaxoSmithKline. 
A-158 16:35 
Connectomics in brain pathology  
M.P. van den Heuvel; Utrecht/NL (m.p.vandenheuvel@umcutrecht.nl) 
Healthy brain function depends on efficient functional communication within a 
complex network of structural neural connections, a network known as the 
connectome. Conversely, damage to the brain's network, disrupting local 
neuronal processes and/or global communication between remote functional 
systems may lead to brain dysfunction. In the last few years, emerging 
evidence from a wide variety of studies suggests that connectome 
abnormalities may indeed play an important role in the aetiology of several 
brain disorders. In my talk, I will discuss the results of recent studies 
suggesting an important role for affected connectome organisation in a number 
of neurological and psychiatric disorders. In particular, I will highlight the 
findings of affected functional and structural brain network in 
neurodegenerative disorders such as Alzheimer's and ALS, as well as discuss 
how the application of network science and connectomics may aid our 
understanding of the biological basis of psychiatric disorders such as autism 
and schizophrenia.  
Learning Objectives:
1. To understand the role of connectome architecture in (cognitive) brain 
function and dysfunction using diffusion MRI/functional MRI. 
2. To become familiar with connectomics as a tool for examining disease 
pathology in a wide range of neurological and psychiatric brain disorders. 
A-159 16:55 
Linking structure and function: the role of modeling in understanding the 
pathophysiology  
G. Deco; Barcelona/ES (gustavo.deco@upf.edu) 
The interplay of the brain's intrinsic activity and the external world has seen a 
revival in the last decade, especially in neuroimaging. A long-held assumption 
in many of these studies has been that ongoing brain activity is sufficiently 
random that it averages out in statistical analysis. Hence, imaging studies are 
termed 'activation' paradigms, where experimental manipulation results in the 
activation of cerebral circuits that are necessary for performing the task. 
Nevertheless, a large amount of recent literature reports a body of 
observations that there are consistently distributed patterns of activity during 
rest. This fact has led to the suggestion that it might be possible to characterise 
network dynamics without needing an explicit task to drive brain activity. 
Indeed, numerous neuroimaging experiments have evidenced the solid 
existence of spontaneous long-range correlations, i.e. functional connectivity 
(FC), by fMRI, MEG, and EEG techniques. The functional connectivity is 
defined as the statistical dependence between remote neurophysiological 
dynamics. The emergence of resting functional connectivity is intrinsically 
linked with the underlying anatomical connections between those areas, i.e. 
the structural connectivity. Whole brain modeling can indeed establish a direct 
link between structure and function. Furthermore, the modeling can shed light 
on the origin of pathological functional disfunction by making the link with the 
underlying anatomy explicit. We will show how, structural DTI tractography, 
functional imaging and modelling studies can be combined for reaching this 
goal.  
Learning Objectives:
1. To understand large-scale models of the whole brain. 
2. To learn about the mechanisms underlying resting and task activity. 
3. To become familiar with the fusion of structural (diffusion MRI) and functional 
(functional MRI/MEG) data. 
Panel discussion:  
What will connectomics bring to clinicans in the future?  17:15
16:00 - 17:30 Room E1  
Musculoskeletal  
RC 710  
Trauma to the paediatric skeleton  
Moderator:  
M. Padrón; Madrid/ES 
A-160 16:00 
A. Pelvis/hips  
N. Boutry, B. Herbaux; Lille/FR (nboutry@gmail.com) 
Traumas to the paediatric pelvis and hip include traumatic dislocations of the 
hip, fractures of the femoral neck, fractures of the pelvic ring, acetabular 
fractures and apophyseal avulsion fractures. Traumatic dislocations of the hip, 
fractures of the femoral neck, fractures of the pelvic ring and acetabular 
fractures are rare in children (less than 5% of paediatric fractures), as 
compared to adults. These fractures are commonly the result of high-energy 
trauma. Imaging is based on plain radiographs, but CT and MRI are very useful 
to precisely assess bone (CT) and cartilage and soft tissue (MRI) lesions. 
Imaging enables accurate diagnosis, appropriate treatment and detection of 
potential complications (femoral head osteonecrosis, premature physeal 
closure …). In contrast with the previous injuries, apophyseal avulsion 
fractures of the hip and pelvis are common in children and adolescents, usually 
associated with athletic activities. In most cases, these fractures are of good 
prognosis and can be treated conservatively when minimally displaced. Plain 
radiographs confirm avulsion injuries to ossified apophyses, but MRI and 
ultrasound are the modalities of choice to demonstrate injuries to nonossified 
apophyses and to assess apophyseal displacement.  
Learning Objectives:
1. To become familiar with the types of injuries seen in the paediatric 
pelvis/hips. 
2. To understand the strengths and weaknesses of different imaging 
modalities. 
A-161 16:30 
B. Elbow  
K.J. Johnson; Birmingham/UK (karl.johnson@bch.nhs.uk) 
The elbow is a very common site for fractures in a child. The challenge for the 
radiologist is to differentiate normal variants of growth from possible injury and 
this is usually achieved by having good-quality radiographs and an 
understanding of normal growth. It is important to recognise those fractures 
which require surgical intra-operative treatment. In a small number of cases 
when assessing for vascular integrity, intra-articular extent and injury to 
cartilaginous structures, ultrasound and MR imaging have a valuable role. This 
lecture will give an overview of the radiographic appearance of fractures, 
highlight the features which require orthopaedic intervention and illustrate the 
use of additional imaging modalities.  
Learning Objectives:
1. To become familiar with the types of injuries seen in the paediatric elbow. 
2. To understand the strengths and weaknesses of different imaging 
modalities. 
A-162 17:00 
C. Spine  
L.B.O. Jans; Ghent/BE (lennartjans@hotmail.com) 
The diagnosis of C-spine injury is more complex in children than in adults. 
Early diagnosis is crucial since delayed diagnosis results in high morbidity and 
mortality. Leading mechanisms of pediatric C-spine trauma are motor vehicle 
accidents, sports and pedestrian injuries. Due to their anatomy, children are 
prone to different types and locations of injuries. Children < 10 yeas of age are 
more likely to injure the spinal cord itself and are prone to dislocations and high 
(C1-C4) bony injuries. Children > 10 years of age more often sustain C-spine 
fractures. In children under the age of 2 years, radiographs are rarely helpful. 
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AP and lateral radiographs are helpful in children aged between 2 and 8 years. 
In children aged > 8 years, additional lateral and odontoid views are obtained. 
Anatomical variants such as pseudosubluxation of C2-C3, widening of the 
atlantodental interval and ossification centres may appear to be of concern on 
imaging, but are normal. Abnormal radiographic findings require additional 
imaging to differentiate them further with CT on the area of concern. MRI is 
mandatory if signs of atlantorotary subluxation and spinal cord injury without 
radiologic abnormality (SCIWORA) are present. MRI identifies injuries to the 
spinal cord that are not apparent with other modalities, and should be used 
when a child presents with a neurologic deficit but normal radiographs on CT 
scan.  
Learning Objectives:
1. To become familiar with the types of injuries seen in the paediatric spine. 
2. To understand the strengths and weaknesses of different imaging 
modalities. 
16:00 - 17:30 Room E2  
Foundation Course: Breast Imaging  
E³ 720b  
Image-guided breast biopsy  
Moderator:  
G. Esen; Istanbul/TR 
A-163 16:00 
A. US-guided biopsy of breast and axilla  
L.J. Pina Insausti; Pamplona/ES (ljpina@unav.es) 
Nowadays, ultrasound (US) has become the first choice for performing most 
breast biopsies. The main advantages of this technique are non-ionising 
radiation, full control of the needle position in real time and widespread use of 
US equipments at all centres. US allows access to difficult places (such as the 
axilla or near the nipple), multiple lesions can be safely biopsied in one single 
session, the breast is not compressed, there is excellent comfort for patients 
and radiologists, local anaesthesia and haematoma do not hide the lesion and 
it is a cost-effective technique. However, the main limitation is that the lesion 
must be visible on US. US-guided fine-needle cytology was widely used in the 
past, but today its use has decreased. US-guided core-needle biopsy has 
proven to be a reliable technique to perform a biopsy for breast lesions, 
showing a sensitivity value of about 98%. Furthermore, it can be safely used 
for performing biopsies of axillary lymph nodes. Vacuum-assisted devices can 
be used not only for diagnostic purposes, but also for therapeutic ones, 
because small palpable benign lesions (such as fibroadenomas), papillomas 
and radial scars can be completely removed.  
Learning Objectives:
1. To learn how to do it. 
2. To become familiar with the possible complications. 
3. To consolidate knowledge on the value of axillary FNA vs. core biopsy. 
A-164 16:30 
B. Stereotactic vacuum-assisted biopsy  
R.M. Mann; Nijmegen/NL (r.mann@rad.umcn.nl) 
Stereotactic breast biopsy is the performance of tissue sampling under 
mammographic guidance. As with any imaging technique, some lesions are 
only seen with mammography. When these lesions are suspicious (e.g. 
BIRADS 3 or higher), there are no imaging techniques that can downgrade this 
suspiciousness directly, although for BIRADS 3 lesions follow-up might be a 
viable alternative. In mammography, most lesions that are only visible on the 
mammogram consist of clusters of microcalcifications. These harbour a 
likelihood of around 25% being malignant and should thus be classified as 
BIRADS 4. This implies that tissue sampling is mandatory. Different from 
ultrasound-guided biopsy, it is not possible to perform a real-time biopsy under 
mammographic guidance. Rather, stereotactic biopsy uses triangulation to 
assess the depth of a lesion within the breast, while the lesion location in the x- 
and y-plane is assessed on a scout view. The needle is positioned using the 
coordinates thus obtained. Since there is no real-time feedback of the accuracy 
of needle positioning, it is necessary to obtain substantially more tissue than 
under ultrasound guidance. Therefore, vacuum-assisted systems are essential. 
In case of calcified lesions, the biopsy result is controlled by x-ray. 
Calcifications should be present in the sample. Biopsy complications that occur 
under stereotactic guidance are usually limited. Most common is the formation 
of large haematomas. Scarring may also occur.  
Learning Objectives:
1. To learn how to do it. 
2. To become familiar with the possible complications. 
3. To appreciate the advantages of large core needles. 
Author Disclosure:
 R.M. Mann: Speaker; Bayer Healthcare. 
A-165 17:00 
C. MRI-guided biopsy  
C. Smith; Dublin/IE (csmith@mater.ie) 
Breast magnetic resonance (MR) imaging is the most sensitive modality 
available to evaluate the breast for cancer. It can detect lesions that are occult 
at mammography and ultrasound. It has a limited sensitivity and the positive 
predictive value ranges between 15 and 40%. Histopathological assessment of 
MR-detected lesions is therefore mandatory. Some of these lesions will be 
visible at second-look ultrasound and can be biopsied sonographically. A 
significant number however will only be discernable on MR, and MR-guided 
biopsy is therefore the sampling technique of choice. MR biopsy has become 
an essential component of any breast imaging practice. Several MR-biopsy 
techniques are available including the grid-localising, pillar and post and the 
freehand techniques. The technique for preparing and performing a MR-guided 
vacuum-assisted biopsy using the grid-localising technique is reviewed. 
Potential complications, limitations of MR breast biopsy and actions to prevent 
failure are discussed. Imaging-histologic correlation is essential to ensure 
accurate sampling. Clip placement and follow-up imaging should be performed 
to ensure sampling, including ultrasound correlates. Finally, new developments 
in MR-guided therapeutic interventions are discussed.  
Learning Objectives:
1. To learn how to do it. 
2. To become familiar with the possible complications. 
3. To learn about the potential of MRI-guided treatment. 
16:00 - 17:30 Room F1  
Joint Course of ESR and RSNA (Radiological Society of North 
America): Emergency Radiology  
MC 722  
Abdominal emergencies  
Moderators:  
S.E. Mirvis; Baltimore, MD/US 
A. Palko; Szeged/HU 
A-166 16:00 
A. Abdominal injuries  
A. Palko; Szeged/HU (palkoand@gmail.com) 
Abdominal injuries require a timely and reliable diagnosis to prevent potentially 
lethal outcomes. The armoury of clinical tools (physical examination, lab tests) 
does not fulfil these criteria, since they are either not fast or not reliable. 
Imaging diagnostic modalities help the clinician to acquire the necessary 
amount of information to initiate focused and effective treatment. However, the 
selection of the appropriate imaging algorithm, modality and technique, as well 
as the precise detection and interpretation of essential imaging findings are 
frequently challenging, especially because the circumstances, under which 
these examinations are performed (open wounds, bandages, non-removable 
life-supporting equipment, lack of patient cooperation, etc)., are frequently less 
than optimal. Knowledge of critical imaging signs, symptoms and the role they 
play in the evaluation of the patient's condition, as well as fast decision-making 
and ability to closely cooperate with the clinicians are skills of key importance 
for radiologist members of the trauma team.  
Learning Objectives:
1. To understand the significance of injury mechanism and its role in the 
formation of abdominal lesions and their complications. 
2. To learn about the role of proper imaging techniques and diagnostic 
algorithms in the prompt diagnosis of abdominal injuries. 
3. To learn more about typical and unusual findings of various abdominal 
traumatic conditions. 
A-167 16:30 
B. The enemy within: non-traumatic abdominal emergencies  
R.J. Zagoria; San Francisco, CA/US (Ron.zagoria@ucsf.edu) 
This presentation will describe the technique and important findings for CT 
stone studies as well as the accuracy of this study. An explanation of when IV 
contrast should be given to augment a CT stone study and findings of GU and 
non-GU diseases that can mimic symptoms of stone disease will be provided. 
Examples and descriptions of acute mesenteric vascular abnormalities, bowel 
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obstruction and infectious conditions will be included. Ways to differentiate and 
categorise emphysematous infections for proper treatment will be described. 
Lower tract emergencies will also be illustrated and described. A systematic 
approach to evaluating abdominal CTs will be described to avoid mistakes.  
Learning Objectives:
1. To learn how to better analyse CT scans for non-traumatic causes of 
abdominal pain. 
2. To learn about the CT signs and causes of bowel ischaemia. 
3. To learn about the CT findings of common causes of an 'acute' abdomen. 
4. To learn about the imaging findings of acute, non-traumatic urinary tract and 
GI tract emergencies. 
A-168 17:00 
C. Interactive case discussion  
A. Palko1, R.J. Zagoria2; 1Szeged/HU, 2San Francisco, CA/US
Using cases and an audience response system, this segment of the course will 
go over the optimal imaging approach for patients presenting with acute 
abdominal pain and abdominal injuries. CT findings will be emphasised. Key 
imaging findings of traumatic and nontraumatic causes of acute abdominal 
pain including gastrointestinal tract and urinary tract pathology will be 
explained. A systematic approach for the imaging evaluation of patients with 
abdominal emergencies will be illustrated and explained including proper scan 
protocols and analysis of imaging findings. Imaging diagnosis of blunt and 
penetrating abdominal injuries, urinary tract obstruction, infection, bowel 
obstruction, and ischemia will be emphasised.  
Learning Objectives:
1. To learn how to better analyse CT scans for traumatic and non-traumatic 
causes of abdominal pain. 
2. To learn about the CT signs and causes of bowel ischaemia and injuries. 
3. To learn about the CT findings of common causes of traumatic and non-
traumatic 'acute' abdomen. 
4. To learn about the imaging findings of acute, traumatic and non-traumatic 
urinary tract and GI tract emergencies. 
16:00 - 17:30 Room F2  
Special Focus Session  
SF 7a  
Renal artery denervation in the 
management of resistant hypertension  
A-169 16:00 
Chairman's introduction  
F. Fanelli; Rome/IT (fabrizio.fanelli@uniroma1.it) 
Transcatheter renal denervation represents a novel therapy for treating 
patients with treatment-resistant hypertension, leading to higher risk of major 
cardiovascular events. An overview of sympathetic nervous system anatomy, 
physiology and physiopathology will be followed by a description of the 
technical aspects of renal denervation. First, results in patients with therapy-
resistant hypertension look very promising. However, these data need to be 
confirmed. Importantly, long-term efficacy and safety need to be assessed. As 
a consequence, the treatment cannot be considered, at the moment, standard 
therapy. Future studies need to address other disease conditions characterised 
by sympathetic hyperactivity, including heart failure, chronic kidney failure and 
others. It is a general opinion that in the near future the treatment will also be 
applied to lesser severe hypertensive patients. Future studies should also 
include formal cost-effectiveness analyses.  
Session Objectives: 
1. To understand resistant hypertension and sympathetic nervous system 
pathophysiology. 
2. To understand the principles of patient selection. 
3. To become familiar with the principles and the selection of devices. 
Author Disclosure:
 F. Fanelli: Consultant; WL Gore & Associates, Medtronic, Cook. Speaker; WL 
Gore & Associates, Medtronic, Cook, Covidien. 
A-170 16:05 
Resistant hypertension and sympathetic nervous system  
M. Sapoval; Paris/FR (marc.sapoval2@egp.aphp.fr) 
Hypertension is the most frequent cardio vascular disease and is responsible 
for most strokes, cardiac failures, and renal failures. Control of blood pressure 
using medical treatment is usually achieved by employing different classes of 
drugs. Resistant hyperension is defined by a patient taking 3 drugs and still 
having blood pressure higher than 140/90 mm Hg. The data obtained from a 
general population living in the USA between 2003 and 2008 indicate that 
resistant HT is observed in approximately 9% of treated HT patients. Patients 
with resistant HT can suffer from target organ damage and from the early onset 
of cardiovascular complications, leading to an increase in morbidity and 
mortality. It has been shown that the CV prognosis is directly related to the BP 
level, which justifies the treatment of resistant HT in order to obtain BP control 
In resistant hypertension. It is recognised that there is sympathetic over activity 
and previous experience of surgical denervation has confirmed this 
physiopathological evidence. Recent experience with percutaenous renal 
denervation has shown improvement of blood pressure level in patients 
presenting with resistant hypertension. Many clinical trials are ongoing to try to 
better understant the role of renal denervation in the management of resistant 
hypertension.  
Learning Objectives:
1. To understand the pathophysiology of hypertension. 
2. To become familiar with relationship between blood pressure and 
autonomous nervous system. 
3. To learn about the complications associated with resistant hypertension. 
Author Disclosure:
 M. Sapoval: Consultant; Medtronic, Cordis, ReCor, Boston. Investigator; 
Medtronic, Cordis, ReCor, Boston. 
A-171 16:28 
Renal artery denervation: current technologies, indications and 
contraindications  
G. Goh; London/UK (gerard.goh@stgeorges.nhs.uk) 
Renal denervation can be achieved by a number of different techniques that 
include radiofrequency ablation, intraluminal and high-intensity focussed 
ultrasound ablation, chemical ablation and radiation ablation. Radiofrequency 
and ultrasound ablation are currently the most commonly used techniques. 
Most of the evidence to date is derived from studies and trials based on 
devices that use radiofrequency ablation technology. There are a number of 
currently CE-marked devices available and each device differs in the catheter 
design, generator design and energy delivery. These device types include 
single-point ablation, multi-point ablation, balloon-mounted systems and 
irrigated technology. The indications for renal artery denervation have been 
formulated by various international and European societies based on the 
various clinical trials and studies. These indications include patients with true 
resistant hypertension, age 18-85 years, eGFR > 45 ml/min/1.73 m2 (MDRD 
formula), single renal arteries with diameter > 3-4 mm with a landing zone of 
20-21 mm depending on the device, no significant renal artery stenosis > 30%, 
no renal artery aneurysm, no previous renal artery angioplasty or stenting and 
the absence of significant valvular heart disease where lowering blood 
pressure will be dangerous.  
Learning Objectives:
1. To understand the principles of renal denervation. 
2. To understand the differences between the different systems available. 
3. To learn about indications and contraindications. 
Author Disclosure:
 G. Goh: Consultant; Boston Scientific, Covidien. Research/Grant Support; 
Covidien. Speaker; St Jude Medical. 
A-172 16:51 
Procedural technique and clinical results  
J.A. Reekers; Amsterdam/NL (j.a.reekers@amc.uva.nl) 
Renal denervation of the sympatic nerves around the renal arteries is a new 
catheter technique to treat patients with resistant hypertension. Resistant 
hypertension is seen in about 10%-20% of all patients with hypertension. The 
mechanism of sympatic nerve driven resistant hypertension will be explained. 
The available techniques for RDN will be discussed, focusing on the pros and 
cons of each technique. Currently, RF ablation, HIFU and cryo-ablation are the 
techniques under investigation. The technique and physics of renal 
denervation with radiofrequency ablation will be explained in more detail, 
focusing on available devices in the market. Patient selection and non-
responders will be discussed. The current evidence from the available trials will 
be reviewed. The future of RDN and the role of radiology and the radiologist 
will be illuminated.  
Learning Objectives:
1. To become familiar with the procedural technique. 
2. To learn about parameters influencing clinical outcome. 
3. To learn how to build a dedicated service. 
Author Disclosure:
 J.A. Reekers: Advisory Board; J&J for RDN. 
Panel discussion: How do you start a service?  17:14
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16:00 - 17:30 Room G/H  
Genitourinary  
RC 707  
Renal and adrenal tumours  
Moderator:  
M. Moschetta; Bari/IT 
A-173 16:00 
A. Adrenal masses: a practical approach  
G. Heinz-Peer; St. Pölten/AT (Gertraud.Heinz@stpoelten.lknoe.at) 
The adrenal glands are composite endocrine organs consisting of the steroid 
hormone-producing cortex and the catecholamine-synthesising medulla. The 
increased use of imaging modalities has demonstrated the presence of varying 
sized mass lesions in up to 5% of individuals subjected to CT studies for 
reasons unrelated to adrenal dysfunction. Most of these incidentally discovered 
lesions are non-functioning benign lesions of cortical origin. However, 
incidentalomas may also represent functioning lesions and malignant masses. 
Clinical diagnostic and biochemical evaluation is used to further subdivide 
functional and non-functional adrenal lesions. F-DOPA has been found to be of 
high sensitivity and specificity in PET imaging of pheochromocytoma. CT and 
MR imaging are first choice in characterisation of adrenal lesions. Techniques 
of dual energy CT and histogram analysis may offer additional information. 
PET-CT has been shown to contribute to the diagnostic power, especially in 
oncologic patients. Knowledge of the physiologic appearance of adrenal glands 
in 18-FDG PET is necessary to correctly identify pathologic processes. FDG-
PET also has the ability to detect metastatic lesions in non-enlarged adrenal 
glands. In addition, FDG-PET has the advantage of simultaneously detecting 
metastases at other sites. The role of MR-DWI and MR-spectroscopy in 
characterising adrenal masses has to be defined by further studies. 
Differentiating benign from malignant adrenal masses using non-invasive 
imaging methods can reduce the need for percutaneous adrenal biopsy in 
patients with underlying malignant disease and the follow-up imaging of 
incidentally detected adrenal adenomas.  
Learning Objectives:
1. To become familiar with the different imaging appearances of adrenal 
masses including pathological relation. 
2. To learn about the different imaging techniques in order to improve 
evaluation of benign versus malignant adrenal masses. 
3. To understand the impact of imaging given the fact that a patient either has 
or doesn't have a known malignancy. 
A-174 16:30 
B. Staging renal cancer  
M. Notohamiprodjo; 
Munich/DE (mike.notohamiprodjo@med.uni-muenchen.de) 
Renal cell carcinoma (RCC) is the most common malignant tumour of the 
kidney. As response rates to radiation and nonantiangiogenic chemotherapy 
are low, surgical excision, i.e. radical nephrectomy has been the treatment of 
choice. However novel treatment options have emerged, so that imaging of 
RCC is of increasing interest. Nephron sparing partial nephrectomy has 
become an accepted operative option and antiangiogenic agents such as 
inhibitors of tyrosine kinase (TK) and mammalian target of rapamycin (mTOR) 
have been approved for treatment of advanced RCC. Thus, it has become 
important to perform correct local staging and identify patients suitable for 
partial nephrectomy using standardised scoring systems such as RENAL or 
PADUA. Furthermore, optimal imaging strategies for monitoring of advanced 
and metastatic RCC are discussed, as current antiangiogenic therapy 
evaluation in clinical routine is based only on morphological imaging 
information, but changes in tumour size may lag behind functional changes. 
Finally, common side effects, i.e. pneumonitis, of vascular disruptive agents 
are addressed.  
Learning Objectives:
1. To be able to recognise the CT/MRI/US findings for staging. 
2. To learn about the optimal imaging protocol for the diagnosis and staging of 
renal cancer. 
3. To understand treatment options and implications. 
Author Disclosure:
 M. Notohamiprodjo: Investigator; Novartis, GSK. 
A-175 17:00 
C. How to deal with small indeterminate renal masses  
J.-M. Correas, O. Hélénon; Paris/FR (jean-michel.correas@nck.aphp.fr) 
Characterisation of renal masses can be performed using three categories with 
respect to the lesion size and gross architecture: the indeterminate very small 
masses, the cystic, and solid renal masses. Lesions with diameters below 
10 mm are usually difficult to classify due to partial volume effect that prevents 
accurate CT attenuation measurement. In the general population, these lesions 
are likely to be microcysts and do not require further workup. Better 
characterisation remains needed in selected patient populations such as 
patients with hereditary renal tumour disease and previous history of renal 
carcinoma. In this case, MRI combining T2w, Diffusion-Weighted imaging and 
Dynamic contrast enhanced sequences or contrast-enhanced US may help 
differentiate very small cysts from solid neoplasms. Cystic renal mass 
characterisation still relies on Bosniak's classification with 5 categories: benign 
(I) and minimally complicated (II) cysts, indeterminate cystic lesions (IIF and III) 
and malignant cystic masses (IV). Some cystic masses remain unclassified at 
CT because of atypical attenuation characteristics or enhancement properties. 
US, contrast-enhanced US, and MRI are now playing a key role by providing 
additional diagnostic information that help distinguish between atypical fluid 
filled masses and atypical solid neoplasms, especially poorly enhancing solid 
papillary RCC. The characterisation of small solid renal tumours starts at CT 
with the identification of macroscopic fat, a typical feature of angiomyolipoma. 
In the case of non-fatty indeterminate renal neoploasms, percutaneous-guided 
biopsy can be performed when accurate characterisation is needed before 
surgery or when renal metastases or lymphoma are suspected.  
Learning Objectives:
1. To become familiar with the various appearances of small indeterminate 
renal masses. 
2. To learn about the respective roles of US, CT and MR imaging in 
investigating small renal masses. 
3. To learn the main pitfalls in assessing small renal masses. 
16:00 - 17:30 Room I/K  
Special Focus Session  
SF 7b  
Imaging biomarkers in cancer drug 
development  
A-176 16:00 
Chairman's introduction  
B.E. Van Beers; Clichy/FR (bernard.van-beers@bjn.aphp.fr)
Drug development being a complex and costly process, there is an increasing 
need for imaging biomarkers to take go/no go decisions in the early clinical 
phases. The RECIST criteria based on tumour size measurements at CT are 
currently used for this purpose. However, additional functional and molecular 
biomarkers have been developed to assess the early biological effect of drugs 
on tumours. Development of imaging biomarkers is a structured process in 
which new biomarkers are discovered, validated and qualified against 
biological processes and clinical end points. The validation not only concerns 
the determination of the sensitivity and specificity, but also the measurement of 
reproducibility. Reproducibility assessments, standardisation of the acquisition 
and data analysis methods and quality control are crucial when imaging 
biomarkers are used in multi-centre trials. Functional and molecular 
parameters obtained at perfusion imaging, diffusion-weighted MR imaging and 
PET are being developed and validated. The perspectives (earlier assessment 
of response to treatment) and limitations (limited validation and 
standardisation) of these imaging biomarkers in cancer drug development will 
be presented. 
Session Objective: 
1. To introduce the general context of imaging biomarkers in drug 
development. 
A-177 16:05 
Qualification of imaging biomarkers in drug development  
J.C. Waterton; Manchester/UK (John.Waterton@manchester.ac.uk) 
Most imaging tests used in cancer drug development are correctly called 
biomarkers. Important imaging biomarkers include TNM stage, PFS and OR. 
More recently, pharmacodynamic imaging biomarkers such as FDG-SUV and 
Ktrans have been introduced. Drug developers are reluctant to use more 
exploratory unvalidated imaging biomarkers (i.e. cannot distinguish a true 
negative from a false negative). The extensive literature on biomarker 
validation mostly refers to biochemical biomarkers extracted as analytes from 
biospecimens and is unhelpful to radiologists. Unlike biospecimen biomarkers, 
the quality and validity of imaging measurements as biomarkers depend 
crucially on the use of a diagnostic imaging device, in the presence of the 
patient, in a manner for which the device (a) was not designed, (b) has not 
received regulatory approval and (c) may be unfamiliar to the user in the trial 
site. Technical validation and biological validation are orthogonal activities. 
''Technical validity'' is confidence that the imaging biomarker can be measured 
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reliably anywhere in the world. ''Biological validity'' is confidence that the 
biomarker correctly reports some underlying biology that is important to the 
patient's future clinical outcome. Since the physician always has access to the 
patient's clinical status and history, the biomarker is only useful if it provides a 
better forecast than clinical data alone. (If the forecast is near perfect, the 
biomarker might be a surrogate end point). Technical and biological validations 
are massive undertakings best achieved by consortia, and in particular public-
private partnerships, of which the Innovative Medicines Initiative in Europe and 
the Biomarkers Consortium in the USA, are prominent examples.  
Learning Objectives:
1. To understand the steps and hurdles in drug development and the need for 
imaging biomarkers. 
2. To consolidate knowledge on the steps towards the qualification of imaging 
biomarkers. 
3. To learn about the problem of double validation for the use of biomarkers in 
drug development. 
Author Disclosure:
 J.C. Waterton: Employee; AstraZeneca. Research/Grant Support; 
AstraZeneca. Shareholder; AstraZeneca. 
A-178 16:28 
Functional imaging in cancer drug development  
N.M. deSouza; Sutton/UK (nandita.desouza@icr.ac.uk) 
The standard imaging assessment of tumour response relies on size 
measurements, which, with predominantly cytostatic targeted agents, may not 
reflect the drug effect. Functional imaging biomarkers have the potential to 
quantify the biological characteristics of tumours and measure on-target and 
off-target effects that indicate early likelihood of response to a specific therapy, 
which can then be used to guide the optimal biological dose and drug 
schedule. Serial, non-invasive assessments of whole tumour are possible. This 
is particularly important in the context of inter and intra-patient tumour 
heterogeneity, as different parts of the tumour and primary vs metastatic 
lesions may be biologically different and these characteristics may change with 
treatment. However, functional imaging end points suffer from variability, which 
can be very significant in a multicentre setting. Strict quality assurance and 
quality control measures need to be implemented at the start of a trial and the 
variability across centres documented. Data acquisition protocols need to take 
account of equipment variations. Data analysis methodology needs 
standardisation of software, central review and preferably double reading of 
scans. Automation may not always prove the most robust and reliable option. 
This presentation will focus on the factors that are crucial in determining the 
compatibility of data in multicentre trials with functional imaging end points.  
Learning Objectives:
1. To learn about the potential role of quantitative imaging in processes related 
to tumour growth such as cell metabolism, cell death, and vascular function in 
the assessment of tumour response. 
2. To become familiar with the issues of accuracy, reproducibility and 
standardisation for using functional imaging biomarkers in drug development. 
Author Disclosure:
 N.M. deSouza: Research/Grant Support; CRUK and EPSRC Cancer Imaging 
Centre in association with MRC and Department of Health (England; grant 
C1060/A103334), NIHR funding to the Clinical Research Facility in Imaging 
and the Biomedical Resea. 
A-179 16:51 
Quantitative nuclear medicine in drug development  
W. Weber; New York, NY/US 
Nuclear medicine techniques can detect and quantify very low concentrations 
of radiolabelled pharmaceuticals in the human body. This allows investigators 
to use nuclear imaging for various purposes during drug development. Nuclear 
imaging can visualise drug targets that are only present in nanomolar 
concentrations and can thus identify patients most likely for therapies directed 
against these targets. A recent example is folate receptor SPECT imaging for 
the selection of patients for treatment with a folate-targeted drug conjugate. In 
addition, nuclear imaging and specifically PET can measure the concentration 
of pharmaceuticals within tumour and normal organs over time. Nuclear 
imaging can also be used to monitor target inhibition, for example the blocking 
of oestrogen receptors by anti-oestrogens. Finally, nuclear imaging can assess 
tumour response to therapy by measuring changes in tumour metabolism or 
proliferation, e.g. with FDG- and FLT PET/CT. This allows an earlier and more 
sensitive detection of tumour response than morphologic techniques. Since 
PET is a whole body imaging technology, PET imaging can also be used to 
study the heterogeneity of target expression, tissue pharmacokinetics, target 
inhibition and response. PET imaging is now widely available in many 
countries and has become internationally standardised. It is therefore a robust 
clinical technique that will increasingly be used during drug development.  
Learning Objectives:
1. To understand the role and limitations of radiolabelled functional and 
molecular imaging biomarkers in drug development from the preclinical phase 
to phase 3. 
2. To consolidate knowledge on the specific role of radiolabeled versus other 
imaging biomarkers. 
Author Disclosure:
 W. Weber: Advisory Board; Endocyte, MSD. Grant Recipient; Bayer, Philips. 
Panel discussion:  
What new imaging biomarkers are on the horizon in  
drug development?  17:14
16:00 - 17:30 Room L/M  
Interventional Radiology  
RC 709  
The diabetic foot: contribution of 
interventional radiology  
A-180 16:00 
Chairman's introduction  
J. Lammer; Vienna/AT (johannes.lammer@akhwien.at) 
There are about 80.000 patients per year in Europe who lose their leg. About 
70% are due to diabetic ischaemic and ulcerative leg problems. In diabetic 
patients the prevalence of foot ulcerations is about 20% and the risk for 
developing foot ulcerations is increased four times. Diabetic foot problems may 
be due to neuropathy and malperfusion or a combination of both. The 
neuropathic ulcer and the neuroischaemic ulcer are usually at the plantar 
pedis, have a punched-out appearance and are painless. Bone deformities 
(Charcot foot) may be associated. The arterial ulcer is usually at the toe, 
forefoot and ankle, with pale, cold skin and it may be painful. Patients need a 
multimodality approach involving a diabetologist, vascular specialist 
(angiologist, vascular surgeon, interventional radiologist) and podiatrist. Pain 
control, antibiotic and antithrombotic treatment and the treatment of 
cardiovascular risk factors and other co-morbid disease have to be done first. 
In case of ischaemic pain and ulceration imaging such as MRA and CTA is the 
next step. Patients should be referred to a team of vascular specialist early in 
the course of their disease to plan for revascularisation options. 
Revascularisation is the optimal treatment for patients with an ischaemic and 
neuroischaemic diabetic foot.  
A-181 16:05 
A. Pathophysiology of the diabetic foot  
V. Bérczi; Budapest/HU (Berczi@hotmail.com) 
The incidence of diabetes mellitus, associated with both predisposing genetic 
and environmental factors, is increasing globally. Several major clinical trials 
have proved that complications may occur many years following proper 
glycaemic control. Besides peripheral arterial disease, sensory and motor 
neuropathy along with an altered response to infection is of crucial importance. 
Recent studies have showed that microvascular occlusive arterial disease is 
not a major factor affecting the diabetic foot; infrapopliteal macrovascular 
disease and microvascular dysfunction (e.g. arteriovenous shunting, 
precapillary sphincter malfunction, capillary leakage, venous pooling) are major 
components of impaired perfusion of diabetic foot. There are no randomised 
controlled trials analysing the major outcome following endovacular or open 
bypass surgery. The major outcomes, however, were similar in the case series: 
1-year limb salvage showed a median of 85% (interquartile range 80-90%) and 
78% (interquartile range 70.5-85.5%) following open surgery and endovascular 
treatment, respectively. Limb salvage rate, however, was considerably higher 
with either type of revascularisation compared to medical therapy. Negative 
pressure wound therapy, hyperbaric oxygen therapy, effective off-loading or 
nonweight-bearing therapies (total contact casts rather than removable 
devices) have also shown promising results in recent publications. The 
International Working Group on the Diabetic Foot (IWDGF) has produced a 
guideline in 2011 on the diagnosis and treatment of peripheral arterial disease 
in patients with diabetes and foot ulcers (Diabetes Metab Res Rev 2012;28 
(Suppl 1):179-217; Diabetes Metab Res Rev. 2012;28 (Suppl 1):218-24). 
Diabetic foot ulcers should be managed by a multidisciplinary team (medical, 
surgical, endovascular, podiatric, nursing and orthotic experts).  
Learning Objectives:
1. To undertstand the pathophysiology of the diabetic foot. 
2. To learn about foot care. 
3. To understand the outcomes and complications. 




B. Imaging and angiosom concept  
A. Basile; Catania/IT (antodoc@yahoo.com) 
Endovascular arterial revascularisation is today a solid option in the 
management of CLI with low complication rates and limb salvage rates 
comparable with surgery. The restoration of adequate blood flow to the foot is 
crucial to facilitate wound healing, provide pain relief, and avoid whatever 
amputations. The angiosome concept was first introduced in 1987 by Taylor 
and further developed by Attinger for planning treatment of ischaemic lesions 
of the foot. They divided the foot into six distinct angiosomes, arising from tibial 
and peroneal arteries. Planning the procedure on the basis of this concept will 
yield the best local results of wound healing, compared with the indirect 
intervention. A proper pre-procedure assessment through colour Doppler US 
and DSA of lower limbs is mandatory for guiding the procedure through the 
vessels of the foot. Several studies have evaluated the efficacy of PTA in the 
BTK and the reliability of the angiosome model, approaching 100 % with a limb 
salvage rate of up to 87% at 12 months. On the basis of these data, we can 
conclude that PTA in diabetic patients with BTK disease is a safe and effective 
technique. The first endovascular treatment option is related to the angiosome 
model, but when not feasible the indirect technique is also a valid and similarly 
effective procedure.  
Learning Objectives:
1. To understand the angiosome concept. 
2. To understand variations in blood supply to the foot. 
3. To apprciate the impact of the angiosome concept on treatment strategy. 
A-183 16:51 
C. Special techniques for crural endovascular revascularisation  
S.D. Qanadli; Lausanne/CH (Salah.Qanadli@chuv.ch) 
To face technical failures, up to 20% in crural chronic total occlusion a decade 
ago, different approaches and dedicated devices and technologies have been 
developed in the last few years. Furthermore, percutaneous revascularisations 
are gaining more interest, particularly in patients with critical limb ischaemia not 
only as first-line treatment, but also as the only possible treatment for complex 
lesions and high-risk patients. Special techniques for crural endovascular 
revascularisations are by design techniques rarely used in routine practice, but 
could offer wide possibilities for the interventional radiologist to solve 
challenging situations and manage complex lesions. These techniques include 
options for arterial access (trans-popliteal, trans-tibial, trans-pedal), 
approaches for crossing chronic total occlusion (assisted endoluminal, lambda 
technique, re-entry technologies) and uncommon routes for 
angioplasty/recanalisation (trans-metatarsal loop technique, trans-collateral 
techniques). Combined antegrade and retrograde approaches have also been 
developed as well as related methods for successful re-entry. Deciding when 
the patient/lesion is a potential candidate for special techniques is also a 
crucial issue. The interventional radiologist should be able to convert at any 
time if necessary the strategy of treatment to another one. He should also be 
able to select the most appropriate technique for the patient in planning 
revascularisation. Continuous medical education and training is however 
mandatory and for some techniques the learning curve is relatively long.  
Learning Objectives:
1. To review different tools for crural endovascular revascularisation. 
2. To learn about different access points. 
3. To discuss how to select the appropriate technique. 
Author Disclosure:
 S.D. Qanadli: Consultant; BARD, ABBOTT VASCULAR, CORDIS. Patent 
Holder; Calibrated Vascular Introducer, Multimodality Vascular Phantom. 
Research/Grant Support; BIOTRONIK, BARD, ABBOTT VASCULAR. 
Panel discussion:  
Is there a role for pretherapeutic imaging besides catheterisation 
angiography?  17:14
16:00 - 17:30 Room N/O  
Head and Neck  
RC 708  
The orbit:  
you can't see what you haven't learnt  
Moderator:  
U.Y. Ayaz; Mersin/TR 
A-184 16:00 
A. Anatomy and commonly encountered postoperative findings  
N. Hosten; Greifswald/DE (hosten@uni-greifswald.de) 
Pathology of the eye and orbit is rare in the radiologist's practice. However, 
differential diagnosis is not too difficult if the compartment model is applied. In 
the orbit, different anatomical structures like the optic nerve as part of the CNS, 
muscles for moving the globe, vascular structures and glandular tissue are 
present in a very small space. Each anatomical structure is found in a special 
compartment; each compartment may give rise to a different group of 
pathologies, and only to these pathologies: glioma in the optic nerve, 
rhabdomyosarcoma in the eye muscles, varix in the venous vessels (intraconal 
compartment) and pleomorphic adenoma in the lachrymal gland. 
Understanding the compartments in the orbit is therefore the key to 
differentiating different pathological entities. This presentation explains the 
orbital anatomy, how the compartments are differentiated, and what changes in 
anatomy treatment may induce.  
Learning Objectives:
1. To become familiar with the examination technique according to the clinical 
presentation. 
2. To learn about the anatomic compartments of the orbit. 
3. To understand post-treatment imaging findings. 
Author Disclosure:
 N. Hosten: Author; MRI of the Eye and Orbit Thieme Publisher. Grant 
Recipient; INTERREG Program European Comunity. Shareholder; Siemens 
AG. 
A-185 16:30 
B. Congenital and inflammatory disease  
T.A. Ferreira; Leiden/NL (T.A.Ferreira@lumc.nl) 
Orbital congenital lesions are uncommon. They can be diagnosed prenatally, 
at birth or later during childhood. Several orbital components can be involved. 
We will focus on congenital globe lesions (such as staphyloma, coloboma, 
persistent hyperplastic primary vitreous, Coats disease), the developmental 
cysts such as epidermoids and dermoids, and vascular malformations such as 
lymphangioma and vascular tumours, e.g. capillary haemangioma. Orbital 
Inflammatory and Infectious lesions are on the other hand common. Orbital 
pseudotumour can involve any area of orbit, being one of the great mimickers 
in the orbit. If located in the orbital apex and/or cavernous sinus, it will be 
called Tolosa-Hunt syndrome. Other inflammatory processes in the orbit are 
sarcoidosis and Wegener and Sjogren syndrome. Among infections the most 
common is the orbital cellulitis, mostly secondary to a sinusitis and frequent in 
the urgency setting. The role of the radiologist is to assess whether it is 
preseptal or already postseptal or complicated by a subperiosteal phlegmon or 
abscess. Also of importance is to know and evaluate the possible intracranial 
complications. Finally, we will focus on inflammatory and infectious lesions of 
some specific regions such as the globe and lachrymal gland and give some 
clues for their differentiation.  
Learning Objectives:
1. To appreciate imaging findings in congenital globe and orbit disease. 
2. To learn about inflammation and infection. 
3. To become familiar with the complications and pathways of orbital infections. 
A-186 17:00 
C. Benign and malignant neoplastic tumours  
W. Müller-Forell; Mainz/DE (wibke.mueller-forell@unimedizin-mainz.de) 
As more than 100 pathologies can be seen in the orbit, a systematic approach 
is very important to come to the right diagnosis. The main and most helpful 
criteria of differential diagnosis of any orbital pathology is the definition of the 
affected orbital compartment, as some tumours may only or preferentially 
involve specific orbital structures. The criteria of the most frequent masses of 
the globe, malignant melanoma and retinoblastoma are presented as well as 
those of cavernoma and lymphoma, the main representatives of intraconal 
tumours. There are numerous extraconal neoplasms, only few arising from the 
nasal sinuses, and only a little number of tumours of the optic nerve. The 
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presentation will include the most frequent as well as rare, but important 
tumours.  
Learning Objectives:
1. To become aquatinted with the differential diagnoses of orbital masses. 
2. To learn an approach to differentiating orbital tumours. 
3. To appreciate the typical imaging findings of benign and malignant orbital 
neoplasm. 
16:00 - 17:30 Conf. Room M3  
Oncologic Imaging: Follow-up of Systemic and Local Therapies  
CC 718  
Imaging after systemic therapies: the 
standards  
Moderator:  
M. Nadrljanski; Belgrade/RS 
A-187 16:00 
A. RECIST criteria  
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
The routine practice of oncologic imaging requires standardisation, which 
means that we need to harmonise technical protocols and agree on the 
meaning of selected words for the radiological report. The words "Response, 
"Progression" and "Stable disease" are precisely defined according to 
internationally accepted thresholds and criteria. Although the rules are quite 
simple and rather easy to apply, they are very efficient in the classification of 
the response to treatment, and therefore for the medical decisions. However, 
the role of the radiologist is not limited to measurements and calculation. The 
detection of new lesions may be challenging and requires experience. The 
differential between cancer progression and complications of the treatment 
might be very difficult and requires an adequate communication with the 
referring clinician. Overall, most of the decisions taken by the clinician will be 
related to imaging results, stressing the importance of adequate protocols and 
reports.  
Learning Objectives:
1. To consolidate knowledge on the evaluation of solid tumour response. 
2. To learn some tips and tricks to help bring RECIST to everyday practice. 
3. To understand the advantages and limitations of RECIST. 
A-188 16:30 
B. PERCIST: evolving considerations for PET response criteria in solid 
tumours  
T.F. Hany; Zurich/CH (thomas.hany@gmail.com) 
In solid as well as non-solid tumours, PET/CT imaging using 18-fluoro-
deoxyglucose (FDG) has demonstrated the ability to a) correctly stage disease, 
b) demonstrate therapy response and c) predict therapy outcome. FDG uptake 
can be measured objectively; however several factors in the standardisation 
processes of tracer application, image acquisition and post-processing are 
needed for reproducibility. The term standard uptake value (SUV) 
measurement is used for compensating the influence of injected dose, decay 
time and body mass and represents FDG uptake in any selected pixel of the 
image. For therapy assessment, drop in FDG uptake represents tumour cell 
kill, notably a negative PET scan does not exclude viable tumour cells but 
overall has a better outcome. PET response criteria in solid tumours (PERCIST 
1.0) have been introduced to refine previously established PET response 
criteria by EORTC. Major changes concern the use of lean body mass-based 
SUV (SUL), SULpeak measurement in a fixed ROI, use of only a single target 
lesion and normalization to liver uptake. Metric measurements in CT 
component of the PET/CT as an intrinsic asset like in RECIST 1.1 have not yet 
been introduced, but might be crucial in the future. The proposed PERCIST 1.0 
criteria are not yet standard, since several limitations hamper its general use 
but may improve metabolic tumour response assessment.  
Learning Objectives:
1. To learn about the evaluation of solid tumours through metabolic imaging. 
2. To understand the benefits of metabolic imaging. 
A-189 17:00 
C. Evaluation of brain tumours  
C. Majós; Barcelona/ES (cmajos@bellvitgehospital.cat) 
Malignant gliomas (WHO grade III and IV) are the most common primary 
tumours of the brain. According to consensus guidelines, the standard of care 
of these tumours includes maximal safe surgical resection followed by 
combined treatment with chemoradiotherapy. Radiological assessment is 
critical in the follow-up and should be performed at four different times: 1. 
Within 72 hours after surgery, an early post-operative MRI must be done to 
evaluate residual tumour and to be used as baseline for follow-up. 2. Two to 
six weeks after completing radiotherapy, a new MRI examination is 
recommended to evaluate the response to treatment. Four possibilities are 
envisaged according to the RANO criteria: complete response, partial 
response, stable disease or progressive disease. The evaluation of this first 
MRI examination after RT is challenging and the pseudoprogression 
phenomenon can appear. Advanced MR techniques may be of help in this 
respect. 3. Additional follow-up should then be performed by MRI every 2 to 4 
months to rule out clinically silent progression. 4. In any case, an MRI 
examination must be completed when there is a clinical suspicion of 
progressive disease. Several options for treatment can be offered when 
progressive disease is detected, including antiangiogenic drugs. Evaluation of 
response to these drugs is challenging too, and the pseudoresponse 
phenomenon can then appear. Due its complexity, it is recommended that the 
management of malignant gliomas be performed in the context of 
multidisciplinary teams and that the radiologists are strongly involved in these 
teams.  
Learning Objectives:
1. To learn about the evaluation criteria for brain tumours. 
2. To become familiar with the evaluation of brain tumours after treatment with 
various therapies. 
16:00 - 17:30 Board Room A  
Special Focus Session  
SF 7c  
Educational challenges for radiographers  
A-190 16:00 
Chairmen's introduction  
G. Paulo1, L. Bonomo2; 1Coimbra/PT, 2Rome/IT
We are facing complex times with no parallel in human history. The worldwide 
economic crisis, in combination with a non-regulated process of globalisation, 
is pressuring countries to change their social and political model. These 
changes are affecting academic institutions and the health-care sector. Higher 
education was always more internationally open than most sectors because of 
its immersion in knowledge, which was never worried about country juridical 
boundaries. It is well recognised that it was the knowledge created by 
universities research that contributed to the development of societies. We, as 
European citizens, must be able to transmit the message that having more 
knowledge and being capable of understanding better the world we live in will 
make us stronger, more successful and more competitive. European academic 
institutions must be prepared for this shift of paradigm and understand that 
they are no longer educating only for their country but for the globalised world. 
It is also important to bear in mind that developed health-care systems are 
suffering several pressures and a call for a new inter-professional collaboration 
concept is needed, based on each one's roles and responsibilities, towards a 
better and more efficient health-care delivery for the patients. In this session, 
the invited speakers will give us an overview about the challenges that 
academic Institutions will face in the near future and the way they must adapt 
to become more attractive and at the same time guarantee that radiographers 
and radiologists are educated and trained according to the highest professional 
standards.  
Session Objectives: 
1. To appreciate the challenges that academic institutions must face in order to 
educate graduates with the ability to work internationally and to actively 
contribute to the healthcare sector of the future. 
2. To explore innovative approaches in education and assessment. 
3. To highlight the importance of inter-professional collaboration in order to 
ensure that graduates are ready to meet the demands of the modern 
healthcare sector. 
A-191 16:05 
Challenges in undergraduate education  
L.J.O.C. Lanca; Lisbon/PT (luis.lanca@estesl.ipl.pt) 
Radiographers operate a wide range of sophisticated equipment and perform a 
range of techniques in several radiological procedures. They are responsible 
for the radiation delivered to the patient while assuring safety and image quality 
at an acceptable level for an accurate diagnosis. Education and training in 
radiography, in line with the constant technological developments, is a 
requirement to be fulfilled by higher education institutions (HEI). This is of 
major importance in undergraduate education where radiographers learn to 
play an effective role as healthcare providers in planning, preparing and 
performing accurate and safe radiological procedures within the diagnostic or 
therapeutic field. The European Qualifications Framework (EQF) for 
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radiography, in terms of the development of knowledge, skills and 
competences, provides a European standard for the development of 
radiography learning outcomes at EQF level 6. This constitutes an opportunity 
to develop, tune, advance and promote standards of radiographic practice, 
education and research throughout Europe. The EQF provides guidance to 
increase the educational and professional recognition of radiography in 
Europe. At a European level, the cooperation between HEI in undergraduate 
radiography education would be an opportunity to provide discussions of 
mutual concern, explore new perspectives and views of different cultures, and 
also share learning and teaching methods. International cooperation is an 
opportunity to improve and provide the harmonisation of education regarding a 
professional group that plays an effective role in healthcare in their field of 
competence and expertise.  
Learning Objectives:
1. To understand radiography undergraduate education requirements and how 
they meet current challenges in healthcare. 
2. To appreciate the European Qualifications Framework for radiography in 
terms of the development of knowledge, skills and competences. 
3. To highlight the importance of international cooperation in undergraduate 
radiography education. 
A-192 16:28 
Innovative approaches to educational enhancement: teaching and 
assessment  
J. Mc Nulty; Dublin/IE (jonathan.mcnulty@ucd.ie) 
There is a vast amount of evidence available from the published literature that 
higher education institutions continue to explore innovation in both teaching 
and assessment practices. This is especially true of health professional 
programmes as evidenced by the abundance of literature relating to medicine, 
nursing, radiography and other allied health professions. Such higher 
education, health professional programmes would appear to be more 
innovative than many other disciplines often as a direct attempt to mirror the 
dynamic clinical environment in which most graduates will work. There are, 
however, challenges associated with any such educational innovations and 
novel approaches to delivery and assessment. These specific challenges must 
be carefully considered in parallel with the larger challenges facing higher 
education institutions, both nationally and internationally, along with the 
professions which they contribute to. Through a case study approach, 
supported by published peer-reviewed literature, institutional reports and 
research, this presentation will consider international best practice in education 
along with the value of collaborative, inter-professional approaches to teaching 
and assessment.  
Learning Objectives:
1. To understand the factors influencing the change in approaches to teaching 
and assessment as evidenced by the published literature. 
2. To become familiar with international best practice in teaching and 
assessment. 
3. To appreciate the value of inter-professional collaborative approaches to 
both teaching and assessment. 
4. To understand and appreciate approaches to teaching and assessment from 
the students perspective. 
A-193 16:51 
Perception of changes: the radiologist's point of view  
B. Ertl-Wagner; Munich/DE (Birgit.Ertl-Wagner@med.uni-muenchen.de) 
The European Training Curriculum for Radiology is a living document that was 
last revised in March 2013. It outlines the post-graduate training for physicians 
who want to specialise in radiology. The ESR recommends a 5-year 
postgraduate training period to become a radiologist divided into 3+2 years 
(level I and II training). In order to subspecialise in an area of interest, further 
training is necessary (level III training). With a changing medical environment 
and increasing economic pressures, both radiologists and radiographers face 
challenges. In order to succeed, both groups will need to stand together and 
focus on synergies, while minimising areas of conflict.  
Learning Objectives:
1. To become familiar with the European Training Curriculum for Radiology. 
2. To evaluate the differences in training for radiologists and radiographers. 
3. To understand the best way towards collaboration between radiologists and 
radiographers. 
Panel discussion:  
Joint approaches by radiologists and radiographers:  
the key to success  17:14
16:00 - 17:30 Room P  
Vascular  
RC 715  
Dialysis fistula: imaging and intervention  
Moderator:  
H.I. Manninen; Kuopio/FI 
A-194 16:00 
A. Assessment of vascular access malfunction  
R. Uberoi; Oxford/UK (raman.uberoi@orh.nhs.uk) 
Haemodialysis accesses have become the most commonly performed type of 
vascular surgical procedure. However, only 50% of all haemodialysis accesses 
remain patent at 3 years. Autogenous fistulas have a higher rate of primary 
failure compared to prosthetic grafts (50% vs. 15%), but the long-term patency 
of fistulas is superior to that of grafts. Autogenous fistulas fail after a median of 
3 to 7 years, whereas prosthetic arteriovenous grafts fail after a median lifetime 
of only 12 to 18 months. The pathogenic stenoses causing access failure occur 
in various locations, but the most common site in prosthetic arteriovenous 
grafts is at the anastomosis between the graft and outflow vein, as identified in 
47% (23,246) to 60% of cases, or in the outflow vein itself in autogenous 
arteriovenous fistulas. Clinical assessment alone will detect a large number of 
failing fistulas. By assessment of the thrill, pulse character, palpation of the 
fistula itself, excessive bleeding and difficulty needling a fistula may all indicate 
a failing fistula. If the venous pressures during haemodialysis exceed 120 mm 
Hg, fistula flow falls to< 500 ml/min, graft flow decreases to< 650 ml/min, or 
access blood flow falls by more than 25%. A fistulogram is recommended if 
monitoring or surveillance suggests that thrombosis is either imminent or has 
already occurred. Duplex can be used to assess the fistula, but cannot 
visualise the central veins. MR and CT venography has also been used in 
many patients successfully.  
Learning Objectives:
1. To learn about the imaging features of the malfunctioning vascular access. 
2. To learn about screening protocols and the results of screening. 
3. To learn about the most common problems and how to detect them. 
A-195 16:30 
B. Treating the stenosed access  
D. Henroteaux; Liège/BE (denis.henroteaux@chrcitadelle.be) 
Treatment of symptomatic stenosis of vascular access is essential as it can 
lead to thrombosis and loss of vascular access. But treatment can lead to 
restenosis. The treatment of stenosis remains a challenge which requires a 
good knowledge of different materials (guidewire, catheters, balloons and 
stents). Though the pathophysiological mechanism of stenosis is different for 
native fistulas, grafts or restenosis, the treatment technique remains the same. 
The basic principle is the use of high inflation pressure balloon angioplasty. 
Whatever the material used, the key is to have no residual stenosis greater 
than 30%. So far, no study has demonstrated the superiority of the "new" tools 
(cutting balloon, drug-eluting balloon, cryotherapy) regarding restenosis. 
Except perhaps for anastomotic grafts stenosis, stents should be reserved to 
treat complications or failure of balloon angioplasty. The stents indications are 
residual elastic stenosis, wall obstructive damage, acute rupture during 
angioplasty, aneurysm or restenosis. Complications of stenosis treatment are 
rare, but can lead to the loss of vascular access. The main complications are 
thrombosis and acute rupture. As with any treatment, there have been 
contraindications: infection, distal ischaemia, high flow, newly created or 
surgically revised access (< 6 weeks). When dealing with a vascular stenosis 
access, never compromise on the future, but think about the surgical 
alternative. So, the management of stenosis vascular access must also be 
multidisciplinary.  
Learning Objectives:
1. To learn about treatment techniques, material and equipment. 
2. To become familiar with the difference between treating dialysis fistulas and 
grafts. 
3. To learn about complication management. 




C. Treating the thrombosed access  
L. Turmel-Rodrigues; Tours/FR (luc.turmel@wanadoo.fr) 
Percutaneous treatment of a thrombosed dialysis access can be extremely 
challenging. The major concern does not stem from the fact that the procedure 
can be complexly long, but arises rather from the management of its 
complications, which can be serious particularly when the access is branched 
onto the brachial artery. Access infection is an absolute contraindication. 
Temporary contraindications include fluid overload and severe hyperkalaemia.  
Percutaneous thrombectomy of grafts is very well standardised and 
predictable: size of 6 mm, well palpable wall which is easy to needle, small 
average clot burden, and an underlining stenosis almost always found at the 
venous anastomosis. Thrombectomy of AVFs is subject to variations in 
approach and technical difficulties depending on their anatomical 
particularities. 
All techniques employed follow 2 rules: first, the removal of thrombi and, 
second, dilation of the stenosis responsible for the thrombosis. Heparin and 
antibiotics must be injected. The basic principle is to place in the arterialized 
vein or graft 2 introducer sheaths in opposite directions to work on both the 
venous outflow and arterial inflow. Thrombus lysis or removal can be achieved 
by mechanical, pharmacological and pharmaco-mechanical methods. All 
techniques may work in grafts given that the modest amount of thrombus 
(3.2 ml on average) can be simply pushed into the lungs. Prosthetic grafts are 
thus easier to declot than native fistulas, but they are much more prone to early 
rethrombosis. Thrombi located at the arteriovenous anastomosis form a firm 
and rubbery plug, frequently and notoriously resistant to thrombolysis.  
Learning Objectives:
1. To learn about treatment techniques, material and equipment. 
2. To become familiar with the difference between treating dialysis fistulas and 
grafts. 
3. To learn about complication management. 
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08:30 - 10:00 Room A  
Interactive Teaching Sessions  
E³ 820a  
Thoracic changes after treatment  
A-197 08:30 
A. Drug-related conditions  
T. Franquet; Barcelona/ES (tfranquet@santpau.cat) 
Drug-induced lung disease is an increasingly common cause of morbidity and 
mortality. The diagnosis is based on clinical history and consistent radiologic 
findings. Lung biopsy is performed in a small percentage of cases. High-
resolution CT may demonstrate different parenchymal patterns including 
diffuse alveolar damage, acute or chronic alveolar haemorrhage, nonspecific 
interstitial pneumonia (NSIP), hypersensitivity pneumonitis, organising 
pneumonia, and eosinophilic pneumonia. The imaging and histologic 
manifestations are often nonspecific. A systematic approach to the radiological 
evaluation of drug-related lung diseases is essential and includes not only 
chest imaging pattern recognition, but also integration of available clinical 
information.  
Learning Objectives:
1. To understand pulmonary changes related to treatment. 
2. To understand the mechanisms of injury to the lung in drug related 
conditions. 
Author Disclosure:
 T. Franquet: Author; Amirsys/Elservier. 
A-198 09:15 
B. Device-related conditions  
G.R. Ferretti; Grenoble/FR (GFerretti@chu-grenoble.fr) 
In this interactive session, we will present and discuss several cases illustrating 
thoracic changes after instrumental procedures in the thorax such as surgery, 
radiofrequency ablation, interventional endoscopy, and intensive care. 
Radiologists have an important role in assessing the results of these 
procedures as well as in depicting the complications. However, knowledge of 
the normal appearance after those procedures has to be presented.  
Learning Objectives:
1. To understand changes related to lines and wires in ICU patients. 
2. To learn about findings related to surgery. 
08:30 - 10:00 Room B  
Emergency Radiology  
RC 817  
Polytrauma: redefining imaging issues for 
management priorities  
A-199 08:30 
Chairman's introduction: advanced imaging, logistics and management 
priorities in patients after polytrauma  
H. Alkadhi; Zurich/CH (hatem.alkadhi@usz.ch) 
The initial imaging workup of polytrauma patients remains challenging. Besides 
hardware requirements, workflow issues continue to evolve, with the current 
focus on the introduction of whole body CT into the early resuscitation phase of 
severely injured patients as a standard and basic diagnostic imaging method. 
This session is aimed at a thorough discussion on the requirements for 
advanced imaging in the early clinical situation in emergency radiology. Focus 
is directed on the issues of radiation dose as well as on CT and contrast media 
protocols.  
A-200 08:40 
A. Chest and abdomen  
M. Scaglione; Castel Volturno/IT (mscaglione@tiscali.it) 
Thoraco-abdominal injuries are a significant cause of death in the 
polytraumatised patients. Early recognition and communication of life-
threatening thoraco-abdominal injuries is the major task of the radiologists 
involved in the emergency room. Although most of these patients reach the 
hospital prior to dying, lethality continues to remain high. Heart, thoracic great 
vessels, trachea, bronchus, pleura, lung, diaphragm, 
abdominal/retroperitoneal, vascular and solid organ injuries are potential cause 
of death. Any appropriate surgical/interventional management approach must 
be carried out "around the clock", before thoraco-abdominal injuries reach the 
level of clinical evidence. On the other hand, non-operative management has 
actually become the standard of care for the most serious thoraco-abdominal 
injuries. These goals become feasible if a correct contrast-enhanced MDCT 
diagnosis, in a dedicated facility in which the trauma team works effectively 24 
h a day, 7 days a week, is performed. Thus, in this lecture, the most serious 
thoraco-abdominal injuries will be illustrated, with special emphasis on 
vascular/injuries as well as the value of post-processing techniques, protocols, 
pitfalls, tips and tricks. Furthermore, the importance of a rational and integrated 
imaging approach will be pointed out and, finally, the role of the radiologist in 
the emergency room will be emphasised.  
Learning Objectives:
1. To become familiar with the most important imaging findings and their 
impact on patient management. 
2. To understand common classification systems, trauma scoring systems and 
their impact on patient management. 
3. To learn about typical and atypical imaging findings. 
A-201 09:00 
B. Spine and pelvis  
G. Schueller; Bülach/CH (gerd.schueller@spitalbuelach.ch) 
Spinal and musculoskeletal trauma account for significant morbidity in severely 
traumatised patients. Traumatic injuries to the spine encompass a variety of 
frequently occurring disorders and primarily result in stable injury. Although 
rare, unstable disorders comprise injuries to the bone, the discs, and the 
ligaments. In the majority of cases, spinal cord injuries result in devastating 
medical and social consequences. Severe musculoskeletal disorders usually 
are the result of high-impact accidents, such as motor vehicle accidents and 
falls from a height. For instance, the injured pelvic ring causes one of the most 
life-threatening conditions that the trauma team must handle. Pelvic injuries are 
often associated with severe arterial, venous, and/or osseous bleeding. 
Radiography is no longer recommended as the primary screening modality in 
spinal and pelvic trauma for adults. Despite the radiation dose burden of CT, 
patients with a high risk of spine injury receive MDCT imaging, as it is the 
method of choice. MR imaging is indicated primarily when patients present with 
myelopathy, and to search for spinal cord pathology. Interventional radiology 
plays a major role in the therapy of complex traumatic pelvic disorders.  
Learning Objectives:
1. To become familiar with the pathomechanisms and classification of spinal 
and pelvic trauma treatment options. 
2. To become familiar with the image interpretation of the spine and the pelvis. 
3. To learn about typical imaging findings based on CT and MR imaging. 
A-202 09:25 
C. Extremities  
U. Linsenmaier, L. Geyer; Munich/DE 
(Ulrich.Linsenmaier@kliniken-pasing-perlach.de) 
Extremity injuries in patients after polytrauma can be complex and are initially 
often difficult to be fully diagnosed. Emergency radiology diagnosis is today 
mostly based on a standardised whole body CT (WBCT), which can be 
extended with CTA and adapted to cover extremity injuries. Extremity injuries 
comprise: fractures of (1) long bones, (2) articular joints, (3) complex fractures 
of hands and feet, (4) vascular, (5) soft tissue, (6) nerve and plexus injuries 
and (7) amputations. Imaging protocol: *MDCT is indicated in all major and 
complex bony fractures and is carried out early or integrated with WBCT. CTA 
using MIPs and MPRs enables a thorough workup. * The role of US and CR is 
limited. * The role of MR and MRA (in stable patients only) is to evaluate 
unstable articular injuries, injuries of tendons or major ligaments and nerve and 
plexus injuries). * The role of DSA is mostly for intervention. Clinical findings 
and findings from WBCT determine how to proceed, "first things are done first" 
in a priority-oriented clinical algorithm. Treatment of extremity injuries must 
therefore be priority oriented and carefully planned in the context of possible 
concurrent injuries and a possible risk of multi-organ failure (MOF).  
Learning Objectives:
1. To become familiar with imaging strategies, the role of CR, CT and MR. 
2. To understand common classification systems and their impact on patient 
management. 
3. To learn about typical and atypical imaging findings. 
Panel discussion: How to speed up your diagnoses  09:45




08:30 - 10:00 Room C  
Interactive Teaching Session  
E³ 820b  
Central nervous system changes after 
treatment: what you need to know  
A-203 08:30 
A. Drug-related conditions  
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
Systemic drugs can be used for the treatment of CNS and non-CNS diseases. 
Both classes can affect the brain inadvertently. Common general drugs that 
affect the brain in a bystander manner are steroids (~1% brain volume 
reduction), recreational drugs (alcohol, cocaine, heroin, XTC), metronidazole 
and anti-epileptic drugs (corpus callosum demyelination) and 
immunosuppressants like cyclosporine/tacrolimus (PRES/RPLS) and 
methotrexate. Mechanisms of action include neurovascular compromise, 
fluid/metabolite shifts and toxic effects to myelin of other tissue components. 
Among CNS-targeted drugs, especially immunomodulating agents may cause 
specific side effects. Cytokine-release syndromes may occur with broad-acting 
agents such as general T cell antibodies. Specific side effects may occur in 
multiple sclerosis, where treatment with natalizmumab may cause reactivation 
of JC virus leading to progressive multifocal leukencephalopathy (PML). Upon 
withdrawal of therapy, this may then evolve into an Immune reconstitution 
inflammatory syndrome (IRIS). In Alzheimer disease, novel antibodies or 
vaccinations against amyloid may cause amyloid related imaging abnormalities 
(ARIA), which may present with microhaemorrhage on T2* images, or with 
edema and effusion on FLAIR.  
Learning Objectives:
1. To understand changes related to systemic treatment. 
2. To learn about CNS treatment agents. 
A-204 09:15 
B. Imaging of treated brain tumours  
J. Alvarez-Linera; Madrid/ES (jalinera@ruberinternacional.es) 
The objective of this session will be to review the diagnostic value of 
conventional sequences as well as the use of contrast in the monitoring of 
brain tumours, with special attention to gliomas. Also, we will address the 
advantages and limitations of advanced techniques: perfusion, diffusion, and 
spectroscopy. Immediately after surgery, the main objective of neuroimaging is 
the detection of the remaining tumour. It may also be necessary to rule out 
complications such as haemorrhage, ischaemia or infection. The fundamental 
technique is MRI with contrast in the first 48 hours and also diffusion 
sequences. In late follow-up, the goal is to differentiate the changes secondary 
to treatment of those related to tumour progression or recurrence. In these 
cases, conventional sequences present important constraints and are useful 
studies of diffusion, perfusion and spectroscopy. During follow-up after 
chemoradiotherapy, the objective is to assess tumour response. The response 
according to the new RANO criteria will be revised. The combination of 
chemotherapy and radiotherapy, as well as the use of anti-angiogenic drugs 
causes changes that complicate the assessment of the response to treatment, 
with cases of pseudoprogression and pseudoresponse. In these cases, 
perfusion techniques, diffusion and spectroscopy can provide relevant 
information, although it is necessary to standardise the quantification to make 
its wide use possible.  
Learning Objectives:
1. To appreciate CNS manifestations after surgery. 
2. To understand CNS changes after radiotherapy and other non-surgical 
treatments. 
08:30 - 10:00 Room D  
Genitourinary  
RC 807  
Contrast media safety: update  
A-205 08:30 
Chairman's introduction  
P. Reimer; Karlsruhe/DE 
The speakers in this course will update the audience on contrast media safety 
such as steps to be taken before contrast administration and present the 
newest safety guidelines. The first speaker will cover new concepts of non-
renal reactions to contrast media explaining which hypersensitivity reactions 
are allergic and non-allergic. The audience may learn assessing symptoms 
according to the Ring and Messmer classification and understand the 
importance of tryptase sampling and skin testing in the follow-up. The second 
speaker will address NSF. The presentation will review the pathophysiology, 
risk factors, recent recommendations and prevention of NSF. Patients with 
GFR less than 30 ml/min/1.73 m2 have increased risk of developing NSF. Low-
stability gadolinium contrast media show the strongest association with NSF. 
Following existing guidelines on the use of gadolinium contrast agents 
minimises the risk of NSF. Potential long-term harm from gadolinium 
accumulation in the body and legal issues are discussed. The last speakers 
will cover contrast medium-induced nephropathy with more recently published 
guidelines related to that issue. The presentation will include the definition of 
CIN and the choice of contrast medium and prophylactic measures. Recent 
changes in ESUR guidelines will be explained. The risk of CIN is considered 
significantly lower following iv. CM administration and patients referred for 
enhanced CT are genuinely at risk if they have an eGFR < 45 ml/min/1.73 m2.
Volume expansion with isotonic saline or sodium bicarbonate may be used for 
preventing CIN in at-risk patients.  
Author Disclosure:
 P. Reimer: Investigator; Bayer Health. Speaker; Bayer Health, Bracco. 
A-206 08:35 
A. Acute non-renal reactions to contrast media: new concepts  
O. Clément; Paris/FR (olivier.clement@inserm.fr) 
Acute immediate hypersensitivity reactions occur within the hour following the 
administration of contrast media. They can be seen with Iodinated and 
gadolinium-based contrast agents. Over the last ten years, new concepts have 
emerged in the way of understanding, managing and exploring hypersensitivity 
reactions. The clinical appearance is best classified by the Ring and Messmer 
scoring, from Grade 1 (cutaneous and subcutaneous signs) to Grade 4 
(cardiovascular arrest). The mechanisms involve either true IgE-mediated 
hypersensitivity or non-allergic hypersensitivity. The differential diagnosis in 
favour of allergy is made on a triad: clinical signs (the more severe, the more 
are the chances to be allergic), elevated tryptase levels in the plasma 
(indicating mastocyte triggering) and positive skin tests performed one month 
after the reaction. These new concepts induce important consequences in 
managing hypersensitivity reactions: be prepared to treat the patient 
adequately, be prepared to draw blood after the reaction to dose tryptase 
levels, send the patient to a dedicated allergologist, and forget about the 
preventive role of premedication against severe reactions.  
Learning Objectives:
1. To learn which hypersensitivity reactions are allergic and non-allergic. 
2. To learn the clinical symptoms according to the Ring and Messmer 
classification. 
3. To understand the importance of tryptase sampling and skin testing in the 
follow-up. 
Author Disclosure:
 O. Clément: Board Member; French society of Radiology. 
A-207 08:58 
B. Nephrogenic systemic fibrosis: from pathophysiology to 
recommendations  
H.S. Thomsen; Herlev/DK (henrik.thomsen@regionh.dk) 
Gadolinium (Gd) belongs to the lanthanides in the periodic table, all of which 
affect collagen. The ability to hold the Gd ion varies from chelate to chelate, 
with non-ionic linear chelates being the weakest binders. Transmetalation 
(exchange of Gd with another ion, e.g. zinc) leads to NSF, a horrifying very late 
adverse reaction to some Gd-CM. Since 2007, the various Gd-CM have been 
classified into 3 groups: high risk (of NSF), intermediate risk and low risk. The 
authorities have introduced several restrictions on the use of high-risk agents, 
which will be followed by every physician in the EU. The agents are 
contraindicated in 1) patients with severely reduced renal function including 
dialysis, 2) acute renal insufficiency, 3) neonates and 4) pregnant women. 
They may only be used with caution in patients with moderately reduced renal 
function and children less than 1 year old. There must be at least 7 days 
between 2 injections in those patients. Renal function must always be 
determined by laboratory methods before use of high-risk agents. Women 
should stop lactation for 24 hours. These agents should never be given at 
doses higher than 0.1 mmol/kg per examination in any patient. For the 
intermediate and low-risk agents, the restrictions are significantly less; they 
should only be used with caution in patients with severely reduced renal 
function including dialysis. If a physician does not follow these rules, he or she 
will have legal problems as they have been introduced into the SPC by the 
authorities.  





1. To understand the underlying pathophysiology. 
2. To learn about the clinical implications of the recent 
recommendations/guidelines. 
3. To become familiar with legal issues. 
A-208 09:21 
C. Contrast medium-induced nephropathy and new guidelines  
F. Stacul; Trieste/IT (fulvio.stacul@aots.sanita.fvg.it) 
The Contrast Media Safety Committee (CMSC) of the ESUR has updated its 
guidelines on contrast medium-induced nephropathy (CIN). The ACR recently 
updated its guidelines as well. New guidelines were produced by nephrological 
societies. The topics reviewed include the definition of CIN, the choice of 
contrast medium, and the prophylactic measures used to reduce the incidence 
of CIN. The CMSC considered it appropriate to keep the definition of CIN that 
was agreed in 1999. However, nephrologists have recently agreed on a new 
definition. In the previous guideline, a number of risk factors were listed (raised 
S-creatinine levels, particularly secondary to diabetic nephropathy, 
dehydration, congestive heart failure, age over 70 years, concurrent 
administration of nephrotoxic drugs). The significance of these risk factors has 
been confirmed and new risk factors were added. The CMSC agreed that the 
risk of CIN was significantly lower following intravenous CM administration and 
concluded that patients referred for enhanced CT were genuinely at risk if they 
had an eGFR < 45 ml/min/1.73m2. The previous CMSC guideline suggested 
the use of low or iso-osmolar CM in patients with risk factors for CIN and the 
CMSC considered that this previous guideline should not be changed. The 
CMSC considered that there was enough evidence to recommend that either 
volume expansion with isotonic saline or sodium bicarbonate may be used for 
preventing CIN in at-risk patients, while the efficacy of NAC and other drugs in 
reducing the incidence of CIN remained unproven. Guidelines produced by 
other societies provide very similar suggestions, thus further validating these 
recommendations.  
Learning Objectives:
1. To become familiar with newest guidelines on contrast-induced nephropathy 
(CIN). 
2. To understand the future clinical implications of the new guidelines. 
Author Disclosure:
 F. Stacul: Advisory Board; GE Healthcare. Speaker; Bracco, GE Healthcare. 
Panel discussion:  
What is the most appropriate radiological approach to patients with 
falling eGFR and when should contrast media be administered and when 
should it not?  09:44
08:30 - 10:00 Board Room B  
Paediatric  
RC 812  
Autoimmune disorders in children  
Moderator:  
M.P. García-Peña; Barcelona/ES 
A-209 08:30 
A. The joints in juvenile idiopathic arthritis  
L.-S. Ording Müller; Oslo/NO (lilsofie.ording@googlemail.com) 
JIA is the most common rheumatic entity in childhood and includes a subset of 
childhood arthritis, all of which are characterised by chronic synovitis with a 
potential risk of progressive joint destruction. Radiological investigations in JIA 
should ideally be able to determine the presence and degree of active 
inflammation, precursors of bony destructions and established erosions. 
However, there are many pitfalls in the interpretation of joint pathology in 
children. Ultrasonography is often the initial tool in the assessment of arthritis 
and can depict joint fluid and synovitis. Erosions and cartilage destruction of 
small joints may also be seen. The major problems are standardising the 
imaging technique and the lack of normal standards of anatomy in US in 
children. Radiographs can show bone erosions and may depict cartilage loss 
indirectly through joint space narrowing, but are insensitive to inflammation and 
early joint destruction. MRI is the only imaging modality that can assess all 
relevant anatomical structures in joint inflammation and is sensitive to early 
inflammation and destruction. However, large variations in the amount of joint 
fluid, bone marrow oedema-like lesions and changes resembling erosions are 
seen in children and also in healthy individuals. The differentiation between 
true pathology and normal findings on MRI in children remains a challenge, 
particularly in early disease. In this lecture, the role of radiographs, ultrasound 
and MRI and the typical radiological findings in joint pathology in JIA will be 
presented. Current knowledge on validity and reliability of the different imaging 
techniques in JIA will be discussed.  
Learning Objectives:
1. To learn about the different joint lesions in JIA. 
2. To understand when to use US or MRI. 
3. To learn how to recognise the typical imaging patterns. 
A-210 09:00 
B. The digestive tract  
E. Alexopoulou; Athens/GR 
Inflammatory bowel disease (IBD) is a range of diseases, which includes 
Crohn disease, ulcerative colitis, and indeterminate colitis. The combined 
effects of the four basic components seem to result in the disease: 
environmental changes, genetic factors, intestinal microbiota alterations and 
immune system deregulation. In children with unknown IBD, US is considered 
to be the first choice imaging technique which is performed before endoscopy. 
Bowel wall thickening, location and length of the disease, echogenicity of the 
bowel wall, the presence or not of normal stratification, ulcers, bowel stiffness, 
stricture or distention can often be detected with US. Additional information 
about the surrounding fat and the presence of mesenteric nodes can be 
obtained. The absence of bowel wall thickening has a strong negative 
predictive value. MR enterography is the technique of choice in children with 
known IBD, as it is a reproducible and well-tolerated examination, lacking 
radiation and providing excellent information about bowel disease. MR 
enterography clearly illustrates: a) bowel loop appearance (fixed, dilated, 
strictured, pseudo sacculation appearance); b) bowel wall (thickness, focal 
lesions such as ulceration, pseudopolyps and mural abscess, type of signal on 
T2 -W sequences and pattern of enhancement after iv contrast injection); c) 
extramural signs (fibrofatty proliferation, "comb sign", fistula, abscess, 
mesenteric nodes). CT should be performed in cases where MRI is 
contraindicated or in acute-emergency situations, when US is inadequate. It 
remains also an examination of choice for abscess drainage, to depict its exact 
extension and select the most appropriate access route.  
Learning Objectives:
1. To learn the basics of mechanisms related to autoimmune enteritis. 
2. To appreciate the role of US, CT and MRI. 
3. To become familiar with imaging findings useful in the diagnosis. 
A-211 09:30 
C. Multiple sclerosis in children  
C. Adamsbaum, B. Husson, K. Deiva, M. Tardieu; Le Kremlin Bicêtre/FR
(c.adamsbaum@bct.aphp.fr) 
The recent criteria for paediatric MS (Mult Scler 2013, 19, 1261-7) and the 
revised McDonald criteria for adults and adolescent MS allow the diagnosis of 
MS at the time of the first demyelinating clinical event. Brain MRI plays an 
important role in those criteria, as it can demonstrate the classical 
dissemination in time and space and helps earlier diagnosis, which is of major 
importance since the present recommendation in children is to start 
immunomodulating treatments as soon as diagnosis is established. Among 
paediatric MS, 14% begin before the age of 6 years and 30% before the age of 
10 years, frequently with an ADEM presentation in young children as initial 
manifestation of MS. However, only 20% of the ADEM indicate MS onset and 
the most predictive factors should be known, i.e. periventricular, deep white 
matter, corpus callosum high T2 signal lesions and black holes on T1 
sequences. MRI evaluation is also instrumental in differential diagnoses such 
as nonrelapsing ADEM, vasculitis, immunogenetic diseases and occasionally 
leukodystrophies. Finally, brain MRI is useful to evaluate the risk of more 
severe MS.  
Learning Objectives:
1. To understand the difference between children and adults. 
2. To become familiar with imaging findings. 
3. To learn about the principle differential diagnosis. 
08:30 - 10:00 Room E1  
State of the Art Symposium  
SA 8  
Radiology and obesity  
A-212 08:30 
Chairman's introduction  
S.A. Jackson; Plymouth/UK (simon.jackson1@nhs.net) 
The obesity epidemic represents one of the most significant European and 
public health challenges in the 2 1st century with prevalence of the disease 
having tripled in many countries during the past 30 years. This is resulting in an 




ever increasing cost to healthcare systems including hospital and in particular 
radiology services which face unique challenges when imaging this group of 
patients. Obesity significantly increases the patient's risk of various comorbid 
diseases including the incidence of cancer, diabetes, and cardiovascular and 
liver pathology with a multidisciplinary team approach mandatory for optimal 
patient care. This multidisciplinary symposium will review the implications of 
the epidemic with cutting edge, in-depth lectures presented by European 
experts addressing the epidemiology, role of imaging in the bariatric surgical 
patient as well as the importance of abnormal fat deposition in the liver.  
Session Objectives: 
1. To learn about the impact of the obesity epidemic on European healthcare. 
2. To appreciate the value of imaging techniques in the management of the 
post-operative bariatric patient. 
3. To understand the role of radiology in fatty liver disease and the importance 
of imaging during subsequent patient surveillance. 
A-213 08:35 
Obesity: causes and consequences to the patient  
R. Batterham; London/UK (r.batterham@ucl.ac.uk) 
Obesity is one of the greatest 2 1st century public health challenges. Its 
prevalence has tripled in many European Union (EU) countries since the 
1980s. Currently, 52% of EU adult population is overweight and 17% obese, 
and the numbers of those affected continue to rise. Overweight and obesity are 
risk factors for numerous health problems, including hypertension, diabetes, 
cardiovascular diseases, respiratory problems, musculoskeletal diseases and 
some forms of cancer. Mortality also increases sharply once the overweight 
threshold is crossed. Because obesity is associated with higher risks of chronic 
illnesses, it is linked to significant additional health care costs and is already 
responsible for 2-8% of health costs. Changes in our environment are the main 
driver for this increase in overweight/obese. However, a person's genetic 
make-up can either increase or decrease their chances of becoming 
overweight. The gastrointestinal tract is the body's largest endocrine organ 
producing hormones that regulate bodyweight. Dietary modifications, such as 
caloric restriction, are the first-line obesity treatments. However, dieting 
produces only moderate weight-loss with poor weight-loss maintenance. 
Compensatory gut hormone changes induced by dieting are thought to 
contribute to the failure of dieting. In contrast, bariatric surgery is an efficacious 
treatment modality for obesity, producing durable weight-loss, amelioration of 
obesity-associated co-morbidities and reduced mortality. Consequently, the 
number of bariatric procedures undertaken within Europe has doubled in the 
last 5 years with 112,000 procedures undertaken in 2011. There is increasing 
evidence that surgically-induced alterations in circulating gut hormones 
mediate the weight-loss and metabolic beneficial effects of bariatric surgery.  
Learning Objectives:
1. To understand the epidemiology of obesity and its impact on European 
healthcare provision. 
2. To appreciate the aetiology of obesity and the scientific rational for surgical 
treatment. 
3. To learn about the effects of obesity on health. 
A-214 08:58 
Imaging of modern surgical procedures and their complications  
M. Rengo; Latina/IT (marco.rengo@gmail.com) 
We will illustrate the common bariatric procedures, in particular their normal 
appearance on different diagnostic technique as well as their early and late 
complications. We will illustrate the correlation between conventional barium 
studies and advanced imaging with MDCT and MR. We will explain how to 
optimise MDCT and MR acquisition protocol according to the clinical indication. 
We will explain what to evaluate before redo surgery, in particular quantitative 
and functional analysis. We will illustrate the role of interventional radiology in 
the management of early postoperative complications, in particular in the 
management of patients subjected to gastric banding.  
Learning Objectives:
1. To understand the common bariatric surgical procedures and post operative 
imaging appearances. 
2. To appreciate the role of imaging in the assessment of suspected immediate 
and long-term postoperative complications. 
3. To become familiar with the role of interventional radiology in the 
postoperative period, including gastric band follow-up. 
A-215 09:21 
Fat: where it shouldn't be  
V. Vilgrain1, M. Ronot1, B. Leporcq2, S. Lambert2, B.E. Van Beers1; 1Clichy/FR,
2Paris/FR (valerie.vilgrain@bjn.aphp.fr) 
Non-alcoholic fatty liver disease comprises a variety of pathological disorders 
ranging from simple steatosis to steatohepatitis. This condition is common in 
the Western population and is typically associated with obesity and the 
metabolic syndrome. Its incidence increases dramatically. Diagnosis of fatty 
liver and distinction between simple steatosis and steatohepatitis are keys 
because the latter can lead to extensive fibrosis and cirrhosis with an 
increased risk of hepatocellular carcinoma (HCC). Imaging plays a crucial role 
in diagnosing fatty liver. The two most important imaging modalities are 
ultrasound and MR imaging. Ultrasound can exclude major steatosis but lacks 
accuracy to precisely quantify fat, while MR is the most accurate for 
quantification. The technique of reference is MR spectroscopy, but 
sophisticated sequences based on chemical shift principle have been shown 
as accurate as MR spectroscopy. Unfortunately, imaging has still limitations to 
assess the presence of fibrosis and inflammation which are associated with 
steatohepatitis and functional tools could be of interest. Today, imaging is 
combined with clinical and biological biomarkers to evaluate the risk of 
steatohepatitis. Due to the increased risk of HCC and cirrhosis-related 
complications in patients with steatohepatitis, patients at risk should be 
enrolled in the surveillance programme.  
Learning Objectives:
1. To understand the pathophysiology of fatty liver disease and its link to 
cirrhosis. 
2. To become familiar with the role of imaging in the detection and 
quantification of fat in the liver. 
3. To learn about the importance of imaging in the surveillance of patients with 
fatty liver disease. 
Panel discussion:  
How to optimise an imaging service for the obese patient?  09:44
08:30 - 10:00 Room E2  
Foundation Course: Breast Imaging  
E³ 820c  
Multidisciplinary team meeting  
from Milan, IT  
A-216 
Multidisciplinary team meeting from Milan, IT  
P. Panizza, R. Agresti, L. Lozza, G. Bianchi, B. Paolini; Milan/IT
(pietro.panizza@istitutotumori.mi.it) 
The concept of breast cancer units originates from the need for making 
available to all women in Europe high-quality breast services where breast 
disease could be looked after by specialists working as teams. Such teams 
have to provide all the services related to breast cancer, including genetics and 
prevention, treatment of the primary tumour, care of advanced disease, 
palliation and follow-up of previously treated women. The breast unit is made 
up of a group of dedicated breast cancer specialists including a radiologist, 
radiographer, surgeon, reconstructive surgeon, pathologist, medical oncologist, 
radiation oncologist and breast care nurse. The specialists involved in breast 
cancer units have access to all the facilities required for high-quality care and 
spend most of their working time dealing with breast cancer. In our hospital, we 
routinely work as a team and to make it possible we organise weekly meetings 
involving specialists from different disciplines to evaluate and plan patient care 
at any step of the diagnostic and therapeutic process. Each year, we take care 
of about 1.500 newly diagnosed patients with primary breast cancer and of 
10.000 patients in follow-up. About 500 are patients who undergo RT. After a 
short introduction from our fellows from pathology, surgery, oncology and 
radiation therapy, who will discuss their role in the breast unit, we will try to give 
a practical demonstration of the everyday work of breast units with particular 
emphasis on the role of the radiologist.  
Session Objectives:
1. To learn about breast cancer management. 
2. To understand when imaging is necessary for planning a therapeutic 
strategy. 
3. To appreciate multidisciplinary team work. 
4. To become familiar with the various breast unit disciplines other than 
radiology. 
08:30 
A. Radio-pathologic correlation/cooperation  
B. Paolini; Milan/IT 
Learning Objectives:
1. To understand how radiology can help in precancerous conditions. 
2. To consolidate knowledge on benign appearing masses which prove to be 
malignant. 
3. To appreciate the pathologist's input at a multidisciplinary meeting. 





B. The surgeon's point of view  
R. Agresti; Milan/IT 
Learning Objectives:
1. To understand what the surgeon needs to know before operation. 
2. To learn how to ensure that postoperative images are understood. 
3. To appreciate the surgeon's input at a multidisciplinary meeting. 
08:50 
C. Oncologist/radiotherapist's point of view  
G. Bianchi, L. Lozza; Milan/IT 
Learning Objectives:
1. To understand what the oncologist needs to know before starting treatment. 
2. To learn how to ensure that post-treatment images are understood. 
3. To appreciate the oncologist's input at a multidisciplinary meeting. 
09:00 
D. MDT discussion  
P. Panizza; Milan/IT 
08:30 - 10:00 Room F2  
Special Focus Session  
SF 8  
Image-guided prostate biopsies: a 
paradigm shift  
A-217 08:30 
Chairman's introduction  
J.C. Vilanova; Girona/ES (kvilanova@comg.cat) 
MR imaging has been playing an increasing role in the clinical management of 
prostate cancer. New MR techniques, multi-parametric (mp-MRI) acquisition, 
are showing improved assessment for prostate cancer detection and 
characterisation. The implementation of the new methodology on MRI needs to 
standardise the use and establish the recommendations for the clinical 
indications, as it has recently been presented. Prostate cancer is usually 
diagnosed with systematic blinded transrectal ultrasound biopsies. However, 
this method has low accuracy and for this purpose different approaches have 
been recently developed to change and improve the approach to diagnose 
prostate cancer. The challenge is to achieve an optimal and accurate method 
for an imaging-guided prostate biopsy.  
Session Objectives: 
1. To learn about the current role of imaging in managing prostate biopsy. 
2. To become familiar with the current recommendations and guidelines for 
multi-parametric technique of prostate MRI and the standardisation of 
reporting. 
3. To learn about different approaches to improving the performance of 
prostate biopsy. 
A-218 08:35 
MRI definition of the target: the ESUR scoring system  
P. Zamecnik; Nijmegen/NL (Patrik.Zamecnik@radboudumc.nl) 
The European Society of Urogenital Radiology (ESUR) published, in 2012, the 
new clinical guidelines for evaluation of the multi-parametric MRI of the 
prostate. This structured reporting/scoring system (PI-RADS) is based on 
literary evidence and consensus of experts' opinions. The PI-RADS scoring 
system is similar to that already employed by breast imaging (BI-RADS) and 
reflects the probability of a prostatic lesion to be significant. Each lesion can be 
scored in all sequences used in the multi-parametric prostate MRI protocols 
(T2- and diffusion weighted imaging, dynamic contrast enhanced imaging and 
MR spectroscopy) based on defined MRI criteria, which are specific for each 
sequence. Based on the scoring in the particular sequences a final PI-RADS 
score for each lesion can be assessed. For each lesion a five-grade scoring 
systems was created where, for example, the score 1 means that clinically 
significant disease is highly unlikely to be present and score 5 clinically 
significant disease is highly likely to be present. This lecture elucidates the 
principles of this scoring system and its impact on the target definition for the 
invasive diagnostics and therapy.  
Learning Objectives:
1. To show the value of standardisation of reading multi-parametric MRI using 
(PI-RADS). 
2. To learn how the PI-RADS reading should be done. 
3. To understand how localisation of PI-RADS 4 and 5 lesions can be used to 
aim biopsy. 
A-219 08:53 
A targeted-only biopsy strategy: impact on overdiagnosis and 
overtreatment  
N.B. Delongchamps; Paris/FR (nicolasbdl@hotmail.com) 
Prostate cancer screening with PSA and extended systematic biopsy protocols 
have led to the over-detection and over-treatment of small and well 
differentiated cancers, considered clinically insignificant. These cancers cover 
up to 70% of the overall prevalence and may not be of any threat. 
Multiparametric (mp)-MRI has shown recently its value in the detection, 
localisation and characterisation of prostatic tumour foci larger than 0.2 cm, 
and may be of value to address the issue of over-detection and over-treatment. 
An MRI-targeted biopsy strategy alone, without any additional systematic 
biopsies, has been suggested to decrease the detection rate of insignificant 
tumours while increasing that of potentially aggressive tumours. In patients 
with no evidence of lesion on mp-MRI, the biopsy may probably be deferred. In 
patients with localised prostate cancer, mp-MRI may also become a 
cornerstone in the selection, guidance and surveillance of patients managed 
with focal therapy. The rational for this new modality of treatment is to 
decrease over-treatment by destroying exclusively the index lesion detected on 
mp-MRI. The precision of such treatments may be increased with MRI-
transrectal ultrasound image fusion, allowing for real time navigation during the 
procedure.  
Learning Objectives:
1. To consolidate knowledge of the clinical consequences of PSA screening 
and extended biopsy strategies. 
2. To understand and develop the scientific rational of targeted-only biopsy. 
3. To learn about the results of targeted-only biopsy. 
4. To learn about the implications for patient management and the selection of 
focal therapy. 
Author Disclosure:
 N.B. Delongchamps: Speaker; LUT forum (Astellas), Janssen. 
A-220 09:11 
MRI-guided biopsies: pros and cons  
B. Hamm; Berlin/DE (bernd.hamm@charite.de) 
Allowing accurate detection of high-grade prostate cancer, multiparametric 
magnetic resonance imaging (mp-MRI) techniques have expanded the role of 
targeted biopsies of the prostate. MRI-guided prostate biopsy (MRGB) differs 
from systematic prostate sampling using transrectal ultrasound (TRUS) in that 
tissue can be specifically sampled from suspicious areas within the prostate. 
MR image guidance and targeting accuracy are the distinguishing features of 
MRGB compared with systematic (random) TRUS biopsies. Nevertheless, 
TRUS-guided biopsy is still the most widely used approach in patients with 
suspected prostate cancer. With TRUS-guided biopsy, there is an association 
between the number of tissue cores obtained and the cancer detection rate. 
However, this association has its limits since some areas within the prostate 
cannot be sampled at all or are difficult to reach with this biopsy technique. Mp-
MRI, on the other hand, helps in the workup of suspicious prostate lesions by 
integration of several techniques. These techniques range from cognitive 
fusion to direct MR-guided biopsy, which means that only targeted tissue 
samples are obtained. The recent introduction of software-based fusion of MRI 
datasets with real-time ultrasound images for prostate biopsy combines the 
diagnostic accuracy of MRI with the wide availability of ultrasound-guided 
biopsy.  
Learning Objectives:
1. To become familiar with the indications for MRI-guided biopsies. 
2. To learn about the technical approach. 
3. To learn about contraindications and complications. 
4. To understand future developments in biopsies guided by MRI/US fusion. 
Author Disclosure:
 B. Hamm: Board Member; Deutsche Röntgengesellschaft, European 
Congress of Radiology, European Society of Radiology, ESMRMB, European 
School of Radiology, Deutsche Forschungsgemeinschaft. Consultant; Bayer 
Schering Pharma, Toshiba. Grant Recipient; Kendle/ MorphoSys AG. 
A-221 09:29 
TRUS-guided biopsies with TRUS-MRI image fusion: pros and cons  
F. Cornud; Paris/FR (frcornud@imagerie-tourville.com) 
The accuracy of multiparametric MRI has greatly improved the ability of 
localising tumour foci of prostate cancer. This property can be used to perform 
a TRUS-MR image registration, a new technological advance, which allows for 
an overlay of an MRI onto a TRUS image to target a prostate biopsy towards a 
suspicious area. Three types of registrations have been developed: cognitive-
based, sensor-based and organ-based registration. Cognitive registration 
consists of aiming at a suspicious area during biopsy with the knowledge of the 
lesion location identified on multiparametric MRI. Sensor-based registration 
consists of tracking in real time the TRUS probe with a magnetic device, 




achieving a global positioning system which overlays in real time prostate 
image on both modalities. Its main limitation is that it does not take into 
account prostate and patient motion during biopsy Two systems (Artemis and 
Uronav) have been developed to partially circumvent this drawback. Organ-
based registration (Koelis) does not aim at tracking the TRUS probe, but the 
prostate itself to compute in a 3D acquisition the TRUS prostate shape, 
allowing for a registration with the corresponding 3D MRI shape. This system is 
not limited by prostate/patient motion and allows for a deformation of the organ 
during registration. The pros and cons of each technique and the rationale for a 
targeted-biopsy only policy are discussed.  
Learning Objectives:
1. To learn the physical principles of TRUS-MRI image registration. 
2. To become familiar with the different types of registration (cognitive, sensor-
based, organ-based). 
3. To learn about the accuracy of TRUS-MRI image registration-based prostate 
biopsies. 
4. To understand the potential applications of TRUS-MRI image registration to 
guide focal therapy. 
Panel discussion:  
Are we ready for the standardisation of MRI to manage prostate guided 
biopsy in routine clinical practice?  09:47
08:30 - 10:00 Room G/H  
EFOMP Workshop  
Between diagnosis and therapy:  
new technology in imaging of the prostate  
EF 1  
Imaging of the prostate for radiotherapy  
Moderators:  
P. Sharp; Aberdeen/UK 
J.N. Vassileva; Sofia/BG 
A-222 08:30 
Welcome address  
V.E. Sinitsyn1, P. Sharp2; 1Moscow/RU, 2Aberdeen/UK 
A-223 08:40 
Radiologist point of view: clinical and technical requirements for imaging 
of the prostate  
H.-P. Schlemmer; Heidelberg/DE (h.schlemmer@dkfz.de) 
Prostate cancer is associated with high morbidity and accordingly high 
socioeconomic impact. Due to overdiagnosis and overtreatment, avoidable 
morbidity and costs are feared in a selective but unpredictable patient group. 
The conventional way of establishing the diagnosis and making individual 
treatment decisions relies on the individual PSA serum level and pathologic 
Gleason score from systematic TRUS biopsy samples, which has well-known 
limitations. Patient stratification for choosing the best individual treatment 
becomes increasingly challenging, as various less invasive treatment 
alternatives and active surveillance have been established. Multiparametric MR 
imaging has been proven to be remarkably advantageous in this context for 
detecting cancer, characterising its heterogeneity and aggressiveness, 
targeting the most aggressive part (the dominant intraprostatic lesion, DIL), 
guiding the biopsy needle to that area and evaluation of local tumour 
spreading. The gained information supports individualised decision-making 
concerning treatment selection, planning, guidance, monitoring and follow-up. 
In case of active surveillance, functional MR parameters additionally yield 
objective and reproducible biomarkers for monitoring temporal changes of 
individual tumour aggressiveness during follow-up. PET imaging of prostate 
cancer with the use of various radiotracers is an ongoing research field applied 
in clinical studies. The recently developed novel PET/MR technology 
furthermore opens the window to improved molecular diagnostics concerning 
biologic cancer characterisation and detection of early cancer spread into 
lymph nodes and bone marrow. Multiparametric MR and PET/MR imaging will 
be an important role for comprehensive assessment and staging of prostate 
cancer and thus for individualised patient management.  
Learning Objectives:
1. To become familiar with conventional diagnostic pathways and different 
treatment options of prostate cancer. 
2. To appreciate the role of multiparametric MR and MR-targeted biopsy for 
clinical management of prostate cancer patients. 
3. To learn about novel developments of PET and PET/MR imaging for 
improved diagnosis and (re-)staging of prostate cancer. 
Author Disclosure:
 H.-P. Schlemmer: Advisory Board; Siemens. Research/Grant Support; 
Siemens. Speaker; Siemens. 
A-224 09:10 
Ultrasound imaging in the treatment of prostate cancer  
W.J. van der Putten; Galway/IE (wil.vanderputten@hse.ie) 
Radiotherapy of the prostate typically takes the form of either external beam 
radiotherapy or alternatively, brachytherapy using radioactive seed implants. In 
both cases, the use of ultrasound has been proven to be highly useful and this 
presentation will give an current state of the art overview of ultrasound in 
external beam and radioactive seed radiotherapy. In the case of external beam 
radiotherapy, accurate localisation of the prostate is essential to ensure 
adequate target coverage with minimal damage to normal tissue. Dedicated 
ultrasound scanners are able to provide sub millimeter localisation of the 
prostate superior to the imaging traditionally obtained using CT scanners. This 
positional information can be obtained daily. In addition, ultrasound allows the 
imaging of patients with metal hip implants which are normally difficult to image 
using CT. Apart from the benefits of the technique, some pitfalls will also be 
highlighted. In the case of prostate brachytherapy, the use of ultrasound in the 
3-D volume imaging of the prostate both prior and during treatment will be 
discussed. In both cases, some time will be spend discussing the Quality 
Assurance requirements for ultrasound imaging systems.  
Learning Objectives:
1. To learn about the use of ultrasound in image guided radiotherapy. 
2. To understand the clinical capabilities of ultrasound guided radiotherapy. 
3. To understand and appreciate the limitations of the technology. 
A-225 09:35 
Cone beam computed tomography for treatment of prostate cancer  
A. Torresin, B. Bortolato, M. Brambilla, C. Carbonini, P. Colombo, M. Minella, 
A. Monti, M. Parisotto, L. Trombetta; Milan/IT (alberto.torresin@unimi.it) 
Image-guided radiation therapy (IGRT) with onboard kilovoltage cone-beam 
CT (CBCT) allows image guidance during radiotherapy treatments for patient 
setup and dose replanning. All these items will be discussed in connection with 
other topics: organ dose and image quality. It is compulsory to convert CBCT-
image's pixels from arbitrary grey scale to Hounsfield unit (HU). This 
conversion was obtained using a Catphan 600 phantom. The same phantom is 
used for image quality evaluation; standard CTDI head and body phantoms 
and a Farmer chamber were used to measure the CBDI to estimate organ and 
effective doses by Monte Carlo software of different protocols of acquisition. 
CTDosimetry software (ver.1.0.4-ImPACT) and PCXMC2.0 Rotation software 
were used. To verify the dose replanning techniques by CBCT, horizontal and 
vertical dose profiles were compared with the same obtained from CT. Patient 
replanning was verified using CBCT vs CT in terms of conformity Index. Image 
quality parameters of CBCT (in comparison with CT images) are fine for spatial 
resolution, but are less useful for low contrast. CBDI of 5.7 mGy/100 mAs was 
measured; 4 mSv effective dose, 26 mGy prostate dose and 32 mGy bladder 
dose were evaluated and discussed during the presentation. Replanning on 
cylindrical phantom shows a mean percentage difference for each profile 2%
and a variation on D mean in all inserts < 3%. The mean percentage difference 
between parameters characterising CT and CBCT-based plan values is less 
than 5%. The replanning showed a substantial agreement with doses 
evaluated on the reference CT-image; patient dose must be evaluated for all 
radiation sources.  
Learning Objectives:
1. To learn about application of digital imaging in cancer treatment. 
2. To understand image quality and patient dose in CBCT. 
3. To appreciate the interdisciplinary approach of using CBCT in radiation 
therapy. 
4. To become familiar with concept of image quality and patient dose in CBCT. 
5. To consolidate knowledge of rule of Medical Physics Expert for planning and 
verification in cancer treatment. 




08:30 - 10:00 Room I/K  
Head and Neck Imaging  
CC 819  
How to perform and read a head and neck 
study (part 1)  
Moderator:  
J. Olliff; Birmingham/UK 
A-226 08:30 
A. Cranial nerve examination made easy  
J. Casselman; Bruges/BE (jan.casselman@azbrugge.be) 
Cranial nerves I-VI have an anteroposterior course and are best examined in 
the coronal plane. Cranial nerves VII-XII run in an anterolateral direction and 
are therefore best examined in the axial plane. These two planes also allow 
left-right comparison which makes lesion detection easier. Lesions involving 
the cranial nerve nuclei can be detected on axial proton-density/T2/multi-echo-
GE images and diffusion-weighted images can exclude acute infarction. The 
cisternal segment of the cranial nerves is best detected on heavily T2-weighted 
images (DRIVE/FIESTA/3D-TSE/CISS). At 3-tesla, 3D-sequences (e.g. b-FFE) 
can be used and it is often possible to cover the cisternal segments of all 12 
cranial nerves. In the cavernous sinus, the cranial nerves can only be 
evaluated on coronal gadolinium-enhanced high-resolution T1-weighted 
images and similar axial images are needed to evaluate the nerves in the 
jugular foramen and hypoglossal canal. Axial and coronal Gd-enhanced high-
resolution T1-weighted with or without fat suppression are used to image the 
extracranial course of the cranial nerves. Today, the TSE-DIXON sequences 
provide non-FatSat and FatSat images simultaneously, making cranial nerve 
imaging faster and easier. Time-of-flight images can be used to study 
neurovascular conflicts, although these can also be detected on submillimetric 
Gd-enhanced T1 images. Of course, it is important to know the major anatomy 
of the cranial nerves and the most frequently occurring lesions. The above-
mentioned imaging techniques, the most important anatomy and the most 
frequently occurring lesions will be demonstrated and discussed in this lecture.  
Learning Objectives:
1. To learn how to perform an examination and evaluation of cranial nerves. 
2. To become familiar with some technical issues in obtaining good quality 
images. 
3. To learn some basic information regarding cranial nerves anatomy. 
Author Disclosure:
 J. Casselman: Equipment Support Recipient; World reference site for MR 
equipment Philips. Speaker; Speaker at lunch sessions and meetings 
organised by Philips. 
A-227 09:00 
B. MRI of the lower neck - feasible?  
S. Gerevini; Milan/IT (gerevini.simonetta@hsr.it) 
MRI study of the lower neck space includes the study of anatomy and 
pathologies of the thoracic outlet, or cervicothoracobrachial junction, extending 
from the cervical spine and the mediastinum to the lower border of the 
pectoralis minor muscle, the brachial plexus and the supraaortic vessels 
(carotid, subclavian arteries and veins). For this, use of a dedicated head and 
neck coil is fundamental to avoid frequent artefacts arising from air and the 
passage between different surfaces. Only in case of thoracic outlet evaluation, 
a dynamic angio-MRI study should be performed and this means the use of a 
surface coil. MRI protocol of the lower neck should include T1- and T2-
weighted sequences. Both fat-saturated proton density and T2 with STIR 
sequences can be used to overcome the inhomogeneity of the magnetic field, 
especially with large FOV. Sand bags can be placed on either side of the neck 
and suprascapular region of the patient to improve image quality. Also, flow 
saturation bands can be utilised to limit blood flow artefacts. Also, volumetric 
sequences are in common use to obtain a quick examination. Breath or cardiac 
gating can be helpful. Abnormal findings of brachial plexus consist of nerve 
signal abnormalities with mild or marked hyperintensity on T2-weighted, being 
aware of magic angle effects and swelling. In case of thoracic outlet syndrome, 
MRI protocol should define the compression of brachial plexus components 
arteries and or veins, both in indifferent and dynamic MRI acquisition.  
Learning Objectives:
1. To learn how to overcome difficulties in performing a lower neck study. 
2. To understand how to avoid the most common pitfalls. 
3. To become familiar with differential diagnosis. 
A-228 09:30 
C. CT and MRI of temporal bone: user's guide  
F. Veillon; Strasbourg/FR 
CT and MR imaging of the temporal bone must be performed with a precise 
technique. In CT it is important to locate the box of the study above and not in 
the orbit to avoid the lenses. Irradiation is divided by 10 compared with a study 
through the orbit. The axial sections must be parallel to the lateral semicircular 
canal the coronal, sagittal sections are completed by oblique coronal views 
through the long process of the incus and the head of the malleus to get the 
ossicular V. Double oblique sections through the 2 componants of the V permit 
a view of the stapes and also the malleus and incus in 3 D (MIP : 3 mm). MRI 
must be performed parallel to the roof of the orbit permiting very good axial 
sections in the plane of the lateral semicircular canal (T1 and T2). The internal 
auditory meatus and the inner ear must be analysed with 1 mm axial sections 
(SE) after intravenous gadolinium injection completed by a high resolution T2 
(gradient echo or SE) 0.3-0.4 MM, depending on the machine (3T, 1,5 T). The 
middle ear in chronic otitis media must be studied with T1, diffusion and high 
resolution T2. There is no need of contrast medium injection apart from the 
complication: fistula of the lateral semicircular canal, thrombosis of the sigmoid 
sinus. The different pathologies are then discussed: external auditory meatus 
and middle ear pathologies: CT first. MRI is useful for postoperative 
cholesteatomas. Inner ear malformations, otosclerosis, trauma: CT. 
Labyrinthitis, inner ear hemorragia, schwannomas, internal auditory canal 
content: MRI. 
Learning Objectives:
1. To learn about acquisition protocols for temporal bone examination. 
2. To learn how to evaluate images and learn which post-processing tools to 
use. 
3. To learn how to report on temporal bone findings. 
08:30 - 10:00 Room L/M  
Vascular  
RC 815  
Imaging and intervention in acute 
ischaemic stroke  
Moderator:  
K.A. Hausegger; Klagenfurt/AT 
A-229 08:30 
A. Acute stroke imaging  
J. Tacke; Passau/DE (josef.tacke@klinikum-passau.de) 
Revascularisation time windows for patients with acute ischemic stroke are 
generally restricted up to 4.5 hours in the anterior and up to 8 hours is the 
posterior perfusion area. Later treatment attempts require more accurate 
prediction of risk and benefit, as safety and efficacy at these time strata are 
less well. Thus, rapid and effective imaging is important for decision-making 
concerning intrarterial catheter based recanalisation and/or thrombolytic 
therapy. Advanced imaging techniques identify irreversible infarction as well as 
tissue at risk. Diffusion-weighted MRI detects ischemia within minutes of onset, 
whereas perfusion-weighted MRI and CT perfusion studies disclose the 
ischemic penumbra. Combined, they provide information on mismatched 
tissue, i.e. potentially salvageable brain. In addition, non-catheter angiographic 
techniques like CT or MR angiography are a useful adjunct to localise arterial 
occlusion. As an attempt to a reliable emergency examination, the following 
protocol has been proven to be robust: for the anterior perfusion area, a non 
contrast CT may exclude cerebral bleeding and is followed by CT angiography 
(including supraaortic and intracranial vasculature). If technical available, CT 
perfusion should be performed in addition. In ischaemic strokes of the 
vertrebrobasilar region, CTA is essential to exclude basilary stenoses or 
thrombotic occlusion. If the stroke onset remains unclear or might extend the 
above mentioned time window, MR stroke imaging (i.e. diffusion, FLAIR and 
perfusion sequences) is suggested as MR offers a higher sensitivity. Anyway, 
the best method for each emergency stroke imaging center is depending on 
clinical availability 24h/365 days, technical equipment and - finally - individual 
experience of the emergency team.  
Learning Objectives:
1. To learn about parenchymal and vascular stroke imaging. 
2. To become familiar with appropriate imaging protocols for all imaging 
modalities. 
3. To learn about the pros and cons of each modality. 





B. Indication for intervention  
D. Vorwerk; Ingolstadt/DE (dierk.vorwerk@klinikum-ingolstadt.de) 
Some recent publications have questioned interventional treatment of stroke as 
an alternative to iv thrombolysis only. These papers - albeit published in high-
ranking sources - usually do not describe the modern concepts of 
interventional stroke treatment. Interventional radiologists, therefore, are 
convinced by their practical experience that the modern concept of combining 
iv thrombolysis with mechanical thrombectomy by stent retrievers offers a 
benefit to a subgroup of patients with severe stroke. This includes anatomical 
level of occlusion - basilar artery or single vertebral artery, proximal carotid 
occlusion with distal tandem occlusion, carotid T obstruction and M1 occlusion. 
M2 occlusions are debatable. Besides location, the clinical status of the patient 
before stroke and time of onset, absence of early CT signs of stroke or 
bleeding and clinical contraindications to iv thrombolysis such as recent 
surgery influence the decision-making. More difficult than the description of 
technical success is prediction of clinical success. There are a couple of scores 
such as Thrive available that may be used for outcome forecasting. The 
amount of collateral flow is frequently used as a decision tool, but is not always 
easy to quantify. Mismatch scores and penumbra have been questioned 
recently. In conclusion, anatomical factors are pretty easy to identify to indicate 
treatment, but the clinical and functional setting still lacks quick and reliable 
parameters that allow a clear decision-making, particulary in borderline cases.  
Learning Objectives:
1. To learn how to define the indication for treatment. 
2. To learn about the treatment decision-making process. 
3. To learn about the classification of lesions and indications for treatment. 
A-231 09:30 
C. Mechanical revascularisation  
A. Dörfler, T. Engelhorn; Erlangen/DE (arnd.doerfler@uk-erlangen.de) 
The refresher course addresses the current state-of the-art use of different 
mechanical revascularisation strategies, devices and potential complications. 
In addition, multimodal imaging applications with a focus on patient selection 
for endovascular recanalisation therapies, as well as new techniques to guide 
endovascular therapy within the angio suite are presented. Finally, some 
organisational aspects important for providing an interdisciplinary interventional 
stroke service are discussed. The ultimate goal of an acute endovascular 
stroke intervention is neurological recovery or improvement. Recanalisation of 
an arterial occlusion is key in achieving this goal. Clinical data suggest that 
endovascular stroke treatment results in higher recanalisation rates and may 
provide superior clinical outcomes when compared with intravenous 
thrombolytic therapy only. However, these higher recanalisation rates are far 
away in being paralleled by equally higher rates of favourable outcomes in 
recanalised patients. Thus, patient selection remains crucial. Besides the 
careful neurological assessment, brain imaging is here of major importance. 
The case presentations illustrate that imaging may help in patient selection for 
subsequent thrombolytic/endovascular therapies by differentiation of patients 
who may profit from intravenous or interventional therapy in an even extended 
time window from those who do not. There are a number of key areas 
supported by evidence-based medicine necessary for a high-level 
interventional stroke service. As a precondition, a neurointerventional stroke 
service has to be organised within a multidisciplinary acute stroke team. Inside 
the hospital, it is all about streamlined pathways. Any possible delays should 
be minimised at every step.  
Learning Objectives:
1. To learn the difference between mechanical and pharmacological stroke 
treatment. 
2. To learn about different mechanical revascularisation techniques. 
3. To learn how to manage complications. 
08:30 - 10:00 Room N/O  
Interventional Radiology  
RC 809  
Percutaneous treatment of chronic back 
pain and sciatica  
A-232 08:30 
Chairman's introduction  
A. Gangi; Strasbourg/FR (gangi@unistra.fr) 
Back pain has a diverse etiology and causes pain, suffering and disability 
which have a great social and economic impact. Minimally invasive 
percutaneous techniques can improve the quality of life of well selected 
patients.  
Author Disclosure:
 A. Gangi: Other; Proctoring Galil Medical. 
A-233 08:35 
A. Sacroiliac joint syndrome  
D.J. Wilson; Oxford/UK (david.wilson@ndorms.ox.ac.uk) 
Sacroiliac joint pain may arise from a number of conditions including 
inflammatory arthritis, degeneration, fractures and tumours. Studies suggest a 
prevalence of 10% to 60% pain arising from the joint in patients with positive 
clinical signs. Temporary effect is provided by a mixture of local anaesthetics 
with steroids with a response varying between 50% and 80% in reported 
series. Dual blocks using agents of differing duration are considered more 
precise, but are less often used in practice. Imaging including MR and 
scintigraphy are of limited predictive value. Injections may be into the synovial 
joint, around the joint or adjacent to the nerve innervation of the joint. There is 
evidence that para-articular sources of pain are common and injection outside 
the joint may be more effective. Sl-joint injections are performed through a 
dorsal approach guided by ultrasound, fluoroscopy or low-dose CT. Short-
acting agents may have lasting benefit, but radiofrequency ablation has been 
employed in an attempt to obtain long-term response. The evidence for lasting 
therapeutic response to intra-articular or periarticular injection of steroids and 
conventional radiofrequency neurotomy is weak. There is fair evidence of long-
term response to cooled radiofrequency neurotomy.  
Learning Objectives:
1. To learn about relevant anatomy and clinical presentations of the syndrome. 
2. To learn more about the available treatments. 
3. To learn about clinical results and possible further developments. 
A-234 08:58 
B. Facet joint syndrome  
A.D. Kelekis; Athens/GR (akelekis@med.uoa.gr) 
Facet joints account for 25-40% of all low back pain. They are affected by 
osteoarthritis, joint space narrowing, intra-articular vacuum phenomenon/fluid, 
osteophytes, synovial cyst and ligament hypertrophy. Conservative therapy is 
initially proposed. Percutaneous facet joint steroid infiltrations are minimally 
invasive procedures involving injection of corticosteroid with or without local 
anaesthetic inside the joint. They also can provide diagnostic verification of a 
certain facet joint acting as the pain source. The injectate usually contains a 
long-acting corticosteroid mixed with a local anaesthetic. Sodium hyaluronate 
solutions or ozone were tested; however more and extensive studies are 
necessary. Other options are either percutaneous ablation or surgical 
arthrodesis. Fluoroscopy, computed tomography or magnetic resonance can 
be used for guidance. Fluoroscopy has the advantage of real-time imaging. 
Cone-beam CT can also be used. Computed tomography provides better 
anatomy information, but has increased radiation dose for the patient. 
Magnetic resonance has higher cost and longer duration. A recent study 
concluded that it is twice the cost of CT-guided infiltrations. MRI can be used in 
combination with focal ultrasound for ablation, a technique which is still under 
investigation. Success depends upon patient selection (59-94% immediate and 
27-54% long-term relief). The level of evidence is moderate for lumbar spine 
concerning short- and long-term improvement. However, the most recent 
guidelines released (American Society of Pain Physicians) state that it is the 
oldest and most commonly used technique. The success rates with its safety 
profile and least invasiveness seem to make it an attractive therapy.  
Learning Objectives:
1. To understand the difference between facet joint and disc disease. 
2. To learn about different treatment options for facet disease. 
3. To learn how to manage patients. 
A-235 09:21 
C. Intervertebral disc syndrome  
N. Amoretti; Nice/FR (amorettinicolas@yahoo.fr) 
Low-back (LBP) is a frequent complaint and a leading cause of disability in the 
general population. Epidemiological studies have identified many individual, 
psychosocial, and occupational risk factors for its onset, but the primary 
causative mechanisms of LBP remain largely undetermined. Psychological 
factors have an important role in the transition from acute to chronic pain and 
related disability. A variety of minimally invasive techniques have been 
investigated over the years as treatment of back pain related to disc disease. 
Besides the classical surgical intervention, new therapeutic options have been 
proposed secondary to the progress in interventional imaging. Randomised 
clinical trials are important to assess treatments of painful conditions and low 
back pain. Due to the expected placebo effect and the subjective nature of pain 
assessment in general, the variable natural history of hernia and low back pain 
often responds to conservative care. After the commercial withdrawal of 
chymopapain, the need for new substances or devices to treat intervertebral 




disk hernias is important. The goal of this communication is to give our point of 
view and experience in the treatment of symptomatic herniated disks by IR in 
patients in whom open surgery was indicated.  
Learning Objectives:
1. To understand possible treatment techniques for disc disease. 
2. To learn more about clinical and imaging findings in treatment. 
3. To learn about published results on percutaneous disc treatment. 
Panel discussion:  
How can imaging methods separate candidates for percutaneous therapy 
and surgery?  09:44
08:30 - 10:00 Conf. Room M3  
Oncologic Imaging: Follow-up of Systemic and Local Therapies  
CC 818  
Imaging after systemic therapies: 
advanced techniques  
Moderator:  
K. Brindle; Cambridge/UK 
A-236 08:30 
A. What can we expect from biomarkers  
B.E. Van Beers; Clichy/FR (bernard.van-beers@bjn.aphp.fr) 
Biomarkers are quantitative parameters measured with imaging methods that 
can objectively assess disease status. Anatomical imaging biomarkers based 
on tumor size measurements (RECIST) are often used but have limitations 
because tumor size decrease may be delayed or absent. Therefore, 
mRECIST, EASL and Choi criteria based on size measurements of viable, 
contrast-enhancing tumor regions or on tumor attenuation are increasingly 
used for assessing the effect of targeted treatments. Moreover, there is a 
growing interest for validating functional imaging biomarkers such as perfusion 
and diffusion parameters obtained with ultrasound, CT and MR imaging. 
Although promising for early assessment of response to treatment, these 
newer functional biomarkers need extensive validation and standardisation for 
their wide clinical use. Validation includes the assessment of reproducibility 
and accuracy, whereas standardisation concerns image acquisition and post-
processing. The added value of the more complex functional biomarkers 
relative to the viability parameters should also be shown. Viability and 
functional imaging biomarkers are evolving and emerging parameters for the 
early assessment of response to treatment.  
Learning Objectives:
1. To become familiar with biomarkers. 
2. To consolidate knowledge of various biomarkers and their utility. 
A-237 09:00 
B. MRI biomarkers: from acquisition to post-processing  
O. Lucidarme, M. Wagner; Paris/FR (olivier.lucidarme@psl.ap-hop-paris.fr) 
MRI biomarkers must be able to show how tumours respond to specific 
treatment. They need to allow assessment of the effectiveness of new 
treatment more rapidly than classical clinical end points. These biomarkers 
must be easy to obtain to facilitate a large spread of the technique. They have 
to be reproducible. The longest diameter of the tumour remains the easiest 
biomarker that can be obtained from any kind of morphologic acquisition with 
no need of post-processing. Additional information about the tissular 
organisation and cellularity can be now easily obtained using modern scanners 
through diffusion-weighted sequences. The ease with which those sequences 
are obtained for a while masked the necessity to perform a more complex post-
processing than the one initially done to get reliable biomarkers. There are 
numerous MRI biomarkers of microcirculation, reflecting O2 consumption, 
blood volume, blood flow, vessel permeability and extravascular volume. To 
get them, we need more sophisticated acquisitions and image processing that 
take into account the T1 of the tissue, arterial input function, respiratory motion, 
etc. Most of these new MRI biomarkers are now used in research and in phase 
I studies, but have not been validated in more advanced clinical trials or in 
clinical practice. To use them widely and reliably, we need to perfectly 
understand the consequences of the choices we make during the acquisition 
and post-processing of these biomarkers.  
Learning Objectives:
1. To become familiar with MRI biomarkers. 
2. To learn some tips and tricks for MRI biomarker evaluation. 
Author Disclosure:
 O. Lucidarme: Board Member; Roche, Boehringer Ingelheim. Speaker; 
Bracco. 
A-238 09:30 
C. Assessing the precision and accuracy of biomarker imaging: is it 
reproducible?  
D.-M. Koh; Sutton/UK 
New targeted treatments in cancer can be effective without significantly 
reducing tumour size. There are already a large number of targeted treatments 
that are licensed to treat a range of cancers. For some of these cancers, there 
is currently no reliable method to tell whether the drug is effective and new 
response, predictive and prognostic biomarkers are required. Functional 
imaging techniques such as diffusion-weighted MRI, dynamic contrast-
enhanced MRI and FDG-PET imaging are being developed or applied as 
response biomarkers. However, for these to be useful in a wider multi-centre 
setting, the measurements need to be precise, repeatable and reproducible. 
We discuss these properties in the context of emerging imaging response 
biomarkers.  
Learning Objectives:
1. To understand imaging biomarker precision (repeatability and 
reproducibility) and accuracy and how it is evaluated. 
2. To learn how to interpret biomarker precision and accuracy in the context of 
the biomarker's intended use. 
08:30 - 10:00 Board Room A 
Cardiac  
RC 803  
Quantification of myocardial perfusion: 
which test is the best (PET, MRI, MDCT)?  
Moderator:  
A. Jacquier; Marseille/FR 
A-239 08:30 
A. PET for evaluation of perfusion, absolute myocardial blood flow and 
coronary flow reserve  
J. Bucerius; Maastricht/NL (jan.bucerius@mumc.nl) 
Coronary artery disease (CAD) and its related cardiac disorders are still the 
number one cause of death in the USA and the Western world. Up to date, 
single photon computed tomography (SPECT) using traditional radiotracers 
like thallium-201 or Tc-99m sestamibi is the most utilised imaging technique for 
the assessment of myocardial perfusion. However, over the past decade, there 
has been a growing interest in cardiac imaging with positron emission 
tomography (PET) and, indeed, a paradigm shift has been witnessed in the 
use of myocardial perfusion imaging (MPI) with PET taking advantage of the 
superior imaging properties of PET over SPECT. Therefore, PET MPI is now 
being increasingly used for routine clinical evaluation of patients with known or 
suspected CAD. Furthermore, it is being used not only at large academic 
institutions, but also at community hospitals and even in private practice. 
Several factors contribute to this shift in the use of PET MPI, including the 
growing availability of combined PET and computed tomography (CT) systems, 
mainly driven by oncological applications, radiotracer, like rubidium-82 or 18 F-
flurpiridaz, which can be used in clinical routine, changes in reimbursement, 
and the increasing clinical evidence supporting the value of PET/CT MPI. The 
lecture "PET for evaluation of perfusion, absolute myocardial blood flow and 
coronary flow reserve" will cover several aspects of the growing field of PET 
MPI.  
Learning Objectives:
1. To understand the molecular tracers used to asses myocardial perfusion by 
PET. 
2. To appreciate the strengths and limitations of PET in evaluating of 
myocardial perfusion. 
3. To become familiar with its role in different clinical scenarios. 





B. Stress perfusion CT imaging for the detection and quantification of 
relevant coronary stenosis  
F. Bamberg; Munich/DE (fabian.bamberg@med.uni-muenchen.de) 
Besides the visualisation of coronary morphology, computed tomography (CT) 
has shown feasibility to also assess myocardial perfusion. Currently, there are 
two different approaches to CT-based myocardial perfusion imaging: single-
shot and dynamic, sequential acquisitions over a predefined scan time. The 
presentation will cover basic concepts of both approaches and highlight 
protocol details and findings in these stress acquisitions. Also, emerging 
scientific results with respect to diagnostic accuracy, the detection of 
hemodynamically relevant coronary stenosis and prognostic implications will 
be discussed.  
Learning Objectives:
1. To learn about protocol setup and interpretation of stress myocardial 
perfusion CT. 
2. To understand the prognostic implications and therapeutic considerations of 
CT perfusion parameters. 
3. To appreciate the value of stress myocardial perfusion CT for the detection 
of significant coronary stenosis. 
Author Disclosure:
 F. Bamberg: Research/Grant Support; Bayer Healthcare. Speaker; Bayer 
Healthcare, Siemens Healthcare. 
A-241 09:30 
C. Analysis of myocardial perfusion using MRI  
R. Manka; Zurich/CH (robert.manka@usz.ch) 
Over the past few years, cardiovascular magnetic resonance imaging (CMR) 
has been increasingly established as an important method in the diagnosis of 
cardiovascular disease. Many studies have shown the equality or even 
superiority of CMR compared to other imaging modalities (e.g. nuclear 
medicine and echocardiography). CMR offers important advantages like the 
absence of ionising radiation, high spatial resolution, and the combination of 
perfusion imaging with tissue characterisation. The main clinical applications in 
the assessment of coronary artery disease (CAD) include ventricular function, 
myocardial viability and perfusion. In clinical routine, myocardial perfusion is 
determined by contrast-enhanced first-pass perfusion techniques during 
pharmacological stress using coronary vasodilators (e.g. adenosine) or ß-
adrenergic agents (e.g. dobutamine). Non-invasive characterisation of 
myocardial microcirculation is thought to reflect myocardial tissue supply much 
better than mere luminographic detection and quantification of epicardial 
coronary stenosis, and has been shown to be useful for planning of 
revascularisation procedures and cardiac risk stratification. In several studies 
on the prognostic value of CMR in CAD assessment, normal stress perfusion 
CMR was highly predictive for a good prognosis, thus able to identify patients 
in whom invasive angiography can be deferred safely.  
Learning Objectives:
1. To learn about protocol setup and interpretation of stress myocardial 
perfusion CT. 
2. To understand the role of CMR perfusion imaging as a tool for diagnosis and 
prognosis of coronary artery disease. 
3. To discuss how CMR perfusion can be utilised in the assessment of 
microvascular disease. 
08:30 - 10:00 Room P  
Joint Session of the ESR and ESMRMB  
Diffusion MRI: everything you always 
wanted to know but never dared to ask  
Moderators:  
E.-M.B. Larsson; Uppsala/SE 
M. Smits; Rotterdam/NL 
A-242 08:30 
Diffusion MRI: the bare basics  
C.A.M. Wheeler-Kingshott; London/UK (c.wheeler-kingshott@ucl.ac.uk) 
The purpose of this lecture is to demonstrate how it is possible to sensitise the 
MR signal to water molecules diffusion in tissue and how to use calculated 
indices to reflect structural integrity. The concept of diffusion-weighted imaging 
will be introduced with particular emphasis on the pulsed gradient spin echo 
(PGSE) sequence. Methods to calculate the apparent diffusion coefficient 
(ADC) will be described and the concept of the diffusion tensor (DT) will be 
explained. Image processing of diffusion data includes steps like eddy current 
distortion correction, model fitting and potentially registration of maps to a 
reference space. Indices that are reproducible and rotationally invariant will be 
described, such as fractional anisotropy (FA), mean diffusivity (MD), axial 
diffusivity (AD) and radial diffusivity (RD). Examples of when to use the ADC 
maps or the DT indices will be given in relation to pathologies such as stroke, 
multiple sclerosis and neurodegenerative diseases. Strategies for result 
presentation such as region of interest approach, histogram analysis and tract-
based methods will be shown. Limitations and advantages of diffusion imaging 
methods such as DT do not preclude the use of this technique in research and 
clinical radiology for investigating structural changes in disease.  
Learning Objectives:
1. To understand the basic principles of diffusion MRI (diffusion-weighted 
imaging, diffusion tensor imaging). 
2. To learn how to select an optimal diffusion-weighted imaging protocol for 
clinical neuro and body imaging. 
Author Disclosure:
 C.A.M. Wheeler-Kingshott: Advisory Board; Biogen (BG12). Author; 
Publications in Peered Reviewed Journals. Employee; University College 
London. Research/Grant Support; Multiple Sclerosis Society of great britain 
and Northern Ireland, Biogen, Novartis, Medical Research Council, 
Engineering and Physical Sciences Research Council, International Spinal 
Research TrustInternational Society. Speaker; Invited speaker at national and 
international conferences and iniversities. 
A-243 08:50 
Processing and analysing diffusion MRI data  
W. Van Hecke; Antwerp/BE (wim.vanhecke@ua.ac.be) 
Diffusion imaging methods have a lot of potential to be used in clinical practice. 
However, although diffusion-weighted imaging has been increasingly applied, 
clinical use of diffusion tensor imaging is limited to date. This is in part due to 
the lack of standardisation and the need for more complex analysis tools to 
evaluate the data. During this lecture, an overview will be provided of some 
analysis methods for diffusion-weighted and tensor imaging. I will discuss the 
different parameters that can be obtained as well as some advantages and 
limitations of the different analysis methods.  
Learning Objectives:
1. To learn about post-processing of diffusion-weighted imaging and the 
terminology for diffusion parameters. 
2. To learn about qualitative analysis of diffusion-weighted images including T2 
shine-through. 
3. To learn about quantitative measurements of diffusion parameters in clinical 
radiology. 
4. To understand different possibilities for analysing diffusion tensor imaging in 
clinical radiology. 
Author Disclosure:
 W. Van Hecke: Founder; icoMetrix. 
A-244 09:10 
Clinical applications of diffusion MRI (neuro)  
E.-M.B. Larsson; Uppsala/SE (elna-marie.larsson@radiol.uu.se) 
It is highly recommended to include diffusion-weighted imaging (DWI) in the 
routine protocols for MRI of the brain. DWI as well as automatically calculated 
apparent diffusion coefficient (ADC) map is used for evaluation. The ADC 
values of gray and white matter are identical in the adult brain. Restricted 
diffusion (high signal on DWI and low signal on ADC) is seen not only in acute 
stroke, but can also be present in some brain tumours, the necrotic centre of 
abscesses, some acute MR plaques, some contusions, encephalitis, 
Creutzfeldt-Jakob disease, metabolic diseases, etc. This finding is thus not 
specific, but is very helpful combined with clinical information and the signal 
pattern on other sequences. Acute stroke has restricted diffusion during the 
first 7-10 days and the diffusion gradually increases to become very high in a 
chronic infarct. The diffusion changes in ischemic brain and spinal cord tissue 
are usually irreversible, but may be reversible. Brain tumours with high 
cellularity, such as lymphoma, glioblastoma multiforme, medulloblastoma and 
metastases from small cell lung carcinoma, usually have restricted diffusion. 
The surrounding vasogenic oedema has increased diffusion. In the central 
necrosis of a pyogenic abscess the diffusion is restricted, while it is increased 
in the necrotic centre of a malignant brain tumour. Reversible diffusion 
restriction in the cortex, the hippocampi and thalami can be seen in patients 
with status epilepticus. Diffusion tensor imaging has so far had limited clinical 
use, but may be useful, e.g. for the preoperative evaluation of brain tumours.  
Learning Objectives:
1. To understand the differential diagnostic possibilities of high signal intensity 
lesions on diffusion weighted images (DWI) of the brain and spinal cord. 
2. To become familiar with the appearance of acute, subacute and chronic 
stroke on DWI. 
3. To learn about the appearance of cerebral tumours, infection/inflammation, 
neurodegenerative diseases and traumatic lesions on DWI. 
4. To understand the present use of diffusion tensor imaging (DTI) and 
diffusion tensor tractography (DTT) in clinical neuroradiology. 





Clinical applications of diffusion MRI (body)  
H. Ahlström; Uppsala/SE (hakan.ahlstrom@akademiska.se) 
The signal intensity in diffusion-weighted imaging (DWI) reflects the cell density 
in the tissue. DWI, including apparent diffusion coefficient (ADC) maps, can 
therefore be used to differentiate highly cellular from acellular regions of 
tumours, distinguish cystic from solid lesions, and monitor change in tumour 
cellularity over time, reflecting response to therapy. In general, tumours have 
high signal intensities in DWI, but low corresponding ADC values compared to 
normal/benign/reactive tissues. DWI has a wide range of clinical applications, 
which includes cancer imaging, imaging of infections and inflammations, 
evaluation of trauma and visualisation of peripheral nerves. Of these, the most 
promising application appears to be in oncological imaging. There is, e.g. now 
evidence to recommend inclusion of DWI in MRI protocols for lesion detection 
and characterisation in the liver. The advent of whole body (WB) MRI including 
WB-DWI (from root of the neck to groin) has introduced tumour imaging with a 
systemic approach compared to established multi-modal diagnostic algorithms. 
It has been found valuable for staging, therapy evaluation and surveillance of 
tumours, especially in children. However, DWI is generally recommended to be 
incorporated into oncologic MRI protocols of both WB-MRI and of selected 
organs, because it provides additional valuable information to the conventional 
MR sequences. DWI of the body is frequently prone to imaging artefacts, which 
can obscure or mimic lesions. To minimise misinterpretations, analysis of the 
raw b-value images directly in conjunction with ADC maps and conventional 
coregistered sequences is recommended.  
Learning Objectives:
1. To understand the present indications for whole-body DWI and DWI of 
selected organs of the body. 
2. To learn how to interpret whole-body DWI qualitatively and quantitatively, 
including tricks and pitfalls. 
3. To learn about the oncologic applications of DWI in the body. 
4. To learn about the appearance of other diseases of the body on DWI. 
Author Disclosure:
 H. Ahlström: Research/Grant Support; Astrazeneca. 
Panel discussion  09:50
10:30 - 12:00 Room A  
Interactive Teaching Session  
E³ 920a  
The treated spine and joints  
A-246 10:30 
A. Imaging of the postoperative spine  
P.N.M. Tyrrell; Oswestry/UK (prudencia.tyrrell@rjah.nhs.uk) 
Spinal surgery is most frequently performed to decompress (disc herniation, 
stenosis, malignant infiltration), fuse and stabilise (particularly following trauma 
or infiltrative destructive processes) and correct deformity. Often, there may be 
a combination of these procedures at one operation. Surgical instrumentation 
or bone graft is sometimes employed. Patients may present themselves with 
symptoms early or late following the procedure. This interactive session seeks 
to address the variety of surgical procedures undertaken and subsequently 
imaged post-operatively because of symptoms. The session aims to help one 
to understand and become familiar with the expected post-operative imaging 
appearances related to the surgical procedure, learn about abnormal 
pathological features as a cause of symptoms in the acute and more chronic 
situation and explore the diagnosis and differential diagnosis. This may include 
post-operative fibrosis versus recurrent disc herniation versus post-operative 
infection. Failure of fusion due to failure of instrumentation or inadequate take 
of bone graft can give rise to pseudoarthrosis. Recurrent stenotic symptoms 
may relate to an inadequate decompression, recurrent disc herniation, post-
operative haematoma, extension of a malignant process or ischaemic damage.  
Learning Objectives:
1. To understand changes related to surgery. 
2. To learn about changes related to non-surgical treatments. 
A-247 11:15 
B. Imaging of joint replacement  
M. Zanetti; Zurich/CH (marco.zanetti@hirslanden.ch) 
Joint replacement surgery for the treatment of arthritis most often offers the 
patient excellent results. However, there are potential complications that a 
radiologist should know about. It is essential to understand the importance of 
pre- and postoperative imaging for evaluating patients. Most commonly, 
standard radiographs are used to assess the patients after joint replacement. 
However, CT, nuclear medicine methods as well as MR imaging play an 
increasing role in such patients. The radiologist should be aware of the most 
common type of prosthesis and the most common complications after joint 
replacement. These complications include postoperative prosthesis loosening, 
prosthesis fractures, periprosthetic fractures, postoperative infection, rotation 
failure of the prosthesis, and soft tissue abnormalities such as surrounding 
tendon tears. This interactive session seeks to address the variety of joint 
replacements which are undertaken and subsequently imaged postoperatively 
as a result of symptoms. The session aims to help one to understand and 
become familiar with the expected postoperative imaging appearances related 
to joint replacement, learn about abnormal pathological features as a cause of 
symptoms and explore the diagnosis and differential diagnosis.  
Learning Objectives:
1. To learn about changes related to surgery. 
2. To understand changes related to non-surgical treatments. 
10:30 - 12:00 Room B  
ESR meets Serbia  
EM 2
A guided tour of radiology in Serbia  
Welcome by the ESR President  
G. Frija; Paris/FR 
Presiding:  
M.A. Lucic; Sremska Kamenica/RS 
V.E. Sinitsyn; Moscow/RU 
A-248 10:30 
Introduction  
M.A. Lucic; Sremska Kamenica/RS (milos.a.lucic@gmail.com) 
Serbia is a beautiful country where East and West merged and often collided 
for centuries, and where nowadays Eastern cultural heritage meets and mixes 
with the Western heritage in a lovely and unprecedented way, with a lot of 
charm and with a variety of extraordinarily natural beauty and plenty of both 
traditional and gastronomical wonders to explore. It extends from the edges of 
the Pannonian flatland in the north, over the Danube and Sava rivers to the 
gradually growing wonderful mountains in the south. Already in 1897, the first 
X-ray unit was installed, and only twenty years later X-ray units are present in 
most state-owned and private hospitals in Serbia. Nowadays, slightly more 
than half of the thousand radiologists in Serbia perform a broad variety of 
diagnostic imaging and interventional techniques in different radiological units, 
including numerous CT, MRI, and few PET/CT units distributed in five 
university centers, a number of public clinical centers and hospitals, and also in 
the private sector. Several centers are fully equipped with PACS and RIS 
systems, and are capable of performing teleradiology services. There are still 
significant challenges in Serbian radiology in the field of education and 
research, planning and implementation of national radiology networks, 
improvement of standard clinical practice and financing the new equipment. 
Yet since radiologists' enthusiasm overwhelms most of the difficulties, 
radiology in Serbia provides nowadays a broad variety of modern and 
competent diagnostic and interventional procedures, improving the 
management and treatment of our patients.  
Session Objectives: 
1. To get a brief insight into the variety of radiological techniques in Serbia 
today. 
2. To learn about interventional radiological techniques in the therapy of 
varicoceles. 
3. To understand the potential of MRI in the diagnosis of non-ischaemic 
cardiomyopathies. 
4. To appreciate the concept and importance of foetal MRI in the early 
detection of CNS abnormalities. 
A-249 10:35 
Interventional treatment of varicoceles  
P.M. Bosnjakovic, Z. Radovanovic, D.A. Stojanov, A. Bojanovic; Nis/RS
Varicoceles are considered to be one of the most frequent causes of male 
infertility. The entity represents the insufficiency of the spermatic vein, which by 
an unknown mechanism causes inefficient spermatogenesis. A variety of 
techniques for spermatic vein occlusion have been described since 1966, 
when the first interventional treatment took place. We aim to describe and 
review the variety of techniques used by the authors and evaluate our own 
experiences with more than 2000 treated patients. In 30 years, more than 2000 
patients have been treated. The methods have been changing over time taking 
into consideration developments in interventional tools and experiences of 
other authors. Successful catheterization was achieved in almost all of the 
patients. Most frequently, the so-called "sandwich technique" was used 




considering the embolic device at the level of the inguinal ligament, then 
sclerotic agent followed by another embolic device more proximally. Using this 
technique it is possible to protect the pampiniform plexus and obliterate all the 
collateral veins and parallel anastomosis. Gelfoam plugs were used in the vast 
majority of patients and pushable or detachable coils only when there was a 
technical demand (large vein, difficult distal positioning of the catheter). 
Aetoxisclerol was the most frequently used sclerosant. Initial vein occlusion 
was achieved in all patients. Two puncture site complications occurred. In one 
patient, the tip of the catheter broke and was flown to the right middle 
pulmonary artery branch and subsequently percutaneously extracted without 
clinical consequences. The reccurence rate was within literature limits. The 
percutaneous treatment of varicoceles has been proven to be safe and 
efficient.  
Learning Objectives:
1. To learn about the different radiological techniques for spermatic vein 
occlusion during the last 50 years. 
2. To understand radiological treatment compared to other treatment options. 
3. To appreciate the importance of varicoceles. 
A-250 10:55 
Interlude: Radiology in Serbia at a glance  
T. Stosic-Opincal; Belgrade/RS (topincal@gmail.com) 
Radiology in Serbia, since its beginning, has been inextricably linked to 
European radiology. There are written documents testifying to the fact that the 
first x-ray appliances in Serbia had emerged and had been used for medical 
purposes only two years after Wilhelm Conrad Röntgen discovered x-rays in 
1895. The real beginnings of diagnostic radiology in Serbia can be linked to the 
establishment of the General State Hospital in 1908, where the first x-ray 
cabinet was installed. Later discoveries in the field of radiological techniques, 
materials and contrast agents were also immediately accepted by the Serbian 
radiology community. The first cerebral angiography was performed in 1935, 
which may be considered as the beginning of neuroradiology in Serbia. The 
second half of the twentieth century is characterised by the introduction and 
wide application of ultrasound, CT and MR diagnostics and outbreak of 
vascular and nonvascular interventional radiology procedures in the areas of 
neuroradiology, uroradiology, and cardiovascular and gastrointestinal 
radiology. For years, Serbian interventional radiology has successfully kept 
pace with achievements of the most relevant centres worldwide. Nowadays, 
Serbian radiologists monitor and enforce the most complex modern procedures 
in different areas of radiology. The rapid development of science and 
information technology has enabled the daily monitoring of all modern 
developments, methods and approaches and their increasingly faster 
introduction into practice.  
A-251 11:00 
MRI in non-ischaemic cardiomyopathies  
R. Maksimovi; Belgrade/RS (ruzica.maksimovic@med.bg.ac.rs) 
Non-ischaemic cardiomyopathies (NICM) refer to myocardial diseases caused 
by mechanical and/or electrical disorder in the absence of significant coronary 
artery disease, valvular heart disease, hypertension, or congenital heart 
disease. NICM often present with genetic mutations, but no clinically apparent 
disease. In some cases, the presence of fibrotic tissue could cause adverse 
events and, therefore, the use of late enhancement (LE) post-gadolinium 
technique is necessary in evaluating these patients. LE suggestive of fibrotic 
tissue could be found in up to 35% of patients with NICM. In the majority of 
cases (up to 65%), midwall/subepicardial enhancement could be found; patchy 
enhancement, often at septal junctions, has been registered in 35% of patients, 
while the least common pattern of LE was subendocardial (5%). In ischaemic 
cardiomyopathy (ICM), subendocardial or transmural is a typical pattern of 
hyperenhancement and is related to coronary artery distribution. Furthermore, 
LE has the potential to provide important information for risk stratification in 
clinical practice. In NICM, the extent of fibrosis has been shown to be 
independently associated with increased rates of future adverse events 
including all-cause mortality, while in ICM myocardium with LE in more than 
50% of wall thickness is unlikely to recover contractile function following 
coronary revascularisation. As many NICM disorders are associated with the 
presence of scar tissue, LE in NICM is nonspecific and should be correlated 
with clinical presentation and history, which is critical in the evaluation of these 
patients.  
Learning Objectives:
1. To learn how to differentiate non-ischaemic and ischaemic 
cardiomyopathies. 
2. To understand and describe patterns of delayed enhancement in non-
ischaemic cardiomyopathies and their prognostic value. 
3. To learn how to develop an accurate differential diagnosis of non-ischaemic 
cardiomyopathies based on MRI features. 
A-252 11:20 
Interlude: Hop-on, hop-off sightseeing tour of Serbia  
S. Stojanovic; Novi Sad/RS (tupsons@gmail.com) 
In the interlude between scientific lectures, you are most welcome to hop on a 
sightseeing tour around Serbia during which we shall stop at a few stations 
where the natural and cultural heritage of our country will be shown. Nota 
bene: some of the sights will be visible to everyone and some only to 
radiologists. Ten thousand years of human effort and five billion years of 
European soil refinement will blink in front of your eyes through the window we 
have made with red churches' walls, azure skies and a silver sparkle of our 
spirit. All the time, a bit of grayscale shadow will supplement the picture as we 
in radiology are so used to. Fragments of past and present will make a mosaic, 
the glance of which will hopefully light up your day. When you hop off our tour, 
we believe, some pictures will become part of your emotional memory and 
maybe will make you wish to see them in vivo.  
A-253 11:25 
The role of prenatal MRI in foetal central nervous system abnormalities: a 
case-based pictorial review  
K. Koprivsek; Sremska Kamenica/RS (katarina.koprivsek@gmail.com) 
MRI provides a unique opportunity for studying in vivo central nervous system 
development. Its higher contrast resolution compared with prenatal sonography 
allows better visualisation of sonographically occult normal CNS structures as 
well as structural abnormalities. In clinical praxis, prenatal MRI has become a 
mandatory tool in evaluating: a) foetuses that have abnormalities suspected on 
the basis of foetal sonography; b) foetuses with increased risk for brain 
abnormalities even in the setting of a normal prenatal sonogram (family history 
of CNS anomalies or a genetic/metabolic disorder); c) foetuses potentially at 
risk due to maternal illness; d) foetuses with congenital malformation, which 
are candidates for prenatal or neonatal surgical treatment; e) foetuses that 
could not be evaluated by sonography due to oligohydroamnion, maternal 
obesity, difficult position of the foetal head, or US reverberation on foetal 
calvaria in advanced gestational age. We will present a selection of foetal CNS 
abnormalities detected in our Institution during the last 8 years, including 
ventriculomegaly, abnormalities of the posterior fossa, agenesis of the corpus 
callosum, cerebral cortex developmental abnormalities, spine developmental 
abnormalities and a variety of encephaloclastic lesions. In all previously listed 
cases, prenatal MRI could provide either crucial or additional information, 
which can lead to the accurate diagnosis of different CNS developmental 
abnormalities (cortical, commissural and posterior fossa malformation), specific 
disorder or syndrome, further enabling adequate pregnancy management and 
parents' counselling.  
Learning Objectives:
1. To learn about normal anatomical findings and sequences used. 
2. To know when, why and how to perform a prenatal CNS MRI study and what 
to look for. 
3. To learn how to confirm the presence of foetal CNS pathology, define its full 
extent, characterise it and demonstrate associated abnormalities using 
prenatal MRI. 
4. To learn about a selection of relevant cases from our institution, including 
ventriculomegaly, abnormalities of the posterior fossa, agenesis of the corpus 
callosum, cerebral cortex developmental abnormalities, spine developmental 
abnormalities and a variety of encefaloclastic lesions. 
5. To assess the potential of prenatal MRI in parent counselling, management 
of pregnancy and delivery, and postnatal care planning. 
Panel discussion:  
Radiology in Serbia: frequently asked questions  11:45
10:30 - 12:00 Room E2  
Foundation Course: Breast Imaging  
E³ 920b  
How to report  
Moderator:  
R. Holland; Nijmegen/NL 
A-254 10:30 
A. Mammography  
F.J. Gilbert; Cambridge/UK (fjg28@cam.ac.uk) 
This lecture will cover the standard mammographic views required, the 
reporting systems for mammograms together with BIRADS and other 
European systems, breast density, feature analysis, information the clinician 
requires in a cancer case and how to approach a B3 lesion. ACR Practice 
guidelines (2008) recommend obtaining previous mammograms as you can 




dismiss an abnormality that is unchanged for 5 years or that has been 
previously worked up and are able to detect subtle new lesions more easily, 
although this has not been confirmed in the screening situation. In a structured 
report the following information is recommended: indication, breast density, 
description of lesion, size, location, comparison to previous findings, overall 
assessment, management recommendations and a score to indicate the level 
of suspicion. Examples of different common conditions seen on mammography 
will be shown including soft tissue masses, microcalcification, architectural 
distortion and asymmetry.  
Learning Objectives:
1. To become familiar with BI-RADS mammography descriptors and 
assessment categories. 
2. To understand which information a clinician needs to find in a breast cancer 
patient's report. 
3. To learn about the basic parts of a structured report, specifically in BI-RADS 
3 lesions. 
Author Disclosure:
 F.J. Gilbert: Speaker; Bracco. 
A-255 11:00 
B. Breast US  
J. Camps Herrero; Valencia/ES (juliacamps@gmail.com) 
Breast ultrasound is one of the main imaging modalities in breast radiology, it 
allows us to characterise lesions and also guide interventional procedures. The 
BI-RADS categorisation of ultrasonographic findings facilitates the diagnostic 
approach and also helps the radiologist to use a common language, 
understood not only by the rest of the radiological community, but also by other 
breast cancer professionals. Ultrasound can be a diagnostic procedure on its 
own, but is mainly a modality that characterises the findings of other modalities 
(mammography and MRI) and, as such, correlation between all these 
techniques is the mainstay of everyday clinical practice. This act of correlating 
and integrating the information of all modalities is what makes a breast 
radiologist a key actor in the diagnosis, staging and follow-up of breast cancer 
and other benign or high-risk entities. The final product of this integration will 
be the radiological report, the means by which we convey all the information 
we have gathered through all the procedures to our clinical colleagues. This 
report shall also follow some composition rules to be clear and concise.  
Learning Objectives:
1. To become familiar with BI-RADS US descriptors and assessment 
categories. 
2. To learn how to integrate clinical information into radiological findings. 
3. To learn how to write a breast US report in a cancer patient. 
Author Disclosure:
 J. Camps Herrero: Advisory Board; Bayer. Speaker; Bayer. 
A-256 11:30 
C. MRI of the breast  
M.H. Fuchsjäger; Graz/AT (michael.fuchsjaeger@medunigraz.at) 
As with any other modalities, breast magnetic resonance imaging (MRI) 
examinations should be reported in a structured way following the guidelines of 
the respective national, continental or international societies. Adequate non-
clinical information (i.e. patient name, date and type of examination, etc). is 
indispensable. Any breast imaging report has to follow a stringent structure 
including indication, clinical history, clinical findings, brief description of 
technology used, assessment of parenchymal density, detailed description of 
significant findings, comparison with previous imaging studies and final 
assessment according to BI-RADS. Indications and contraindications of breast 
MRI will be discussed. Significant findings at breast MRI include foci (small 
contrast-enhancing spot, NOS, < 5 mm), mass lesions, "non-mass-like 
enhancement" (no mass lesion, partly diffuse regional contrast enhancement of 
various size) and associated findings. Furthermore, as breast MRI is a 
functional study, the different appearance patterns of kinetic contrast 
enhancement will be presented. The current status and the appropriate use of 
the BI-RADS MRI lexicon will be discussed. Any breast MRI report should not 
only follow the guidelines, but also follow a red thread, be consistent, express 
confidence and be comprehensible to clinicians. The overall final BI-RADS 
assessment is based on the most worrisome finding, taking into account both 
breasts and all imaging methods (mammography, ultrasound, MRI) evaluated. 
Furthermore, adequate communication of the result, as well as do's and don'ts 
of the report wording will be discussed.  
Learning Objectives:
1. To become familiar with BI-RADS MRI descriptors and assessment 
categories. 
2. To learn how to integrate clinical information and conventional imaging 
findings into a breast MRI report. 
3. To learn how to compose a complete report with all morphological and 
kinetic information obtained. 
10:30 - 12:00 Room G/H  
EFOMP Workshop  
Between diagnosis and therapy:  
new technology in imaging of the prostate  
EF 2  
Novel approaches to imaging and 
treatment  
Moderators:  
O. Ciraj-Bjelac; Belgrade/RS 
R. Padovani; Udine/IT 
A-257 10:30 
High intensity focussed ultrasound for the treatment of prostate disease  
G. ter Haar; Sutton/UK (gail.terhaar@icr.ac.uk) 
High-Intensity focused ultrasound provides a method of selectively delivering 
ablative thermal energy to a predetermined tissue volume whilst leaving 
surrounding and overlying tissues unharmed. For the prostate, three potential 
treatment routes are available: trans-perineal, trans-urethral and trans-rectal. 
The trans-rectal approach, under ultrasound guidance, has been the most 
commonly used clinically. Whole gland, nerve sparing and partial ablations 
have all been used. The principles of the HIFU technique, available devices 
and published clinical results will be discussed.  
Learning Objectives:
1. To learn about high intensity focused ultrasound (HIFU) and its use in 
prostate disease. 
2. To appreciate the advantages and disadvantages of HIFU treatments of the 
prostate. 
Author Disclosure:
 G. ter Haar: Equipment Support Recipient; Philips. 
A-258 11:00 
MR imaging of the prostate  
G. Payne; London/UK (Geoffrey.Payne@icr.ac.uk) 
The prostate is a small glandular organ, whose main function is to secrete 
seminal fluid. In young men it comprises of mainly the peripheral zone (70%) 
and a smaller central gland. However, the central gland enlarges with age to 
form the larger part. The main diseases of the prostate are inflammation, 
hyperplasia, and cancer (the most important). Approximately 70% of cancers 
arise in the peripheral zone. The main applications of MRI are for cancer 
detection, staging, and recurrence. MRI is increasingly used for radiotherapy 
planning owing to its good soft-tissue contrast when compared with CT 
scanning. Endo-rectal RF receiver coils, usually inflated with air or 
perfluorocarbon but sometimes of a rigid design, improve signal detection of 
the prostate. Phased-array surface coils may also be used or (preferably) in 
combination. T1-weighted imaging helps to distinguish haemorrhage caused by 
biopsy. On T2-weighted images the peripheral zone appears brighter, owing to 
a larger proportion of prostatic ducts, while tumours generally appear darker. 
More sophisticated MR methods are increasingly used to help diagnosis. In 
diffusion-weighted images (DWI) tumours appear relatively bright, but dark in 
the corresponding calculated map of Apparent Diffusion Coefficient (ADC), 
owing to the more cellularly-dense nature of tumours, and hence, reduced 
diffusion. In dynamic contrast-enhanced MRI (DCE-MRI) tumours appear bright 
owing to increased vasculature. Magnetic resonance spectroscopic imaging 
(MRSI) of normal prostate is dominated by high levels of citrate from the 
prostatic ducts; in cancer this is reduced while choline is increased. 
Prostatectomy samples allow one to verify image contrast against histology.  
Learning Objectives:
1. To become familiar with the main methods and applications of MRI in 
prostate. 
2. To understand some of the problems associated with prostate MR. 
A-259 11:30 
New developments in molecular imaging of the prostate  
M. de Jong; Rotterdam/NL (m.hendriks-dejong@erasmusmc.nl) 
Recent studies on prostate cancer have provided a number of relevant targets 
for imaging and treatment purposes. Today, imaging plays an important role in 
different aspects of the disease, but its role should grow in answering clinical 
questions at various phases of the disease. Relevant targets for imaging 
include metabolites (including glucose, acetate, choline, and amino acids), 
antigens (including prostate-specific membrane antigen), receptors (GRP 
receptor, CXCR4, androgen receptor), proliferation, angiogenesis, and 
hypoxia. In this presentation, a range of radiotracers for potential use in the 




imaging of prostate cancer will be discussed, as well as options to tailor 
nuclear imaging tracers to the various phases of the heterogeneous disease.  
Learning Objectives:
1. To learn about biomarkers for molecular imaging of the prostate. 
2. To appreciate new ways to improve molecular imaging of the prostate. 
10:30 - 12:00 Room N/O  
Joint Session of ESR/ESMOFIR and ESMI  
Molecular and functional imaging methods 
for interventions  
Moderators:  
P. Brader; Vienna/AT 
F.M.A. Kiessling; Aachen/DE 
A-260 10:30 
Interventional oncology based on molecular and functional imaging  
R. Bale; Innsbruck/AT (reto.bale@i-med.ac.at) 
The fusion of morphologic (CT and MRI) and functional (PET, SPECT) imaging 
modalities (PET, SPECT) has become widely available and part of the 
standard diagnostic workup in cancer patients. For many years, neurosurgeons 
have already relied on multimodal imaging data during brain tumour surgery to 
identify hyper- or hypometabolic tissue. The availability of PET and SPECT
data during percutaneous ablation procedures may also be helpful to facilitate 
treatment planning, probe placement, probe re-positioning, and early detection 
of residual disease following percutaneous image-guided ablation of cancer. 
However, up to now conventional US- and CT-guided thermal ablation 
procedures rely on morphologic information only. Intraoperative 
implementation of multimodal data requires the application of frame-based or 
frameless stereotactic techniques, both relying on the establishment of an 
accurate relationship between the patient's preoperative image space and the 
intraoperative physical space. In image-guided neurosurgery, 
CT/MRT/SPECT/PET data are registered to the patient using rigid body 
transformation. Due to respiratory motion and different patient positioning 
during image acquisition and the actual intervention, soft tissue deformations in 
the liver occur. Thus, the images and the surgical presentation do not match 
between preoperative imaging and intervention, leading to an extensive 
degradation of spatial guidance. This presentation illustrates solutions for these 
fundamental problems that occur during 3D-navigated liver interventions, 
including patient immobilisation and repositioning, respiratory triggering and 
intraoperative imaging. In addition, examples of CT/MRI/SPECT/PET-guided 
stereotactic and robotic liver tumour biopsies and ablations (RFA, MWA, IRE) 
are demonstrated.  
Learning Objectives:
1. To learn about new image-guided therapies using molecular and functional 
information. 
2. To become familiar with MI methods used for guiding interventions. 
3. To understand new ablation techniques like electroporation. 
Author Disclosure:
 R. Bale: Equipment Support Recipient; iSys has supported the Section of 
Microinvasive Therapy with testing equipment. Patent Holder; RB is a (co-) 
inventor of the Atlas aiming device and the BodyFix immobilisation device and 
a (co-)shareholder in its financial returns. 
A-261 11:00 
MR-guided focused ultrasound in drug delivery and gene expression  
C. Moonen; Utrecht/NL (C.Moonen@umcutrecht.nl) 
The goal of ultrasound-triggered, image-guided drug delivery is to increase the 
therapeutic index and decrease adverse effects of drugs. The bio-effects of 
focused ultrasound can lead to local tissue heating, cavitation, and radiation 
force, which can be used for 1) local drug release from nanocarriers circulating 
in the blood, 2) increased extravasation and cellular uptake of drugs and/or 
carriers, and 3) enhanced diffusivity of drugs. Thermo-sensitive liposomes 
have been suggested for local drug release in combination with local 
hyperthermia more than 25 years ago. Microbubbles may be designed to 
enhance cavitation effects. Real-time imaging methods, such as magnetic 
resonance, as well as optical and ultrasound imaging have led to novel insights 
and methods for ultrasound-triggered drug delivery. Image guidance of 
ultrasound can be used for: 1) target identification and characterisation; 2) 
spatio-temporal guidance of actions to release or activate the drugs and/or 
permeabilise membranes; 3) evaluation of biodistribution, PKPD; 4) 
physiological read-outs to evaluate the therapeutic efficacy. Liposomes may 
carry both hydrophilic and hydrophobic drugs in their aqueous interior and lipid 
bilayer membrane, respectively. The circulation half-life may be increased by 
incorporating polyethylene glycol (PEG)-lipids in the bilayer. Recent 
publications have shown that ultrasound-triggered delivery is feasible. Real-
time imaging methods, such as magnetic resonance, optical and ultrasound 
imaging may lead to novel insights and methods for ultrasound-triggered drug 
delivery.  
Learning Objectives:
1. To learn about the basic principle of MR-guided focused ultrasound and 
drug delivery. 
2. To appreciate the potential clinical applications of these methods. 
3. To understand how MR-guided focused ultrasound can monitor gene 
expression. 
Author Disclosure:
 C. Moonen: Research/Grant Support; Philips Healthcare, Celsion Corp. 
A-262 11:30 
Intraoperative imaging: a new dimension of imaging for radiology  
V. Ntziachristos; Munich/DE 
Up to now, the success of surgical tumour resection has always been limited 
by the surgeon´s vision. The human eye is not an accurate detector of small 
cancer cell clusters and it cannot accurately differentiate cancerous from 
healthy tissues due to lack of "visible" contrast. By combining a fluorescent 
probe targeting the folate receptor and a multi-spectral real-time fluorescence 
camera to observe the operating field, we found that, using fluorescence 
molecular imaging, 3-fold more lesions can be identified compared to 
conventional surgery. These first in-human results point to molecular-based 
clinical decision-making in surgical and endoscopic procedures as a paradigm 
shift over decision-making based on human vision. The talk describes current 
progress with instruments, methods and applications in the field of intra-
operative imaging. Pre-clinical and clinical results are presented and the 
advantages and limitations of the method as well as future directions will be 
discussed. The emerging field of multispectral optoacoustic tomography 
(MSOT) is also outlined.  
Learning Objectives:
1. To learn that intraoperative molecular imaging has the potential to shape the 
future of surgical procedures. 
2. To understand that this techniques can improve the sensitivity, accuracy and 
contrast of tumour delineation and lymph node interrogation. 
3. To learn about further advances in the development and clinical translation 
of intraoperative imaging modalities. 
12:15 - 12:45 Room A  
Plenary Session 
HL 2  
Wilhelm Conrad Röntgen Honorary 
Lecture  
Presiding:  
V.E. Sinitsyn; Moscow/RU 
A-263 12:15 
Mysteries of the human brain unveiled: imaging of white matter 
microstructure and neuroplasticity  
P.M. Parizel; Antwerp/BE (paul.parizel@uantwerpen.be) 
The human brain remains one of nature's great mysteries, and is considered 
science's final frontier. This greyish lump of tissue with a weight of 1.5 kg 
contains some 100 billion neurons, each of which are connected to thousands 
of other nerve cells in an intricate network of white matter fibers. In the 
previous century, the brain was perceived as a fixed three-dimensional 
landscape, with brain functions confined to certain locations (e.g. motor and 
sensory cortex, visual cortex, auditory cortex). This concept of 
neurolocalisationism was in line with the philosophy that there should be "a 
place for everything, and everything should be in its place". Advanced 
quantitative MRI techniques for acquisition and data analyis (fMRI, DWI, DTI, 
VBM), help to unravel white matter connectivity of the human brain, and are 
able to show that the brain can modify its structure and function in response to 
changing circumstances (such as learning, memory, hormones). This process, 
which is known as neuroplasticity, occurs at different levels and different time 
scales. For example, in response to injury, changes may occur at cellular level 
as well as on a larger scale with cortical remapping. Some processes may take 
months or years (e.g. physical therapy and training) whereas some forms of 
neuroplasticity happen within hours or days (e.g. changes in brain volume and 
connectivity during the female menstrual cycle, which have been linked to 
behavioral changes). In summary, quantitative MRI techniques help to unveil 
the mysteries of the human brain and have opened exciting new fields of active 
research such as white matter connectivity and neuroplasticity.  
Author Disclosure:
 P.M. Parizel: Board Member; icoMetrix. Founder; icoMetrix. 




12:30 - 13:30 Room E2  
The Beauty of Basic Knowledge: Skeletal Radiology  
MC 26C  
Inflammatory/infectious disorders  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK 
A-264 12:30 
Inflammatory/infectious disorders  
V.N. Cassar-Pullicino; Oswestry/UK (Victor.Pullicino@rjah.nhs.uk) 
There are a host of inflammatory and infective insults that can manifest focally 
or diffusely within the musculoskeletal system. The appearances of the 
underlying pathological processes in both the soft tissues and skeleton cover a 
very wide imaging spectrum. The appearances vary, depending on the timing 
and degree of inflammatory insult and the host response in the involved 
tissues. The approach of this lecture will cover the imaging manifestations 
using all modalities covering radiography, ultrasound, CT, scintigraphy and 
magnetic resonance imaging. The basic knowledge that is required will be 
displayed in 4 major musculoskeletal categories covering disorders involving 
the Soft Tissues, Joints, Bones and Entheses. The imaging manifestations will 
also be linked with the evolution of the pathological processes covering acute, 
sub-acute and chronic stages of the inflammatory/infective disorders. By the 
end of the session the audience should have a clear understanding in making 
best use of the imaging modalities in the correct diagnosis of a wide variety of 
inflammatory and infective conditions that can affect the musculoskeletal 
system.  
Learning Objectives:
1. To learn about the pathomechanisms involved in inflammatory and 
infections disorders. 
2. To understand the imaging appearances and their differential diagnosis in 
the acute, sub-acute and chronic phases of infection. 
3. To become familiar with the spectrum of imaging features of inflammatory 
disorders in the axial and peripheral skeleton. 
12:30 - 13:30 Room F1  
The Beauty of Basic Knowledge: Interventional Radiology  
MC 25C  
Basics of arterial PTA/stent  
Moderator:  
M. Bezzi; Rome/IT 
A-265 12:30 
Basics of arterial PTA/stent  
R. Uberoi; Oxford/UK (raman.uberoi@orh.nhs.uk) 
Arterial PTA and stenting is firmly established as primary treatment in the 
management of athero-occlusive disease, particularly of peripheral limb arterial 
disease (PAD). Patients are selected on the basis of symptoms such as short 
distance claudication or critical limb ischaemia for lower limb disease or 
appropriate ischaemic symptoms in other territories in the renal and mesenteric 
territories and head and neck vessels. Commonly used grading systems such 
as the Fontaine or Rutherford scores can be useful in patient selection. Where 
treatment is required, noninvasive imaging is utilised to look for the site, 
severity and extent of arterial disease. Most centers use duplex imaging as the 
primary imaging modality; MRA or CTA are often used with a higher sensitivity 
and specificity; and invasive angiography is reserved for problem solving or 
immediately prior to intervention. The TASCII classification has been devised 
to select patients for either endovascular or surgical intervention. However, 
most centres will adopt an endovascular approach first. All patients should be 
on good medical therapy, i.e. aspirin and statins, with good blood pressure and 
diabetic control where appropriate. When carrying out interventions, an access 
sheath is used, peri-procedural heparin administered and lesions crossed 
using selective catheters and commonly hydrophilic guidewires. Subintimal 
crossing of occlusions can be much simpler than trying to cross lesions 
luminally. Balloon angioplasty and or stenting may be applied differently 
depending on the site and extent of the lesions. The evidence for drug-eluting 
technologies has also been growing with improved patency rates compared to 
standard balloon angioplasty.  
Learning Objectives:
1. To understand the clinical principles of patient selection and preprocedural 
imaging. 
2. To understand how to gain safe access for PTA, and to learn about the 
range of techniques available for safely crossing arterial stenosis and 
occlusions. 
3. To become familiar with the indications for arterial stenting and correct 
balloon, or stent, selection. 
14:00 - 15:30 Room B  
EFRS meets Russia  
EM 5
The role of the radiographer in image 
acquisition and processing  
Moderators:  
S. Geers Van Gemeren; Utrecht/NL 
S. Mamedova; Moscow/RU 
A-266 14:00 
Introduction  
S. Geers-van Gemeren1, S. Mamedova2; 1Utrecht/NL, 2Moscow/RU
During the EFRS meets Russia session, radiographers have the opportunity to 
get information about the role and education of radiographers in the different 
European countries. The radiographer is a health-care team member who 
interacts with other professionals in the primary and secondary health-care 
environment to provide an optimum diagnostic or therapeutic outcome. 
Radiographer education therefore requires that the curriculum covers a wide 
range of scientific, medical, pathological, sociological, ethical and technical 
subjects together with the development of appropriate clinical skills. The 
curriculum should also include the development of research and audit skills to 
ensure the constant improvement of service quality for the benefit of service 
users. The session will include a panel discussion about the role of the 
radiographer in image acquisition and processing.  
Session Objectives: 
1. To understand the background of education and training in Russia. 
2. To gain awareness of the importance of education and training in Europe. 
3. To understand the common issues among radiographers in Europe. 
A-267 14:10 
MRI safety: the radiographers' role  
V. Labutin; Chelyabinsk/RU (vlad_lab@mail.ru) 
The tasks of the assistant to the radiologist are: filling of the protocol of 
research, survey of the patient, instructing the patient according to safety 
measures, positioning the patient, placement of coils of strengthening, 
beginning of magnetic and resonant research - the research is approved by the 
doctor, introduction of contrast substance (in the presence of the certificate of 
the procedural sister) and supervision over the patient during MR research. 
Furthermore, the other tasks are briefing on patient safety, excluding 
introduction of the patient to metal objects on MR tomography, explaining the 
procedure of the study, informing about the duration of the study, wearing 
noise-cancelling headphones, warning about possible vibration and loud 
sounds, and providing a globular button to call the nurse.  
Learning Objectives:
1. To understand the safety aspects of MRI practice. 
2. To understand possible safety measures in MRI practice. 
3. To gain awareness of the radiographers' role in MRI safety. 
A-268 14:25 
Contribution of radiographer to success of coronary MDCT  
E. Hichina; Moscow/RU (lenahichina@mail.ru) 
Today coronary CT-angiography has become a well-established and proven 
diagnostic modality. Quality of coronary and cardiac CTA datasets has 
tremendous significance for correct diagnosis. A radiographer has a pivotal 
role in performance of coronary CTA. Coronary CTA is one of the most 
challenging examinations for radiographers because even a small mistake at 
any stage of examination may ruin the whole study. Before the scanning 
procedure, the radiographer performs a check for possible contraindications to 
contrast media injection (history of adverse reactions to contrast media and 
impairment of renal function are the most important ones). The radiographer 
checks the patient's heart rhythm and takes part in administration of beta-
blockers for control of the heart rate. A detailed knowledge of different 
scanning modalities of CT-machine is a must. Radiation exposure to the 
patient from coronary CTA examinations has been one of the major public 




concerns. This is why the radiographer should be aware of different 
approaches to the performance of low-dose CTA (prospective gating, tube 
current modulation, high-pitch scanning) according to patient body 
composition. The radiographer should have knowledge of when and how to 
use radiation dose control in an appropriate way. Another big issue is injection 
protocols. Selection of optimal bolus timing and iodine load results in high-
quality CTA images. The radiographer has to know the basics of CT image 
reconstruction and interpretation in order to perform different types of 
reconstructions from the raw data according to the radiologist's requests and 
be able to recognise image artifacts. Clinical examples of the radiographer's 
role for performance of coronary CTA will be given.  
Learning Objectives:
1. To learn the importance of patient selection and preparation in achieving 
high quality scans. 
2. To understand the practical techniques available for performing of low-dose 
CTA, injection protocols. 
3. To learn how to recognise image artifacts.  
A-269 14:40 
Interlude: Russian art and culture  
I. Arkhipova, V. Sinitsyn, E. Mershina; Moscow/RU (iarkhipova77@mail.ru) 
Every country is famous for its architecture, history, literature, music, 
museums, etc. However, there are some distinctive features for Russia. 
"Russia is a riddle wrapped in a mystery inside an enigma." These words by 
the famous British statesman Winston Churchill aptly throws light on the 
pulsating art and culture of Russia. The different aspects of Russian art and 
culture find its best expression in the rich heritage. Just feeling the nature and 
boundless expanses of the country can understand the mysterious Russian 
soul, works of art and real masterpieces.  
A-270 14:50 
Cardiac MDCT in children with congenital heart diseases  
V. Bereznitskiy, K. Serkova; Moscow/RU (vsber@mail.ru) 
In CT studies of children with congenital heart diseases, it is mandatory to 
keep the x-ray dose, amount of contrast agent and study time as low and as 
short as possible and simultaneously get the best diagnostic image quality. 
How can we reduce the x-ray dose? By minimising the volume coverage, 
reducing the voltage, minimising the effect of "overranging", use of x-ray 
protective equipment, use of tube current modulation technique, use of iterative 
reconstruction technique. How can we reduce the amount of contrast agent by 
volume? By covering of only necessary anatomic volume, minimising scanning 
time, use of adequate speed injection in ml/sec, which depends on catheter 
position and size, blood flow and anatomic structures. How can we reduce the 
amount of iodine concentration in the contrast agent? By lowering the voltage 
we may reduce the iodine concentration and get higher absorption CT values 
(HU). How can we reduce the time of cardiac CT studies? By preparing the 
study protocol ahead, preparing all necessary equipment in the CT room, 
warming up of the contrast agent before the study. What is the radiographer's 
role in cardiac CT studies? To take care along with the responsible radiologist 
the above-mentioned needs, to take care of adequate room and instrument 
temperature, to take care that only absolutely necessary people with adequate 
x-ray protection are in the study room, for performing the necessary image 
post-processing, archiving and distribution of studies.  
Learning Objectives:
1. To understand MDCT techniques in cardiac imaging. 
2. To learn about the use of MDCT for children with congenital heart disease. 
3. To gain awareness of the radiographers' role in cardiac MDCT. 
A-271 15:05 
MDCT in polytrauma patients: the radiographers' role  
A. Tarasenko, E. Iasakova; Krasnodar/RU 
The purpose is to evaluate the quality of imaging in forced position of patients 
with anesthetic support. The role of laboratory technician in CT post 
processing. We analysed images of unconscious patients on artificial lung 
ventilation on 24- and 64-slice computer homographs GE and Siemens and 
monitored them through the infusion. During investigation the patients were in 
forced positions, as a result they got artifacts from upper extremities on the 
abdominal cavity. We analysed 157 patients - hands under the butt, 135 
patients - hands on the chest (abdomen), 57 patients - arms along the body. 
According to the images the smallest number of artifacts was identified when 
the patient was on the table with hands under the butt. Different variations of 
the patient's hands position and the problem of choice of this position will be 
offered for researching. The reconstruction the laboratory assistant can 
execute and also the results of tests will be presented. By order of the doctor 
the laboratory technician builds 3D and 4D reconstructions of fractured ribs, 
pelvis, facial skeleton, sagittal and coronary reconstructions of spine in case of 
its fracture.  
Learning Objectives:
1. To understand MDCT techniques. 
2. To learn about the use of MDCT for polytrauma patients. 
3. To gain awareness of the radiographers' role in image acquisition. 
Panel discussion:  
The radiographers' role in image acquisition and processing  15:20
14:00 - 15:30 Room P  
MITIGATE Session  
Molecular imaging and targeted-image 
guided therapy in gastrointestinal stromal 
tumours
Moderators:  
S. Aime; Turin/IT 
S.O. Schönberg; Mannheim/DE 
14:00 
Introduction  
S. Aime1, S.O. Schönberg2; 1Turin/IT, 2Mannheim/DE  
A-272 14:10 
Introduction to the MITIGATE concept  
S.O. Schönberg; 
Mannheim/DE (stefan.schoenberg@rad.ma.uni-heidelberg.de) 
Gastrointestinal stromal tumours (GIST) are a rare disease that metastasises 
in up to 85% of patients with subsequent median progression-free survival 
(PFS) of around 30 months. Tumours are characterised by activating mutations 
in the KIT or the PDGFRA gene and treatment is mainly based on tyrosine 
kinase inhibitors designed to block mutated receptors. However, drug 
resistance is often based on mutations changing the conformity of the receptor, 
leaving little effective therapeutic options. To date, second line chemotherapy 
offers a median PFS of 6-9 months and external beam radiotherapy is limited 
by organs at risk close to the tumour. Alternative approaches like 
endoradiotherapy or minimally-invasive ablation techniques are effective for 
local control but are inconsistently used and are not tailored to the individual 
patient's type of disease. To address these issues, the MITIGATE project 
proposes a closed-loop personalised treatment concept combining 
endoscopic-assisted tissue sampling, inline biotechnology and targeted 
molecular PET imaging probe development combined with minimally-invasive 
treatment monitored by new MR imaging techniques. A consistent value chain 
across European research institutes and SMEs will be established for mass 
spectrometry of tumours, linkage of radiochemical molecular imaging probes, 
design of new animal models and targeted therapeutic radiopharmaceuticals. 
This closed-loop platform will minimise fragmentation of treatment approaches 
by a coherent molecular-based multimodality concept, thus providing new 
treatment options. The MITIGATE platform can be expanded to further patient 
cohorts with oligometastatic diseases such as other sarcomas or renal cell 
carcinoma.  
Author Disclosure:
 S.O. Schönberg: Research/Grant Support; EU-FP7 Project (2013-2017). 
A-273 14:25 
Molecular imaging and targeted endoradiotherapy: key methods to 
overcome TKI-resistancies?  
B. Wängler; Mannheim/DE (Bjoern.Waengler@medma.uni-heidelberg.de) 
Gastrointestinal stromal tumours (GIST) are characterised by highly specific 
genetic mutations. Several specific targets are overexpressed in a majority of 
the tumours. On the other hand, secondary resistancies limit the usability of 
highly specific chemotherapeutics such as Imatinib. Instead of applying 
cascades of alternative TKI inhibitors in order to find an efficient one, 
quantitative molecular imaging and targeted Endoradiotherapy could be 
considered. For the detection of GIST by imaging, 18 F-
fluorodeoxyglucose (FDG)-PET is widely accepted to visualise the tumour 
burden. However, as FDG gives no molecular information of potential targets 
for treatment, new radiopharmaceuticals have to be developed to visualise and 
quantify other target-structures expressed by GIST that would be able to be 
addressed. This molecular information can be used both for designing a 
conventional treatment or an advanced strategy: i.e. targeted 
endoradiopharmaceuticals. Compared to conventional chemotherapy this 
method has the great advantage that not only tumour cells expressing the 
targeting vector are affected but also tumour cells within the range of the 
radiation of the decaying radiopharmaceutical. This method is used with great 
success in the case of neuroendocrine tumours using labeled octreotate 




derivatives (a small cyclic peptide binding to the somatostatin-receptor) and 
non-Hodgkin's lymphoma applying Y-90 labeled Zevalin (a monoclonal 
antibody binding to the CD20 antigen). The success of these methods relies on 
the crossfire-effect, meaning that a certain margin of tissue surrounding the cell 
targeted by the specifically accumulating endoradiopharmaceuticals is 
destroyed as well, depending on the penetration range of the emitted radiation. 
Thus, the development of new radiopharmaceuticals for the specific diagnosis 
and treatment of GIST would strongly improve the outcome of the tumour 
patient.  
A-274 14:40 
Stereotactic radiofrequency ablation of liver tumours: does improved 
targeting increase tumour response?  
R. Bale, G. Widmann, P. Schullian, M. Haidu, W.R. Jaschke; Innsbruck/AT
(werner.jaschke@i-med.ac.at) 
The purpose is to describe stereotactic radiofrequency ablation (SRFA) and to 
review its inital results in the treatment of patients with primary and secondary 
liver tumours. One retrospective review includes 90 consecutive patients with 
106 SRFA sessions for the treatment of 72 hepatocellular carcinomas (HCC) 
and 105 metastases (1). In two other studies the outcome after SRFA of 
intrahepatic cholangiocellular carcinomas (ICC) (2) and colorectal liver 
metastases (CRLM) (3) was evaluated. The overall technique effectiveness 
was 95.5% with a local recurrence at 1 year of 2.9%. Technique effectiveness 
was not significantly different for lesions< 3 cm (95.9%) and 3-5 cm (100%). 
After treatment of 17 inoperable consecutive patients with 52 ICCs a median 
overall survival of 60 months was achieved. A median OS of 58 months and 
OS rates of 92%, 66% and 48% at 1, 3 and 5 years in patients with resectable 
CRLM were achieved. Tumour size did not affect OS and DFS. RFA probes 
can be precisely planned, positioned and distributed by means of stereotaxy. 
Especially in large liver tumours the local recurrence rate can be greatly 
reduced by precise stereotactic placement of multiple radiofrequency probes. 
These improved local control rates result in better long-term survival rates.  
Author Disclosure:
 R. Bale: Shareholder; Coshareholder Atlas aiming device. Other; Coinventor 
Atlas aiming device. 
A-275 14:55 
Functional and molecular imaging in tumour therapy response 
assessment  
S. Aime; Turin/IT (silvio.aime@unito.it) 
In the MITIGATE project further development of currently used MRI and CT 
techniques will be tackled in order to obtain functional and metabolic 
information which are mandatory to detect early response to the targeted 
radiopharmaceutical approach. New Gd-based agents are under scrutiny in 
order to improve DCE-MRI procedures and attain more precise information on 
the tumour microvascularity level as well on the vessel permeability and the 
assessment of extracellular pH and MMP activity. The X-nuclei MRI (23Na 
sodium) is a non-invasive imaging technique, which enables the measurement 
of the tissue sodium concentration (TSC) in humans. The direct link of the TSC 
with the tissue integrity and viability provides a promising approach for 
monitoring tumour tissue, and could also help to assess cytoxicity and cell 
death by means of breakdown of the sodium-potassium-pump. However, 23Na 
MRI is challenging because of the low in vivo abundance, the fast transversal 
relaxation rate and the low gyromagnetic ratio of the 23Na ions in human tissue. 
New MR measuring sequences for X-nuclei MRI will be developed to establish 
a standardised TSC measurement method within the EU for better 
comparability. Furthermore, the X-nuclei MR data will be reconstructed, scaled 
and fused with further imaging modalities.  
Discussion  15:10
16:00 - 17:30 Room A  
Interactive Teaching Session  
E³ 1120  
What to look for after treatment of lung 
cancer  
A-276 16:00 
A. Imaging of surgically treated lung cancer  
C. Heussel; Heidelberg/DE 
Chest x-ray, CT, and MRI are shown to demonstrate early, intermediate, and 
late findings after lung surgery and during follow-up. Complications frequently 
seen on intensive care unit, "lines and wires", typical change of the chest and 
caveats are shown, "Problem zones " of imaging after surgery and hints for 
long-term follow-up are presented.  
Learning Objectives:
1. To appreciate the complications after surgery for lung cancer. 
2. To understand the anatomic changes which occur after surgery for lung 
cancer. 
Author Disclosure:
 C. Heussel: Consultant; Schering-Plough, Pfizer, Basilea, Boehringer 
Ingelheim, Novartis, Roche, Astellas, Gilead, MSD, Lilly, Intermune, Fresenius. 
Patent Holder; Methods and Device For Representing the Microstructure of the 
Lungs. IPC8 Class: AA61B5055 FI, PAN: 20080208038, Inventors: W. 
Schreiber, U. Wolf, A.W. Scholz, C.P. Heussel. Research/Grant Support; 
Siemens, Pfizer, MeVis. Shareholder; Stada, GSK. Speaker; Gilead, Essex, 
Schering-Plough, AstraZeneca, Lilly, Roche, MSD, Pfizer, Bracco, MEDA 
Pharma, Intermune, Chiesi, Siemens, Covidien, Pierre Fabre, Boehringer 
Ingelheim, Grifols, Novartis. 
A-277 16:45 
B. Imaging of non-surgical treatment of lung cancer  
B. Ghaye; Brussels/BE (benoit.ghaye@uclouvain.be) 
Lung cancer is the leading cause of death related to cancer. Most patients are 
inoperable as they present with advanced stage disease or even a localised 
tumour associated with poor general condition, limited cardiopulmonary 
function or a too high surgical risk. According to the stage of the disease, 
chemotherapy, radiotherapy and percutaneous ablation therapies are the 
current therapeutic options for inoperable patients. It is important that 
radiologists are familiar with the various response and complication imaging 
patterns related to each of those treatments. The timeline modifications after 
radiation therapy and percutaneous ablation and the diagnostic management 
of drug-induced lung disease will be reviewed. This presentation will 
summarise the current evidence and how to detect early recurrences after 
those treatments.  
Learning Objectives:
1. To learn about changes after radiotherapy. 
2. To learn about sequela after percutaneous ablation of lung tumours. 
3. To understand changes after chemotherapy of lung cancer. 
16:00 - 17:30 Room B  
ESR meets ESC (European Society of Cardiology)  
EM 3
The role of imaging in the cardiac patient  
Welcome by the ESR President  
G. Frija; Paris/FR 
Presiding:  
V.E. Sinitsyn; Moscow/RU 
P.E. Vardas; Iraklion/GR 
A-278 16:00 
Introduction  
P.E. Vardas; Iraklion/GR (cardio@med.uoc.gr) 
Cardiovascular medicine owes much of its spectacular development to the 
parallel evolution of imaging techniques in the last thirty years. The complex 
contemporary techniques in interventional cardiology, electrophysiology, and 
cardiac surgery require advanced imaging modalities. In current times, a wide 
spectrum of imaging techniques - such as fluoroscopy, MRI, non-contact 
mapping, echo techniques - is performed in organised cardiovascular labs 
while computed tomography and nuclear techniques are provided by the 
collaborative departments of radiology and nuclear medicine. It is indeed the 
collaborative spirit among specialists that bring about the results patients 
desire.  
Session Objective: 
1. To better understand the needs of clinicians and what imaging can provide 
in different clinical settings. 
Author Disclosure:
 P.E. Vardas: Advisory Board; Menarini, Bayer, Servier. Board Member; ESC. 
Employee; Iraklion University Hospital. Research/Grant Support; Medtronic, 
Boehringer. Speaker; Menarini, Bayer, Servier, Boehringer, Bristol. 
A-279 16:05 
Assessing myocardial viability  
M. Lombardi; San Donato Milanese/IT
(massimo.lombardi@grupposandonato.it) 
Cardiac magnetic resonance (CMR) is a very versatile imaging technique for 
the assessment of patients with left ventricular dysfunction and has become a 




central method for characterising the etiology of the dysfunction. Indeed, wall 
thinning less than 6 mm and aneurysmal motion are morphological signs of 
transmural necrosis. Furthermore, a low dosage of dobutamine (10-20 
microg/min) is used to detect functional reserve in the case of viable tissue. A 
further option offered by CMR is late contrast enhancement (LE) imaging, 
which allows identifying the presence of fibrotic tissue as well as necrotic 
infarcted myocardium. The sensitivity and specificity of late hyperintensity is, 
respectively, 0.86 and 0.94. Similar results can be obtained with 99mTC-
tetrofosmina G_SPECT. There is a relation between transmural extension of 
hyperenhancement and the recovery of contractile function after coronary 
revascularisation. The chance of recovery decreases progressively with the 
transmural extension of late hyperintensity, since the average value of the 
latter is 10±7% in the segments that recover and 47±14% in the segments that 
do not recover contractile function. CMR was also shown to be able to predict 
response to cardiac resynchronisation Therapy differentiating between 
nonischemic and ischaemic cardiomyopathy LE-CMR may allow to precisely 
delineate the presence and the location of fibrosis, avoiding the placement left 
ventricular leads in necrotic areas and in particular when the scar is located in 
the posterolateral area.  
Learning Objectives:
1. To learn how MRI can help in assessing patients with CAD. 
2. To become familiar with different protocols in CMR, and learn how they can 
be applied in clinical practice while assessing viability. 
A-280 16:23 
Assessing acute chest pain  
R. Rosenhek; Vienna/AT 
"No abstract submitted" 
Learning Objectives:
1. To learn what CT can do in the patient with acute chest pain. 
2. To appreciate the clinical evidence for different applications of CT in this 
setting. 
A-281 16:41 
Assessing valvular heart disease  
S. Muzzarelli1, J. Schwitter2; 1Lugano/CH, 2Lausanne/CH
(stefano.muzzarelli@cardiocentro.org) 
At the beginning of the presentation, a short overview will be given on the 
relevance and prevalence of valvular heart diseases with special focus on 
Europe and the data collected in the EuroHeart Survey. Also, the aetiologies of 
the various valve diseases will be briefly mentioned. In the second part, special 
attention will be given to aortic stenosis (AS) and mitral regurgitation (MR), as 
these two entities are responsible for up to 60% of all valvular heart diseases. 
Echocardiography is well accepted as the backbone examination of any 
valvular heart disease evaluation. Echocardiographic criteria for severe AS and 
MR are reviewed as well as their importance for the indication of valve repair or 
valve replacement. In the third part, we will focus on newer "cross-sectional" 
imaging technologies such as cardiac MR and CT. In particular, the strengths 
of cardiac MR in the assessment of regurgitant lesions will be demonstrated. In 
addition, the value of cardiac MR for the pre-interventional evaluation of 
congenital heart diseases will be discussed. Similarly, the crucial role of 
cardiac CT in the workup for transaortic valve implantation (TAVI) will be 
illustrated. Finally, the yield of these novel techniques in the context of 
combined valvular and ischaemic heart disease will shortly be reviewed.  
Learning Objectives:
1. To better understand the role of cardiac MRI in valvular heart disease. 
2. To appreciate the added value of MRI vs other imaging modailities. 
A-282 16:59 
Assessing interventions  
V. Delgado; Leiden/NL (v.delgado@lumc.nl) 
Cardiac resynchronisation therapy (CRT) and transcatheter valve heart (THV) 
interventions have been important therapeutic breakthroughs for heart failure 
patients and patients with valvular heart disease and contraindications for 
surgery. Patient selection is crucial to optimise procedural outcomes and 
therapeutic efficacy. Multimodality imaging plays a central role in patient 
selection and procedural strategy planning. Assessment of left ventricular 
dyssynchrony, cardiac venous anatomy and extent and location of myocardial 
scar are key to identify heart failure patients who will respond to CRT. Step-
wise use of non-invasive imaging modalities, including echocardiography, 
nuclear imaging, magnetic resonance imaging and multidetector row computed 
tomography (MDCT), has been common practice to select patients for CRT. 
Recent technological advances have allowed integration or fusion of imaging 
modalities to create 3-dimensional models that provide relevant information. 
Multimodality imaging is also crucial to optimise the results of THV 
interventions. Detailed anatomical and geometrical evaluation of the mitral 
valve with current 3-dimensional imaging techniques has permitted better 
selection of patient candidates for transcatheter edge-to-edge mitral valve 
repair and accurate procedural guidance. For transcatheter aortic valve 
implantation, accurate measurement of the aortic annulus with 3-dimensional 
echocardiography or MDCT allows us accurate selection of the prosthesis size 
to minimise the risk of complications, and evaluation of the procedural access 
(transarterial or transapical) with MDCT permits accurate procedural strategy 
planning. The learning objectives of this session include: providing an overview 
of current imaging modalities to select patients for CRT and THV interventions 
and how to use them in clinical practice.  
Learning Objectives:
1. To understand the role of the multimodality approach to cardiac 
interventions. 
2. To understand how imaging helps in selecting, monitoring and following up 
such patients. 
Author Disclosure:
 V. Delgado: Consultant; medtronic and St.Jude Medical. 
Panel discussion  17:17
16:00 - 17:30 Room C  
Modern Imaging of the GI Tract  
CC 1121  
Perianal fistula disease:  
all you need to know  
Moderator:  
D. Weishaupt; Zurich/CH 
A-283 16:00 
A. Perianal anatomy and imaging techniques  
K. Horsthuis; Amsterdam/NL (k.horsthuis@amc.uva.nl) 
The inner layer of the anal canal consists of squamous and columnar 
epithelium with the transitional zone at the dentate line. The muscular 
component of the anal sphincter consists of an inner layer of circular smooth 
muscle (internal sphincter), extending downwards from the rectum, and an 
outer striated muscular layer extending downwards from the levator ani 
muscle, comprising the puborectalis muscle and the external sphincter. 
Between these layers is the fat-containing intersphincteric space, including the 
continuation of smooth-muscle fibers of the longitudinal muscle of the rectum. 
Outside the anal sphincter is the fat-containing ischioanal space. Magnetic 
resonance imaging (MRI) and endoscopic ultrasonography have become the 
mainstay for preoperative imaging of perianal fistulas. For complex tracts, MRI 
seems preferable. MRI can be performed using an endoluminal coil or a 
phased-array surface coil. A state-of-the-art imaging protocol should include T2 
TSE sequences in three orthogonal planes, with the axial and coronal 
sequences angulated at the anal canal. Addition of a fat-saturated T2 TSE 
sequence is recommended for optimal conspicuity of inflammatory changes 
and post-contrast T1-weighted imaging can also be helpful. Intersphincteric 
infection is the principal feature of perianal fistulas; this is generally not found 
in other conditions. Veins can be mistaken for fistulas, but in contrast to 
fistulas, veins usually are thin-walled, tortuous, symmetric structures. A 
pilonidal sinus may resemble a fistula, but absence of extension to the 
intersphincteric space helps one to discriminate between them. Haemorrhoids 
and anal tags may resemble small submucosal fluid collections, but are easily 
diagnosed at clinical examination.  
Learning Objectives:
1. To understand anal canal anatomy. 
2. To become familiar with state-of-the-art protocols for imaging the anal canal. 
3. To learn about normal variants which mimic anal disease. 
A-284 16:20 
B. Perianal fistula disease: the basics  
S. Halligan; London/UK (s.halligan@ucl.ac.uk) 
This lecture will describe the pathogenesis of fistula-in-ano, with a focus on 
cryptoglandular disease, so that the radiologist can understand how the 
various classifications of fistulas arise. The Park's classification for fistula-in-
ano will be described with reference to cryptoglandular disease and other 
aetiologies. The surgical questions that need to be answered by imaging will 
be presented, followed by a description of what the radiologists need to include 
in their report for it to be clinically useful. The role of anal ultrasound and MRI 
for preoperative fistula imaging will be described, with explanation as to why 
the latter is fundamental to modern management of the disease.  





1. To understand the pathophysiology and classification of perianal fistula 
disease. 
2. To become familiar with the role of US and MRI in assessing fistula disease. 
3. To learn about the basic reporting of fistula disease. 
A-285 16:40 
C. Perianal fistula disease: advanced  
F. Maccioni; Rome/IT (francesca.maccioni@uniroma1.it) 
Perianal fistulising disease develops in approximately half of the adult and 
paediatric patients with Crohn's disease (CD), with a relevant impact on their 
quality of life. In patients with CD, particularly those with severe fistulising ileal 
or colo-rectal disease, complex ramified anal fistulas associated with 
abscesses (Parks' classification type 3-4 or S.James Hospital classification 
type 4-5) are more frequently observed than in other patients. Perianal disease 
thus represents a severe complication of CD, which may change disease 
management, by requiring specific pharmacological and/or surgical treatments. 
A non-responsive disease eventually may lead to total proctectomy with 
ileostomy. MRI represents the gold standard diagnostic modality, because it 
provides a comprehensive staging of both enteric and perianal disease, with 
high accuracy and without invasiveness. Moreover, MRI is the ideal tool for 
monitoring disease response to therapy, being able to detect the inflammatory 
activity of perianal fistulas with high accuracy. So far, several clinical indexes 
have been proposed to measure fistula's activity, including the Perianal 
Disease Activity Index (PDAI). Similarly, several MRI classifications of fistula's 
activity, based either on T2-weighted or T1-weighted contrast-enhanced 
imaging, have been proposed, although a widely accepted imaging severity 
score is not available yet. Several cases of complex perianal fistulising CD of 
increasing severity will be shown, with anatomical and clinical correlations, 
staging and activity description, particularly in patient follow-up and treatment 
monitoring. Finally, differential diagnoses with other benign conditions which 
may affect the anal canal, including inflammatory infective diseases, 
hydradenitis and pilonidal disease will be discussed.  
Learning Objectives:
1. To lean about complex perianal fistula disease, particularly in Crohn's 
disease. 
2. To understand the role of imaging in patient follow-up and treatment 
monitoring. 
3. To learn about benign inflammatory conditions which may affect the anal 
canal, including hydradenitis and pilonidal disease and how they are 
differentiated from perianal fistulae. 
A-286 17:00 
D. Interactive case discussion  
D. Weishaupt; Zurich/CH (dominik.weishaupt@triemli.zuerich.ch) 
The interactive case discussion will highlight clinically relevant aspects of 
perianal fistula disease in selected clinical cases. A patient case of each of the 
subtopics of the categorical course is presented.  
Learning Objectives:
1. To become familiar with typical cases demonstrating the crucial role of 
imaging perianal fistula disease. 
2. To learn about typical imaging findings. 
3. To be aware of potential pitfalls in imaging perianal fistula disease. 
16:00 - 17:30 Room D  
Chest  
RC 1104  
Patterns in chest radiology: are there 
subtype patterns of ground glass opacity 
(GGO)?  
A-287 16:00 
Chairman's introduction  
A. Oikonomou; Toronto, ON/CA (anastasia.oikonomou@sunnybrook.ca) 
Ground̻glass opacity (GGO) is characterised on HRCT by the presence of a 
hazy increase in lung opacity that does not cause obscuration of underlying 
bronchial and vascular margins. Although a very common finding, it also 
constitutes a very nonspecific term since it can be seen in a variety of different 
intraalveolar and interstitial processes with different histology including 
inflammatory, infectious and neoplastic diseases that have a common 
physiologic mechanism: partial displacement of air. Ground̻glass opacity may 
even be seen in normal processes such as poor ventilation in dependant lung 
areas and in expiration. Moreover, GGO can represent either an ongoing, 
active and potentially treatable disease or an irreversible process. To interpret 
correctly this highly nonspecific but very significant finding, it is crucial to 
attempt to further classify the different large main entities in which this 
radiological finding appears. Are there specific radiological and HRCT findings 
that can help us differentiate GGO in autoimmune̻inflammatory conditions 
from infectious and neoplastic processes? Are there associated findings other 
than GGO, such as nodules, reticulation or focal disease, and distribution of 
findings that can narrow the differential diagnosis? Systematic evaluation of 
GGO and associated findings as well as integration with clinical information 
(acute, subacute or chronic symptoms) is essential in defining GGO subtypes 
to improve the radiological diagnosis.  
Session Objectives:
1. To learn about the prevalence and low specificity of GGO. 
2. To appreciate the need for a definition of GGO subtypes to improve 
radiological diagnoses. 
A-288 16:05 
A. Ground-glass opacification: why do we see it and what does it mean?  
S.R. Desai; London/UK (sujal.desai@nhs.net) 
Radiologists who regularly review high resolution CT (HRCT) should be aware 
of the range of patterns and, more importantly, their potential pathological 
meaning. A pattern of ground-glass opacification is one of the more common 
HRCT findings but, to the unwary, its interpretation can be problematic. An 
important underlying principle is that a ground-glass pattern may be caused by 
any process - physiological or pathological - which partially displaces air. 
Physiological (i.e. non-disease-related) ground-glass opacification is perhaps 
most commonly seen in subjects who, for whatever reason (e.g. 
breathlessness, obesity), are unable to maintain or achieve a satisfactory 
inspiratory effort during scanning. A generally increased lung density (in 
contrast to adults) is also a feature in infants and young children simply 
because there are fewer alveoli in the developing lung. Finally, it is worth 
noting that intravenous contrast administration (presumably because of a 
relative but temporary increase in capillary blood volume causing partial 
displacement of air) can unpredictably increase lung density. Disease 
processes which lead to partial filling of the air spaces, thickening of the 
interstitium, partial collapsing of alveoli, and/or increased capillary blood 
volume will also manifest as a pattern of ground-glass opacification. In clinical 
practice, the recognised causes of ground-glass opacities on HRCT include 
pulmonary oedema (cardiogenic or otherwise), infections (e.g. pneumocystis 
jiroveci pneumonia) and some of the idiopathic interstitial pneumonias (e.g. 
non-specific interstitial pneumonia and respiratory bronchiolitis associated 
interstitial lung disease). The presentation will review and revise the causes of 
physiological and disease-related ground-glass opacification on HRCT.  
Learning Objectives:
1. To appreciate the different physiological conditions which cause GGO 
pattern. 
2. To learn about the associations and reversibility of physiology-related GGO. 
A-289 16:28 
B. Inflammatory and infectious GGO  
K. Marten-Engelke; Göttingen/DE (kmarten@med.uni-goettingen.de) 
Ground-glass opacity (GGO) is defined as increased attenuation of the lung 
parenchyma without obscuration of the pulmonary vascular markings on CT 
images. GGO may be the result of a variety of interstitial and alveolar 
infectious and noninfectious inflammatory diseases. As an imaging finding 
alone, GGO does not usually allow a specific diagnosis. GGO in inflammatory 
disorders is often present in the company of other interstitial or alveolar 
findings. However, the number of diseases that cause diffuse isolated GGO or 
GGO as the predominant finding is relatively small and can be prioritised with 
clinical information. The most common cause of diffuse isolated GGO in 
immunocompromised hosts are a variety of diffuse, opportunistic pneumonias, 
e.g. pneumocystis jiroveci pneumonia (PCP), cytomegalovirus pneumonia 
(CMV) or herpes simplex pneumonia (HSV), which constitute the first 
differential. Chronic onset disorders in immunocompetent patients include 
cellular nonspecific interstitial pneumonia (NSIP), subacute hypersensitivity 
pneumonitis (HP), organising pneumonia, air-space sarcoid, and drug-induced 
lung disease. In these disorders, ancillary findings such as an associated 
reticular pattern with traction bronchiectasis/bronchiolectasis (NSIP), 
mediastinal lymphadenopathy (sarcoidosis), superimposed nodularity or cysts 
or may help to refine the diagnosis. In patients with collagen vascular 
disorders, e.g. scleroderma, GGO secondary to pulmonary involvement needs 
to be differentiated from drug-induced lung disease. This refresher course will 
put GGO in the context of outpatients versus inpatients, the acuity of clinical 
symptoms, e.g. fever, cough and dyspnoea, signs of massive systemic 
inflammation, and the clinical situation such as inhalational history, 
pneumotoxic drug administration, immunocompromise, or bone marrow 
suppression. 





1. To learn more about the inflammatory conditions which cause GGO. 
2. To appreciate the histopathological correlates of inflammatory and infectious 
GGO. 
3. To become familiar with GGO in autoimmune and infectious lung disease. 
A-290 16:51 
C. GGO in dysplasia and neoplasia  
G.R. Ferretti; Grenoble/FR (GFerretti@chu-grenoble.fr) 
In this course, we will review the dysplastic and neoplastic conditions that are 
associated with persistent GGO in the lung parenchyma. We will separate 
these conditions into those that are responsible for localised diseases such as 
single nodular GGO and those responsible for more extended diseases. 
Nodular GGO can be separated into pure or mixed or part-solid nodules. 
Pathology-radiology correlations show that nodular GGO are related to atypical 
adenomatous hyperplasia (AAH), adenocarcinoma (ADC) in situ (AIS), 
minimally invasive ADC (MIA), and invasive ADC according to the new 
IASLC/ATS/ERS lung adenocarcinoma classification. Differential diagnosis 
includes exceptional metastases of angiosarcoma and melanoma as well as 
infection, inflammation and localised fibrosis. Diffuse GGO related to neoplastic 
conditions is rare and may be due to lepidic ADC (former advanced ADC with 
BAC component), diffuse large B-cell non-Hodgkin's lymphoma, intravascular 
lymphomatosis (IVL) or mucosa-associated lymphoid tissue (MALT) 
lymphoma. These neoplastic diseases should be differentiated from infectious 
and inflammatory causes of diffuse GGO. We will review the value of different 
morphological CT criteria to differentiate benign from malignant localised GGO, 
such as the size, the morphology (round, oval, flat), presence of mixed vs. pure 
GGO, and the multiplicity of nodular shadows. Discussion will also include the 
changes that may occur within the nodule as well as the mean doubling time. 
The role of PET CT and transthoracic biopsy will be discussed. Finally, we will 
present the current recommendations regarding the management of nodular 
GGO.  
Learning Objectives:
1. To learn more about the dysplastic and neoplastic conditions causing GGO. 
2. To appreciate the histopathological correlates of dysplastic and neoplastic 
GGO. 
3. To understand how to estimate malignancy on the basis of GGO pattern. 
Panel discussion:  
How should we report and manage ground glass opacity?  17:14
16:00 - 17:30 Room E1  
Musculoskeletal  
RC 1110  
The ankle and foot  
Moderator:  
S.J. Ostlere; Oxford/UK 
A-291 16:00 
A. Ankle sprain: patterns of injury  
J.L.M.A. Gielen, P. Van Dyck, J. Veryser; Antwerp/BE (jan.gielen@uza.be) 
It is the purpose of this lecture to briefly discuss ankle distortion-related lesions 
with emphasis on failed radiographic diagnosis, discuss their significance and 
management implications and define the diagnostic pathways in the acute and 
subacute stage. Significant lesions are those with no return to sports activities 
after 12 months; these have our major interest. In the acute setting of ankle 
distortion, the Ottawa clinical decision rules are accepted to decide whether or 
not radiographic evaluation is needed; about 35% of radiographic examinations 
can be avoided. Additional evaluation is restricted to patients with residual pain 
during reevaluation one week after trauma. Assessment of fractures with the 
Lauge Hansen classification has a major advantage, as it defines the stability 
at the talocrural and distal tibiofibular joint. Only in restricted cases, additional 
examinations may be needed to rule out instability. Although radiographs 
easily detect displaced fractures, occult fractures may occur; also, grade II-III 
ligament lesions and peroneal tendon dislocation may go undetected. 
Additional imaging evaluation should focus on the detection of significant 
lesions. Significant lesions are talar fractures and complete calcaneofibular 
ligament tears. The latter is explained by the instability at the level of the 
subtalar joint with associated sinus tarsus syndrome. In case of residual local 
tenderness posterior and inferior to the lateral malleolus, the fibulocalcanear 
ligament and retinaculum peroneorum lesions are best evaluated with 
(dynamic) ultrasound. MRI or CT is used to detect occult fractures in case of 
residual talocrural joint effusion with anterior talar tenderness during 
endorotation and plantar flexion.  
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue and 
osteoarticular injury. 
2. To become familiar with the patterns of bone and soft tissue injury in the 
ankle and foot. 
A-292 16:30 
B. Inflammatory disorders  
R. Lalam; Oswestry/UK (radhesh.lalam@rjah.nhs.uk) 
The ankle and foot can be affected by inflammation from a number of 
diseases. The main focus of this lecture will be inflammation secondary to 
infection and systemic inflammatory disorders. Due to its function in locomotion 
and weightbearing, the foot is specifically susceptible to infections secondary 
to penetrative trauma including foreign bodies or to abnormal repetitive 
pressure. In addition, both seropositive and seronegative arthropathies can 
affect the foot. Other unusual causes of inflammation include chronic recurrent 
multifocal osteomyelitis, osteoarthritis, mechanical disorders and sensory loss. 
This lecture will deal with the various patterns of inflammation in the context of 
pathogenesis and discuss the imaging features that aid in diagnosis. The 
importance of the clinical context in diagnosis will also be discussed.  
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue and 
osteoarticular inflammation. 
2. To become familiar with imaging findings of specific inflammatory conditions. 
A-293 17:00 
C. Tumours and tumour-like lesions  
I.-M. Noebauer-Huhmann; Vienna/AT (iris.noebauer@meduniwien.ac.at) 
Soft tissue tumours of the foot and ankle are rare. This leads to frequent 
misdiagnosis or diagnostic delay, which is of importance, especially in the few 
patients with unsuspected malignancy. By the use of ultrasound, some entities 
which are clearly benign and do not require further imaging can be identified. In 
the other lesions, MR is the imaging modality of choice; additionally, 
radiography should be performed. Several common benign soft tissue tumours 
and those of intermediate type, as well as tumour-like lesions of the foot and 
ankle region, exhibit typical MR features, e.g. the Morton neuroma, the plantar 
fibromatosis and aggressive fibromatosis/extra-abdominal desmoids, lipoma, 
ganglia, and also vascular malformations and extraskeletal chondromas. MR 
findings of synovial lesions, such as pigmented villonodular synovitis (PVNS) 
and the giant cell tumour of the tendon sheath (GCTTS), as well as synovial 
chondromatosis, are also characteristic. It is important not to misdiagnose the 
most common malignant tumour of that region, the synovial sarcoma, as the 
growth rate may be slow. The same is true for clear cell sarcoma, which tends 
to have a high incidence of distant metastases and a high recurrence rate. 
Lesions that are indeterminate or likely malignant require histologic diagnosis. 
Biopsy may be performed by ultrasound or MR guidance. The importance of 
MRI for staging of soft tissue tumours will be discussed, including the 
recognition of compartmental involvement and relation to adjacent 
neurovascular structures.  
Learning Objectives:
1. To learn more about the spectrum of intra and para-articular soft tissue 
tumours, and tumour-like soft tissue lesions. 
2. To become familiar with US and MRI findings of specific soft tissue lesions. 
16:00 - 17:30 Room E2  
Multidisciplinary Session: Managing Patients with Cancer  
MS 11
Characterisation and treatment of renal 
tumours: new paradigms  
A-294 16:00 
Chairman's introduction  
N. Grenier; Bordeaux/FR (nicolas.grenier@chu-bordeaux.fr) 
This session will be devoted to recent changes of paradigms in the 
management of renal tumours. Fist, characterisation of solid renal tumours has 
improved, using an association of morphological and functional information, 
using US, CT and, more recently, multiparametric MRI, and by extending the 
indications of percutaneous biopsy in undetermined cases. Second, surgical 
and radiological treatments have improved with the development of indications 
and techniques of nephron-sparing procedures (open, laparoscopic or 
robotised) and of percutaneous thermoablations (RF, cryo, microwaves, 
electroporation), with a larger consideration of active surveillance for the 
elderly. Third, antiangiogenic treatments have changed the prognosis of 




metastatic renal tumours, at least for certain tumour types, and may help as 
neoadjuvant phases before ablation.  
Session Objectives: 
1. To learn about the actual capabilities of imaging for characterising renal 
tumours. 
2. To become familiar with emerging therapeutic strategies. 
3. To understand the imaging requirements for staging metastatic tumours and 
monitoring new treatments. 
A-295 16:05 
Characterising solid renal tumours in 2014: from morphology to function  
N. Grenier, F. Cornelis; Bordeaux/FR (nicolas.grenier@chu-bordeaux.fr) 
Characterising tumours before deciding on the most appropriate treatment is a 
general rule in oncology. Cystic tumours are now adequately graded based on 
Bosniak's classification. However, this pre-therapeutic characterisation is not 
currently systematic in case of solid renal tumours, as it remains difficult in 
clinical practice due to the high prevalence of renal cell carcinomas (RCC) and 
the lack of reliable imaging criteria for recognition of benign versus malignant 
tumours. As a result, approximately 10% to 20% of surgically excised renal 
masses are actually benign. To avoid these unnecessary ablations, pre-
therapeutic image-guided biopsy has been proposed, but its use is still debated 
as it is invasive and time consuming. New validated imaging criteria, able to 
accurately differentiate the most common tumour types but also indolent vs 
more aggressive malignant lesions, would be useful to reduce the number of 
unnecessary biopsies or to consider the most appropriate treatment for a 
tumour or active surveillance. Among these, MR imaging plays a major role 
based on chemical shift gradient echo (GRE) sequences, signal intensity on 
T2-weighted images, dynamic contrast-enhanced sequences, diffusion-
weighted sequences and late contrast-enhanced images. Multiparametric MR 
imaging is now performed in clinical practice in most primary care centres. 
Therefore, using different combinations of two or several parameters, it is now 
possible to distinguish certain renal tumours. A larger validation of all these 
combinations is still necessary to define those having a clinical significance for 
routine practice.  
Learning Objectives:
1. To learn about the capabilities of multiparametric imaging for 
characterisation of tumours. 
2. To understand the impact of characterisation on biopsy strategies. 
3. To become familiar with functional techniques applied to renal tumours. 
A-296 16:25 
New therapeutic approaches for localised renal tumours: the urologist's 
opinion  
J.-J. Patard; Le Kremlin-Bicêtre/FR (jean-jacques.patard@bct.aphp.fr) 
The widespread use of modern imaging has led to increased detection of 
small, low-stage, low-grade renal tumours. In this setting, partial nephrectomy 
(PN) has progressively emerged as a standard of care. PN was first used in 
absolute indications (solitary kidneys, bilateral tumours, renal chronic disease) 
and thereafter in elective cases for tumours measuring less than 4 cm. 
Nowadays, PN is recommended for all T1 tumours, because perhaps it is 
technically feasible and the negative margins can be safely obtained. In 
parallel, PN modalities have evolved from open to laparoscopic and now 
robotic-assisted approach. Robotic PN combines the advantages of open 
(short ischaemic time) and laparoscopic PN approaches (low morbidity, 
reduced postoperative pain, short hospital stay). In the meantime, reliable 
anatomical classifications have helped urologists to predict PN complexity and 
postoperative morbidity. The use of ablative treatment was first restricted to 
patients who were not suitable for or who refused surgical treatment. The 
advantages of these mini-invasive treatments compared to PN are: possibility 
of an outcome procedure, percutaneous approach, minimal nephron damage, 
very low morbidity and the possibility of repeated treatments. The current 
indications include: small cortical tumours (3 cm) in aged people with 
significant life expectancy, inherited renal or bilateral tumours and solitary 
kidney. Obtaining histology by percutaneous biopsy before treatment is 
recommended. Finally, the current indications for active surveillance include: 
patients > 75 years with multiple and severe comorbidities, renal mass Ø 
< 4 cm, incidental diagnosis and acceptance for repeated imaging.  
Learning Objectives:
1. To learn about expansion and the limitations of conservative surgery. 
2. To become familiar with actual indications of percutaneous image-guided 
ablations. 
3. To learn about application of an active surveillance strategy to renal 
tumours. 
A-297 16:45 
Impact of imaging in targeted therapy of metastatic renal cancer: the 
oncologist's opinion  
A. Ravaud; Bordeaux/FR (alain.ravaud@chu-bordeaux.fr) 
Targeted therapies such as VEGF mAb bevacizumab, VEGF tyrosine kinase 
inhibitors (sunitinib, pazopanib, axitinib and sorafenib) and mTOR inhibitors 
(temsirolimus and everolimus) have been approved and included in European 
guidelines. Pre-therapeutic imaging prerequisites are mainly based on the 
natural history of MRCC. This justifies imaging through a thoracoabdominal CT 
scan. Outside clinical symptoms, there is no need for bone imaging or brain CT 
scan; the latter nevertheless could be done because of influencing the 
therapeutic strategy. PET scan should not be done due to low sensitivity. The 
evolution of metastatic sites by comparison from previous imaging is useful to 
evaluate the natural history. Outside clinical trials or research imput the 
strategy is to use the drug in an optimal way to increase PFS. So far, 
monitoring has to inform about change in RECIST criteria for CR, PR, SD or 
PD, and if PD is a real PD such as RECIST PD or a slowing PD. In conclusion, 
standard CT scan and RECIST are adapted to real life. Nevertheless, more 
information on the mode of action of targeted drugs should be interesting for 
knowledge and research purpose, without any impact on the management of 
patients. Additional imaging could be done with additional criteria than RECIST 
on CT scan, by vascular functional imaging and PET scan.  
Learning Objectives:
1. To learn about new targeted drugs for metastatic renal cancer. 
2. To understand the pre-therapeutic imaging prerequisites. 
3. To learn about the role of imaging for monitoring treatments. 
Author Disclosure:
 A. Ravaud: Advisory Board; Member of Global, European and/or French 
boards in renal cell tumor for Pfizer, Novartis, Bayer, GSK, Aveo, Astellas, 
BMS. Investigator; international PI for study for Pfizer, Novartis; steering 
committe for trials for Pfizer, Novartis, BMS. Research/Grant Support; 
institutional grant support by Pfozer, Novartis, Roche. Other; Travelling and 
housing suppport for meetings by Pfizer, Novartis. 
Case presentation and discussion  17:05
16:00 - 17:30 Room F1  
Breast  
RC 1102  
Clinical challenges in breast MRI  
A-298 16:00 
Chairman's introduction  
F.J. Gilbert; Cambridge/UK (fjg28@cam.ac.uk) 
Breast MRI is recognised as a useful tool for a number of clinical indications, 
but remains relatively challenging. Recognising the importance of an evidence-
based approach to the development of protocols will influence the further 
integration of this technique into everyday clinical practice in the management 
of breast cancer patients. There remain concerns regarding the potential of 
over-diagnosis from breast MRI. The aim of this integrated RC is to inform the 
clinical practice with regard to the establishment of breast MRI in specific 
clinical and imaging scenarios, namely, using MRI for surveillance in high-risk 
patients, monitoring response to neo-adjuvant chemotherapy and developing 
protocols for the indeterminate imaging scenario of non-mass-like 
enhancement. The establishment of protocols to maximise the specificity and 
sensitivity of the technique of breast MRI in such indeterminate clinical and 
imaging scenarios will be discussed.  
Author Disclosure:
 F.J. Gilbert: Speaker; Bracco. 
A-299 16:05 
A. High-risk patients: establishing clinical protocols  
J. Veltman; Almelo/NL (j.veltman@zgt.nl) 
Contrast-enhanced MRI has, especially in younger women with dense breasts, 
a superior sensitivity for detecting breast cancer. Young women usually do not 
need screening unless they have an increased risk for developing breast 
cancer. An increased risk can be based on a positive familial history or on a 
proven gene mutation. The BRCA1 and BRCA2 gene mutations are the most 
well known related to an increased breast cancer risk. In this group, false-
negative rates up to 62% have been reported for mammography. Several 
papers have demonstrated the value of contrast-enhanced MRI in high-risk 
screening for early detection and even demonstrated a more favourable lymph 
node status for these women. An upcoming MRI technique for detecting and 
classifying breast lesions is diffusion-weighted imaging (DWI). The main 




advantages of DWI are the short examination time and that no contrast is 
needed. In literature, DWI has demonstrated great diagnostic potential. 
Especially high sensitivities have been reported (80%-97.8%). The high 
sensitivity values reported give DWI the potential to become a fast, non-
contrast, and therefore relatively cheap, highly sensitive screening technique. 
The specificity and spatial resolution are however still moderate. At this point, 
contrast-enhanced MRI is the best available modality for the detection of 
breast cancer in women with an increased risk. The detection of smaller 
lesions, patient anxiety, the often benign morphologic characteristics seen in 
cancers and the often aggressive nature of breast cancer in young women 
should lower the threshold for MRI-guided-biopsies.  
Learning Objectives:
1. To become familiar with the literature on the role of breast MRI in screening 
of high-risk patients. 
2. To understand current protocols in clinical practice. 
3. To appreciate the challenges of breast MRI imaging in this patient group. 
Author Disclosure:
 J. Veltman: Advisory Board; Hologic. 
A-300 16:28 
B. Non-mass like enhancement (NMLE): when to biopsy?  
C.K. Kuhl; Aachen/DE (ckuhl@ukaachen.de) 
Non-mass like enhancement is a frequent finding in breast MRI. It relates to 
the fact that enhancement occurs in the normal-appearing fibroglandular tissue 
that surpasses that of the other parts of the parenchyma. There is no 
associated space-occupying lesion. In pre-contrast non-fat-suppressed or fat-
suppressed T1- and T2-weighted images, there is usually no correlate 
observable. The differential diagnosis of non-mass-like enhancement is 
between benign nonspecific fibrocystic disease/adenosis, hormonal 
stimulation, and subclinical mastitis on one hand, vs DCIS or (less likely) 
diffusely infiltrating (usually lobular) cancer on the other. Key components of 
differential diagnosis is configuration of the enhancement (does it follow the 
orientation of the milk duct or not?) and symmetry (symmetric or asymmetric). 
Less important criteria are internal enhancement (internal architecture) and 
enhancement kinetics. It is important to realise that enhancement kinetics can 
only be used to corroborate the suspicion of DCIS - but they cannot be used to 
alleviate the indication to biopsy a finding which, based on configuration and 
asymmetry, is suspicious. Management depends on the different constellation 
of clinical, mammographic, and MRI findings. It usually includes short-term 
follow-up (6 months) and, if stable/persistent, MR guided vacuum biopsy.  
Learning Objectives:
1. To learn about the clinical significance of NMLE. 
2. To understand differential diagnosis for NMLE. 
3. To become familiar with a work-up algorithm of NMLE cases. 
A-301 16:51 
C. Monitoring response to neo-adjuvant chemotherapy  
T.H. Helbich; Vienna/AT (Thomas.Helbich@meduniwien.ac.at) 
Assessment of the change in tumour burden is an important feature of the 
clinical evaluation of cancer therapeutics. Tumour shrinkage and time to the 
development of disease progression are important end points in cancer clinical 
trials. However, these end points are useful only if based on widely accepted 
and readily applied standard criteria. Criteria, known as RECIST, were 
published and are updated on a regular base. The revised RECIST includes a 
new imaging appendix and underlines the importance of moving from anatomic 
unidimensional assessment to either volumetric anatomical assessment or 
functional assessment with PET or MRI. The goal of the lecture is to discuss 
the value of the different MR imaging techniques (e.g. MR spectroscopy, 
diffusion-weighted imaging, angiogenesis mapping, PET-MRI), which evaluate 
response to treatment in breast cancer. Participants will learn about particular 
imaging challenges of assessing response to neo-adjuvant chemotherapy. In 
addition, they will learn to understand clinical aspects of neo-adjuvant 
chemotherapy based on RECIST.  
Learning Objectives:
1. To understand the clinical aspects of neo-adjuvant chemotherapy. 
2. To appreciate evidence-based protocols for imaging in this clinical setting. 
3. To learn about particular imaging challenges of assessing response to neo-
adjuvant chemotherapy.
Author Disclosure:
 T.H. Helbich: Advisory Board; Philips. Grant Recipient; Siemens, Guerbet. 
Panel discussion:  
How can the specificity and sensitivity of breast MRI in these 
indeterminate clinical and imaging scenarios be maximised?  17:14
16:00 - 17:30 Room F2  
Professional Challenges Session  
PC 11  
The role of social media in radiology  
A-302 16:00 
Chairman's introduction  
P. Pokieser; Vienna/AT (peter.pokieser@meduniwien.ac.at) 
Currently, the ESR has been using social media in many successful ways to 
improve the contacts among members and to boost our fast development as 
one of the most advanced scientific communities in the world. Our session 
"The role of social media in radiology" presents the view of 4 experts, 
acknowledged leaders of international IT projects. It seems to be important to 
discuss the major implications of social media for radiology, the leading clinical 
discipline in information technology. Davide Caramella will clarify the 
relationship of social media to professional societies and especially to the ESR, 
including their basic features. The "Social media generation" has developed 
from schoolkids to students and, recently, to teachers as well. Alexander 
Sachs represents the young professional expert of ELearning in Radiology and 
will reflect the current user behaviour. Osman Ratib will share his view on how 
social networks enhance the communication between radiologists, non-
radiologists and patients. Critical aspects of the pros and cons of large 
communication scenarios are followed by some ideas of future developments. 
Jürgen Brandstätter will indicate the patient´s view. Most patients see social 
network communications with their radiologist as useful for, e.g. appointment 
management or other non-sensitive communication. Besides communicating 
personal health data, a wide area of potential useful other possibilities are at 
hand, like anonymised health data for reviewing purposes, second opinion or 
education of patients. The fast development of social media may induce hopes 
and fears; the four speakers of this session will present them in a panel 
discussion.  
Session Objectives: 
1. To learn about social networks which are important for the ESR and its 
members. 
2. To understand the intentions and motivations behind social networks. 
3. To appreciate the unique services and opportunities offered by different 
types of networks. 
4. To become familiar with the pros and cons of using social networks. 
A-303 16:05 
Major social media networks and their relationship to professional 
societies  
D. Caramella; Pisa/IT (davide.caramella@med.unipi.it) 
The widespread use of social networks in all professional activities has 
attracted a great interest in the recent years. In medical applications, the main 
concerns include the possible consequences in terms of patients' 
confidentiality protection, perceived role of the physician, patient-physician 
relationship, and caregivers' distraction during professional activities. There are 
no doubts, however, that social networks are beneficial in enhancing the 
information flow between scientific societies and their professional members, 
without any interference at the point of care. Social networks have proved to be 
extremely effective in updating members about relevant news concerning their 
areas of interests and in allowing them to be informed about the educational 
activities promoted by their scientific societies. This presentation focuses on 
the social network activities promoted by the ESR via Facebook, YouTube, 
Twitter and other blogs.  
Learning Objectives:
1. To learn about the ESR's relations with to social networks. 
2. To understand the basic features of Facebook, YouTube, Twitter and blogs. 
3. To learn about the productive use of ESR networking for its members. 
A-304 16:23 
Impact of social media on the training of radiologists  
A. Sachs; Vienna/AT (alexander.sachs@meduniwien.ac.at) 
In modern times, social media have gained more and more important value in 
exchanging first experiences in radiology from resident to resident. Social 
networks such as Facebook, Twitter, Google plus and others are used to start 
discussion groups about cases and share the growing knowledge with different 
educational concepts in each hospital. Growing e-learning modalities as 
MOOCs, applications for smartphones or tabs and web-based case series or 
learning platforms support the training of radiologist in social media. Modern e-
learning platforms use social media as their first choice of sharing knowledge 
around the whole world about certain illnesses, cases or different decisions of 
therapy. Though sharing information seems to be easier and shows several 




advantages than in former times, social media can also highlight new 
problems. This lecture focuses on user behaviour to improve learning, the 
pedagogic evidence for large group learning with networks and the importance 
of using networks to manage time.  
Learning Objectives:
1. To learn about the current user behaviour of ESR members in order to 
improve learning. 
2. To learn about paedagogic evidence for large group learning with networks. 
3. To appreciate the importance of using networks to manage time. 
A-305 16:41 
Social media networks in communication between radiologists, non-
radiologists and patients  
O. Ratib; Geneva/CH 
While social networks have gained unprecedented popularity in our daily 
environment, they have only limited utilisation in medical applications. The 
paradigm of communication within a given community for exchange and 
sharing of imaging data would certainly have its place in a medical 
environment where there is an increasing need for multidisciplinary 
collaborative work. The required security and confidentiality in management of 
sensitive patient data have often precluded the usage of existing public social 
networks. Professional proprietary systems have emerged in a more restricted 
way with much less flexibility leading to limited use. The exchange of medical 
images adds a level of complexity due both to the size of the data and the 
need for appropriate browsing and visualisation tools. Traditional PACS and 
teleradiology system offer such features, but in a very limited way, far from the 
desired convenience of social networking between groups of users. A 
prototype of such a system aimed essentially at the community of users that 
need to exchange anonymised medical images and data for academic and 
research purposes will be presented and discussed. The project nicknamed 
DICOM SandBox is being tested and evaluated by some users in Europe 
under the coordination of the ESR subcommittee of eHealth and informatics. 
Developed with Open Source software components, it allows using existing 
cloud-based storage services with additional layers of secure DICOM file 
management and visualisation. It allows the community of users to share 
DICOM data with all social networking and notification features beyond simple 
peer-to-peer exchange.  
Learning Objectives:
1. To appreciate how social networks enhance communication between 
radiologists, non-radiologists and patients. 
2. To appreciate the pros and cons of large communication scenarios. 
3. To learn about the future of social networks. 
A-306 16:59 
Interactions between patients and radiologists through social media  
J. Brandstätter; Wiener Neudorf/AT (j.brandstaetter@codewerk.at) 
Social networks have become integral parts of most citizen's use of the 
Internet. Especially, the younger generation uses social networks extensively; 
however the way those tools are used should be chosen carefully. It is one 
thing to use a social network for private interests, but a different one to use it 
as transport media for sensible data like personal health-care data. The 
sensitiveness of citizens regarding privacy has been increased recently by 
different events of misuse or fraud, especially accelerated by the recent privacy 
affairs caused by governmental agencies. Though most patients see social 
network communications with their radiologist useful for, e.g. appointment 
management or other non-sensitive communication, personal medical reports 
or images shall not be shared across this media. Besides communicating 
personal health data, a wide area of potential useful other possibilities are at 
hand (e.g. anonymised health data for reviewing purposes, second opinion, 
education of patients, …). Future developments shall make use of social media 
where useful, but always with deep respect to the patient's privacy rights.  
Learning Objectives:
1. To learn to appreciate the patient's view. 
2. To understand what patients demand from radiologists in social network 
communications. 
3. To become familiar with the patient's view of future developments. 
Panel discussion: Social networks: hopes and fears  17:17
16:00 - 17:30 Room G/H  
Neuro  
RC 1111  
Brain tumours: the central role of 
radiology  
A-307 16:00 
Chairman's introduction  
M.A. Lucic; Sremska Kamenica/RS (milos.a.lucic@gmail.com) 
Apart from the historical, but ever present clinical expectation from the 
neuroradiologist is the answer to the most important question if the patient has 
a brain tumour or not. Nowadays, due to the outstanding technological 
advances in imaging techniques during the last decades, the stakes are 
growing much higher and it is the neuroradiologist on whom lies the initial 
responsibility of answering a large number of questions that are of utmost 
importance for further brain tumour patient care and treatment. Having the 
opportunity to provide the usual and generally basic information regarding 
tumour morphology and exact location and to narrow the differential diagnostic 
possibilities, neuroradiologic expertise now opens a wide spectrum of 
techniques, especially those derived from MRI, such as MR spectroscopy, MR 
perfusion, DWI, DTI, SWI, etc. These provide us the unique possibility of not 
only obtaining and comparing images, but also of exploring multiparametric 
brain maps, allowing us to gain insight into the internal architecture of the 
tumour and the functional and molecular features of the tumorous tissue. This 
consequently defines the actual stand of neuroradiology, indicating the uprising 
clinical urge not only to provide the answers regarding the tumour type, grade 
and possibilities of the most appropriate and patient-individualised therapy 
modality, whether surgical or nonsurgical, but also to accurately assess the 
post-treatment tumour behaviour and status, by differentiating the true tumour 
progression from pseudoprogression, represented by inflammatory responses 
to the radio- and/or chemotherapeutical treatment, and to monitor other 
neurooncological response assessment criteria.  
A-308 16:05 
A. Differential diagnosis and pseudo-tumoural lesions  
H.R. Jäger; London/UK (r.jager@ucl.ac.uk) 
Conventional contrast-enhanced MR imaging gives an indication about the 
likely tumour type and histological grade, but advanced MR imaging methods, 
including perfusion-weighted (PWI) and diffusion-weighted (DWI) imaging, MR 
spectroscopy (MRS) and PET imaging provide additional information which 
helps to refine the diagnosis of intrinsic brain tumours. Contrast enhancement 
can be a feature of low-grade (pilocytic astrocytoma and ganglioneuromas) as 
well as high-grade gliomas (WHO grade III anaplastic gliomas and WHO grade 
IV glioblastomas). Infiltrative low-grade (WHO grade II) astrocytomas do not 
usually enhance, whereas WHO grade II oligodendrogliomas can enhance. 
Higher-grade glial tumours (WHO grade III and IV) tend to have an elevated 
relative cerebral blood volume (rCBV) on PWI, a decreased ADC on DWI and 
increased choline turnover on MRS and PET imaging. A raised rCBV can, 
however, also be seen in low-grade oligodendrogliomas, particularly in those 
with a 1p/19q chromosomal translocation, which is associated with a better 
response to chemotherapy. PWI and DWI are useful in the differentiation of 
glial neoplasms from cerebral lymphoma, which has an increasing incidence in 
the immuno-competent population. DWI and PWI are also very useful in the 
differentiation of enhancing pseudo-tumoural lesion such as cerebral 
abscesses, tumefactive demyelination, pseudoprogression and radiation 
necrosis.  
Learning Objectives:
1. To appreciate the differential diagnosis of tumoural lesions in the diagnostic 
setting. 
2. To learn how to differentiate between tumoural and non-tumoural disease 
using DWI. 
3. To consolidate knowledge on how to combine DWI with other advanced MRI 
tools. 
A-309 16:28 
B. Grading and prognosis: role of perfusion imaging  
Y. Özsunar; Aydin/TR (yeldaozsunar@gmail.com) 
Perfusion imaging plays an important role in the characterisation and 
management of brain tumours. Low-grade brain tumours may transform into 
high-grade gliomas at some point, which is a transformation that is highly 
variable and difficult to predict in an individual patient. Conventional contrast-
enhanced computed tomography (CT) and magnetic resonance (MR) imaging 
are found to be insufficient to depict this transformation and angiogenesis and 




therefore to detect malignancy. However, perfusion imaging provides additional 
information over conventional imaging in terms of tumour physiology and 
haemodynamics, providing important biomarkers for malignancy and 
prognosis. Perfusion CT and MR perfusion techniques such as arteriel spin 
labelling and dynamic susceptibility-weighted perfusion imaging are more 
practical and widely used compared to nuclear medicine methods. These 
perfusion techniques should be considered and used in routine clinical workup 
of brain tumours to asses grading and prognosis.  
Learning Objectives:
1. To understand why perfusion imaging is routinely needed for brain tumours. 
2. To become familiar with principles, applications, and pitfalls of various 
perfusion imaging techniques. 
3. To consolidate knowledge of perfusion imaging for various brain masses 
that can be encountered in daily practice. 
Author Disclosure:
 Y. Özsunar: Research/Grant Support; funding from Adnan Menderes 
University Research Funding Programme. 
A-310 16:51 
C. Monitoring treatment: real or pseudo progression?  
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
Maximal safe resection, radiation therapy and temozolomide chemotherapy are 
the current standard of care for newly diagnosed high-grade gliomas. Still, 
HGG have a poor survival rate. A contributing factor to the poor survival is the 
inability of currently available imaging techniques to accurately delineate the 
tumour, with the result that targeted focal treatment my not be effective. 
Conventional imaging is not able to give an early assessment of the 
effectiveness of radiation and/or chemotherapy. In addition, conventional 
imaging has difficulties in differentiating pseudo-progression, which is a 
common phenomenon in conventional chemo-radiation therapy, from true 
progression. Early identification of patients who suffer from tumour recurrence 
can be of great advantage: it provides the opportunity to adjust individuals 
more rapidly, sparing patients unnecessary morbidity and delay in the initiation 
of other, maybe more effective, treatment. In recent years, different functional 
imaging approaches such as perfusion MRI, diffusion-weighted imaging and 
spectroscopy, have been complementarily used for imaging evaluation of 
treatment response. In this lecture, different advanced MR and CT imaging 
methods used to support differentiation between pseudo-progression and true 
tumour progression to assess treatment response will be discussed. In 
addition, a novel recently published promising technique, the parametric 
response mapping (PRM), a novel voxel-wise analytical method of monitoring 
physiological and environmental changes in a tumour volume during treatment 
will be presented and compared to the traditional methods used. Finally, the 
aim of the lecture is to consolidate the present knowledge and novel ideas in 
brain tumour imaging for assessment of pseudo-progression versus true 
tumour progression.  
Learning Objectives:
1. To understand the challenges and limitations of routine MRI in monitoring 
brain tumour treatment. 
2. To become familiar with the role of advanced imaging biomarkers for early 
assessment of treatment response. 
3. To learn how to integrate routine and advance MRI into clinical practice after 
tumour therapy. 
Panel discussion:  
What is the optimal role of radiology in a tumour  
board session?  17:14
16:00 - 17:30 Room I/K  
Head and Neck Imaging  
CC 1119  
How to perform and read a head and neck 
study (part 2)  
Moderator:  
S. Bisdas; Tübingen/DE 
A-311 16:00 
A. CT and MR perfusion study of the head and neck  
K. Šurlan Popovi; Ljubljana/SI (katarina.surlan@kclj.si)
The purpose of this lecture is to describe the role of functional radiological 
imaging modality-CT and MR perfusion in the evaluation of head and neck 
tumors. Conventional contrast-enhanced CT and/or MR imaging are the 
current standard techniques for the diagnosis and treatment evaluation of the 
head and neck tumors. However, this method is limited in its ability to depict 
the angiogenesis which is a hall-mark of tumor growth. Perfusion imaging 
provides a rapid evaluation of tissue perfusion and can be easily implemented 
in every head and neck CT or MR protocol. The determination of tissue 
perfusion is based on examining the relationships between the arterial, tissue 
and potentially the venous enhancement after the introduction of a bolus of 
contrast material. The quantification of the perfusion values helps to outline the 
malignant tissue as well as to differentiate recurrent disease from nonspecific 
post-therapeutic changes and can be used as a therapeutic monitoring tool 
during and after tumor therapy. 
Learning Objectives:
1. To learn how to perform proper CT/MR perfusion. 
2. To learn how to interpret the results. 
3. To understand which clinical and diagnostic dilemmas can be addressed 
with this technique. 
A-312 16:30 
B. MR diffusion study and how to interpret it  
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch) 
In recent years diffusion-weighted MRI (DWI) gained increasing importance 
and also acceptance in head and neck radiology. Although this functional 
technique is challenging due to air tissue interfaces, its ability to improve the 
diagnostic accuracy is widely accepted. DWI can be applied to detect lesions 
not only in adults, but also in children. It is helpful in lesion characterisation and 
has a great potential to differentiate recurrence from posttherapeutic changes. 
Initial promising results to improve lymph node staging however are difficult to 
reproduce. Image interpretation is performed qualitatively based on visual 
assessment of the high b-value images (b= 800-1000sec/mm2) and the 
corresponding apparent diffusion coefficient (ADC) map. Quantitative image 
analysis is based on the measurement of the underlying ADC value. Solid 
tumors including recurrences are bright on the high b-value images and dark 
on the corresponding ADC map, whereas posttherapeutic changes are bight 
on both the high b-value images as well as the ADC map. Cystic and necrotic 
lesions are typically dark on the high b-value image and bright on the ADC 
map. Furthermore, malignant lesions tend to have a lower ADC compared to 
benign and cystic lesions provided that no necrosis is present. Therefore, 
image interpretation always has to be performed together with morphological 
images to avoid misinterpretation of functional images.  
Learning Objectives:
1. To learn the technique and learn how to perform MR diffusion successfully. 
2. To learn how to interpret the results. 
3. To appreciate the pitfalls and advantages of this method. 
A-313 17:00 
C. PET/CT and MR/PET: the true added value of the method  
M. Becker; Geneva/CH 
PET/CT has established itself as a robust, rapid and reliable technique in head 
and neck oncology. It is mainly used to stage nodal disease, to detect distant 
metastases and synchronous tumours, to identify unknown primary tumours in 
patients with metastatic neck nodes, to assess treatment response and 
prognosis after chemoradiotherapy and for radiotherapy planning. MRI with 
diffusion-weighted imaging (DWI) is routinely used for the assessment of 
submucosal tumour spread, to stage nodal disease, to monitor treatment 
response and to detect recurrent disease. The information provided by PET/CT 
and MRI is often complementary and the recent implementation of hybrid 
MR/PET systems in clinical settings holds promise because it can combine 
morphologic, functional and molecular information. This lecture focuses on 
clinical applications of PET/CT and MR/PET in the head and neck. Current 
evidence about the combined use of PET/CT and MRI with DWI is discussed. 
The principles of MR/PET data fusion are summarised as well as current 
knowledge regarding the diagnostic performance of MR/PET in the head and 
neck. Typical radiologic findings of tumour manifestations are reviewed with 
particular emphasis on the early detection of lesions, their appearance on 
different imaging modalities and the added value of hybrid imaging techniques. 
The variable appearance of functional phenomena mimicking disease as well 
as the potential pitfalls of image interpretation and how to avoid them are 
equally addressed. Major emphasis will be put on how to report the findings in 
a comprehensive way.  
Learning Objectives:
1. To learn what additional information is acquired by PET. 
2. To appreciate the clinical importance of this examination. 
3. To learn how to interpret results and avoid mistakes. 




16:00 - 17:30 Room L/M  
Physics in Radiology  
RC 1113  
Novel developments in CT and their 
impact on dose  
Moderators:  
W. Stiller; Heidelberg/DE 
A.J. van der Molen; Leiden/NL 
A-314 16:00 
A. Impact of CT on patient dose  
R. Bly; Helsinki/FI (ritva.bly@stuk.fi) 
Methods to assess patient dose from CT and its importance for collective 
effective dose to population (population dose) will be presented. Patient dose 
from CT as an effective dose can be estimated using technical dose 
parameters, such as dose length product (DLP) and CT dose index (CTDI) and 
conversion factors. Technical dose parameters can also be used to define 
diagnostic reference values (DRL) that are used as a tool for assessing if CT 
procedures are optimised. Population doses from radiodiagnostic procedures 
in Europe were estimated for the first time in the recent DOSE DATAMED 2 
(DDM2) project (www.ddmed.eu) launched by the European Commission. 
Examples of calculation procedures for CT dose will be presented. Typical 
effective doses for some procedures will be presented as well as existing DRLs 
in Europe. The estimated population dose per caput in Europe is 1 mSv, which 
is lower than the corresponding dose in the USA (3 mSv) or Australia (1.7 
mSv). The highest average contribution is from CT, 56 %. There are high 
variations between countries in frequencies and typical effective doses. This 
presentation will review the available data in European countries using graphs.  
Learning Objectives:
1. To learn about the European-wide DoseDataMed2 survey. 
2. To understand the impact of CT practice on population exposure. 
3. To understand the role of diagnostic reference levels in CT. 
A-315 16:30 
B. New frontiers in CT: functional and spectral imaging  
A. Persson; Linköping/SE (anders.persson@cmiv.liu.se) 
Multi-energy and functional imaging CT has reached a robustness allowing the 
use of this new technology in clinical routine for a variety of different clinical 
questions. This presentation will discuss the basic principles and the strengths 
and limitations of the techniques. Implementations of multi-energy methods for 
material characterisation and of CT methods for functional imaging will be 
discussed. Contrary to normal single-energy CT systems, multi-energy CT 
scanners allow simultaneous scanning at two peak X-ray energies. When the 
attenuation is measured at two energies, their values are not exactly 
proportional to each other, which open new diagnostic possibilities. 
Measurements at two spectra can be achieved using multiple kVp and/or 
filtration or with detectors with energy discrimination. These methods have 
different pros and cons such as sensitivity to subject motion and dose 
efficiency. To be able to acquire functional data such as perfusion, images are 
acquired dynamically following the injection of a contrast agent and 
physiological models are used to convert the measured contrast agent 
concentration to perfusion estimates. Methods that acquire multiple images 
have the potential to increase the radiation dose to the patient, so CT protocols 
need to be optimised.  
Learning Objectives:
1. To learn about new developments in functional and spectral CT imaging. 
2. To appreciate the impact on patient dose. 
A-316 17:00 
C. New image reconstruction techniques  
J. Sijbers; Antwerp/BE (jan.sijbers@ua.ac.be) 
In computed tomography, 3D images are reconstructed from a number of x-ray 
radiographs that were acquired at different angles. Tomographic reconstruction 
relates to the generation of a 3D image based on these acquired radiographs. 
Most tomographic reconstruction methods are based on a technique called 
filtered back projection (FBP) in which a sharpened version of the radiographs 
are back projected to generate the 3D image. While it has been the standard 
reconstruction method, mostly due to its speed and good quality if many 
radiographs are available, iterative reconstruction methods are emerging. The 
reason for that is that FBP suffers from important disadvantages. In this talk, 
the basic concepts of iterative reconstruction are explained and its virtues are 
detailed. The flexibility of iterative reconstruction methods is demonstrated for 
the field of x-ray computed tomography. Finally an outlook is given with respect 
to future research on tomographic reconstruction.  
Learning Objectives:
1. To understand the principles of iterative reconstruction techniques in CT. 
2. To learn about advances in iterative reconstruction algorithms. 
3. To appreciate the impact on patient dose. 
16:00 - 17:30 Room N/O  
Interventional Radiology  
RC 1109  
Gynaecological and obstetrical 
haemorrhagic emergencies  
A-317 16:00 
Chairman's introduction  
A.-M. Belli; London/UK (Anna.Belli@stgeorges.nhs.uk) 
Interventional radiology (IR) has been increasingly applied in the management 
of obstetric and gynaecological haemorrhage. National reviews of maternal 
deaths from post-partum haemorrhage have recognised that maternal deaths 
may be prevented by IR and that all obstetric units should have protocols and 
arrangements in place to ensure appropriate and timely referral to IR. The 
important role that IRs play in the management of fibroids has also highlighted 
how these techniques can be applied to other gynaecological conditions which 
may result in haemorrhage. This session will start by describing which 
gynaecological disorders may result in haemorrhage and the technical aspects 
of treatment followed by the published evidence for embolisation. The session 
will then focus on obstetric haemorrhage, with an emphasis on prophylaxis and 
how women deemed at high risk for haemorrhage might be managed safely. 
The techniques used for prophylaxis of haemorrhage will be described in detail 
and the published data presented. The final presentation will concentrate on 
the technical aspects of embolisation when haemorrhage has occurred to 
ensure the best results by knowing the relevant anatomy and appropriate 
technique of embolisation. The published evidence of the results of 
embolisation in PPH will be presented. These presentations will be followed by 
a panel discussion on how IRs can reduce the radiation dose whilst 
simultaneously ensuring successful outcomes for their therapies, an important 
issue in a young and fertile group of women.  
Author Disclosure:
 A.-M. Belli: Advisory Board; Boston Scientific. Investigator; Covidien, 
Eurocor, Bayer. 
A-318 16:05 
A. Etiology and treatment of benign and malignant gynaecological 
causes of massive bleeding  
O. Pellerin; Paris/FR (olivier.pellerin@egp.aphp.fr) 
Gynaecologic massive bleeding related to benign and malignant causes is 
under the scope of all radiologists because of being diagnostic and also 
because of its implication in interventional radiology procedures. The causes 
are uterine fibroids (UF) and post-partum hemorrhage (PPH). However, 
oncologic disease, arterio-venous abnormalities, or iatrogenic injuries are less 
commonly known to be eligible for embolisation procedures. Usually, surgical 
homeostasis attempts or radical hysterectomy is preferred to embolisation 
procedures. Despite the good clinical outcome for hysterectomy and the 
hazardous success rate of conservative treatment, both are unsatisfactory to 
patients. Pelvic artery embolisation (PAE) could dramatically change the 
patients' clinical issue. The purposes of this lecture are to: revise the pelvic 
arterial anatomy (possible arterial anastomosis or variation); outline the 
aetiology of non-obstetric massive menometrorrhagia; expose the typical 
clinical presenting features; describe the imaging appearances of the 
etiologies; and discuss patient section, procedure technique, pitfalls and 
complications.  
Learning Objectives:
1. To learn more about causes of massive bleeding due to gynaecological 
disorders. 
2. To learn about diagnostic imaging and therapeutic embolisation. 
3. To learn about published results obtained through embolisation. 
A-319 16:28 
B. Can we prevent post-partum haemorrhage  
J.K. Gupta; Birmingham/UK (j.k.gupta@bham.ac.uk) 
In my lecture, I shall identify a patient at risk for post-partum haemorrhage and 
the obstetric complications that can arise as a result. I shall indicate how to 
become familiar with preventive measures and medication, and discuss more 




about techniques for invasive prevention and the role of uterine artery 
embolisation as a possible preventive technique  
Learning Objectives:
1. To learn how to identify a high-risk patient. 
2. To become familiar with preventive measures and medication. 
3. To learn more about techniques for invasive prevention. 
4. To learn about the results obtained through preventive techniques. 
A-320 16:51 
C. Treatment of post-partum haemorrhage  
A. Krajina, I. Kalousek; Hradec Králové/CZ (antonin.krajina@fnhk.cz) 
Obstetric haemorrhage occurring mainly in the postpartum period is a 
significant cause of maternal morbidity and death. Blood loss of over 500 and 
1000 ml after vaginal delivery or caesarean section, respectively, complicates 
4% of deliveries. Major blood loss of more than 1000 ml occurs following less 
than 1% of all deliveries. The causes include uterine atony, retained placenta 
products, placental abnormalities, uterine rupture, lower genital tract laceration, 
cervical ectopic pregnancy and coagulopathies. Generally, treatment is based 
on administration of uterotonic drugs, vaginal packing, surgical ligation of 
uterine arteries and even hysterectomy is sometimes needed. Transcatheter 
embolisation of uterine, pudendal, vaginal arteries and ovaries is considered to 
be superior and should be the first-line treatment for intractable obstetric 
haemorrhage where interventional radiology is available. Angiography reveals 
extravasation of contrast agent in more than 50% of these patients. The most 
frequent extravasation is from vaginal artery, and then from pudendal and 
uterine arteries. Depending on the extravasation location and haemodynamic 
stability of a patient, 5 F catheters or coaxial microcatheter technique is utilised 
for catheterisation. Gelatin foam, microparticles acrylic glue and microcoils are 
the most frequent embolic agents. The embolisation procedure usually does 
not require general anaesthesia and can be repeated if bleeding continues. 
Primary success rate in bleeding control is reported from 80 to 90 %. The most 
commonly reported long-term side effects after embolisation were transient 
buttock numbness and urinary frequency. The transcatheter pelvic artery 
embolisation for obstetric intractable bleeding is a fertility-preserving alternative 
to hysterectomy.  
Learning Objectives:
1. To learn about clinical evaluation of post-partum haemorrhage. 
2. To become familiar with relevant anatomy. 
3. To understand catheterisation and embolisation techniques. 
4. To become familiar with results of embolisation. 
Panel discussion:  
How can radiation doses be reduced during treatment? 17:14 
16:00 - 17:30 Conf. Room M3  
Head and Neck  
RC 1108  
Skull base lesions: imaging studies and 
differential diagnosis  
Moderator:  
S. Kösling; Halle a.d. Saale/DE 
A-321 16:00 
A. Anterior cranial fossa with special emphasis on olfactory apparatus 
lesions  
T.P.J. Duprez; Brussels/BE (thierry.duprez@uclouvain.be) 
Medical imaging has nowadays integrated the diagnostic armamentarium of 
anosmic patients regarding not only qualitative assessment of the olfactory 
tract, but also quantitative evaluation of olfactory bulb volumes which are 
known to closely correlate to the olfactory function. Many clinical studies on 
various pathological conditions have evidenced the value of such 
measurements in the workup of olfactory dysfunction for both aetiologic and 
prognostic purposes. Imaging workup also plays a role in the medico-legal 
evaluation of post-traumatic anosmia together with electrophysiological and 
clinical olfactory tests. Technical improvements in fibre tracking (FT) using 
diffusion-tensor imaging (DTI) and appropriate designs of olfactory stimulation 
at BOLD-based functional MRI (fMRI) are expected to allow insights into the 
neurophysiological processes and circuitry of olfaction in the very near future. 
Imaging workup of the anosmic patients will be the cornerstone of this lecture. 
The relevance of the different imaging techniques will be detailed. Beyond the 
workup of anosmia, a comprehensive overview of the most common lesions of 
the olfactory tract seen in clinical practice will be given. Additional review of 
lesions observed at the anterior cranial fossa in the near vicinity of the olfactory 
tract will be done, which comprehensively includes all commonly observed 
developmental, traumatic, inflammatory and neoplastic conditions not arising 
from the olfactory tract. Their potential impact on the olfactory function or on 
other sensory/neurological functions will be underlined. Clues to 
clinical/radiological differential diagnoses of the most common conditions and 
radiological features of the anterior cranial fossa will be highlighted.  
Learning Objectives:
1. To learn the imaging techniques and anatomy of the anterior skull base with 
an emphasis on the olfactory apparatus. 
2. To become familiar with the imaging findings. 
3. To learn how to differentiate between lesions in the anterior skull base. 
A-322 16:30 
B. Middle cranial fossa pathologies  
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
The central skull base, the floor of the middle cranial fossa, has a complex 
anatomy and is pierced by a variety of foramina and canals providing 
crossroads for spread of disease between the extra-cranial head and neck and 
the intracranial compartment. Disease spread into the intracranial compartment 
indicates a dismal prognosis, as often it becomes inoperable due to 
involvement of vital structures including cranial nerves, carotid artery and/or 
brain parenchyma. Imaging plays a pivotal role in the assessment of these 
structures which are not amenable to clinical inspection and can dramatically 
change the patient's management. In this complex anatomical area, CT and 
MR have a complementary role in providing a comprehensive roadmap for 
treatment planning. Of major importance is the pterygopalatine fossa, the 
cavernous sinuses and orbital apex. The former, lying between the pterygoid 
plates and the maxillary sinus, is a major crossroad between the intra- and 
extracranial compartments and should be carefully inspected. Pathologies 
affecting the central skull base are varied and may originate from the skull 
base proper, from the middle cranial fossa or from the extracranial head and 
neck. By looking at the centre of the lesion, its tissue characteristics and 
pattern of growth, it is often possible to provide a useful differential diagnosis 
and, most importantly, to map the lesion's extent. Here, we present a 
radiologist-friendly approach to central skull base pathology highlighting the 
most important features in the differential diagnosis and treatment planning.  
Learning Objectives:
1. To become familiar with imaging strategies and anatomy of the middle 
cranial fossa. 
2. To learn about imaging findings of common lesions. 
3. To learn how to differentiate between the lesions in middle cranial fossa. 
A-323 17:00 
C. Posterior cranial fossa pathologies  
H. Tanghe; Rotterdam/NL (tanghe@planet.nl) 
1. The jugular foramen: The jugular foramen is an opening in the skull base. 
The radiologic evaluation requires high-quality imaging with CT and MR. 
Angiography is reserved for preoperative embolisation. It is important to 
recognise the "pseudo lesions". The most common tumour of the jugular 
foramen is the paraganglioma. The second is the schwannoma of the lower 
cranial nerve, and the jugular foramen meningioma is the third most common. 
The differential diagnosis shall be discussed. 2. The cerebellopontine angle 
(CPA) and the internal auditory canal (IAC): The IAC is a bony conduit for 
several nerves and a vessel, the neurovascular bundle. The CPA is a cistern of 
the peripheral cerebral spinal fluid, and several anatomical structures pass 
through this. It is also the place of some frequent disease processes. Most of 
the lesions in the CPA are benign tumours with order of frequency: vestibular 
schwannoma and meningioma. The third most common lesion is a benign 
cystic lesion: the epidermoid cyst. In the IAC, you can encounter the same 
benign tumoural lesion as in the CPA, but also inflammatory lesions, viral 
lesions and malignant lesions. Why is it important in your imaging protocol of 
the IAC and CPA region to use gadolinium? The differential diagnosis of 
different lesions shall be discussed.  
Learning Objectives:
1. To learn about the imaging techniques and anatomy in the posterior cranial 
fossa. 
2. To become familiar with the imaging findings of common posterior cranial 
fossa pathologies. 
3. To learn how to differentiate between the lesions in the posterior cranial 
fossa. 




16:00 - 17:30 Board Room A  
Radiographers  
RC 1114  
Evidence-based practice in medical 
imaging: a tool to improve the quality of 
care
Moderators:  
C.J. Herold; Vienna/AT 
D. Katsifarakis; Athens/GR 
A-324 16:00 
A. The radiographer as the interface between patient and technology: 
clinical judgement and professional accountability  
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt) 
Health care is characterised by several specific features making it different 
from traditional markets. Two of the key features are: the impossibility of 
patients to make choices, due to asymmetry of knowledge between them and 
their health-care providers; the fact that patients create an agency relationship 
with health-care providers, delegating to them the decision about the care 
delivered. Due to these characteristics and to the fact that patients are fragile 
when they need care, there is a natural tendency for patients to rely on health-
care professionals. It is in this complex socio-technical environment that 
radiographers must be aware of their roles and responsibilities and ensure 
professional autonomy and accountability; demonstrate an ethical and 
knowledgeable understanding of the profession; apply professional practice in 
securing, maintaining or improving health and well-being; develop knowledge, 
skills and competences that underpin their education and training, contributing 
to the wellbeing of the patient; understand that professional advancement 
arises out of evidence-based practice and is acquired through focused 
research. This demands for a focus on patient care and safety, based on high 
professional standards. EBP is the best way to achieve this desideratum, as it 
combines the best research evidence with clinical knowledge and expertise, 
addressing the patient in a holistic way. Since the radiographer is the ultimate 
interface between patient and technology, it is crucial to create a real teamwork 
concept, using guidelines for the roles and responsibilities of each team 
member as the pathway to minimise practice error, maximising patient and 
staff safety.  
Learning Objectives:
1. To understand the importance of the radiographer in the application of 
evidence-based practices. 
2. To appreciate the need for systematic evaluation of health care technology. 
3. To learn about the importance of critical assessment of research data and 
clinical guidelines. 
A-325 16:30 
B. Justification and optimisation in medical imaging  
J. Santos; Coimbra/PT (joanasantos@estescoimbra.pt) 
The use of ionising radiation in medical exposures is well documented across 
countries. Recent studies indicate that a substantial fraction (20 to 50%) of 
these procedures is unnecessary when taking into consideration patient clinical 
indication. Defensive medicine, economic interest, poor patient clinical 
information, patient pressure and the lack of knowledge about other alternative 
procedures, taking into account the benefits and risks, are the principal causes 
of unnecessary radiological examinations. Patients must be referred to a 
medical imaging department for an examination that should be justified 
according to clinically appropriate image criteria and informed of the potential 
benefits and risks. Following justification, the optimisation of practice is 
essential to ensure the minimal exposure of radiation dose to the patient whilst 
diagnostic efficacy is maintained. The principal aim of optimisation is getting a 
narrower dose distribution, with lower mean and 75th percentile values of the 
diagnostic reference level. Optimisation processes need to consider several 
factors including the type of examinations, body region, clinical information, 
available equipment technology and image processing tools. To implement this 
process, a multidisciplinary teamwork is essential where radiographers, being 
the pivot between patient and technology, have an essential role. To 
understand and apply optimisation procedures, radiographers should be aware 
of the international guidelines, standards and directives. All medical imaging 
procedures must be audited to analyse if the workflow processes (referral, 
justification, optimisation and radiation protection principles) are according to 
the recommendations to create a radiation protection safety culture.  
Learning Objectives:
1. To learn about developing and consolidating approaches to justification in 
medical imaging. 
2. To learn about current optimisation in medical imaging. 
3. To become familiar with international recommendations, standards and 
directives. 
A-326 17:00 
C. Service development through evidence-based approaches  
E. Metsala; Helsinki/FI (eija.metsala@metropolia.fi) 
Although we are approaching the year 2014, a lot of clinical radiography is not 
based on best evidence. Lot of clinical decision-making is based on, for 
example, traditional practices that we cannot argue as being the best possible 
ones. In this presentation, barriers to using research and other sources of 
evidence and facilitators of evidence-based (EB) radiography are described. 
The role radiographers have in developing EB guidelines and procedures may 
vary according to educational level and work description. Developing EB 
guidelines is not the work of every radiographer, but obeying them is. The 
speaker gives some suggestions on what to do in a situation if there are no EB 
guidelines and procedures in ones' country or institution and no group that 
develops them. With the framework of "the new work order" and increasing 
implementation of new work processes, professionals are faced with new 
modes of collaboration requiring communicative skills as well as multi-
professional competencies between all the stakeholders across the hospital. 
Some evidence about the consequences of ineffective communication in the 
field of radiography is presented. In addition to benefits associated with the 
procedure of clinical audit, uniform good quality protocols for examinations and 
uniform national/international criteria help to perform comparisons between 
radiology units. Clinical audit also works as an educational tool and as a 
feedback tool for the staff on their performance. It also points out the need for 
corrective actions.  
Learning Objectives:
1. To appreciate the challenges in implementing evidence-based approaches 
in the radiology department. 
2. To appreciate the radiographers' role in developing clinical guidelines and 
procedures. 
3. To understand the importance of enabling effective communication between 
stakeholders across the hospital. 
4. To learn about the importance of audit practices as part of evidence-based 
service development. 
16:00 - 17:30 Room P  
EDiR Session  
European Diploma in Radiology: and the 
beat goes on!  
A-327 16:00 
Chairman's introduction: setting the scene for the European Diploma  
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
Initiatives from professional organisations are probably the most powerful 
engines for the construction of Europe, and in many cases open the road for 
legal and political advances. Many medical specialties felt that there was a 
need for the harmonisation and standardisation of medical training over 
Europe. The ESR has shared this opinion and has elaborated a unanimously 
appreciated training curriculum, which is constantly updated. Establishing the 
EBR (European Board of Radiology), with the mission to organise a European 
diploma was the logical next step. Today, 10 examinations have already been 
organised and more that 350 candidates from European countries and abroad 
have applied. The trainee who passes the examination proves his professional 
skills and has reached the objectives assigned in the curriculum. In this 
session, we will explain how ESR organises the diploma. We will review, 
capitalising on our current experience, the main lessons learnt from the past 
editions, the keys for success and reasons for failure, as seen by the 
examiners. We will also learn about the "Diploma adventure", from the point of 
view of a successful candidate.  
Session Objectives:
1. To learn more about the organisation of the European Diploma (EDiR). 
2. To appreciate the benefits of taking the examination. 
3. To be informed about the experience acquired by the examiners and the 
candidates. 
4. To understand the development of the EDiR in Europe and abroad. 





Who really needs a European Diploma in Radiology?  
W. Schima; Vienna/AT (wolfgang.schima@khgh.at) 
National radiology training programmes in Europe differ to a large extent, 
regarding length of training, content, and the presence or absence of a national 
board examination for certification. Thus, for cross-border radiologic activities, 
the level of training and expertise applying to radiologists is difficult to assess 
under these circumstances. There is an increasing number of medical 
subspecialties, which organise European diplomas. More than 20 
subspecialties (e.g. anaesthesiology, ophthalmology, urology, etc). organise 
European examinations, which are well received among the respective 
communities. Growing numbers of residents in training successfully stand this 
test of knowledge and practical skills. Recognition of European diplomas by 
national authorities is an issue, which will increase the level of acceptance. The 
present status of the recognition process in European countries will be 
summarised.  
Learning Objectives:
1. To learn why the European Diploma in Radiology is useful in the era of 
cross-border radiology and teleradiology. 
2. To understand how EDiR contributes to the harmonisation of the training 
programmes across Europe and, at the same time, sets a standard of quality. 
3. To appreciate the experience from other specialties, demonstrating that 
European diplomas are a general trend in medical specialties. 
A-329 16:25 
Learn from past mistakes: lessons to improve your preparation and 
performance  
S. Barter1, L. McKnight2; 1Cambridge/UK, 2Langland/UK
(suebarter@btinternet.com) 
Case material for the diploma will test knowledge in general radiology at a 
standard to be expected at the end of training as outlined in the ESR 
curriculum. All ten ESR-recognised subspecialty areas of the curriculum will be 
tested. The written exam comprises two computer-based sections, a multiple 
response section, and a short case section. There will be 75 multiple response 
questions. These questions comprise both multiple options format, a single 
stem with 5 answer options, and short imaging studies where candidates are 
asked to either annotate the image from a drop-down menu, or select the 
radiological features displayed or differential diagnosis from the options given. 
A special scoring system has been developed to prevent guessing. The short 
case section comprises 4 or 5 case-based questions. You may practice using 
the self-assessment tests on the ESR website which follow the same format as 
the written examination. For the oral cases, you must have a systematic 
method and perform under pressure, which takes practice. You may rehearse 
with experienced radiologists who feedback on your performance. You can 
break a radiology report into 3 areas, observations, interpretation and 
conclusion. Conclusions should take into account the clinical information. 
Candidates often forget this under pressure, so ask for it to be repeated. Your 
differential diagnosis should be logical and comprehensive. The 3 commonest 
causes of an abnormality is a good topic to revise. Suggest if further imaging 
tests are indicated and give an indication of urgency. Each case is marked 
separately.  
Learning Objectives:
1. To learn how questions are formulated and selected for the written and oral 
examinations. 
2. To become aware of some examples of the most common errors made by 
the candidates. 
3. To learn the best approach to the oral examination and what examiners 
really expect from the candidates. 
4. To learn some tricks that may help candidates prepare for EDiR. 
Author Disclosure:
 S. Barter: Board Member; Scientific Board EBR. 
A-330 16:55 
We made it! The Turkish Board of Radiology values EDiR  
S.S. Özbek; Izmir/TR (sureyya.ozbek@ege.edu.tr) 
As a well-known statement in the academic world of education, "assessment 
drives learning". With the help of carefully prepared and performed 
examinations, it is possible to emphasise and instill the training curriculum. 
Due to different reasons, training of radiology in European countries is highly 
varied. Like in our experience in Turkey, a central examination system, 
accompanied by a neatly prepared training charter and curriculum, is a good 
starting point to solve the problem. We believe that a common European 
assessment system like EDiR will contribute a great deal to the harmonisation 
of radiological training and establishment of quality standard in every country. 
The need for harmonising the training is not unique to radiology. This is why in 
more than 30 medical disciplines, European diploma examinations are now 
being organised. Furthermore, in some disciplines like urology, annual and 
online "In-Service Assessment" of residents and practising urologists allows 
the participants to evaluate their current knowledge base against the current 
European standards, and also provides the trainers and directors knowledge 
about the teaching and learning process in education centres. Although there 
are huge diversities among different European centres, the urgent need of 
harmonising radiology training and setting a standard of quality are felt by all 
radiologists in Europe. Establishing and institutionalising a common 
assessment system in European radiology appears to be the shortest way to 
reach this goal. This is why we should support "European Diploma in 
Radiology" by any means and work hard to promote its recognition throughout 
the continent.  
Learning Objectives:
1. To learn the reasons why the Turkish Board of Radiology has decided to 
recognise the EDiR as equivalent to the first part of their national examination. 
2. To understand how EDiR contributes to the harmonisation of training 
programmes across Europe and, at the same time, sets a standard of quality. 
3. To appreciate the experience from other specialties, demonstrating that 
European diplomas are a general trend in medical specialties. 
A-331 17:15 
I did it! Lessons from a successful candidate  
J. Muscat, A. Mizzi; Birkirkara/MT (jessica2860@gmail.com) 
The purpose of this lecture is to outline a candidate's incentive for taking the 
exam, share my EDiR experience and discuss the EDiR's 'returns' from a 
candidate's point of view. Hailing from the small island state of Malta, local 
postgraduate training is a concept almost as new as the EDiR itself. The 
October 2012 sitting of the EDiR happened to fill in the gap just prior to the UK 
Final FRCR Part 2B I was preparing to take in the spring. Preparation for the 
EDiR went, quite simply, in tandem with that for the FRCR consisting of 
revision cases - online and in textbooks - of imaging-by-system and the vitally 
important "hot" seat sessions - mimicking the oral exam - with consultant 
radiologists. Another factor that influenced my taking the EDiR was undeniably 
the venue - the Journées Françaises de Radiologie in Paris. Though 
postgraduate training in radiology may vary, as aptly put by Prof Maximillian F. 
Reiser, the aim of the EDiR is "the enhancement and harmonisation of 
radiological training in Europe": the EDiR can now be considered a potential 
European certification in radiology and as such an opportunity not to be 
missed!  
Learning Objectives:
1. To understand the general atmosphere of an EDiR exam from the 
perspective of a candidate. 
2. To understand the candidate's motivation for applying for the examination. 
3. To appreciate what the real and potential benefits of taking the examination 
are. 
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08:30 - 10:00 Room A  
Interactive Teaching Session  
E³ 1220  
Pitfalls in brain imaging  
A-332 08:30 
A. CT  
L. van den Hauwe, J.W. Van Goethem, C. Venstermans, F. De Belder, 
T. van der Zijden, M. Voormolen, P.M. Parizel; Antwerp/BE
(lucvdhauwe@mac.com) 
The majority of emergency CT studies reported by junior radiologists or 
general radiologists out-of-hours comprise brain scans. Brain CT studies are 
often performed to detect acute life-threatening abnormalities, such as stroke, 
intraparenchymal or subarachnoid haemorrhage, cerebral edema, etc. 
Misrecognition of these often subtle, but life-threatening abnormalities can lead 
to inappropriate patient management and worsen patient outcome. Errors in 
interpretation can generally be categorised as either perceptual or cognitive in 
nature. Perceptual errors are those in which the radiologist does not see the 
abnormality, resulting in a false-negative interpretation (e.g. basilar artery 
thrombosis, deep cerebral venous thrombosis, PRES,…). Cognitive errors, on 
the other hand, are those in which an abnormality is identified but the meaning 
or significance of the abnormality is not recognised. Cognitive errors can result 
in false-positive interpretation if, for example, a normal anatomic variant is 
mistaken for a pathologic condition. While the ͒more common normal variants 
and artefacts often do͒ not present a problem to experienced clinicians and 
neuroradiologists, less experienced individuals should beware of these 
diagnostic hazards. To reduce false-negative and false-positive reporting, a 
checklist of the review areas (blind spots) to be verified on any brain CT scan 
will be offered and the most frequent normal variants will be discussed.  
Learning Objectives:
1. To learn about common pitfalls in CT evaluation of the brain. 
2. To become familiar with anatomical variants potentially mimicking disease. 
A-333 09:15 
B. MRI  
D. Prayer; Vienna/AT (daniela.prayer@meduniwien.ac.at) 
Pitfalls in brain imaging comprise perceptual or cognitive errors of 
interpretation of imaging findings. Errors of perception refer to a missing of a 
pathology that is present on an image, while cognitive errors consist of a wrong 
interpretation of a seen structure or pathology. Interpretation may be false 
negative or false positive. In addition, a wrong conclusion may be drawn 
resulting from missing, incomplete or false clinical information, or as a 
consequence of a lack of knowledge of differential diagnoses. Perception 
errors are frequently the consequence of incomplete examination protocols 
where lesions are missed (for instance, acute ischaemic changes without the 
use of diffusion-weighted Imaging) or signals, for instance, flow-related 
phenomena are misinterpreted. Asymmetric positioning of the patient`s head 
may also lead to misinterpretation of side differences, especially in the 
temporal lobe. Another source of perception errors might be reduced attention 
(especially at night shifts) and have been proved to occur in regions that are 
"potential blind spots", as the sulci, cavernous sinus, Meckel cave, dural 
sinuses, brainstem, and skull base foramina. Perceptual errors may be avoided 
by following a checklist when reading images. All sequences should be used 
for comparison of signal intensities to distinguish artefacts from pathology. 
Another very important fact to avoid misinterpretation lies in a profound 
knowledge of morphologic and metabolic age-related changes of the brain and 
of anatomical normal variants (such as, for instance, accentuated Virchow 
Robin spaces in certain locations).  
Learning Objectives:
1. To learn about common pitfalls in MRI evaluation of the brain. 
2. To become familiar with anatomical variants potentially mimicking disease. 
08:30 - 10:00 Room B  
Abdominal Viscera  
RC 1201  
The many faces of benign liver lesions  
Moderator:  
A. Ba-Ssalamah; Vienna/AT 
A-334 08:30 
A. Vascular  
M. Karcaaltincaba; Ankara/TR (musturayk@yahoo.com) 
Benign hypervascular focal liver lesions include haemangioma, focal nodular 
hyperplasia, hepatic adenoma, angiomyolipoma, nodular regenerative 
hyperplasia and haemangioendothelioma. Tips for differentiation of benign and 
malignant hypervascular liver lesions will be presented. US, CT and MRI 
findings will be summarised with emphasis on typical and atypical findings. 
Liver imaging is important for noninvasive diagnosis of hypervascular benign 
liver lesions and confidence in diagnosis can obviate biopsy in routine clinical 
practice.  
Learning Objectives:
1. To become familiar with typical and infrequent manifestations of benign 
hypervascular focal liver lesions. 
2. To learn how to differentiate between benign and malignant lesions. 
3. To appreciate the limitations and complementary roles of CT and MR. 
A-335 09:00 
B. Cystic  
G. Brancatelli; Palermo/IT (gbranca@yahoo.com) 
Cystic liver lesions can be classified based on their nature as benign and 
malignant. In the benign category are, among others, developmental and 
infectious/inflammatory cysts, while neoplastic cyst can be subdivided into 
primary and secondary. Developmental cysts originate from abnormal ductal 
plate malformation and consist of hepatic (bile duct) cyst, bile duct 
hamartomas, Caroli's disease and polycystic liver disease. 
Infectious/inflammatory cysts include, among others, abscesses (pyogenic and 
amoebic) and hydatid cysts. Primitive neoplastic cystic lesions are 
cystoadenoma and cystoadenocarcinoma. Secondary lesions can originate 
mostly from mucinous tumours such as colon and ovary. The role of cross-
sectional imaging in the detection and characterisation of these entities will be 
discussed, with an emphasis on the differential diagnosis with CT and MR 
Imaging.  
Learning Objectives:
1. To understand the features of congenital and infectious cystic liver lesions. 
2. To learn how to differentiate between benign and malignant cystic lesions. 
Author Disclosure:
 G. Brancatelli: Speaker; Bayer. 
A-336 09:30 
C. Hepatocellular  
F. Caseiro-Alves; Coimbra/PT (caseiroalves@gmail.com) 
Benign hepatocellular neoplasms are being recognised with increased 
frequency using cross-sectional imaging. One of the main goals is to be able to 
make a clear-cut differential diagnosis between focal nodular hyperplasia 
(FNH) and hepatocellular adenoma (HCA) since patient management is 
substantially different. Despite the sound knowledge acquired in the last few 
years about the morphological features of FNH using various cross-sectional 
imaging techniques, new players in the field have arisen such as diffusion-
weighted MR imaging (DWI) and use of hepatobiliary contrast agents. These 
new biomarkers offer a different view over FNH and allow a more accurate 
characterisation even in more atypical cases. Concerning HCA, current 
knowledge implies that the sub-types of this neoplasm should be known since, 
again, patient management differs and these patients are no longer seen as 
compulsory surgical candidates. These sub-types will be further discussed and 
the role of imaging for risk stratification (haemorrhage and malignant 
transformation) will be addressed. Further, illustrative cases of combined 
FNH/HCA cases will be demonstrated along with the main imaging clues for a 
successful differential diagnosis.  





1. To understand the typical aspect of hepatocellular benign lesions on US, CT 
and MRI. 
2. To learn when a liver specific contrast medium can help us in the proper 
characterisation of hepatocellular benign liver lesions. 
3. To understand the classification of liver adenomas, prognosis and imaging 
characteristics. 
Author Disclosure:
 F. Caseiro-Alves: Advisory Board; Euromedic. Consultant; Bayer Schering. 
08:30 - 10:00 Room C  
Modern Imaging of the GI Tract  
CC 1221  
Imaging the postoperative patient  
Moderator:  
M. Hellström; Gothenburg/SE 
A-337 08:30 
A. What the surgeon does: surgical procedures and normal postoperative 
anatomy  
M.M. Maher; Cork/IE (m.maher@ucc.ie) 
In most upper and lower gastrointestinal surgical units, imaging is frequently 
required in patients suspected of post-operative complications or in whom 
recovery would appear delayed. Interpretation of these studies can be 
challenging and requires an appreciation of expected imaging appearances of 
the post-operative abdomen as well as the anatomy of common surgical 
procedures. Imaging findings in the post-operative abdomen can vary 
significantly, depending on the surgical procedure performed and this can 
result in pitfalls for the radiologist.  
Learning Objectives:
1. To understand common surgical procedures performed in the esophagus, 
stomach, small bowel and colon. 
2. To appreciate the normal appearance of an enteric anastamosis on 
fluoroscopic and cross-sectional imaging. 
3. To understand the normal appearances of haemostatic packing and other 
surgical devices on radiological investigations. 
A-338 08:50 
B. Do I need to re-operate? Postoperative imaging and immediate 
complications  
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk) 
Imaging in the early postoperative period is complex. It is essential for 
radiologists to know the new anatomic arrangement after surgery and to 
understand the range of normal postoperative appearances. This latter aspect 
can be particularly difficult, because the radiological findings are affected by 
the type of operation performed (open vs. laparoscopic) and the complexity of 
the surgery (such as the presence of adhesions or haemorrhage) as well as 
the underlying comorbidity of the patient. Patients may be considered in 4 
broad categories: haemodynamically unstable patients who may be bleeding; 
patients with distension or unopened bowels who may have obstruction or 
ileus; patients with sepsis in whom to search for an intraabdominal collection or 
leak; and patients who do not follow an expected recovery for which the cause 
is unclear. CT is the primary imaging technique, with ultrasound reserved 
predominantly for liver and renal transplants or assessment of perihepatic 
collections, and fluoroscopy for routine postoperative assessment of upper and 
lower GI anastomoses. CT protocols should be optimised to detect particular 
complications with positive luminal contrast for assessment of anastomotic 
leaks (8%), triple phase imaging for bleeding (without positive oral contrast) 
and delayed phase imaging to detect ureteric injury. Since each operation has 
a specific range of expected complications, these should be considered when 
deciding on the protocol and in light of the patient's clinical status. Excellent 
communication with the surgical team is required to make an accurate 
diagnosis and in particular where haemostatic compound or mesh for hernia 
repair was used.  
Learning Objectives:
1. To understand the best imaging options for investigating suspected 
postoperative complications. 
2. To appreciate the normal appearances of the abdomen and pelvis after 
surgery, in particular with regard to free fluid, haematoma and free gas, and 
when to suspect complications. 
3. To become familiar with the radiological appearances of common and more 
unusual post-operative complications and their interventional radiological 
management. 
Author Disclosure:
 D.J.M. Tolan: Equipment Support Recipient; Vital Imaging. Speaker; Bracco. 
A-339 09:10 
C. It still hurts: follow-up imaging and long-term complications  
L. Curvo-Semedo; Coimbra/PT (curvosemedo@gmail.com) 
Radiologists should be aware of the newer surgical techniques and expected 
post-operative alterations, to yield a correct interpretation of a post-surgery 
imaging examination, thus being able to differentiate a normal post-operative 
ﬁnding from a potential complication. In this setting, it is crucial to perform a 
technically adequate imaging examination, so that post-operative anatomical 
and functional ﬁndings may be evaluated. Therefore, the aim of this lecture is 
to give an overview of the contribution of various imaging modalities in the 
diagnosis of late post-operative complications following GI tract surgery. It will 
include a mention of the technical issues that need to be considered to achieve 
better diagnostic accuracy, as well as a description and illustration of the main 
imaging findings of late post-operative complications. Those include disease-
related (recurrence for malignancy or inflammatory disease) and procedure-
related (anastomotic strictures, internal herniation, adhesions and 
intussusception, among others) complications. Focus will be placed on cross-
sectional imaging techniques, which at present constitute the workhorse for 
detecting and characterising late post-operative complications after GI tract 
surgery. In this way, imaging has an obvious and pivotal role in planning 
therapy, since some late complications are usually treated in a conservative 
way while others require a surgical approach.  
Learning Objectives:
1. To become familiar with the long-term complications of surgery to the GI 
tract. 
2. To appreciate the appropriate use of imaging in the assessment of long-term 
complications. 
3. To learn about the radiological investigation of suspected postoperative 
adhesions. 
A-340 09:30 
D. Interactive case discussion  
M. Hellström; Gothenburg/SE 
08:30 - 10:00 Room D  
Chest  
RC 1204  
Lung cancer: staging and personalised 
imaging in 2014  
Moderator:  
E.J.R. van Beek; Edinburgh/UK 
A-341 08:30 
A. Lung biopsy: who, how and why  
F. Laurent; Pessac/FR (francois.laurent@chu-bordeaux.fr) 
Lung biopsy of a suspected lung cancer remains a well-established technique 
for histopathologic examination in patients with suspected lung cancer. 
Complications can nevertheless occur and therefore indication should be given 
after carefully balancing the benefits and drawbacks for a particular patient. 
The method should be clearly considered complementary to alternate methods 
of tissue sampling, fiberoptic endoscopic, mediastinoscopy or US-guided 
endoscopy, surgical biopsies and resection during a multidisciplinary 
discussion. Several steps are needed in the preparation of the biopsy 
procedure, including informed consent, management of anticoagulation and 
anti-platelet medications, imaging assessment of the lesion and its 
environmental lung, and planing of the needle trajectory procedure. The choice 
of the guiding method and the most appropriate biopsy needle is still largely 
dependent on local skills and habits. CT-guided percutaneous biopsies using 
coaxial automated core biopsy needles offer many advantages. Needle 
manipulation can help to reach difficult targets. Participation of the patient is 
needed in terms of respiratory manoeuvres and breathhold. Complications may 
occur such as pneumothoraces haemorrhage and air embolism. Knowledge of 
the respective risk factors and the potential method of prevention or treatment 
by operators are essential.  
Learning Objectives:
1. To learn when biopsy is necessary in patients with lung cancer. 
2. To understand the importance of molecular diagnostic testing in lung cancer. 
3. To appreciate the different techniques available for obtaining a histological 
diagnosis in patients with lung cancer. 





B. Pre and post-treatment tumour assessment  
N. Tacelli; Brussels/BE (ntacelli@gmail.com) 
The therapeutic response of lung cancer can be objectively evaluated on the 
basis of changes in the tumoural size or depiction of metastases, such 
proposed in the RECIST criteria (Response Evaluation Criteria In Solid 
Tumours). Recent advances in cancer biology have triggered development of 
novel targeted therapies designed to disrupt specific biologic pathways. Among 
them, antiangiogenic drugs represent a promising strategy for non-small cell 
lung carcinomas (NSCLC). These agents are more cytostatic rather than 
cytotoxic, explaining the limitations of tumour response assessment based on 
morphological criteria. Dynamic contrast-enhanced imaging techniques have 
the potential to quantify tumoural angiogenesis. In particular, dynamic contrast-
enhanced multidetector-row CT (DCE-CT) represents a promising tool to 
provide non-invasive and repeatable assessment of the angiogenic process 
within non-small cell lung cancers (NSCLC), offering the possibility to generate 
morphological and functional information from the same examination. DCE-CT 
allows the calculation of regional tumour blood flow, blood volume, flow-
extraction product, and permeability-surface area product, over the entire 
tumoural volume, using mathematical models and dedicated softwares. DCE-
CT can depict early changes in lung cancer vascularity, before tumour 
shrinkage, that could help predict response to antiangiogenic drugs. Becoming 
familiar with this technique enables the radiologist to integrate it into clinical 
practice and to assist the thoracic oncologist in the pre-therapeutic and 
follow-up evaluation of NSCLC patients treated by antiangiogenic drugs. This 
new approach should improve patient's selection for targeted therapies.  
Learning Objectives:
1. To learn about the practical approach for assessing disease response in 
patients with lung cancer. 
2. To become familiar with new therapies in lung cancer. 
3. To appreciate new techniques such as perfusion CT in assessing disease 
prognosis and response in lung cancer. 
A-343 09:30 
C. The role of PET-CT and whole body MRI  
F. Gleeson; Oxford/UK (fgleeson@mac.com) 
It is now accepted that PET-CT is of value in the staging of lung cancer and 
reduces the number of unnecessary thoracotomies. Its role has been further 
clarified by recent publications on its value in assessing mediastinal nodal 
involvement, tumour aggressiveness using either standardised uptake value or 
total glycolytic volume, and response to neoadjuvant chemotherapy. More 
recently, MRI has been investigated as a tool to detect distant disease using 
diffusion-weighted imaging, and there are a number of trials that have 
compared both PET-CT and DWI MRI retrospectively and prospectively. This 
presentation will summarise the current available data and the likely benefits of 
either imaging modality  
Learning Objectives:
1. To learn about the role of PET-CT in staging and determining prognosis in 
lung cancer. 
2. To appreciate the role of PET-CT in determining disease response in lung 
cancer. 
3. To become familiar with the potential use of whole body MRI and DWI in 
lung cancer. 
08:30 - 10:00 Board Room B  
Paediatric  
RC 1212  
Paediatric emergencies  
Moderator:  
J.-P. Van Nieuwenhuyse; Luxembourg/LU 
A-344 08:30 
A. The acute non-traumatic neurological patient: CT or MRI?  
E. Vázquez; Barcelona/ES (evazquez@vhebron.net) 
Neurological deficits in children are an urgent condition that depends 
significantly on imaging for a prompt and accurate diagnosis because of the 
significant overlap present in clinical history, presentation and neurological 
examination. Different imaging modalities, such as ultrasound, computed 
tomography (CT) or magnetic resonance imaging (MRI), are utilised dependent 
on the age of the patient and neurological symptoms. The purpose of the 
present lecture is to discuss the causes and imaging appearance of acute 
neurological conditions in childhood, broadly classified into stroke, infection, 
inflammatory demyelination, metabolic disorder, cerebral neoplasm or 
neurotoxicity. Imaging also plays an outstanding role in the management of 
paediatric oncology patients presenting with acute neurological symptoms 
related to disorders of blood cell counts, immunosuppression, neurotoxicity of 
therapy, or progression of the primary malignancy. A review of the main 
indications to perform a neuroimaging procedure in these children will be 
undertaken as well as a differential diagnosis based on representative cases 
selected from the daily routine in a paediatric tertiary hospital. Practical 
algorithms with the preferential use of either CT or MRI will be developed for 
each section. CT continues to be the first imaging modality in these patients in 
many centres, despite the accompanying radiation, because of the easy 
availability and no requirement of sedation. However, MR imaging is nowadays 
better for imaging these children owing to no radiation, the more completely 
provided information and the useful advanced techniques that can be used, 
such as diffusion imaging (DI), spectroscopy, arterial spin labelling (ASL), and 
susceptibility weighted imaging (SWI).  
Learning Objectives:
1. To learn about the currently limited role of CT in the non-traumatic acute 
setting. 
2. To become familiar with radioprotection strategies and protocols adapted to 
children. 
3. To consolidate knowledge on the role of MRI as the modality of choice for 
acute non-traumatic neurologically ill children, with an emphasis on newer 
techniques. 
4. To become familiar with imaging findings and the main differential diagnosis 
of acute neurological conditions in children. 
A-345 09:00 
B. Imaging of acute chest pain and distress in children  
C.E. de Lange; Oslo/NO (clange@ous-hf.no) 
Acute chest pain in children is a common complaint in the emergency 
department, but patients rarely present with significant distress or life-
threatening symptoms requiring immediate care or resuscitation. The most 
frequently reported cause is benign musculoskeletal pain followed by 
respiratory and gastrointestinal causes, while cardiac causes are less frequent. 
A thorough clinical history and careful physical examination will determine, in 
most cases, the patients in need of further investigation to establish a 
diagnosis. In this regard, radiology plays an important role, especially in the 
emergency setting in patients with more serious associated symptoms like 
acute breathing difficulties, swallowing problems, fever or sepsis. When 
choosing the appropriate technique for investigation, the consequences of 
radiation exposure in children must be considered. Plain radiography and 
fluoroscopy still remain the most important and frequently used tools to gain 
information on various acute chest/pulmonary problems. Ultrasonography is 
the first choice for diagnosis/treatment of pleural effusions. Multidetector 
computed tomography and magnetic resonance imaging are mainly used for 
investigating pulmonary/mediastinal masses and congenital abnormalities of 
the great vessels and the lungs. This lecture will discuss the choice of imaging 
technique and the urgency of radiological management depending on the 
symptoms and age of the patient. The imaging characteristics of the different 
causes of acute chest pain and/or distress in children will be reviewed, 
represented by the more common conditions involving the chest wall, 
respiratory tract, oesophagus and the heart, as well as less frequent causes 
such as tumours, manifestations of congenital malformations and non-
accidental trauma.  
Learning Objectives:
1. To understand the role of radiographs, US, CT and MRI. 
2. To become familiar with the most common conditions that cause acute chest 
pain and distress in children. 
3. To appreciate the different differential diagnoses, depending on the age of 
the patient. 
4. To understand the consequences of delaying their diagnosis and treatment. 
A-346 09:30 
C. The role of the interventional radiologist in paediatric trauma  
J.B. Karani; London/UK (john.karani@nhs.uk) 
Outcome data from trauma series have demonstrated improved patient 
survival by the prompt diagnosis of a range of injuries and the recognition of 
life-threatening sequels, principally that of active arterial haemorrhage. Widely 
used trauma scoring systems are applicable in the paediatric population, 
although the mechanisms and combination of injuries may differ from those 
encountered in adults. A CT diagnosis of active haemorrhage demands early 
operative or non-operative intervention with embolisation or use of alternative 
endovascular techniques including deployment of vascular stents. This 
principle is applicable to blunt or penetrating liver, splenic, renal or pelvic 
trauma. It is also applicable in some cases to severe mediastinal and limb 
vascular injury. Important caveats are firstly the use of CT in an overall trauma 
service and avoidance of any inappropriate irradiation. Secondly, in paediatric 
interventional practice, due regard needs to be given to the delivery of 
implantable devices that may have adverse sequels in later life. Nevertheless, 
the demand for immediacy in intervention may outweigh any such 




consideration. This presentation will summarise the importance of imaging and 
intervention in both the early and delayed complications of trauma with an 
emphasis on abdominal and thoracic trauma.  
Learning Objectives:
1. To understand the role of CT, CTA and conventional angiography in the 
diagnosis of traumatic vascular complications. 
2. To understand the importance of vascular and non-vascular intervention 
following trauma in children. 
08:30 - 10:00 Room E1  
Musculoskeletal  
RC 1210  
Peripheral nerve imaging: MRI and US  
Moderator:  
M. Maas; Amsterdam/NL 
A-347 08:30 
A. Anatomy and pathology of the brachial plexus  
S. Gerevini; Milan/IT (gerevini.simonetta@hsr.it) 
Brachial plexus originates from the ventral branches of the cervical nerve roots 
from C5 to T1. It is composed of roots, trunks, divisions, cords, and branches, 
topographically divided into supraclavicular (roots and trunks), retroclavicular 
(divisions), and infraclavicular sections (cords and branches). MRI has the 
advantages of multiplanar imaging, high tissue contrast, and relative paucity of 
artefacts. The T1-weighted sequences display topographic anatomy including 
muscles, blood vessels, and nerves stressed by tissue fat planes. The nerves 
appear as elongated fibres that are isointense to the scalene muscle, 
posteriorly and superiorly to the curvilinear flow void of the subclavian artery. 
The fat-suppressed PD and T2-weighted and STIR sequences detect signal 
alterations of the BP. General abnormal findings include: loss of fat planes 
around part or all BP components, nerve signal abnormalities with mild or 
marked hyperintensity on T2-weighted images that can be associated with 
swelling, focal or extensive enhancement of the nerves after Gad injection on 
T1 fat sat images. Differences in signal intensity should be judged by visual 
inspection, which is susceptible to a subjective point of view; the comparison of 
both sides of BP has a relevant role in judging the presence of signal 
alterations, especially when they are smooth and/or focal. The pathology of 
brachial plexus can be divided into nontraumatic and traumatic brachial 
plexopathies. Among nontraumatic brachial plexopathies, we find radiation 
fibrosis, metastatic breast cancer and primary or metastatic lung cancer. Other 
pathologies are tumours and inflammatory disease or thoracic outlet disease.  
Learning Objectives:
1. To understand the anatomy of the brachial plexus as seen with MRI. 
2. To appreciate the range of pathology seen at the brachial plexus. 
3. To become familiar with the MRI findings of brachial plexus pathology. 
A-348 09:00 
B. Upper limb nerve entrapment  
D. Weishaupt; Zurich/CH (dominik.weishaupt@triemli.zuerich.ch) 
The peripheral nerves of the upper limb are affected by a number of 
entrapment and compression neuropathies. These syndromes involve the 
brachial plexus as well the musculocutaneous, axillary, subscapular, ulnar, 
radial and median nerves. Clinical examination and electrophysiological 
studies are traditionally the mainstay of diagnostic workup. However, 
ultrasonography and magnetic resonance imaging (MRI) may provide key 
information about the exact anatomic location of the lesion or may help to 
narrow the differential diagnosis. In certain patients with the diagnosis of a 
peripheral neuropathy, imaging using either ultrasonography or MRI may help 
establish the cause of the condition and provide information crucial for 
conservative management or surgical planning. In addition, imaging is 
particularly valuable in complex cases with discrepant nerve function test 
results.  
Learning Objectives:
1. To become familiar with the strengths and weaknesses of US and MRI for 
assessing upper limb nerves. 
2. To appreciate the imaging findings of upper limb nerve entrapment. 
A-349 09:30 
C. Lower limb nerve entrapment  
C. Martinoli; Genoa/IT (carlo.martinoli@libero.it) 
A variety of peripheral neuropathies can be encountered in the lower limb. 
Most are entrapment syndromes affecting many nerves, such as the sciatic, 
gluteal, femoral, lateral femoral cutaneous, obturator and pudendal around the 
hip, the peroneal and its branches and the saphenous at the knee, the 
superficial peroneal at the lateral leg, the tibial with its plantar and calcaneal 
branches at the ankle, the deep peroneal and the interdigital nerves in the foot. 
Although clinical examination and nerve conduction studies are the mainstay of 
the diagnostic workup of peripheral neuropathies, ultrasound (US) and 
magnetic resonance (MR) imaging may provide key information about the 
exact anatomic location of a lesion and the nature of the constricting finding or 
may help narrow the differential diagnosis. In patients with peripheral 
neuropathies of the lower extremity, US and MR imaging may provide critical 
information for planning an adequate treatment strategy. Although US and MR 
imaging have followed parallel paths for nerve imaging with little comparison of 
the two modalities, US seems to have some advantages over MR imaging, 
including higher spatial resolution, time effectiveness, the ability to explore long 
nerve segments in a single study and to examine tissues in both static and 
dynamic states.  
Learning Objectives:
1. To become familiar with the strengths and weaknesses of US and MRI for 
assessing lower limb nerves. 
2. To appreciate the imaging findings of lower limb nerve entrapment. 
08:30 - 10:00 Room E2  
Neuro  
RC 1211  
Stroke: diagnosis, mimics and treatment  
A-350 08:30 
Chairman's introduction  
B.F. Schuknecht; Zurich/CH (image-solution@ggaweb.ch) 
Advances in diagnosis of acute stroke have been achieved by brain imaging. 
CT or MRI distinguish ischaemia from haemorrhage and may identify acute clot 
(dense artery sign) or vessel wall pathology by "black blood MRI". DWI 
provides evidence of early infarction. CT and MRA enable identification of large 
vessel pathology as potential source of embolic or haemodynamic ischaemia. 
Supplementary techniques are CT or MR perfusion. On MRI perfusion, a 
mismatch between the area of restricted diffusion and perfusion (PWI) is a 
signature of the penumbra. The tissue of PWI restriction outside of the DWI 
abnormality represents "tissue at risk". Similarly on CT perfusion, the region of 
reduced cerebral blood volume presumably represents irreversible infarction 
and the area of reduced CBF and extended MTT visible beyond the cerebral 
blood volume abnormality represents potentially reversible ischaemia. 
Morphologic imaging and advanced standardised perfusion/penumbral stroke 
protocols aim at identifying lesions that are amenable to acute stroke therapy 
and exclude pathologies that mimic stroke but do not represent vascular 
disease. Since iv tPA has become an approved therapy from 1996, the number 
of acute stroke patients entitled for treatment has remained limited (~ 5) 
despite extension of the time frame from 3 to 4.5 h. DWI-FLAIR mismatch and 
an individualised assessment of the ischaemic penumbra may serve in the 
identification of patients within the appropriate time frame. By selection of 
patients with advanced brain imaging and initiation of appropriate therapy, a 
further increase in good outcomes and reduction of the incidence of 
symptomatic haemorrhage may be achieved.  
A-351 08:35 
A. Imaging acute stroke: value of CTA and perfusion  
P.M. Parizel, C. Venstermans, F. De Belder, T. Van der Zijden, 
J.W. Van Goethem, L. van den Hauwe, M. Voormolen; Antwerp/BE
(paul.parizel@uantwerpen.be) 
In recent years, the role of imaging in the patient admitted with an acute 
neurologic deficit has changed significantly, due to the arrival of new 
treatments for acute stroke, aimed at re-establishing blood flow, reducing 
infarct size and protecting the brain at risk. The first goal is to differentiate 
haemorrhagic from ischaemic stroke and to rule out other stroke mimics. This 
can be achieved by performing nonenhanced CT scan of the brain. The next 
strategic imaging objectives include: demonstration of major blood vessel 
occlusion (e.g. by CT angiography) and identification of potentially salvageable 
brain tissue, the so-called "penumbra" (e.g. by CT perfusion). CT angiography 
is performed during rapid intravenous bolus injection of a high-concentration 
iodinated contrast agent. The FOV should cover not only the intracranial 
arterial circulation, but also the arteries of the neck, to exclude dissection. CT 
perfusion is also achieved by bolus injection of contrast, followed by a series of 
fast images or volume acquisition. CT densities change over time and reflect 
the iodine concentration. Perfusion images are processed to generate 
parametric maps, which reflect: regional cerebral blood flow (rCBF), blood 
volume (rCBV), mean transit time (MTT), and time to peak (TTP).The 
combination of CT angiography and CT perfusion provides a unique insight 
into the pathophysiology of the cerebral circulation. These techniques are now 




essential tools in the management of acute stroke and in selecting those 
patients who are potential candidates for advanced therapies such as 
thrombolysis or thrombectomy.  
Learning Objectives:
1. To become familiar with a comprehensive imaging protocol in patients with 
suspected stroke. 
2. To understand the advantages and limitations of CTA and perfusion in the 
initial work-up of stroke patients. 
3. To recognise the different imaging patterns in stroke and their prognostic 
value. 
A-352 08:58 
B. Stroke mimickers and pitfalls  
P. Vilela; Lisbon/PT (ferrovilela@sapo.pt) 
"Stroke mimic" is classically used to describe nonvascular diseases that 
present with acute focal neurologic deficit corresponding to a consistent 
vascular distribution, which may resemble or may even be indistinguishable 
from stoke. It is estimated that up to 15% of stroke-like presentations are due 
to mimickers. There are several neurological and psychiatric disorders that can 
have such a clinical presentation, such as seizures and/or postictal status, the 
most frequent one. The other classical clinical stroke mimickers include: 
multiple sclerosis, migraine (specially hemiplegic migraine), metabolic 
disturbances (more commonly hypoglycaemia/hyperglycaemia), intracranial 
tumours or infections and the conversion reactions. Brain imaging plays a key 
role in the diagnosis and management of acute stroke by differentiating 
ischaemic from haemorrhagic lesions, identifying the vessel occluded and 
estimating the viable brain tissue that is at risk for stroke. Imaging is also 
important to exclude some of the aforementioned stroke mimics. The more 
comprehensive stroke imaging protocols, with CT perfusion/angiography 
and/or with MRI, have reduced significantly the misdiagnosis of stroke. MRI-
DWI is the most sensitive and specific imaging modality for depicting ischaemic 
stroke. However, it is also essential to be aware that there are some 
pathological processes that can mimic stroke in imaging studies. These include 
some disorders that may present themselves with lesions associated with 
restricted diffusion, like transitory postictal brain abnormalities, migraine and 
encephalitis. The author reviews the most common clinical and imaging stroke 
mimics and highlights the importance of brain imaging in depicting these 
mimickers and avoiding the potential adverse effects of stroke therapy in these 
patients.  
Learning Objectives:
1. To learn the differential diagnosis of stroke. 
2. To understand the role of CT and MRI in the work-up of stroke and related 
disorders. 
3. To recognise imaging patterns that may mimic stroke clinically and 
radiologically. 
A-353 09:21 
C. Treatment: only intravenous?  
L. Pierot, S. Soize, S. Emeriau; Reims/FR (lpierot@chu-reims.fr) 
Imaging plays a central role in the management of stroke, which is an 
important health issue according to the number of patients involved and the 
severity of the disease. It helps to select patients who will benefit from a 
revascularisation therapy (IV thrombolysis or endovascular treatment) at the 
acute phase of stroke. If the value of perfusion/diffusion MRI mismatch in the 
evaluation of penumbra is still a matter of debate, other imaging factors are 
associated with the clinical outcome including length of clot, Flair positivity, and 
collateral circulation. If IV thrombolysis using rtPA is still the reference 
treatment, endovascular treatment is emerging since several years as a 
feasible and efficacious alternative singularly since the appearance of stent 
retrievers. Recent neutral randomised trials comparing IV thrombolysis and 
endovascular treatment have shown the critical role of appropriate imaging in 
the selection of patients who can benefit from acute revascularisation as well 
as the importance of using the most efficacious endovascular devices. 
Prevention of stroke is partially based on the treatment of cervical and 
intracranial stenosis. Several randomised trials comparing carotid angioplasty 
and carotid endarterectomy were initially negative, but a recent meta-analysis 
showed that below the age of 70 years both techniques were equivalent. The 
place and value of endovascular treatment of intracranial arterial stenosis is 
still controversial after the publication of the SAMMPRIS results.  
Learning Objectives:
1. To understand how imaging can help select patients for intravenous 
treatment of acute ischemic stroke. 
2. To understand what the current indications are for the endovascular 
treatment of acute ischemic stroke. 
3. To understand the current role of the endovascular treatment in the 
prevention of stroke. 
Author Disclosure:
 L. Pierot: Consultant; Codman, Covidien/EV3, Microvention, Penumbra, 
Sequent. 
Panel discussion:  
What is the future of stroke prevention and treatment?  09:44
08:30 - 10:00 Room F1  
Special Focus Session  
SF 12  
Imaging of thyroid nodules  
A-354 08:30 
Chairman's introduction  
T. Beale1, S. Colley2; 1London/UK, 2Birmingham/UK
(Steve.Colley@uhb.nhs.uk) 
The management of thyroid nodules has been continuously evolving. I hope 
that during this session you will understand the important differences in the up-
to-date national and international guidelines on thyroid nodule management 
and understand the role of the radiologist in the multidisciplinary thyroid 
meetings. The features that are suggestive of benign, indeterminate and 
malignant nodules will be demonstrated. Advances in both radiological and 
cytological techniques such as US elastography and BRAF mutation analysis 
that may help triage patients with thyroid nodules will be covered. The differing 
biopsy techniques (fine needle aspiration, non-aspiration (FNA and FNNAC) 
and trucut biopsy) and their roles will be highlighted. There will be time for an 
open question and answer discussion with all the speakers before the end of 
the session.  
Session Objectives: 
1. To become familiar with the management of thyroid nodules. 
2. To learn about the imaging features suggestive of both benign and 
malignant thyroid nodules. 
3. To learn how to optimise imaging of thyroid nodules and the role of newer 
techniques such as US elastography. 
4. To understand which nodules require FNA/biopsy. 
A-355 08:35 
Management  
T. Beale1, S. Colley2; 1London/UK, 2Birmingham/UK
(Steve.Colley@uhb.nhs.uk) 
The management of thyroid nodules and the guidelines of the various 
interested parties, surgeons, endocrinologists, nuclear medicine physicians, 
radiologists and ultrasound specialists, vary across the world, indeed between 
different countries within the EU, and are constantly evolving. I will discuss how 
the thyroid multidisciplinary meeting (MDT) works at our institution and the role 
of the radiologist in it. The current differing international guidelines on the 
management of thyroid nodules will be mentioned, highlighting their salient 
points and differences. The role of the differing imaging modalities used in the 
management of thyroid nodules will be discussed based on differing clinical 
scenarios. Finally, the management of the common clinical scenario of the 
incidental thyroid nodule will also be discussed.  
Learning Objectives:
1. To understand the role of the radiologist as part of a multidisciplinary team. 
2. To learn about current guidelines on the management of the thyroid nodule. 
3. To understand the role of various imaging modalities in the patient with 
thyroid nodule. 
A-356 08:58 
US and US elastography  
A.S. McQueen; Newcastle upon Tyne/UK (andrewmcqueen7@hotmail.com) 
Thyroid disease is ubiquitous and usually benign; therefore accurate imaging 
of the thyroid is a major challenge for radiology. Significant advances in 
conventional ultrasonography allow superb visualisation and anatomic 
characterisation of thyroid pathology and the impact of broader bandwidths, 
higher frequencies, spatial compound imaging and novel signal processing 
techniques will be discussed in this session. The key B mode features of 
thyroid nodules are discussed with reference to relevant clinicoradiological 
guidelines, specific pitfalls and limitations. A significant number of nodules 
remain indeterminate after conventional assessment, and imaging advances 
that enable more accurate, non-invasive thyroid characterisation are highly 
attractive, potentially reducing unnecessary biopsy and surgery for a large 
number of patients. Ultrasound elastography offers a potentially useful adjunct 
to conventional sonography in thyroid disease with a growing evidence base 
indicating that thyroid malignancies are typically stiffer than benign lesions and 
that a 'soft' cutoff value with a high negative predictive value is feasible. 
However, elastography studies have included a variety of different techniques, 




patient/nodule selection and assessment methods; therefore the current role of 
elastography will be discussed.  
Learning Objectives:
1. To become familiar with the US features of thyroid pathology. 
2. To understand the role of US elastography in thyroid nodules. 
3. To consolidate knowledge on pitfalls in the US assessment of thyroid 
nodules. 
A-357 09:21 
Fine needle biopsy of the thyroid nodule  
F. Campoy-Balbontín, M.C. Jurado-Gomez; Sevilla/ES
(fcampoy2000@gmail.com) 
Thyroid nodules are very common. The clinical importance of thyroid nodules 
rests with the need to exclude thyroid cancer, which occurs in 5-15%. 
Ultrasound (US) has been widely attempted to differentiate benign from 
malignant nodules and to guide fine needle biopsy (FNB). However, 
considerable overlap between benign and malignant characteristics has been 
found. Nowadays, there are a number of different guidelines for the 
management of thyroid nodules. At our hospital, we have adopted the 
guideline proposed by the Society of Radiologist in Ultrasound (2005). The 
different elements necessary to perform the FNB procedure are demonstrated; 
the transducer probe, the needles, the slides, the syringe. The way of 
managing these elements is shown by figures and videos, with different skills 
and performances to optimise the procedure and get the best sample. US-
control FNB can be in parallel or perpendicular, both methods are 
demonstrated. Thyroid FNB is usually non-aspirated, but sometimes it has to 
be undertaken with aspiration; when and how to change from one method to 
another is explained. With good technique, the insufficient cytological rate can 
be significantly reduced, with which the need for core biopsy diminishes. 
Although the complication rate for core biopsy is low, FNB is safer and if 
performed correctly has a high diagnostic yield. Core biopsy should be limited 
to those nodules with a second insufficient FNB cytological result, with US 
findings suspicious for malignancy.  
Learning Objectives:
1. To understand when it is necessary to perform a fine needle biopsy of the 
thyroid nodule. 
2. To understand the different techniques used to perform thyroid FN and how 
to optimise them. 
3. To learn when a biopsy may be required. 
Panel discussion:  
What is the role of the radiologist in the management  
of thyroid nodules?  09:44
08:30 - 10:00 Room F2  
Breast  
RC 1202  
Multimodality breast imaging  
A-358 08:30 
Chairman's introduction  
M. Lesaru; Bucharest/RO (mlesaru@hotmail.com) 
Multimodality breast imaging is emerging as radiologists have access to new 
technologies coinciding with the refinement of operative techniques. One of the 
challenges for radiologist remains the correct preoperative staging, especially 
the metastatic involvement of axillary lymph nodes. Multimodality imaging has 
new accurate solutions. The imaging follow-up of patients with sophisticated 
oncoplastic techniques is another challenge where multimodality breast 
imaging is the solution. Coincident with this increasing contribution to the 
diagnostic process is the emerging role of the breast imager as a therapeutic 
clinician, making use of innovative image-guided procedures. In this integrated 
RC, experts will present a clinical update on these newer techniques and there 
will be an opportunity to discuss how the evolution of such techniques is 
changing the nature of the modern multidisciplinary team meeting.  
A-359 08:35 
A. Conventional, functional and interventional lymph node assessment  
R.M. Pijnappel; Utrecht/NL (r.m.pijnappel@umcutrecht.nl) 
Metastatic involvement of axillary lymph nodes has been known to be one of 
the most important prognostic factors for women with breast cancer. The 
traditional approach to staging the axilla is either lymph node sampling 
procedures or sentinel node biopsy. The main diagnostic features of potentially 
malignant involvement of the axilla are abnormal lymph node morphology 
(shape and cortical thickness). There has been a concerted effort in recent 
years to find imaging techniques that might facilitate accurate axillary staging. 
So far, no imaging technique alone (CT, MRI, scintigraphy and ultrasound) has 
been capable of differentiating between positive and negative lymph nodes of 
the axilla in breast cancer. Recent techniques like gadofosveset-enhanced 
magnetic resonance imaging and high spatial resolution 7-T MRI imaging 
appear promising; however ultrasound-guided sampling of suspicious lymph 
nodes by core or FNA remains the standard of care in assessing the axilla prior 
to treatment planning. Ultrasound-guided axillary lymph node sampling is an 
effective method of assessing the axilla. A recent meta-analysis shows that 
ultrasound can be expected to achieve sensitivity approaching 50% for 
detecting abnormal nodes in those that eventually prove to be nodal metastatic 
disease. The false-negative rate where biopsy is performed is around 25%. It is 
impossible to detect the sentinel node by ultrasound alone. Therefore a new 
promising technique was introduced, injecting an ultrasound-contrast agent 
around the nipple. Using this method, it is possible to detect the sentinel node 
in 90% and therefore lower the false-negative rate of US-guided biopsy with 
another 15%.  
Learning Objectives:
1. To learn about normal lymph node morphology. 
2. To understand criteria suggestive of morphological abnormality. 
3. To become familiar with factors affecting overall sensitivity of pre-operative 
lymph node assessment. 
Author Disclosure:
 R.M. Pijnappel: Advisory Board; Hologic, without financial reimbursement. 
A-360 08:58 
B. Multimodality assessment of the breast following oncoplastic surgery  
M. Torres-Tabanera, S. Pérez-Rodrigo; Madrid/ES
(mtorrestabanera@gmail.com) 
Oncoplastic breast procedures were introduced to fill the gap between 
comprehensive oncologic surgical treatment of breast cancer and the 
achievement of cosmetic results that fulfill patient expectations in both, body 
imaging and psychological well-being. Due to its complexity and relevance for 
the patient, the decision of performing these procedures must be made as part 
of the multidisciplinary approach of breast cancer treatment. As a 
consequence, the role of breast radiologists has expanded beyond the 
anatomic region of the breast and the usual imaging techniques. Basic 
knowledge of the different oncoplastic techniques is mandatory to understand 
the spectrum of findings from a multi-modality approach. Implants and/or 
autologous reconstruction techniques (pedicle, free or perforator flaps, as well 
as lipofilling techniques) are widely applied. The role of the radiologist in the 
multidisciplinary team is twofold: assessment during the planning stage, and 
imaging evaluation at follow-up. The assessment during the planning stage 
includes the determination of the local extent of the disease that makes the 
choice of the appropriate surgical technique possible, and the imaging study of 
the donor site in those cases where autologous reconstruction is elected. 
Imaging evaluation at follow-up comprises the recognition of changes and 
potential pitfalls after reconstruction, the identification of short/mid/long-term 
reconstruction complications, and the detection of recurrent/second 
carcinomas. Controversial aspects will be reviewed, such as the probability of 
recurrence after oncoplastic surgery, the need to establish multimodality 
follow-up protocols and the interrelations between the autologous tissues and 
the mastectomy bed or remaining breast.  
Learning Objectives:
1. To learn about the range of oncoplastic breast procedures in current clinical 
practice. 
2. To become familiar with imaging features resulting from oncoplastic surgery. 
3. To appreciate the potential pitfalls encountered while imaging such cases. 
A-361 09:21 
C. Image-guided therapy in breast lesions: indications and techniques  
R.M. Mann; Nijmegen/NL (r.mann@rad.umcn.nl) 
The use of image guidance for surgical planning has only recently been 
accepted. The use of intraoperative ultrasound in women undergoing 
lumpectomy is associated with a higher rate of negative margins. The 
combination of image guidance and radiological intervention techniques also 
harbours the possibility of tumour treatment without surgery. Most techniques 
make use of the placement of needles within the tumour. Treatment is 
performed by heating, freezing or extracting the tumour tissue. Currently, 
radiofrequency ablation under ultrasound guidance is being furthest evaluated. 
However, in RFA even after optical complete tumour ablation, residual vital 
tumour tissue is still found in many cases. This is mainly dependent on tumour 
size with poorer results (50-60% success rates) in tumour over 2 cm, and 
better results (~90% success rate) in smaller tumours. Adequate tumour size 
estimation is thus of vital importance. Currently, since remaining vital cells 
cannot be excluded, the technique is limited to use in patients who cannot 
undergo surgery due to poor health state. Larger series in which RFA is 
combined with radiotherapy have not been reported. It is therefore not clear 
whether it is important to actually excise residual vital tumour. Similar 




restrictions currently hold for cryotherapy, laser ablation and hifu. Large 
vacuum-assisted needles and the breast lesion excision system can be used to 
remove the tumour through a minimal incision in the skin. However, margin 
evaluation is difficult. Nevertheless, these techniques are already optional for 
the removal of high-risk lesions and can potentially be combined with (focused) 
radiotherapy.  
Learning Objectives:
1. To understand indications for therapeutic interventions in malignant and 
benign lesions. 
2. To learn about current image-guided therapeutic techniques in malignant 
and benign lesions. 
3. To appreciate potential future developments of therapeutic interventions. 
Author Disclosure:
 R.M. Mann: Speaker; Bayer Healthcare. 
Panel discussion:  
How is the evolution of multimodality breast imaging changing the nature 
of the multidisciplinary meeting (MDM)?  09:44
08:30 - 10:00 Room G/H  
Genitourinary  
RC 1207  
Female imaging: how I do it?  
Moderator:  
V. Panebianco; Rome/IT 
A-362 08:30 
A. Imaging female congenital anomalies  
G. Restaino; Campobasso/IT (gennares@hotmail.com) 
The Müllerian ducts are paired embryologic structures that undergo fusion and 
resorption between the 6th-11th weeks of gestation to give rise to the uterus, 
fallopian tubes, cervix, and upper two-thirds of the vagina. Non-development, 
defective vertical or lateral fusion, or resorption failure of the Müllerian ducts 
can result in formation of Müllerian duct anomalies (MDAs), whose reported 
prevalence ranges between 0.4% and 8%-10%. The classification revised by 
the American Society for Reproductive Medicine in 1988 is the most widely 
accepted. Obstructive MDA can occur in infants as palpable pelvic mass, at 
menarche with cyclic pelvic pain, or pelvic mass, and primary amenorrhea. 
Complications include hematocolpos, hematometra, hematosalpinx, 
endometriosis, pelvic adhesions, and obstruction of urinary tract. MDAs are 
commonly associated with renal and other anomalies; thus, identification of 
both kidneys is important. Accurate diagnosis of an MDA is essential because 
of the high associated risk of infertility, endometriosis and miscarriage, and 
since the management approach varies depending on the type of 
malformation. Hysterosalpingography (HSG) is routinely used in evaluation of 
infertility. Because a key component of MDAs characterisation is the external 
uterine fundal contour, HSG is limited for this purpose. Ultrasonography (US) is 
initially performed to evaluate uterine anatomy and to assess for associated 
renal abnormalities. MRI is reserved for complex or indeterminate cases to 
characterise the uterine anomaly and evaluate the possibility of a vaginal 
abnormality, or after a seemingly normal US when clinical opinion ensures its 
use, or to make decisions on management strategies and preoperative 
planning.  
Learning Objectives:
1. To learn about the embryology of normal and abnormal female genital tract. 
2. To understand the role of different available imaging techniques for female 
congenital anomalies: ISG, TV-US and MRI. 
3. To learn about the examination technique and understand the imaging 
findings of MRI in the different classes of female congenital anomalies. 
A-363 09:00 
B. PET-CT in the female pelvis: how I do it?  
A.G. Rockall; London/UK (a.rockall@imperial.ac.uk) 
This refresher course will focus on the radiologist's approach to using PET-CT 
within the context of the gynaecologic oncology multidisciplinary meeting. The 
current indications for using FDG-PET/CT will be discussed for cervix, 
endometrial and ovarian cancer as well as the potential use of FDG-PET/CT in 
rare gynaecologic cancers. The value of adding FDG-PET/CT to the patient 
management pathway will be presented alongside the potential pitfalls in 
interpretation as well as controversies. Future developments, including 
potential new tracers, will be mentioned.  
Learning Objectives:
1. To understand the role of PET-CT in staging of various pelvic tumours and 
detection of tumour recurrence. 
2. To learn about the advantages and limitations of PET-CT in imaging the 
female pelvis. 
3. To appreciate the role of PET-CT with respect to other imaging techniques 
in the diagnostic algorithms of pelvic tumours. 
Author Disclosure:
 A.G. Rockall: Research/Grant Support; Merck and Co. Speaker; Novartis, 
Guerbet. 
A-364 09:30 
C. How to image cystic tumours of the ovary  
R. Forstner, M. Meissnitzer; Salzburg/AT (r.forstner@salk.at) 
Cystic lesions account for the vast majority of ovarian masses and are 
detected incidentally in 5-18%. Their spectrum ranges from non-neoplastic 
cysts to benign tumours, e.g. cystadenomas and dermoids to the rare ovarian 
cancer. Diagnostic criteria in US, CT and MRI are based on the clinical 
background (age, menopausal status, medical history, and tumour markers) 
and the morphology of the ovarian mass. Typical of a benign cystic lesion is its 
pure cystic structure or thin septations, fatty or haemorrhagic contents, and 
mild enhancement of solid components in a complex solid and cystic ovarian 
mass. Thus, patients can be categorised into 3 different risk groups. 
Sonography has been established as the first-line imaging modality to assess 
the ovaries. Recently, management guidelines have been adopted for cystic 
ovarian lesions. In these guidelines, also cystic adnexal incidentalomas are 
included. MRI is most useful as a complementary technique in sonographically 
indeterminate masses. An algorithmic approach will render a specific diagnosis 
in the vast majority of cases. In complex cystic lesions, integration of DWI and 
dynamic contrast-MRI allows differentiation of rare benign complex tumours, 
e.g. cystadenofibroma from ovarian cancer. Pitfalls of cystic ovarian tumours 
include cystic fibroids, peritoneal cysts, and extraperitoneal cystic tumours. 
Compared to US, both CT and MRI are superior in assessing large cystic 
pelvic masses. Criteria to differentiate between intra- and extraperioneal origin 
include displacement patterns and identification of the vascular pedicle. Careful 
analysis of imaging and clinical findings usually allows differentiation of 
inflammatory tumours from ovarian cancer.  
Learning Objectives:
1. To learn about specific imaging algorithms of ovarian cystic tumours. 
2. To understand certain imaging features that can differentiate ovarian from 
non-ovarian cystic tumours in the pelvis. 
3. To become familiar with the pitfalls in imaging of ovarian cystic tumours and 
the lessons to be learned from them. 
08:30 - 10:00 Room I/K  
Head and Neck Imaging  
CC 1219  
What do I see? Clinical radiological 
interaction (part 1)  
Moderator:  
S. Robinson; Vienna/AT 
A-365 08:30 
A. Temporal bone: conductive hearing loss and cholesteatoma  
B. De Foer, F. Offeciers; Wilrijk-Antwerp/BE
The diagnostic methods available in patients with conductive hearing loss are: 
personal and family history, otoscopy, audiology, imaging, surgical inspection 
and counseling. The most important reasons for imaging are: atypical history, 
suspicion of congenital hearing loss, suspected otoscopic image, asymmetric 
bone conduction thresholds, profound mixed hearing loss and suspected 
tympanometry. CT can be used to detect otosclerosis, tympanosclerosis, 
posttraumatic ossicular lesions, superior semicircular canal dehiscence and 
cholesteatoma. MRI can be used to exclude schwannoma, congenital 
cholesteatoma and residual and recurrent cholesteatoma after prior surgery. 
This lecture will illustrate the value of CT and MRI in the evaluation of 
cholesteatoma patients as well as prior to first stage surgery and prior to 
second look surgery. Different subtypes of surgery will be highlighted and 
illustrated. The growing importance of MR imaging and diffusion weighted 
(DW) imaging in particular will be illustrated in the evaluation of cholesteatoma 
patients. The role of echo-planar and non-echo-planar DW imaging will be 
discussed as well as the eventual use of delayed gadolinium-enhanced T1-
weighted imaging.  





1. To become familiar with pathologies causing CHL. 
2. To understand what the clinician needs in order to perform surgery. 
3. To learn about possible pitfalls and complications. 
A-366 09:00 
B. Temporal bone: sensorineural hearing loss and deafness  
J. Casselman1, F. Offeciers2, B. De Foer2; 1Bruges/BE, 2Antwerp/BE
MR is the modality of choice in patients with congenital or acquired 
sensorineural hearing loss (SNHL) and the complete auditory pathway from the 
cochlea to the auditory cortex must be studied in these patients. The labyrinth, 
internal auditory canal (IAC) and cerebellopontine angle (CPA) are best 
studied using submillimetric heavily T2W images, showing the intralabyrinthine 
fluid and nerves. But submillimetric Gd-enhanced T1W images or 3D-Flair 
images remain more sensitive. The auditory pathway in the brainstem is best 
studied with a multi-echo sequence (m-FFE/medic/merge) or T2W TSE 
sequence and the auditory cortex is best studied on T2W TSE images. The 
clinical information provided by the otologist will direct the radiologist to a 
certain part of the auditory pathway or will let him use certain imaging 
techniques. For instance, congenital malformations in the labyrinth and IAC 
must be excluded in case of congenital SNHL, and in case of mixed hearing 
one will start with CT to exclude otosclerosis. The most frequent pathology in 
the labyrinth (labyrinthitis, intralabyrinthine schwannoma, congenital 
malformation, post-traumatic lesions), the IAC and CPA (cochleovestibular 
schwannomas, meningiomas, epidermoid tumours and facial nerve neuritis) 
and central auditory pathway (MS, infarction, tumor and trauma) will be 
illustrated using clinical examples and the important "otologist-radiologist" team 
work will be stressed.  
Learning Objectives:
1. To become familiar with causes of SNHL and diagnostic possibilities. 
2. To learn which pathologies can be successfully treated and what information 
is needed from the radiologist. 
3. To learn about interesting cases highlighting the role of diagnostic imaging in 
treatment planning. 
A-367 09:30 
C. Laryngeal and hypopharyngeal cancer  
R. Maroldi, P. Nicolai; Brescia/IT 
For tumours that nearly always arise from the investing mucosa, like in the 
larynx and hypopharynx, it is endoscopy that directly maps the superficial 
extent and grades the functional impairment (arytenoid and vocal cord 
movement, pyriform sinus distensibility). In addition to white light, the recent 
use of narrow band imaging endoscopic technology, enhancing fine capillaries 
in the mucosal surface, enables the detection of neoangiogenesis caused by 
early squamous cell carcinoma. Conversely, submucosal spread is the domain 
of cross-sectional imaging techniques. Therefore, it is the integration of the two 
classes of data, along with the information about patient conditions, which 
permits the choice of the most proper treatment strategy. In early and 
advanced glottic cancer, treatment planning is modulated by information about 
deep neoplastic invasion into the paraglottic space, the cartilage or the supra-
subglottis subsites. This information can be derived by discriminating the 
tumour tissue from intra-laryngeal muscles, fat spaces and the cortical rim of 
ossified cartilages. Though MR shows a greater contrast resolution than CT, it 
is hampered by a significantly longer acquisition time. This means more 
artefacts caused by breathing and movement. Nevertheless, MR has the 
potential to unravel the signals from submucosal tissues, separating tumour 
from oedema, muscles, fat and ossified cartilages. Advanced laryngeal and 
hypopharyngeal cancers need to preliminary assess local (nodes) and distant 
(metastases) spread. CT-PET is the more accurate tool. The multidisciplinary 
approach to the processing of the whole frame of data is essential to offer the 
patient the best care.  
Learning Objectives:
1. To learn about different types of laryngeal cancer and treatment options. 
2. To understand the role of diagnostic imaging in treatment planning. 
3. To review clinical cases in order to highlight the role of clinical-radiological 
cooperation. 
08:30 - 10:00 Room L/M  
Physics in Radiology  
RC 1213  
Cone-beam CT  
Moderators:  
D. Bor; Ankara/TR 
S.J. Golding; Oxford/UK 
A-368 08:30 
A. Fundamentals of cone-beam CT  
M. Kachelrieß; Heidelberg/DE (marc.kachelriess@dkfz.de) 
Traditionally, x-ray CT scanners were equipped with a single or a few detector 
rows only, image reconstruction was assuming parallel slices, which was a 
good approximation for these fan-beam systems. About a decade ago the 
number of slices increased to 16 or more and the parallel slice approximation 
was no longer valid. The cone-beam nature of these multi-slice CT (MSCT) 
scanners had to be taken into account by specific cone-beam reconstruction 
algorithms. While these MSCT systems - today they are simultaneously 
acquiring up to 320 slices - are cone-beam CT systems in a general sense, the 
notion of cone-beam CT (CBCT) is also associated with a specific kind of cone-
beam CT, namely those equipped with flat detectors, i.e. the non-diagnostic or 
non-clinical CT systems. MSCT, in contrast, is a cone-beam CT system for 
diagnostic use, i.e. a clinical CT system. This distinction between MSCT and 
CBCT is useful, as there are decisive differences in application, performance, 
and in image reconstruction. These differences will be reviewed in the 
presentation, with a particular focus on why image quality in MSCT is so much 
better than in CBCT.  
Learning Objectives:
1. To understand the principles of volumetric image formation with flat 
detectors. 
2. To understand the difference between CBCT and MSCT. 
3. To learn about reconstruction techniques and image processing. 
4. To become acquainted with the important image quality parameters. 
A-369 09:00 
B. Medical applications of cone-beam CT  
M. Grass; Hamburg/DE (michael.grass@philips.com) 
Cone-beam (CB) imaging with flat detectors is performed on a variety of 
different imaging systems. The most important area is CB imaging using 
interventional C-arm systems. The minimally invasive procedures carried out 
on these systems benefit from the availability of high-resolution 3D images for 
intervention planning, guidance and outcome control. Interventional CB 
imaging was first applied in neuroradiology using rotational angiography 
acquisitions. Today, it is used for a variety of procedures in interventional 
radiology, cardiology and oncology based on angiographic and soft tissue 
protocols. One of the inherent advantages of this approach is the direct 
registration of the volume images into the interventional procedure. Other 
application areas of CB imaging using different scanning systems are onboard 
imaging in radiation therapy or the integration of flat detector tomography and 
SPECT. This part of the course teaches the generation of 3D volume 
information from flat detector systems and its utilisation in different clinical 
applications. Image acquisition protocols, scan modes, and system design 
parameters are explained. Application-specific calibration and processing steps 
are introduced to show how CB imaging is tailored for specific clinical 
applications. Examples are presented for angiographic and soft tissue 
volumetric imaging. Medical applications utilising the tomographic images for 
diagnosis, intervention planning, guidance, or outcome control are discussed.  
Learning Objectives:
1. To become acquainted with the applications of CB imaging. 
2. To learn about systems design and parameters. 
3. To understand image quality characteristics. 
4. To learn how to use cone-beam images in image-guided interventions. 
Author Disclosure:
 M. Grass: Employee; Philips Research. 
A-370 09:30 
C. 3D dentomaxillofacial imaging  
K. Horner; Manchester/UK (keith.horner@manchester.ac.uk) 
In the last decade, three-dimensional dentomaxillofacial imaging through cone-
beam CT (CBCT) technology has become widely available. Dental CBCT 
(digital volumetric tomography; DVT) equipment is compact and often 
affordable to dentists. The driver for dental CBCT was implant dentistry, but its 
use has spread to other areas, including paediatric applications. Radiation 
doses are variable. Some systems offer a fixed, large, field of view and others 




fixed exposure factors, obstructing attempts at optimisation. Typically, doses 
are at least an order of magnitude greater than for "conventional" imaging. 
Image quality is also variable, which means that certain equipment may be 
unsuitable for some clinical applications. There is often scope for lower 
exposure factors to be used than those recommended by manufacturers. A key 
aspect of using CBCT relates to justification. Imaging in three dimensions may 
be perceived by dentists as inevitably superior, a view which is often implicitly 
encouraged by those selling equipment. The research on diagnostic efficacy is, 
however, limited. In 2012, the European Commission published "Radiation 
Protection 172: Evidence-based Guidelines on Cone Beam CT for Dental and 
Maxillofacial Radiology". This provides a comprehensive set of 
recommendations, including referral criteria, a quality assurance programme 
and optimisation strategies. Priorities for future research relate to exposures to 
the necessary image quality requirements for specific clinical applications, 
along with research on the impact on clinical outcomes of CBCT-based 
treatments. It is clear that much work remains before the place of CBCT in 
dentistry can be established.  
Learning Objectives:
1. To become acquainted with CBCT systems for dentomaxillofacial imaging. 
2. To learn about image quality characteristics and patient dose compared with 
other techniques. 
3. To learn how to access CB images and influence the clinical outcome. 
08:30 - 10:00 Room N/O  
Interventional Radiology  
RC 1209  
Thoracic nonvascular interventions  
A-371 08:30 
Chairman's introduction  
O. Akhan; Ankara/TR (akhano@tr.net) 
The role of nonvascular interventional radiology of thorax for both diagnosis 
and treatment has significantly increased in the last 20 years. Although these 
procedures are technically easy with highly successful results, thoracic 
nonvascular interventional procedures are not unfortunately routinely 
performed in all of the interventional units. The most commonly performed 
procedures generally under CT guidance are transthoracic biopsies of the lung, 
mediastinal lesions and pleura. The others include percutaneous drainage of 
thoracic collections such as pleural effusions, empyema and mediastinal 
collections. Image-guided tumour ablation performed by either radiofrequency 
ablation (RFA) or microwave (MW) as a nonvascular thoracic intervention has 
become a serious treatment alternative in patients with lung tumours (either 
non-small cell lung cancer or lung metastasis) since the year 2000. 
Interventional radiologists are expected to understand the clinical indications of 
these procedures at the first step. In addition, the techniques of the procedures 
and possible risk of complications in their management methods should be 
learnt by interventional radiologists as well. This refresher course will help us to 
discuss the main indications, techniques and complication management of 
these procedures.  
A-372 08:35 
A. Lung biopsy  
T. Sabharwal; London/UK (Tarun.Sabharwal@gstt.sthames.nhs.uk) 
Lung biopsy is most commonly now performed under CT guidance. It has a 
high technical success rate. Common complications include pneumothorax, 
bleeding, sepsis, pain and failure. Air embolism is a rare complication. PET 
scan is a useful tool to guide for appropriate target. Ultrasound is useful for 
biopsying pleural-based lesions.  
Learning Objectives:
1. To understand the role of lung biopsy. 
2. To learn how to properly plan a lung biopsy. 
3. To understand common complications and their management. 
A-373 08:58 
B. Percutaneous drainage of thoracic fluid collections  
I. Vollmer; Barcelona/ES (ivollmer@hospitaldelmar.cat) 
Drainage of thoracic fluid collections is a relative emergency. We will review 
the different thoracic fluid collections that can be drained by radiologists: 
pleural (parapneumonic, empyema, and malignant effusions), mediastinal, 
chest wall, pulmonary (lung abscesses and infected tumours) and pericardial 
effusions. We will answer the following questions about the main thoracic fluid 
collections: how to diagnose, when and how to drain, which guidance 
(ultrasound or CT-fluoroscopy), and procedures to perform before and after the 
drainage. The choice of imaging to detect thoracic fluid collections and guide 
drainage depends on the availability of the modalities, the imaging 
characteristics, location of the collection, and the comfort and expertise of the 
operator with the specific modalities. We will also review the main 
complications of percutaneous drainage of thoracic fluid collections 
(pneumothorax, pain, drain dislodgement and drain blockage) and compare 
these complications with those related to large-bore chest catheters inserted 
by thoracic surgeons.  
Learning Objectives:
1. To learn the imaging features of thoracic fluid collections. 
2. To learn when and how to drain thoracic fluid collection. 
3. To understand patient management. 
A-374 09:21 
C. RFA of lung tumours  
P.L. Pereira; Heilbronn/DE (philippe.pereira@slk-kliniken.de) 
The incidence of lung cancers continues to increase and primary lung cancer 
remains the leading cause of cancer-related deaths in both women and men. 
Therapy of lung tumours includes resection, radiation therapy, chemotherapy, 
thermal ablation or a combination of these treatment modalities. Image-guided 
percutaneous thermal ablation therapies are minimally invasive techniques 
established in the local treatment of hepatic, renal, or osseous tumours. 
Among these techniques, radiofrequency ablation (RFA) has now attained 
consideration for therapy of small pulmonal tumours. Other ablation techniques 
that have been used for treatment of lung tumours include cryoablation, laser 
(LITT) and more recently microwave ablation (MWA) and irreversible 
electroporation (IRE). Ablative techniques may produce a complete and 
irreversible tumour tissue destruction through application of either hot or cold 
thermal energy, or through permeabilisation of the cell membrane while using 
IRE. CT is currently the imaging modality that is most widely used for planning, 
monitoring the ablation's course and for assessment of treatment response. 
Only patients with stage I and stage II lung cancer and those with small 
metastases are potential candidates for ablation. The medical history and 
physical examination of the patient as well as recent imaging with CT should 
be evaluated to determine the indication for thermal ablation. Percutaneous 
lung RFA is considered as a safe procedure with an overall morbidity rate from 
15.2% to 55.6% and mortality rate from 0% to 5.6%; it requires less costs and 
offers faster recovery, and reduced morbidity and mortality.  
Learning Objectives:
1. To learn about the best indications for RFA in comparison to other treatment 
options. 
2. To appreciate the imaging problems during and after lung ablation. 
3. To learn about outcome after RFA. 
Author Disclosure:
 P.L. Pereira: Advisory Board; Terumo. Consultant; Terumo. Research/Grant 
Support; Celon Olympus, Siemens Medical Solutions. Speaker; 
Angiodynamics, Terumo. 
Panel discussion:  
Is there a role for other imaging modalities besides CT?  09:44
08:30 - 10:00 Conf. Room M3  
Oncologic Imaging: Follow-up of Systemic and Local Therapies  
CC 1218  
Assessing HCC response to …  
Moderator:  
C. Bartolozzi; Pisa/IT 
A-375 08:30 
A. Systemic therapies  
V. Vilgrain, M. Ronot, M. Zappa, S. Faivre, E. Raymond; Clichy/FR
(valerie.vilgrain@bjn.aphp.fr) 
Sorafenib, a tyrosine kinase inhibitor, has shown clinical efficacy in patients 
with hepatocellular carcinoma (HCC) and is the standard of care for patients 
with advanced-stage HCC. Nowadays, many targeted therapies are evaluated 
in HCC either as sole treatment or in combination with other treatments such 
as tumour ablation, chemo-embolisation, and surgical resection. Therefore, 
there is a need to assess the efficacy of targeted therapy in HCC. RECIST is 
the reference method to evaluate treatment efficacy in solid tumours, but does 
not seem appropriate in evaluating targeted therapy as objective responses 
are seen in very few cases in patients treated with sorafenib or sunitinib. New 
criteria have been proposed to evaluate the treatment efficacy of nonsurgical 
treatments in patients with HCC. The most common ones are the Choi criteria, 
the EASL criteria, and the modified RECIST criteria. All these criteria mainly 
focus on internal tumour changes such as appearance of necrosis or 
disappearance ot tumour hypervascularity. Many examples will be shown 




during the lecture. Another approach is based on functional imaging and 
especially perfusion-related imaging. Contrast-enhanced ultrasound, CT 
perfusion and dynamic contrast-enhanced MR imaging have the capability to 
assess perfusion changes in patients under treatment. The advantages and 
disadvantages of these modalities will be discussed. Lastly, other functional 
tools that are not routinely used will be presented.  
Learning Objectives:
1. To learn about difficulties in HCC assessment with local therapy. 
2. To become familiar with various evaluation criteria of HCC. 
A-376 09:00 
B. Endovascular therapies  
R. Lencioni; Pisa/IT (riccardo.lencioni@med.unipi.it) 
Tumour response in oncology is usually measured according to Response 
Evaluation Criteria in Solid Tumors (RECIST). The RECIST model - developed 
in 2000 and revised in 2009 with the publication of the version 1.1 - was 
designed for evaluation of cytotoxic agents. It offers a simple approach to 
determining anatomic size and lesion changes during treatment as an indicator 
of response. However, it does not address measures of antitumour activity 
other than tumour shrinkage and was shown to be unable to capture the 
anticancer activity of tumour-directed therapies used in the treatment of HCC, 
such as transarterial chemoembolisation (TACE) and radioembolisation. Given 
the poor correlation observed between response evaluation by conventional 
metrics and overall survival, a group of experts in HCC clinical trials convened 
by the American Association for the Study of Liver introduced the concept of 
viable tumour in HCC response assessment, and proposed specific 
amendments to standard RECIST. The resulting criteria were named modified 
RECIST (mRECIST) for HCC. The mRECIST criteria have been endorsed by 
several scientific societies and organisations and have been increasingly used 
in HCC clinical research. A growing body of scientific evidence suggests that 
mRECIST- designed for response assessment in clinical trials - may translate 
into a tool for clinical practice.  
Learning Objectives:
1. To appreciate the value of different imaging techniques for assessment of 
intra-arterial HCC therapies. 
2. To become familiar with post-treatment imaging after intra-arterial therapies 
according to type of therapy. 
A-377 09:30 
C. Ablative therapies  
C. Ayuso; Barcelona/ES (cayuso@clinic.ub.es) 
The evaluation of treatment efficacy is a key issue with prognostic and patient 
survival implications. It is crucial to have objective and reproducible criteria for 
specific groups of patients. The goal of ablative therapies of HCC is to induce 
tumoural tissue destruction. Complete response (CR) after initial chemical and 
thermal percutaneous ablation, defined as the absence of contrast 
enhancement of the treated tumour at CEUS, dynamic CT or dynamic MR, has 
been reported to correlate to long-term survival. Nevertheless, the clinical 
effectiveness of imaging techniques to assess initial treatment success differs 
according to tumour size. The success rate of RF has been demonstrated to 
be superior to PEI in HCCs > 2 cm, and depends on the ability to ablate all 
viable tumour tissue including an adequate tumour-free margin all around the 
lesion of 0.5 to 1 cm. Thus, the effectiveness of RF directly depends on the 
tumour location and size. RF is considered an effective treatment in lesions 
3 cm and its effectiveness is progressively reduced along with tumour size and 
it is not effective in lesions > 5 cm. CEUS beyond 1 month may confirm or 
detect residual tumour, deserving a final ablation procedure. CT and MR are 
more effective in the follow-up to confirm CR and detect local recurrence, or 
additional HCC lesions in the liver parenchyma. The presence of transient 
hyperaemic inflammatory changes in the periphery of the treated area is a 
common finding that should be considered to avoid overestimation of the 
recurrence rate.  
Learning Objectives:
1. To learn about the value of different imaging techniques for the assessment 
of ablative HCC therapies. 
2. To become familiar with post-treatment imaging after ablative therapies 
according to type of therapy. 
08:30 - 10:00 Board Room A  
Radiographers  
RC 1214  
How important are state-of-the-art displays 
to radiology?  
A-378 08:30 
Chairman's introduction  
C. Vandulek; Kaposvár/HU (cvandulek@gmail.com) 
One of the major characteristics of medical imaging in the twenty-first century 
is the dramatic influx of novel technology. This impact of new technology and 
techniques is experienced in all imaging modalities. The continuous 
development and implementation of highly sophisticated medical products and 
devices is key to the evolution of medical imaging leading to the improvement 
of patient care in terms of quality and positive outcomes. This session will 
analyse state-of-the-art displays (monitors, smartphones, tablets) and their 
applications in modern imaging. The session will provide a brief overview of 
displays in the current imaging chain. It will then evaluate the various 
specifications and parameters associated with displays. The session will 
evaluate current QA standards of modern displays as well as the challenges 
surrounding such novel technologies.  
Session Objectives: 
1. To appreciate the technical parameters associated with display devices and 
why we need to be familiar with them. 
2. To consider the evolution of display devices since the introduction of digital 
imaging techniques. 
A-379 08:35 
A. Primary class displays  
W.A. Hummel; Leeuwarden/NL (willy.hummel@kcl.znb.nl) 
Image quality can be described in terms of resolution and contrast. An image 
displayed on a monitor consists of differences in brightness. The display 
monitor is at the end of the image chain in radiology, which starts at the X-ray 
tube. There are several factors in this chain that have influence on the contrast 
displayed on the monitor. Diagnostic image quality can be described as 
observed contrast, which is not only dependent on the displayed image, but is 
also influenced by ambient conditions. For the primary class displays, typical 
characteristics of display monitors; such as resolution, homogeneity, 
luminance, contrast, monochrome or color, must be appropriate for the 
radiologist to execute a reliable diagnosis. Calibration of display monitors is 
also important. Which parameters are significant and what is the effect of 
variation of these parameters. There are standards like DICOM GSDF and 
technical standard from ACR-AAPM-SIIM.  
Learning Objectives:
1. To understand the range of display devices currently on the market for 
medical imaging purposes. 
2. To explore current legislation and guidelines related to the use of display 
devices in radiology. 
3. To become familiar with current legislation and guidelines on quality control 
and quality assurance procedures. 
A-380 08:58 
B. Is a smartphone all that is required?  
R. Toomey; Dublin/IE (rachel.toomey@ucd.ie) 
Both within and outside the clinical environment, the use of smartphones and 
tablet computers is increasing. Reported applications range from teaching and 
education to navigation in surgical procedures. Interest in the use of 
smartphones and tablets for viewing radiological images has been growing. 
However, these portable displays can differ significantly from conventional 
radiological displays. In order to determine where and how smartphones and 
tablets can be used appropriately, it is important to understand these displays 
and the challenges associated with them. This presentation will outline the 
current and potential uses of smartphones and tablet computers in radiology 
and compare their performance with other radiological displays and standards. 
The possible limitations/benefits of smartphones and tablets as display devices 
for radiological images will be discussed. Recent research in the field will be 
reviewed, with emphasis on studies of diagnostic efficacy.  
Learning Objectives:
1. To become familiar with the growing evidence base that both supports and 
opposes the use of hand-held display devices in medical imaging. 




2. To learn about ongoing developments in radiology display devices and 
whether or not these can currently be justified. 
3. To learn about examples of appropriate and inappropriate use of state-of-
the-art-display devices in radiology. 
A-381 09:21 
C. Clinical requirements for image display  
D. Pekarovic, U. Zdešar; Ljubljana/SI (dean.pekarovic@kclj.si) 
In modern clinical environment, diagnostic monitors have replaced glowboxes 
and films and have become an important part of the imaging chain. The 
required specifications and the quality of monitors largely depend on their 
purpose, beginning from quite simple monitors used for the preview of 
radiographic images placed on modality or in control room to monitors used by 
high-end diagnostic workstations. Decision about the kind of monitor for certain 
workplace is also very important from the economic standpoint as there are 
large differences in their prices. Besides monitor specifications, also ambient 
conditions and ergonometry in the reading rooms are also very important 
issues which need to be considered to ensure optimal environment for clinical 
image reading. Some of good and bad examples will be given in the 
presentation. As with other radiological equipment, also diagnostic monitors 
need to be controlled to ensure their optimum performance. Quality control 
begins with monitor acceptance testing and setting up measurement 
parameters which are to be followed. Practically all monitor vendors include 
some QC software within their workstations which can, together with some 
independent measurements, form an efficient quality control programme. In the 
last steps, how to deliver all information regarding image quality and possible 
presets on the diagnostic monitor and how not to confuse the user are 
important.  
Learning Objectives:
1. To become familiar with clinical requirements in terms of the primary class 
displays used. 
2. To appreciate the practical steps involved in the implementation of a quality 
assurance programme for radiology displays. 
3. To understand the key considerations in evaluating the appropriateness of 
display devices. 
Panel discussion:  
The pros and cons of cutting-edge display devices  09:44 
 08:30 - 10:00 Room P  
EDiR Workshop  
European Diploma in Radiology: what a 
hearty meal!  
A-382 
Appetiser: what is behind the curtain  
Y. Menu; Paris/FR 
Sitting an examination is always a source of anxiety. The EDiR exam is no 
exception. This workshop is dedicated to those who want to take the EDiR 
exam, or become examiners, and would like to learn more about its format and 
discover some tips and tricks. The EDiR organisers and examiners have 
decided to build an interactive, friendly and enjoyable session in order to teach 
the essentials. Some will play the role of the examiners, some the role of the 
candidate. In order to simulate the candidate's experience, this session will 
have no safety net. Some senior members will expose themselves to real 
difficult questions in general radiology. Fortunately, we hope that the attendees 
will be able to help the "candidates" to succeed. Hopefully, you will enjoy this 
session and get some very useful information for your EDiR exam.  
A-383 
Pièce de résistance: live EDiR performance  
L. McKnight1, J. Vilar2, Y. Menu3; 1Langland/UK, 2Valencia/ES, 3Paris/FR  
A-384 
Catch of the day: fun and nasty tricks to succeed or to fail  
S. Barter1, W. Schima2, L.E. Derchi3, M.M. Thurnher2; 1Cambridge/UK,
2Vienna/AT, 3Genoa/IT
A-385 
Nightcap: the EDiR tomorrow  
Y. Menu; Paris/FR
10:30 - 12:00 Room B  
ESR meets Mexico  
EM 4
Oncology imaging in Mexico  
Welcome by the ESR President  
G. Frija; Paris/FR 
Presiding:  
C. Rodríguez Treviño; Mexico/MX 
V.E. Sinitsyn; Moscow/RU 
J. Tanus Hajj; Mexico/MX 
A-386 10:30 
Introduction  
C. Rodríguez Treviño, J. Tanus-Hajj; Mexico/MX
The Mexican Society of Radiology and Imaging, SMRI, was the first radiology 
society in the country. It was constituted in 1926, first as Mexican Society of 
Electroradiology, and in 1942 transformed to Mexican Society of Radiology; 
adding Imaging in the first years of 1970. The Mexican Federation of Radiology 
and Imaging, FMRI, was established in 1972 and is constituted by all the 32 
national radiology societies. Simultaneously, the Mexican Board of Radiology 
began to work in relation to radiologist´s certification. The presidents of these 
institutions have a two-year term. As presidents of SMRI and FMRI, we 
mention our appreciation for the invitation to the European Congress of 
Radiology-European Society of Radiology so that our institutions can 
participate in this important programme: ECR Meets Mexico. Since our Society 
and our Federation were established many decades ago, among our main 
objectives have been promoting continual medical education in radiology and 
contributing to the development of standards of excellence and reliable and 
personalised radiology in a framework of professionalism. For some years, we 
have had the support of radiologist members of ESR-ECR in Mexican courses, 
academic meetings and congresses. The last International Congress of 
Radiology was set in Cancun, Mexico, in 2002, and was organised by FMRI in 
conjunction with the International Society of Radiology, ISR, and the European 
Society of Radiology. For this and other academic support, we also want to 
express our special thanks.  
Session Objectives: 
1. To express our appreciation to the ECR for inviting Mexico to participate. 
2. To learn about Mexican radiology organisations. 
3. To learn about Mexico's participation in international radiology meetings. 
A-387 10:35 
Abdominal imaging in oncology  
L.A. Sosa-Lozano; Mexico City/MX (antonsosarad@gmail.com) 
Abdominal malignancies are an important health problem in Mexico. Like in 
many other middle-income countries, there has been an epidemiological 
transition with an overall increase in oncologic diseases. Colorectal, gastric 
and liver carcinomas are some of the frequent abdominal malignancies. 
Colorectal cancer is a disease that is curable if detected early and even 
preventable if precursor polypoid lesions are removed. Imaging plays a critical 
role in staging at diagnosis. Additionally, virtual colonoscopy is an accepted 
modality in cancer screening. High-resolution magnetic resonance imaging 
(MRI) has become a pivotal modality in the pretreatment assessment of rectal 
carcinoma. Computed tomography (CT) is an excellent modality in the 
preoperative staging of gastric cancer and follow-up after treatment. Positron 
emission tomography (PET) combined with CT (PET/CT) is particularly helpful 
for gastric and colonic carcinoma staging. Hepatocellular carcinoma (HCC) is 
also common. Cirrhosis related to alcohol and hepatitis C infection are by far 
the commonest aetiologies. Ultrasound (US) in conjunction with alpha-protein 
is the most widely used modality for screening purposes. CT and MR are 
confirmatory modalities. The advent of hepatospecific gadolinium contrast 
agents has been very helpful in the characterisation of focal lesions in cirrhotic 
patients. The use of multidetector CT (MDCT) in pancreatic carcinoma for the 
detection of vascular and adjacent organ invasion is crucial in treatment 
planning. Over the last few decades, there has been an important improvement 
in imaging techniques resulting in better quality images. Imaging is critical not 
only for the diagnosis, but also for treatment planning and follow-up.  
Learning Objectives:
1. To learn about the imaging of common oncologic gastrointestinal diseases. 
2. To understand the importance of imaging in liver and colon cancer. 
3. To learn how imaging supports oncologic institutions. 





Interlude: Meet Mexico  
J. Ramírez-Arias; Mexico/MX (jlramirez.arias@saludangeles.com) 
The presentation has the objective of giving the audience a synthesised 
panorama of our country situated in North America, with more than 110 million 
inhabitants and a large prehispanic history based on the Aztec, Toltec and 
Maya cultures, and also of interesting facts related to the three centuries of 
colonial existence under the Spain influence and dominium until the 1810 war 
of Independence. After 1880, Mexico has never had an international war; the 
last was against the northern border country, the United States. Also, we will 
give important data on how in 1910 the Mexicans rebelled against a 30-year 
dictator, General Porfirio Diaz. The Mexican Revolution was a long and cruel 
war, but later opened the doors to democracy and a complex developmental 
era began that is still in process. Some demographic and contributions to 
health, science and culture issues will be mentioned and also the works of 
Mexican scientists, writers and philosophers who have been presented awards 
including the Nobel Prize. In relation to well-known Mexican artists such as 
Diego Rivera and Frida Khalo, some facts of their works will be presented.  
Learning Objectives:
1. To learn some Mexican history. 
2. To learn about the demographics of Mexico. 
3. To learn about Mexican culture in the 2 1st century. 
A-389 11:00 
Interventional radiology in oncologic patients  
G. Elizondo-Riojas; Monterrey/MX (elizondoguillermo@hotmail.com) 
Interventional radiology (IR) is becoming an increasingly prominent 
subspecialty in the care of oncologic patients. Its role extends from initial 
diagnosis to minimally invasive treatment of the malignancy and its 
complications. Image-guided biopsies are increasingly performed using 
minimally invasive techniques. Also, an integral part of care of these patients is 
vascular access as a means of medication, chemotherapy or parenteral 
nutrition, and interventional radiologists can place required the devices with 
well-established safety and efficacy. IR also plays a substantial role in the 
therapy of oncologic patients, through local tumor treatments such as 
transarterial chemo-embolisation and locoregional control with 
radiofrequency/cryo ablation, as well as management of complications of 
malignancy such as pain, obstruction (biliary, ureteral, etc)., venous thrombosis 
and drainage of thoracic and abdominal collections. In Mexico, IR is a growing 
subspecialty, and more medical students nowadays want to be radiologists and 
eventually become interventional radiologists. This is a paradigm shift. More 
and more radiologist wants to be involved with patient management and to be 
more than just "observers" in the process of patient care. We have to be 
prepared to offer this opportunity to our residents; otherwise other specialties 
will "have to fill the empty space" that we have left. Interventional oncology has 
all the advantages to fulfil this opportunity. It is our chance to contribute to the 
advancement of medical care.  
Learning Objectives:
1. To appreciate the role of interventional radiology in the management of 
oncologic patients. 
2. To learn how interventional radiology changes the quality of life for patients 
with cancer. 
3. To understand the impact of interventional radiology procedures in the 
outcome of some neoplastic diseases. 
A-390 11:20 
Interlude: Origins and development of radiology in Mexico  
M.E. Stoopen-Rometti; Mexico/MX (mstoopen@clinicalomas.com.mx) 
Mexican radiology started in 1896, just a few months after the discovery of x-
rays. During the last few decades, as well as in other countries, there has been 
a great development both in public and private sectors, which will be described 
in this interlude.  
Learning Objectives:
1. To learn about the history of radiology in Mexico. 
2. To learn about the development of radiology in Mexico. 
3. To learn about the present and future of radiology in Mexico. 
A-391 11:25 
Modern issues in oncologic ultrasound  
J. Tanus-Hajj; Mexico/MX (jtanus59@hotmail.com) 
Advances in ultrasound (US) technology allow confident characterisation of 
masses. These include harmonic imaging, compound imaging, power Doppler, 
faster frame rates, higher resolution transducers, three-dimensional (3D) US, 
US contrast agents and, more recently, elastography and fusion imaging. High-
frequency transducers provide superb spatial and soft-tissue resolution, 
permitting substantially improved differentiation of subtle lesion, margin 
resolution, and lesion conspicuity in the background of normal tissue. 
Elastography features such as size ratios, shape, homogeneity, and maximum 
lesion stiffness complement conventional US in the analysis of lesions. 
Ultrasound contrast agents have overcome some of the limitations of Doppler 
ultrasound techniques with demonstration of irregular branching central or 
penetrating vascularity within a solid mass raising suspicion of malignant 
neovascularity (neoangiogenesis). Ultrasound contrast agents can provide 
important information in the assessment of lesions to be treated by 
locoregional therapies, which include ablation (feeding vessels), trans-arterial 
chemo/radio-embolisation, detecting viable tumour persistence following this 
treatment; facilitation of needle positioning in cases of poor lesion delineation, 
and assessment of local tumour progression. It facilitates needle positioning in 
cases of incomplete or poor lesion delineation on unenhanced ultrasound. US 
contrast agents are an important key during the evaluation of the immediate 
treatment effect of ablation and guidance for immediate re-treatment of 
residual tumour.  
Learning Objectives:
1. To understand the role of ultrasound in the management of oncology 
patients. 
2. To learn how ultrasound is used in large oncology centers. 
3. To learn about the modern concepts of ultrasound in oncology patients. 
Panel discussion:  
Mexican requirements for international collaboration for  
research programmes, including requirements for visiting professor 
programmes  11:45
10:30 - 12:00 Room C  
Modern Imaging of the GI Tract  
CC 1321  
Inflammatory bowel disease  
Moderator:  
S.A. Taylor; London/UK 
A-392 10:30 
A. Cross-sectional imaging protocols  
M.A. Patak; Zurich/CH (Michael.Patak@hirslanden.ch) 
The aim of this lecture is to give an overview of the techniques for imaging 
inflammatory bowel disease (IBD) of the small bowel and the colon with either 
ultrasound (US), multidetector row computed tomography (MDCT) or with 
magnetic resonance imaging (MRI) and compare the different modalities for its 
strength and weakness. Optimal imaging of the bowel begins with the 
preparation phase. The small bowel has to be distended for a concise 
examination. This is mainly done orally, which is named enterography. A 
solution of 2.5% mannitol seems to be the one preparation technique mostly 
used for small bowel distension. Another technique is the enteroclysis, 
application of contrast after intubation of the small bowel. The comparative 
advatages and disatvantages of the two preparation methods will be 
discussed. This intraluminal contrast gives a neutral contrast in CT and a 
biphasic signal in MR. The colon can be prepared in a fashion similar to 
colonoscopy meaning total cleansing. Another possibility is the so called fecal 
tagging whereas the stool will be contrasted with an additive to standardised 
food. Therefore no cleansing is needed for preparation. Imaging parameters 
will be discussed for MR and CT. The aim of imaging for the bowel should be 
to establish the following: 1) presence, severity, and extent of disease; 2) 
activity of the disease and 3) extra-intestinal complications. US, MR and MDCT 
have proven to be a good tool to evaluate the extent, the activity of the disease 
and the presence of extraluminal complications. Pros and cons will be 
discussed when to use which technique.  
Learning Objectives:
1. To understand state-of-the-art MRI, CT and US protocols for imaging IBD. 
2. To appreciate the comparative advantages and disadvantages of 
enterography and enteroclysis protocols. 
3. To learn about protocol modifications when evaluating the colon. 
A-393 10:50 
B. Small bowel disease  
J. Stoker; Amsterdam/NL (j.stoker@amc.uva.nl) 
Classification of small bowel Crohn's disease is helpful for assessing disease 
activity and treatment monitoring. Similar to clinically based classification, also 
imaging-based classification systems have been developed, of which some 
have been externally validated. Important imaging features for determining 
disease activity include bowel wall thickness and vascularity/enhancement; at 
MRI, also wall oedema plays a role. Stenoses, fistulas and abscesses are 
important sequels. For assessment and monitoring of small bowel disease 




activity, ultrasound is readily available and gives detailed local information but 
is limited by the restricted field of view, communication of results to clinicians 
and comparison of examinations on time. Computed tomography (CT) is fast, 
readily available and gives a detailed, reproducible overview, but radiation 
exposure and contrast resolution are limitations. Magnetic resonance imaging 
combines a good, reproducible overview with high contrast resolution, dynamic 
information and no radiation exposure and is therefore preferable in many 
situations, but the longer examination times than for CT, availability and costs 
are limiting factors. For the diagnosis of stenoses, fistulas and abscesses, 
either technique can be used, although the unrestricted view of CT and MRI 
favour these techniques in many situations. In acute situations, US and CT are 
more accessible than MRI. In that setting US can be considered, but when the 
examination is inconclusive or the patient has clear inflammatory signs, CT is 
preferable.  
Learning Objectives:
1. To learn about the classifications of small bowel Crohn's disease. 
2. To become familiar with cross-sectional imaging signs of disease activity 
and complications. 
3. To understand a rational deployment of cross-sectional imaging techniques 
according to clinical indication, highlighting the main advantages and 
disadvantages of CT, MRI and US. 
Author Disclosure:
 J. Stoker: Consultant; Robarts Clinical Trials. 
A-394 11:10 
C. Colitis  
J. Rimola; Barcelona/ES (jrimola@clinic.ub.es) 
Endoscopy is currently considered the reference standard for the evaluation of 
colonic pathologies, including colitis. It allows direct visualisation of the mucosa 
and in obtaining tissue sample. However, it has major limitations including the 
invasiveness of the technique, incomplete endoscopy and risk of perforation. 
Endoscopy cannot, therefore, help to estimate the depth of involvement of 
transmural inflammation and extraluminal complications. By contrast, an 
evolving role for cross-sectional imaging in the evaluation of patients with 
colitis has been increasingly recognised, especially in the setting of Crohn's 
disease (CD), since cross-sectional imaging has been demonstrated to have a 
high diagnostic accuracy not only for assessing the presence and extension of 
luminal disease, but also for evaluating CD-related acute or chronic 
complications. Establishing the ultimate cause of colitis may sometimes be 
challenging and histology cannot be conclusive. However, cross-sectional 
imaging may provide additional information that is useful in the workup of 
colitis.  
Learning Objectives:
1. To learn about the cross-sectional imaging features of colitis. 
2. To become familiar with differentiating infectious, inflammatory, ischaemia 
and autoimmune conditions based on cross-sectional imaging criteria. 
3. To appreciate an integrated approach to the use of cross-sectional imaging 
in colonic inflammatory bowel disease. 
A-395 11:30 
D. Interactive case discussion  
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk) 
The use of cross-sectional imaging has been increasing in the evaluation of 
inflammatory bowel disease. Following their presentations on imaging 
protocols and features of small bowel disease and colitis, each speaker will 
present a case to illustrate the learning points covered in their lectures. The 
session will be moderated by the chairman and the audience will have full 
opportunity to ask questions of all the panel.  
Author Disclosure:
 S.A. Taylor: Research/Grant Support; NIHR HTA. Other; study reader for 
Robarts. 
10:30 - 12:00 Board Room B  
RTF - Radiology Trainees Forum  
TF 1  
Highlighted Lectures  
Moderators:  
V.H. Koen; Harleem/NL 
N. Pyatigorskaya; Paris/FR 
A-396 10:30 
Imaging hepatocellular carcinoma at the era of multimodality and hybrid 
imaging  
A. Luciani, F. Legou, J. Chalaye, M. Chiaradia, F. Pigneur, M. Djabbari, 
C. Costentin, E. Itti, A. Rahmouni; Creteil/FR 
Multimodality imaging is essential in a wide variety of oncology situations. 
Anatomic imaging, whether using US, CT or MRI, is mandatory for tumour 
localisation. Moreover, the evaluation of treatment response mostly relies on 
size assessment, whether uni- or bi-dimensional. With the advent of new 
targeted bio-therapies, functional imaging has progressively been integrated in 
the imaging strategies whether for better tumour characterisation or for optimal 
evaluation of treatment response. Hence, assessment of molecular targets by 
PET is supplemented by the recent developments of diffusion MRI, reflecting 
tissue architecture and cellularity, tissue perfusion, reflecting angiogenesis, 
and magnetisation properties of tissues. HCC is a primary liver tumour where 
the use of multimodal anatomic, functional and metabolic imaging appears of 
particular interest. According to EASL and AASLD recommendations, non-
invasive diagnosis of HCC can be performed using dynamic contrast enhanced 
cross sectional imaging. Liver MRI provides optimal sensitivity and specificity 
for the detection of as small as 1 cm large HCC. Recent reports have 
suggested that the prognosis of HCC lesions could be anticipated based on the 
combined analysis of metabolic 18 F -FDG PET CT, as well as with diffusion 
weighted imaging. The objective of this lecture will be to highlight the potential 
of combining both metabolic and multimodal cross sectional imaging in order to 
improve the management of patients with HCC.  
Learning Objectives:
1. To appreciate the role of combined multimodal imaging for the management 
of patients with HCC. 
2. To better understand the role of metabolic imaging for the management of 
patients with HCC. 
3. To understand the role of multimodal functional imaging for prognosis 
assessment in HCC patients. 
A-397 11:00 
The (extra)ordinary night shift at the ER  
K. Petrovic; Novi Sad/RS (smakap@sbb.rs) 
Besides the accuracy, working at the ER requires maximal shortening of the 
diagnostics time, which has a significant influence on the patient's outcome. 
Thus, it is the radiologist's duty to be familiar with the pathophysiological 
mechanism of the disorders, specific protocols, possibilities and limits of certain 
examinations, and also to be aware of all possible pearls and pitfalls, to make 
the correct diagnosis. Pathology encountered at the ER has an extremely wide 
range and requires expertise in all imaging modalities from head to toe. The 
more the radiologist is aware of all possible situations, the more is the 
diagnosis accurate, and information given to the clinician is more valuable. The 
aim of this presentation is to point out the possibility of encountering different 
pathological conditions in different body regions. Moreover, it is important to be 
reminded that in radiology there are different modalities, each of which has its 
own indications and limits. This lecture reviews the selected series of cases 
from the ER Department of Clinical Center of Vojvodina, pointing out the most 
common possible differential diagnosis and possible diagnostic mistakes, 
which often occur due to the lack of experience.  
Learning Objectives:
1. To point out the in-depth knowledge and experience in all imaging modalities 
and all body regions required for a radiologist to perform a routine work at the 
ER. 
2. To present a series of cases that are most and less often encountered at the 
ER, discuss the possible differential diagnosis and mistakes which could 
potentially be made. 
A-398 11:30 
Diagnosis and management of pancreatic cystic lesions  
R.J. Méndez; Madrid/ES (ramiro.mendez@salud.madrid.org) 
Pancreatic cystic lesions are frequently diagnosed in patients with clinically 
suspected pancreatic disease, but they are also increasingly detected on 
imaging studies performed due to other abdominal processes. The prevalence 




of pancreatic cysts increases with patient's age. Most symptomatic cysts will be 
surgically resected, whereas asymptomatic lesions should be managed 
depending on the likelihood of causing harm to the patient. Cystic lesions can 
be inflammatory or neoplastic. The incidence of pseudocysts is low without a 
history of pancreatitis. Some pancreatic cystic neoplasms are malignant, but 
even benign lesions can become symptomatic depending on its size and 
location in the pancreas. The radiologist detects most of the pancreatic cystic 
lesions and should also play an important role in the clinical decision-making 
process. Cyst size, morphology, calcifications, contrast enhancement, location 
in the pancreas, relation with pancreatic ducts, patient's age and gender are 
important data to classify the lesion. A specific radiological diagnosis is not 
possible in every patient, but in many cases this information is enough to 
decide on a conservative approach with imaging follow-up. If a more 
aggressive lesion is a concern, then endoscopic ultrasound and fluid analysis 
can help to better characterise some pancreatic cystic lesions. Cyst puncture is 
only recommended if fluid analysis results will modify the patient's 
management. Patient's age, status and preferences should also be taken into 
account. When follow-up is recommended, the preferred imaging technique 
and interval should be indicated.  
Learning Objectives:
1. To learn about the prevalence of pancreatic cystic lesions in the general 
population and how frequently they are detected on imaging studies. 
2. To understand the different types of pancreatic cystic lesions, with emphasis 
on the more frequent aetiologies. 
3. To become familiar with the radiological signs helping to classify the 
pancreatic cysts. 
4. To learn about the consensus guidelines for the management of pancreatic 
cystic lesions. 
10:30 - 12:00 Room N/O  
Professional Challenges Session  
PC 13  
Doing good not harm - understanding 
audit and its role in reducing patient dose  
A-399 10:30 
Chairman's introduction  
P. Cavanagh; Taunton/UK (peter.cavanagh@gmail.com)
The Chair will set the scene for the need for effective radiation protection in 
clinical radiology and highlight the role of clinical audit as a tool in achieving 
this.
Session Objectives: 
1. To appreciate the case for improved radiation protection in diagnostic 
radiology. 
2. To understand the principles of clinical audit. 
3. To learn how clinical audit can be an effective tool in radiation dose 
reduction. 
4. To recognise the relative merits of both internal and external Audit. 
A-400 10:35 
Internal audit in the UK  
S. Barter; Cambridge/UK (suebarter@btinternet.com) 
Clinical audit is defined as a professionally led method of improving patient 
care through the systematic examination of systems, processes and outcomes 
against chosen and agreed standards. It can readily be carried out by 
individuals, groups or whole departments. If properly conducted, clinical audit 
can be an effective way of examining what we do to provide reassurance on 
performance, and to improve patient care. The Clinical Radiology Audit 
Committee (CRAC) of the Royal College of Radiologists (RCR) co-ordinates 
national radiology audit activity. It promotes and facilitates audit through 
nominated audit leads in each hospital, who act as a link between the RCR 
and their department. At least one national audit is carried out annually, with 
data collected via electronic submission and the anonymised results presented 
at an annual Audit Forum. Individual departmental results are analysed using 
statistical process control (SPC) methodology. This enables identification of 
departments underperforming against the national mean, and recommending 
corrective action, by redesigning the process being audited, or by identifying 
and eliminating specific root causes locally. The Committee has developed a 
web-based tool for facilitating local audit, "AuditLive", a fully searchable 
collection of templates which can be downloaded and adapted. Fellows are 
also able to submit their own templates for publication hence sharing best 
practice. Trainees are encouraged to participate in audit through Audit Poster 
competitions at National Radiology Scientific Meetings. Our experience leads 
us to believe that audit succeeds when relevant, locally owned and properly 
structured, and multi-professional, and the RCR model encourages this.  
Learning Objectives:
1. To comprehend the role of clinical audit in radiology practice. 
2. To understand how to facilitate clinical audit locally and nationally. 
3. To become familiar with some of the systems developed in the UK by the 
Royal College of Radiologists. 
Author Disclosure:
 S. Barter: Board Member; Chair Case Collection Committee European Board 
of Radiology, Member of Scientific Board European Board of Radiology. 
Employee; Cambridge University Hospitals Foundation NHS Trust. 
A-401 10:58 
Models of external audit in the Netherlands  
S. Geers-van Gemeren; Utrecht/NL 
In the Netherlands clinical audit is legally obligatory for healthcare professions 
in order to be able to practise since 2010. Clinical audit is a tool designed to 
improve the quality of patient care, experience and outcome through formal 
review of systems, pathways and outcome of care against defined standards, 
and the implementation of change based on the results. The quality of the 
provision of care by professionals is assessed by peers. In the fields of 
Radiology, Nuclear Medicine and Radiotherapy, different models of clinical 
audit are used. For radiotherapy a multidisciplinary audit has been used since 
2003. For Nuclear medicine a multidisciplinary audit has been implemented 
since 2013. For radiology the clinical audit for radiologists and for 
radiographers are separate. Implementation of the multidisciplinary audits 
needs requirements and adjustments of the audit system. This process is 
complex and needs approval of the members of all involved societies. To 
support the clinical audit a web based tool ADAS (General Digital Audit 
System) is used. The development of professional standards is a prerequisite 
to start clinical audit. The use of ADAS in multidisciplinary audits is a 
requirement to be able to audit different professions and focus on the content 
and the quality of their contribution to patient care. Clinical audit is a good tool 
to improve the quality of patient care. Important are the professional standards, 
the culture of learning and willing to improve by the professionals. “Every 
defect is a treasure.” 
Learning Objectives:
1. To learn about the different Dutch models of external clinical audit. 
2. To comprehend the importance of professional standards, the culture of 
learning and willingness to improve. 
3. To become familiar with the use of a digital audit system to support 
multidisciplinary clinical audit. 
A-402 11:21 
External regulatory audit in Finland  
R. Seuri; Helsinki/FI (raija.seuri@hus.fi) 
Directive 97/43/Euratom states that the clinical audit of medical imaging should 
be carried out in accordance with national procedures. The Finnish solution 
has been regulatory external audits every five years by radiological 
professionals with special training for audits. All radiological units have so far 
been audited at least twice, and the third time is performed on site in the unit. 
Although the purpose is to audit the process of radiological practises compared 
to "good practise", special focuses are recommended by the Finnish advisory 
committee for clinical audit, set by the National Institute for Health and Welfare. 
At the beginning focus was on the organisation and documentation of the 
structure and processes of imaging practise like justification, optimisation and 
quality control, but also encouragement and guidance to self-assessment. 
Later special focus has been on paediatric imaging and CT, and the third cycle 
will target deeper to CT practises. The auditing group includes at least a 
radiologist and a radiographer to audit a small unit, and a medical physicist if 
the unit has high-dose modalities like CT. During the audit the auditors work for 
an independent organisation. Multi-professionality gives both insight and the 
possibility to contact all professionals in imaging practise. The focus of clinical 
audit is on quality improvement; it is a way to both give and get feed-back and 
education. It is not control or inspection, but encouragement and guidance to 
self evaluation and implementation of good practises.  
Learning Objectives:
1. To comprehend the supportive role of clinical audit. 
2. To understand the different roles of clinical audit and technical quality 
control. 
3. To become familiar with the Finnish clinical audit system. 
Author Disclosure:
 R. Seuri: Consultant; STUK - Radiation and Nuclear Safety Authority, 
Finland. Other; Auditor: Labquality, Finland. 
Panel discussion:  
How can we use audit more effectively in reducing 
patient dose?  11:44




12:15 - 12:45 Room A  
Plenary Session  
HL 3  
Samuil A. Reinberg Honorary Lecture  
Presiding:  
V.E. Sinitsyn; Moscow/RU 
A-403 12:15 
The tempestuous genesis of MRI: credit and discredit  
M.A. Meyers; East Setauket, NY/US (jimenez1234@optonline.net) 
We often think of the scientific researcher as detached, objective, and 
dispassionate, nobly labouring without any expectation of reward. Nothing 
could be further from the truth. Scientists are as subject to ambition, 
competitiveness, envy and even guile as any person. Lifting the veil on 
scientific discovery reveals to us the human dramas that underlie not only the 
coveting of recognition, but also great conflicts over priority and credit. 
Nowhere are the stakes higher than for that pinnacle of scientific honour: the 
Nobel Prize. MRI has had a notably tempestuous genesis - a cogent episode 
that has much to teach us. It involved an explosive clash of personalities; 
deceit and rampant self-interest; challenges to the basic concept of scientific 
behavior; legal suits and validation by the United States Supreme Court; and 
declamations of denunciation in the international press. It persisted as a 30-
year battle - a prize fight, a blood feud - between two protagonists: one whose 
seminal contribution established the biologic basis of MRI, and the other whose 
flash of insight served as a cornerstone of diagnostic imaging. One was 
awarded the Nobel Prize in medicine in 2010. The other was excluded. Why?  
Learning Objectives:
1. To understand the human elements in the process of discovery. 
2. To understand the factors that determine the attribution of priority and credit. 
3. To understand the courage to think on entirely new lines with innovative 
combinations of insights from different fields. 
4. To understand the challenge of being in a race with another researcher. 
5. To understand the power of entrenched dogma. 
6. To understand the temptation of scientific misconduct. 
12:30 - 13:30 Room E2  
The Beauty of Basic Knowledge: Skeletal Radiology  
MC 26D  
Metabolic, endocrine and marrow disease  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK 
A-404 12:30 
Metabolic, endocrine and marrow disease  
B. Vande Berg, A. Larbi, V. Perlepe, J. Malghem, F.E. Lecouvet; Brussels/BE
(bruno.vandeberg@uclouvain.be) 
1. Metabolic disorders of the skeleton involve the mineralised components of 
the skeleton. They affect all bone components histologically, but involvement 
patterns may vary depending on the age of the patient (growing versus adult 
skeleton) as well as the type of bone (cortical versus trabecular bone). They 
can be depicted on radiographs and CT images, but remain occult on MR 
images because the bone marrow is spared in the vast majority of these 
disorders. MR imaging can help in the assessment of local complication such 
as fractures. 2. Metabolic disorders of the bone marrow can affect either red 
(anemia…) or yellow marrow as well as the balance between these 2 marrow 
types in the body. Medical imaging plays a limited role in the assessment of 
these disorders, but marrow changes associated with these metabolic 
conditions must be recognised to avoid confusion with neoplastic conditions.  
Learning Objectives:
1. To appreciate the musculoskeletal manifestations of systemic disorders and 
their underlying pathomechanisms. 
2. To understand the pathological processes involved in these imaging 
abnormalities. 
3. To appreciate the strengths and weaknesses of imaging modalities in 
assessing these disorders. 
12:30 - 13:30 Room F1  
The Beauty of Basic Knowledge: Interventional Radiology  
MC 25D  
Tumour ablation: a primer  
Moderator:  
M. Bezzi; Rome/IT 
A-405 12:30 
Tumour ablation: a primer  
T.K. Helmberger; Munich/DE (Thomas.Helmberger@klinikum-muenchen.de) 
In primary and secondary malignant tumours of solid organs, in most of the 
cases surgical resection is considered the curative treatment. However, this is 
possible only in about 20% of the cases with tumour-dependent recurrence 
rates of 60% and even more. The main components for adjuvant, neo-adjuvant 
and finally palliative therapy are the permanently growing number of chemo- 
and antibody therapies. Nevertheless, in many cases these therapies provide 
no definitive or long-lasting success, necessitating multimodality treatment 
concepts. In the meantime, local ablative techniques represent the main 
components of these concepts. Three main minimally invasive tumour-ablative 
techniques can be differentiated: chemo-ablation (percutaneous alcohol 
injection, transarterial chemo-embolisation, chemotherapy, chemo-perfusion), 
thermo-ablation (radiofrequency-, microwave-, laser-ablation, high-intensified 
focused ultrasound, cryo-ablation) and radio-ablation (radio-embolisation, 
interstitial brachytherapy, percutaneous stereotactic radiation). These ablation 
techniques differ significantly among each other with respect to their mode of 
action and indications; nevertheless, their benefit is high tolerance and at the 
same time high therapeutic efficacy, which can easily be combined with other 
treatment modalities. The different minimally invasive techniques will be 
discussed together with specific short- and long-term results and 
complications.  
Learning Objectives:
1. To understand the indications for tumour ablation. 
2. To learn about the technique and devices for image-guided ablation. 
3. To learn about results, complications and follow-up strategies. 
14:00 - 15:30 Room A  
Interactive Teaching Session  
E³ 1420  
Common and uncommon errors in plain 
film and CT imaging of the chest: how to 
improve your performance  
A-406 14:00 
Common and uncommon errors in plain film and CT imaging of the chest: 
how to improve your performance  
D. Tack1, N. Howarth2; 1Baudour/BE, 2Chêne-Bougeries/CH
Missed lung lesions are one of the most frequent causes of malpractice issues. 
Chest radiography plays an important role in the detection and management of 
patients with lung cancer, chronic airways disease, pneumonia and interstitial 
lung disease. Among all diagnostic tests, chest radiography is essential for 
confirming or excluding the diagnosis of most chest diseases. However, 
numerous lesions of a wide variety of disease processes affecting the thorax 
may be missed on a chest radiograph. The chest radiograph will also help 
narrow a differential diagnosis, help to direct additional diagnostic measures, 
and serve during follow-up. The diagnostic usefulness of the radiograph will be 
maximised by the integration of the radiological findings with the clinical 
features of the individual patient. CT has a tremendous spatial resolution that 
helps detect lesions in the chest and has proven to be more sensitive and 
specific than chest radiographs. However, missing lesions or misinterpreting 
lesions in CT of the chest is not uncommon. In this session, we will provide 
interactive cases of chest examinations (radiographs and CT) in which lesions 
have been missed and or misinterpreted, with a special focus on how 
correlation with MDCT of missed lung lesions can help improve interpretation 
of plain chest radiographs.  





1. To learn about the common reasons for errors in the interpretation of plain 
film and CT imaging. 
2. To understand how a side-by-side comparison of the chest x-ray and MDCT 
with missed lesions can help reduce the busy radiologist's error rate. 
3. To learn about the skills required for accurate interpretation of plain film and 
CT imaging of the chest. 
14:00 - 15:30 Room B  
New Horizons Session  
NH 14  
Imaging in precision medicine  
A-407 14:00 
Chairman's introduction  
H. Hricak; New York, NY/US (hricakh@mskcc.org) 
This session will explore the value of imaging for facilitating precision medicine, 
in which molecular data (including genomics, proteomics and metabolomics) is 
used to classify patients into subpopulations and tailor treatments to the 
specific molecular characteristics of their diseases. Imaging already plays a 
limited role in precision medicine, primarily through the use of molecular 
imaging techniques (e.g. PET/CT, MRI/PET and hyperpolarised MRI) and 
theranostics (the combination of an imaging agent with a therapeutic entity). In 
the near future, the role of imaging in precision medicine will increase at a 
gradually accelerating pace through the development of new molecular 
imaging probes and theranostic agents and through progress in radiogenomics 
(the correlation of radiologic findings with genomic features). This session will 
discuss recent findings and methodologies in radiogenomics as well as the use 
of nanotechnology for designing novel molecular imaging probes and 
theranostics. In addition, as theranostics is often considered the essence of 
precision medicine, the session will provide an in-depth look at current and 
emerging theranostic strategies and their special benefits for treatment 
selection, assessment of dose distribution of targeted therapies, and treatment 
follow-up.  
Session Objectives: 
1. To understand the importance of imaging in precision medicine. 
2. To learn about the emerging field of radiogenomics. 
3. To appreciate the value of nanotechnology for molecular imaging and 
theranostics. 
A-408 14:05 
Radiogenomics and personalised (precision) medicine  
G.P. Krestin; Rotterdam/NL (g.p.krestin@erasmusmc.nl) 
"Precision medicine" as well as related notions, such as personalised 
medicine, or stratification medicine, all revolve around the idea that the 
consideration of individual characteristics - molecular and otherwise - can 
improve medical research and practice. Precision medicine is a multi-faceted 
approach to medicine that integrates molecular and clinical research with 
patient data and outcomes. Individual assessment of the location and extent of 
an alteration is and always has been the basis of medical imaging, whether the 
'alteration' is a disease, a malformation, or an injury. As such, medical imaging 
intrinsically enables "precision medicine". The addition of genomic data in the 
last twenty years allows new correlations to be made between cellular 
genomics and tissue-scale imaging. Structural and functional imaging and the 
automated analysis of large amounts of image data have only recently reached 
a stage where they can be used on a large scale and in a population setting. 
Identifying common genetic variants that contribute to explain variance in 
imaging phenotypes by a systematic analysis of the genome is based on 
genome-wide association studies (GWAS). The power of GWA analyses has 
been recently demonstrated with the identification of susceptibility genes 
involved in a range of imaging phenotypes like coronary artery calcifications, 
intracranial volume, or size of the hippocampus. These developments highlight 
new etiological pathways and are expected to improve the understanding of 
the molecular basis of some diseases. Correlation between genotype and 
imaging phenotypes may be relevant for further characterising the 
development of disease states.  
Learning Objectives:
1. To understand new concepts of precision medicine. 
2. To learn about the potential correlation between genomics and imaging 
phenotypes. 
3. To appreciate the future role of imaging in precision medicine. 
Author Disclosure:
 G.P. Krestin: Advisory Board; Technion University, LMU,. Consultant; GEHC 
Europe. Grant Recipient; Siemens, GEHC, Bayer HC, Philips HC, Bracco SA. 
A-409 14:28 
Use of nanotechnology, imaging and therapy  
T. Lammers; Aachen/DE (tlammers@ukaachen.de) 
Advances in nanotechnology and chemical engineering have led to the 
development of a significant number of novel materials for diagnosis and 
therapy. Many different diagnostic and therapeutic nano- and micro-materials 
have been designed and evaluated over the years, including, e.g. gadolinium-
containing dendrimers, USPIO nanoparticles and microbubbles for functional 
and molecular imaging, and drug-loaded liposomes, polymers and micelles for 
temporally and spatially controlled drug delivery to tumors and to sites of 
inflammation. In the literature, such advanced nano- and micromaterials are 
generally claimed to be highly useful and broadly applicable. A critical 
reflection on their specific capabilities, however, as well as on their 
pharmacokinetic properties, biodegradability and toxicity is often lacking. In the 
present lecture, I will briefly introduce the rationale for using diagnostic and 
therapeutic nanomaterials. I will highlight several clinically relevant examples in 
which nano- and micromaterials hold potential for improving disease diagnosis 
and detail how combining diagnostic and therapeutic properties within a single 
'nanomedicine' formulation can be used to individualise and improve (chemo-) 
therapeutic treatments.  
Learning Objectives:
1. To learn about the design and construction of nanoparticles for use in 
imaging and therapy. 
2. To appreciate both the advantages and limitations of using nanoparticles as 
agents for both imaging and therapy. 




W. Weber; New York, NY/US 
Precision medicine requires diagnostic tests that predict the effectiveness of 
specific therapeutic interventions for individual patients. This close interaction 
between therapeutics and diagnostics is expressed in the term "theranostics". 
A frequently used example for a theranostic is the staining of tumours for 
HER2 expression prior to therapy with HER2 antibodies, such as trastuzumab 
or pertuzumab. Theranostic has also been practised since many years in 
nuclear medicine by using radioiodine scans to select patients for treatment 
with iodine-131. A more recent example is the selection of patient for peptide 
receptor-targeted radiotherapy (PRRT) by somatostatin receptor imaging. 
Imaging is highly attractive for theranostics, because it allows investigators to 
study the spatial and temporal heterogeneity of target expression, whereas in 
vitro assays generally analyse a small part of the tumour at one point in time. 
Several molecular imaging probes, such 89Zr-trastuzumab or folate receptor 
targeting ligands, are in clinical development as in vivo companion diagnostics. 
Imaging companion diagnostics can also be used to assess tissue 
pharmacokinetics and thereby help to determine the optimal dose and dose 
schedule of therapeutic agents. They can also identify unexpected interactions 
between two therapeutic agents. For example, studies with 11C-docetaxel have 
shown that bevacizumab can markedly decrease the intratumoral delivery of 
docetaxel. Finally, imaging-based companion diagnostics can assess target 
inhibition, as demonstrated by the inhibition of uptake of the androgen receptor 
ligand 18F-FDHT in metastatic prostate cancer treated with anti-androgens. 
Imaging-based companion diagnostics are therefore expected to play an 
important role in establishing precision medicine.  
Learning Objectives:
1. To become familiar with current and emerging theranostic strategies and 
technologies. 
2. To understand the value of theranostics for assessing dose distribution and 
the efficacy of targeted therapy. 
3. To understand the key benefits of theranostics for treatment selection and 
follow-up. 
Author Disclosure:
 W. Weber: Advisory Board; Endocyte, MSD. Grant Recipient; Bayer, Philips. 
Panel discussion:  
Imaging in precision medicine: extracting simplicity  
from complexity  15:14




14:00 - 15:30 Room C  
Modern Imaging of the GI Tract  
CC 1421  
Rectal cancer  
Moderator:  
L.C.O. Blomqvist; Stockholm/SE 
A-411 14:00 
A. Imaging protocols  
S. Gourtsoyianni; London/UK (sgty76@gmail.com) 
ERUS technique as well as the state-of-the-art MR imaging protocols tailored 
according to the presenting rectal tumor site, allowing trained radiologists to 
obtain all necessary information for appropriate treatment decision-making, will 
be described. Normal cross-sectional appearances as well as morphological 
and signal changes encountered in pelvic structures/tissues that may be 
involved in primary rectal cancer will be illustrated. The influence of imaging 
findings on initial therapeutic approach and potential limitations of different 
imaging techniques will be discussed.  
Learning Objectives:
1. To become familiar with state-of-the-art MRI and US protocols for rectal 
cancer staging. 
2. To understand the normal appearances of the rectum and perirectal tissues 
on cross-sectional imaging. 
3. To understand the advantages and disadvantages of imaging techniques in 
evaluating the rectum. 
A-412 14:20 
B. How to stage lymph nodes in rectal cancer  
G. Brown; Sutton/UK (gina.brown@rmh.nhs.uk) 
The staging and categorisation of malignant lymph nodes in patients with rectal 
cancer is a topical issue and has resulted in some degree of confusion. Much 
enthusiasm has been expended in determining whether mesorectal nodes are, 
or are not, involved in the primary disease process, as there is a perception 
that nodal disease is an important determinant of local recurrence. This 
incorrectly perceived association of nodal status and a high risk of pelvic 
recurrence have propagated the concept that this should be the primary 
indication for neoadjuvant therapy regardless of whether TME surgery is to be 
performed. Furthermore, misinterpretation of involved local nodes results in 
over-treatment of patients, if firstly involved nodes alone are considered as a 
poor prognostic factor, and secondly the optimal treatment of involved nodes is 
pelvic radiotherapy plus a non-systemically acting but radiosensitising dose of 
chemotherapy within chemoradiotherapy (CRT) schedules. In this lecture, the 
evidence for risk factors associated with nodal disease and validated risk 
factors for local recurrence will be reviewed. The evidence for both the optimal 
techniques and objective criteria for assessing lymph nodes with magnetic 
resonance imaging (MRI) will be presented.  
Learning Objectives:
1. To learn about the importance of lymph node staging in rectal cancer. 
2. To become familiar with an approach to assessing lymph nodes and be 
aware of pitfalls. 
3. To appreciate the influence of nodal status on treatment outcomes. 
A-413 14:40 
C. Assessment after treatment  
R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
The standard treatment for advanced rectal cancer is preoperative 
chemoradiotherapy (CRT) followed by standard resection of the rectum and 
mesorectum. Neoadjuvant CRT allows downsizing and downstaging of the 
tumour, leading to improved resectability and local control. While the role of 
MRI in rectal cancer treatment is recognised and MRI is recommended as part 
of the standard staging workup, its role for restaging after preoperative 
treatment is more controversial. This lecture will provide an understanding of 
whether and how MRI can assess treatment response in rectal cancer and how 
it may impact treatment decision. The attendees will learn about the difficulties 
in image interpretation and learn about potential new imaging techniques to 
improve its performance.  
Learning Objectives:
1. To understand the role of imaging in treatment response assessment of 
rectal cancer. 
2. To learn about imaging features which identify viable disease after chemo-
radiation. 
3. To appreciate the role of imaging in the modern management of patients 
with rectal cancer. 
A-414 15:00 
D. Interactive case discussion  
L.C.O. Blomqvist; Stockholm/SE 
14:00 - 15:30 Room D  
Chest  
RC 1404  
Pulmonary infections: the old and the new  
Moderator:  
N. Sverzellati; Parma/IT 
A-415 14:00 
A. Mycobacterial infections  
C. Beigelman; Lausanne/CH 
Primary TB typically presents with consolidation in the middle and lower lobes, 
and necrotic lymphadenopathy. Fibrosis, tuberculomas and calcified nodes 
may result as sequelae. Cavitation and tree-in-bud appearance involving the 
apical and posterior segments of the upper lobes and the superior segments of 
the lower lobes are the hallmarks of reactivation TB is typically seen in 
immunocompetent patients. In immunocompromised patients, primary TB 
findings are more commonly observed, as miliary or disseminated disease or 
atypical manifestations in case of severe immunosuppression. Pleural effusion 
and tracheobronchial involvement may be observed. The "classical" 
appearance of non-TB mycobacteria (NTM), less common and more indolent 
than TB, typically affects males more than 50 years old with pre-existing 
pulmonary disease or underlying immunologic disorder. Despite a great 
overlap in the radiologic appearances of both infections, the presence of 
cavities on sites other than the upper lobes should suggest an NTM infection. 
The "nonclassical" form related to MAC infection that predominantly affects 
elderly women with no pre-existing pulmonary disease mainly consists in mild 
bronchiectasis and centrilobular nodules predominantly located in the lingula 
and middle lobe. A high rate of lymphadenopathy and disseminated disease 
are seen in immunocompromised patients. The radiologist has to ensure the 
diagnosis of active TB and mention scarring before starting specific treatments; 
to suggest NTM infections, immune reconstitution inflammatory syndrome with 
paradoxical worsening in HAART treated HIV-infected patients as multi-drug 
resistant TB; to appreciate the extent of disease and follow-up; to diagnose the 
complications; to propose MRI or PET scans in some situations.  
Learning Objectives:
1. To appreciate the imaging features of primary and post-primary infections in 
TB. 
2. To learn about the similarities and differences between TB and non-TB 
mycobacterial infections. 
3. To understand the radiologist's role in diagnosis. 
A-416 14:30 
B. Infectious disease in immuno-compromised patients  
C. Heussel; Heidelberg/DE 
The appropriate investigational technique, frequently targeted differential 
diagnosis, and the special needs of immunocompromised patients need to be 
understood by the referring physician as well as by the radiologist. Thus, an 
intensive interdisciplinary co-operation on a patient basis, as well as on a 
department basis is essential. Early detection of a focus is the major goal in 
febrile neutropaenic patients. As pneumonia is the most common focus, chest 
imaging is a special radiological task. The sensitivity of chest x-ray, especially 
in the supine position, is known to be low. Therefore, the very sensitive thin-
section multislice-CT became the gold standard in neutropenic hosts and might 
be cost-effective in comparison to antibiotic treatment. The infiltrate needs to 
be localised, so that this information can be used as guidance for invasive 
procedures for further microbiological workup. Furthermore, the radiological 
characterisation of infiltrates gives a first and rapid hint to differentiate between 
different sorts of infectious (e.g. typical bacterial, atypical bacterial, fungal) and 
non-infectious aetiologies. Follow-up investigations need careful interpretation 
according to disease, recovery, and concomitant treatment. Due to a high 
incidence of fungal infiltrates, interpretation of the follow-up of an infiltrate must 
use further parameters besides the lesion size. Besides the lungs, also other 
organs systems such as brain, liver and paranasal sinuses need attention and 
are to be imaged with the appropriate technique.  
Learning Objectives:
1. To appreciate the various types of immuno-deficiencies and their related 
infections. 
2. To become familiar with the role of the radiologist in immuno-compromised 
patients. 
3. To learn how to follow pulmonary infections in immuno-compromised 
patients. 





 C. Heussel: Consultant; Schering-Plough, Pfizer, Basilea, Boehringer 
Ingelheim, Novartis, Roche, Astellas, Gilead, MSD, Lilly, Intermune, Fresenius. 
Patent Holder; Methods and Device For Representing the Microstructure of the 
Lungs. IPC8 Class: AA61B5055 FI, PAN: 20080208038, Inventors: W. 
Schreiber, U. Wolf, A.W. Scholz, C.P. Heussel. Research/Grant Support; 
Siemens, Pfizer, MeVis. Shareholder; Stada, GSK. Speaker; Gilead, Essex, 
Schering-Plough, AstraZeneca, Lilly, Roche, MSD, Pfizer, Bracco, MEDA 
Pharma, Intermune, Chiesi, Siemens, Covidien, Pierre Fabre, Boehringer 
Ingelheim, Grifols, Novartis. 
A-417 15:00 
C. Emerging infections  
T. Franquet; Barcelona/ES (tfranquet@santpau.cat) 
Despite advances in diagnosis and treatment, new pulmonary infections have 
been diagnosed. Streptococcus pneumoniae remains the main aetiological 
agent in outpatients with community-acquired pneumonia (CAP). Elderly 
patients or those with toxic habits and various comorbidities favour the 
development of severe CAP. In addition, the development of nucleic acid 
amplification techniques has emphasised the role of concomitant bacterial and 
viral pneumonia in the outcome of CAP in elderly patients. Healthcare-
associated pneumonia has been recently defined as a different infectious 
condition by the American Thoracic Society/Infectious Diseases Society of 
America (ATS/IDSA). The main concern of this new disease is the risk of 
having an infection due to multidrug-resistant pathogens. With the advent of 
HAART and increased long-term survival of HIV-positive patients, the range of 
pulmonary manifestations has also evolved. In patients with haematological 
malignancies or after HSC transplant, Aspergillus is a common infection. 
Actually, Aspergillus spp. isolation from LRT samples in COPD may indicate an 
increased diagnosis possibility of IPA. New emerging viruses such as Human 
metapneumovirus (hMPV), SARS-associated coronavirus, and Avian influenza 
caused by the H5N1 virus have been diagnosed. In 2009, an outbreak of a 
novel swine-origin influenza A (H1N1) virus was reported. The clinical 
diagnosis of new pulmonary infections as well as the presence of concomitant 
bacterial and viral infections has been significantly enhanced by improved 
laboratory methods. A systematic approach to the radiological evaluation of 
lung infections is essential and includes not only chest imaging pattern 
recognition, but also integration of available demographic, clinical and 
laboratory information.  
Learning Objectives:
1. To learn more about emerging infections. 
2. To become familiar with radiological patterns and conditions which suggest 
viral infections. 
3. To learn how to improve diagnostic accuracy. 
14:00 - 15:30 Board Room B  
Paediatric  
RC 1412  
Normal variants in paediatric imaging: not 
to be confused with disease  
Moderator:  
M. Raissaki; Iraklion/GR 
A-418 14:00 
A. Brain  
A. Rossi; Genoa/IT (andrearossi@ospedale-gaslini.ge.it) 
The paediatric central nervous system is a complex structure undergoing rapid 
development. As such, there is a rapid, continuous modification of what is 
"normal" in relation to age and the stage of development. Knowledge of the 
normal patterns of brain development in the clinically relevant ages from 0 to 
18 years is necessary to interpret neuroimaging findings correctly. Knowledge 
of embryology and normal variants is also greatly helpful. MR imaging 
equipment and parameters need to be adjusted and optimised for paediatric 
studies. Pitfalls often occur from the misunderstanding of normal conditions 
that are perceived as abnormal based on a comparison with the appearance of 
the normal brain in adults. This includes, for instance, the evaluation of the 
brain in the first 2-3 years of life during the course of the process of 
myelination. A summary of the most frequent conditions that may lead to 
misinterpretation of findings will be provided.  
Learning Objectives:
1. To learn about normal variants in the neonatal and child's brain. 
2. To understand the typical imaging characteristics of normal variants that 
should suffice for correct interpretation. 
3. To become familiar with the differentiation between normal variants and 
disease. 
A-419 14:30 
B. Chest and abdomen  
S.G.F. Robben; Maastricht/NL (s.robben@mumc.nl) 
A wide spectrum of anomalies of thoracic and abdominal organs may be 
encountered on radiologic evaluation. These anatomic variants and 
developmental anomalies can all pose a diagnostic challenge to the radiologist. 
Familiarity with these anomalies, the imaging techniques available for their 
study, and their variable imaging manifestations is necessary for differentiating 
them from pathology. A basic understanding of the embryologic development 
and normal anatomy of thoracic and abdominal organs and vessels is also 
essential for identifying these anomalies. This review explores the wide 
variability in appearance of the normal thoracic and abdominal organs during 
imaging, stressing a thorough understanding of normal anatomy to recognise 
normal variants.  
Learning Objectives:
1. To learn about normal variants in the neonatal and paediatric chest and 
abdomen. 
2. To become familiar with the imaging appearances of common normal 
variants. 
3. To understand how to differentiate between normal variants and disease. 
A-420 15:00 
C. Musculoskeletal  
F. Saez; Barakaldo/ES (fersaez@yahoo.com) 
The skeleton of a child is a developing system with a variety of changing 
normal appearances. Imaging studies, especially plain films, are requested for 
many clinical reasons, and the radiologist is in the position to determine if an 
image is a normal finding or we are dealing with a lesion. The way the physis 
and epiphysis grow, ossify, and fuse constitutes a great source of 
physiologically bizarre appearances, which the radiologist must be familiar 
with. This talk will concentrate on the plain film diagnosis of some of the most 
common musculoskeletal variants. Other imaging modalities will also be shown 
when appropriate for the case. Irregularities, asymmetries, partial fusions, 
hypo- or hyper-dense bone areas, accessory bones, prominent normal 
structures, external artifacts, and potential fracture lines are the most often 
encountered pseudolesions. A defective radiological technique may also be 
potentially misleading. Patient age, location of the supposed "abnormality" and 
lack of significant local symptoms are key factors. Usually plain films, 
correlated with regional clinical findings, are the only imaging method that is 
required. However, in certain doubtful situations, ultrasound, CT, MRI, bone 
scan, or even biopsy may be needed to reach the right diagnosis. Unnecessary 
overuse of these imaging modalities, and the subsequent family anxiety that 
ensues from this overuse, should be avoided with careful analysis of the X-ray 
and clinical findings.  
Learning Objectives:
1. To learn about normal variants in the neonatal and paediatric 
musculoskeletal system. 
2. To become familiar with the imaging appearances of common normal 
variants. 
3. To understand how to differentiate between normal variants and disease. 
4. To learn how to integrate age, location and clinical history with the 
radiological features before establishing a diagnosis. 
14:00 - 15:30 Room E1  
Musculoskeletal  
RC 1410  
How I do and report  
Moderator:  
F. Kainberger; Vienna/AT 
A-421 14:00 
A. MRI of the hip  
J. Teh; Oxford/UK (jamesteh1@googlemail.com) 
The purpose of this lecture is to cover the clinical presentation, underlying 
pathological processes and essential MRI features of relatively common 
conditions affecting the hip. As the hip is afflicted by different conditions 
according to age, this is how the various pathological entities will be presented. 
A simple imaging algorithm is presented showing the role of MRI. The role of 
MR arthrography in the assessment of the dysplastic hip and femoro-
acetabular impingement is covered. A structured approach to MRI reporting is 
outlined.  





1. To learn about standardised imaging. 
2. To understand the MRI specific findings that aid diagnosis. 
3. To learn a structured approach to reporting. 
A-422 14:30 
B. MRI of the spine and sacroiliac joints  
A. Feydy; Paris/FR (antoine.feydy@cch.aphp.fr) 
MRI is the preferred imaging modality for spinal and SIJ imaging in patients 
with suspected or established spondyloarthropathies (SpA). There is a need to 
perform standardised and efficient MR protocols in this clinical setting. The 
main goals are to detect inflammatory active lesions and also structural 
lesions. In addition, the MRI should be able to diagnose other diseases such 
as disk degenerative disease, DISH, or metastases in patients with 
nonconfirmed SpA. A systematic approach is recommended for MRI reading. 
The radiologist report has to focus on the more specific MRI findings of SpA, if 
present, and to give a conclusion regarding the activity and the structural 
damages.  
Learning Objectives:
1. To learn standardised imaging. 
2. To understand the MRI specific findings that aid diagnosis. 
3. To learn a structured approach to reporting. 
A-423 15:00 
C. MRI of the hand  
C. Schueller-Weidekamm; Vienna/AT
(claudia.schueller-weidekamm@meduniwien.ac.at) 
MRI of the hand requires high spatial resolution, perfect immobility, and 
homogeneous fat suppression. The hand can either be placed in the 
Superman position, which often is uncomfortable for the patients, or both 
hands can be placed above the abdomen next to each other while the patient 
is in the supine position. Standard sequences are axial PD, followed by coronal 
T1 TSE, and T2 TSE FS in the coronal and sagittal planes. Additional 3D 
gradient echo sequences with fat saturation are recommended to assess 
ligaments and cartilage, as well as the triangular fibrocartilage complex 
(TFCC). In certain cases, MR arthrography with thin-slice T1 FS is helpful for 
further evaluation of the wrist ligaments. In inflammatory diseases, such as 
rheumatoid arthritis, static or dynamic T1 FS sequences are useful to assess 
tenosynovitis and synovitis. The most common injuries and inflammation of the 
hand and wrist are discussed with special emphasis on key findings for an 
accurate diagnosis. The awareness of advantages and drawbacks of other 
imaging modalities, such as conventional radiographs and CT, should be 
strengthened. The clinical impact of the radiological report is discussed to 
strengthen the importance of proper terminology for the description of 
pathological findings. The structure of the report should be clear and concise, 
and should allow an interaction and broad communication with clinicians.  
Learning Objectives:
1. To learn about standardised imaging. 
2. To understand the MRI specific findings that aid diagnosis. 
3. To learn a structured approach to reporting. 
14:00 - 15:30 Room E2  
Oncologic Imaging  
RC 1416  
Gastro-entero-pancreatic neuro-endocrine 
tumours (GEP-NET): a multidisciplinary 
update
A-424 14:00 
Chairman's introduction  
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
Gastro-enteropancreatic neuroendocrine tumours (GEP-NET) are a 
heterogeneous group of cancers that differ in their biology and clinical 
presentation. Diagnosis of these tumours has been improved by advances in 
pathology and classification and by the combined use of structural imaging and 
functional imaging modalities. Multimodal imaging is increasingly recognised 
both in detecting and staging disease and also in characterising biological 
patterns of lesions that may be relevant to the selection and delivery of 
therapy. In this course, the complex nature of GEP-NET and the intrinsic uses 
and limitations of each diagnostic imaging modality will be underlined. Insights 
to hybrid structural and molecular imaging techniques will be provided and 
discussed.  
A-425 14:05 
A. Tumour biology, pathogenesis and classification  
B. Wiedenmann; Berlin/DE (bertram.wiedenmann@charite.de) 
Neuroendocrine tumour cells are characterised by the coexpression of 
neuronal and epithelial proteins and cellular organelles such as synaptic 
vesicles containing synaptophysin of neurons and intermediate 
filaments/cytokeratins of the epithelial cells. Based on the presence of 
secretory vesicles and the continous, uncontrolled vesicular release of biogenic 
amines, neuropeptides and hormones, patients suffer in half of the cases of so 
called functional symptoms and syndromes. Examples are the carcinoid 
syndrome (excessive release of serotonine) or the Zollinger-Ellison syndrome 
(excessive release of gastrin). Activation or inhibition of certain G-protein 
coupled receptors (e.g. somatostatin receptors) or channel proteins (R-type 
calcium channels) can lead to the control of the hypersecretion or so called 
functionality of the affected patients. Medical interference with signal 
transduction pathways involving tyrosine kinase receptors as such mTor and 
channel proteins can lead to an inhibition of cellular and tumour growth. These 
observations have led to the establishment of new therapies, especially for 
pancreatic NETs using especially mTor and tyrosine kinase inhibitors. Whereas 
the tumorigenesis is unknown in the case of sporadic NETs, hereditary NETs 
appear to develop via a menin mutation through the intermediate stage of 
hyplasia before they develop the full metastatic potential. Based on the above 
given tumour biological and histopathological findings, a rather robust 
classification for NETs has been developed by the European Neuroendocrine 
Tumor Society (ENETS) using a TNM-classification together with a grading-
system. Furthermore, the formerly used terms such as APUDOMa, 
Neurocrestoma, Carcinoid, etc. have been largely replaced by the meanwhile 
generally accepted term neuroendocrine tumour.  
Learning Objectives:
1. To learn about the basic aspects of GEP-NET biology, pathogenesis and 
classification. 
2. To understand the epidemiology and current treatment options. 
3. To become familiar with rational clinical management. 
Author Disclosure:
 B. Wiedenmann: Advisory Board; Novartis, IPSEN Biotech, Pfizer. Speaker; 
Novartis, IPSEN Biotech. 
A-426 14:28 
B. The current role of nuclear medicine  
C. Deroose; Leuven/BE (christophe.deroose@uzleuven.be) 
This presentation will focus on the pivotal role of nuclear medicine in the 
diagnosis and treatment of neuroendocrine tumours (NETs). The metabolic 
and molecular imaging capabilities of both positron emission tomography 
(PET) and single photon emission tomography (SPECT) have made a great 
impact on the clinical management of patients with these tumours. A poster 
child of molecular imaging in oncology is scintigraphy of the somatostatin 
receptor (SSR). 111In-DTPA-octreotide has a substantial value in detection, 
diagnosis and staging of NET and more particularly in gastroenteropancreatic 
NETs. Newer SSR-binding radiopharmaceuticals have been developed for 
PET, mainly with gallium-68 as radiolabel, with higher affinity and more 
advantageous pharmacokinetics. When used with high-resolution and rapid-
throughput multimodal whole body imaging of modern PET/CT cameras, these 
tracers provide the current state-of-the art SSR imaging. We will also discuss 
the clinical value of metabolic tracers, such as [18F]-FDG for glucose 
metabolism imaging, [18F]-DOPA and [11C]-HTP ([11C]5-hydroxytryptophan) for 
amino acid metabolism imaging. The clinical merits and indications of these 
tracers will be explained. The continuously evolving quest to develop tracer for 
other receptor systems expressed on NETs will be illustrated, e.g. bombesin, 
VIP, CCK and glucagon-like peptide receptor ligands. Finally, the role of 
imaging as selection for metabolic and peptide receptor radionuclide therapy 
will be discussed.  
Learning Objectives:
1. To learn about the cellular properties and GEP-NET used in molecular 
imaging. 
2. To become familiar with the different modalities and new tracers being used. 
3. To learn about the performance of the different methods available. 
Author Disclosure:
 C. Deroose: Advisory Board; Merck; Endocyte. 
A-427 14:51 
C. Anatomical imaging: transabdominal US, endoscopic US, MDCT and 
MRI: which is the most appropriate imaging approach?  
V. Vilgrain, M.-P. Vullierme, P. Ruszniewski, A. Sauvanet; Clichy/FR
(valerie.vilgrain@bjn.aphp.fr) 
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are a 
heterogeneous group of neoplasms that arise from cells of the diffuse 
neuroendocrine system and may present with a wide spectrum of clinical 




presentations. Their prognosis is mainly related to their biology, proliferation 
and differentiation. The main goals of imaging are the diagnosis and the 
staging of these tumours. The diagnostic challenge is very different in 
functional tumours where clinical presentation and laboratory parameters are 
of utmost importance and in nonfunctional tumours where imaging may show 
characteristic features such as hypervascularisation and calcifications. Staging 
is also essential as locoregional involvement and distant metastases (such as 
liver metastases) may change the therapeutic approach and are major 
prognostic factors. Multimodal workup included morphological imaging 
modalities with CT and MR imaging, and endoscopic ultrasound was the most 
useful and functional imaging. The latter includes somatostatin receptor 
scintigraphy, FDG PET and more recent functional tools such as PET using 
68Ga and 18 F-DOPA. Imaging may also play a role in assessing prognosis in 
combination with tumour differentiation and tumour proliferation, obtained from 
pathologic examination. Last, imaging is useful in evaluating tumour response 
after treatment. Although surgery remains the only potentially curative therapy 
for patients with primary GEP-NETs, other available treatments include 
chemotherapy, interferon, somatostatin analogues, and targeted therapies. 
Imaging criteria rely not only on changes in tumour size, but also on internal 
tumour changes.  
Learning Objectives:
1. To learn how to recognise the specific imaging features of GEP-NET. 
2. To learn about the strengths and weaknesses of the different imaging 
modalities. 
3. To understand the optimal use of the different imaging modalities in relation 
to tumour location and staging. 
Panel discussion:  
The future of hybrid imaging  15:14
14:00 - 15:30 Room F1  
Special Focus Session  
SF 14a  
Assessment of brain perfusion with 
arterial spin labelling (ASL)  
A-428 14:00 
Chairman's introduction  
X. Golay; London/UK (x.golay@ucl.ac.uk) 
The purpose of this session is to bring the audience up to date with a novel 
MRI method capable of measuring brain perfusion. This method is called 
arterial spin labelling (ASL) and provides a complete non-invasive means to 
quantitatively assess cerebral blood flow (CBF). As with any MRI technique, 
ASL relies on proper setting of many technical parameters to provide an 
adequate image quality, with minimal influence from potential artefacts. A 
recent position paper, co-signed by members of the Perfusion Study Group 
from the International Society for Magnetic Resonance in Medicine and the 
European COST-funded Action on 'ASL in Dementia', has established a series 
of simple guidelines to help promote this technology in clinical practice. These 
guidelines will be provided within this session. The created CBF maps will then 
be analysed, and a simple description of the main features and clinical 
characteristics of these physiological images will be given to the audience. In 
particular, a proper difference in the meaning of CBF in several diseases will 
be highlighted, as it can be either causative, such as e.g. in stroke and 
cerebrovascular diseases, where a reduced CBF leads to a breakdown in 
tissue homeostasis, or consequential, as in e.g. dementia, in which a reduction 
of CBF is the mere reflection of impaired metabolism, combined or not with an 
underlying brain atrophy. Following this session, the radiologist or clinician 
should be able to better appreciate ASL-based SBF maps in several 
neurological conditions.  
Session Objectives: 
1. To understand which elements are key to ensuring the optimal estimation of 
cerebral blood flow by ASL. 
2. To become familiar with the imaging features of ASL. 
3. To understand the clinical role of ASL in neurological diseases. 
Author Disclosure:
 X. Golay: Research/Grant Support; Philips Healthcare. 
A-429 14:05 
An introduction to ASL, its jargon and methods  
M. Guenther; Bremen/DE (Matthias.Guenther@mevis.fraunhofer.de) 
Perfusion is an important parameter to assess the status and liability of organs 
and tissue. Typically, exogenous contrast agents are administered to measure 
this quantity. Arterial spin labelling (ASL) is capable of estimating perfusion 
without the use of exogenous contrast media by labelling inflowing blood 
magnetically. This labelling process can happen either in a short time over an 
extended region or over a longer time period, but in a localised area. These 
techniques are called pulsed ASL (PASL) or continuous ASL (CASL), 
respectively. For quantification, a critical parameter is the time the labelled 
blood takes to flow from the region of labelling to the imaging region. This time 
is typically called bolus arrival time (BAT) or arterial transit time (ATT). It is 
important to either reduce the influence of this transit time on measured signal 
intensity or directly estimate it. Applying proper bio-physical models, the 
perfusion-weighted data can then be converted in absolute measures of 
perfusion. More sophisticated methods allow measuring of the main feeding 
artery of each imaging voxel (vascular territory mapping) or assessing other 
parameters beyond perfusion, allowing more detailed assessment of tissue 
status and function."  
Learning Objectives:
1. To learn the basics of ASL, its methods and proposed implementation in 
clinical platforms. 
2. To understand the influence of parameter choices on perfusion images. 
3. To become familiar with basic quantification techniques in ASL. 
Author Disclosure:
 M. Guenther: CEO; mediri Gmbh, Heidelberg, Germany. Research/Grant 
Support; Siemens Healthcare, Erlangen, Germany. 
A-430 14:28 
The use of ASL in cerebrovascular disease  
J. Hendrikse; Utrecht/NL (j.hendrikse@umcutrecht.nl) 
Obvious applications of arterial spin labelling in clinical MR protocols are 
cerebral blood flow measurements in patients with acute or chronic 
cerebrovascular disease. In patients with acute stroke, the cerebral blood flow 
measurements may indicate the infarct core, with severely decreased 
perfusion and the infarct penumbra, with decreased perfusion but still viable 
brain tissue. In chronic cerebrovascular disease, arterial spin labelling CBF 
measurements show the regionally impaired haemodynamics distal to a carotid 
obstruction. With adequate collateral blood flow, these areas may be relatively 
small and with a failure of compensatory mechanism the cerebral blood flow 
may fall below a critical level. In acute stroke patients, ASL MRI may show 
compensatory hyperperfusion in stroke regions after the recanalisation of an 
occluded artery. Other applications of arterial spin labelling are clinical MR 
protocols in children. In addition to CBF-weighted images, ASL MRI has also 
the ability to measure timing parameters: typically, the time it takes for the 
magnetically labelled arterial blood to flow from the arteries in the neck to the 
brain tissue, which may be delayed in patients with cerebrovascular disease. 
Furthermore, ASL MRI has the ability to visualise the (collateral) perfusion 
territories of the brain feeding arteries in many clinical applications. In patients 
with cerebrovascular disease, a pitfall may be the absence of label in brain 
regions due to delayed (collateral) flow, which also may result in high ASL 
signals in (collateral) arteries.  
Learning Objectives:
1. To appreciate the different roles of ASL in cerebrovascular diseases. 
2. To become familiar with the different types of calculated images obtained 
from multi-time points and selective pulses ASL. 
3. To become familiar with the limitations and pitfalls of ASL. 
A-431 14:51 
The use of ASL in non-vascular brain disease  
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl) 
Arterial spin labelling (ASL) is a non-invasive MRI technique with which 
cerebral blood flow (CBF) can be measured quantitatively. Although the first 
publications of ASL MRI date over 10 years back, it is only now that ASL is 
commercially available on MRI systems from all major vendors and is making 
its way into clinical practice. The main areas of interest for current and future 
nonvascular clinical application of ASL MRI of the brain are dementia and 
neuro-oncology. ASL is proposed as a diagnostic alternative to fluorodeoxy-D-
glucose (FDG)-PET in the workup of dementia patients. ASL has several 
advantages over FDG-PET. Crucially, it can easily be added to the routinely 
performed structural MRI examination. Feasibility studies show that ASL 
provides reliable CBF maps in dementia. In patients with established 
Alzheimer's disease and frontotemporal dementia, hypoperfusion patterns are 
seen that are similar to hypometabolism patterns with FDG-PET. Current and 
future studies in this field will need to demonstrate the validity of ASL in the 
diagnostic workup of the individual patient, early in the disease process. 
Studies on ASL in brain tumour imaging indicate a high correlation between 
areas of increased CBF as measured with ASL, and increased cerebral blood 
volume as measured with dynamic susceptibility contrast-enhanced perfusion 
imaging. The major advantages of ASL for brain tumour imaging are the fact 
that CBF measurements are not influenced by breakdown of the blood brain 
barrier, as well as its quantitative nature, facilitating multicentre and 
longitudinal studies.  





1. To understand the role of ASL in non-vascular brain disease. 
2. To become familiar with current and future indications for the use of ASL in 
non-vascular brain disease. 
3. To appreciate the limitations and pitfalls of ASL. 
Panel discussion:  
How relevant is ASL in clinical practice today?  15:14
14:00 - 15:30 Room F2  
Breast  
RC 1402  
Update on BI-RADS  
Moderator:  
M.G. Wallis; Cambridge/UK 
A-432 14:00 
A. Mammography  
U. Bick; Berlin/DE (Ulrich.Bick@charite.de) 
The Breast Imaging Reporting and Data System (BI-RADS®) for 
mammography of the American College of Radiology (ACR®) consists of 
several components, a standardised lexicon of terms to be used during 
reporting, a 4-step coding system for the mammographic density as a 
surrogate parameter for the mammographic sensitivity, and a group of 
assessment categories ranging from 0 to 6 for structured communication 
regarding the recommended further management. The goal of BI-RADS® is to 
improve the quality of breast imaging reporting and communication. In addition, 
by providing structured reports it facilitates regular quality assurance 
measures. The BI-RADS® atlas for mammography is currently in its fourth 
edition and was released in 2003. The upcoming 5th edition is expected soon 
and will be incorporated into the course as it becomes available.  
Learning Objectives:
1. To learn about the BI-RADS lexicon. 
2. To understand the usefulness of BI-RADS system. 
3. To become familiar with the mammography descriptors. 
A-433 14:30 
B. Ultrasound  
F. Thibault; Paris/FR (fabienne.thibault@curie.fr) 
The Breast Imaging Reporting and Data System (BI-RADS) was first 
developed by the American College of Radiology for standardising the 
reporting of mammography. Since its first publication in 1993, new editions 
have also addressed breast ultrasound (US) and MR imaging examination. 
The new (fifth) edition will be published soon. On the form, this new version 
was designed to include a web-based format. Substance includes updates in 
lexicon descriptors, e.g. masses, calcifications, associated features (now 
comprising surrounding tissue with stiffness assessment), and special cases. 
US descriptors will be reviewed in the lecture. Of note, guidance on how to link 
BI-RADS descriptors with management recommendations has been added in 
the report section. A new approach to outcome assessment (audit section) is 
being proposed for screening US. The appropriate use of descriptors is 
expected to increase the accuracy of imaging interpretation. For relevant 
patient management, US analysis is to be integrated with other available 
imaging, as well as with clinical data.  
Learning Objectives:
1. To learn about the BI-RADS lexicon. 
2. To understand the usefulness of BI-RADS system. 
3. To become familiar with the ultrasound descriptors. 
A-434 15:00 
C. MRI  
K. Pinker-Domenig, P.A.T. Baltzer; Vienna/AT
(katja.pinker@meduniwien.ac.at) 
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the 
breast is a well-established non-invasive imaging technique. It has clinical 
application in the screening of high-risk patients, diagnosis and staging of 
breast cancer, monitoring neoadjuvant chemotherapy and post-treatment 
follow-up. To standardise the reporting of DCE-MRI of the breast and minimise 
false-positive results without compromising sensitivity, the American College of 
Radiology (ACR) introduced the Breast Imaging-Reporting and Data System 
(BI-RADS®) MRI lexicon in 2003. BI-RADS relies on the combined analysis of 
morphological appearance and lesion enhancement kinetics. It is widely used 
for reporting DCE-MRI of the breast and is applicable at any given field 
strength. It aims to provide an up-date report on the BI-RADS® lexicon and 
instill confidence in using BI-RADS® descriptors. The BI-RADS® system may 
be placed in a broader clinical context to highlight its value for standardised 
reporting of DCE-MRI of the breast.  
Learning Objectives:
1. To learn about the MRI BI-RADS® lexicon. 
2. To learn how to recognise the descriptors defined in the MRI BI-RADS® 
lexicon. 
3. To understand the clinical relevance of the BI-RADS® system and apply the 
BI-RADS® lexicon when reporting MRI of the breast. 
14:00 - 15:30 Room G/H  
Special Focus Session  
SF 14b  
Treatment with MR-guided focused US 
(FUS)  
A-435 14:00 
Chairman's introduction  
W.M.W. Gedroyc; London/UK (w.gedroyc@imperial.ac.uk) 
MR-guided focused ultrasound is a new therapeutic modality which can allow 
selective destruction and or heating of tissues in deep body areas under close 
image guidance control. These talks will introduce the field and allow you to 
understand the areas of current work and areas of future development in this 
rapidly expanding field.  
Session Objectives: 
1. To become familiar with MR-guided focused ultrasound. 
2. To understand the advantages of focused ultrasound. 
3. To learn in which areas focused ultrasound is evolving successfully. 
A-436 14:05 
Description of technique  
C. Moonen; Utrecht/NL (C.Moonen@umcutrecht.nl) 
High-intensity focused ultrasound (HIFU) is the only clinically viable technology 
that can be used to achieve a local temperature increase deep inside the 
human body in a non-invasive way. MRI guidance of the procedure allows in 
situ target definition and identification of nearby healthy tissue to be spared. In 
addition, MRI can be used to provide continuous temperature mapping during 
HIFU for spatial and temporal control of the heating procedure and prediction 
of the final lesion based on the received thermal dose. The primary purpose of 
the development of MR-guided HIFU was to achieve safe non-invasive tissue 
ablation. The technique has been tested extensively and is now accepted in 
the clinic for ablation of uterine fibroids. MR-guided HIFU for ablation shows 
conceptual similarities with radiation therapy. However, thermal damage 
generally shows threshold-like behaviour with necrosis above the critical 
thermal dose and full recovery below. MR-guided HIFU is being clinically 
evaluated in the cancer field. This presentation will cover the basic 
technologies for treatment of stationary tissues, and some advances towards 
treatment of mobile abdominal organs.  
Learning Objectives:
1. To learn how MR-guided focused ultrasound is generated. 
2. To understand the current physical limitations of this technique. 
3. To learn how the technology is being improved to overcome the limitations 
of administering focused ultrasound to patients. 
Author Disclosure:
 C. Moonen: Research/Grant Support; Philips Healthcare. 
A-437 14:28 
Uterine fibroids and adenomyosis  
Y. Inbar; Tel Hashomer/IL (Yael.Inbar@sheba.health.gov.il) 
Magnetic resonance imaging-guided focused ultrasound (MRgFUS) for the 
noninvasive treatment of uterine fibroids has been used in a clinical setting 
since 2003. During the past decade, many improvements have been made in 
the treating systems, making treatments easier, faster, safer and fitting a wider 
range of patients. In this presentation, I will talk about the advances made over 
the years in the MRgFUS systems, helping to overcome many previously 
encountered obstacles. We will discuss patient selection and suitability and 
review the current success rates of the procedure. In addition, we will address 
the issue of adenomyosis, another uterine pathology frequently encountered 
that can produce symptoms similar to uterine fibroids. For these patients 
treatment options are extremely limited, making MRgFUS an attractive 
treatment option.  





1. To learn which patients are suitable for MR-guided focused ultrasound of 
uterine fibroids. 
2. To understand the current success rates of this procedure. 
3. To appreciate the outcome of FUS is in the treatment of adenomyosis of the 
uterus. 
Author Disclosure:
 Y. Inbar: Research/Grant Support; Insightec. 
A-438 14:51 
Transcranial FUS  
E. Martin; Zurich/CH (Ernst.Martin@kispi.uzh.ch) 
Transcranial focused ultrasound (tcMRgFUS) is a novel technique for 
noninvasive neurosurgical interventions, that is magnetic resonance imaging 
guided for target definition and treatment planning with continuous temperature 
measurements in real time. TcMRgFUS has no trajectory restrictions and does 
not involve ionising radiation. The ability to focus ultrasound energy through 
the intact skull precisely to desired targets, while avoiding collateral brain 
tissue damage, thus, minimising adverse effects by mistargeting is certainly 
attractive. Since no device is implanted, there is no restriction to future 
diagnostic workup with high-field MR imaging. TcMRgFUS allows treating a 
variety of chronic, therapy-resistant neurological diseases by focusing high-
intensity ultrasound energy (HIFU) to the thalamus, subthalamus or basal 
ganglia. Ongoing clinical studies on over 130 patients with neuropathic pain, 
essential tremor, Parkinson's disease and obsessive compulsive disorder are 
very encouraging. They promise tcMRgFUS to become a noninvasive 
alternative treatment option for patients with therapy-resistant neurological and 
neuropsychiatric disease. Moreover, ablation of pathological tissue as in brain 
tumours and brain metastases is urgently needed to supplement traditional 
neurosurgical procedures. Future trends: preclinical studies using low-intensity 
focused ultrasound (LIFU) have shown to silence dysfunctional neuronal 
circuits and to transiently modulate neural functions. This eventually may lead 
to better targeting during functional neurosurgical interventions such as FUS 
and DBS. Moreover, in combination with microbubbles, LIFU pulses enable 
opening of the blood-brain-barrier, facilitating drug delivery to specific targets in 
the brain. Conclusion: TcMRgFUS promises new therapeutic approaches for 
a variety of brain diseases that may change patient management.  
Learning Objectives:
1. To understand how focused ultrasound can be utilised in the brain. 
2. To learn which conditions can be treated successfully. 
3. To understand how this technique will evolve and what role it will play in the 
management of chronic and acute neural conditions. 
Panel discussion:  
How can this technology be spread more widely?  15:14
14:00 - 15:30 Room I/K  
Head and Neck Imaging  
CC 1419  
What do I see? Clinical radiological 
interaction (part 2)  
Moderator:  
B. Ozgen Mocan; Ankara/TR 
A-439 14:00 
A. Presurgical and postsurgical imaging: free flap reconstructions  
A. Trojanowska, P. Trojanowski; Lublin/PL
The use of microvascular free flaps for reconstructions allowed for the 
development of extensive resections of head and neck tumours. Radiological 
evaluation of patients subjected to reconstructive operations using free flaps 
requires the in-depth knowledge of flap structure and anatomy. Imaging allows 
delineation of the tumour and planning the extent of resection. Availability of 
reconstructive surgery extends the scope of surgical intervention, but requires 
meticulous consideration of the choice of flaps. It is necessary to investigate 
with imaging the donor site to ensure adequate flap size, shape and 
vasculature. At the same time it is of paramount importance to assure that flap 
harvesting does not endanger functionality and blood supply to the donor site. 
Imaging studies of the donor site can reveal vascular abnormalities and 
therefore prevent acute and chronic donor site ischemia. In the follow-up of 
patients with transplanted tissues, specific difficulties in detecting recurrence 
exist because there is an altered anatomy. This lecture is based on the 
interpretation of CT and MR cases illustrating follow-up of microvascular free 
flaps used for the reconstruction of defects resulting from head and neck 
cancer surgery, with particular attention to the role of radiologic-clinical 
cooperation for the appropriate interpretation of imaging findings.  
Learning Objectives:
1. To become familiar with major flap types used for head and neck 
reconstructions and the importance of reconstructive surgery. 
2. To understand how to evaluate images for surgery planning. 
3. To learn how to perform follow-up studies in patients after free flap 
reconstructions in order to avoid possible pitfalls. 
A-440 14:30 
B. Sinonasal imaging for functional endoscopic sinus surgery (FESS)  
V. Lund, G. Madani; London/UK
Computerised tomography offers the gold standard in terms of imaging the 
extent of disease and the fine detailed anatomy, both pre-requisites to the safe 
practice of endoscopic sinus surgery (ESS). A variety of protocols minimising 
radiation dose to the lens whilst providing high-quality images have been 
described, depending on the scanner and whether image guidance is being 
used. In general for ESS in chronic rhinosinusitis with or without nasal polyps, 
coronal and axial views are sufficient though sagittal cuts are recommended 
when surgery on the frontal sinus is contemplated. The anatomy varies 
considerably on an individual basis and includes a range of anatomic variants, 
which although do not predispose to the disease, require careful evaluation 
pre-operatively. MRI plays a limited role in benign inflammatory disease, 
though it may be undertaken secondarily when the diagnosis is unclear.  
Learning Objectives:
1. To learn about common sinonasal pathologies. 
2. To understand why we use FESS and what information is needed to plan a 
surgery. 
3. To learn about several interesting cases in order to understand the 
importance of cooperation between the radiologist and clinician. 
A-441 15:00 
C. Sinonasal tumours: key clinical questions  
V. Lund1, N.J.M. Freling2; 1London/UK, 2Amsterdam/NL 
The analysis of a sinonasal tumour requires MRI for differentiation between 
tumour and secretions or polyps, to assess the local extension and spread into 
adjacent compartments (skull base, intracranial, orbit, deep facial 
compartments) and to depict perineural spread. T2, T1 and high-resolution 
postcontrast series preferably in three, but at least in two different planes, are 
needed. CT provides additional information of bony structures and serves as a 
road map for surgical navigation. A fascinating benign sinonasal tumour is 
inverted papilloma, which has a high recurrence rate if not removed in toto and 
may harbour carcinoma in < 5% of patients. CT may show the attachment of 
the tumour as an area of increased sclerosis, which directs the surgeon to plan 
the operation. In patients with recurrent inverted papilloma, providing 
information to the radiologist about its presumed localisation is important, the 
more so in patients suffering from polyposis. Malignant tumours are uncommon 
and of a large histologic variety. About 80% arise in the maxillary sinus; 70% 
are squamous cell carcinomas. They are often large at diagnosis, because 
clinical symptoms of nasal obstruction or headache are non-specific. Diagnosis 
is by biopsy. In view of the rapid development of advanced endoscopic 
techniques, preoperative imaging is extremely important to assess accurately 
tumour extension. The skull base and dura as well as the lamina papyracea 
should be scrutinised for tumour locations to foresee an additional cranio-
endoscopic approach to a standard endonasal endoscopic approach. Finally, 
imaging may play a role in differentiating non-nasal disease, e.g. primary bone 
tumours, from mucosal disease.  
Learning Objectives:
1. To learn about the most important sinonasal tumours and techniques for 
their evaluation. 
2. To become familiar with key surgical questions and contraindications for 
surgery. 
3. To learn about several cases in order to understand the role of clinical-
radiological cooperation. 




14:00 - 15:30 Room L/M  
Physics in Radiology  
RC 1413  
Good radiation and bad radiation?  
How to assess and communicate radiation 
risk to patients and referring physicians  
Moderators:  
M.M. Rehani; Vienna/AT 
P. Vock; Spiegel/CH 
A-442 14:00 
A. Radiation risk: a patient's perspective  
N. Bedlington; Vienna/AT (nicola.bedlington@eu-patient.eu) 
To discuss risk/benefit considerations in medical imaging from the perspective 
of patients and highlight some of the pre-requisites to ensure trust and 
confidence. This presentation will draw on the work of the European Patients' 
Forum on patient safety, quality of care, health literacy, and patient 
empowerment, to explore what are the key factors to consider in radiation risk 
analysis, from a patient's perspective, recognising that 'one size does not fit 
all'. It will examine what constitutes quality information in this environment, 
effective dialogue between the patient and the radiologist, and the 
interdisciplinary team, informed consent and transparency of data. It will also 
highlight some of the particular challenges regarding vulnerable patients, and 
those requiring on-going treatment due to chronic disease (s).  
Learning Objectives:
1. To understand the fears of patients. 
2. To learn what's expected from physicians and techs. 
3. To learn about ideal communication strategies. 
A-443 14:15 
B. Radiation risks for patients and staff  
P. Gilligan; Dublin/IE (PGilligan@materprivate.ie) 
The justification for medical procedures is based on the assumption that the 
benefit outweighs the risk. This presentation looks at the radiation risk factors 
from recent high-profile papers (Pearce et al., 2012) and publications from 
international bodies such as BEIR and ICRP. At lower radiation doses (< 100 
mSv), quantifying, understanding and communicating radiation risk to staff, 
patients and referring clinicians presents a range of challenges. Advances in 
health information systems will facilitate more precise dose risk relationships. 
There are a number of approaches to stochastic radiation risk assessment 
such as organ-/age-based assessment and effective dose equivalent 
assessment. At-risk groups, such as children and pregnant women, need 
special focus. EU directives demand special attention for high-dose 
interventional procedures and CT scans. These techniques, particularly if 
repeated, require further risk assessment regarding potential deterministic 
effects such as erythema, hair loss, and radiation-induced cataractogenesis. 
This paper looks at strategies in consenting, monitoring, and follow-up of such 
high-dose effects. The practical implications of the new occupational ICRP eye 
dose limits for interventional practice are also examined.  
Learning Objectives:
1. To get the latest information on stochastic risks in radiology. 
2. To understand the risks for children as compared with adults. 
3. To get the latest information on tissue reaction to medical procedures. 
4. To learn about radiation cataract and its dose dependence. 
A-444 14:40 
C. Risk in MRI  
R. Peeters; Leuven/BE (ronald.peeters@uzleuven.be) 
With the advent of higher field scanners in clinical practice and the construction 
of 'MRI compatible' implanted devices, the list of the do's and don'ts while 
performing an MRI examination changes constantly. In this presentation basic 
safety guidelines and rules will be explained regarding static magnetic field 
effects, time varying magnetic field effects, radiofrequency field effects and 
acoustic noise effects both with regard to the patient as well as the personnel 
using the equipment. Due to the advances in medical technology the list of 
possible 'safe' and 'unsafe' items changes almost daily. Therefore it is very 
important to have all the information about the patient's condition and implants 
prior to the MRI procedure in order to asses possible contraindications in 
advance. While until a couple of years ago cardiac pacemakers and 
neurostimulators were contraindicated in the MRI environment, the advent of 
'MRI compatible' pacemakers and other implanted devices introduces 
challenges in patient safety. In fact these devices are only safe in certain 
configurations and also in a lot of cases specific MRI scan sequences and RF 
antennas are only allowed. Following the European EMF directive, where the 
MRI part is derogated, the protection of staff working with EM fields also 
became a topic of debate. What are the possible risks for staff working with 
MRI magnets and how can one implement practical rules for the safe use of 
the MRI equipment.  
Learning Objectives:
1. To learn about the risks for patients from MRI procedures. 
2. To learn about the contraindications for MRI scans. 
3. To learn about risks for staff in an MRI department. 
A-445 15:05 
D. Communicating risks to patients and the public  
N. Leitgeb; Graz/AT 
Risk communication is much more than just talking about an issue. It requires 
specific background knowledge and skills. It needs to be based on adequate 
facts of risk assessment such as provided by SCENIHR, the strength of 
evidence and remaining uncertainties. While evidence for health-relevant 
effects is convincing for X-ray imaging, and heating effects due to absorption of 
radio-frequency electromagnetic fields (RF-EMF) are well understood in MRI, 
the existence of adverse stochastic side-effects from exposure to MRI RF-EMF 
is less clear since they have been classified as possibly carcinogenic (class 
2B) by WHO’s IARC. Little is known about potential health risks from ultra-high 
static magnetic fields used in MRI. The still frequent use of gynecologic 
ultrasonic imaging for non-medical purposes such as for generating videos for 
parents (baby cinema) in spite of the ban in established guidelines 
demonstrates that risk awareness varies among physicians and parents.  
This can be explained by the fact that risk perception mechanisms are complex 
and risk perception almost uncoupled from quantitative risk levels. 
Consequently, in addition to sound factual knowledge, risk communication 
requires specific skills to help avoiding the numerous communication pitfalls 
such as using inadequate language, in particular gobbledygook, incorrect 
simplifications, inadequate parameters, misleading wording, tricky comparisons 
and ambiguous messages. Emotions and confusing mind models such as 
about the vulnerability of newborn and children or about dose-response 
relationships need also to be taken into account. Another challenge is targeting 
risk communication to stakeholders, in particular to lay people such as in 
communicating risks from inadequate behavior to patients with electronic 
implants. 
Learning Objectives:
1. To become familiar with communicating risk according to the imaging 
modality. 
2. To become familiar with important rules in communication. 
3. To understand the relationship between threat/hazard and parents' 
perception regarding imaging for their child. 
4. To learn how to select a risk communications strategy suited to parents and 
children. 
Author Disclosure:
 N. Leitgeb: Other; European Commission’s Scientific Committee of Emerging 
and Newly Identified Health Risks (SCENIHR). 
14:00 - 15:30 Conf. Room M3  
Oncologic Imaging: Follow-up of Systemic and Local Therapies  
CC 1418  
Follow-up of thermal ablation (part I)  
Moderator:  
P. Wiggermann; Regensburg/DE 
A-446 14:00 
A. The zone of cell death and collateral phenomena in cross-sectional 
imaging: from histopathology to the standardisation of terms  
A. Denys; Lausanne/CH (Alban.Denys@chuv.ch) 
The field of image-guided ablation has expended recently with new ablation 
techniques like micro-wave, irreversible electroporation, cryoablation. 
Nevertheless, after each treatment, whatever the technique used, we will leave 
in place in the treated organ, a scar instead of the tumour. Follow-up of these 
treated areas are done by radiologists using CT of MR or contrast enhanced 
ultrasound. Standardisation of terms has been done in 2003 by an international 
committee presided by Dr. Goldberg. This allows reporting criteria identical 
from one center and from one country to another. Furthermore, it allows a 
more homogeneous literature and evaluation of success. Nevertheless, 
techniques are not all the same and the cellular and tissue damage in the 
tumour and around it in the healthy parenchyma are not identical and does not 
have the same evolution over time.  





1. To understand histopathological changes after various ablation techniques. 
2. To become familiar with post-ablation imaging based on histopathological 
correlation of ablation zones in various organs. 
3. To learn about the correct terms for reporting and publishing on post-
ablation imaging. 
A-447 14:30 
B. PET/CT for the evaluation of ablative therapy: Who? Where? When? 
Does it help?  
D. Deandreis; Villejuif/FR (Desiree.DEANDREIS@igr.fr) 
Thermal ablation is frequently used to treat liver, lung and bone tumoural 
lesions because of its safety, efficacy and tolerability. One issue is the lack of 
reliable imaging modality to assess treatment efficacy and to detect early 
relapse. Several papers have demonstrated that 18 FDG PET/CT is a useful 
tool to follow-up ablated liver tumour, detecting residual disease easily and 
earlier than conventional imaging. Few reports evaluating the usefulness of 
18 FDG-PET/CT in the follow-up of ablated lung lesions are available, but 
prospective studies show promising results, with a high negative predictive 
value of this technique. Very few data are available on bone lesions and further 
studies are needed to assess the role of 18 FDG-PET/CT in the follow-up of 
these lesions. In general, the in vivo typical aspect of completely ablated lesion 
on 18 FDG-PET/CT is a ring shape, diffuse, peripheral, homogeneous 18 FDG 
uptake at the treated lesion; on the other hand, the presence of heterogeneous 
and focal uptake is more frequently related to disease relapse. SUVmax 
(Standardised Uptake Value) is not a reliable indicator. It is higher in case of 
disease relapse than in completely ablated lesions, but also in case of 
important inflammatory reaction. Finally, the best time point to evaluate 
ablation efficacy still remains to be defined, but 18 FDG-PET/CT should be 
performed at least 3 months after treatment to avoid dubious or inconclusive 
findings due to inflammatory reaction.  
Learning Objectives:
1. To understand who are the best candidates for a PET/CT follow-up of 
ablation therapies. 
2. To learn what is the optimal timing of PET/CT in the follow-up of ablative 
therapies. 
A-448 15:00 
C. Everyday practice: MRI and CT for evaluating response to thermal 
ablation  
C. Dromain, C. Caramella, L. Vilcot, S. Ammari, F. Deschamps; Villejuif/FR
(dromain@igr.fr) 
The aim of thermal ablation treatment is to generate an area of 
thermocoagulation whose diameter is larger or at least equivalent to that of the 
tumour. This necrotic scar usually shrinks with time, but most often very slowly. 
Therefore, the criteria of response based on size measurement cannot be 
applied. The pattern of thermal ablation is similar whatever the thermo-ablation 
technique used. On CT imaging, thermal ablation areas are well circumscribed 
and oval shaped. The criterion commonly used to assess the efficacy is the 
absence of enhancement in the thermal ablation necrosis, which corresponds 
to tissue devoid of viable tumour. On MR imaging, the thermo-ablation areas 
are typically hyperintense on unenhanced T1 due to the presence of 
proteinaceous material, and hypointense on T2, explained by the dehydrating 
effect of thermal damage. The residual tumour is typically round in shape and 
located at the periphery of the necrotic area or in contact with large vessels. 
MR imaging allows earlier detection of residual liver tumour than CT imaging.  
Learning Objectives:
1. To become familiar with the imaging aspects of successful ablation. 
2. To learn about the main pitfalls of post-ablation imaging. 
3. To consolidate knowledge of the imaging aspects of most common 
complications. 
Author Disclosure:
 C. Dromain: Advisory Board; Roche, Novartis. Consultant; GE Healthcare. 
Research/Grant Support; GE Healthcare. Speaker; GE healthcare, Roche, 
Guerbet, Pfizer. C. Caramella: Advisory Board; Roche. F. Deschamps:
Speaker; GE Healthcare. 
14:00 - 15:30 Board Room A  
Radiographers  
RC 1414  
Cutting-edge imaging: translating research 
into clinical reality  
A-449 14:00 
Chairman's introduction  
C. Malamateniou; London/UK (christina.malamateniou@kcl.ac.uk) 
Neurodegenerative diseases, cancer and heart disease perhaps summarise 
the major challenges to medicine in this century, a challenge in accurate 
diagnosis and also in treatment. Recent technological advances in medical 
imaging technology mean that these challenges can be dealt with more 
efficiently. Anatomy can be studied faster, safer and with higher spatial 
resolution and precision. In addition to anatomy, the study of function has 
become feasible; more sophisticated hardware and software are being used to 
get the required data to map out the functionality and understand how this 
relates to anatomy to offer a more comprehensive view of normal development 
and explain pathological conditions. At the same time, researchers and 
clinicians are urged to create a platform for reciprocal communication to 
facilitate translation of the research findings to a graspable clinical benefit for 
the patients. This translational platform will allow flagging the major clinical 
questions, inform current and future research experiments and at the same 
time help utilise recent research findings in the clinical setting. This session will 
review state-of-the-art MRI techniques and document different approaches to 
translational imaging. It will also allow understanding the obstacles and 
remedies in implementing translational medicine.  
Session Objectives: 
1. To appreciate the impact of continued technological developments in 
medical imaging on patient care. 
2. To understand the challenges of translating cutting-edge imaging 
technologies from research into clinical reality. 
A-450 14:05 
A. Advanced imaging of neurodegenerative disease  
E. Hughes; London/UK (emer.hughes@kcl.ac.uk) 
Many neurological diseases are associated with progressively reduced 
cognitive function. Recent evidence suggests that proficient cognitive function 
depends on an appropriate interaction between large-scale cognitive control 
networks in the brain. It is hypothesised that damage to white matter micro-
structure, as found in many neurological diseases, disrupts the integrated 
operation of these networks and results in impaired cognitive function. 
Diffusion tensor imaging (DTI) has been used to investigate alteration to white 
matter micro-structure and resting state fMRI (rsFMRI) has proven to be a 
useful technique to assess brain function in multiple cortical systems. However, 
the combined use of these techniques in the clinical setting has not yet taken 
hold. In this presentation, I will demonstrate the flexibility of these MRI 
techniques in assessing brain structure and function and address their 
feasibility of use in a clinical setting.  
Learning Objectives:
1. To become familiar with advances and developments in neuro-MRI 
techniques. 
2. To learn about state-of-the-art neuro-MRI research and the steps required to 
make these techniques a clinical reality. 
3. To appreciate the role of the radiographer in advanced neuro-MRI. 
A-451 14:28 
B. Advanced oncological imaging  
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es) 
Imaging in oncology is a growing field within radiology. Different tomographic 
techniques are used either isolated or as multimodality-multivariable imaging, 
as there is an increasing need to combine morphological and functional 
information. Different cutting-edge modalities, such as PET-CT, DW-MR, CE-
MR and MR-spectroscopy, are standard in most clinical scenarios. New 
images have advantages providing excellent soft-tissue contrast and 
multidimensional functional, structural and morphological information. The 
development of new diagnostic imaging research areas, mainly in the field of 
oncology, cardiology and neuropsychiatry, will impact the way medicine is 
performed today. Both clinical and experimental multimodality studies, in 
humans and animals, will have to demonstrate an efficient use of the imaging 
information provided by the modalities to affect the future of medical imaging. 
We will comment on the impact of continued technological developments in 
medical imaging on patients with cancer (diagnosis, staging and follow-up) and 




the challenges of imaging technologies from research into clinical reality. The 
recent advances and developments in measurements and biomarkers which 
have led to a greater understanding of cancer will be commented, together with 
the morphologic, metabolic and functional oncological imaging research and 
clinical practice. Finally, the role of the radiographer in advanced oncological 
imaging techniques will be evaluated.  
Learning Objectives:
1. To become familiar with advances and developments which have led to a 
greater understanding of disease processes, improved monitoring and better 
clinical outcomes. 
2. To learn about state-of-the-art oncological imaging research and the steps 
required to make these techniques a clinical reality. 
3. To appreciate the role of the radiographer in advanced oncological imaging 
techniques. 
A-452 14:51 
C. Advanced cardiac imaging  
M.L. Dijkshoorn; Rotterdam/NL 
In the last 15 years cardiac CT imaging has developed from a high radiation 
dose research technique in a selected population into a low-dose clinical 
routine examination. The CT scanners have made great advances in 
applicability, image quality and radiation dose reduction. But does this mean 
that now we should provide every patient with potential coronary stenosis a 
CT-Angiography scan? Research on the topic of coronary CTA also has made 
a development over time. At first the potential of the technique in limited 
populations on single vendor scanners was investiged. Later larger multicenter 
studies together with protocol optimization techniques were performed. Results 
have led to guidelines on patient selection and technique suitability. All the 
technical developments in this field have led to a wide diversity of scan 
protocols for different patients with the same clinical question. The role of the 
radiographer in this field is challenging because standard protocols are more 
difficult to apply and more individual patient based protocol/parameter choices 
should be made. Until now cardiac CT imaging has mainly focused on 
anatomic evaluation of the coronaries for calcium scoring and rule-out of 
coronary stenosis. Just being able to provide nice images of the coronaries is 
not enough for every patient. A lot of patients get additional functional exams 
like SPECT or an exercise test. However, new functional CT imaging 
techniques like CT-Perfusion and CT-FFR (Fractional Flow Reserve) are on 
the horizon. Further research is in progress to clarify the potential and clinical 
position of these new techniques. 
Learning Objectives:
1. To become familiar with advances and developments in cardiac CT that 
have led to a greater understanding of disease processes, earlier diagnosis, 
improved monitoring and better clinical outcomes. 
2. To explore current state of the art cardiac CT imaging research and the 
steps required to make these techniques a clinical reality. 
3. To appreciate the role of the radiographer in advanced cardiac CT imaging 
techniques. 
Author Disclosure: 
M.L. Dijkshoorn: Consultant; Clinical training consultant Siemens Healthcare, 
The Netherlands 
Panel discussion:  
Bridging the gap between research and clinical reality:  
a team approach  15:14
14:00 - 15:30 Room P  
Special Focus Session  
SF 14c  
Dental imaging  
A-453 14:00 
Chairman's introduction  
J. Fruehwald-Pallamar; Vienna/AT
(julia.fruehwald-pallamar@meduniwien.ac.at) 
When imaging the head and neck region with CT or MRI, teeth are always 
present. We frequently encounter radiolucent or radiopaque lesions of the jaw 
on scans performed for other indications. Familiarity with typical dental 
conditions is necessary to subject the patients to the right therapy. To correctly 
evaluate and describe those lesions, this special focus session on dental 
imaging gives the radiologist a tool to report dental lesions. The anatomy of 
panoramic and CT images will be reviewed in the first talk. Technical details as 
well as pitfalls will be presented. In the second talk, the focus is on pre- and 
post-surgical imaging with CT where typical lesions of the jaw will be 
presented. An insight into imaging the teeth with MRI will be given by the third 
speaker. The discussion on the impact of radiologists on dental images will 
complement this special focus session's theme.  
Session Objectives: 
1. To learn about the potential of cone-beam CT and MRI in dental imaging. 
2. To become familiar with maxillofacial anatomy. 
3. To understand postsurgical changes. 
A-454 14:05 
Review of dentomaxillofacial anatomy with panoramic views and cone-
beam CT  
A. Suomalainen; Helsinki/FI (anni.suomalainen@hus.fi) 
Panoramic radiography produces a single image of the maxilla, mandible, 
teeth, temporomandibular joints and maxillary sinuses. During the exposure, 
the x-ray source and the detector rotate synchronously around the patient 
producing a curved surface tomography. This horseshoe-shaped zone of sharp 
image is called the focal trough/image layer. Advantages of this technique are 
a good overview of lower facial hard tissues, the convenience of an extraoral 
examination, a low patient radiation dose, and low costs. Disadvantages are 
limited width of the sharply imaged layer, variable magnification, and oblique 
projection, especially in the upper premolar region. Patient positioning is most 
important for obtaining a detailed panoramic radiograph. In addition to patient 
position errors, patient movement during exposure and metal objects can 
cause artefacts. Also, ghost images caused by structures located between the 
x-ray source and the rotation centre can hamper diagnostics. CBCT is a 
radiographic imaging method that allows accurate 3D imaging of hard tissues. 
During a CBCT scan, the scanner rotates around the patient's head (180°-
360°) obtaining multiple sequential planar projection images by a 2D detector. 
The scanning software collects the data which is processed to create a 
volumetric data set with isotopic voxels with varying FOV. Disadvantages of 
CBCT imaging are poor soft tissue contrast and artefacts. In addition to normal 
panoramic and CBCT anatomy, after this presentation the audience will be 
familiar with the panoramic and CBCT techniques as well as common errors 
and pitfalls of these techniques.  
Learning Objectives:
1. To learn about normal panoramic and cone-beam CT anatomy. 
2. To understand techniques of image acquisition. 
3. To become familiar with common errors and pitfalls. 
A-455 14:28 
Pre-surgical and post-surgical imaging with MDCT and cone-beam CT  
A. Gahleitner; Vienna/AT (andre.gahleitner@meduniwien.ac.at) 
Multislice-CT and more recently cone-beam-CT have become an established 
method for anatomic imaging of the jaws prior to dental implant placement. 
Commonly referred to as "dental-CT", these high-resolution imaging 
techniques have gained importance in diagnosing dental-associated diseases 
of the mandible and maxilla. Especially in patients with inflammations, cysts, 
oro-antral fistulas, odontogenous sinusitis, impacted teeth and dental fractures, 
new indications have emerged. Unfortunately, most radiologists have had little 
experience in this area and many of the dental-CT findings remain 
undescribed. Hence, we will determine the CT appearance of frequent dental-
related diseases of the jaws and demonstrate typical pre- and postoperative 
findings. This presentation reflects our experiences from 18 years of 
performing dental-CT with 36.000 investigations, closely working together with 
dentists and oral surgeons.  
Learning Objectives:
1. To learn about the typical findings from pathological conditions of the jaw, 
which confront dentists and oral surgeons. 
2. To understand these findings in cross-sectional imaging like multislice and 
cone-beam CT. 
3. To learn about the usual treatments for these conditions in order to know 
how they are used in dental radiology. 
A-456 14:51 
Dental MRI  
S. Rohde; Dortmund/DE (stefan.rohde@klinikumdo.de) 
This lecture will discuss the potential of dental MRI in the field of inflammatory 
and neoplastic disease of the periodontal space. Experimental and preliminary 
clinical data from high-field dental MRI will be presented with a special focus 
on the visibility of critical anatomical structures on high-resolution sequences. 
The results will be compared to high-resolution cone-beam CT.  
Learning Objectives:
1. To become familiar with the technical requirements. 
2. To learn about the advantages and disadvantages of dental MRI in 
comparison to cone-beam-CT. 
3. To appreciate its potential and future prospective. 
Panel discussion:  
What is the impact of radiologists in dental imaging?  15:14




16:00 - 17:30 Room A  
Interactive Teaching Session  
E³ 1520  
Thoracic emergencies  
A-457 16:00 
A. Vascular  
E. Castañer; Sabadell/ES (ecastaner@tauli.cat) 
Based on representative cases, we will review the main causes of thoracic 
non-traumatic vascular emergencies (acute aortic syndrome, pulmonary 
thromboembolism and haemoptysis); MDCT angiography has become the first-
line imaging test for the diagnosis of these entities. As acute aortic disease is 
the most common fatal condition in patients with chest pain and prompt 
recognition and treatment are of paramount importance, we will review the 
spectrum of acute aortic pathology focusing on the distinctive findings of each 
entity (classic dissection, intramural haematoma and penetrating aortic ulcer) 
and upgrading the clues for their diagnosis. Acute pulmonary embolism (PE) 
remains a common clinical challenge. MDCT pulmonary angiography has 
become the first-line imaging study in the diagnosis of PE because of its 
speed, accuracy, low interobserver variability and ability to provide alternative 
diagnoses. We will review the role of MDCT in the evaluation of acute 
thrombotic PE: findings of acute PE (including how to evaluate the severity of 
an episode of PE at CT pulmonary angiography) and some potential pitfalls. 
Massive haemoptysis is a life-threatening condition that is associated with a 
high mortality rate. Haemoptysis usually involves bleeding from the bronchial 
arteries or, less frequently, from nonbronchial systemic arteries. Haemoptysis 
of pulmonary arterial origin is rare, estimated at less than 10% of haemoptysis 
cases. MDCT angiography permits noninvasive, rapid, and accurate 
assessment of the cause and consequences of haemorrhage into the airways 
and helps guide subsequent management.  
Learning Objectives:
1. To become familiar with the main causes of thoracic vascular emergencies. 
2. To understand the role of MDCT angiography in thoracic emergencies. 
3. To learn about the radiological signs in vascular thoracic emergencies and 
its impact on the management of these patients. 
A-458 16:45 
B. Pulmonary  
C.M. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
Acute respiratory failure can have multiple underlying causes including 
infection, fluid overload, immunological diseases or exacerbation of preexisting 
lung disease. Since the clinical symptoms are nonspecific, imaging plays an 
important role. The first imaging method is mostly the chest radiograph, easy to 
access and to obtain, but non-diagnostic in many cases. (HR)CT offers more 
possibilities to define the differential diagnosis. The option of this interactive 
workshop will be to get familiar with the spectrum of diseases that can cause 
acute respiratory failure and learn about key findings in radiography as well as 
CT to reduce the differential diagnosis. The interaction between preexisting 
lung disease, clinical information (e.g. chemotherapy, rheumatoid arthritis, 
COPD) and imaging findings will be discussed using clinical case studies. 
Options and also limitations of imaging findings will be illustrated. The following 
scenarios will be taken into account: acute cardiac failure and various 
appearances of oedema; acute immunological-toxic disorders including drug-
induced lung disease and inhalational injuries; exacerbations of preexisting 
lung disease including fibrotic and obstructive lung disorders; severe infections 
causing respiratory failure and their complications.  
Learning Objectives:
1. To learn about the role of imaging in severe attacks of obstructive lung 
disease. 
2. To become familiar with direct and indirect signs of pleural disease causing 
respiratory failure with special emphasis on the intensive care patient. 
3. To learn about imaging features which are helpful for the differential 
diagnosis of pulmonary consolidations causing respiratory failure. 
4. To understand the interaction between comorbidity, age and extent of 
pulmonary disease resulting in severe respiratory failure and the role of 
imaging in it. 
16:00 - 17:30 Room B  
Abdominal Viscera  
RC 1501  
Technical advances in liver and pancreatic 
imaging
Moderator:  
D.J. Lomas; Cambridge/UK 
A-459 16:00 
A. CEUS and elastography  
G.H. Mostbeck; Vienna/AT (gerhard.mostbeck@wienkav.at) 
Contrast-enhanced ultrasoud (CEUS) and elastography are evolving US 
techniques that have already found their ways into clinical practice (CEUS) or 
will do so in the next few years (elastography). CEUS is performed with 2nd-
generation US contrast media, but these contrast media are not available 
worldwide. In many European countries, SonoVue® (Bracco, IT) is the only 
available contrast, consisting of micro-bubbles less than the size of red blood 
cells. In contrast to CT and MR contrast media, these bubbles are strictly 
intravascular. For US imaging, low mechanical index US techniques are used 
to see the resonance of sound by these bubbles. CEUS is excellent for the 
differential diagnosis of focal liver lesions based on vascularisation and specific 
contrast uptake (imaging the wash-in and wash-out of US contrast over time 
with excellent temporal resolution) and increases US sensitivity to liver 
metastases in colorectal cancer patients. However, CEUS is only useful when 
there are excellent US conditions. In pancreatic US, CEUS allows to 
differentiate adenocarcinoma from neuroendocrine tumours based on 
vascularisation (US contrast uptake). Whereas elastography (strain 
elastography or shear wave elastography) is established for the diagnosis of 
liver fibrosis, there are no general recommendations for using these various 
techniques to measure the "hardness of a focal lesion" in focal liver and 
pancreas lesions.  
Learning Objectives:
1. To become familiar with novel technical applications that are useful in liver 
and pancreatic diseases. 
2. To understand the underlying pathophysiologic processes. 
3. To learn about the strengths and limitations of CEUS compared with CT and 
MRI in the study of focal liver lesions and pancreatic diseases. 
A-460 16:30 
B. Diffusion and perfusion  
M.A. Bali; Brussels/BE (mbali@ulb.ac.be) 
Diffusion-weighted MR imaging (DW-MRI) provides information on tissue 
cellularity, extracellular space tortuosity and integrity of cell membranes by 
measuring the motion of water molecules in tissues modified by flows (blood 
vessels, glandular ducts,.). and interaction with cellular components. Integrated 
in conventional-MR acquisition protocol, DW-MRI increases sensitivity for 
lesion detection. The apparent diffusion coefficient (ADC) can be calculated 
using a mono-exponential relationship between signal attenuation and b-value. 
This fitting is influenced by microcapillary perfusion. A more sophisticated 
approach (intravoxel incoherent motion, IVIM) would enable estimation of 
parameters that separately reflect tissue diffusivity and microcapillary 
perfusion. Using IVIM-analysis, the derived quantitative parameters describe 
tissue diffusivity, perfusion and perfusion fraction. By providing qualitative and 
quantitative information, DW-MRI is applied in oncology to characterise 
malignancy, including lesion aggressiveness, and to monitor treatment 
response. Perfusion imaging is a useful tool to achieve information concerning 
tissue vasculature, microvascular permeability and interstitial space 
characteristics. Dynamic contrast-enhanced techniques (DCE-CT, DCE-MR) 
are based on the analysis of the contrast agent (tracer) biodistribution in 
tissues. Quantitative parameters are obtained using pharmacokinetic models, 
as transfer constant Ktrans, extracellular-extravascular space fraction ve, 
vascular tissue fraction vp and the rate constant Kep. Quantitative DW-MR and 
DCE-MR parameters are increasingly used as imaging biomarkers to predict 
tumour response and/or to monitor the effects of therapy, especially when anti-
cancer agents with novel models of action are used (anti-angiogenic, tyrosine 
kinase inhibitors and several others). Therefore, these new imaging biomarkers 
may have a pivotal role in correctly evaluating tumour response and stratify 
and managing cancer patients.  
Learning Objectives:
1. To learn about the technical requirements necessary for diffusion-weighted 
MRI and how to avoid artefacts. 
2. To learn about the technical requirements for CT and MRI perfusion. 
3. To become familiar with imaging biomarkers useful in tumour evaluation. 





C. Liver specific contrast agents  
B.J. Op de Beeck; Antwerp/BE (bart.op.de.beeck@uza.be) 
For state-of-the-art MR liver and pancreatic imaging, a field strength of at least 
1.5T is required. All non-blood pool gadolinium chelate-based contrast agents 
are suitable for dynamic liver and pancreatic MRI. All gadolinium chelates 
should be routinely administered at a rate of 1-2 ml/s followed by a 20 ml saline 
flush at 1-2 ml/s using a power injector. To obtain hepatobiliary phase imaging 
in addition to dynamic phase imaging, the use of liver-specific contrast agents 
is required. Gd-EOB provides the highest hepatocyte enhancement, but an 
overlap between delayed phase and hepatocyte phase has to be considered 
during dynamic evaluation. The hepatocyte phase can be considered adequate 
when contrast is detected in the intrahepatic bile ducts. Hepatobiliary phase 
imaging benefits from a gradient echo high flip angle, depending on magnet 
field strength. In the absence of liver function impairment and biliary 
obstruction, contrast-enhanced MR cholangiography can be obtained with Gd-
EOB at 20-40 minutes, and with Gd-BOPTA at 60-120 minutes. When the 
differential diagnosis is primarily between solid benign lesion vs. metastasis, 
the use of a liver-specific CA is recommended, due to the ability to diagnose 
FNH confidently. The combined interpretation of dynamic and hepatobiliary 
phase improves diagnostic accuracy of MR imaging for the detection of HCC. 
Hemangiomas and intrahepatic CCC result in relative hypointensity in the late 
vascular phase after Gd-EOB administration. When combined with T2-
weighted MRCP, contrast-enhanced MRC allows morphologic and functional 
assessment of the biliary system.  
Learning Objectives:
1. To learn about the principals and recent technical advances in the use of 
liver specific contrast agents for liver imaging. 
2. To appreciate the similarities and differences between the classes of 
contrast agent. 
3. To become familiar with indications of liver specific contrast in biliary 
diseases. 
4. To learn about future directions of MRI contrast agents. 
16:00 - 17:30 Room C  
Modern Imaging of the GI Tract  
CC 1521  
Gastrointestinal stromal tumours (GIST)  
Moderator:  
M. Zins; Paris/FR 
A-462 16:00 
A. Pathology and treatment options  
B. Seddon; London/UK (beatrice.seddon@uclh.nhs.uk) 
Gastrointestinal stromal tumours (GIST) are rare malignant tumours arising 
within the wall of the gut from the interstitial cells of Cajal, which act as 
pacemaker cells controlling peristalsis. The crude annual incidence of clinically 
detected GISTs is approximately 10 cases per million in Europe. The median 
age at diagnosis is approximately 63 years, and 80% of patients are older than 
50 years. However, a small number of cases do occur in younger people and 
children, and these are usually syndromic GISTs. GISTs can occur at any site 
of the gut from the oesophagus to rectum, although they can also arise in the 
extra-gastrointestinal abdominal and pelvic locations, so-called e-GISTs. The 
commonest location is the stomach (55%), followed by the small intestine 
(35%) and rectum (5%). Diagnosis is by biopsy, with spindle cell or epithelioid 
morphology, and immunohistochemical staining for CD117 (the protein product 
of the KIT gene) and/or DOG-1 receptors. Approximately, 80% of GISTs have 
mutations in the KIT gene, 10% have mutations of the PDGFRA gene, and the 
remaining 10% have no mutation (wild-type) or rare gene mutations. Early 
stage disease is managed by surgery, followed by 3 years of adjuvant imatinib 
(a tyrosine kinase inhibitor with activity against KIT and PDGFRA receptors) for 
cases at high risk of relapse. Advanced metastatic disease is treated with 
imatinib, with a median duration of response of approximately 2 years. At 
disease progression, second-line treatment is with sunitinib, with a median 
duration of response of approximately 6 months.  
Learning Objectives:
1. To learn about the prevalence and typical location of GIST tumours. 
2. To understand the histological and genetic characteristics of GIST tumours 
and the differential diagnosis. 
3. To become familiar with the treatment options for GIST tumours. 
Author Disclosure:
 B. Seddon: Author; Author on paper on sunitinib in GIST. 
A-463 16:20 
B. Disease staging and treatment planning  
C. Hoeffel; Reims/FR (choeffel-fornes@chu-reims.fr) 
Imaging plays a major role in the detection, characterisation and staging of 
gastrointestinal tumours (GISTs). Imaging of GISTs depends on the mode of 
presentation and the local availability. Endoscopic ultrasound and computed 
tomography (CT) are the most widely used imaging methods. GISTs have a 
spectrum of radiological appearances depending on tumour size and site of 
origin, but often show certain key radiological features. Multiphase 
multidetector row CT is necessary to detect and stage GISTs and multiplanar 
imaging is important so as to define the likely organ of origin of the mass, 
which may be a challenging task. The clinical diagnosis of a GIST is based 
mainly on imaging, as biopsy runs the risk of tumour rupture or seeding of the 
biopsy tract. In patients with an unresectable primary tumour or metastatic 
disease at presentation, biopsy confirmation is important before starting 
medical treatment. CT or/and MRI are used to assess primary tumour 
extension, local invasion and the presence of metastases, with main sites of 
metastasis being the liver and the omentum.  
Learning Objectives:
1. To appreciate the imaging modalities available for staging GIST tumours, 
and to understand the advantages and disadvantage of each. 
2. To learn about optimised acquisition protocols. 
3. To become familiar with the imaging differential diagnosis of GIST tumours 
and the role of biopsy. 
4. To appreciate the radiological staging of GIST tumours, including typical 
sites of metastatic disease. 
A-464 16:40 
C. Treatment response assessment and disease follow-up  
A. Graser; Munich/DE (Anno.Graser@med.uni-muenchen.de) 
Gastrointestinal stromal tumours (GISTs) are treated with targeted therapy 
regimes. These treatment strategies are based on the suppression of tumour 
vasculature using the tyrosine kinase inhibition pathway. Drugs like imatinib 
and sunitinib exhibit specific changes in tumours and metastases that can be 
detected on cross-sectional imaging. These changes differ significantly from 
standard treatment effects of cytotoxic chemotherapy. While the latter leads to 
destruction of tumour cells and thereby to a reduction of tumour size, the 
former will cause a decrease in vascularity and thereby in attenuation and 
enhancement of lesions while the size may remain unchanged. Radiologists 
have to be aware of these specific patterns of response to treatment. This 
presentation will include a review of the Choi criteria which have been 
developed for the assessment of GIST lesions under treatment. Also, current 
imaging strategies focusing on time-resolved CT imaging (CT perfusion 
imaging) will be presented. The aim of this lecture is to provide a practical 
approach to response imaging in GIST patients integrating both existing and 
novel strategies.  
Learning Objectives:
1. To understand the role of imaging in disease treatment response 
assessment and the pros and cons of available modalities. 
2. To appreciate the imaging criteria used in the assessment of disease 
response. 
3. To learn how imaging can help guide appropriate therapy. 
Author Disclosure:
 A. Graser: Grant Recipient; Bayer Healthcare, Siemens Healthcare. 
Research/Grant Support; Bayer Healthcare, Siemens Healthcare. Speaker; 
Siemens Healthcare, Bracco Diagnostics, Pfizer Pharma, GlaxoSmithKline. 
A-465 17:00 
D. Interactive case discussion  
M. Zins; Paris/FR 
16:00 - 17:30 Room D  
Cardiac  
RC 1503  
Cardiac CT and MRI in difficult patients: 
what to do?  
A-466 16:00 
Chairman's introduction  
M. Hamilton; Bristol/UK (Mark.Hamilton@UHBristol.nhs.uk) 
Performing high-quality examinations is easy in the ideal patient. However, 
many subjects present challenges that if not overcome may lead to a failed 
examination. For example, the obese, the breathless, the arrhythmic, the 




elderly and the young can all present special problems that require a greater 
depth of understanding to obtain a diagnostic study. This session will help you 
in your quest for reliable high-quality investigations for all.  
A-467 16:05 
A. Coronary CTA in patients with severe arrhythmias and high heart rate  
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at) 
Besides all advances in scanner technology, heart rate remains a critical issue 
for coronary CTA, and motion artefacts due to cardiac function represents still 
the most frequent reason for limited diagnostic image quality in cardiac CTA. 
Thus, the target heart rate is defined depending on the scanner system used 
and ranged between below 60 bpm and below 70 bpm. However, in a number 
of patients heart rate control is not possible or not successful (i.e. children, 
emergencies, heart transplant recipients), whereas a relevant proportion of 
CTAs are performed in patients with heart rates higher than the target 
frequency. During this presentation, the possibilities for heart rate control by 
beta blocker injection and beyond will be discussed and possible workflows will 
be presented. Furthermore, examination strategies for patients with high heart 
rates will be presented including reverse dose modulation, high-pitch scanning, 
systolic scanning and more. Finally, tools for reconstruction and assessment of 
patients scanned at higher heart rate will be introduced. Different to high heart 
rates and even more critical with regard to image quality is arrhythmia. Due to 
the complexity of cardiac synchronisation, a CT suite is not the place for 
cardiac resynchronisation, whereas the indication to CTA has to be 
reevaluated depending on referring diagnosis and severity of arrhythmia. Since 
there are patients undergoing CTA because of arrhythmia including patients 
prior to ablation treatment, strategies for examination and image reconstruction 
in case of arrhythmic patients have to be established and will be presented.  
Learning Objectives:
1. To understand the criteria for optimal patient selection and preparation to 
achieve best results. 
2. To learn about acquisition techniques in patients with arrhythmias and 
tachycardia. 
3. To become familiar with the post-processing techniques available for 
optimising image quality following the scan. 
A-468 16:28 
B. Severe coronary calcinosis and stents: tips and tricks in image 
acquisition and interpretation  
F. Pugliese; London/UK (francesca.pugliese@libero.it) 
Cardiac computed tomography (CT) has become a widely available diagnostic 
tool used in a range of heart conditions. The commonest application of this 
technique is in the evaluation for coronary artery patency (coronary CT 
angiography) in patients with chest pain. When coronary arteries are heavily 
calcified, or post-coronary angioplasty with stent implantation, diagnostic 
problems can occur. In these circumstances, the evaluation of the coronary 
arteries on CT is hampered by the occurrence of high-density artefacts caused 
by calcifications and stent struts. These artefacts may preclude the appropriate 
assessment of the coronary lumen. The presence of motion artefacts in the 
dataset or image noise in very large patients may exacerbate the problem. In 
this scenario, accurate patient selection and preparation remain key to ensure 
that the diagnostic yield of the cardiac CT study is good. Optimisation of scan 
parameters (kV), contrast injection protocol and use of appropriate post-
processing techniques (e.g. dedicated convolution filters) play an important 
role in daily clinical practice. Recent technical developments include dual-
energy scan techniques and gemstone spectral detector systems that acquire 
simultaneously high and low kilovoltage datasets. This is done to achieve 
tissue differentiation. In principle, by using monochromatic image 
reconstruction, the effect of high-density artefacts may be decreased. Using a 
similar principle, high-density structures can be subtracted from the image. The 
introduction of iterative reconstruction algorithms may play a role in that these 
algorithms are theoretically more accurate in the modeling of physical noise 
and tissue geometries.  
Learning Objectives:
1. To understand the challenge of calcification and stents when performing 
coronary CTA. 
2. To become familiar with technical features that maximise image quality in 
this patient group. 
3. To be aware of the accuracy of coronary CTA in stented or calcified vessels 
with the optimum imaging techniques. 
A-469 16:51 
C. Cardiac MRI: potential problems and how to avoid them  
E. Mershina; Moscow/RU (elena_mershina@mail.ru) 
Lack of movement artefacts is one of the major prerequisites for good image 
quality in cardiac MR. It is crucial to have the minimum possible image 
acquisition time. It is important to make both TE and TR as short as possible. 
Data acquisition should be synchronised with patient's ECG or pulse. Special 
attention should be paid to good quality of ECG recordings (good contact of 
electrodes with the skin, electrodes positioning, using of dielectric pad). In 
patients with arrhythmia, prospective ECG synchronisation should be used 
instead or a retrospective one, or special protocols may be applied for 
arrhythmia correction. Breathing artefacts are usually not a problem for cardiac 
MRI, because most sequences are acquired during a single breath-hold. Using 
SSFP and parallel imaging allows obtaining a complete set of cine MR images 
through the whole heart in 1-8 short breath-hold periods. The technique of real-
time cardiac MR is a good way to perform successful examinations even in 
difficult patients, especially the ones with heart failure. Other systemic MR-
artefacts (aliasing, chemical shift, magnetic susceptibility, off-resonance) 
should be recognised and diminished or eliminated by the operator. These 
artefacts are more prominent in case of 3 T systems. Late-enhancement 
studies with Gd are very dependent on the correct selection of the TI time. 
Phase-contrast MRI requires VENC calibration in cases of valve stenoses. To 
meet the challenges and the benefits of cardiac MRI, one must balance the 
constraints of signal- and contrast-to-noise ratios, spatial and temporal 
resolution, scan time and image quality.  
Learning Objectives:
1. To learn about the importance of patient selection and preparation in 
achieving high-quality scans. 
2. To understand the practical techniques available for performing a successful 
scan in difficult patients such as those with arrhythmia or poor breath-holding 
ability. 
3. To learn how imaging parameters can be changed for optimal results. 
Panel discussion:  
When to scan and when not to?  
How can we make the best of what we have?  17:14
16:00 - 17:30 Board Room B  
Paediatric  
RC 1512  
Paediatric MSK radiology: what is 
important?
Moderator:  
R.A.J. Nievelstein; Utrecht/NL 
A-470 16:00 
A. Scoliosis: what the radiologist needs to know  
A. Geoffray, J.-L. Clément; Nice/FR (a.geoffray@lenval.com) 
Scoliosis, a common spinal deformity in teenagers, especially girls, progresses 
during their growth until the end of puberty. Therapeutic choices, which are 
either medical - with corset - or surgical, depend on this progression. Follow-up 
is mainly clinical. However, radiographs are often indicated to give precise 
information: AP and lateral views of the spine in standing position remain the 
basis of this follow-up. Obtaining a good image quality at all levels of the spine 
has been a technical challenge for a long time, and the question of radiation 
dose is also a main concern, as these radiographs require a high radiation 
dose. Fortunately, radiographic techniques have greatly improved over the 
past few years: From the conventional 90 or 120 cm film to digital screens and 
now flat screens, we now obtain better quality images with less radiation. 
Today, EOS system using Xenon chamber is the best to give good AP and 
lateral views. It allows 3D reconstructions with minimal radiation dose. On 
these radiographs, measures can be performed, essentially Cobb's angle. It 
helps in evaluating progression of the curves and making surgical decisions. 
Other imaging techniques are requested only in particular situations as in the 
presence of neurological symptoms or general disease such as 
neurofibromatosis, or in young children with malformative scoliosis and 
sometimes preoperatively. CT is best to study the vertebrae; it objectivates 
vertebral malformations (agenesis, hypoplasia, blocks). MR will be requested 
to study the cord, nervous roots, craniospinal junction and the soft tissues. 
Collaboration between the radiologist and spinal surgeon is essential.  
Learning Objectives:
1. To understand how to balance the need for information on the progression 
of scoliosis against the exposure to ionising radiation. 
2. To become familiar with the essential measurements in the scoliotic spine, 
their reliability and validity. 
3. To understand the role of the radiologist in scoliosis imaging. 
A-471 16:30 
B. Benign bone tumours and pseudotumours in children: the pitfalls  
D. Dumitriu; Brussels/BE (dana.dumitriu@uclouvain.be) 
Benign bone lesions in children are commonly an incidental radiographic 
finding. They may also cause pain, a palpable mass or pathological fracture. It 




is the radiologist's role to follow a diagnostic algorithm helping him decide on 
the following points: Is the lesion a tumour or not? Is a normal variant 
excluded? If it is a tumour, does it show signs of malignancy? Is the 
radiological aspect typical for a "don't touch lesion" or are other investigations 
necessary? The key elements in the diagnostic process, as for most bone 
lesions, are: the age of the patient, the type of bone and bone segment 
involved, the location within the bone, the presence of signs of aggressiveness 
(type of osteolysis, limits, presence and type of periosteal reaction). 
Conventional x-rays should never be absent from the initial workup of a focal 
bone lesion in a child, as they provide essential features for differential 
diagnosis and, in most cases, eliminate the need for other more costly 
techniques. The need and priority for other imaging techniques, such as CT, 
MRI and bone scintigraphy, are decided on a case-by-case basis and 
sometimes a combination of these techniques, which complement each other, 
is needed. It is the radiologist's responsibility to recommend histological 
analysis of a lesion via biopsy whenever the imaging aspect is not 
characteristic or indicates signs of possible malignancy.  
Learning Objectives:
1. To recognise the most common benign bone tumours and pseudo-tumours. 
2. To understand the differences between benign bone tumours, pseudo-
tumours and malignancies in children. 
3. To understand imaging modalities that could help in the differential diagnosis 
of benign bone tumours and pseudo-tumours in children. 
A-472 17:00 
C. Congenital bone dysplasias  
A.C. Offiah; Sheffield/UK (amaka.offiah@nhs.net) 
The 2010 Nosology and Classification of Genetic Skeletal Disorders subdivides 
456 conditions into 40 groups defined by molecular, biochemical and/or 
radiographic criteria. 316 conditions are associated with mutations in at least 
one of 226 different genes. Some of these conditions are rare or even 
extremely rare (occurring in fewer than 1 in 100,000 of the population). Clearly, 
the general paediatric radiologist cannot be expected to correctly recognise 
and diagnose all of these conditions. The approach is to perform a set of 
radiographic images dependent on the patient's age/size and to develop a 
standard system for reviewing these images. The standard set of images for a 
patient over 2 to 3 years of age consists of AP and lateral skull, AP chest, AP 
pelvis, lateral thoracolumbar spine, AP one upper limb, AP one lower limb and 
DP left hand. Variations on this routine dysplasia skeletal survey will be 
discussed and a standard system for interpreting the images will be presented 
using radiographs of the commoner skeletal dysplasias as examples.  
Learning Objectives:
1. To understand the role of the radiologist in diagnosing congenital bone 
dysplasias. 
2. To understand how to classify bone dysplasias. 
3. To learn how to report radiological studies related to bone dysplasias. 
Author Disclosure:
 A.C. Offiah: Advisory Board; BioMarin - Management of Spinal Cord 
Compression in Patients with MPS IVA. Author; Fetal and Neonatal Skeletal 
Dysplasias (Published by Radcliffe Ltd). Speaker; Over the past 10 years I 
have given multiple lectures in relation to the imaging of skeletal dysplasias. 
Other; I am Chairperson of the Skeletal Dysplasia Group for Teaching and 
Research. 
16:00 - 17:30 Room E1  
Special Focus Session  
SF 15a  
Body composition: a new string to the 
radiologist's bow  
A-473 16:00 
Chairman's introduction  
G. Guglielmi; Foggia/IT (giuseppe.guglielmi@unifg.it) 
In the last few years, interest in body composition (BC) analysis, which is the 
quantification and characterisation of relative amounts of muscle, fat, bone, 
and other vital parts composing the human body, has grown rapidly for clinical, 
research and epidemiological purposes. Studying body composition has 
gained great importance for the comprehension and decoding of a multitude of 
patho-physiological processes (e.g. obesity, diabetes and endocrine diseases 
and also gastrointestinal, renal, nervous, infectious diseases, etc). and 
physiological and para-physiological conditions as in athletes or growth and 
ageing processes. Although the main imaging techniques, which include dual-
energy x-ray absorptiometry (DEXA), computed tomography (CT), and 
magnetic resonance imaging (MRI), offer a differentiated and attractive 
analysis of BC, they still need to find a definite position in clinical practice.  
Session Objectives: 
1. To become familiar with abnormalities involving fat mass, lean mass and 
bone. 
2. To understand the importance of body composition for clinical purposes, 
research purposes and epidemiological purposes. 
3. To learn about the predictive value of body composition variables. 
A-474 16:05 
Body composition: why and how?  
J.E. Adams; Manchester/UK (judith.adams@manchester.ac.uk) 
Through 'programming' low birth weight is associated with increased rates of 
coronary heart disease, stroke, hypertension & non-insulin dependent 
diabetes. Prediction of morbidity and mortality from body composition, 
particularly fat, stimulates the importance and application of accurate and 
precise methods for quantitative assessment of body composition; the gold 
standard for which is cadaver analysis, but other methods have to be 
implemented in vivo. Body composition alters in many chronic diseases, 
starvation cases, metabolic syndromes, and senescence stages, and is a key 
component of health. Several techniques are available which vary in simplicity 
and complexity of use. Each make assumptions and may not measure body 
composition directly, but make predictions from other measurements made. 
Skinfold thickness measurements assess regional fat and are quick and simple 
to perform at all ages. Reproducibility is good, but less so in obesity. There is 
some limitation of reference data to express results as standard deviation 
scores (SDS). Body mass index (BMI; weight/height2) is widely used as an 
index of relative weight expressed as SDS for gender, age and ethnicity. Waist 
circumference (WC) is a measure of central fat, and can also be expressed as 
a ratio to hip circumference. Bioelectric impedance analysis (BIA) measures 
body impedance to a small electric current, which estimates total body water 
(TBW) from which can be derived fat free mass (FFM). TBW can also be 
measured by neutron activation. Air displacement plethysmography (Bod Pod) 
is a new method for body composition assessment.  
Learning Objectives:
1. To understand normal body composition in children and adults. 
2. To learn how body composition can be altered by disease. 
3. To appreciate the clinical relevance of assessing body composition. 
4. To understand the non-imaging methods available for measuring body 
composition, with their advantages and limitations. 
A-475 16:25 
Computed tomography: what does it measure and how?  
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr) 
CT allows measurement of total body fat and enables differentiation of 
subcutaneous from visceral adipose tissue. Body fat can be estimated using 
the conventional technique of manual planimetry. Using planimetry, the user 
delineates manually the boundaries of subcutaneous and visceral fat in each 
CT image. However, this method is labour intensive, time-consuming, and, 
therefore, not easily applicable in routine clinical practice. Another CT method 
used for the estimation of abdominal fat is the semiautomatic measurement of 
adipose tissue area. Abdominal fat is assessed in a CT slice by using a fixed 
range of Hounsfield units to define the area of adipose tissue. A limitation of 
this method is that the attenuation range of fat may vary among individuals. 
The stereological volume estimation method is based on the Cavalieri's 
principle. According to this principle, the volume of an object can be measured 
by cutting it into equally spaced slices and measuring the area of the object on 
each slice. To measure body fat using stereology, a square grid of test points 
is randomly superimposed on each CT section. All points lying inside the fat 
tissue region are selected by the user and the software automatically 
calculates the total number of points hitting the fat. Stereology provides the 
possibility for efficient fat volume assessment. However, research studies are 
needed to optimise the stereological estimation of fat and compare 
stereological measurements with those from other adipose tissue 
measurement CT techniques.  
Learning Objectives:
1. To appreciate the role of CT imaging in body composition analysis. 
2. To learn how to measure visceral and subcutaneous adipose tissue using 
CT. 
3. To understand the advantages and limitations of CT techniques (planimetry, 
thresholding, stereology) in evaluating adipose tissue. 
A-476 16:40 
MRI: current and future applications  
D.C. Karampinos; Munich/DE (dimitrios.karampinos@tum.de) 
MRI has been emerging as an ionising radiation-free imaging modality to 
measure fat distribution in the human body and fat content in different organs. 
The present talk will first introduce MRI methods to measure fat distribution, 




including the well-established T1-weighted imaging and the emerging Dixon 
imaging approaches. The challenges related to the data acquisition and image 
post-processing of the two imaging approaches in the study of fat distribution 
will be reviewed. Examples will be shown from the current use of MRI in 
investigating adipose tissue distribution alterations or differences in patients 
with metabolic disorders, including obesity and diabetes. Quantitative MRI 
methods enabling the measurement of fat content with high spatial resolution 
will be then presented, with a focus on water-fat separation methods. The 
technical challenges associated with the establishment of MRI-based fat 
content, as an accurate and reproducible imaging biomarker will be discussed. 
The selection of pulse sequence parameters and image reconstruction 
algorithm in a state-of-the-art water-fat separation experiment will be 
explained. Applications will be shown from the growing literature of MRI-based 
fat quantification in abdominal organs (e.g. liver) and in skeletal muscles, 
aiming to show the great premise of quantitative water-fat MRI in quantifying 
fat content with high spatial resolution in different body parts. At the end of the 
talk, the potential of quantitative water-fat MRI will be discussed in the 
emerging application of measuring bone marrow fat content and its association 
with bone health and metabolic disorders.  
Learning Objectives:
1. To become familiar with MRI techniques for measuring fat content and fat 
composition. 
2. To learn about the current use of MRI in measuring adipose tissue 
distribution in metabolic disorders. 
3. To learn about the potential of MRI for measuring bone marrow fat content in 
osteoporosis. 
Author Disclosure:
 D.C. Karampinos: Research/Grant Support; Philips Healthcare. 
A-477 16:55 
DXA: technical aspects and application  
A. Bazzocchi; Bologna/IT (abazzo@inwind.it) 
The key role of dual-energy x-ray absorptiometry (DXA) in the management of 
metabolic bone diseases is well known. The role of DXA in the study of body 
composition and in the clinical evaluation of disorders which directly or 
indirectly involve the whole metabolism as they may induce changes in body 
mass and fat percentage is less known or less understood. DXA has a range of 
clinical applications in this field, from assessing associations between adipose 
or lean mass and the risk of disease to understanding and measuring the 
effects of pathophysiological processes or therapeutic interventions, in both 
adult and paediatric human populations as well as in pre-clinical settings. DXA 
analyses body composition at the molecular level that is basically translated 
into a clinical model made up of fat mass, non-bone lean mass, and bone 
mineral content. DXA allows total and regional assessment of the three above-
mentioned compartments, usually by a whole body scan. Since body 
composition is a hot topic today, manufacturers have steered the development 
of DXA technology and methodology towards this. New DXA machines have 
been designed to accommodate heavier and larger patients and to scan wider 
areas. New strategies, such as half-body assessment, permit accurate body 
scan and analysis of individuals exceeding scan field limits. Although DXA is a 
projective imaging technique, new solutions have recently allowed the 
differential estimate of subcutaneous and intra-abdominal visceral fat. The 
transition to narrow fan-beam densitometers has led to faster scan times and 
better resolution; however, inter- or intra-device variation exists depending on 
several factors.  
Learning Objectives:
1. To appreciate the role of DXA in the study of body composition. 
2. To understand potential limitations and pitfalls of DXA in the analysis of body 
composition. 
3. To learn about technical elements and methods, and to become familiar with 
biomarkers in DXA. 
Panel discussion:  
How to rationalise the use of body composition analysis in radiological 
practice  17:15
16:00 - 17:30 Room E2  
State of the Art Symposium  
SA 15  
Tumour response assessment in clinical 
practice  
A-478 16:00 
Chairman's introduction  
E. De Kerviler; Paris/FR (eric.de-kerviler@sls.aphp.fr) 
In cancer patients, disease-free survival is a good indicator for tumour 
response, but for many common cancers, treatment of disseminated disease is 
often noncurative. The increased duration of survival is related to changes in 
tumour size after treatment. However, the anatomical determination of tumour 
response has some limitations, especially when non-cytotoxic targeted 
therapies are used. With these new treatments options, the lack of progression 
may be associated with a good improvement in outcome, even in the absence 
of major shrinkage of tumours. New imaging biomarkers are therefore needed 
to assess therapeutic response. Molecular imaging is now playing a prominent 
role in the monitoring of cytostatic targeted therapies. PET-CT, dynamic 
contrast enhancement studies or diffusion-weighted imaging are the most 
promising ones. The aim of this session is to present the state of the art in 
tumour response assessment with regard to new therapeutic regimens.  
Session Objectives: 
1. To understand the role of the radiologist in cancer patient management. 
2. To appreciate the key issues of tumour assessment in oncology. 
3. To become familiar with the most common response criteria used in practice 
and in clinical trials. 
4. To learn about future imaging biomarkers in response assessment. 
A-479 16:05 
Endpoints for therapy response assessment: the oncologist's 
perspective  
J. Carles; Barcelona/ES (jcarles@vhio.net) 
In early oncologic times, treatments of different malignancies were reported in 
different ways. C. Gordon Zubrod and others first articulated the model of 
multicentre clinical trials and argued for standards to be agreed for included 
and excluded subjects, the method of assigning treatment and in measuring 
response. Nowadays, we have better knowledge of tumour biology; however, 
we continue using the classical response criteria (WHO and RECIST) and 
overall survival as a primary goal for effective treatment in most of the 
malignancies. In the last few years, different criteria for responses have been 
reported to evaluate the disease and a lot of discussions between authors 
have been reported. Now, we can use the RECIST criteria v1.1, implement the 
PERCIST criteria and also forget the IMMUNOTHERAPY criteria. Furthermore 
in the last few years, different treatments such as vaccines, antiangiogenics 
and targeted therapies have increased our arsenal in the treatment of different 
malignancies such as kidney cancer, prostate cancer, breast cancer and so on. 
Another problem for our patients is that those diseases have a long evolution 
after the first-line treatment. We have to be able to define in each disease the 
treatment line and type of treatment to determine which evaluation criteria are 
necessary and which is the objective of treatment, PFS or OS. We have to be 
aware that if we are not able to define such topics, we may be losing active 
treatments.  
Learning Objectives:
1. To learn about prognostic implications in survival. 
2. To understand new endpoints in targeted therapies. 
3. To appreciate differences between chemotherapies and targeted therapies. 
A-480 16:23 
Revised RECIST guidelines: principles, practical applications and pitfalls  
L.S. Fournier; Paris/FR (laure.fournier@egp.aphp.fr) 
RECIST 1.1 are the criteria most often used in studies to evaluate response to 
treatment in solid tumors. On each follow-up examination, response is defined 
by a combination of unidimensional measurement of 'target lesions', qualitative 
evaluation of 'non-target' lesions, and presence/absence of 'new lesions'. CT 
and MRI are the preferred modalities for RECIST evaluation, and evaluations 
must be performed using the same modality, in the same plane. We will review 
anatomic locations which should be avoided, and how to deal with intercurrent 
events resulting in the impossibility of measurement. Cases when RECIST 
seems inadequate will be discussed, including evaluation of bone metastases, 
and focal therapy. Finally, though these criteria were developed for drug trials, 
they may provide a frame for reading examinations and writing reports in 
routine practice. Reproducible, objective and quantitative criteria help to define 




a common language between radiologists and clinicians, so that the latter can 
make an informed treatment decision based on sound conclusions.  
Learning Objectives:
1. To learn about the RECIST 1.1 criteria. 
2. To become familiar with the conditions necessary to implement them. 
3. To understand the limits of their application. 
4. To learn useful lessons from these criteria for routine clinical practice. 
Author Disclosure:
 L.S. Fournier: Author; Pfizer, Merck. Speaker; Pfizer. 
A-481 16:41 
Criteria beyond RECIST: Choi, mRECIST, EASL-AASLD, PERCIST  
S. Gwyther; Redhill/UK (GwytherSJ@aol.com) 
Radiological response evaluation using anatomical imaging was developed in 
the 1980s in early Phase II clinical trials. Potential new anti-cancer agents were 
assessed by measuring tumour size before and during therapy and a pre-
determined reduction in size constituted response. Radiological response 
represents an objective surrogate for patient benefit and was the primary end 
point in early Phase II studies. If a pre-defined percentage of patients achieved 
the required response, then the agent proceeded to large Phase II and III 
studies where clinical time to progression or progression-free survival 
comprised the primary end point. Between 1980 and 2000, there were 
extraordinary advances in cross-sectional imaging techniques which became 
widely available. Different imaging techniques were introduced piecemeal with 
different co-operative groups adding different requirements, so meaningful 
comparisons from one trial to another could not be made. In 2000, the RECIST 
criteria were introduced requiring specific imaging stipulations and a minimum 
baseline tumour size to unify the different criteria and enable meaningful 
comparisons from one study to another. Further advances continue to be made 
regarding anatomical and functional imaging. Not all anti-cancer agents are 
cytocidal and many studies now use time to progression or progression-free 
survival defined by radiological imaging as the primary end point. Certain 
tumour types respond in a unique manner requiring the employment of specific 
response criteria in these tumour types to adequately demonstrate response. 
Some of these tumour types and their specific response criteria will be 
discussed.  
Learning Objectives:
1. To learn about the role of radiological response evaluation in clinical trials. 
2. To understand how radiological response evaluation has evolved and 
continues to evolve. 
3. To understand which response criteria are utilised in specific tumour types. 
A-482 16:59 
Emerging biomarkers for response assessment: pros and cons  
M.C. Roethke; Heidelberg/DE (m.roethke@dkfz.de) 
Non-invasive response assessment of new specific anti-cancer therapies is an 
emerging field of oncologic imaging. In the past few years, large efforts were 
undertaken to develop new functional biomarkers to enable an earlier 
diagnosis, improved risk stratification and treatment monitoring of oncological 
diseases. Imaging biomarkers reflect changes in tumour biology, which can be 
differentiated into certain categories (e.g. cell density, tumour heterogeneity, 
iron concentration, elastic properties, or cellular receptors). In a first step, 
alternative qualitative and quantitative imaging biomarkers for the different 
modalities (MRI, CT, PET) are elucidated. For magnetic resonance imaging, 
new techniques with potential for treatment response monitoring such as 
diffusion-weighted imaging, susceptibilityweighted imaging, and elastography 
will be assessed. Then, quantification of iodine uptake of contrast-enhanced 
CT as an imaging biomarker will be addressed. Novel PET imaging strategies 
for therapy monitoring will be mentioned with focus on receptor targeting 
tracers (e.g. PSMA, DOTATOC). Furthermore, the role of PET-CT/MRI is 
mentioned to facilitate functional techniques in oncological imaging with 
imaging biomarkers. The potential clinical use of prior introduced biomarkers is 
demonstrated for several cancer entities (e.g. HCC, prostate cancer, malign 
melanoma, multiple myeloma, glioblastoma). Advantages and disadvantages 
of the illustrated imaging biomarkers are discussed during this part of the 
lecture.  
Learning Objectives:
1. To become familiar with alternative biomarkers for therapy monitoring. 
2. To understand different categories of imaging biomarkers. 
3. To learn about the use of emerging biomarkers for tumour assessment in 
selected cancer entities. 
4. To appreciate the advantages and disadvantages of emerging imaging 
biomarkers for tumour response assessment. 
Panel discussion:  
Personalised response criteria for personalised therapies?  17:17
16:00 - 17:30 Room F1  
Special Focus Session  
SF 15b  
Evidence-based radiology, comparative 
effectiveness research, and health 
technology assessment  
A-483 16:00 
Chairman's introduction  
M.G.M. Hunink; Rotterdam/NL (m.hunink@erasmusmc.nl) 
In today's health-care climate, there is an ever-increasing need to justify what 
we do. Evidence-based radiology (EBR), comparative effectiveness research 
(CER), and health technology assessment (HTA) provide tools that help us 
justify imaging decisions. The tools include a hierarchy of study designs to 
evaluate diagnostic tests, checklists to appraise diagnostic studies, 
observational studies, clinical trials, decision modelling, simulation studies, and 
economic evaluation. Understanding these concepts is essential to use the 
published results in justifying what we do. The goal is to image the right 
patient, at the right time, using the right test and with the right interpretation so 
that patients will be advised on the right therapy. Ultimately, the aim is to 
maximise patient outcomes at an affordable cost. This session will cover the 
state of the art in EBR, CER, and HTA and demonstrate how the results are 
used in imaging decisions.  
Session Objectives: 
1. To understand what is meant by evidence-based radiology (EBR), 
comparative effectiveness research (CER), and health technology assessment 
(HTA). 
2. To understand the concept of imaging the right patient at the right time, 
using the right test. 
3. To learn how to use evidence for justified imaging decisions in day-to-day 
clinical practice. 
Author Disclosure:
 M.G.M. Hunink: Advisory Board; NIPED Prevention Compass, Netherlands. 
Author; Decision Making in Health and Medicine. Employee; Adjunct 
appointment, Harvard University. Research/Grant Support; ZonMW and STW, 
Netherlands. 
A-484 16:05 
Evidence-based imaging  
F. Sardanelli; Milan/IT (f.sardanelli@grupposandonato.it) 
The application of evidence-based medicine to medical imaging was relatively 
delayed in comparison to other specialties. Radiologists should be aware of the 
necessity to justify radiological examinations and imaging-based interventional 
procedures on the basis of the best available evidence. Diagnostic tests can be 
evaluated with studies exploring their value in terms of: 1. technical 
performance; 2. diagnostic performance; 3. diagnostic impact; 4. therapeutic 
impact; 5. patient outcome; 6. societal impact. Notably, this is a one-way logic 
chain. While improvement at the upper levels implies improvement at some of 
the lower levels, the vice versa is not always true (e.g., a better diagnostic 
performance does not always imply a therapeutic impact or a better patient 
outcome). Moreover, different degrees of recommendations are based on 
different levels of evidence, with experts' opinion as the lowest level of 
evidence and meta-analyses of high-quality homogeneous studies and 
multicentre studies being the best level of evidence. The quality of studies 
needs to be evaluated in terms of internal and external validity, the former 
regarding study implementation (protocol violations, reference standard, 
measurements, and readers' independence), the latter regarding study 
planning (study design, subjects selection, methods, and statistical analysis). 
Biases influencing the internal validity limit the intrinsic value of study results, 
while those influencing external validity limit the generalisability of study results 
to clinical practice. Finally, high-quality research must be planned to build the 
evidence in favour of radiological procedures, especially for new technologies 
which tend to enter the market without any preliminary demonstration of 
efficacy.  
Learning Objectives:
1. To understand the different levels of evidence in the medical literature. 
2. To become familiar with the hierarchy of studies for diagnostic tests. 
3. To understand the concepts of internal and external validity. 
4. To learn how different forms of bias can influence reported results in the 
literature. 





State-of-the-art methods in EBR, CER, and HTA relevant to imaging  
U. Siebert; Hall i. Tirol/AT 
More and more, clinical guideline developers and reimbursement decision 
makers need to base their work and decisions on solid evidence. This 
presentation will introduce the key concepts and principles of evidence-based 
medicine (EBM), comparative effectiveness research (CER), and health 
technology assessment (HTA) and their application to the field of radiology. In 
particular, it will be discussed which role observational studies, clinical trials, 
and decision-analytic modeling play in EBR, CER, and HTA and when each of 
these study types is needed to assess imaging technologies. Specific topics 
include the assessment of bias, optimising cutoffs and multiple test strategies, 
making causal inferences, explicitly weighing benefits, risks and costs, and 
considering ethical, legal and social implications (ELSI). 
Learning Objectives:
1. To become familiar with state-of-the-art methods used in EBR, CER and 
HTA. 
2. To understand how observational studies, clinical trials, and decision-
analytic modeling all play a role in EBR, CER and HTA. 
3. To understand how these methods can be applied to the systematic and 
evidence-based evaluation of imaging tests. 
Author Disclosure: 
U. Siebert: Other; Department of Public Health and Health Technology 
Assessment, UMIT - University for Health Sciences, Medical Informatics and 
Technology and ONCOTYROL - Center for Personalized Cancer Medicine, 
Hall i., Department of Health Policy and Management, Harvard School of 
Public Health and Department of Radiology, Massachusetts General Hospital, 
Harvard Medical School, Boston, MA, USA. 
A-486 16:51 
Translating EBR, CER, and HTA results into imaging decisions in daily 
practice  
F.J. Gilbert; Cambridge/UK (fjg28@cam.ac.uk) 
The excitement generated by the discovery of x-rays led to the early adoption 
of this technology in many hospitals around Europe. Over the last three 
decades, the explosion of new medical imaging technologies together with the 
recognition by clinicians of the value of these for their patients has meant that 
imaging budgets have increased exponentially. Evidence based radiology 
(EBR) is a relatively new approach designed to inform clinicians of the most 
appropriate technique to use in a given clinical scenario. The comparative 
effectiveness research (CER) is used by healthcare systems to develop a 
strategic approach to rationalise the availability of imaging investigations. The 
Health Technology Assessment (HTA) funding approach is a mechanism to 
assess new and emerging imaging technologies in a systematic timely manner. 
The UK has a nationally funded healthcare system which is designed to deliver 
equitable care for the population free at the point of delivery. The challenge for 
the UK has been to ensure the highest quality service by delivering the most 
appropriate technology and care for patients in a timely manner. The National 
Institute for Clinical Excellence (NICE) is an independent body which gives 
guidance on new drugs and medical devices. This body requires robust 
scientific evidence on which to base their decisions. To create the evidence 
base, the imaging studies need to be of a certain standard to be included 
(CONSORT, STARD, etc). An example from oncologic imaging will be used to 
show how EBR influences daily practice.  
Learning Objectives:
1. To learn how EBR, CER, and HTA contribute to imaging decisions. 
2. To understand how EBR, CER, and HTA influence daily practice through an 
example from oncologic imaging. 
Author Disclosure:
 F.J. Gilbert: Speaker; Bracco. 
Panel discussion:  
Can EBR, CER, and HTA results provide justification for imaging 
decisions and how do we implement the results?  17:14
16:00 - 17:30 Room F2  
Special Focus Session  
SF 15c  
Childhood abdominal emergency 2014:  
the dos and don'ts  
A-487 16:00 
Chairman's introduction  
E. Alexopoulou; Athens/GR 
Acute abdomen and abdominal trauma are both emergencies with potential 
fatal sequela when under/ misdiagnosed. Imaging plays a crucial role in the 
diagnosis and management. US is the imaging technique of choice in most 
cases, as it is rapid, portable, lacks radiation and there is no need for sedation 
in young infants. US accuracy can be enhanced by iv contrast agents 
administration. However, limitations may occur in obese children, in deep 
structures, or because of gas filled bowel loops. On the other hand, CT 
provides excellent visualisation without limitations by obesity, gas, or deep 
lesions. However, there is always the radiation exposure risk of the 
radiosensitive paediatric patient, while sedation is required in non co-operative 
young children. The aim of this session is to understand "which" is the modality 
of choice and "why", for the most common paediatric abdominal emergencies.  
Session Objectives: 
1. To learn about the most common paediatric abdominal emergencies. 
2. To become familiar with the advantages and disadvantages of CT and 
ultrasound in abdominal emergencies. 
3. To understand which is the modality of choice for abdominal emergencies. 
A-488 16:05 
The acute abdomen: US is the answer  
S.G.F. Robben; Maastricht/NL (s.robben@mumc.nl) 
Several paediatric diseases are real abdominal emergencies. Any delay in 
diagnosis and treatment may result in death or severe morbidity. These 
diseases are highly age dependent. Newborn infants may have congenital 
diseases as Hirschsprung's disease or meconium ileus or may develop 
necrotising enterocolitis, incarcerated inguinal herniation and midgut volvulus. 
Infants and preschool children have intussusceptions, urinary tract infections 
and (rare) haemolytic uraemic syndrome. Children and adolescents have 
appendicitis, genito-urinary infections, ovarian torsion and Henoch Schonlein 
purpura. Considering radiation dose in children and the excess value of 
ultrasonography (US) in small individuals, US plays an important role as initial 
diagnostic modality in paediatric abdominal emergencies. Sensitivity and 
specificity for US in diagnosing intussusception, midgut volvulus, urinary tract 
abnormalities and appendicitis is over 90%. Conventional abdominal 
radiographs or fluoroscopy are valuable in Hirschsprung's disease, meconium 
ileus, malrotation and necrotising enterocolitis. I consider CT as an additional 
technique when the initial techniques (US and conventional radiography) are 
inconclusive. MRI is seldom indicated in paediatric patients with abdominal 
emergencies because of motion artefacts in anxious children and sometimes 
limited MR capacity. Delay in diagnosis of the above-mentioned diseases may 
be devastating, ranging from life-long disability to death. Therefore, it is 
important to consider these diagnoses and to initiate prompt adequate 
diagnostic workup.  
Learning Objectives:
1. To learn about the most common and devastating paediatric abdominal 
emergencies. 
2. To understand the value of ultrasonography in acute abdomen. 
3. To understand the consequences of any delay in diagnosis. 
A-489 16:23 
The acute abdomen: CT is the answer  
A. Paterson; Belfast/UK (anniezunz@gmail.com) 
Abdominal pain is a common symptom in children, and whilst the majority will 
have a self-limiting condition, in some the pain may indicate an acute medical 
or surgical condition that requires prompt investigation and treatment. In the 
paediatric setting, the primary imaging modality for those with an acute 
abdomen is ultrasound. However, there are certain patient groups - often older 
children or adolescents - in whom CT plays an important role. It is well 
acknowledged that CT is non-operator dependent: an important factor for 
children presenting to emergency departments outside children's hospitals. 
The speed of a CT exam is valuable in the acute setting, as is the capability to 
obtain images without having to touch the tender abdomen of a distressed 
child. CT offers a global perspective of the abdomen, and image quality is not 
hindered by the presence of excessive bowel gas, an abnormal body habitus 




or in the obese patient. CT is especially helpful in those with suspected 
retroperitoneal pathology, in the investigation of immunocompromised patients 
and those with complex post-operative problems. CT guidance may be 
required to facilitate percutaneous abscess drainage, particularly for deep 
pelvic collections. In addition, CT plays a vital role as a 'problem-solver' when 
ultrasound has failed to fully answer the clinical question posed. This short 
presentation will utilise clinical studies to illustrate the benefits of CT in the 
investigation of the acute abdomen, both as the initial imaging modality and as 
a second line tool following ultrasound.  
Learning Objectives:
1. To understand the advantages of CT as a primary imaging modality for 
children with acute abdomen. 
2. To learn about clinical scenarios in which CT is relevant. 
3. To appreciate the use of CT as an adjunct to ultrasound. 
A-490 16:41 
Abdominal trauma: US is better  
V. Miele; Rome/IT (vmiele@sirm.org) 
Ultrasonography (US) is a reliable technique whose advantages are rapidity, 
portability and accuracy in depicting intraperitoneal fluid without interrupting 
resuscitation and without radiation exposure. In the haemodynamically 
unstable paediatric patients, it represents the first line together with the x-ray 
evaluation. US for trauma has become more standardised and is worldwide 
known with the acronym of FAST (focused abdominal sonography for trauma) 
or E-FAST (extended-FAST) used in depicting also pleural and pericardial 
effusions and pneumothorax. Nevertheless, many parenchymal injuries are not 
correctly visualised at baseline US and some traumatic solid organ lesions can 
occur without hemoperitoneum. In case of haemodynamically stable patients, 
who have suffered a low-energy trauma, the greater time available allows the 
use of specific US contrast agents, enabling a better identification of traumatic 
organ injuries. Contrast-enhanced ultrasonography (CEUS) has a greater 
sensibility and specificity in the identification of parenchymal traumatic lesions, 
both in the first evaluation and follow-up, and could avoid unnecessary 
radiation and iodinated contrast medium exposure. In case of 
haemodynamically stable paediatric patients, who have suffered a high-energy 
trauma, US is not recommended as first-line investigation, because CE-MDCT 
should be performed first. Only in the follow-up, CEUS can be considered an 
alternative to CT. In conclusion, E-FAST and CEUS should be considered as a 
useful tool in the assessment and monitoring of paediatric trauma. This 
examination can be performed at the patient's bedside, representing a useful 
alternative to CT in the paediatric traumatised patients and in the follow-up of a 
known abdominal injury.  
Learning Objectives:
1. To understand the differences in the diagnostic paths of paediatric patients. 
2. To learn about the diagnostic efficacy and limitations of ultrasonography. 
3. To become familiar with the use of the contrast-enhanced ultrasonography 
(CEUS). 
A-491 16:59 
Abdominal trauma: CT is better  
M. Raissaki; Iraklion/GR (mraissaki@yahoo.gr) 
CT has been considered a sensitive, specific, and accurate test in the 
identification and grading of injuries, especially in the severely injured child. It 
should be overemphasised that traumatised children differ from adults: 
haemodynamically stable children may actually be actively bleeding and 
rapidly deteriorate. Conversely, children have smaller calibre vessels, stronger 
vasoconstriction, and stronger solid organ capsules; bleeding may stop 
spontaneously, organ rupture is more difficult and delayed rupture is rare. This 
is why few children will undergo laparotomy or trans-arterial embolisation. The 
goal of imaging is to clear the abdomen in multi-traumatised children, identify 
those that may rapidly deteriorate because of clinically silent active bleeding, 
increase the surgeon's confidence level and define short- and long-term 
medical management. Due to children's increased radiosensitivity, all CT scans 
should be indicated based on appropriate early clinical evaluation, assessment 
of risk factors for abdominal injuries and evaluation of the closely monitored 
child. ALARA includes the availability of outside scans upon admission, 
avoiding non-contrast scans and multiple phases and applying age- and 
weight-dependent exposure parameters. CT should not be performed as 
follow-up unless there is clinical deterioration. CT has the advantage of rapidly 
identifying and delineating with high resolution solid organ, vascular, 
mesenteric, bowel injuries and pending oligaemic collapse (hypoperfusion 
complex or shock bowel). Important fractures and thoracic injuries may be 
simultaneously revealed with CT. The objective documentation of intra-
abdominal injuries is extremely important in suspected child abuse.  
Learning Objectives:
1. To understand that children are not small adults. 
2. To learn about trauma CT protocols according to the ALARA principle. 
3. To become familiar with types of injuries, which can be appropriately 
evaluated with CT. 
Panel discussion:  
US or CT in paediatric abdominal emergencies?  17:17
16:00 - 17:30 Room G/H  
Neuro  
RC 1511  
Spine, cord and intervention  
Moderator:  
C. Hoffmann; Tel Hashomer/IL 
A-492 16:00 
A. Intramedullary pathology  
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at) 
Evaluation of MR imaging in a patient with an intramedullary lesion should 
focus on key features: a) the location of the lesion on the cross-sectional area 
of the cord, best evaluated on axial images, b) the length of the lesion 
evaluated on sagittal images, c) the presence of cavitation and cysts, d) signal 
intensity on T2-WI, e) the presence of enhancement and enhancement type, 
and f) associated leptomeningeal enhancement. The knowledge of the 
presence or absence of the brain lesions is important information for narrowing 
the differential diagnosis. The clinical picture and the onset of symptoms will 
help the differentiation between the neoplastic and inflammatory and vascular 
lesions. In this lecture, the imaging characteristics and typical patterns of 
intramedullary lesions will be presented. A diagnostic algorithm, which includes 
imaging, clinics and CSF analysis, will be discussed.  
Learning Objectives:
1. To become familiar with the differential diagnosis of intramedullary lesions. 
2. To learn how to differentiate between inflammatory, vascular and neoplastic 
cord disease. 
3. To recognise the most common intramedullary lesions. 
A-493 16:30 
B. Spondylodiscitis, degenerative or tumoural?  
G. Lycklama à Nijeholt; The Hague/NL (g.lycklama@mchaaglanden.nl) 
A common clinico-radiological situation is the differentiation between spinal 
infection, degenerative changes and osteopaenia, and spinal tumour. In most 
cases, conventional CT and/or MRI will allow a certain differentiation, and 
additional biopsies are mainly used to obtain tissue for bacteriological or 
histopathological classification. Advanced MR techniques such as DWI may 
sometimes help in increasing diagnostic certainty, but are seldomly used in 
day-to-day practice. Spinal infections typically present around the intervertebral 
disc, but may also present as isoloated spondylitis without disc involvement, 
and sometimes the infection quickly spreads to the epidural space. 
Degenerative changes my sometimes mimic infection due to strong gadolinium 
enhancement. The main differential diagnosis of spinal tumorous processes is 
osteopaenic changes (oedema), and CT may be helpful in such cases, for 
example to demonstrate degenerative gas in the vertebral body. Rare causes 
of spinal abnormalities such as atypical pathogens and rare tumours may 
cause diagnostic problems; often the fastest road to a diagnosis is biopsy in 
those cases.  
Learning Objectives:
1. To understand the pathogenesis of degenerative and infectious spinal 
disease. 
3. To become familiar with the diagnostic algorithm of patient selection. 
4. To understand the natural evolution and treatment effects of spinal disease. 
A-494 17:00 
C. Percutaneous treatment of spinal diseases  
M. Muto; Naples/IT (mutomar2@gmail.com) 
The correct clinical diagnostic approach to spine disease is mandatory in the 
selection of patients to be treated. The anatomy and the relationship between 
different structures must be known in detail to understand the source of the 
pain and so to treat it percutaneously. MR, CT, dynamic x-ray and NM bone 
scan in selected cases can be used to understand the reason for the pain. MR 
with T2 STIR sequence or T2 Fat SUPP technique is mandatory to show bone 
marrow oedema and to decide on which metamer to perform the treatment. CT 
is often necessary after MR in primary and secondary spine tumours. Disk 
disease can be seen either on CT or MR. Two major treatments must be 
considered: discogenic pain and vertebrogenic pain, and for this reason disk 
treatment and vertebral treatment. Disk treatment includes many mini-invasive 
systems to use; however, no treatment has been shown to be superior to the 
others, with good clinical results in 75-80% of the cases, even at long-term 
follow-up. VP and assisted techniques are available for the treatment of not 




only porotic fragility fractures, but also of primary and secondary spine tumours 
such as traumatic fractures.  
Learning Objectives:
1. To understand the clinical indications for percutaneous treatment of spinal 
diseases. 
2. To learn which diagnostic modality to suggest. 
3. To become familiar with the different percutaneous techniques available. 
16:00 - 17:30 Room I/K  
Head and Neck Imaging  
CC 1519  
Tailoring head and neck examinations to 
the clinical symptoms (part 1)  
Moderator:  
M.I. Furmanek; Warsaw/PL 
A-495 16:00 
A. Impaired eye movements  
M.G. Mack; Munich/DE (m.mack@radiologie-muenchen.de) 
A wide variety of lesions in and around the orbita can impair eye movement. 
CT and MR imaging is frequently used to confirm or exclude lesions in and 
around the orbit in patients with impaired eye movement. First of all, it is very 
important to know the exact clinical history of the patients. CT is excellent for 
confirming a mass; however MRI is more sensitive and arrives often at a single 
most likely diagnosis. Characteristic imaging features may help distinguish 
among lesions that have overlapping clinical presentations. This review 
focuses on some of the common orbital masses. In this lecture common 
benign and malignant lesions will be discussed. Vascular lesions include 
capillary (infantile) haemangioma, cavernous haemangioma, and 
lymphangioma. Benign tumours include optic nerve sheath meningioma, 
schwannoma, and neurofibroma. Malignancies that are reviewed include: 
lymphoma, metastasis, rhabdomyosarcoma, and optic glioma. In addition, 
benign and malignant lesions affecting the eye movement from outside of the 
orbit (e.g. from the paranasal sinuses, nasopharynx and skull base) will be 
discussed.  
Learning Objectives:
1. To learn about impaired eye movement and understand its causes. 
2. To learn about the imaging algorithm. 
3. To become familiar with differential diagnosis. 
A-496 16:30 
B. Trigeminal neuralgia  
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
Trigeminal neuralgia is a unique form of facial pain, defined by the International 
Association for the Study of Pain as a sudden, unilateral, brief, stabbing, 
recurrent pain in the distribution of one or more trigeminal nerve branches, 
triggered by a specific event. Additional diagnostic criteria of the International 
Headache Society include paroxysmal, stereotypic pain attacks and absence 
of associated neurological deficits. It is due to trigeminal nerve compression at 
the root entry zone, a transitional zone between central and peripheral 
myelination, where the myelin sheath is thinner and more prone to 
compression and electrical stimulation. The most common cause is vascular 
compression, by aberrant loops of the SCA, AICA, PICA or vertebro-basilar 
dolichoectasia, leading to a neurovascular conflict. Small size of the prepontine 
and CPA cisterns has been identified as a predisposing factor. Occasionally, 
expansile lesions of the skull base or CNS compress the root entry zone and 
lead to atypical trigeminal neuralgia. MR imaging is the modality of choice to 
evaluate these patients and requires specific tailored protocols to depict its 
causes, including 3D heavily T2W images reconstructed in the three planes 
and an angiographic sequence for the depiction of neurovascular conflicts. As 
neurovascular contacts are quite common in the general population, strict 
imaging criteria for the diagnosis of NVC have emerged. The offending vessel 
needs to cross the nerve perpendicularly and deviate or indent its course at the 
REZ. A pictorial review of the most common causes of trigeminal neuralgia and 
trigeminal neuropathy will be presented.  
Learning Objectives:
1. To understand the causes of trigeminal neuralgia and its clinical symptoms. 
2. To learn about the relevant anatomy and appropriate imaging methods. 
3. To become familiar with the relevant radiological images, differential 
diagnosis and limitations of the method. 
A-497 17:00 
C. Facing problems of the face: facial pain, tics and palsy  
B. Verbist; Leiden/NL (b.m.verbist@lumc.nl) 
Facial impairments may be due to neuropathies of the trigeminal and facial 
nerve. This lecture will focus on the seventh cranial nerve. This nerve is a 
complex, mixed nerve with motor fibres, parasympathetic fibres, sensory fibres 
to the external auditory canal and special sensory (taste) fibres to the tongue. 
The most common presentation of facial nerve dysfunction is facial palsy. The 
paresis or paralysis of facial muscles may be caused by several conditions 
such as developmental abnormalities, infectious or inflammatory disease or 
tumoural lesions. Other presentations of facial nerve dysfunction are facial tics 
or hemifacial spasm and pain. The indications for imaging, choice of imaging 
modality and possible imaging findings in case of facial palsy, facial tics and 
facial nerve-related pain will be discussed.  
Learning Objectives:
1. To understand the possible causes of facial impairments. 
2. To become familiar with the cranial nerves involved. 
3. To learn how to choose appropriate imaging modality and which critical 
structures to evaluate. 
16:00 - 17:30 Room L/M  
Physics in Radiology  
RC 1513  
IT tools for dose tracking and workflow 
optimisation
Moderators:  
P. Mildenberger; Mainz/DE 
A. Trianni; Udine/IT 
A-498 16:00 
A. DICOM and IHE standards  
D. Peck; Detroit, MI/US (donaldp@rad.hfh.edu) 
The development of the DICOM Standard is done through Working Groups of 
the DICOM Standards Committee. The Working Groups perform the majority of 
work on the extension and corrections to the Standard. The extensions are 
made through development of Supplements and corrections are done through 
Change Proposal (CP) mechanism. In this presentation, the procedures used 
to create the Standard will be reviewed and some of the most recent changes 
discussed. As a collaboration of professional societies and companies, 
Integrating the Healthcare Enterprise (IHE, www.ihe.net) seeks to establish 
methods wherein health computer systems can communicate to achieve 
specific functional objectives. These involve development of methodologies to 
implement standards such as DICOM, HL7, etc. In this presentation, the 
procedures used to create the IHE profiles will be reviewed.  
Learning Objectives:
1. To understand the current DICOM standard. 
2. To learn about new DICOM efforts that will significantly impact imaging 
systems operations. 
3. To understand how IHE coordinates the integration and management of 
DICOM objects. 
A-499 16:30 
B. Patient dose tracking: a must have?  
W. Pavlicek; Scottsdale, AZ/US (pavlicek.william@mayo.edu) 
Patient Dose Tracking is rapidly growing in the USA as a large number of 
commercial products are available in response to user demand. These 
products leverage the work that has gone into the development of the DICOM 
Dose Structured report and the proliferation of digital imaging systems. Medical 
physicists are crucial team members as they are most capable of performing 
patient dose measurements and calculations. Noteworthy is that the 'toolbox' of 
the medical physicist is expanding. Informatics with Patient Dose Tracking 
tools invariably includes familiarity at some detail with DICOM structure and 
tags, Dose Structured Reports (SR), SR Readers, RIS content and orders, 
modality work list broker content, modality (imaging) specific content as well as 
PACs, Archive rules for storage/retrieval and EMR. Patient-specific information 
and the highly detailed specifics of the individual dose prescription are 
necessary for advanced estimates of information. A Dose Tracking system (a 
QA tool outside of the normal imaging device that uses content provided by 
Dose SR and other information systems) usually strives to elevate the quality 
of the dose estimate, using informatics tools such as patient and organ models, 
dosimetry engines, and predictive statistics. General use cases for Dose 
Tracking will be presented including advanced dose estimations for individual 
patient exams and QA review for both CT and fluoroscopy. Examples of 




tracking of prescriptions by patient, protocol/procedure and operator for 
determination of patient dose history, 'outliers', continuous improvement (using 
DMAIC tools) or for meeting regulatory or accrediting bodies will be included.  
Learning Objectives:
1. To identify informatics and tools for tracking patient radiation dose. 
2. To learn about some possible use cases in clinical practice. 
3. To learn about some examples of patient radiation dose tracking. 
A-500 17:00 
C. To identify pitfalls and support technique optimisation  
E. Vaño; Madrid/ES (eliseov@med.ucm.es) 
With the introduction of digital radiology, it is possible to have automatic 
systems to collect and archive patient dose data individually, in addition to 
demographic, geometric, and other procedural parameters, as part of the 
DICOM header or through other DICOM services. These automatic systems 
mean significant benefits for patient dosimetry and quality control. Different 
approaches were used, depending on the availability and level of 
implementation of the DICOM standard, including extracting the technical 
information from the headers, using the radiation dose structured reports 
(which contain accumulated dose over several irradiation events), analysing 
the MPPS messages sent by the modalities to the radiology information 
system, and implementing optical character recognition techniques on saved 
screen images. Before issuing a formal patient dose report, the medical 
physicists should verify and correct all patient dose data. All these approaches 
allow managing more information and provide better capacity to audit the full 
imaging procedure and to help with the optimisation. The current level of 
technology allows doing so at a reasonable cost and with a great benefit for the 
clinical practice. Automatic detection of abnormal patient doses or mistakes in 
the technical parameters used and their prompt correction is possible. 
Diagnostic reference levels will be effortlessly reviewed with such systems. 
Some examples of pitfalls and possible optimisation actions will be presented.  
Learning Objectives:
1. To learn about sources of information that could help in identifying possible 
pitfalls. 
2. To understand how to interpret the data stored. 
3. To learn about some examples of pitfalls and possible optimisation in clinical 
practice. 
16:00 - 17:30 Conf. Room M3  
Oncologic Imaging: Follow-up of Systemic and Local Therapies  
CC 1518  
Follow-up of thermal ablation (part II)  
Moderator:  
R. Bale; Innsbruck/AT 
A-501 16:00 
A. Follow-up imaging of thermal ablative therapies for lung tumours  
T. De Baere, F. Deschamps, L. Tselikas; Villejuif/FR (debaere@igr.fr) 
Within a few minutes following ablation, CT of the ablation zone will 
demonstrate an extensive area of ground glass opacity (GGO). A GGO of at 
least 4.5 mm peripheral to the tumour is predictive of complete ablation. As 
early as 24 hours post-treatment, the entire ablated region usually appeared as 
a well-demarcated homogeneous dense opacity on CT that corresponded to 
necrotic tissue and its surrounding rim of granulation tissue. This zone of 
ablation is the "baseline post-ablation imaging" for follow-up. Then, a relatively 
slow involution of the ablation zone will occur with various patterns, including 
nodular, fibrosis, disappearance, cavitation and atelectasis. Morphologic 
features of local tumor progression are an increase in the overall size or a 
change in the shape of the ablation zone (even without enhancement). It is 
generally considered that an ablation volume that does not increase in size on 
subsequent imaging after the baseline post-ablation imaging is a complete 
ablation. The relatively slow decrease in size of the ablation zone renders CT 
morphologic evaluation responsible for late discovery of local tumour 
progression. PET/CT is able to discover incomplete ablation earlier than CT at 
a stage the disease remains small. Patients who have very early evaluation 
with PET/CT are at risk of either false-positive result due to early inflammation 
process, or false-negative result due to early inflammation masking active 
tumor foci. 3 or 6 months after ablation can be a reasonable time for PET/CT.  
Learning Objectives:
1. To consolidate knowledge on the imaging aspects of successful ablation. 
2. To become familiar with the main pitfalls of post-ablation imaging. 
3. To learn about the imaging aspects of most common complications. 
A-503 17:00 
C. Follow-up imaging of thermal ablative therapies for kidney tumours  
D.J. Breen; Southampton/UK (David.Breen@uhs.nhs.uk) 
Image-guided ablation of kidney tumours has been increasingly set to become 
the standard of care treatment for smaller (< 5 cm) renal tumours, yet ablation 
remains a non-extirpative technique and is therefore paramount, in this 
curative setting, that imaging follow-up should reliably confirm complete tumour 
eradication. Early on in radiofrequency ablation (RFA), control remained 
problematic and inadequate treatment was evidenced by residual marginal 
crescents of viable, enhancing disease. In the current era of more definitive 
ablation with multipolar techniques, cryo- and microwave ablation (MWA), this 
pattern of treatment failure should rarely, if ever, be encountered. Typically 
following adequate ablation imaging should confirm a completely non-
enhancing tumour and a related cortical ablation zone. Whilst non-
enhancement is an accepted surrogate of tumour non-viability, most 
practitioners look for additional collateral features such as the 'halo' sign, 
appearing as a soft tissue ring in the adjacent peri-renal fat, usually a sound 
marker of complete tumour eradication. Follow-up data have shown that 
cryoablation (CRA) can yield robust outcomes, but often incurs notable 
haemorrhagic change and a 'rind-like' feature around the ablation zone. CRA 
also appears to induce faster involution of the treated tumour, whereas RFA 
and MWA can induce a persistent granulomatous mass which only very slowly 
involutes over a number of years. Late local recurrence is increasingly rare at 
around 2-3%, but can occur as nodules of enhancing disease as late as 3-6 
years after the initial treatment. Subtraction MR can be useful, but to date PET 
and perfusion techniques still lack resolution and specificity.  
Learning Objectives:
1. To learn about the post-ablation aspects, according to the ablation technique 
used. 
2. To become familiar with the imaging aspects of successful ablation. 
3. To appreciate the imaging aspect of most common complications. 
A-502 16:30 
B. Follow-up imaging of percutaneous local treatment of bone tumours  
A. Gangi, J. Garnon, G. Tsoumakidou; Strasbourg/FR (gangi@unistra.fr) 
Multiple percutaneous image-guided therapies are currently available for 
thermal ablation of bone tumours. Thermal sources for these treatment 
modalities include high-intensity ultrasound, laser, microwave, radiofrequency, 
and cryotherapy. The predictability of thermal ablation is adequate to limit 
collateral damage and complications, however, is limited by biologic and 
anatomic variability of tissue. Clinical evaluation is essential in symptomatic 
tumours. Close imaging follow-up with CT, MRI, bone scan, and PET plays a 
vital role in the management of the post-thermal ablation patient and detection 
of complications. Recurrences or regrowth can be considered for repeated 
thermal ablation if the lesion is discovered early, before the tumour geometry, 
location, or distribution become unfavourable. The imaging features could vary 
with the different ablation method. The radiologist reporting the follow-up 
imaging should be familiar with different ablation methods. MRI with dynamic 
contrast enhanced imaging and subtraction allows to detect recurrences in 
hypervascular tumour. Contrast enhancement on T1-weighted MRI imaging 
seems to be predictive of clinically unsuccessful ablation. On CT scan, bone 
reconstruction can be visualised but is a slow process, particularly in adults. 
PET scan is an excellent morphologic and metabolic image to follow-up the 
tumours. However, the inflammation produce after ablation can be misleading, 
particularly during the first three months. Imaging follow-up plays an essential 
role in the management of the post-thermal ablation patient and detection of 
complications.  
Learning Objectives:
1. To learn about the post-ablation aspects, according to the ablation technique 
used. 
2. To consolidate knowledge on the imaging aspects of successful ablation 
from various types of follow-up imaging, including CT and MRI. 
Author Disclosure:
 A. Gangi: Other; Proctoring Galil Medical. 




16:00 - 17:30 Board Room A  
Radiographers  
RC 1514  
The interventional suite of 2014: 
responsibilities and challenges  
Moderators:  
K. Haller; Wiener Neustadt/AT 
B. Marincek; Cleveland, OH/US 
A-504 16:00 
A. Today's technology: requirements for a cutting-edge interventional 
suite  
D. Catania; Milan/IT (cataniadiego@hotmail.com) 
Interventional radiology (IR) is an evolution of radiology that treats many 
diseases, originally treated by traditional surgery. The clinical importance of IR 
has been demonstrated over the years by performing procedures that offer the 
benefit of therapeutic treatments, competitive from the point of view of a 
shorter hospitalisation time. Indeed, thanks to IR, patients are treated in a less 
invasive manner, hospitalisation is limited and thus promotes the containment 
of social costs. To maintain standards clinical oversight needs to focus upon 
correct organisational, functional and technological appropriateness of 
practice. To achieve correct IR performance, it is necessary to guarantee that 
all the instrumental guides (fluoroscopy, ultrasound, computed tomography 
equipment) function optimally, the procedural equipment including 
guides/catheters/stents, etc. are chosen according to their technical features 
and their characteristics are appropriate for use, incorporating cost 
considerations. As the complexity and variety of interventional procedures 
grow, there is an increasing need to ensure the appropriate training of 
specialised IR staff. Consideration of dedicated education and continued 
professional development options for radiographers working in IR is of priority. 
The Italian Association of Interventional Radiographers (AITRI) is very 
important in sharing guidelines in a multidisciplinary environment to 
standardise and harmonise the knowledge and skills of the team in hybrid 
theatre and interventional suites. Interventional radiology technology is rapidly 
expanding and, to maintain safe and efficient practice, careful consideration of 
current and potential future organisational needs and the training of staff within 
an IR suite require detailed consideration.  
Learning Objectives:
1. To learn about interventional procedures and their impact on economic 
factors and outcome. 
2. To become familiar with the range of technologies in interventional radiology 
suites and hybrid theatres. 
3. To appreciate the staffing requirements associated with interventional 
radiology suites and hybrid theatres. 
4. To appreciate the education and training needs of radiographers working in 
interventional radiology. 
A-505 16:30 
B. Radiation risk and radiation protection considerations  
A. Widmark; Østerås/NO (anders.widmark@nrpa.no) 
The lecture will discuss where new and current knowledge about radiation risk 
and effects are coming from. A brief overview of the different sources of 
knowledge, including Hiroshima and Nagasaki Life Span Study, will be given. 
The most important stakeholders involved in research and formulating 
guidelines for radiation protection, with special emphasis on the new main 
publication from the International Committee on Radiological Protection 
(ICRP), and the impact on radiographic practice will be discussed. New tissue 
weighting factors for breast glandule gives a significant higher risk for females 
today, especially in the pubertal age. On the other hand, they have the risk for 
hereditary effects significantly decreased. Estimation of risk, both in general 
and in the individual, will be discussed. Regarding staff protection, there is a 
new recommendation for annual dose limit for the eye lens. The previous 
annual dose limit was 150 mSv, and this is now recommended to be 
decreased to 20 mSv averaged over five years with no single year exceeding 
50 mSv. The new recommendation can be a limiting factor in interventional 
radiology and cardiology, if sufficient protection is not used.  
Learning Objectives:
1. To understand the importance of radiation protection in interventional 
radiology for patients and staff. 
2. To appreciate the latest recommendations for staff radiation protection in 
interventional radiology. 
3. To appreciate the important role of the interventional radiographer in 
radiation protection. 
A-506 17:00 
C. Changing professional roles  
B. Hallinan; Dublin/IE (barryhallinan@beaumont.ie) 
The improvement of patient care and aims for the highest possible levels of 
service are to the forefront of the modern "interventional suite". Role 
development experiences will be explored, considering need, effect and 
management of development. Service demands, the need to extend those 
provided, the limited number of radiologists, financial constraints and the 
requirement for continuous professional development at state level provide 
much stimulus for professional radiographic role development. Increased job 
satisfaction, reduced waiting lists and improved patient experience all provide 
largely positive results it appears. Resistance from radiologists, 
multidisciplinary team members and radiographers themselves however, can 
provide unnecessary barriers to change. Once abridged the blurring of 
professional lines and insecurity within multidisciplinary team members may 
also occur. Various experiences would suggest that only by allowing ownership 
of change by all the clinical stakeholders involved, thus empowering them, 
leads to successful development. On examination clear guidelines and distinct 
protocols must be established, taking account of current workload, to create 
the ideal scenario for good multidisciplinary team ethos, where members have 
overlapping yet clearly defined roles. Professional accountability, responsibility 
and an understanding of those role's are all key, but without correct training, 
including support and resources, no regime for role development can be 
achieved successfully. Clinical audit not only ensures the delivery of high 
quality and effective care in line with best practice, whilst ensuring cost 
effectiveness, but also provides the confidence for all involved, especially the 
interventional patient.  
Learning Objectives:
1. To understand the factors influencing change in professional roles within 
interventional radiology. 
2. To learn about the potential impact of enhanced professional roles and a 
multidisciplinary team approach on service delivery and patient outcomes. 
3. To understand the need for clear protocols and guidelines along with 
appropriate training and audit of practice when implementing such changes. 
16:00 - 17:30 Room P  
ENCITE Session  
ENCITE based insights for molecular 
imaging in guidance of therapy  
Moderator:  
M. Neeman; Rehovot/IL 
16:00 
Introduction  
M. Neeman; Rehovot/IL (michal.neeman@weizmann.ac.il) 
A-507 16:05 
A dual-modality gene reporter for in vivo imaging  
K. Brindle; Cambridge/UK (kmb1001@cam.ac.uk) 
There have been many attempts to develop gene reporters for MRI, however 
these give relatively modest image contrast that can be difficult to detect. I will 
describe in this talk a reporter that gives intense and positive contrast in MR 
images (up to ~8x increase in signal), which can also be used with radionuclide 
imaging, thus combining the sensitivity of radionuclide imaging with the spatial 
resolution of MRI. The contrast obtained is directly related to the degree of 
gene expression and is readily reversible, thus allowing longitudinal studies of 
changes in expression.  
Author Disclosure:
 K. Brindle: Research/Grant Support; GE Healthcare. 
A-508 16:20 
MR imaging for pancreatic cells transplantation  
M. Hájek, D. Jirák, V. Herynek; Prague/CZ (Milan.Hajek@medicon.cz) 
The transplantation of pancreatic islet into the liver is an excellent example of 
successful cell therapy. Transplanted islet visualisation in vivo using a non-
invasive imaging method, for example MRI, is necessary to prove technical 
success. Monitoring of transplanted islets in vivo and long-term tracking their 
fate using MRI requires their labelling by a suitable contrast agent in vitro prior 
to transplantation. Under ENCITE project we successfully performed animal 
experiments, which proved therapy potential of labelled pancreatic islets. 
Labelled islets implanted into the rat liver were viable and induced long-term 
normoglycemia in diabetic rats. MRI proved their viability and even distribution 
in the host tissue. These results allowed performing a clinical study on a group 
of 12 patients, which were transplanted by iron labelled pancreatic islets from 
cadaver donors. The successful pilot experiment enabled introducing of 




transplantation of native islets into routine clinical practice. Search for better 
alternative sites, improved immunosuppression and alternative insulin-
producing cells require multimodal and multifunctional molecular probes. 
Currently we test polymer meshes as artificial transplant sites, effect of 
mesenchymal stem cells as a supportive net for beta cells, and novel cellular 
probes combing 1H, 19 F labels and fluorescent ones.  
A-509 16:35 
Optical imaging in the clinic  
J. Dijkstra; Leiden/NL (j.dijkstra@lumc.nl) 
Recently a lot of developments have been done in the field of optical imaging. 
New sensitive devices made it possible to use both visible and near infrared 
light as diagnostic tool and guidance tool. The advantage of near infrared is 
that the penetration depth in tissue is much better than for visible light, allowing 
to see deeper. By using techniques like augmented reality, the data from 
infrared, both anatomical and functional, can be presented to the operator in 
real-time. Optical imaging is used e.g. as an evaluation tools for 
mammography where the optical spectral properties of the tumor cells is used 
to monitor the effectiveness of chemo treatment. The spectral properties of the 
breast are measured using a laser at different wavelengths and a camera to 
create tomographically a 3D volume. Dedicated near infrared probes which 
bind to certain tissue types make it possible to look for e.g. remaining tumor 
tissue in resection margins during surgery. This techniques also allow to 
visualise structures which should be avoided during procedures like nerves. By 
adding multispectral imaging, the endogenous contrast can be used. Different 
tissues have their own absorption spectrum which can be shown as additional 
information, for instance the ration Hb/HbO2. Optical imaging also allows for 
acquiring images at near microscopic resolution real time in-vivo by using 
Optical coherence tomography. This modality is being tested to provide 
information about the presence of certain cell types very fast where otherwise 
histology is needed.  
A-510 16:50 
Mesenchymal stem cells constructs for image-guided cell therapy in 
myocardial ischemia and digestive fistulas  
O. Clément, E. Blondiaux, G. Rahmi, L. Pidial, A. Silva, F. Gazeau, C. Wilhelm, 
G. Autret; Paris/FR (olivier.clement@inserm.fr) 
Regenerative medicine has recently emerged as a potential therapeutic tool. A 
number of preclinical and clinical trials have been conducted in many diseases 
ranging from diabetes to myocardial infarction and neuro-regenerative 
diseases that assess the feasibility and benefits of injecting stem cells. 
However, outcomes relating to graft survival remain generally unsatisfactory, 
whether the process of injection is direct, intravenous or catheter-guided. To 
overcome such issues, tissue engineering has potential to improve cell 
engraftment and therapeutic response including functional parameters. This 
work aimed to evaluate mesenchymal stem cell constructs for image-guided 
cell therapy in myocardial ischemia and digestive fistulas. We tried to options: 
1. Fibrin patches based on fibrinogen monomers polymerised with thrombin 
and seeded with cells. 2. Constructs based on 3D multilayers of confluent cells 
sheets. Tissue constructs were labelled with iron oxide particles and evaluated 
in a model a myocardial infarction for the fibrin patches or digestive fistula for 
the 3D constructs. MRI at 4.7 was performed at various time points after 
treatments using a high resolution coil. Fibrin patches could induce a 
therapeutic effect by increasing the left ventricular ejection fraction compared 
to sham. 3D constructs induced an increased number of fistula healing and 
enhanced micro-vasculature density compared to controls. MRI of labelled 
stem cell constructs allowed a good evaluation of the models and showed 
increased therapeutic efficacy. The proposed paracrine mechanisms will be 
discussed.  
A-511 17:05 
Is cell imaging relevant for the clinic? Lessons to be learned from pre-
clinical research  
U. Himmelreich; Leuven/BE (Uwe.Himmelreich@med.kuleuven.be) 
Non-invasive imaging of therapeutic cells has become a popular field of 
research over the last decade. This interest was mainly based on the hope that 
the location, migration but also function of immune, stem and other cells can 
be visualised over time in individuals. The development of novel contrast 
agents and mechanisms for MRI but also other imaging methods has resulted 
in exciting basic research findings. In particular, the application of relatively bio-
tolerant iron oxide based nanoparticles has fostered the hope for direct 
translation into clinical research and general practice. However, pre-clinical 
research has also highlighted several limitations of nanoparticle based cell 
imaging by using MRI including the generation of unspecific contrast, 
difficulties to quantitatively image engrafted cells, unambiguous contrast, 
adverse effects on cell biology, limitations for longitudinal follow-up or the lack 
of functional information. Such shortcomings are traditionally overcome in pre-
clinical research by combining MRI with other imaging modalities like 
bioluminescence imaging or positron emission tomography. Our research 
focuses on the optimisation of cell labeling strategies for robust, sensitive and 
potentially quantitative visualisation of stem and progenitor cells in therapy 
models in vivo to assess cell behavior after engraftment. The sensitivity, 
stability, toxicity and adverse effects on the cell biology by the labeling 
procedure were studied for iron oxide based particles. The potential of Gd-
chelates and 19F labeled compounds for cell labeling has been assessed in 
vitro and in vivo. Based on our preclinical research finding the potential of 
future applications in patients will be explored.  
Discussion  17:20
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08:30 - 10:00 Room A  
Interactive Teaching Session  
E³ 1620  
Pitfalls in heart imaging  
A-512 08:30 
A. CT  
G. Bastarrika; Toronto, ON/CA (bastarrika@unav.es) 
Cardiac CT is becoming the imaging modality of choice for an increasing 
number of clinical indications, not only to rule out coronary artery disease but 
also to evaluate cardiac morphology and function, and to determine patient 
outcome after coronary artery revascularisation. However, as with any other 
imaging tools, appropriate interpretation of cardiac CT examinations is required 
to assess the clinical value of this newly established diagnostic imaging 
modality. This process requires performance of thorough cardiac CT 
acquisition protocols, detailed knowledge of standard cardiac anatomic and 
physiologic terminology, as well as appropriate postprocessing, reading and 
reporting. In particular, radiologists need to recognise and be aware of the 
imaging findings that may confound and lead to interpretation errors. This 
lecture will summarise the practical aspects of postprocessing, reading and 
reporting of non-invasive cardiac CT examinations. The value and limitations of 
every available CT postprocessing technique including two-dimensional 
multiplanar reformations, curved multiplanar reformats, maximum intensity 
projection (MIP) and volume rendered images will be explained. Moreover, 
hints for improving reading results by recognising technical causes for various 
artefacts in cardiac CT will be elucidated and reading approaches to diminish 
false positives, false negatives and inaccuracies when assessing coronary 
artery stenosis will be suggested.  
Learning Objectives:
1. To learn about practical aspects of post-processing, reading and reporting 
non-invasive cardiac CT examinations. 
2. To learn how to improve reading of results by recognising technical causes 
for various artefacts in cardiac CT. 
3. To become familiar with approaches to reducing inaccuracies and 
misinterpretations when assessing coronary artery stenosis. 
A-513 09:15 
B. MRI  
M. Francone; Rome/IT (marco.francone@uniroma1.it) 
Cardiac magnetic resonance (CMR) is a complex imaging technique due to the 
intrinsic anatomical and technical peculiarities of the exam. These include the 
non-orthogonal cardiac orientation within the chest cavity requiring dedicated 
acquisition planes and the complex respiratory and cardiac motion to which the 
heart is subject and requiring a combination of ECG-gated and breath-hold 
sequences. Potential additional anatomical pitfalls also include normal 
structures and variants like the moderator band, papillary muscles, and the 
presence of prominent crista terminalis or myocardial trabeculations, whose 
recognition is mandatory and may mimic in some cases a pathological 
condition. Technical issues of CMR concern the continuous intracavitary inflow 
of protons and the associated "slow-flow" artifacts (limiting visualisation of 
endomyocardial border in some cases) pitfalls related to ECG gating, like 
inadequate synchronisation or the T-wave swell phenomenon; and finally a 
series of specific artifacts intrinsically related to the use of different pulse 
sequences that may interfere with image quality. An additional, more complex 
issue to consider is also the widespread diffusion of high-field magnets which 
have further enhanced those aspects. Knowledge of the spectrum of those 
CMR peculiarities is mandatory to approaching and providing a correct 
diagnosis according to the main clinical request. The present lecture will review 
the most important anatomical and technical pitfalls of CMR examination and 
offer, when possible, practical solutions to overcome those limitations.  
Learning Objectives:
1. To learn about common pitfalls in MRI evaluation of the heart. 
2. To become familiar with cardiac anatomical variants potentially mimicking 
disease. 
Author Disclosure:
 M. Francone: Speaker; Bracco Medical Imaging. 
08:30 - 10:00 Room B  
Special Focus Session 
SF 16a  
Shoulder imaging and intervention  
A-514 08:30 
Chairman's introduction  
I. Beggs; Edinburgh/UK (ian.beggs@luht.scot.nhs.uk) 
Shoulder imaging and intervention are becoming increasingly important in 
clinical practice. This session considers the indications, techniques, imaging 
findings and relative merits of diagnostic ultrasound and MRI of the shoulder. 
The indications, techniques and results of US-guided interventional procedures 
are also considered. A panel discussion will deal with controversies in shoulder 
imaging such as the accuracy of US and MRI in assessing rotator cuff tears, 
tendinosis, impingement and muscle atrophy, and the efficacy of US-guided 
interventions. Audience participation in the discussion will be welcome.  
Session Objectives: 
1. To learn how to perform US and MRI of the rotator cuff. 
2. To appreciate the advantages and limitations of both techniques. 
3. To become familiar with US-guided interventions of the shoulder. 
A-515 08:35 
US of the rotator cuff  
A. Plagou; Athens/GR (athena.plagou@gmail.com) 
The shoulder is an anatomic area that is very commonly evaluated with 
musculoskeletal ultrasound. Ultrasonography is widely recognised as a reliable 
means of assessing rotator cuff disease with accuracies reaching 100% for full-
thickness tears and 90-95 % for partial-thickness tears. Diagnostic accuracy 
depends mostly on the skills and experience of the examiner. A 
comprehensive ultrasound (US) examination requires, first of all, sound 
knowledge of the anatomy. A specific scanning protocol must be adopted in 
every US examination in patients with shoulder disease, because focal 
symptoms do not correlate with the location of the disease. The greatest 
importance of ultrasonography in rotator cuff assessment lies in its dynamic 
character. Several dynamic manoeuvres can reveal pathologies such as 
subacromial impingement. Last, but not least there are several scanning pitfalls 
such as anisotropy. Anatomy key structures as well as the US technique and 
scanning protocol will be presented in this lecture. Dynamic manoeuvres will 
be described and demonstrated with videos. Scanning pitfalls will be 
emphasised. Advantages and disadvantages of the US examination compared 
to other imaging modalities will be discussed.  
Learning Objectives:
1. To understand the indications for ultrasound in rotator cuff disease. 
2. To appreciate the dynamic aspect of ultrasound and its diagnostic 
importance. 
3. To become familiar with the ultrasound examination protocol. 





MRI of the rotator cuff  
S. Waldt; Munich/DE (Waldt@roe.med.tum.de) 
Guidelines concerning the MR examination technique of the rotator cuff will be 
presented in this session. On intermediate-weighted MR images, tendinopathy 
and partial and complete tears of the rotator can be differentiated with high 
diagnostic accuracy. Indications for MR arthrography, especially for the 
detection of small articular sided partial tears in athletes, will be presented as 
well. Established classification systems for the description of rotator cuff tears 
will be discussed. Besides characterisation of rotator cuff lesions, especially in 
view of therapeutic decision-making, recognition of the underlying 
pathomechanism is necessary. Therefore, the role of imaging is to detect 
different structural findings that are suggestive of a possibly underlying 
impingement syndrome. In primary impingement syndromes imaging 
abnormalities of the rotator cuff, the overlying bursa and the coracohumeral 
arch represent the centre of imaging findings. Primary extrinsic impingement is 
caused by structural abnormalities of the coracoacromial arch, whereas 
secondary extrinsic impingement is related to glenohumeral instability. Types 
of internal impingement (posterosuperior and anterosuperior impingement) are 
secondary to rotator cuff and/or capsular dysfunction. Posterosuperior 
impingement can be diagnosed on MR arthrograms by identification of the so-
called "kissing lesion" pattern, with corresponding lesions of the undersurface 
of the rotator cuff, posterosuperior labrum, greater tuberosity and superior 
glenoid. Imaging abnormalities of this condition will be discussed.  
Learning Objectives:
1. To become familiar with MR imaging features of rotator cuff tears. 
2. To learn about an optimised MR imaging protocol for the diagnosis of rotator 
cuff tears. 
3. To understand basic pathomechanisms and MR classification systems for 
categorising rotator cuff tears. 
A-517 09:21 
US-guided interventions of the shoulder  
L.M. Sconfienza; San Donato Milanese/IT (io@lucasconfienza.it) 
The shoulder is one of the joints in the human body that is most subject to a 
number of pathologic conditions, both in young and in elderly subjects, such as 
subacromial-subdeltoid bursitis, calcific tendinopathy, and degenerative 
conditions. Being inexpensive, readily available, and radiation-free, ultrasound 
is the imaging modality of choice to guide interventional procedures around the 
shoulder. Thanks to its high resolution and multiplanar capabilities, ultrasound 
can be used to guide needles precisely in the tendons of the rotator cuff or 
within the joint space, both gleno-humeral and acromio-clavicular. This 
approach can be used to perform a number of different procedures. When 
dealing with bursitis, a needle can be guided within the subacromial bursa to 
aspirate fluid and to inject anti-inflammatory drugs. In case of calcific 
tendinopathy, one or two needles can be used to dissolve calcium deposit and 
drain it, providing patients prompt relief. In selected patients with overuse 
tendinopathy, ultrasound can be used to guide intratendinous injection of 
platelet-rich plasma that has been reported to be helpful in stimulating tendon 
healing. Although minimally invasive, these procedures should be performed in 
an ultrasound ward with a high degree of sterility, as risk of infection can be 
concrete.  
Learning Objectives:
1. To become familiar with US-guided interventional techniques for the 
shoulder. 
2. To understand the indications for interventions. 
3. To appreciate the types and doses of therapeutic agents. 
Panel discussion:  
Controversies and confusion in shoulder imaging  09:44
08:30 - 10:00 Room C  
Modern Imaging of the GI Tract  
CC 1621  
Oesophageal and gastric cancer  
Moderator:  
W. Schima; Vienna/AT 
A-518 08:30 
A. Modern imaging: an update  
A. Ba-Ssalamah; Vienna/AT (ahmed.ba-ssalamah@meduniwien.ac.at) 
Multi-detector computed tomography (CT) offers new opportunities in the 
imaging of the gastrointestinal tract. Its ability to cover a large volume in a very 
short scan time, and in a single breath-hold with thin collimation and isotropic 
voxels, allows the imaging of the entire oesophagus, stomach, and the whole 
chest and abdomen with high-quality multiplanar reformation and three-
dimensional reconstruction. Preparation of the patients by fasting from solid 
food approximately 6 hours prior the examination is important. Proper 
distention of the oesophagus and stomach by oral administration of 
effervescent granules and water, and optimally timed administration of 
intravenous contrast material are required to detect and characterise the 
disease. Preoperative staging of oesophageal and gastric carcinoma appears 
to be the main indication for MDCT and may replace endoluminal ultrasound 
(EUS) in the staging of advanced cancers. The use of various reconstruction 
techniques, including virtual gastroscopy (VG) using a volume-rendering (VR) 
technique, is promising for the detection of early gastric cancer. The 
application of the texture analysis technique to distinguish between the 
different types of gastric and esophageal tumors is still evolving. Finally, the 
introduction of FDG PET, in combination with MDCT, has resulted in further 
optimisation of the diagnostic workup of oesophageal cancer, as well as 
specific types of cases of gastric cancer. By providing morphologic and 
functional information in the same setting, this technique has come to be the 
modality of choice, when available.  
Learning Objectives:
1. To learn about the appropriate use of modern imaging techniques in the 
staging of oesophageal and gastric cancer. 
2. To become familiar with optimised imaging acquisition protocols, including 
patient preparation. 
3. To appreciate the use of emerging visualisation techniques, including virtual 
gastroscopy. 
A-519 08:50 
B. How to provide the perfect staging report  
R.M. Mendelson; Perth/AU (richard.mendelson@health.wa.gov.au) 
The diagnosis of oesophageal and gastric cancer is usually based on 
endoscopic findings accompanied by biopsy. However, staging is a matter for 
diagnostic imaging and is the major determinant of disease management. This 
should be discussed within a multidisciplinary forum (multidisciplinary team 
[MDT] meeting) in which the radiologist plays a crucial part. Accurate staging - 
usually based on the TNM staging criteria - is essential and the radiologist's 
report should reflect this pivotal role. The TNM staging of oesophageal cancer 
and gastric cancer will be discussed in detail. The phases in staging is 
essentially a filtering process which seeks to initially exclude distant metastasis 
and/or advanced local disease, initially by optimally protocolled CT scanning, If 
CT shows advanced disease, treatment is palliative, but even under these 
circumstances imaging will help determine the method of palliation. 
Conversely, if CT demonstrates localised disease, 18 F FDG-PET scanning for 
oesophageal cancer and for selected cases of gastric cancer is indicated. If 
this, too, shows no nodal or distant metastasis, accurate T staging with EUS 
will help determine whether the patient proceeds directly to surgery or 
undergoes neo-adjuvant chemo/radiotherapy prior to surgery, or in the case of 
oesophageal cancer may be suitable for EMR. The role of staging laparoscopy 
in gastric cancer will also be discussed. In summary, the radiologist and 
nuclear medicine physician are crucial in determining treatment. Their reports 
are lynch pins in the MDT discussion of patient management. It is therefore 
essential that the imaging report should optimally inform this discussion.  
Learning Objectives:
1. To learn about the latest TMN staging in oesophageal and gastric cancer. 
2. To appreciate the imaging criteria for local, nodal and metastatic disease, 
and understand the accuracy of imaging staging. 
3. To become familiar with the structure of a perfect imaging report. 
A-520 09:10 
C. Assessment after treatment  
A.M. Riddell; London/UK (Angela.Riddell@rmh.nhs.uk) 
It is now established that for the majority of patients with oesophageal and 
advanced gastric cancer, there is survival benefit from the use of neoadjuvant 
therapy. Therefore, there is a requirement for imaging to accurately restage the 
tumour and to assess the response to neoadjuvant therapy, to provide 
prognostic information and to direct future management. Restaging following 
therapy is challenging, as differentiating treatment-related fibrosis/oedema 
from viable tumour is problematic with both CT and endoscopic ultrasound. 
The T and N staging accuracy for both modalities falls following neoadjuvant 
therapy. Inconsistencies in measurements due to alterations in the degree of 
gastric/oesophageal distension can also limit the accuracy of RECIST criteria 
to determine the response. Functional imaging techniques such as PET-CT 
offer an improved method for assessing response. Alterations in the 
Standardised Uptake Value (SUV) occur much earlier than changes in size; 
therefore a metabolic response can be detected sooner, allowing for more 
rapid alterations in treatment strategies. Acute complications following 
oesophagogastrectomy generally occur within the thorax and are either related 
to a leak at the anastomosis/mediastinitis or respiratory complications such as 
pneumonia or a pleural effusion. Intra-abdominal collections may develop 




following oesophagogastrectomy and gastrectomy. Late complications 
following both procedures are often due to tumour recurrence: locoregional 
such as lymph node recurrence or at the anastomosis; metastatic spread such 
as haematogenous spread or via the peritoneum or pleura. Currently, there is 
no consensus on the most appropriate timing or frequency of postoperative 
imaging.  
Learning Objectives:
1. To understand the role of imaging in treatment response assessment. 
2. To appreciate the imaging signs of viable or recurrent tumour after therapy. 
3. To learn about the common surgical procedures and potential pitfalls in 
interpreting postoperative imaging. 
A-521 09:30 
D. Interactive case discussion  
W. Schima; Vienna/AT 
08:30 - 10:00 Room D  
Chest  
RC 1604  
Pulmonary arterial hypertension  
Moderator:  
A.P. Parkar; Bergen/NO 
A-522 08:30 
A. An overview of pulmonary artery hypertension  
N.J. Screaton; Cambridge/UK (Nicholas.Screaton@papworth.nhs.uk) 
Pulmonary hypertension is defined by increased mean pulmonary arterial 
pressure > 25 mmHg at rest or > 30 mmHg during exercise. PH causes 
significant mortality and morbidity, but commonly presents with non-specific 
clinical signs and symptoms resulting in significant delay in accurate diagnosis 
and specific treatment. Untreated PH is progressive with increased pulmonary 
vascular resistance leading to right ventricular failure and ultimately death. The 
current Dana Point classification of pulmonary hypertension is clinically based. 
It groups diseases with similar pathophysiological mechanisms and therapeutic 
approaches. Groupings include conditions characterised by diffuse small 
vessel narrowing (Group 1 and Group 1'), PH secondary to left sided cardiac 
disease (Group 2), chronic hypoxic pleuro-parenchymal disease (Group 3), 
chronic thrombo-embolic pulmonary hypertension CTEPH (Group 4), and a 
miscellaneous group of diseases with either unclear or multi-factorial 
aetiologies (Group 5). In the Dana Point classification, small vessel diseases 
are subdivided into Group 1 which primarily affect the pulmonary arterioles and 
Group 1' affecting the capillary/venous pulmonary circulation (pulmonary 
capillary haemangiomatosis and pulmonary veno-occlusive disease). The 
differentiation of Group 1 from Group 1' diseases is important since in group 1' 
arteriolar dilatation treatments can cause life-threatening pulmonary oedema. 
Group 4 is synonymous with CTEPH with other causes of large vessel 
obstruction (vasculitis and pulmonary artery tumour) being considered as 
Group 5 disorders. Recent advances include an increased understanding of 
molecular mechanisms underpinning PAH, facilitating targeted therapy 
development, a rapidly expanding role of surgical pulmonary endarterectomy in 
proximal CTEPH, and recognition of imaging as a potential therapeutic end 
point.  
Learning Objectives:
1. To learn about the epidemiology of pulmonary artery hypertension. 
2. To become familiar with the clinical symptoms, signs and causes of 
pulmonary artery hypertension. 
3. To appreciate the importance of and difficulties in treating pulmonary artery 
hypertension. 
A-523 09:00 
B. CT in pulmonary artery hypertension  
M.-P. Revel; Paris/FR (marie-pierre.revel@htd.aphp.fr) 
CT allows depicting pulmonary hypertension (PH) and helps identifying its 
cause, therefore playing a crucial role in the diagnostic workup. CT features of 
pulmonary arterial hypertension include dilatation of the pulmonary artery 
trunk, with a diameter greater than or equal to 29 mm, a ratio to the aortic 
diameter greater than 1:1 and a segmental artery-to-bronchus ratio greater 
than 1:1 in at least three pulmonary lobes. On ECG-gated CT, right pulmonary 
artery distensibility shows the best diagnostic value with 86% sensitivity and 
96% specificity for a cutoff value of 16.5%. Among the various causes of 
secondary PH, CT is especially useful for detecting signs of chronic 
thromboembolic pulmonary hypertension, including wall-adherent thrombi, 
bands, webs or chronic arterial occlusion, mosaic lung attenuation and 
systemic collateral supply. CT shows signs of pulmonary edema, such as 
thickening of the interlobular septa, centrilobular ground glass opacities, 
mediastinal lymph node enlargement and pleural effusion in PH caused by 
pulmonary veno-occlusive disease, left heart diseases or mediastinal fibrosis. 
Signs of lung parenchyma diseases may be indentified on CT; PH is a late 
complication in patients with pulmonary fibrosis, sarcoidosis or chronic 
obstructive lung disease, but may affect systemic sclerosis patients with limited 
lung parenchyma involvement. Congenital cardiac abnormalities with untreated 
right-to-left shunting resulting in Eisenmenger syndrome, such as ventricular or 
atrial septal defect and patent ductus arteriosus are easily recognised on CT. 
Conversely, signs of peripheral pulmonary arteriovenous shunting in 
portopulmonary hypertension and PH caused by hepatopulmonary syndrome 
are more difficult to assess.  
Learning Objectives:
1. To learn about the CT diagnosis of pulmonary artery hypertension. 
2. To become familiar with the causes of pulmonary artery hypertension on CT. 
A-524 09:30 
C. MRI in pulmonary artery hypertension  
J. Biederer; Heidelberg/DE (Juergen.Biederer@med.uni-heidelberg.de) 
For the assessment of pulmonary arterial hypertension (PAH), the dedicated 
30 min MRI protocol would comprise a free breathing and noncontrast-
enhanced examination, short T2-w sequences, dynamic contrast-enhanced 
perfusion imaging, a high-resolution angiogram, a 3D breath-hold acquisition, 
dynamic steady-state free precession or gradient echo sequences of the heart 
and a study of myocardial late enhancement. The morphologic sequences 
show typical features of PAH: right atrial/ventricular dilatation, enlargement of 
the pulmonary trunk/main pulmonary arteries and peripherally attenuated 
pulmonary vessels. Incidental infiltrates, nodules or masses of the lung, 
mediastinum and chest wall would be covered. The first pass contrast-
enhanced perfusion imaging demonstrates an increased mean transit 
time/decreased pulmonary blood flow, but a relatively homogeneous lung 
perfusion (important to differentiate from CTEPH, where multiple segmental 
perfusion defects would be expected). The cardiac part shows right ventricular 
mass, wall thickness and functional changes correlating with elevation of 
pulmonary arterial pressure: distortion of the interventricular septum, area 
change of the pulmonary trunk, right ventricular volume/stroke volume as well 
as pathologic right/left ventricular end-diastolic volume indexes. Late 
enhancement of the right ventricular wall would correlate with myocardial 
fibrosis. Furthermore, optional experimental velocity-encoded sequences 
(ideally for multidirectional flow visualisation, "4D flow") show a decreased 
pulmonary artery blood flow velocity, increased retrograde flow and 
inhomogeneous velocity profiles. In conclusion for the near future, given the 
availability of scanner time and appropriate experience of the team, thoracic 
MRI is probably the most comprehensive and effective single examination for 
the diagnosis and follow-up of PAH.  
Learning Objectives:
1. To learn about the MRI diagnosis of pulmonary artery hypertension. 
2. To appreciate the role of MRI in the assessment of pulmonary artery 
hypertension. 
3. To become familiar with MRI techniques in the assessment of pulmonary 
artery hypertension. 
Author Disclosure:
 J. Biederer: Equipment Support Recipient; Siemens. Speaker; Siemens. 
08:30 - 10:00 Board Room B  
Special Focus Session  
SF 16b  
Multisystemic malignancies in organ-
based radiology  
A-525 08:30 
Chairmen's introduction  
I.E. Tyurin1, H. von Tengg-Kobligk2; 1Moscow/RU, 2Berne/CH 
In the era of organ-based radiology, the group of diseases known as 
multisystemic malignancies represents an obvious challenge to both 
radiologists and oncologists. The necessity to match the growing possibilities 
of different imaging modalities with widespread multisystemic pathology and 
clinical sufficiency resulted in upgrading well-known diagnostic algorithms. The 
precise knowledge of clinical staging systems and classification, and the 
pathologic and physiologic mechanisms of the disease pathways are important 
for planning imaging modalities and specific protocols. Perfect imaging of 
multisystemic malignancies now includes not only traditional anatomic-based 
modalities, but also much more often different types of whole body scanning 
such as CT, MRI, PET and their combination in SPECT/CT, PET/CT and now 
even PET/MRI. New imaging modalities and growing possibilities of traditional 
imaging techniques obviously influence the current clinical guidelines for this 




pathology. Finally, the perfect assessment of clinical course of the disease and 
possible outcomes, the understanding of tumor response criteria and therapy-
induced changes are significant for image interpretation in patients with 
multisystemic malignancies.  
Session Objectives: 
1. To appreciate the complexity of the clinical management of patients with 
multisystemic malignant diseases. 
2. To learn about the potential of whole-body CT and MRI, including pitfalls and 
limitations. 
3. To become familiar with the clinical role of PET/CT and MR/PET, including 
radiotracers. 
A-526 08:35 
Multiple myeloma  
M.-A. Weber; Heidelberg/DE (MarcAndre.Weber@med.uni-heidelberg.de) 
Multiple myeloma is a haematologic disorder characterised by the infiltration 
and proliferation of monoclonal plasma cells mainly in the bone marrow. The 
main symptoms are hypercalcaemia, renal impairment, cytopaenia/anaemia 
and bone disease - summarised as CRAB-criteria. Symptomatic multiple 
myeloma is consistently preceded by asymptomatic premalignant stages called 
monoclonal gammopathy of undetermined significance and smoldering multiple 
myeloma. These stages also present with detectable monoclonal protein 
and/or monoclonal plasma cells in bone marrow, but do not show any end 
organ impairment. Staging of multiple myeloma is based on the measurement 
of the monoclonal protein in serum and urine as well as the assessment of 
impairment of haematopoiesis, renal function and mineralised bone. In the last 
decade, the development of novel therapeutic agents has led to an increase in 
response rates and survival time of patients with multiple myeloma, which 
further stresses the value of response assessment by imaging. Cross-sectional 
imaging like MRI, CT and PET-CT is currently replacing conventional 
radiological surveys in the initial workup and follow-up of patients with 
monoclonal plasma cell diseases. Recent studies demonstrate the added value 
of MRI in improving initial staging by unravelling a diffuse infiltration of bone 
marrow by plasma cells, a focal pattern or a combination of both. Also, PET-CT 
can detect response to therapy earlier than conventional response criteria. 
Furthermore, recent studies revealed that a complete remission of myeloma 
confirmed by MRI or PET-CT goes along with a better prognosis compared to a 
complete response based only on serological parameters.  
Learning Objectives:
1. To learn about the role of clinical staging systems and imaging in work-up 
and classification of plasma cell disorders with a focus on multiple myeloma 
and to learn about parameters of disease activity. 
2. To understand the pathophysiologic mechanisms of multiple myeloma and 
to learn about the effects of abnormal plasma cells on bone remodeling cells. 
3. To become familiar with response criteria and therapy-induced changes and 
to compare the significance of imaging and serological markers for response 
evaluation in multiple myeloma. 




A. Mikhaylov; Moscow/RU (azatmihailov@gmail.com) 
Over the last 40 years, there have been numerous efforts to classify lymphoid 
malignancies, culminating in the WHO classification introduced in 2008. So it is 
clear that malignant lymphomas require a sophisticated diagnostic approach 
based on clinical features, morphology, immunophenotyping and genetic 
analysis. It is essential that such an approach underpins the clinical 
management of these diseases, many of which are amenable to cure. The 
same situation is present in radiology staging procedures - it has a multi-
disciplinary approach. A wide range of staging procedures can include all 
radiology methods from CXR and chest and abdominopelvic computed 
tomograph to whole body MRI, scintigraphy and PET-CT scans.  
Learning Objectives:
1. To learn about the current classification and staging of lymphomas. 
2. To become familiar with classic imaging patterns of lymphomas. 
3. To understand the role of imaging in the follow-up of lymphoma patients. 
A-528 09:21 
Melanoma  
M.A. Fischer; Zurich/CH 
Malignant melanoma (MM) originates from the melanocytes of the basal layer 
of the epidermis showing a rising incidence and high mortality in the white, 
Western population. Risk factors of melanomagenesis like sun exposure are 
well known and early detection with surgical resection of MM is essential for 
patient prognosis. Staging of MM is based on tumour thickness, ulceration, 
lymph node and distant metastases. Lymph flow and chemotaxis are thought 
to be responsible for the homing of MM cells, resulting in satellite or in-transit 
lesions of the regional lymph node system. Distant spread of MM is thought to 
transpire intra- and extravascularly (along the external vessel lattices) 
supported by specific mechanisms of extravasation and protection of MM cells 
against the local immune system. To date, many imaging methods, such as 
ultrasound, computed tomography (CT), magnetic resonance imaging, and 
positron emission tomography/CT, are used in the diagnosis of MM and its 
metastases, whereas lymphoscintigraphy has become an important tool for 
workup of the lymph node drainage patterns. Radiological challenges include 
improved staging and re-staging of multi-systemic MM. Accordingly, current 
imaging guidelines and the role and applications of the different imaging 
modalities in advanced MM (stage III / IV) are reviewed with regard to their 
usefulness in patient management. However, standardised imaging protocols 
and integration of functional information to morphological imaging are needed 
in the future to allow for improved detection and guidance of treatment in 
patients with MM.  
Learning Objectives:
1. To learn about the prognosis factors of melanoma. 
2. To understand the metastatic pathways and time course of melanoma. 
3. To become familiar with imaging guidelines in cutaneous melanoma. 
Panel discussion:  
What is the role of imaging in the staging of malignancies?  09:44
08:30 - 10:00 Room E1  
Abdominal Viscera  
RC 1601  
Pancreatic inflammation  
Moderator:  
R.J. Méndez; Madrid/ES 
A-529 08:30 
A. Acute pancreatitis  
M. Zins; Paris/FR (mzins@hpsj.fr) 
The original Atlanta Classiﬁcation of acute pancreatitis established in 1992 is 
outdated. In 2012, an international working group has modified the Atlanta 
Classification for acute pancreatitis to update the terminology and provide new 
morphologic classifications.The revised classiﬁcation of acute pancreatitis 
identiﬁed two phases of the disease: early (first week) and late (after the first 
week). Acute pancreatitis is subdivided into two types: interstitial oedematous 
pancreatitis and necrotising pancreatitis. If the diagnosis of acute pancreatitis 
is established by abdominal pain and by increases in the serum pancreatic 
enzyme activities, a contrast-enhanced CT is not usually required for diagnosis 
in the early phase. This revised classification introduces new terminology for 
pancreatic fluid collections. Depending on the presence or absence of 
necrosis, acute collections in the first 4 weeks are called acute necrotic 
collections or acute peripancreatic fluid collections. Once an enhancing 
capsule develops, persistent acute peripancreatic fluid collections are referred 
to as pseudocysts and acute necrotic collections, as walled-off necroses. All 
can be sterile or infected. This classiﬁcation of acute pancreatitis allows a 
consistent, worldwide classiﬁcation and should avoid confusion in the 
terminology of pancreatic fluid collections.  
Learning Objectives:
1. To learn how imaging should be scheduled for patients with acute 
pancreatitis. 
2. To become familiar with the imaging features and the terminology proposed 
in the Atlanta classification. 
A-530 09:00 
B. Chronic pancreatitis and IPMN  
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
The role of diagnostic imaging in chronic and inflammatory pancreatitis and 
IPMNs is to detect structural changes of the ducts and of pancreatic 
parenchyma, assess the functional integrity of the gland, detect associated 
complications, and assist in management. These goals are generally fully 
achieved using MDCT and MR imaging. In this lecture, the advantages and 
limitations of each technique will be discussed and illustrated. Key features 
allowing differential diagnosis of both entities will be underlined.  
Learning Objectives:
1. To learn the classical aspect of IPMN on imaging. 
2. To learn how it merges with chronic pancreatic disease and how can we 
differentiate both. 
3. To understand the role of different imaging techniques in assessing both 
diseases. 





C. Paraduodenal and autoimmune pancreatitis  
S.A. Jackson; Plymouth/UK (simon.jackson1@nhs.net) 
Autoimmune pancreatitis (AIP) was first described in 1961 and represents a 
rare form of immune mediated chronic pancreatitis which is characterised by a 
marked infiltration of lymphocytes and plasma cells into pancreatic tissue. 
Whilst the majority of cases present with diffuse gland involvement, 
approximately 30% of patients demonstrate either segmental or focal 
involvement of the pancreas. Clinical presentation is very variable with patients 
describing a range of symptoms; severe pain however is uncommon. Imaging 
plays a central role in the diagnosis and management of AIP and knowledge of 
the radiological appearances, which can vary significantly due to the various 
degrees of fibrosis and inflammatory infiltrate, is critical. Cardinal features 
include focal or diffuse pancreatic enlargement with the loss of normal lobular 
architecture. In addition, pancreatic duct involvement as demonstrated by 
single or multiple focal strictures with limited more proximal dilatation is 
common. Whilst these appearances may suggest a diagnosis of AIP 
correlation with clinical history, serology and histopathology is mandatory to 
accurately diagnose atypical cases. In contrast, paraduodenal pancreatitis is a 
specific and rare form of segmental chronic inflammation characterised by 
fibrous tissue formation in the "groove" area between the duodenum, head of 
pancreas and lower common bile duct. The pathology was first described in 
1973 and has since been subdivided into pure, segmental and non-segmental 
forms. Whilst the radiological diagnosis of both AIP and paraduodenal 
pancreatitis remains challenging, the presentation will emphasise relevant 
imaging strategies as well as provide tips and tricks for accurate diagnosis.  
Learning Objectives:
1. To become familiar with the clinical presentation and the radiological signs 
that may be observed in autoimmune pancreatitis. 
2. To become familiar with the diagnostic criteria for the disease. 
3. To learn about the strategies for managing doubtful clinical situations. 
08:30 - 10:00 Room E2  
Oncologic Imaging  
RC 1616  
Management of bone metastases  
A-532 08:30 
Chairman's introduction  
H. Ahlström; Uppsala/SE (hakan.ahlstrom@radiol.uu.se) 
Bone scintigraphy is often used in combination with CT and clinical information 
for staging and therapy response evaluation of bone metastases. Magnetic 
resonance (MR) imaging is a technique that is known to be valuable both for 
detection of bone metastases and for evaluation of their response to treatment. 
Integrated positron emission tomography with computed tomography (PET/CT) 
combines the functional data from PET with anatomic information of CT in a 
single examination. 18 F-fluoride is a non-specific PET tracer that has recently 
shown very high sensitivity for bone metastases. For accurate response 
evaluation, it is important to recognise not only changes in bone metastases, 
but also the effects of treatment on unaffected, normal parts of the bone 
marrow. These latter therapy-related benign changes could otherwise be 
misinterpreted as disseminated disease or vice versa. Despite the fact that the 
methods mentioned above, alone or in combination, have improved the 
assessment of bone metastases, they often remain non-specific. A specific 
diagnosis can in many cases only be achieved with a bone biopsy. This 
refresher course will give you an overview of the present imaging methods for 
detection and characterisation of bone lesions. Indications for, and how to 
perform, ablation and cementoplasty of bone metastases will be presented. 
Optimal algorithms for treatment follow-up of bone metastases and advantages 
and disadvantages with different imaging methods will be reviewed. Also, 
future development of diagnostic and therapeutic methods will be included in 
the presentations, e.g. potential role of emerging PET imaging probes for 
assessing bone malignancies.  
Author Disclosure:
H. Ahlström: Research/Grant Support; Astrazeneca. 
A-533 08:35 
A. Diagnostic approach: the role of hybrid imaging  
K. Herrmann; Würzburg/DE (Herrmann_K1@klinik.uni-wuerzburg.de) 
This presentation will include a short review of the epidemiology of primary and 
metastatic bone disease, its classification and staging definitions. Then we 
discuss the role of radionuclide imaging in initial and subsequent treatment 
strategy considerations. Another aim is to provide guidelines for the 
appropriate use and applications of diagnostic radionuclide approaches for the 
assessment of bone diseases. The focus of this presentation will be on the role 
of radionuclide imaging in metastatic prostate, breast and lung cancer in the 
context of other available diagnostic imaging approaches. The ability of hybrid 
imaging technologies to achieve improved diagnostic accuracy will be 
emphasised and when appropriate the potential role of emerging PET imaging 
probes for assessing bone malignancies discussed. If feasible, the availability 
and effectiveness of radionuclide-based therapeutic approaches for malignant 
bone diseases will be reviewed.  
Learning Objectives:
1. To learn about the standard MRI pulse sequence protocol for the 
assessment of bone metastases. 
2. To understand the physiological and metabolic tumour properties which can 
be assessed with different PET tracers. 
3. To become familiar with potential pitfalls and abnormalities that mimic 
metastases. 
A-534 08:58 
B. Therapeutic radiological approaches: from ablation to cementoplasty  
T. De Baere, L. Tselikas, F. Deschamps; Villejuif/FR (debaere@igr.fr) 
Bone metastases occur in about 20% of cancer patients and can induce pain 
and/or a pathological fracture. Cementoplasty and percutaneous thermal 
ablation techniques (radiofrequency, cryotherapy) can help in pain relief and 
consolidation. Cementoplasty is mostly performed in vertebral and acetabular 
metastases (even if other bony structures can be treated) with a clearly 
demonstrated analgesic effect. The role of cementoplasty versus radiotherapy 
and/or opioid is still debated. The proof of benefit in consolidation of bone by 
cementoplasty is not well demonstrated, and cementoplasty is still inadequate 
in structures subject to high mechanical stresses such as long bones. For such 
purpose, percutaneous deployment of orthopaedic hardware such as 
percutaneous screw fixation has been developed. Last, cementoplasty is not 
an antitumour treatment and cannot therefore be offered as a cure for bone 
metastasis. Thermal ablation is currently performed for pain palliation of bone 
metastases, in selected patients, namely in locations difficult to treat with 
cementoplasty. In a subset of bone metastases, thermal ablation can also be 
curative. Indeed, out of 88 curative intent thermal ablation of 122 bone 
metastases, the 1-year complete treatment rate was 67% [95%CI: 58%-75%]. 
In multivariate analysis, the good prognostic factors for complete local 
treatment were: metachronous bone metastasis (p=0.004), no cortical erosion 
(p=0.01), small metastasis size (p=0.001), no neurological structures in the 
vicinity (p=0.002).  
Learning Objectives:
1. To understand the clinical relevance and indications for ablation and 
cementoplasty of bone metastases. 
2. To learn how to perform state-of-the-art ablation and cementoplasty. 
3. To become familiar with possible complications of these interventions. 
A-535 09:21 
C. Assessment of tumour response: techniques and timing  
G. Cook; London/UK (Gary.Cook@kcl.ac.uk) 
Skeletal metastases are associated with significant morbidity and have high 
impact on health costs. Effective palliative treatments are available, but less 
than 50% of patients respond in terms of tumour markers, pain or quality of life 
and all treatments are associated with some toxicity. It is generally accepted 
that the current imaging techniques are inadequate for measuring treatment 
response in a clinically relevant time frame such that skeletal metastases are 
usually considered as non-measurable disease in clinical routine and trials. 
There is therefore a need for non-invasive, objective methods to evaluate 
treatment response of skeletal metastases at earlier time points to guide 
clinical care. In addition to imaging structural changes in bone (e.g. X-ray, CT), 
it is now possible to image a number of biological characteristics of bone 
metastases including tumour metabolism, tumour cellularity, and osteoblast 
and osteoclast activity. Methods currently available, or being actively 
investigated, include 99mTc-MDP SPECT/CT, 18F-fluoride PET/CT, 18F-FDG 
PET/CT, 11C/18F-choline PET/CT, RGD-SPECT/PET and DW-MRI. Some of 
the tracer methodologies will potentially be applicable for and complementary 
to PET/MRI. The timing of follow-up imaging after commencing treatment is still 
under investigation. It is likely that tumour-specific methodologies may reflect 
response/non-response earlier than bone-specific methods due to a prolonged 
flare in reactive bone in responding metastatic sites.  
Learning Objectives:
1. To understand the techniques and quantitative parameters used for 
treatment response evaluation. 
2. To learn the optimal timing for follow-up imaging after treatment. 
3. To become familiar with common pitfalls in the interpretation of post-
treatment MRI and PET. 
Panel discussion:  
How to differentiate between bone metastases and chronic inflammatory 
or treatment-induced changes  09:44




08:30 - 10:00 Room F1  
Special Focus Session  
SF 16c  
Structured reporting  
A-536 08:30 
Chairman's introduction  
A. Palko; Szeged/HU (palkoand@gmail.com) 
Structured reporting is an opportunity and a challenge at the same time. Expert 
speakers of this session will present and discuss their views on the subject, 
contributing to the clear vision of the members of audience on this complicated 
subject, convincing us to take this technique as an opportunity to improve and 
standardise the quality of our reporting activities.  
Session Objectives: 
1. To become familiar with the concept of structured reporting. 
2. To learn more about the various techniques and technical requirements of 
structured reporting. 
3. To understand how structured reporting and decision support tools may 
assist the work of radiologists. 
Author Disclosure:
 A. Palko: Advisory Board; Euromedic. 
A-537 08:35 
Structured reporting: from clinical needs to technical challenges  
M. Fatehi; Tehran/IR (fatehi@irsr.org) 
Even though structured reporting (SR) has been appreciated as one of the 
effective methods of electronic reporting, there are not that many real 
applications to facilitate utilisation of this technique in practice. Why it is so? 
The radiologists want a flexible tool to create clear, concise reports in a 
reasonably short time. Like all template-based reporting systems, the 
application must be tailored to preferences of multiple users in a radiology 
department. The report templates should also be flexible in terms of length to 
avoid inappropriately detailed reports. The final appearance of the report is 
critical for acceptance by clinicians. Accordingly, the technical challenges of 
development of SR systems may be grouped as: "user interface", "database 
structure", and "output file/document" problems. Flexibility to comply with 
different user preferences will lead to both user interface design and database 
structure challenges. One of the major technical challenges is the 
transformation of structured data to a final text to be acceptable and applicable 
for the referring physician. Also, exporting of reports to DICOM format using 
DICOM-SR concepts is still a challenge. Multi-media formats are becoming 
more and more popular specially in SR reports. The purpose of this 
presentation (based on examples from published and personally developed SR 
solutions) is to follow through the clinical needs of a radiologist to the technical 
challenges of implementing a clinical-, not a research-, structured reporting 
application.  
Learning Objectives:
1. To become familiar with different approaches to structured reporting. 
2. To understand the technical difficulties of developing a flexible structured 
reporting application. 
3. To learn about structured reporting tools available for radiology practice. 
A-538 08:53 
Structured reporting in the US  
C.E. Kahn; Milwaukee, WI/US (kahn@mcw.edu) 
Effective communication of radiology results is critical to high-quality health 
care. To that end, the Radiological Society of North America (RSNA) has 
developed a library with more than 200 best-practice radiology reporting 
templates. The templates are freely available online (www.radreport.org) and 
have been accessed more than 750,000 times. The new IHE "Management of 
Radiology Reporting Templates" (MRRT) profile builds upon the web's 
Hypertext Markup Language version 5 (HTML5) to provide an international 
standard for describing and exchanging reporting templates. This presentation 
will describe the RSNA report template library, introduce the international 
MRRT standard for report templates, and describe opportunities for ESR 
members and affiliated societies to participate. The broad goals of this initiative 
are to improve the quality of radiology reports, increase the productivity of 
radiologists, promote the use of practice guidelines, and advance data-driven 
health care.  
Learning Objectives:
1. To explore a library of 'best practices' radiology reporting templates. 
2. To become familiar with international standards for radiology reporting 
templates. 
3. To understand how structured reporting will promote the use of practice 
guidelines and will advance data-driven health-care. 
A-539 09:11 
Structured reporting in Europe: the ESR initiative  
O. Ratib; Geneva/CH 
The RSNA has initiated a new initiative called RadReport with the aim of 
helping promote standard reporting and improve reporting practices by creating 
a library of clear and consistent report templates (http://reportingwiki.rsna.org/). 
This project also supported in part by the National Institute of Biomedical 
Imaging and Bioengineering (NIBIB) has already gained the participation of 
numerous countries around the world, contributing with reports in different 
languages. These report templates are "structured" in the sense that they 
incorporate reusable knowledge, or meaning, to the clinical reporting process. 
They are free and not subject to licence restrictions on their reuse. Recently, 
the ESR eHealth and Informatics Subcommittee has decided to engage in 
promoting this initiative in Europe and supporting its development. Professor 
Charles Kahn from Medical College of Wisconsin, who is an active member of 
the RSNA working group on standard reporting, has joined the ESR 
subcommittee to help promote this initiative in Europe as well. There are 
already over 250 templates and the number of views is increasing every day 
(over 150,000 downloads so far). Most of the templates are in English, but 
there are several also in Arabic, Chinese, Turkish, Spanish, etc. There is also 
interest in translating the templates to other languages. In an effort to support 
this worldwide initiative, the ESR eHealth and Informatics Subcommittee 
decided to encourage National Societies to contribute to the submission and 
translation of templates and participate in the Subspecialty and Allied Sciences 
Societies to create reporting templates.  
Learning Objectives:
1. To review the adoption of structured reporting in Europe. 
2. To understand the challenges and differences in local regulation and 
practices. 
3. To learn about the joint efforts of the ESR with RSNA and how to participate. 
A-540 09:29 
Implications for radiological practice and decision support tools  
J.O. Barentsz; Nijmegen/NL (jelle.barentsz@radboudumc.nl) 
Structured interpretation and reporting for detecting significant prostate cancer 
is crucial, as it allows comparing inter-observer interpretation variability, 
reduces this variability by stimulating discussion of the individual scores, 
enhances communication with the clinicians in a uniform way, facilitates quality 
assurance plus research, and in this way improves patient outcome. In this 
presentation, the PI-RADS scoring system will be shown and discussed, and 
fast effective structured reporting using computer software will be presented.  
Learning Objectives:
1. To understand why structured reporting is needed, and what the advantages 
are for clinical care. 
2. To learn how structured reporting should be carried out. 
3. To become familiar with the content of a structured report. 
4. To learn how computer programmes can help. 
Author Disclosure:
 J.O. Barentsz: Owner; The Radboudumc department of radiology has CE 
approval of PROCAD software. Other; The Radboudumc department of 
radiology owns and produces Sinerem/Combidex. 
Panel discussion:  
Structured reporting in the daily practice: friend or foe?  09:47
08:30 - 10:00 Room G/H  
Neuro  
RC 1611  
Neuroimaging in dementia  
A-541 08:30 
Chairman's introduction  
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
In a rapidly ageing society, dementia prevalences are sharply increasing. 
Furthermore, knowledge about disease mechanisms is constantly evolving. A 
more nosologic approach in the workup of dementia is required to improve 
prognostication, patient management as well as select appropriate treatment. 




Radiologists will be confronted with a marked increase in the number of 
requests for imaging. This requires a thorough knowledge of the relevant brain 
anatomy, choice of appropriate structural and molecular imaging modalities 
and interpretation of MRI and PET/SPECT in the most prevalent disorders in a 
structured fashion.  
A-542 08:35 
A. Anatomy of the limbic system  
T.A. Yousry; London/UK (t.yousry@ucl.ac.uk) 
The term "limbic" has been used in many different connotations. To understand 
the anatomy, we have to define the term first. The clearest definition stems 
from Broca: "Le grand lobe limbic". Defined as such, the limbic lobe is 
composed of 2 main structures: the limbic and the intralimbic gyri. 1. The limbic 
gyrus is composed of the subcallosoal gyrus anteriorly, followed in an arc by 
the cingulate gyrus, isthmus and parahippocampal gyrus. The latter is 
composed of 2 parts: i) a posterior narrow segment, the superior surface of 
which is called subiculum, and ii) a more voluminous anterior segment, also 
known as the piriform lobe. The latter consists of the anterior part of the uncus 
and the entorhinal area. 2. The intralimbic gyrus arches within the limbic gyrus. 
It is divided into 3 parts: i) anterior (prehippocampal rudiment); ii) superior 
(indusium griseum); and iii) inferior (hippocampus). The latter consists of 2 
lamina rolled inside each other: the cornu ammonis and the dentate gyrus, with 
the cornu ammonis consisting of 4 neuronal fields (CA1-4). To understand the 
function, we have to understand the connections that define this function. The 
interplay with the insula is of particular importance. In summary, we will review 
the MRI characteristics of the components of the limbic lobe, their connections, 
and their function, using 1.5 T, 3 T and 9.4 T high field imaging. At the end of 
this lecture, you will know definition (s) of the limbic lobe, its major 
subdivisions, connections and functions.  
Learning Objectives:
1. To understand the architecture of the limbic system. 
2. To recognise the structure and connections of the hippocampus and medial 
temporal lobe. 
3. To become familiar with the imaging characteristics at various field strengths 
and pulse-sequences. 
Author Disclosure:
 T.A. Yousry: Advisory Board; Biogen Idec. Author; T Yousry. Research/Grant 
Support; UCL/UCLH Biomedical Research Centre, GlaxoSmithKline, MS 
Society of Great Britain and Northern Ireland, MRC, Wellcome Trust, Stroke 
Association, British Heart Foundation, Novartis, Biogen Idec. Speaker; ESOR, 
King Abdullah Medical City. 
A-543 08:58 
B. Structural MRI and CT: beyond exclusion  
M.P. Wattjes; Amsterdam/NL (m.wattjes@vumc.nl) 
Structural neuroimaging is increasingly used in the diagnosis of 
neurodegenerative diseases. In a memory clinic setting, computed tomography 
(CT) and magnetic resonance imaging (MRI) have become the most important 
paraclinical diagnostic tools. Recent guidelines on the diagnosis and 
management of disorders associated with dementia state that neuroimaging 
should be performed at least once during the diagnostic workup. In the past, 
neuroimaging had been performed to exclude potentially treatable causes of 
dementia. However, this exclusionary approach of neuroimaging in the 
diagnosis of dementia has been replaced by an inclusionary approach driven 
by conclusive evidence that CT and MRI can substantially support the clinical 
diagnosis by the demonstration of a distinct atrophy pattern and the 
assessment of vascular (co)morbidity. For these purposes, the use of visual 
rating scales allows a fast and reproducible assessment of global/regional 
cortical atrophy and vascular white matter pathology. More recently, new 
imaging markers such as cerebral microbleeds and superficial siderosis haven 
been identified and linked to Alzheimer pathology. In addition, next to structural 
MRI, advanced and quantitative MRI methods have been introduced in the 
clinical setting. MRI perfusion techniques such as arterial spin labelling (ASL) 
demonstrated a diagnostic value in memory clinic patients, particularly in those 
showing no or inconclusive pathology on structural MRI.  
Learning Objectives:
1. To become familiar with pathophysiology and clinical manifestations of 
common dementing disorders. 
2. To learn how to define a comprehensive imaging protocol for dementia 
work-up. 
3. To appreciate the role of modern imaging techniques for defining structural 
signs of dementia. 
Author Disclosure:
 M.P. Wattjes: Advisory Board; Biogen Idec. Board Member; European 
Radiology. 
A-544 09:21 
C. Molecular imaging: when is it needed?  
H. Urbach, P.T. Meyer; Freiburg/DE (horst.urbach@uniklinik-freiburg.de) 
Cognitive decline is a clinical symptom in many neurodegenerative disorders. 
MRI is typically performed in the initial diagnostic workup of these patients. As 
a structural imaging modality, MRI is often unrevealing while several molecular 
imaging modalities show disease-associated alterations: 18F-FDG-PET shows 
reduced glucose metabolism in neocortical association cortices, mainly in the 
posterior cingulate, precuneus and temporoparietal regions. Since glucose 
metabolism is normally higher in the posterior cingulate and precuneus, 
reduced glucose metabolism must be specifically sought for or highlighted by 
voxel-based analysis. 18F-FDG-PET aids in the diagnosis of frontotemporal 
lobar degeneration (FTLD), cortico-basal degeneration (CBD) and dementia 
with Lewy bodies (DLB) by showing fronto-temporal, asymmetric fronto-parietal 
or temporo-parieto-occipital hypometabolism, respectively. Amyloid imaging 
with 11C-PiB and 18F-labelled compounds is of great research interest. Although 
the first compound has recently been approved for clinical use in the USA and 
EU, availability is still limited. Nigrostriatal degeneration highlighted by 18F-
fluorodopa-PET or (dopamine transporter) 123I-FP-CIT-SPECT is present in 
Parkinson's disease (PD), CBD, DLB, multiple system atrophy (MSA), and 
progressive supranuclear paralysis (PSP), but absent in essential tremor or 
drug-induced parkinsonism. Patients with vascular parkinsonism may show 
focal defects to normal tracer uptake. In MSA and less so also CBD and PSP, 
123I-iodobenzamide-SPECT shows a loss of striatal dopamine receptors, while 
cardiac 123I-metaiodobenzylguanidine uptake (i.e., post-ganglionic sympathetic 
innervation) is normal in contrast to Parkinson's disease. However, recent 
studies demonstrate that 18F-FDG-PET is superior for the differential diagnosis 
of parkinsonism showing striatal and cerebellar hypometabolism in MSA and 
mainly frontal (mesial and premotor cortex), thalamic and brainstem 
hypometabolism in PSP.  
Learning Objectives:
1. To become familiar with the molecular pathology of common dementing 
disorders. 
2. To appreciate technical aspects and interpretation of SPECT and PET in 
dementia. 
3. To understand the interpretation and significance of molecular imaging in the 
diagnosis of dementia. 
Panel discussion:  
How to integrate imaging, clinical and CSF findings into a dementia 
clinic?  09:44
08:30 - 10:00 Room I/K  
Head and Neck Imaging  
CC 1619  
Tailoring head and neck examinations to 
the clinical symptoms (part 2)  
Moderator:  
P.-Y. Marcy; Nice/FR 
A-545 08:30 
A. Horner's syndrome  
D.L. Reede; Brooklyn, NY/US (Deborah.Reede@downstate.edu) 
Horner's syndrome (HS) occurs when there is interruption of the 
oculosympathetic pathway (OSP). This presentation reviews the anatomy of 
the OSP and clinical findings associated with lesions along this pathway. The 
imaging findings of lesions associated with HS at various levels of the OSP, 
classified as preganglionic HS (first- and second-order neuron HS) or 
postganglionic HS (third-order neuron HS) are demonstrated. Imaging and 
clinical findings of common lesions encountered at various levels of the OSP 
are presented to demonstrate the role of imaging in the evaluation of patients 
who present with HS. The clinical symptoms of HS may cause little if any 
functional impairment in most patients. However, since both benign and 
malignant processes are associated with HS, a thorough clinical evaluation is 
required. Once a lesion is localised clinically within the OSP by a combination 
of physical examination and pharmacological testing, the radiologic 
examination can be appropriately tailored.  
Learning Objectives:
1. To understand the importance of this syndrome as well as its common and 
uncommon causes. 
2. To become familiar with crucial anatomical landmarks. 
3. To learn about the imaging findings. 





B. Dysphagia  
P. Pokieser; Vienna/AT (peter.pokieser@meduniwien.ac.at) 
Dynamic imaging of swallowing from the mouth to the duodenum is the only 
clinical test providing a fast and accurate diagnostic overview of the upper GI 
function. Swallowing disorders are divided into those with dysphagia that 
means problems during eating or drinking, with suspicion of aspiration as an 
important subgroup and those with sensations like the globus syndrome or 
noncardiac retrosternal pain. Oropharyngeal dysphagia in patients with 
neuromuscular diseases or postoperative conditions can be evaluated 
precisely and within the same session as oesophageal motility disorders, 
stenoses or postoperative problems are detected and in a complementary 
fashion to endoscopy, pH monitoring and manometry. The exclusive ability of 
dynamic imaging of swallowing is to diagnose combined disorders of the 
pharynx and the oesophagus, to detect and localise subtle and multiple benign 
stenoses of the upper GI tract and to combine visualisation of pathophysiology 
and bolus transport as well. Radiologic evaluation concentrates on 7 functional 
units, which represent the visible "moving areas" of deglutition, where evident 
pathologic conditions can be found: 1) oral cavity and tongue, 2) soft palate, 3) 
epiglottis, 4) hyoid and larynx, 5) pharyngeal constrictors, 6) 
pharyngoesophageal segment, 7) oesophagus and stomach. This lecture 
intends to explain the common causes of dysphagia, the approach to a tailored 
examination and the use of an advanced imaging technique. Further, the 
basics of taking the swallowing history and the structure of reporting 
swallowing disorders along the seven functional units will be provided.  
Learning Objectives:
1. To understand the common causes of dysphagia. 
2. To learn how to tailor radiological examinations to the symptoms. 
3. To become familiar with advanced imaging techniques helpful in the 
evaluation of swallowing difficulties. 
A-547 09:30 
C. Hoarseness  
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Hoarseness is defined as a rough or noisy quality of voice. The possible 
causes of hoarseness are manifold, ranging from benign diseases such as the 
common cold to malignant tumours. Therefore, hoarseness as a symptom 
should always be taken seriously. Evaluation of a patient with hoarseness by a 
head and neck specialist will always starts with a history and a physical 
examination including laryngoscopy. After these examinations, a diagnosis can 
be established in most patients without additional imaging. The aetiologies of 
hoarseness are: 1) inflammation/infection, 2) trauma, 3) neoplasms, 4) others 
(including medical conditions, e.g. hypothyroidism) and 5) vocal cord paralysis. 
This presentation will focus on imaging of vocal cord paralysis. Vocal cord 
paralysis should not be considered a diagnosis, but as a symptom of (possible) 
underlying disease. When vocal cord palsy is discovered, this is frequently a 
reason to perform cross-sectional imaging. The radiological workup needs to 
include the full course of the vagus nerve. Moreover, reporting radiologists 
need to be able to recognise the radiological signs of vocal cord palsy in the 
absence of hoarseness, since many patients with cord palsy are asymptomatic 
(up to 30%). The anatomy of the vagus nerve and its laryngeal branches that 
innervate the intrinsic muscles of the larynx will be discussed. Then the 
(expected) course of the vagus nerve and recurrent laryngeal nerve will be 
shown. Finally, radiological signs of vocal cord palsy will be discussed using 
examples from daily practice.  
Learning Objectives:
1. To understand the underlying causes of this clinical symptom and their 
importance. 
2. To learn what to look for and which imaging method to use. 
3. To become familiar with differential diagnosis and the limitations of 
diagnostic imaging studies. 
08:30 - 10:00 Room L/M  
Special Focus Session  
SF 16d  
Imaging follow-up of vascular 
interventions  
A-548 08:30 
Chairman's introduction  
M. Szczerbo-Trojanowska; Lublin/PL (mst@radiology.com.pl) 
In contemporary medicine, endovascular techniques often replace 
conventional methods of treatment, including surgery, in the management of 
an increasing range of diseases. This requires development of specific 
methods assessing the effectiveness of treatment and able to detect 
complications that may be much different from those occurring in conventional 
therapy. This is first of all seen in the endovascular treatment of patients 
suffering from vascular lesions and neoplastic diseases. Commonly, there is a 
high initial technical success of endovascular treatment, but the durability is not 
always satisfactory and needs to be further examined. Endovascular treatment 
is bound to the risk of specific complications, often without clinical symptoms. 
Therefore, there is a need to use imaging follow-up of these patients. 
Interventional radiologists are aware of the importance of those issues and 
should play an important role in developing and deciding about the follow-up 
scheme and choice of the best imaging methods for these patients. Besides in-
depth knowledge of the treatment, radiologists are also familiar with the 
possible complications and can offer an optimal, minimally invasive and cost 
effective diagnosis and treatment.  
Session Objectives: 
1. To learn about the long-term results of vascular interventions. 
2. To become aware of the complications in vascular interventions in general. 
3. To become familiar with the endovascular treatment of complications 
following vascular interventions. 
A-549 08:35 
Imaging follow-up and treatment of complications of angioplasty and 
stenting  
R. Morgan; London/UK (robert.morgan@stgeorges.nhs.uk) 
The potential imaging methods for follow-up after angioplasty (PTA) and/or 
stenting include Doppler ultrasound, CTA and MRA. Although excellent images 
can be obtained by CTA and MRA, the drawbacks of these studies for routine 
follow-up are obvious. (access to CT and MR equipment, cost, contrast 
medium, ionising radiation, etc). In the UK, the most common imaging method 
is duplex ultrasound. There is no established role for the use of ultrasound 
contrast agents. Ultrasound is freely available in the majority of centres, is 
inexpensive and complication free. Follow-up by ultrasound may be 
undertaken by radiologists, although more usually by technologists in vascular 
laboratories. In practice, few patients are followed up by any imaging study at 
all unless they develop symptoms. The main category of patients who undergo 
some form of imaging follow-up after PTA/stenting are patients with surgical 
bypass grafts, who are usually routinely followed up whether they have 
undergone angioplasty/stenting or not. In view of the fact that this is a lecture 
on follow-up after intervention, procedural complications are excluded from the 
discussion. The complications of angioplasty and stenting are similar. The 
main early complications are restenosis or reocclusion. Other early 
complications are related to the arterial puncture site and include haematoma, 
dissection, occlusion and pseudoaneurysms. The main late complications are 
restenosis and reocclusion. Treatment of restenosis and reocclusion usually 
involves additional angioplasty or stents using conventional or drug-eluting 
balloons or stents. Cutting balloons, atherectomy and cryotherapy have a 
controversial role based on limited evidence.  
Learning Objectives:
1. To learn about selection of imaging methods used for follow-up. 
2. To become aware of the early and delayed complications. 
3. To become familiar with endovascular methods used to treat complications. 
A-550 08:58 
Imaging methods for postprocedural evaluation and follow-up of EVAR  
E. Brountzos; Athens/GR (ebrountz@med.uoa.gr) 
Imaging after EVAR primarily focuses on the prevention of aneurysm rupture. 
Other late complications include limb occlusion, graft migration, graft infection, 
and endoleaks. CT angiography (CTA) at standardised intervals has been the 
modality of choice. Recently, concerns regarding radiation exposure, contrast-
induced nephropathy and increasing costs advocate for less CTA imaging 
and/or for changing the surveillance protocols. Ultrasonography accurately 
measures aneurysm size, while CEUS detects endoleaks with high sensitivity. 
No endoleaks requiring interventions will be missed by ultrasound. Ultrasound 
only can be used in patients with appropriate body habitus, without EVAR-
related problems (as demonstrated on earlier CTAs), or in patients with 
shrinking or stable aneurysms. Use of duplex only will not lead to an increased 
occurrence of adverse events such as rupture, graft migration or limb 
occlusion, and can lead to a significant reduction of costs related to EVAR 
follow- up by 29%. The presence of endoleak at 30 days is associated with an 
increase in secondary procedures; absence of early endoleak is associated 
with a reduced risk for subsequent aneurysm-related morbidity. Patients with 
aneurysm sacs that are stable or shrinking at 1 year and no evidence of 
endoleak on a CT scan performed at 1 year do not require regular CT scanning 
anymore and can be imaged with ultrasonography.  
Learning Objectives:
1. To learn about imaging protocols used for follow-up. 
2. To become aware of complications of EVAR. 
3. To become familiar with methods used to treat complications. 





Imaging follow-up of oncologic patients after embolisation procedures  
J.I. Bilbao; Pamplona/ES (jibilbao@unav.es) 
The term "embolisation" groups different procedures in which imaging 
guidance is fundamental for both performing the procedure and for the early 
detection of complications. It has been demonstrated by several studies that 
"tumoural response" is tightly associated with survival, thus it is of major 
interest to measure accurately how the tumour is modified by the treatment. 
The "World Health Organisation" - WHO - first published the objective criteria 
for the evaluation of response. These criteria were slightly modified in 2000 
and named as "Response Evaluation Criteria for Solid Tumors"- RECIST. 
Accordingly, "complete response" (CR) corresponds to the disappearance of 
the tumour, "partial response" (PR) is defined when there is a decrease in the 
tumour size equal to or higher than 30% and "progressive disease" (PD) is 
applied when there is an increase equal to or higher than 20%. "Stabilisation of 
the disease" (SD) corresponds to measurements in between > 30% (PR) and 
< 20% (PD). Tumours (until five nodules in the same viscera), no matter if 
necrotic or viable, were evaluated with one measure (its largest diameter). A 
new version ("1.1 RECIST) has introduced modifications, among which is the 
number of nodules (2 instead of 5) that needs to be evaluated. In some 
circumstances, when morphologic criteria (RECIST and WHO) fail to predict 
the outcome, then new functional criteria have been recently established. 
"mRECIST" (which only measures the tumour that uptakes contrast) is an 
accurate classification for HCC. New methods "beyond RECIST" have been 
established for some specific treatments such as targeted therapies.  
Learning Objectives:
1. To learn how to assess results. 
2. To understand how to diagnose and treat early complications. 
3. To learn how to manage recurrent oncological bleeding. 
Author Disclosure:
 J.I. Bilbao: Speaker; Sirtex Medical Europe. 
Panel discussion:  
Cost-effectiveness of imaging follow-up after endovascular  
interventions  09:44
08:30 - 10:00 Room N/O  
Special Focus Session  
SF 16e  
Elastography as a new tool  
A-552 08:30 
Chairman's introduction  
A. Wieczorek; Lublin/PL (rtg@dsk.lublin.pl) 
In this session, the audience will have a comprehensive overview of the 
elastography, its principles and current state-of-the-art clinical applications. 
The session will deliver an overview of currently available methods of both 
ultrasound elastography (USE) and magnetic resonance elastography (MRE), 
their physical principles, technical and equipment requirements as well as the 
influence of various factors for obtained results. Following this session, the 
audience will have insight into clinical applications of elastography in liver, 
prostate and brain diagnostics. The strengths and weaknesses of 
elastographic modalities will be compared and discussed under consideration 
of more established imaging modalities. The session will present potential 
developments of USE and MRE and possible future clinical applications. Panel 
discussion will aim at defining the place of elastography in current and future 
diagnostic algorithms.  
Session Objectives: 
1. To learn about the basic idea of elastography. 
2. To understand the methods of acquiring elastographic images. 
3. To learn about the common indications. 
Author Disclosure:
 A. Wieczorek: Speaker; Speaker supported by B-K Medical Workshops and 
Lectures. 
A-553 08:35 
Principles of US and MR elastography  
I. Sack; Berlin/DE (ingolf.sack@charite.de) 
The well-known sensitivity of the palpating hand for detecting lesions is related 
to the incredibly wide range of values of the shear modulus in the body, 
spanning over eight orders of magnitude. Elastography was invented to exploit 
this high variability of constants by introducing the shear modulus into the 
image contrast of medical ultrasound or magnetic resonance imaging. Today, 
both ultrasound elastography (USE) and magnetic resonance elastography 
(MRE) are in clinical use, predominantly for staging liver fibrosis or 
discriminating tumours in the breast, liver, and prostate. The talk reviews the 
physical principles, technical requirements and current methods of both USE 
and MRE. Furthermore, the strengths and weaknesses of elastographic 
modalities are compared and discussed under consideration of more 
established imaging modalities. An outlook of elastography is given, 
highlighting the real-time feasibility of USE and the sensitivity of MRE to tissue 
pressure.  
Learning Objectives:
1. To learn what elastography is good for and why we need it. 
2. To understand the advantages and disadvantages of ultrasound-based 
elastography (USE) compared with MR elastography (MRE). 
3. To become familiar with the different methods in both USE and MRE. 
4. To learn about the clinical applications. 
A-554 08:53 
US elastography of the prostate  
F. Aigner; Innsbruck/AT (friedrich.aigner@uki.at) 
Suspicion of prostate cancer (PCa) exists in the case of elevated PSA serum 
values and/or suspicious findings on digital rectal examination (DRE). 
Systematic biopsy (SB) will be done to confirm or rule out PCa. Unfortunately, 
an elevation of PSA serum values often is caused by benign changes, e.g. 
prostatitis or adenomyomatosis and not every cancer is palpable on DRE. 
Furthermore, SB may miss clinically significant disease in up to 35%. 
Therefore, a more targeted approach would be desirable and imaging of PCa 
is currently under strong effort. One possibility for visualisation of PCa is the 
representation of tissue elasticity. Usually, cancers have higher cell and vessel 
density than the normal surrounding tissue and therefore are associated with 
increased stiffness. In contrast to DRE, where only the posterior parts of the 
prostate can be reached, RTE does not have this problem, since all anatomical 
regions can be evaluated. Furthermore, this noninvasive technique is time-and 
cost-effective and targeted biopsy or focal therapy of the prostate can be done 
under real-time conditions. Another important issue is that RTE can be 
performed by both urologists and radiologists. Nevertheless, RTE is of limited 
value in the detection of small cancer lesions and there may be problems in 
visualising PCa with predominantly Gleason pattern 3. The lack of data about 
inter- and intraobserver variability and of multicentre studies (now in process) 
are probably the reasons why RTE has not been included in the guidelines of 
urological societies so far.  
Learning Objectives:
1. To understand histopathological patterns of prostate cancer (PCa) in 
correlation with imaging. 
2. To appreciate the advantages of elastography compared with systematic 
biopsy. 
3. To become familiar with the limitations and potentials of elastography for 
PCa detection. 
A-555 09:11 
MR elastography of the brain  
J.-T. Wuerfel; Göttingen/DE (jens.wuerfel@charite.de) 
Cerebral tissue structure is altered in many neurodegenerative diseases, but 
also during physiological processes like maturation or ageing. Structural 
changes directly affect the mechanical tissue properties. Magnetic resonance 
elastography (MRE) is an imaging technique capable of assessing 
biomechanical brain parenchymal properties non-invasively. Viscoelasticity can 
be quantified by analysing the propagation of mechanically elicited shear 
waves in the investigated tissue. Thus, MRE could be a helpful tool to detect 
physiological or pathological processes influencing the cerebral tissue integrity.  
Learning Objectives:
1. To appreciate the advantages and limitations of a virtual palpation of the 
brain. 
2. To become familiar with mechanical wave induction and detection in 
cerebral measurements. 
3. To learn about current and potential clinical applications. 
4. To learn about the relationship between microscopic and macroscopic, as 
well as focal and globally diffuse biomechanical brain parenchymal alterations. 
Author Disclosure:
 J. Wuerfel: Advisory Board; Novartis Advisory Board. 
A-556 09:29 
US and MR elastography of the liver: assessment of liver stiffness with 
elastography techniques  
S.F. Bensamoun; Compiegne/FR (sabine.bensamoun@utc.fr) 
Ultrasound (US) and magnetic resonance elastography (MRE) techniques are 
used in clinical practice for liver exam. These new techniques enable a 
noninvasive follow-up of treatment and therapy. The objective of this talk is to 
show the different steps of US and MR elastography methods performed by 
the radiologist to diagnose the level of fibrosis. Briefly, elastography techniques 




are based on the generation of shear waves inside the liver tissue with specific 
MR liver drivers and ultrasound probes. Subsequently, phase images revealing 
the displacement of the waves will be investigated for healthy and pathological 
(alcoholic fibrosis) livers. Moreover, the development of phantoms mimicking 
the stiffness of biological soft tissues (liver, muscle, …) will be also presented. 
The viscoelastic (elasticity and viscosity) properties of healthy and fibrotic livers 
were measured, and the relevance of these parameters, used as a liver 
diagnostic marker, was analysed. In parallel, an increase of the wavelength as 
a function of the stiffness was obtained for the developed set of phantoms. The 
characterisation of the elastic properties is an excellent marker to differentiate 
minor and major fibrosis. A summary of the advantages and disadvantages of 
US and MR elastography techniques will be presented.  
Learning Objectives:
1. To learn how MR elastography and elastography techniques function. 
2. To understand how to evaluate the liver with elastography. 
3. To appreciate the diagnostic value of elasticity and viscosity. 
4. To become familiar with US and MR elastographic imaging techniques for 
non-invasive follow-up of treatment and therapy. 
Panel discussion:  
Elastography - a revolutionary technique or a waste of time?  09:47
08:30 - 10:00 Conf. Room M3  
Oncologic Imaging: Follow-up of Systemic and Local Therapies  
CC 1618  
Follow-up of local treatments of breast 
cancer  
Moderator:  
M.H. Fuchsjäger; Graz/AT 
A-557 08:30 
A. MRI-guided HIFU therapies in the breast  
M. Sklair-Levy; Tel Aviv/IL (mirisklair@gmail.com) 
Magnetic resonance high-intensity focused ultrasound is an innovative, 
noninvasive tumour ablation technique. MRI and focused ultrasound are 
combined allowing real-time anatomic guidance and temperature mapping 
during treatment. MRI-g FUS treatment is performed under local anaesthesia. 
Imaging: T2-W to define the tumour and T1-W with contrast to verify the 
efficacy after MRgFUS. MRI-guided FUS ablation of breast cancer studies 
demonstrates variable results with complete tumour necrosis in 20% to 100%. 
MRI-guided FUS procedure is well tolerated, with only a minor complication 
such as skin burn. Several issues need to be further investigated for successful 
cancer treatment with MR-guided focused US, including patient selection, 
definition of treatment margins and optimal transducer technology. In 
summary, FUS ablation has the potential to become an important modality for 
noninvasive image-guided treatment of localised breast cancer.  
Learning Objectives:
1. To learn about HIFU in breast tumours. 
2. To become familiar with the post-HIFU aspects of various types of imaging. 
A-558 09:00 
B. Pre-imaging and post-imaging appearance of breast lesion excision 
system (BLES) lesions  
S.D. Allen; Sutton/UK (steven.allen@rmh.nhs.uk) 
The breast lesion excision system (BLES) has evolved as a breast radiological 
technology over the last decade and is now in widespread use in Europe and 
across the world. It was designed as a large biopsy device, but more recently 
due to its unique capability to obtain a single large breast tissue specimen in 
only a few seconds by utilising a radiofrequency cutting and cauterising wave, 
it has increasingly been explored in the therapeutic setting. It is easy to use 
under ultrasound or mammographic guidance with procedures taking a similar 
length of time to that of a vacuum biopsy, and with patient preparation and 
anaesthetic essentially identical. The technical aspects of performing these 
procedures will be detailed as well as its use specifically to perform excisional 
biopsies. This is limited by patient and lesional factors, all of which will be 
discussed in more detail. Following a BLES, the post-procedure appearances 
need to be considered so that follow-up imaging can be interpreted accurately. 
The risks and complications of this procedure are outlined as well as a 
discussion made of the latest papers in this field that may suggest future 
applications and developments.  
Learning Objectives:
1. To understand the mechanism of the BLES technique. 
2. To become familiar with the post-BLES aspects of various types of imaging. 
A-559 09:30 
C. Common features and pitfalls in imaging the treated breast  
J. Camps Herrero; Valencia/ES (juliacamps@gmail.com) 
During the past few years, it has been shown that there is not a single disease 
entity called "breast cancer". There are different subtypes that entail diverse 
recurrence risks. This is the first issue to take into account, and patients will be 
stratified accordingly before any follow-up is planned. Imaging findings in a 
patient treated for breast cancer will depend on the type of treatment: breast 
conserving therapy (BCT), mastectomy (and all the reconstructive techniques), 
radiotherapy and minimally invasive techniques. To differentiate between fat 
necrosis and other common post-treatment changes from relapse, it is 
important to know the timeline when all these changes take place and also 
schedule the follow-up imaging procedures accordingly. Other important issues 
to take into account are the limitations and indications of the different 
modalities (mammography, ultrasound and MRI). Although ultrasound and 
mammography have traditionally been used in the follow-up of these patients, 
MRI is being used more and more often due to its superior multiplanar 
capabilities and the functional information not supplied by the other techniques.  
Learning Objectives:
1. To learn about the postsurgical and post-radiation therapies aspects of the 
breast and their timing. 
2. To learn how to diagnose a recurrence in the treated breast and its 
differential diagnoses. 
3. To become familiar with the imaging findings of post-ablation (RFA) of 
breast. 
Author Disclosure:
 J. Camps Herrero: Advisory Board; Bayer. Speaker; Bayer. 
08:30 - 10:00 Board Room A  
Vascular  
RC 1615  
Venous thrombosis: imaging and 
management  
A-560 08:30 
Chairman's introduction  
O. Pellerin; Paris/FR (olivier@pellerin.as) 
Venous thrombosis is a serious health issue. Two clinical presentations exist 
and both are under the scope of the radiologist. Despite a high efficacy rate of 
anticoagulation, treatment failure or complication occurs. The prevention of 
pulmonary embolism and the management of proximal vein occlusion could be 
done by the interventional radiologist (vena cava filtration, ilio-femoral venous 
network recanalisation). The chronic phase of venous thrombosis is 
responsible for post-thrombotic syndrome. This complication needs to be 
known by the radiology community, because of its insidious presentation and 
the dramatic results of recanalisation when indicated. The goal of this session 
is to point out the clinical importance of venous thrombosis imaging, by 
showing how to diagnose acute or chronic presentation, and to show the 
rationale of the technique and results of interventional radiologic procedure for 
vena cava filtration, and acute and chronic vein occlusion.  
Author Disclosure:
 O. Pellerin: Advisory Board; Siemens Interventional Oncology Advisory 
Board. Employee; Assistance Publique - Hôpitaux de Paris. 
A-561 08:35 
A. Ultrasound, CT and MR venography  
M. Das; Maastricht/NL (m.das@mumc.nl) 
Blood clot formation in the veins is referred to as venous thrombosis (VT). VT 
is most common in the deep veins of the legs and pelvis. If the thrombus 
dislocates to the pulmonary arteries this is referred to as pulmonary embolism 
(PE). The combination of deep vein thrombosis (DVT) and PE is referred to as 
venous thromboembolism (VTE). The diagnosis of DVT and VTE is essential, 
as VTE is potentially fatal. Furthermore, undiagnosed, non-fatal DVT may 
result in negative long-term pathologies (e.g. post-thrombotic syndrome). Major 
risk factors for the development of VTE are thrombophilia, history of DVT, age 
> 60, surgery, obesity, long travel, cancer, immobility and pregnancy. In 
addition, underlying congenital abnormalities or compression syndromes (May-
Thurner syndrome) are also important to diagnose. Diagnosis of VTE is not 
always easy. Primary diagnosis includes clinical (Wells Score) and lab testing 
(D-Dimer). First line imaging testing is done by leg ultrasound (US). If PE is 
suspected CT is indicated immediately. CT of the pulmonary arteries (CTPA) 
may be combined with indirect CT venography (CTV). The question of when to 
combine CTPA and CTV still remains. A favourable approach is to add CTV in 




a negative CTPA. Recently MR venography (MRV) is emerging as 
comprehensive imaging tool especially in patients with chronic DVT to assess 
the extent and underlying causes. In this respect imaging without radiation 
dose with high spatial delineation of vascular abnormalities facilitates 
intervention for thrombolysis or interventional therapy including recanalisation 
and stenting.  
Learning Objectives:
1. To learn about the pros and cons of US compared to CTV and MRV. 
2. To become familiar with imaging parameters, contrast media protocols, flow 
dependent techniques and flow independent techniques. 
3. To understand pitfalls and artefacts characteristic of the respective imaging 
modalities. 
Author Disclosure:
 M. Das: Consultant; Bayer Healthcare, Siemens Healthcare. Research/Grant 
Support; Institutional Grant from Bayer, Siemens. 
A-562 08:58 
B. Epidemiology, prevention and treatment  
C. Binkert; Winterthur/CH (christoph.binkert@ksw.ch) 
1. Epidemiology: acute deep vein thrombosis (DVT) is a common disease 
affecting 70-100 patients per 100'000 per year. A feared complication of DVT is 
pulmonary embolism (PE). 2. Prevention. a) Medication: low molecular heparin 
(LMH) is widely used for immobilised patients to minimise the risk of DVT. 
Alternatively, intravenous unfractionated heparin is used in situations when a 
quick reversal is necessary. b) Non-medication: early mobilisation has been 
widely adopted to activate the muscle pump. If early mobilisation is not 
possible, compression stockings and/or pneumatic compression boots are 
applied to better empty the veins. 3. Treatment: a) Anticoagulation: the main 
goal of anticoagulation is to prevent progression and recurrence of DVT. 
Typically, anticoagulation is started with LMH, followed by vitamin K 
antagonists (Coumadin). The first DVT is generally treated for 3-6 months; 
recurrent DVT for 12 months. b) Compression therapy: compression stockings 
ameliorate pain and leg swelling of acute DVT. In addition, the development of 
a post-thrombotic syndrome (PTS) should be reduced. c) Thrombolysis: the 
main goal of thrombus removal is prevention of PTS. In addition, thrombolysis 
is used for severe ilio-femoral DVT, especially with phlegmasia coerulea 
dolens. There are different ways of thrombolysis: systemic thrombolysis was 
abandoned because of high bleeding complications. Catheter-based 
thrombolysis has shown to reduce the bleeding risk, but it is quite time and 
resource consuming. The latest development is pharmaco-mechanical catheter 
thrombus removal which combines thrombolytic drugs with a mechanical 
maceration. Recent studies (CaVent,TORPEDO) have shown a reduction of 
PTS compared to anticoagulation.  
Learning Objectives:
1. To learn about the epidemiology and clinical presentation of venous disease. 
2. To become familiar with effective prevention measures. 
3. To learn about the different endovascular treatment options. 
Author Disclosure:
 C. Binkert: Speaker; Cook, Covidien. 
A-563 09:21 
C. IVC filters  
G.J. O'Sullivan; Galway/IE (gerard.osullivan2@hse.ie) 
The use of inferior vena cava filters (IVCFs) is a controversial method for the 
prevention of pulmonary emboli. There are large variations in their usage; often 
with ten to one hundredfold differences in placement between different 
countries. Ideally, IVCF usage is based on sensible protocols derived from 
clinical experience and trials. In practice, this is less frequently the case. 
Indications, contraindications and questionable indications (mainly during 
venous thrombolysis) will be discussed. Familiarity with ultrasound guidance 
will be stressed. The key technical steps in the insertion and removal of IVCFs 
will be discussed.  
Learning Objectives:
1. To learn the rationale for IVC filter placement. 
2. To become familiar with the key technical steps and learn how to avoid 
complications during IVC filter placement. 
3. To become familiar with the key technical steps and learn how to avoid 
complications during IVC filter retrieval. 
Author Disclosure:
 G.J. O'Sullivan: Consultant; Covidien Healthcare, Cook Medical, Marvao 
Medical, Optimed, Veniti Medical, Bard, Medtronic, Boston Scientific. 
Panel discussion:  
Current indications for interventional venous thrombosis  
treatment  09:44
08:30 - 10:00 Room P  
Computer Applications  
RC 1605  
Improving workflow efficiency and quality  
A-564 08:30 
Chairman's introduction  
D. Caramella; Pisa/IT (davide.caramella@med.unipi.it) 
The question that this refresher course is aimed to answer is whether novel IT 
tools may actually help in improving quality and workflow efficiency in daily 
radiological practice. In fact, since the early installations of PACS, IT tools have 
often been considered as mere productivity tools rather than enabling 
technologies for fostering quality in medical care. The three distinguished 
lecturers in this course will address the following topics: improving quality and 
efficiency of computerised order entry through decision support, improving 
quality and efficiency of reporting through structure and templates, and 
improving quality and efficiency of dose management through exchange 
between modalities and registries. They will cover all aspects of the 
radiological workflow: from the selection of the most appropriate diagnostic 
procedure, to the efficient reporting of diagnostic and non-diagnostic data 
(such as radiation dose information and contrast media information). They will 
demonstrate how newly adapted IT tools may provide assistance throughout 
the radiological workflow, with potentially enormous gains in terms of patients' 
safety and total quality management.  
Session Objectives: 
1. To appreciate the need for IT tools to ensure quality control. 
2. To understand how to collect data concerning radiation dose. 
3. To learn about the integration of contrast media injectors into PACS. 
A-565 08:35 
A. Improving the quality and efficiency of computerised order entry 
through decision support  
P. Mildenberger; Mainz/DE (peter.mildenberger@unimedizin-mainz.de) 
Electronic communication of requests for radiological procedures is a logical 
and relevant extension to integrated information systems in health care. This 
communication of orders and the entry (OE) into RIS improve the workflows. 
But, quality improvements require additional efforts to link order-entry-solutions 
with health knowledge for ordering the appropriate imaging procedure. These 
Clinical Decision Support (CDS) tools should be based on generally accepted 
and implemented criteria, e.g. evidence-based medicine. It is known that the 
acceptance of such systems, if successful and efficient implementations are 
given, is very good. IT concepts for CDS are well known and standards for 
classifications are available, but semantic interoperability is still a developing 
area. Actually, clinical information systems provide different levels of 
integration of OE and CDS. Further developments could be an implementation 
of interoperability profiles and the representation of CDS knowledge in web-
based services of non-commercial organisations.  
Learning Objectives:
1. To understand the relationship between decision support tools and 
evidence-based medicine. 
2. To learn how decision support tools can be implemented for requesting 
radiological studies. 
3. To appreciate the potential effects of decision support tools on workflow 
efficiency. 
A-566 08:58 
B. Improving quality and efficiency of reporting through structure and 
templates  
E. Neri; Pisa/IT (emanueleneri1@gmail.com) 
The report represents the final stage of the diagnostic imaging process, for 
which the radiologist is responsible. This process is driven by an accurate 
selection of the diagnostic tests, based on the clinical question. Therefore, the 
report should be an expression of this path, depending on the question asked 
by the clinician. The structure of a radiology report for the same clinical 
problem and the same method of investigation varies from country to country 
and between different radiologists. This diversity can be a problem in the global 
world where a patient can have imaging tests from different places with 
different reporting languages, or when patient data is transmitted and shared 
between different centres. There is, therefore, the need to standardise the 
report as much as possible; finalising its structure and contents to a specific 
clinical problem, and possibly using a standard terminology. An attempt to 
solve this problem is in progress with the joint initiative on structured report 
ESR- RSNA (http://www.rsna.org/Reporting_Initiative.aspx), aimed at 
improving reporting practises by creating a library of clear and consistent report 




templates. The main expected benefits of structured reporting templates are 
report uniformity and improvement of communication between referring 
physicians. Literature evidences that structured reporting can also quicken 
report turnaround, and reduce costs and lexical errors; thereby improving the 
quality and safety of radiological practise.  
Learning Objectives:
1. To learn about clinical requirements for structured reports. 
2. To become familiar with the IT requirements for report templates. 
3. To appreciate the potential for generating data for evidence-based radiology. 
A-567 09:21 
C. Improving quality and efficiency of dose management trough 
exchange between modalities and registries  
E. Vaño; Madrid/ES (eliseov@med.ucm.es) 
The European directive on Medical Exposures requires the assessment and 
evaluation of patient doses, especially in procedures involving high doses to 
the patient. In the current draft of the new directive on Basic Safety Standards, 
some requirements on patient dosimetry in diagnostic and interventional 
radiology have been reinforced: X-ray systems should provide dosimetric 
information with the capability of being transferred to the examination report 
(for all CT and interventional systems). Diagnostic reference levels (DRLs) 
shall be reviewed regularly. These requirements will push the industry and the 
users to develop better strategies to evaluate patient doses, transfer these 
values to patient reports (contributing to the patient exposure tracking system) 
and also use available software to process these dosimetric data and perform 
some automatic analysis. This analysis should: a) include periodic calibration 
factors for patient dose quantities, b) include automatic detection of high dose 
values (especially relevant for interventional procedures), c) include statistical 
analysis to update DRLs and compare with the existing ones and d) suggest 
corrective actions to fulfil the quality assurance programmes and the clinical 
audit requirements. DICOM radiation dose structured reports represent a 
significant advantage, but more efforts will be necessary for the automatic 
process of the relevant data contained in the report to verify that the 
radiological risk is acceptable and to suggest, if appropriate, corrective actions 
to improve clinical practice. Without these last steps, patient dosimetry efforts 
and European regulations for radiation safety could only have a moderate 
impact.  
Learning Objectives:
1. To learn about current European regulatory requirements and standards in 
patient dosimetry. 
2. To become familiar with the dose-reporting evolution and structured dose 
reporting. 
3. To appreciate the potential for dose analysis and reporting, as well as future 
registries. 
Panel discussion:  
Will novel IT tools really improve quality and efficiency in daily 
radiological practice?  09:44
10:30 - 12:00 Room A  
Interactive Teaching Session  
E³ 1720  
Changes of the gastrointestinal tract after 
treatment  
A-568 10:30 
A. Gastrointestinal tumours  
A. Laghi; Latina/IT (andrea.laghi@uniroma1.it) 
Gastrointestinal tumors include a variety of lesions, with the most frequent 
being adenocarcinoma of the small and large intestine, small bowel lymphoma, 
neuroendocrine tumours (NETs) and gastrointestinal stromal tumours (GISTs). 
According to histology, location and initial imaging staging, those lesions may 
require completely different therapies: surgery alone, adjuvant chemotherapy 
(CHT), neoadjuvant CHT followed by surgery or a combination of neoadjuvant 
chemoradiotherapy (CRT) followed by surgery. After treatment, imaging 
follow-up is mandatory. The most common post-operative findings after small 
bowel or colonic resections will be presented, together with clues for early 
detection of recurrence. In those cases which underwent adjuvant CHT, 
imaging findings and diagnostic criteria related to the use of either cytotoxic or 
cytostatic drugs will be shown, to facilitate the interpretation of radiologists in 
assessing response to therapy. Finally, tissue changes following neoadjuvant 
CRT will be discussed, particularly in rectal cancer. The possibilities of different 
imaging modalities in assessing either complete or partial response to therapy 
will be presented, with a critical analysis of different imaging findings.  
Learning Objectives:
1. To become familiar with common findings after medical treatment of 
gastrointestinal tumours. 
2. To become familiar with changes after radiotherapy for gastrointestinal 
tumours. 
3. To understand the changes which occur after surgery for gastrointestinal 
tumours. 
Author Disclosure:
 A. Laghi: Speaker; Bracco, General Electric Healthcare, Im3d. 
A-569 11:15 
B. Non-tumoural intestinal diseases  
J. Rimola; Barcelona/ES (jrimola@clinic.ub.es) 
Unlike infectious enteritis, in patients with Crohn's disease (CD) the changes in 
clinical activity have poor correlation with changes in inflammatory lesions after 
medical treatment. Mucosal healing (MH) and improvement in patient's 
symptomatology are usually considered the main objectives of medical 
treatment. However, improvement in clinical symptoms is not always 
associated with mucosal healing and the persistence of severe inflammatory 
lesions augurs a more aggressive disease course in terms of flare-ups, 
hospitalisation requirements and the need for surgery. Endoscopy is the gold 
standard for the assessment of luminal lesions in CD, but given the good 
correlation shown between endoscopy and cross-sectional imaging in 
assessing the activity and severity, imaging is increasingly introduced as a tool 
to monitor medical treatment. There is some evidence indicating that cross-
sectional imaging can be considered a responsive and reliable tool as it 
detects meaningful changes in patients' status over time after therapeutic 
interventions. Besides this, cross-sectional imaging is capable of monitoring 
the colon and the small bowel and penetrating lesions that cannot always be 
assessed by endoscopy. Becoming familiar with the radiological changes 
during and after treatment will be key in the decision-making process.  
Learning Objectives:
1. To become familiar with useful signs after medical treatment of Crohn's 
disease. 
2. To understand the changes which occur after recurrence in Crohn's disease. 
3. To understand the alterations which occur after treatment of intestinal 
infectious processes. 
12:30 - 13:30 Room E2  
The Beauty of Basic Knowledge: Skeletal Radiology  
MC 26E  
Degenerative disease  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK 
A-570 12:30 
Degenerative disease  
K. Bohndorf; Vienna/AT 
Degeneration is routinely defined as a morbid change of cells, tissues and 
even organs. In the MSK system degeneration occurs in bones, joints 
(synarthrosis and diarthrosis), muscles and tendons. Primary degeneration 
implies ageing as well as overuse, based on mircrotrauma. The latter may be 
related to constitutional, professional or sports-related factors. A distinction 
between ageing and overuse is not possible with the use of histology and 
imaging. Only the intensity of the changes, which may be inadequate in 
relation to the age of the patient, may give a hint. On the contrary, the term 
"secondary degeneration" should be used for clearly defined events or 
diseases, which finally will result in the degeneration of tissues. The causes 
are inflammation (RA, infection), metabolic disease (e.g. CPPD) or trauma. 
Other ways to classify degeneration of the MSK system are related to the 
anatomy. Accordingly, degeneration of the particular parts of the peripheral or 
axial skeleton, muscles and tendons has to be discussed. One has to have in 
mind that bones, cartilage, muscles and tendons form a complex unit. The 
single elements of these complex units jointly undergo degenerative 
deterioration, e.g. bone, cartilage, fibrocartilage and capsule are jointly 
involved in case of OA of the knee joint. The same holds true for the 
synchondroses of the spine. At the rotator cuff not only the tendons, but also 
the underlying bone and the muscle tissue are changed.  





1. To learn about the underlying pathomechanisms involved in degenerative 
processes. 
2. To understand the imaging features of degenerative disease in the 
peripheral skeleton. 
3. To understand the imaging features of degenerative disease in the axial 
skeleton. 
12:30 - 13:30 Room F1  
The Beauty of Basic Knowledge: Interventional Radiology  
MC 25E  
Essentials of transcatheter embolisation  
Moderator:  
O.M. van Delden; Amsterdam/NL 
A-571 12:30 
Essentials of transcatheter embolisation  
O.M. van Delden; Amsterdam/NL (o.m.vandelden@amc.uva.nl) 
There are many different types of embolisation, but all share many basic 
principles. The specific approach, technique, materials and equipment used 
may differ depending upon many variables such as the type of vascular 
territory involved (venous, arterial, small vessels, large vessels), clinical setting 
(elective or emergent procedure), and type of underlying disease to be treated 
(e.g. tumor embolisation, acute haemorrhage, vascular malformation, arterio-
venous fistula, etc). Pre-procedural imaging and planning are essential for 
most embolisation procedures and intra-procedural navigation can be done 
with fluoroscopy, DSA, and new 3D-techniques. With proper imaging workup 
prior to embolisation procedure time, radiation dose and contrast load can be 
significantly reduced. Embolisation materials can be roughly divided into liquid 
agents (alcohol, glue, polymers), particulate agents (PVA, calibrate micro-
spheres, drug-eluting beads) and coils (detachable, non-detachable) and plugs 
(Amplatzer®-plugs). Plugs and coils are deployed at the exact site of 
destination and usually easy and safe to use. Particles and liquid agents reach 
their site of destination by flow guidance and can be more difficult and 
unpredictable in their use. Complications include puncture-site complications 
(thrombosis, dissection, haematoma), systemic complications (contrast-
induced nephropathy, allergic reactions) and specific embolisation-related 
complications (non-target organ embolisation, end-organ ischaemia, post-
embolisation syndrome). When used with expertise and proper experience, 
most types of embolisation have good results with acceptable complication 
rates.  
Learning Objectives:
1. To understand the basic concepts and indications for embolisation. 
2. To learn about the practical aspect of embolisation, the techniques of 
endovascular navigation and the deployment of embolisation products. 
3. To learn about results and complications. 
16:00 - 17:30 Room C  
GI Tract  
RC 1901a  
From my workstation:  
difficult cases on review  
A-572 16:00 
Chairman's introduction  
A. Maier; Vienna/AT (andrea.maier@meduniwien.ac.at) 
Although there has been advancement in imaging techniques, several pitfalls 
in the assessment of diseases of the pancreas, small bowel and rectum 
remain. The differentiation and the correct characterisation of tumours and 
inflammatory disease in some cases may be difficult. Also, atypical 
presentation of common tumours or uncommon tumours persists and is a 
challenge. Problematic situations are constantly represented as intestinal 
bleeding and unexpected findings. In this session, we point out the procedure 
of the best imaging modality and protocols of challenging cases.  
A-573 16:05 
A. Pancreas  
C. Triantopoulou; Athens/GR (ctriantopoulou@gmail.com) 
Pancreatic imaging and interpretation of focal lesions remains a challenging 
issue. Despite the advances in imaging techniques and the dedicated protocols 
that are now in use, a possibility for pitfalls remains. These pitfalls are related 
either to the inability of the early recognition of a lesion, or to the wrong 
characterisation of a "mass". Both pitfalls are of great importance, taking into 
account the lethal pancreatic cancer and the possible complications that may 
follow an unnecessary pancreatic surgery. There are many variants of the 
pancreatic parenchyma, the ducts or even vessels, and deep knowledge of the 
pancreatic anatomy and embryology is needed, to be able to recognise these 
variations in imaging. A pancreatic variant may not only be misinterpreted as a 
severe pancreatic disease (e.g. ectopic spleen vs neuroendocrine tumour), but 
may also be the underlying cause of pancreatic inflammatory lesions (e.g. 
ectopic pancreas on the duodenal wall causing groove pancreatitis). Other 
pitfalls are related to the atypical presentation of a common lesion (e.g. 
isoattenuating pancreatic adenocarcinoma), the presence of uncommon 
tumours, diffuse or multifocal diseases, the co-existence of two different 
entities and the heterogeneous or overlapping appearance of cystic lesions. In 
any challenging case, a focused methodology should be applied and the 
diagnostic procedure based on predefined imaging parameters, taking also into 
consideration the clinical and laboratory findings. Excluding pancreatic cancer 
should be the first goal and every attempt should be made to differentiate 
between surgical and non-surgical cases.  
Learning Objectives:
1. To appreciate the challenging variants in pancreatic anatomy. 
2. To learn about the most important pitfalls in pancreatic imaging. 
3. To understand the management of these challenging cases. 
A-574 16:28 
B. Small bowel  
E. Biscaldi; Genoa/IT (ennio.biscaldi@gmail.com) 
Endoscopy is the gold standard in small bowel diseases, but it is a challenging 
technique: the PillCam is a commonly used tool and multidetector CT is a 
diffuse investigation technique. CT enteroclysis/enterography is a worldwide 
tool in intestinal exploration. Throughout the investigation of the small bowel, 
morphologic anomalies or embryonal development defects may be present 
(Meckel's diverticulum, duplications of intestinal tracts). Artefacts may be 
determined and there may be misunderstanding. MDCT is the first tool in 
emergency diagnosis; imaging pitfalls are possible. Unsuspected diseases 
may be revealed: we will see a case of GIST in a patient affected by intestinal 
bleeding of an obscure origin. CT enteroclysis may find unknown or 
unsuspected diseases: correct technical parameters have to be respected, as 
artefacts may be derived from an improper acquisition technique, such as a 
limited distension or poor intravenous enhancement. In follow-up, MR is 
preferred to investigate the intestine, mainly in the young population. 
Unexpected findings may be due to rare pathology: we met a case of 
endometriosis, with ambiguous presentations; patients affected by autoimmune 
pathologies (pyoderma gangrenosum or lupus erythematosus), with unknown 
inflammatory intestinal chronic diseases. In oncology, PET-CT imaging is the 
main diagnostic tool, but there are abdominal pitfalls that limit its effectiveness 
(intestinal hot spots, artefacts from peristalsis): the small bowel may frequently 
obstruct an easy diagnosis. In case of emergency, if the radiological diagnosis 
is not clear, the surgeon determines the management of the patient. In case of 
a defective study technique, a correct examination may be repeated. 
Endoscopy or PillCam may help to detect mucosal lesions invisible at CT.  
Learning Objectives:
1. To learn about the normal anatomy and normal variants. 
2. To learn about the most important pitfalls in imaging assessment of small 
bowel lesions. 
3. To understand the management of these challenging cases. 
A-575 16:51 
C. Rectum  
D.M. Lambregts; Maastricht/NL (d.lambregts@mumc.nl) 
MRI plays a key role in the assessment of disease of the rectum and in 
particular for the staging (and restaging) of rectal cancer. In this session, the 
relevant MR anatomy of the rectum will be discussed. Furthermore, the 
strengths and weaknesses of MRI in the assessment of rectal cancer during 
primary staging and restaging after chemoradiotherapy will be highlighted 
using various rectal cancer cases. Finally, we will discuss some rare tumours 
of the rectum (including GIST and carcinoid).  
Learning Objectives:
1. To learn about normal rectal anatomy and normal variants. 
2. To learn about the most important pitfalls in imaging assessment of rectal 
cancer or rare tumours of the rectum. 
3. To understand the management of these challenging cases. 
Panel discussion:  
What can we learn from challenging cases?  17:14




16:00 - 17:30 Room D  
Chest  
RC 1904  
Take a deep breath and hold:  
why and why not  
A-576 16:00 
Chairman's introduction  
P.A. Grenier; Paris/FR (philippe.grenier@psl.aphp.fr) 
Optimisation of CT and MR techniques has provided new challenges for 
imaging in the assessment of airway and lung diseases. Phenotypic 
abnormalities which can be recognised on visual and quantitative evaluation of 
CT images in COPD patients may improve the diagnostic accuracy, help 
optimise treatment and provide a framework for clinical trials. Although 
expiratory CT helps assess air trapping due to small airway obstruction and 
excessive dynamic collapse of large airways, potential tricks in technique and 
interpretation of CT images must be known. Owing to multiple and successive 
improvements over years, functional and morphologic evaluation of the lung 
using MRI has become reality for clinical practice. Already regarded as a 
favoured cross-sectional imaging in paediatric chest radiology, MRI of the lung 
is gaining new indications also in lung diseases occurring in adults.  
A-577 16:05 
A. New insights into COPD on HRCT  
N. Sverzellati; Parma/IT (nicolasve@tiscali.it) 
The potential for high-resolution computed tomography (HRCT) to uncover 
several morphological subtypes that come under the umbrella term chronic 
obstructive pulmonary disease (COPD) is now more familiar to both 
radiologists and specialist respiratory physicians. A complete approach to the 
classification of COPD would ideally assimilate several parameters through a 
combined visual-quantitative HRCT analysis. The insight that some subjects 
given the label of COPD have "pure" airways diseases or emphysema can be 
readily provided by a simple visual evaluation. The subtypes - centrilobular, 
panlobular, and paraseptal emphysema - can be reliably distinguished on 
HRCT images. The visual assessment of bronchial abnormalities and 
accompanying smoking-related interstitial lung disease may also complete the 
phenotypic classification of COPD. Furthermore, it is now possible to 
objectively quantify the global extent of emphysema, gas-trapping, and 
bronchial metrics by two types of softwares which are now increasingly 
available on latest CT workstations.  
Learning Objectives:
1. To learn about the classification of COPD. 
2. To appreciate the role of HRCT in the classification of COPD. 
3. To become familiar with different methods of analysis of HRCT in COPD. 
A-578 16:28 
B. Using inspiratory and expiratory CT  
A. Devaraj; London/UK 
This presentation will examine the role of expiratory CT in the diagnosis of 
small and large airways diseases. Small airways disease or air trapping may 
be a feature of asthma, COPD and hypersensitivity pneumonitis, and is 
typically characterised by a mosaic attenuation pattern on CT. 
Tracheobronchomalacia and excessive dynamic airway collapse (EDAC) are 
large airways conditions that may be recognised by tracheal narrowing on 
inspiratory and/or expiratory CT. The typical clinical and CT manifestations of 
these diseases will be reviewed. Additionally, a number of important caveats 
with regard to CT in small and large airways disease will be discussed: 1) the 
comparative strengths and limitations of CT, bronchoscopy and lung function 
testing in making the diagnosis; 2) the overlap in appearances that exists 
between diseased and healthy individuals; 3) the variability in definitions of 
conditions such as tracheobronchomalacia. The optimal CT technique for 
imaging of airways disease, including the role of dynamic expiratory CT, will 
also be reviewed.  
Learning Objectives:
1. To learn when inspiratory and expiratory CT may be of value in patients with 
lung disease. 
2. To become familiar with different diseases and their appearances on 
inspiratory and expiratory CT. 
A-579 16:51 
C. Pulmonary disease assessment with MRI  
H.-U. Kauczor; Heidelberg/DE (Hans-Ulrich.Kauczor@med.uni-heidelberg.de) 
For routine clinical applications, a standardised MRI protocol has been widely 
implemented. It addresses the major challenges of MRI of the lung, i.e. low 
proton density, susceptibility artefacts as well as respiratory and cardiac 
motion. Beyond visualisation of lung morphology, which is done in an 
inspiratory breath-hold, functional imaging has become an integral part of the 
routine protocols: perfusion, blood flow, ventilation, respiratory motion, 
diffusion. For perfusion imaging, inspiratory or expiratory scans can be used, 
blood flow measurement should be performed during shallow breathing, and 
ventilation and diffusion are mainly assessed in inspiration. Respiratory motion 
is best assessed by dynamic image acquisitions. Continuous breathing can 
also be combined with triggering or navigators to improve image quality or 
derive functional maps. MRI is recommended as the first-line cross-sectional 
imaging modality in paediatric chest radiology, including cystic fibrosis, 
complicated pneumonia, any pulmonary or cardiovascular anomaly, as well as 
the assessment of mediastinal masses in children and adults. MRI is also 
challenging PET/CT in the staging of lung cancer (TNM) as well as CT and 
echocardiography in the assessment of pulmonary arterial hypertension. MRI - 
even without contrast - is an alternative in the diagnosis of acute pulmonary 
embolism if iodinated contrast medium is contraindicated or in pregnant 
women. MRI should also be used in complicated pneumonia, e.g. in 
immunocompromised patients as well as for the functional assessment of 
chronic obstructive pulmonary disease (COPD) or severe asthma. The role of 
MRI in interstitial lung disease stills needs to be determined.  
Learning Objectives:
1. To learn about different MRI techniques used to assess pulmonary disease. 
2. To appreciate when MRI may be of value in patients with pulmonary 
disease. 
Author Disclosure:
 H.-U. Kauczor: Equipment Support Recipient; Siemens, Philips. Investigator; 
Boehringer. Speaker; Siemens, Bracco, Bayer, Boehringer, Novartis. 
Panel discussion:  
Correlating imaging with lung function and pulmonary  
disease genotypes  17:14
16:00 - 17:30 Board Room B  
Paediatric  
RC 1912  
Imaging the head and skull base  
Moderator:  
J.F. Schneider; Basle/CH 
A-580 16:00 
A. Faciocraniosynostoses revisited  
F. Di Rocco; Paris/FR
Unlike the simple forms of cranisynostosis whose modalities and timing of 
surgical correction are well established, the management of 
faciocraniosynostoses requires a multispecialistic and repeated evaluation of 
the single patients. Their evolution, in fact, depends on the specific genetic 
anomalies but also on the phenotype, which can vary in time, of their clinical 
expression which may lead to different degrees in severity of the associated 
functional disturbances (CSF dynamics impairment, visual deficits, respiratory 
anomalies, etc). Consequently these conditions may require several surgical 
steps the timing of which are dictated by the exact clinical diagnosis and the 
evaluation of the functional status at different ages. Current management of 
faciocraniostenoses is thus based not only on the radiological studies but also 
on the functional assessment of the brain function (e.g. MRI imaging studies, 
metabolic and cerebral blood circulation investigations, respiratory pathways 
volume evaluation, sleep recording). Today's surgical multidisciplinary 
management may benefit a large variety of techniques which extend from free 
bone cranioplasty with intraoperative active fixed expansion to more dynamic 
and less invasive methods which exploit the physiological brain expansion in 
infants or the gradual cranial vault expansion mechanically stimulated by 
springs or distractors. In the present report, we will review the decision making 
process and the rationale on which, at the Necker-Enfants Malades, we base 
the use of the currently available techniques for skull expansion and correction 
of cranial malformations according to the accurate dynamic radiological and 
functional evaluation at different stages of the disease.
Learning Objectives:
1. To learn about the imaging patterns of faciocraniosynostoses. 
2. To learn how and when to image. 
3. To become familiar with associated brain anomalies. 





B. All about the paediatric pituitary gland  
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr) 
MR is the imaging modality of choice for the assessment of the pituitary gland 
(PG) and the hypothalamus. The normal adenohypophysis is bright during the 
first two months of life and appears isosignal to the brain parenchyma 
afterwards. The neurohypophysis is bright, provided that the child is well 
hydrated. The PG height decreases during the first year of life and then 
increases until puberty. Adenohypophyseal deficiency has been associated 
with a small pituitary size, an ectopic neurohypophysis, a hypoplastic or absent 
pituitary stalk, hypothalamic gliomas, craniopharyngiomas and iron overload 
states. Precocious puberty may be idiopathic, but it has also has been 
associated with hypothalamic hamartomas, craniopharyngiomas and 
hydrocephalus. Diabetes insipidus may be secondary to histiocytosis X, 
germinomas and trauma causing pituitary stalk interruption. The hypothalamo-
pituitary axis is evaluated by using sagittal and coronal T1-weighted images 
without and with contrast administration. Dynamic contrast enhancement may 
be useful in the evaluation of disorders responsible of diabetes insipidus. 
Magnetisation transfer imaging may be useful in the evaluation of pituitary 
deficiencies or precocious puberty.  
Learning Objectives:
1. To become familiar with age-related changes of the normal pituitary gland. 
2. To learn about congenital and acquired pathology of the hypothalamo-
pituitary axis. 
3. To understand the pathophysiologic substrate of different imaging patterns. 
A-582 17:00 
C. Imaging of the orbit: the globe and the lachrymal gland  
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
Familiarity with orbital and ocular anatomy is crucial to the understanding of 
disease processes of the orbit. Lesions of the orbit may be divided into those 
which are intraocular and those which are extraocular. The underlying 
aetiology and geneses of many different lesions that can occur in the orbits 
vary depending on the location of the lesions and sometimes on additional 
nonorbital conditions. CT and MRI play crucial roles in the evaluation of orbital 
pathology where often MRI still is a complement to CT examination in the 
evaluation of orbital lesions Familiarity with the radiologic appearance of 
common orbital lesions is important, as many of these lesions will not be seen 
on physical examination. After a very brief anatomic overview, most of this 
lecture will focus on the more common benign and malignant lesions as well as 
differential diagnosis involving the orbit and lachrymal gland in both the 
paediatric and adult population. The lecture will also present suggested 
imaging protocol and standard of care with respect to imaging.  
Learning Objectives:
1. To understand the embryology and imaging findings of the most common 
malformations. 
2. To learn about space-occupying lesions and the differential diagnosis of 
tumours and inflammatory conditions. 
3. To be aware of the role of conventional and advanced MR sequences in the 
diagnostic approach to lesions in the orbit. 
16:00 - 17:30 Room E1  
Musculoskeletal  
RC 1910  
The hand and wrist  
Moderator:  
S. Bianchi; Geneva/CH 
A-583 16:00 
A. Patterns of injury  
A. Navas Canete; Leiden/NL (a.navas_canete@lumc.nl) 
Injury to the wrist and hand is an important clinical problem. First, such injury is 
relatively common. Second, the spectrum of abnormalities is complicated. The 
purpose of this presentation will be to learn more about the imaging 
appearances of soft tissue and osteoarticular injury of the wrist and hand using 
multiple imaging techniques. Emphasis will be placed upon pathomechanics 
and characterisation of greater and lesser arc injury patterns of the wrist. The 
various posttraumatic instability patterns of the wrist will be also discussed.  
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue and 
osteoarticular injury. 
2. To become familiar with the patterns of bone and soft tissue injury in the 
hand and wrist. 
A-584 16:30 
B. Inflammatory disorders  
H. Guerini, J.-L. Drapé; Paris/FR (henri.guerini@gmail.com) 
Rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other inflammatory 
disease can be diagnosed and sometimes differentiated in the early stages of 
the disease on the basis of MRI and/or PDUS features of the hand and wrist. 
Rheumatoid arthritis (RA) activity is closely correlated with inflammation. The 
synovial membrane is the principal site of inflammation in which the 
inflammatory process enhances capillary perfusion and permeability. Doppler 
ultrasonography (DUS), using the amount of colour pixels in the region of 
interest, and dynamic magnetic resonance imaging (DE-MRI) are both able to 
detect this inflammation in the wrist and hand. Although these techniques are 
both capable of monitoring synovium inflammation modifications after RA 
treatment, PDUS has become an essential tool for RA joint monitoring in 
routine practice in view of its sensitivity in the detection of synovitis, feasibility 
in outpatient clinics, and low cost.  
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue and 
osteoarticular inflammation. 
2. To become familiar with imaging findings of specific inflammatory conditions. 
A-585 17:00 
C. Tumours and tumour-like lesions  
E. Llopis1, V. Higueras2, E. Belloch1; 1Valencia/ES, 2Alzira/ES
(ellopis@hospital-ribera.com) 
Radiological study of the wrist and hand is challenging due to its complex 
anatomy with many small structures and the number of normal bone and soft 
tissue variants that might mimic injuries. Moreover, many findings can be 
asymptomatic. Their knowledge is important to avoid misdiagnosis. During this 
lecture we will also review the role of the different imaging modalities, such as 
plain films for wrist alignment and bone structures as well as the important role 
of US and MR in differentiating tumour from tumour-like conditions. We will 
become familiar with some specific radiological findings that allow us to make 
accurate diagnoses of soft tissue and bone lesions.  
Learning Objectives:
1. To learn more about the spectrum of intra and para-articular soft tissue 
tumours, and soft tissue tumour-like lesions. 
2. To become familiar with US and MRI findings of specific soft tissue lesions. 
16:00 - 17:30 Room E2  
Oncologic Imaging  
RC 1916  
Managing incidental findings in cancer 
patients  
A-586 16:00 
Chairman's introduction  
C. Pfannenberg; Tübingen/DE (christina.pfannenberg@med.uni-tuebingen.de) 
With recent advances in cross-sectional imaging, the frequency of detecting 
"incidental findings" has markedly increased. Incidental findings 
(=incidentaloma) are defined as unexpected, asymptomatic abnormalities 
detected by imaging performed for an unrelated reason. These incidentalomas 
have created a management dilemma for both radiologists and clinicians, 
particularly in the cancer patient in whom any mass warrants further 
evaluation. Discovery of incidental findings often leads to a cascade of 
additional tests that is costly, provokes anxiety and exposes patients to the risk 
of unnecessary radiation and intervention. The workup of incidentalomas 
varies widely by physicians, and strategies for optimising patient management 
are only beginning to emerge. In this course, guidelines concerning a rational 
approach to some of the more common incidental abnormalities in cancer 
patients are presented. Basic principles and tools for interpretation of incidental 
findings, common pitfalls and protocol issues regarding the differentiation of 
benign and malignant lesions as well as treatment-induced abnormalities will 
be addressed with a focus on the liver, lung and skeletal system. At the end of 
the session, the speakers will discuss the role of functional imaging techniques 
for characterisation of incidental lesions.  
Session Objectives: 
1. To become familiar with basic principles and common pitfalls in 
interpretation of incidental findings in the lung, abdomen and skeletal system. 
2. To learn how functional imaging (DWI, PET/CT, BS) can help in lesion 
characterisation. 
3. To provide attendees with clear and practical messages for the management 
of the most common incidental findings in cancer patients. 





A. Abdomen: common pitfalls and protocol issues  
A. Ba-Ssalamah; Vienna/AT (ahmed.ba-ssalamah@meduniwien.ac.at) 
An incidentaloma is quite a frequent diagnosis in medicine, in general, and in 
radiology, in particular. By definition, an incidentaloma is an abnormality or a 
tumour found by coincidence without clinical symptoms or suspicion. These 
incidental findings have long posed challenges to physicians, and particularly 
to radiologists as well as health-care providers due to the resulting high costs. 
The scope and scale of these challenges have increased with the introduction 
of new technologies, in particular cross-sectional imaging, such as MDCT and 
MRI using sub-millimetre thin slices. Incidentalomas still cause a management 
dilemma for clinicians, radiologists and even for the patients themselves. This 
dilemma is particularly pertinent to oncology patients. Therefore, a precise 
knowledge of the broad spectrum of incidental findings is crucial. Based on this 
knowledge, we can choose the appropriate radiologic examination that will 
provide a confident diagnosis. This way, needless uncertainty, for both the 
patient and the physician in charge, is avoided. Furthermore, invasive 
procedures, such as biopsies, with the potential for complications, as well as 
cost-intensive follow-up examinations, can be reduced. Furthermore, MRI is 
usually used to detect the side effects of chemotherapy of the liver. Simple 
steatosis is usually reversible, unless the liver receives a 'second hit' of 
damage from other causes leading to other manifestations, including 
chemotherapy-associated steatosis, sinusoidal obstructive syndrome, nodular 
regenerative hyperplasia, veno-occlusive disease, peliosis, pseudo-cirrhosis, 
and sclerosing cholangitis largely due to microvascular injury. Finally, the 
effects of chemotherapy on peritoneal and mesenteric structures after 
performing intraperitoneal chemotherapy will be discussed.  
Learning Objectives:
1. To become familar with the most common benign lesions and pseudo-
lesions of the liver, the adrenal glands, and the pancreas. 
2. To understand the CT and MRI characteristics by which the above-
mentioned lesions and malignant diseases can be distinguished. 
3. To learn how the liver is generally affected by chemotherapy and how to 
make a correct assessment. 
4. To become familiar with the effects of chemotherapy on peritoneal and 
mesenterial structures. 
A-588 16:28 
B. Chest: CT follow-up and advanced techniques  
A.A. Bankier; Boston, MA/US (abankier@bidmc.harvard.edu) 
This presentation will discuss the complex topic of incidental findings in 
thoracic imaging of oncological patients. Incidental findings will be presented 
with respect to their respective organs and anatomical regions. The 
presentation will emphasise the clinical relevancy of the findings as well as the 
specific of risk estimation in oncological patients. Finally, the presentation will 
discuss the usefulness (or lack thereof) of current management guidelines for 
incidental findings, as designed for the general population. Illustrative clinical 
scenarios will be discussed.  
Learning Objectives:
1. To become familiar with the CT characteristics of the most common benign 
and inflammatory/infectious lung lesions, as well as treatment-induced 
abnormalities. 
2. To learn how to distinguish signs of congestive heart failure from tumour 
spread. 
3. To learn how to distinguish benign parenchymal consolidations from 
malignant pulmonary nodules. 
4. To become familiar with the criteria of the Fleischner society for the follow-up 
of indeterminate pulmonary nodules in cancer patients. 
5. To understand the indications for, and the limitations of PET for the 
characterisation of pulmonary nodules. 
Author Disclosure:
 A.A. Bankier: Author; Elsevier. Consultant; Olympus. Grant Recipient; NIH. 
Speaker; ATS. 
A-589 16:51 
C. Skeletal system: is MRI sufficient?  
F.E. Lecouvet; Brussels/BE (frederic.lecouvet@uclouvain.be) 
Radiographs and CT often detect incidental observations in bones, 
corresponding either to normal variants or benign conditions, which require 
additional imaging to rule out malignant conditions. MRI most often provides 
nonambiguous explanation for these observations. Beside this, MRI, targeting 
either the whole body or only the axial skeleton, often including diffusion-
weighted (DWI) sequences, is increasingly used for bone tumour detection in 
many "osteophilic" cancers and haematologic malignancies, without need for 
contrast material injection and without irradiation, with unparallelled sensitivity 
to bone lesions. An important advantage and also a challenge for 
musculoskeletal radiologists are the all organ screening capabilities of DWI, 
demanding careful study of the huge information provided and knowledge 
extending far beyond bones in terms of organs and metastatic spread of 
different cancers. A second major advantage is its ability to detect lesion 
changes under therapy. However, benign lesions and non-neoplastic 
conditions, as well as artefacts may also lead to confusing observations on 
MRI, and particularly on DWI. Anatomical MR sequences as well as other 
imaging modalities are of utmost help to recognise these pitfalls. Whole body 
MRI including DWI sequences has to position itself among other diagnostic 
tools, bone scan, SPECT, and especially PET with its variety of tracers, in the 
currently evolving strategy of bone screening techniques, which will most likely 
vary according to the primary cancer.  
Learning Objectives:
1. To present most frequent x-ray and CT pseudo lesions and benign 
conditions and show how MRI often enables straightforward interpretation of 
these abormalities. 
2. To highlight the strengths of MRI with diffusion weighted imaging (DWi) for 
malignant lesion detection and characterisation within bones, but also beyond 
bones. 
3. To highlight the typical appearance of malignant lesions on projectional and 
cross-sectional imaging. 
4. To learn to differentiate these lesions from normal marrow variations, stress 
lesions, bony pseudo-lesions and other benign conditions, and to become 
familiar with treatment induced changes within lesions and their environment. 
5. To situate MRI amongst other functional imaging techniques (PET, SPECT, 
). 
Panel discussion:  
The role of functional imaging techniques in lesion  
characterisation  17:14
16:00 - 17:30 Room F1  
Abdominal Viscera  
RC 1901b  
Colorectal cancer liver metastases: 
assessing tumour response  
A-590 16:00 
Chairman's introduction  
P.R. Ros; Cleveland, OH/US (Pablo.Ros@UHhospitals.org) 
Colorectal cancer is the 3rd most commonly diagnosed cancer in the world with 
60% of cases diagnosed in the developed world. With an estimated 1.3 million 
new cases clinically diagnosed and over 600,000 people killed worldwide by 
this disease on an annual basis, colorectal cancer is a true public health 
concern. Survival of colorectal cancer is directly related to the extent of disease 
and specifically presence of liver metastases. Imaging plays a key role in the 
initial staging of colorectal cancer and is the gold standard in evaluating extra 
colonic disease, primarily liver metastases. Imaging is also widely used for 
therapy monitoring and staging. CT, MRI, PET/CT and PET/MRI are the key 
imaging modalities. In addition, tumour response therapy assessed with 
morphological and functional biomarkers is increasingly used by advanced 
gastrointestinal oncologic programs. Furthermore, image-guided therapy is 
widely used for patients with unresectable lesions. Liver colorectal metastases 
were the first liver metastases to be treated with image-guided ablation 
techniques. A gamut of ablative techniques exists ranging from transarterial 
embolisation, radiofrequency ablation, highly intensified focused ultrasound, 
brachitherapy etc. In short, diagnosing, characterising and finally assessing 
tumour response after neoadjuvant and image-guided therapy are all functions 
where imaging plays a pivotal role. This course is divided into three logical 
segments dealing with current treatment options, morphological and finally 
functional biomarkers and it is followed by a panel discussion which includes 
audience participation.  
Author Disclosure:
 P.R. Ros: Advisory Board; Philips Healthcare Radiology Medical Advisory 
Network, KLAS, Medical Advisory Board. Research/Grant Support; 
Departmental Research support from Philips Healthcare, Siemens, Toshiba 
Medical Systems and SECTRA. 
A-591 16:05 
A. Current treatment options  
T.K. Helmberger; Munich/DE (Thomas.Helmberger@klinikum-muenchen.de) 
Hepatic metastases in colorectal cancer may occur in 20% to 80% of the 
cases. Considering the general oncological (isolated hepatic tumour load; 
prognostic benefit), and technical (size, number, location of hepatic 
metastases; expected hepatic functional reserve) framework, surgical resection 
is still considered to be the method of choice - even if this statement never had 




been verified by RTCs. Nevertheless, in clinical reality only 20-30% of patients 
with liver metastases may qualify for resection. In consequence, the majority of 
patients need other or at least modified therapeutical pathways including 
adjuvant or neoadjuvant chemotherapy and more and more image-guided local 
ablative therapies. The latter encompass chemo- (transarterial 
chemoperfusion/-embolisation), thermo- (radiofrequency-, laser-, microwave 
ablation, high intensified focused ultrasound), and radio-ablative (radio 
embolisation, interstitial brachytherapy, etc). techniques. Particularly, thermal-
ablative techniques gained wide acceptance over the last years, since ample 
evidence could be presented showing that this method can be applied as 
primary and also complementary therapies in resectable and non-resectable 
metastatic disease. Furthermore, recent data confirm that in multimodality 
therapy concepts, progression free survival and overall survival in patients with 
primarily unresectable and with unfavourable prognosis is comparable to 
surgery with 5-year survival rates more than 50%. Minimally invasive, image-
guided therapies will not replace surgical resection; however, these therapy 
modalities are eligible in a large number of cases and should be implemented 
consequently in multimodality treatment regimens according to the 
interdisciplinary consensus of oncologists, interventional radiologists, and 
surgeons.  
Learning Objectives:
1. To understand the different scenarios in which liver metastases may present 
in relation to patient prognosis and therapeutic options. 
2. To understand the existing therapeutic approaches to liver metastases in 
different scenarios. 
A-592 16:28 
B. Morphological biomarkers  
S. Skehan; Dublin/IE (s.skehan@st-vincents.ie) 
Colorectal liver metastases are typically identified as low attenuation lesions on 
portal venous phase CT. Planning of optimal therapy depends on accurate 
localisation and characterisation of all focal liver lesions and this is best 
achieved with MRI, which should include diffusion-weighted imaging and use of 
hepatocyte-specific contrast medium. The typical MRI signature of colorectal 
metastases includes low signal on T1w, moderately increased signal on T2w, 
irregular peripheral arterial phase enhancement with low signal on portal 
venous phase, restricted diffusion and absent hepatocytes. Morphological 
tumour response can be assessed with either modality. Size-based systems 
for assessing tumour response are widely applied, with RECIST 1.1 the most 
widely used at present. RECIST 1.1 includes several modifications that make it 
more user friendly than RECIST 1.1. More advanced morphological criteria 
have been described for new targeted and molecular therapies, including 
overall attenuation, the tumour-liver interface and the appearance of the 
peripheral rim of enhancement. As hepatic surgeons become more aggressive 
in their approach to resection in patients with liver metastases, it is important to 
understand that disappearance or calcification of liver metastases after 
treatment does not necessarily equate to a complete pathological response. 
The timing of imaging is therefore critical in assisting the surgeon to remove all 
previously affected hepatic segments after chemotherapy.  
Learning Objectives:
1. To learn about the algorithm for detecting and characterising liver 
metastases. 
2. To understand conventional imaging criteria for assessing tumour response. 
3. To learn about the rationale for monitoring patients after radical and 
palliative treatments. 
A-593 16:51 
C. Functional biomarkers  
D.-M. Koh; Sutton/UK 
Conventional size measurement criteria remain the most widely used method 
to determine the response of colorectal liver metastases to treatment. 
However, tumour size reduction is assessed relatively late (e.g. 12 weeks after 
treatment) and new targeted treatment may be effective without reducing 
tumour size. New functional imaging techniques can be applied to quantify 
different aspects of tumour biology and to develop response, and predictive 
and prognostic biomarkers. We discuss the use of diffusion-weighted MR 
imaging, dynamic contrast-enhanced MR imaging and FDG-PET imaging in 
the evaluation of treatment response in patients with colorectal liver 
metastases.  
Learning Objectives:
1. To understand the different functional imaging techniques that can be used 
to monitor response to therapy including perfusion, diffusion MRI and PET/CT. 
2. To learn about efficient algorithms for assessing therapeutic response of 
liver metastases that influence prognosis. 
3. To understand how functional biomarkers are incorporated into multicentric 
trials. 
Panel discussion:  
The "vanishing" lesions: what should you do  17:14
16:00 - 17:30 Room F2  
Breast  
RC 1902  
Emerging breast imaging technologies  
Moderator:  
F. Pediconi; Rome/IT 
A-594 16:00 
A. Digital breast tomosynthesis (DBT)  
P. Skaane; Oslo/NO (PERSKA@ous-hf.no) 
Digital breast tomosynthesis (DBT) is a promising technique for breast imaging 
based on a full-field digital mammography (FFDM) platform. The x-ray tube 
moves through a proscribed arc, and several low-dose projection images are 
acquired. Images are reconstructed into a stack of 1 mm slices. The radiation 
dose is about the same or slightly higher than for FFDM. The most important 
advantage of DBT is the elimination of superimposed tissue, which improves 
detection of lesions otherwise hidden by dense breast parenchyma and 
reduces the interpretation problems caused by overlapping tissue. DBT is 
suggested to improve sensitivity as well as specificity in women with dense 
breast. DBT is superior to FFDM in tumour size assessment and for mass 
visibility and cancer conspicuity. DBT is comparable to FFDM for evaluation of 
microcalcifications. DBT is superior for the detection of spiculated masses and 
architectural distortion. The potential to improve sensitivity and specificity is of 
interest for screening. An open question is whether DBT should be applied in 
one or two views. Two-view DBT would mean a doubling of radiation dose, but 
a solution is the implementation of synthetic 2D images reconstructed from the 
3D dataset of DBT. The synthesised images are created by summing and 
filtering the stack of reconstructed DBT slices. Using synthetic 2D allows 
"combo mode" to be implemented in screening with the same radiation dose as 
for conventional 2D. Results using DBT in breast cancer screening are very 
promising. Different study design of published studies may explain the 
variations of results.  
Learning Objectives:
1. To become familiar with the technique of DBT. 
2. To understand the results of DBT in screening and diagnostics. 
3. To learn about the potential role of DBT in the breast radiological algorithm. 
Author Disclosure:
 P. Skaane: Equipment Support Recipient; Hologic, Inc. sponsored the Oslo 
tomo trial through the use of equipment. Research/Grant Support; Hologic, Inc. 
sponsored the Oslo tomo trial through financial support for additional overtime 
interpretations. 
A-595 16:30 
B. Multiparametric high-field MRI and more  
P.A.T. Baltzer, K. Pinker-Domenig; Vienna/AT (patbaltzer@gmail.com) 
Magnetic resonance imaging of the breast provides a multitude of techniques 
for detection of breast cancer and differentiation of benign from malignant 
lesions. In the last few years, significant improvements of scanner hardware 
and equipment in terms of coils as well as sequence software have been 
achieved. To date, multiparametric quantitative measurement of perfusion, 
diffusion and tissue chemistry is possible at field strengths up to 7 Tesla. 
Although higher field strengths and improved sequence protocols provide 
higher signal and allow faster imaging, specific technical issues have to be 
considered to avoid artefacts and pitfalls. This talk aims to demonstrate the 
possibilities and limitations of multiparametric and (ultra-)/high-field MRI. 
Furthermore, these new techniques are put into the broader clinical context to 
determine the potential value for breast lesion detection and differentiation.  
Learning Objectives:
1. To understand the management of breast lesions based on current MRI 
applications. 
2. To learn how to improve the specificity of breast MRI by adding new 
developing techniques. 
3. To appreciate future developments and limitations. 
A-596 17:00 
C. High-resolution radionuclide breast imaging (PEM and molecular 
imaging)  
T. Wagner; London/UK (Thomas.Wagner@nhs.net) 
Positron emission mammography is a recently developed imaging device using 
positron emission technology. After injection of a positron-emitting radiotracer, 
the radiation is detected by a dedicated high-resolution camera, providing high 
spatial resolution. Commercially available systems include cameras where the 
breast is compressed and which display a 2D image similar in its layout to a 
mammogram and hanging breast devices where a 3D image similar in its 




layout to MRI is produced. These devices have been compared to PET/CT and 
have shown higher spatial resolution, accuracy and sensitivity in detecting 
malignant breast lesions. The most widely studied tracer in PET/CT and in 
PEM is fluorodeoxyglucose (FDG). FDG is a glucose analogue and has had a 
major impact on oncology imaging with PET/CT. Breast carcinomas 
demonstrate increased glucose consumption and the intensity of the uptake 
has been correlated with prognosis, hormonal receptor and HER2 status, Ki67 
and nodal involvement. Current potential indications for PEM are detection and 
characterisation of breast lesions, local staging in patients with known breast 
cancer and baseline assessment prior to neoadjuvant chemotherapy. Future 
developments of PEM will involve new tracers and fusion with other breast 
imaging modalities. Fluorothymidine is a proliferation tracer that seems 
promising in early assessment of response to chemotherapy. Fluoroestradiol 
has the potential to image oestrogen receptor status in vivo. The possibility of 
PEM-guided biopsy is a very exciting development and has the potential to 
select lesions with the highest intensity of uptake. Fusion with MRI, US and 
mammography will increase the diagnostic accuracy.  
Learning Objectives:
1. To become familiar with the current status: what is available and how does it 
work? 
2. To understand the indications: local staging, distant staging, therapy 
monitoring and limitations. 
3. To learn about future prospects: PET-MRI, targeted tracers. 
16:00 - 17:30 Room G/H  
Neuro  
RC 1911  
Ruling out disease:  
a radiologist's headache?  
Moderator:  
P. Demaerel; Leuven/BE 
A-597 16:00 
A. Vasculo-ischaemic lesions: inappropriate for age?  
S. Haller; Geneva/CH (sven.haller@me.com) 
The presentation will focus on two frequent findings on MRI with increasing 
incidence during ageing, notably "unspecific" hyperintense lesions on 
T2/FLAIR and cerebral mircobleeds (CMBs) on T2* or SWI images. Clinico-
radiologic studies suggest that these T2/FLAIR lesions are associated with 
increased risk of cognitive decline, stroke and death. The clinical relevance of 
these lesions probably depends on periventricular versus deep white matter 
location. Radiologic-histopathologic studies correspondingly indicate that the 
degree of histopathologically confirmed demyelination also depends on the 
location of these T2/FLAIR lesions. Cerebral mircobleeds (CMBs) are punctate 
hypointense lesions on T2* or SWI images. While multiple CMBs are 
associated with diseases such as cerebral amyloid angiopathy (CAA), clinico-
radiologic studies demonstrate increased incidence of sporadic CMBs in mild 
cognitive impairment (MCI) and Alzheimer dementia, indicating a degrading 
effect of CMBs on cognition. On the other hand, radiologic-histopathologic 
studies show that not all black spots on T2* or SWI correspond to CMBs. CMB 
mimics include micro-calcifications. The presentation will demonstrate typical 
manifestations of these "unspecific" T2/FLAIR lesions and CMBs during ageing 
and provide tips for the interpretation of these lesions during daily clinical 
routine.  
Learning Objectives:
1. To understand the aetiology and risk factors for small vessel disease. 
2. To appreciate the prognostic impact of extensive vascular white matter 
lesions. 
3. To learn how to interpret vascular white matter lesions according to age and 
decide what is abnormal. 
A-598 16:30 
B. Radiologically isolated syndrome: silent MS?  
A. Rovira-Cañellas, C. Auger; Barcelona/ES (alex.rovira@idi-cat.org) 
With the increasing use of MRI, it has become more common to discover 
incidental brain findings. These findings may be non-specific or have some 
morphological characteristics and geographical distribution highly suggestive of 
a demyelinating disease. The term "radiologically isolated syndrome" (RIS) 
was introduced by Okuda in 2009 to describe those asymptomatic patients with 
radiographic abnormalities highly suggestive of multiple sclerosis (MS). 
Sometimes, these lesions may even meet the MRI criteria for dissemination in 
space, which are currently used to predict future development or conversion to 
MS in patients presenting a clinically isolated syndrome (CIS). However, we 
must not forget that these radiological criteria should be applied only when the 
patient had experienced any clinical manifestations suggestive of a 
demyelinating disease. Therefore, what happens in those patients in whom we 
found highly suggestive lesions but have never had symptoms? Due to lack of 
knowledge about the natural history or evolution of this new syndrome, clinical 
and therapeutic management of these patients is not well established, nor is 
the risk of conversion to MS. Recent data, however, indicate that the presence 
of gadolinium-enhancing cervical cord and cortical lesions significantly 
increases the risk of conversion to CIS or MS. All these data have improved 
the characterisation of RIS subjects and in our understanding of risk factors for 
initial symptom development.  
Learning Objectives:
1. To understand the 2010 revision of the McDonald criteria for MS and 
meaning of RIS. 
2. To become aware of differential diagnosis of MS and red-flags in the 
diagnostic process. 
3. To understand the use of gadolinium and spinal cord imaging in a diagnostic 
setting. 
A-599 17:00 
C. Incidental findings: what to report and what not to report?  
A. van der Lugt; Rotterdam/NL (a.vanderlugt@erasmusmc.nl) 
Incidental findings on brain imaging are defined as previously undetected 
abnormalities of potential clinical relevance that are unexpectedly discovered 
and unrelated to the purpose of the imaging. Incidental findings are 
increasingly detected in clinical practice, with screening, and in the research 
setting. Data on the prevalence of these abnormalities are scarce, the clinical 
course of the findings is often unknown, and the management of such lesions 
is not clear. The prevalence of incidental findings can be expected to vary 
depending on the purpose of the imaging exams. With improvements in 
imaging technology (higher field scanners, new pulse sequences), the number 
of detected incidental findings will increase dramatically. Another important 
point is the advent of imaging biomarkers. Advanced techniques for 
postprocessing and analysis, such as automated segmentation of brain 
structures or voxel based morphometry, will lead to the discovery of imaging 
biomarkers. Once the predictive value of these markers has been established, 
most MRI studies of the brain, both in the clinical and research setting, will 
reveal information that might be relevant for the well-being of patients or 
participants. Although still incidental, these findings can unfortunately no longer 
be considered unexpected. We will soon face large medical, ethical, and 
practical problems as a result of technical improvements. In this lecture, the 
most important incidental findings and their prevalence will be reported. The 
management of incidental findings in the clinical and research setting will be 
discussed. Finally, recommendations for follow-up will be provided.  
Learning Objectives:
1. To become familiar with the frequency of incidental findings on brain MRI. 
2. To understand the clinical relevance of incidental findings - can they cause 
headache? 
3. To learn how to report incidental findings and when to recommend clinical or 
imaging follow-up. 
Author Disclosure:
 A. van der Lugt: Board Member; European Society of Magnetic Resonance 
in Medicine and Biology. Investigator; GE Healthcare. Speaker; GE 
Healthcare. 
16:00 - 17:30 Room N/O  
Head and Neck  
RC 1908  
Imaging laryngeal cancer  
Moderator:  
B. Banko; Belgrade/RS 
A-600 16:00 
A. What matters in staging laryngeal cancer  
R. Maroldi; Brescia/IT (maroldi@med.unibs.it) 
The primary assessment of laryngeal cancer is provided by endoscopy, which 
is accurate in delineating both the superficial extent and functional impairment. 
Imaging techniques are recommended to grade submucosal invasion, local 
and distant spread. In the last few decades, open and endolaryngeal surgical 
procedures as well highly sophisticated RT techniques have been developed to 
treat the tumour while preserving critical laryngeal functions. For example, 
early glottic tumours (Tis-T2) can be treated by endoscopic laser excision or 
RT. The integration of information acquired by endoscopy and imaging is 
essential for proper treatment planning. The radiologist has to know that the 
site of origin (supraglottis vs glottis or subglottis) and local extent (superficial 
and submucosal) are the key tumour-related factors in planning the type of 
treatment. Submucosal invasion has a variable impact depending on the 




location of the primary tumour. The 5 key issues in glottic cancers include the 
invasion of: the posterior paraglottic space, crico-arytenoid joint, and anterior 
commissure and contralateral true vocal cord, and vertical spread towards 
supra and/or subglottis, thyroid or cricoid cartilage. The 5 key issues in 
supraglottic cancers encompass the invasion of: base of the tongue, pre-
epiglottic space, piriform sinus, vertical spread into glottis and subsequent 
cartilage invasion (observed exclusively in transglottic cancers). Function-
sparing surgical techniques - as supracricoid laryngectomies - can be applied 
in advanced cancers when sparing of the posterior commissure, the ipsilateral 
crico-arytenoid joint, the mucosa investing the upper cricoid and the outer 
perichondrium of the thyroid cartilage is demonstrated by endoscopic and 
imaging mapping.  
Learning Objectives:
1. To become familiar with the typical findings of T1-T4 laryngeal cancer. 
2. To learn about the patterns of local nodal involvement. 
3. To understand possible imaging pitfalls in staging. 
A-601 16:30 
B. How to evaluate the post treatment larynx: clinical and histological 
alterations after initial treatment  
P. Zbären; Berne/CH (peter.zbaeren@insel.ch) 
The detection of recurrent laryngeal carcinoma is often challenging. To better 
appraise the expected findings after initial surgery of laryngeal cancer, the 
classical partial laryngectomy and laser laryngeal surgery are briefly presented. 
(Chemo)radiotherapy has become an important treatment modality for 
laryngeal carcinoma. The recurrence rate in T2-T4 laryngeal carcinoma is 
reported to be between 25% and 50%. The difficulty in differentiation between 
radiation reaction (such as oedema, fibrosis and soft tissue and cartilage 
necrosis) and recurrent disease is discussed. A histologic study on whole-
organ sections of 29 recurrent glottic carcinomas is also presented: recurrent 
disease presents with different tumour spread than does a primary carcinoma, 
resulting in difficulties in estimating the extent of tumour recurrence. Currently, 
selected recurrences of early glottic carcinoma are, whenever possible, treated 
by larynx-preserving salvage surgery. In those cases, a precise evaluation of 
the recurrent tumour extent is mandatory for planning larynx-preserving 
salvage surgery. This is especially true in critical regions such as the pre-
epiglottic space, infiltration into cartilage, contralateral tumour spread and 
subglottic tumour extension. The accuracy of crT-classification is relatively low: 
many patients with signs and symptoms suggesting tumour recurrence present 
with post-radiotherapy changes; small tumor foci, often localised in the 
subglottic region, are undetectable by imaging studies.  
Learning Objectives:
1. To appreciate the expected findings after surgery of laryngeal cancer. 
2. To become familiar with findings after non-surgical treatment. 
3. To know about the possible imaging pitfalls due to the histopatholgical 
patterns of disease recurrence. 
A-602 17:00 
C. Can we rule out cancer recurrence?  
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Tissue changes in the neck treated by surgery and/or radiotherapy (RT) make 
the detection of residual or recurrent tumour more difficult. Clinical evaluation 
of the neck is also hampered by these changes. RT-induced fibrosis and post-
surgical scar tissue make palpation of the neck very difficult. Endoscopy is 
hampered by endolaryngeal oedema which can persist for many months post-
RT. Therefore, any (non-invasive) method helping in the detection of 
recurrence is welcome. Patients at risk for local failure after RT can be 
successfully identified by a post-RT CT (or MR) study between 1 to 6 months 
after RT. The optimal time point to perform such a 'baseline study' seems to be 
about 3 to 4 months post-RT. Patients with indeterminate findings are 
candidates for 'imaging surveillance'; i.e. follow-up imaging every 3 to 4 months 
up to a period of 2 years after RT. However, ongoing studies suggest that 
metabolic imaging (FDG-PET) may detect local recurrences with a higher 
accuracy than 'conventional' anatomically based imaging techniques, such as 
CT and MR. CT and/or MR-findings in the treated neck are frequently 
inconclusive. At present, new techniques are available to detect recurrent 
cancer. PET-CT is widely applied in the post-treatment setting. Also, advanced 
MR-techniques such as diffusion weighted imaging (DWI) and dynamic 
contrast-enhanced MR (DCE-MR) can be applied. Focusing on the larynx, the 
advantages of these techniques as well as the limitations will be shown using 
imaging examples from daily practice.  
Learning Objectives:
1. To understand the limitations of clinical examination. 
2. To appreciate the value of different imaging techniques in the detection of 
recurrence. 
3. To become familiar with the imaging findings of recurrent laryngeal cancer. 
16:00 - 17:30 Conf. Room M3  
Molecular Imaging  
RC 1906  
Molecular imaging in oncology  
Moderator:  
E.J. Rummeny; Munich/DE 
A-603 16:00 
A. New PET-tracers for oncology  
W. Weber; New York, NY/US 
During the last 10 years, several hundred new radiotracers for PET imaging of 
cancer have been developed and tested preclinically. These tracers are based 
on proteins (e.g. antibodies and antibody fragments), peptides (e.g. G protein-
coupled receptor ligands) or small molecules (e.g. radiolabelled protein kinase 
inhibitors or metabolic substrates). Using these radiotracers, the expression 
and function of a variety of proteins can be studied in patients, including for 
example glutamine/glutamate metabolism, neutral amino acid transport, 
PSMA, GRPr, SSTr, CXCR4, folate and alpha-v beta-3 integrin expression. 
Some of these radiopharmaceuticals are potential companion diagnostics and 
may allow selection of patients for treatment with radiopharmaceuticals or 
targeted drug conjugates. Preclinical and initial clinical data are promising for 
several new radiotracers, but the key challenge is the clinical validation and 
dissemination of these compounds. Validation and dissemination have been 
hampered so far by regulatory hurdles as well as by the lack of standardised 
trial designs for the validation of imaging agents and the lack of accepted and 
appropriate end points to prove clinical utility. Addressing these issues will be 
critical for the future clinical use of PET and other molecular imaging 
technologies.  
Learning Objectives:
1. To learn about the new specific tracers that can be used in oncologic 
patients. 
2. To appreciate their potential impact on patient management. 
3. To understand their potential and limitations for practice. 
Author Disclosure:
 W. Weber: Advisory Board; Endocyte, MSD. Grant Recipient; Bayer, Philips. 
A-604 16:30 
B. Potential of MRI for molecular imaging in oncology  
F. Gallagher; Cambridge/UK (ferdia.gallagher@doctors.org.uk) 
Imaging targets in cancer range from simple size measurements to more 
specific biomarkers on functional, cellular, metabolic and molecular levels. As 
our understanding of basic tumour biology has advanced, techniques have 
been developed to exploit this information to produce increasingly specific 
molecular imaging tools. The biodistribution of these molecular imaging probes 
should be more specific in diagnosing and assessing cancer than the 
morphological information acquired using anatomical imaging alone. This 
lecture will discuss current and emerging functional and molecular imaging 
techniques using MRI and their applications in oncology. Functional measures 
of tumour blood flow and vascular permeability can be made using dynamic 
contrast-enhanced MRI. Diffusion-weighted imaging is a surrogate for the 
cellular content of the tumour and emerging methods can be used to probe 
features of the extracellular space such as tumour pH and stromal content. On 
the molecular level, cell surface expression of specific proteins and enzyme 
activity within the cell can be imaged; labelled probes have been developed 
which bind to these proteins and a new MR technique is being developed for 
assessing tumour glucose in a similar way to PET. Hyperpolarisation methods 
are emerging to overcome the major limitation of MR: low sensitivity. One such 
approach is dynamic nuclear polarisation, which can probe carbon metabolism 
non-invasively in patients with cancer. Functional and molecular imaging 
techniques with MRI will increasingly be used in radiology in conjunction with 
anatomical imaging methods to improve diagnosis and prognosis, target 
biopsies, as well as predict and detect response to treatment.  
Learning Objectives:
1. To become familiar with the different approaches to molecular imaging with 
MRI. 
2. To understand the role of molecular imaging in oncology. 
3. To learn about emerging MRI techniques for molecular imaging. 
Author Disclosure:
 F. Gallagher: Research/Grant Support; GE Healthcare. 





C. Emerging molecular imaging techniques  
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de) 
With MR-spectroscopy, diffusion-weighted imaging, PET- and SPECT-CT, as 
well as PET-MRI, molecular imaging has already become part of clinical 
routine diagnosis. Also, some contrast agents such as SPIO for MPS-labelling 
and scavenger-receptor binding gadolinium chelates are clinically applied for 
liver and lymph node imaging. However, there are still a number of highly 
promising novel tools that are expected to emerge clinically in the near future. 
In this context, the first part of the talk will give an overview on how optical 
imaging basically works and which future clinical applications can be expected. 
In this context, RAMAN spectroscopy, fluorescence optical reflectance 
imaging, fluorescence mediated tomography, photoacoustic imaging and 
Cerenkov luminescence imaging will be addressed. The second part of the talk 
introduces molecular ultrasound imaging as a safe and preclinically well-
evaluated method. Besides the diagnostic use of molecular ultrasound contrast 
agents, which have been already evaluated in clinical trials, the potential of this 
method also for theranostic purposes will be highlighted.  
Learning Objectives:
1. To become familiar with optical imaging techniques and probes. 
2. To learn about the potential of targeted US contrast agents. 
3. To learn about emerging hybrid imaging techniques. 
16:00 - 17:30 Board Room A  
Cardiac  
RC 1903  
Practical approach to cardiovascular risk 
stratification with CT and MRI  
Moderator:  
G.I. Kirova-Nedialkova; Sofia/BG 
A-606 16:00 
A. Modern views on value of coronary calcium scoring for risk 
assessment  
A. Stadler; Vienna/AT (alfred.stadler@meduniwien.ac.at) 
The assessment of the amount of arterial calcification with computed 
tomography is a standard method in the risk stratification of coronary heart 
disease. Coronary calcium detection by CT has been shown to identify 
atherosclerotic plaque and to quantitatively assess coronary calcium. Many 
studies have demonstrated the association between the degree of coronary 
calcium, the burden of atherosclerosis, and the risk for cardiovascular events 
associated with coronary calcium. The CAC scoring can provide individual risk 
assessment and reclassify the low and particularly intermediate Framingham 
risk cohort into lower- and higher-risk strata. The absence of CAC is associated 
with a very low risk of future cardiovascular events, with modest incremental 
value of other diagnostic tests in this very low-risk group. The role of CAC in 
the workup of symptomatic patients is under discussion and there is evidence 
that the absence of CAC has a high negative predictive value for ruling out 
acute coronary syndrome. Although CAC measurement is highly standardised, 
some technical aspects have to be considered and all possibilities of dose 
reductions utilised. This presentation will show the technical and 
epidemiological fundamentals of CAC scoring and discuss the clinical 
applications of the method.  
Learning Objectives:
1. To understand what kind of information calcium scoring can deliver and the 
appropriate indications. 
2. To become familiar with its role in an asymptomatic and in a symptomatic 
population. 
3. To learn about the current data and guidelines supporting its use in the 
assessment of cardiac risk. 
A-607 16:30 
B. Prognostic value of coronary CTA  
R. Vliegenthart; Groningen/NL (r.vliegenthart@umcg.nl) 
Coronary CTA has gained an important role in the evaluation of patients with 
chest pain, suspected of coronary artery disease (CAD). In comparison to 
invasive coronary angiography, coronary CTA with  64-multidetector CT has 
an excellent sensitivity for coronary stenosis. Specificity for stenosis is less 
excellent, but has improved with newer CT generations. The strongest impact 
of coronary CTA has been on the exclusion of stenosis in symptomatic patients 
at low-intermediate pre-test probability. In contrast to invasive angiography, 
coronary CTA yields more information than just the severity of stenosis. 
Coronary CTA also allows determination of plaque types (calcified, non-
calcified, partly calcified) and quantification of the atherosclerotic plaque 
burden. Also, new developments point to the possibility to assess the 
haemodynamic significance of stenosis based on CT density measurements in 
the coronary arteries, or evaluation of myocardial perfusion. Thus, coronary 
CTA yields quantitative imaging biomarkers that could be used for risk 
stratification in the future. Recent studies have shown that whether or not a 
patient has stenosis and plaque, as well as the type and burden of plaque, 
affects the risk of myocardial infarction and mortality. Therefore, the impact of 
coronary CTA imaging biomarkers reaches beyond the mere assessment of 
stenosis for symptomatic treatment and could potentially alter medical 
management of patients for improvement of long-term prognosis.  
Learning Objectives:
1. To understand the accuracy of CTA in the diagnosis of coronary disease. 
2. To become familiar with the strengths and limitations of the various 
quantification techniques. 
3. To appreciate the prognostic value of CTA in coronary disease. 
Author Disclosure:
 R. Vliegenthart: Grant Recipient; Supported by a grant from the Netherlands 
Organisation for Scientific Research. 
A-608 17:00 
C. Added value of carotid and peripheral artery imaging for risk 
assessment  
L. Natale; Rome/IT (lnatale@rm.unicatt.it) 
Technical protocols optimisation of MRA and CTA of carotid and peripheral 
arteries is crucial for image quality and to complete the analysis of both lumen 
and vessel wall. Furthermore, MRA protocol needs to be integrated with 
dedicated pulse sequences in order to obtain vessel wall imaging that is 
already included in CTA datasets. New CT and MR scanners allow this 
optimisation in terms of radiation exposure, contrast media dose reduction and 
spatial resolution. All these parameters will be discussed for both techniques. 
According to international guidelines, non-invasive imaging indications will be 
discussed, with particular attention to high risk population (e.g.: diabetic 
patients). Some possible imaging biomarkers of plaque composition will be 
discussed.  
Learning Objectives:
1. To become familiar with optimal technical considerations for performing CTA 
and MRA of the carotid and peripheral arteries. 
2. To understand clinical indications for carotid and peripheral CTA and MRA. 
3. To discuss the role of CTA and MRA parameters including plaque imaging 
as biomarkers of cardiovascular disease. 
